0001764046-23-000089.txt : 20230807 0001764046-23-000089.hdr.sgml : 20230807 20230807060241 ACCESSION NUMBER: 0001764046-23-000089 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 94 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230807 DATE AS OF CHANGE: 20230807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLARIVATE Plc CENTRAL INDEX KEY: 0001764046 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 000000000 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38911 FILM NUMBER: 231145493 BUSINESS ADDRESS: STREET 1: 1500 SPRING GARDEN STREET CITY: PHILADELPHIA STATE: PA ZIP: 19130 BUSINESS PHONE: (215) 386-0100 MAIL ADDRESS: STREET 1: 1500 SPRING GARDEN STREET CITY: PHILADELPHIA STATE: PA ZIP: 19130 FORMER COMPANY: FORMER CONFORMED NAME: Clarivate Analytics PLC DATE OF NAME CHANGE: 20190108 10-Q 1 clvt-20230630.htm 10-Q clvt-20230630
0001764046falseDecember 312023FY00-000000000017640462023-01-012023-06-300001764046us-gaap:CommonStockMember2023-01-012023-06-300001764046us-gaap:SeriesAPreferredStockMember2023-01-012023-06-300001764046clvt:PreferredStockPurchaseRightsMember2023-01-012023-06-3000017640462023-07-28xbrli:shares00017640462023-06-30iso4217:USD00017640462022-12-31iso4217:USDxbrli:shares00017640462022-01-012022-12-31xbrli:pure00017640462023-04-012023-06-3000017640462022-04-012022-06-3000017640462022-01-012022-06-300001764046us-gaap:CommonStockMember2022-12-310001764046us-gaap:PreferredStockMember2022-12-310001764046us-gaap:TreasuryStockCommonMember2022-12-310001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001764046us-gaap:RetainedEarningsMember2022-12-310001764046us-gaap:CommonStockMember2023-01-012023-03-3100017640462023-01-012023-03-310001764046us-gaap:RetainedEarningsMember2023-01-012023-03-310001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001764046us-gaap:CommonStockMember2023-03-310001764046us-gaap:PreferredStockMember2023-03-310001764046us-gaap:TreasuryStockCommonMember2023-03-310001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001764046us-gaap:RetainedEarningsMember2023-03-3100017640462023-03-310001764046us-gaap:CommonStockMember2023-04-012023-06-300001764046us-gaap:RetainedEarningsMember2023-04-012023-06-300001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001764046us-gaap:CommonStockMember2023-06-300001764046us-gaap:PreferredStockMember2023-06-300001764046us-gaap:TreasuryStockCommonMember2023-06-300001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001764046us-gaap:RetainedEarningsMember2023-06-300001764046us-gaap:CommonStockMember2021-12-310001764046us-gaap:PreferredStockMember2021-12-310001764046us-gaap:TreasuryStockCommonMember2021-12-310001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001764046us-gaap:RetainedEarningsMember2021-12-3100017640462021-12-310001764046us-gaap:CommonStockMember2022-01-012022-03-3100017640462022-01-012022-03-310001764046us-gaap:TreasuryStockCommonMember2022-01-012022-03-310001764046us-gaap:RetainedEarningsMember2022-01-012022-03-310001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001764046us-gaap:CommonStockMember2022-03-310001764046us-gaap:PreferredStockMember2022-03-310001764046us-gaap:TreasuryStockCommonMember2022-03-310001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001764046us-gaap:RetainedEarningsMember2022-03-3100017640462022-03-310001764046us-gaap:CommonStockMember2022-04-012022-06-300001764046us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001764046us-gaap:RetainedEarningsMember2022-04-012022-06-300001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001764046us-gaap:CommonStockMember2022-06-300001764046us-gaap:PreferredStockMember2022-06-300001764046us-gaap:TreasuryStockCommonMember2022-06-300001764046us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001764046us-gaap:RetainedEarningsMember2022-06-3000017640462022-06-300001764046us-gaap:TreasuryStockCommonMember2022-01-012022-06-300001764046us-gaap:SeriesAPreferredStockMember2023-06-300001764046us-gaap:SeriesAPreferredStockMember2022-06-30clvt:segment0001764046us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberclvt:SmallProductGroupWithinIPSegmentMembersrt:ScenarioForecastMember2023-12-310001764046us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberclvt:SmallProductGroupWithinIPSegmentMembersrt:ScenarioForecastMember2023-10-012023-12-310001764046us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:CustomerRelationshipsMemberclvt:SmallProductGroupWithinIPSegmentMember2023-06-300001764046us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberclvt:SmallProductGroupWithinIPSegmentMember2023-06-300001764046us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberclvt:SmallProductGroupWithinIPSegmentMember2023-04-012023-06-300001764046clvt:ComputerHardwareMember2023-06-300001764046clvt:ComputerHardwareMember2022-12-310001764046us-gaap:LeaseholdImprovementsMember2023-06-300001764046us-gaap:LeaseholdImprovementsMember2022-12-310001764046clvt:FurnitureFixturesAndEquipmentMember2023-06-300001764046clvt:FurnitureFixturesAndEquipmentMember2022-12-310001764046us-gaap:PropertyPlantAndEquipmentOtherTypesMember2023-06-300001764046us-gaap:PropertyPlantAndEquipmentOtherTypesMember2022-12-310001764046us-gaap:CustomerRelationshipsMember2023-06-300001764046us-gaap:CustomerRelationshipsMember2022-12-310001764046clvt:DatabasesAndContentMember2023-06-300001764046clvt:DatabasesAndContentMember2022-12-310001764046us-gaap:ComputerSoftwareIntangibleAssetMember2023-06-300001764046us-gaap:ComputerSoftwareIntangibleAssetMember2022-12-310001764046us-gaap:OtherIntangibleAssetsMember2023-06-300001764046us-gaap:OtherIntangibleAssetsMember2022-12-310001764046us-gaap:TradeNamesMember2023-06-300001764046us-gaap:TradeNamesMember2022-12-310001764046clvt:AcademiaGovernmentGroupMember2022-12-310001764046clvt:IntellectualPropertyGroupMember2022-12-310001764046clvt:LifeSciencesAndHealthcareGroupMember2022-12-310001764046clvt:AcademiaGovernmentGroupMember2023-01-012023-06-300001764046clvt:IntellectualPropertyGroupMember2023-04-012023-06-300001764046clvt:LifeSciencesAndHealthcareGroupMember2023-01-012023-06-300001764046clvt:IntellectualPropertyGroupMember2023-01-012023-06-300001764046clvt:AcademiaGovernmentGroupMember2023-06-300001764046clvt:IntellectualPropertyGroupMember2023-06-300001764046clvt:LifeSciencesAndHealthcareGroupMember2023-06-300001764046clvt:InterestRateSwapEffectiveDateMarch312021FixedRate1695Member2023-06-300001764046clvt:InterestRateSwapEffectiveDateApril302021FixedRate1695Member2023-06-300001764046clvt:InterestRateSwapEffectiveDateMarch312021FixedRate0451Member2023-06-300001764046clvt:InterestRateSwapEffectiveDateOctober312022FixedRate0471Member2023-06-300001764046clvt:InterestRateSwapEffectiveDateOctober312022FixedRate0487Member2023-06-300001764046clvt:InterestRateSwapEffectiveDateAugust42022FixedRate2857Member2023-06-300001764046clvt:InterestRateSwapEffectiveDateAugust52022FixedRate3063Member2023-06-300001764046us-gaap:InterestRateSwapMember2023-06-300001764046us-gaap:InterestRateSwapMember2022-12-310001764046srt:MaximumMemberus-gaap:ForeignExchangeContractMember2023-04-012023-06-300001764046us-gaap:ForeignExchangeContractMember2023-04-012023-06-300001764046us-gaap:ForeignExchangeContractMember2022-04-012022-06-300001764046us-gaap:ForeignExchangeContractMember2023-01-012023-06-300001764046us-gaap:ForeignExchangeContractMember2022-01-012022-06-300001764046srt:ScenarioPreviouslyReportedMemberus-gaap:ForeignExchangeContractMember2022-04-012022-06-300001764046srt:ScenarioPreviouslyReportedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-06-300001764046us-gaap:ForeignExchangeContractMember2023-06-300001764046us-gaap:ForeignExchangeContractMember2022-12-310001764046us-gaap:ForeignExchangeForwardMember2023-06-300001764046us-gaap:ForeignExchangeForwardMember2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Member2023-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2023-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2023-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2023-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-06-300001764046us-gaap:FairValueMeasurementsRecurringMember2023-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel2Member2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMember2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-01-012023-03-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-03-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-03-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2023-04-012023-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-04-012022-06-300001764046us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300001764046clvt:NewSeniorUnsecuredNotes2029Member2023-06-300001764046clvt:NewSeniorUnsecuredNotes2029Member2022-12-310001764046clvt:NewSeniorSecuredNotes2028Member2023-06-300001764046clvt:NewSeniorSecuredNotes2028Member2022-12-310001764046us-gaap:RevolvingCreditFacilityMember2023-06-300001764046us-gaap:RevolvingCreditFacilityMember2022-12-310001764046clvt:TermLoanFacilityMember2023-06-300001764046clvt:TermLoanFacilityMember2022-12-310001764046clvt:SeniorSecuredNotes2026Member2023-06-300001764046clvt:SeniorSecuredNotes2026Member2022-12-310001764046us-gaap:LetterOfCreditMember2023-06-300001764046us-gaap:RevolvingCreditFacilityMember2023-06-300001764046clvt:SeniorUnsecuredNotesMember2023-06-300001764046us-gaap:LetterOfCreditMember2023-06-300001764046clvt:TermLoanFacilityMember2022-10-012022-12-310001764046clvt:TermLoanFacilityMember2023-01-012023-06-300001764046clvt:SubscriptionRevenuesMember2023-04-012023-06-300001764046clvt:SubscriptionRevenuesMember2022-04-012022-06-300001764046clvt:ReOccurringRevenuesMember2023-04-012023-06-300001764046clvt:ReOccurringRevenuesMember2022-04-012022-06-300001764046clvt:TransactionRevenuesMember2023-04-012023-06-300001764046clvt:TransactionRevenuesMember2022-04-012022-06-300001764046clvt:SubscriptionRevenuesMember2023-01-012023-06-300001764046clvt:SubscriptionRevenuesMember2022-01-012022-06-300001764046clvt:ReOccurringRevenuesMember2023-01-012023-06-300001764046clvt:ReOccurringRevenuesMember2022-01-012022-06-300001764046clvt:TransactionRevenuesMember2023-01-012023-06-300001764046clvt:TransactionRevenuesMember2022-01-012022-06-300001764046srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember2023-01-012023-03-3100017640462023-07-012023-06-300001764046us-gaap:SeriesAPreferredStockMember2021-06-012021-06-300001764046us-gaap:SeriesAPreferredStockMemberus-gaap:OverAllotmentOptionMember2021-06-012021-06-3000017640462021-10-012021-10-010001764046us-gaap:RetainedEarningsMember2022-01-012022-06-3000017640462022-02-0700017640462023-05-240001764046clvt:OpenMarketPurchasesMemberus-gaap:SubsequentEventMember2023-07-270001764046srt:MinimumMemberclvt:OpenMarketPurchasesMemberus-gaap:SubsequentEventMember2023-07-272023-07-270001764046srt:MaximumMemberclvt:OpenMarketPurchasesMemberus-gaap:SubsequentEventMember2023-07-272023-07-270001764046us-gaap:CostOfSalesMemberus-gaap:EmployeeStockOptionMember2023-04-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PerformanceSharesMember2023-04-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PhantomShareUnitsPSUsMember2023-04-012023-06-300001764046us-gaap:CostOfSalesMember2023-04-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2023-04-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2023-04-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PhantomShareUnitsPSUsMember2023-04-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-04-012023-06-300001764046us-gaap:EmployeeStockOptionMember2023-04-012023-06-300001764046us-gaap:RestrictedStockUnitsRSUMember2023-04-012023-06-300001764046us-gaap:PerformanceSharesMember2023-04-012023-06-300001764046us-gaap:PhantomShareUnitsPSUsMember2023-04-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:EmployeeStockOptionMember2023-01-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PerformanceSharesMember2023-01-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PhantomShareUnitsPSUsMember2023-01-012023-06-300001764046us-gaap:CostOfSalesMember2023-01-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2023-01-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2023-01-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PhantomShareUnitsPSUsMember2023-01-012023-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-06-300001764046us-gaap:EmployeeStockOptionMember2023-01-012023-06-300001764046us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-06-300001764046us-gaap:PerformanceSharesMember2023-01-012023-06-300001764046us-gaap:PhantomShareUnitsPSUsMember2023-01-012023-06-300001764046us-gaap:CostOfSalesMemberus-gaap:EmployeeStockOptionMember2022-04-012022-06-300001764046us-gaap:CostOfSalesMemberus-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PerformanceSharesMember2022-04-012022-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PhantomShareUnitsPSUsMember2022-04-012022-06-300001764046us-gaap:CostOfSalesMember2022-04-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2022-04-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2022-04-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PhantomShareUnitsPSUsMember2022-04-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012022-06-300001764046us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001764046us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001764046us-gaap:PerformanceSharesMember2022-04-012022-06-300001764046us-gaap:PhantomShareUnitsPSUsMember2022-04-012022-06-300001764046us-gaap:CostOfSalesMemberus-gaap:EmployeeStockOptionMember2022-01-012022-06-300001764046us-gaap:CostOfSalesMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PerformanceSharesMember2022-01-012022-06-300001764046us-gaap:CostOfSalesMemberus-gaap:PhantomShareUnitsPSUsMember2022-01-012022-06-300001764046us-gaap:CostOfSalesMember2022-01-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:EmployeeStockOptionMember2022-01-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PerformanceSharesMember2022-01-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:PhantomShareUnitsPSUsMember2022-01-012022-06-300001764046us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-06-300001764046us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001764046us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001764046us-gaap:PerformanceSharesMember2022-01-012022-06-300001764046us-gaap:PhantomShareUnitsPSUsMember2022-01-012022-06-300001764046us-gaap:EmployeeStockOptionMember2022-12-310001764046us-gaap:RestrictedStockUnitsRSUMember2022-12-310001764046us-gaap:PerformanceSharesMember2022-12-310001764046us-gaap:EmployeeStockOptionMember2023-06-300001764046us-gaap:RestrictedStockUnitsRSUMember2023-06-300001764046us-gaap:PerformanceSharesMember2023-06-300001764046us-gaap:EmployeeStockOptionMember2021-12-310001764046us-gaap:RestrictedStockUnitsRSUMember2021-12-310001764046us-gaap:PerformanceSharesMember2021-12-310001764046us-gaap:EmployeeStockOptionMember2022-06-300001764046us-gaap:RestrictedStockUnitsRSUMember2022-06-300001764046us-gaap:PerformanceSharesMember2022-06-300001764046clvt:WarrantAndShareBasedPaymentArrangementMember2023-01-012023-06-300001764046clvt:WarrantAndShareBasedPaymentArrangementMember2022-01-012022-06-300001764046clvt:WarrantAndShareBasedPaymentArrangementMember2023-04-012023-06-300001764046clvt:WarrantAndShareBasedPaymentArrangementMember2022-04-012022-06-300001764046us-gaap:SeriesAPreferredStockMember2023-01-012023-06-300001764046clvt:AcademiaGovernmentGroupMember2023-04-012023-06-300001764046clvt:AcademiaGovernmentGroupMember2022-04-012022-06-300001764046clvt:AcademiaGovernmentGroupMember2022-01-012022-06-300001764046clvt:IntellectualPropertyGroupMember2022-04-012022-06-300001764046clvt:IntellectualPropertyGroupMember2022-01-012022-06-300001764046clvt:LifeSciencesAndHealthcareGroupMember2023-04-012023-06-300001764046clvt:LifeSciencesAndHealthcareGroupMember2022-04-012022-06-300001764046clvt:LifeSciencesAndHealthcareGroupMember2022-01-012022-06-300001764046clvt:OneOfTheLargerLegalClaimsMember2023-01-012023-06-300001764046clvt:ProQuestMember2021-12-012021-12-010001764046srt:AffiliatedEntityMember2023-04-012023-06-300001764046srt:AffiliatedEntityMember2023-01-012023-06-300001764046srt:AffiliatedEntityMember2023-06-300001764046srt:DirectorMember2023-04-012023-06-300001764046srt:DirectorMember2022-04-012022-06-300001764046srt:DirectorMember2023-01-012023-06-300001764046srt:DirectorMember2022-01-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:OneClarivateProgramMember2023-04-012023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:OneClarivateProgramMember2022-04-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:OneClarivateProgramMember2023-01-012023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:OneClarivateProgramMember2022-01-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:SeveranceAndRelatedBenefitCostMember2023-04-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:SeveranceAndRelatedBenefitCostMember2022-04-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:SeveranceAndRelatedBenefitCostMember2023-01-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:SeveranceAndRelatedBenefitCostMember2022-01-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:SegmentOptimizationProgramMember2023-04-012023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:SegmentOptimizationProgramMember2022-04-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:SegmentOptimizationProgramMember2023-01-012023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMemberclvt:SegmentOptimizationProgramMember2022-01-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:SeveranceAndRelatedBenefitCostMember2023-04-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:SeveranceAndRelatedBenefitCostMember2022-04-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:SeveranceAndRelatedBenefitCostMember2023-01-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:SeveranceAndRelatedBenefitCostMember2022-01-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2023-04-012023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2022-04-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2023-01-012023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2022-01-012022-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:OneClarivateProgramMember2023-04-012023-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:OneClarivateProgramMember2022-04-012022-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:OneClarivateProgramMember2023-01-012023-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:OneClarivateProgramMember2022-01-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:ExitAndDisposalCostsMember2023-04-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:ExitAndDisposalCostsMember2022-04-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:ExitAndDisposalCostsMember2023-01-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:ExitAndDisposalCostsMember2022-01-012022-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:SegmentOptimizationProgramMember2023-04-012023-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:SegmentOptimizationProgramMember2022-04-012022-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:SegmentOptimizationProgramMember2023-01-012023-06-300001764046clvt:ExitAndDisposalCostsMemberclvt:SegmentOptimizationProgramMember2022-01-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:ExitAndDisposalCostsMember2023-04-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:ExitAndDisposalCostsMember2022-04-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:ExitAndDisposalCostsMember2023-01-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:ExitAndDisposalCostsMember2022-01-012022-06-300001764046clvt:ExitAndDisposalCostsMember2023-04-012023-06-300001764046clvt:ExitAndDisposalCostsMember2022-04-012022-06-300001764046clvt:ExitAndDisposalCostsMember2023-01-012023-06-300001764046clvt:ExitAndDisposalCostsMember2022-01-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OneClarivateProgramMember2023-04-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OneClarivateProgramMember2022-04-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OneClarivateProgramMember2023-01-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OneClarivateProgramMember2022-01-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:ProQuestAcquisitionIntegrationProgramMember2023-04-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:ProQuestAcquisitionIntegrationProgramMember2022-04-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:ProQuestAcquisitionIntegrationProgramMember2023-01-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:ProQuestAcquisitionIntegrationProgramMember2022-01-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:SegmentOptimizationProgramMember2023-04-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:SegmentOptimizationProgramMember2022-04-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:SegmentOptimizationProgramMember2023-01-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:SegmentOptimizationProgramMember2022-01-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OtherRestructuringProgramsMember2023-04-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OtherRestructuringProgramsMember2022-04-012022-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OtherRestructuringProgramsMember2023-01-012023-06-300001764046clvt:LeaseAbandonmentCostsMemberclvt:OtherRestructuringProgramsMember2022-01-012022-06-300001764046clvt:LeaseAbandonmentCostsMember2023-04-012023-06-300001764046clvt:LeaseAbandonmentCostsMember2022-04-012022-06-300001764046clvt:LeaseAbandonmentCostsMember2023-01-012023-06-300001764046clvt:LeaseAbandonmentCostsMember2022-01-012022-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:OneClarivateProgramMember2023-04-012023-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:OneClarivateProgramMember2022-04-012022-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:OneClarivateProgramMember2023-01-012023-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:OneClarivateProgramMember2022-01-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:AcademiaGovernmentGroupMember2023-04-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:AcademiaGovernmentGroupMember2022-04-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:AcademiaGovernmentGroupMember2023-01-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:AcademiaGovernmentGroupMember2022-01-012022-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:SegmentOptimizationProgramMember2023-04-012023-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:SegmentOptimizationProgramMember2022-04-012022-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:SegmentOptimizationProgramMember2023-01-012023-06-300001764046clvt:AcademiaGovernmentGroupMemberclvt:SegmentOptimizationProgramMember2022-01-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:AcademiaGovernmentGroupMember2023-04-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:AcademiaGovernmentGroupMember2022-04-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:AcademiaGovernmentGroupMember2023-01-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:AcademiaGovernmentGroupMember2022-01-012022-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:OneClarivateProgramMember2023-04-012023-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:OneClarivateProgramMember2022-04-012022-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:OneClarivateProgramMember2023-01-012023-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:OneClarivateProgramMember2022-01-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:IntellectualPropertyGroupMember2023-04-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:IntellectualPropertyGroupMember2022-04-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:IntellectualPropertyGroupMember2023-01-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:IntellectualPropertyGroupMember2022-01-012022-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:SegmentOptimizationProgramMember2023-04-012023-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:SegmentOptimizationProgramMember2022-04-012022-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:SegmentOptimizationProgramMember2023-01-012023-06-300001764046clvt:IntellectualPropertyGroupMemberclvt:SegmentOptimizationProgramMember2022-01-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:IntellectualPropertyGroupMember2023-04-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:IntellectualPropertyGroupMember2022-04-012022-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:IntellectualPropertyGroupMember2023-01-012023-06-300001764046clvt:OtherRestructuringProgramsMemberclvt:IntellectualPropertyGroupMember2022-01-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OneClarivateProgramMember2023-04-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OneClarivateProgramMember2022-04-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OneClarivateProgramMember2023-01-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OneClarivateProgramMember2022-01-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:LifeScienceAndHealthcareGroupMember2023-04-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:LifeScienceAndHealthcareGroupMember2022-04-012022-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:LifeScienceAndHealthcareGroupMember2023-01-012023-06-300001764046clvt:ProQuestAcquisitionIntegrationProgramMemberclvt:LifeScienceAndHealthcareGroupMember2022-01-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:SegmentOptimizationProgramMember2023-04-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:SegmentOptimizationProgramMember2022-04-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:SegmentOptimizationProgramMember2023-01-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:SegmentOptimizationProgramMember2022-01-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OtherRestructuringProgramsMember2023-04-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OtherRestructuringProgramsMember2022-04-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OtherRestructuringProgramsMember2023-01-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMemberclvt:OtherRestructuringProgramsMember2022-01-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMember2023-04-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMember2022-04-012022-06-300001764046clvt:LifeScienceAndHealthcareGroupMember2023-01-012023-06-300001764046clvt:LifeScienceAndHealthcareGroupMember2022-01-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2022-12-310001764046clvt:ExitDisposalAndAbandonmentCostsMember2022-12-310001764046clvt:ExitDisposalAndAbandonmentCostsMember2023-01-012023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2023-06-300001764046clvt:ExitDisposalAndAbandonmentCostsMember2023-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2021-12-310001764046clvt:ExitDisposalAndAbandonmentCostsMember2021-12-310001764046clvt:ExitDisposalAndAbandonmentCostsMember2022-01-012022-06-300001764046clvt:SeveranceAndRelatedBenefitCostMember2022-06-300001764046clvt:ExitDisposalAndAbandonmentCostsMember2022-06-300001764046us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CurrencySwapMemberus-gaap:SubsequentEventMember2023-07-12iso4217:EUR

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________ to _______
Commission File No. 001-38911
CLARIVATE PLC
(Exact name of registrant as specified in its charter)
Jersey, Channel Islands
N/A
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
70 St. Mary Axe
London EC3A 8BE
United Kingdom
(Address of principal executive offices)
Not applicable
(Zip Code)
Registrant's telephone number, including area code: +44 207 4334000
Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each classTrading Symbol(s)Name of exchange on which registered
Ordinary Shares, no par valueCLVTNew York Stock Exchange
5.25% Series A Mandatory Convertible Preferred Shares, no par valueCLVT PR ANew York Stock Exchange
Series B Preferred Stock Purchase Rights-New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Exchange Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,”



“accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).    Yes     No 
The number of ordinary shares of the Company outstanding as of August 4, 2023, was 676,234,313.



TABLE OF CONTENTS
2

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This quarterly report includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements,” within the meaning of the "safe harbor provisions" of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will”, or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this quarterly report and include statements regarding our intentions, beliefs, or current expectations concerning, among other things, anticipated cost savings, results of operations, financial condition, liquidity, prospects, growth, strategies, and the markets in which we operate. Such forward-looking statements are based on available current market material and management’s expectations, beliefs, and forecasts concerning future events impacting us. Factors that may impact such forward-looking statements include:
any significant disruption in or unauthorized access to our computer systems or those of third parties that we utilize in our operations, including those relating to cybersecurity or arising from cyber-attacks;
our ability to maintain revenues if our products and services do not achieve and maintain broad market acceptance, or if we are unable to keep pace with or adapt to rapidly changing technology, evolving industry standards, macroeconomic market conditions, and changing regulatory requirements;
our loss of, or inability to attract and retain, key personnel;
our ability to comply with applicable data protection and privacy laws;
the effectiveness of our business continuity plans;
our dependence on third parties, including public sources, for data, information and other services, and our relationships with such third parties;
increased accessibility to free or relatively inexpensive information sources;
our ability to derive fully the anticipated benefits from organic growth, existing or future acquisitions, joint ventures, investments, or dispositions;
our ability to compete in the highly competitive industry in which we operate, and potential adverse effects of this competition;
our ability to maintain high annual renewal rates;
the strength of our brand and reputation;
our exposure to risk from the international scope of our operations, and our exposure to potentially adverse tax consequences from the international scope of our operations and our corporate and financing structure;
our substantial indebtedness, which could adversely affect our business, financial condition, and results of operations;
volatility in our earnings due to changes in the fair value of our outstanding warrants each period; and
other factors beyond our control.
The forward-looking statements contained in this quarterly report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under the heading “Item 1A. Risk Factors.” Should one or more of
3

these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We will not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Note on Defined Terms and Presentation
We employ a number of defined terms in this quarterly report for clarity and ease of reference, which we have capitalized so that you may recognize them as such. As used throughout this quarterly report, unless otherwise indicated or the context otherwise requires, the terms “Clarivate,” the “Company,” “our,” “us”, and “we” refer to Clarivate Plc and its consolidated subsidiaries; “LGP” refers to affiliated funds of Leonard Green & Partners, L.P. that from time to time hold our ordinary shares; "CIG" refers to affiliate funds of Cambridge Information Group that from time to time hold our ordinary shares; and "Atairos" refers to the affiliates of Atairos that from time to time hold our ordinary shares.
Unless otherwise indicated, dollar amounts throughout this quarterly report are presented in millions of dollars, except for share and per share amounts.
Website and Social Media Disclosure
We use our website (www.clarivate.com) and corporate social media accounts on Twitter and LinkedIn (@Clarivate) as routine channels of distribution of company information, including news releases, analyst presentations, and supplemental financial information, as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD promulgated by the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Accordingly, investors should monitor our website and our corporate Twitter and LinkedIn accounts in addition to following press releases, SEC filings, and public conference calls and webcasts. Additionally, we provide notifications of news or announcements as part of our investor relations website. Investors and others can receive notifications of new information posted on our investor relations website in real time by signing up for email alerts.
None of the information provided on our website, in our press releases, public conference calls, and webcasts, or through social media channels is incorporated into, or deemed to be a part of, this quarterly report or in any other report or document we file with the SEC, and any references to our website or our social media channels are intended to be inactive textual references only.


4

PART I. Financial Information

Item 1. Financial Statements and Supplementary Data

CLARIVATE PLC
Condensed Consolidated Balance Sheets (Unaudited)
(In millions)
June 30, 2023December 31, 2022
Assets
Current assets:
Cash and cash equivalents$436.1 $348.8 
Restricted cash7.0 8.0 
Accounts receivable, net769.7 872.1 
Prepaid expenses101.9 89.4 
Other current assets76.8 76.9 
Assets held for sale26.1 0.0 
Total current assets1,417.6 1,395.2 
Property and equipment, net50.7 54.5 
Other intangible assets, net9,186.4 9,437.7 
Goodwill2,895.5 2,876.5 
Other non-current assets76.0 97.9 
Deferred income taxes26.5 24.2 
Operating lease right-of-use assets52.9 58.9 
Total Assets$13,705.6 $13,944.9 
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable$108.2 $101.4 
Accrued compensation101.2 132.1 
Accrued expenses and other current liabilities317.1 352.1 
Current portion of deferred revenues939.6 947.5 
Current portion of operating lease liability24.2 25.7 
Current portion of long-term debt1.1 1.0 
Liabilities held for sale6.5 0.0 
Total current liabilities1,497.9 1,559.8 
Long-term debt4,863.2 5,005.0 
Non-current portion of deferred revenues37.9 38.5 
Other non-current liabilities41.4 140.1 
Deferred income taxes262.1 316.1 
Operating lease liabilities64.8 72.9 
Total liabilities6,767.3 7,132.4 
Commitments and contingencies (Note 17)
Shareholders’ equity:
Preferred Shares, no par value; 14.4 shares authorized; 5.25% Mandatory Convertible Preferred Shares, Series A, 14.4 shares issued and outstanding as of both June 30, 2023 and December 31, 2022
1,392.6 1,392.6 
Ordinary Shares, no par value; unlimited shares authorized as of June 30, 2023 and December 31, 2022; 676.1 and 674.4 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively
11,809.2 11,744.7 
Accumulated other comprehensive loss(487.6)(665.9)
Accumulated deficit(5,775.9)(5,658.9)
Total shareholders’ equity6,938.3 6,812.5 
Total Liabilities and Shareholders’ Equity$13,705.6 $13,944.9 
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
5

CLARIVATE PLC
Condensed Consolidated Statements of Operations (Unaudited)
(In millions, except per share data)
Three Months Ended June 30,
20232022
Revenues, net$668.8 $686.6 
Operating expenses:
Cost of revenues224.2 244.1 
Selling, general and administrative costs192.9 186.1 
Depreciation and amortization178.1 175.6 
Restructuring and lease impairments12.2 19.2 
Goodwill and intangible asset impairments135.2  
Other operating expense (income), net14.5 (24.6)
Total operating expenses757.1 600.4 
(Loss) income from operations(88.3)86.2 
Mark to market gain on financial instruments(2.9)(49.0)
Interest expense and amortization of debt discount, net73.0 62.3 
(Loss) income before income taxes(158.4)72.9 
(Benefit) provision for income taxes(35.3)10.5 
Net (loss) income(123.1)62.4 
Dividends on preferred shares18.6 18.7 
Net (loss) income attributable to ordinary shares$(141.7)$43.7 
Per share:
Basic$(0.21)$0.06 
Diluted$(0.21)$0.00 
Weighted average shares used to compute earnings per share:
Basic675.9 674.3 
Diluted675.9 678.4 
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
6

CLARIVATE PLC
Condensed Consolidated Statements of Operations (Unaudited)
(In millions, except per share data)
Six Months Ended June 30,
20232022
Revenues, net$1,297.9 $1,348.8 
Operating expenses:
Cost of revenues453.9 493.3 
Selling, general and administrative costs387.7 379.8 
Depreciation and amortization350.7 352.0 
Restructuring and lease impairments21.6 30.9 
Goodwill and intangible asset impairments135.2  
Other operating income, net(17.5)(38.3)
Total operating expenses1,331.6 1,217.7 
(Loss) income from operations(33.7)131.1 
Mark to market gain on financial instruments(1.8)(149.4)
Interest expense and amortization of debt discount, net146.6 121.8 
(Loss) income before income taxes(178.5)158.7 
(Benefit) provision for income taxes(98.9)26.8 
Net (loss) income(79.6)131.9 
Dividends on preferred shares37.4 37.4 
Net (loss) income attributable to ordinary shares$(117.0)$94.5 
Per share:
Basic$(0.17)$0.14 
Diluted$(0.17)$(0.07)
Weighted average shares used to compute earnings per share:
Basic675.4 678.3 
Diluted675.4 683.2 
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.


7

CLARIVATE PLC
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
(In millions)

Three Months Ended June 30,
20232022
Net (loss) income$(123.1)$62.4 
Other comprehensive income (loss), net of tax:
Interest rate swaps7.3 3.9 
Foreign currency translation adjustment82.6 (626.6)
Total other comprehensive income (loss), net of tax89.9 (622.7)
Comprehensive loss$(33.2)$(560.3)

Six Months Ended June 30,
20232022
Net (loss) income$(79.6)$131.9 
Other comprehensive income (loss), net of tax:
Interest rate swaps(5.1)15.8 
Foreign currency translation adjustment183.4 (861.7)
Total other comprehensive income (loss), net of tax178.3 (845.9)
Comprehensive income (loss)$98.7 $(714.0)
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.


8

CLARIVATE PLC
Condensed Consolidated Statements of Changes in Equity (Unaudited)
(In millions)
Ordinary SharesPreferred SharesTreasury SharesAccumulated
Other
Comprehensive
Income (Loss)
Accumulated
Deficit
Total
Shareholders’
 Equity
SharesAmountSharesAmountSharesAmount
Balance at December 31, 2022674.4$11,744.714.4$1,392.6$$(665.9)$(5,658.9)$6,812.5
Vesting of restricted stock units1.8 — — — — — — — — 
Share-based award activity(0.6)33.7 — — — — — — 33.7 
Dividends to preferred shareholders— — — — — — — (18.8)(18.8)
Net income— — — — — — — 43.5 43.5 
Other comprehensive income— — — — — — 88.4 — 88.4 
Balance at March 31, 2023675.6 $11,778.4 14.4 $1,392.6  $ $(577.5)$(5,634.2)$6,959.3 
Vesting of restricted stock units0.8 — — — — — — — — 
Share-based award activity(0.3)30.8 — — — — — — 30.8 
Dividends to preferred shareholders— — — — — — — (18.6)(18.6)
Net loss— — — — — — — (123.1)(123.1)
Other comprehensive income— — — — — — 89.9 — 89.9 
Balance at June 30, 2023676.1 $11,809.2 14.4 $1,392.6  $ $(487.6)$(5,775.9)$6,938.3 
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
9

CLARIVATE PLC
Condensed Consolidated Statements of Changes in Equity (Unaudited)
(In millions)
Ordinary SharesPreferred SharesTreasury SharesAccumulated
Other
Comprehensive
Income (Loss)
Accumulated
Deficit
Total
Shareholders’
 Equity
SharesAmountSharesAmountSharesAmount
Balance at December 31, 2021683.1 $11,827.9 14.4$1,392.6 0.5 $(16.9)$326.7 $(1,604.4)$11,925.9 
Reclassification of EBT Shares(0.5)— — — — — — — 
Exercise of stock options0.2 0.4 — — — — — 0.4 
Vesting of restricted stock units0.7 — — — — — — — 
Share-based award activity(0.4)21.5 — — — — — 21.5 
Repurchases of ordinary shares(4.1)— 4.1 (66.4)— — (66.4)
Retirement of treasury shares— (34.8)— (2.1)33.3 — 1.5 — 
Sale of treasury shares— — —  1.3 — (0.7)0.6 
Dividends to preferred shareholders— — — — — — (18.7)(18.7)
Net income— — — — — — 69.5 69.5 
Other comprehensive loss— — — — — (223.2)— (223.2)
Balance at March 31, 2022679.0 $11,815.0 14.4 $1,392.6 2.5 $(48.7)$103.5 $(1,552.8)$11,709.6 
Exercise of stock options 0.1 — — — — — 0.1 
Vesting of restricted stock units1.3 — — — — — — — 
Share-based award activity(0.4)18.3 — — — — — 18.3 
Repurchases of ordinary shares(6.6)— — 6.6 (108.6)— — (108.6)
Retirement of treasury shares (132.5)— (8.6)141.7 — (9.2)— 
Sale of treasury shares — —   — 0.3 0.3 
Dividends to preferred shareholders  — — — — (18.7)(18.7)
Net income— — — — — — 62.4 62.4 
Other comprehensive loss— — — — — (622.7)— (622.7)
Balance at June 30, 2022673.3 $11,700.9 14.4 $1,392.6 0.5 $(15.6)$(519.2)$(1,518.0)$11,040.7 
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
10

CLARIVATE PLC
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)

Six Months Ended June 30,
20232022
Cash Flows From Operating Activities
Net (loss) income$(79.6)$131.9 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization350.7 352.0 
Share-based compensation71.6 47.2 
Restructuring and impairments138.7 (1.0)
Mark to market gain on financial instruments(1.8)(149.4)
Amortization of debt issuance costs9.1 7.6 
Gain on legal settlement(49.4) 
Deferred income taxes(47.8)(0.9)
Other operating activities18.8 (33.6)
Changes in operating assets and liabilities:
Accounts receivable121.7 53.8 
Prepaid expenses(11.9)(26.9)
Other assets38.6 (24.8)
Accounts payable6.2 (8.8)
Accrued expenses and other current liabilities(74.2)(150.3)
Deferred revenues(18.4)(29.5)
Operating leases, net(4.5)3.4 
Other liabilities(77.9)(6.1)
Net cash provided by operating activities$389.9 $164.6 
Cash Flows From Investing Activities
Capital expenditures(116.9)(89.1)
Payments for acquisitions and cost method investments, net of cash acquired(1.1)(14.3)
Proceeds from divestitures, net of cash and restricted cash10.5  
Net cash used in investing activities$(107.5)$(103.4)
Cash Flows From Financing Activities
Principal payments on term loan(150.0)(14.3)
Payment of debt issuance costs and discounts0.1 (2.1)
Proceeds from issuance of treasury shares 0.9 
Repurchases of ordinary shares (175.0)
Cash dividends on preferred shares(37.7)(37.7)
Proceeds from stock options exercised 0.5 
Payments related to finance lease(0.5)(1.0)
Payments related to tax withholding for stock-based compensation(9.7)(10.7)
Net cash used in financing activities$(197.8)$(239.4)
Effects of exchange rates1.7 (36.5)
Net increase (decrease) in cash and cash equivalents87.3 (71.2)
Net decrease in restricted cash(1.0)(143.5)
Net increase (decrease) in cash and cash equivalents, and restricted cash$86.3 $(214.7)
Beginning of period:
Cash and cash equivalents348.8 430.9 
Restricted cash8.0 156.7 
Total cash and cash equivalents, and restricted cash, beginning of period$356.8 $587.6 
11

CLARIVATE PLC
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In millions)
Six Months Ended June 30,
20232022
End of period:
Cash and cash equivalents436.1 359.7 
Restricted cash7.0 13.2 
Total cash and cash equivalents, and restricted cash, end of period$443.1 $372.9 
Supplemental Cash Flow Information:
Cash paid for interest136.4 113.4 
Cash paid for income tax22.5 23.7 
Capital expenditures included in accounts payable10.3 23.8 
Non-Cash Financing Activities:
Retirement of treasury shares (175.0)
Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares
6.2 6.2 
Total Non-Cash Financing Activities$6.2 $(168.8)

    
The accompanying Notes are an integral part of these Condensed Consolidated Financial Statements.
12

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)

Note 1: Background and Nature of Operations
Clarivate Plc (“Clarivate,” “us,” “we,” “our,” or the “Company”), is a public limited company organized under the laws of Jersey, Channel Islands, pursuant to the definitive agreement entered into on May 13, 2019 to effect a merger between Camelot Holdings (Jersey) Limited ("Jersey") and Churchill Capital Corp, a Delaware corporation ("Churchill") (the “2019 Transaction”).
The Company is a provider of proprietary and comprehensive information, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science and healthcare companies, corporations and law firms to power the entire innovation lifecycle, from cultivating curiosity to protecting the world's critical intellectual property assets. Clarivate has three reportable segments: Academia & Government ("A&G"), Intellectual Property ("IP"), and Life Sciences & Healthcare ("LS&H"). Our segment structure is organized based on the products we offer and the markets they serve. See Note 16 - Segment Information, for additional information on the Company's reportable segments.

Note 2: Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements of the Company have been prepared on substantially the same basis as our annual consolidated financial statements and should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022. Results from interim periods should not be considered indicative of results for the full year. In the opinion of management, these Condensed Consolidated Financial Statements reflect all adjustments necessary for a fair statement of financial position, results of operations, and cash flows for the periods presented, and such adjustments are of a normal, recurring nature.
The Condensed Consolidated Financial Statements of the Company include the accounts of all of its subsidiaries. Subsidiaries are entities over which the Company has control, where control is defined as the power to govern financial and operating policies. Generally, the Company has a shareholding of more than 50% of the voting rights in its subsidiaries. The effect of potential voting rights that are currently exercisable is considered when assessing whether control exists. Subsidiaries are fully consolidated from the date control is transferred to the Company, and are de-consolidated from the date control ceases. Intercompany accounts and transactions have been eliminated in consolidation.

Note 3: Summary of Significant Accounting Policies
Our significant accounting policies are those that we believe are important to the portrayal of our financial condition and results of operations, as well as those that involve significant judgments or estimates about matters that are inherently uncertain. There have been no material changes to the significant accounting policies discussed in Item 8. Financial Statements and Supplementary Data – Notes to the Consolidated Financial Statements – Note 3 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 1, 2023.
Newly Adopted Accounting Standards
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform between March 12, 2020 and December 31, 2022. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides additional optional guidance on the transition from LIBOR to include derivative instruments that use an interest rate for margining, discounting or contract price alignment. The standard will ease, if warranted, the requirements for accounting for the future effects of the rate reform. Additionally, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform: Deferral of the Sunset Date of Topic 848, which deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024 to align with the amended cessation date of LIBOR. In 2020, the Company adopted ASU 2020-04, and, upon meeting the specified criteria in the guidance, elected the optional expedients for its interest rate swaps and debt agreements with reference to LIBOR. Accordingly, the Company has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt agreements. ASU 2021-01 and ASU 2022-06 did not have an effect on how
13

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
the Company accounts for its interest rate swaps and debt agreements due to our election and application of the optional expedients discussed above in connection with ASU 2020-04.
During the second quarter of 2023, the Company modified the contractual terms of its interest rate swaps and debt agreements to replace the previous LIBOR-based reference rate with the Term SOFR (Secured Overnight Financing Rate). The Company utilized the practical expedients set forth in Topic 848 and has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt instruments.
Recently Issued Accounting Standards
There were no other new accounting standards or updates issued or effective as of June 30, 2023, that have, or are expected to have, a material impact on the Company's Condensed Consolidated Financial Statements.

Note 4: Assets Held for Sale and Divested Operations
During the second quarter 2023, the Company entered into a commercial agreement to sell a small product group within its IP segment for approximately $34 payable over ten years. The divestiture enables improved focus on our core IP business assets and empowers product development and innovation teams to build upon our market-leading IP intelligence, IP lifecycle management and IP services solutions. The transaction, which is expected to close during the fourth quarter of 2023, does not represent a strategic shift, nor is it expected to have a material impact on the Company’s operations or financial results. Accordingly, the divestiture meets the held-for-sale criteria but does not qualify as a discontinued operation as of June 30, 2023.
Prior to the held-for-sale determination and accompanying impairment testing as of June 30, 2023, the carrying amount of the expected assets to be disposed of consisted almost entirely of purchase-related identifiable customer relationship intangible assets of approximately $158. These intangible assets were reduced to estimated fair value of $26.1 based on the estimated present value of the consideration to be paid over ten years and were reclassified to Assets held-for-sale on the Condensed Consolidated Balance Sheet as of June 30, 2023. The related impairment charge of $132.2 is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. The carrying amount of the expected liabilities to be transferred consisted of the remaining deferred tax liabilities associated with those intangibles of $6.5, which were reclassified to Liabilities held-for-sale on the Condensed Consolidated Balance Sheet as of June 30, 2023.
On October 31, 2022, the Company completed the sale of the MarkMonitor Domain Management business (IP segment) to Newfold Digital, a leading web presence solutions provider. During the second quarter 2023, the Company received the $10.5 of deferred closing consideration included in the aggregate sale price.

Note 5: Property and Equipment, Net
Property and equipment, net consisted of the following:
June 30,December 31,
20232022
Computer hardware$49.3 $45.1 
Leasehold improvements15.6 16.1 
Furniture, fixtures and equipment42.0 39.0 
Capital office leases - finance lease asset8.0 8.0 
Other2.2 2.1 
Total property and equipment, gross$117.1 $110.3 
Accumulated depreciation(66.4)(55.8)
Total property and equipment, net$50.7 $54.5 
14

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Depreciation expense was $5.4 and $9.8 for the three months ended June 30, 2023 and 2022, respectively, and $11.3 and $20.4 for the six months ended June 30, 2023 and 2022, respectively.

Note 6: Other Intangible Assets, net and Goodwill
Other Intangible Assets, net
The following tables summarize the gross carrying amounts and accumulated amortization of the Company’s identifiable intangible assets by major class:
June 30, 2023December 31, 2022
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
Finite-lived intangible assets:
Customer relationships$7,778.4 $(994.7)$6,783.7 $7,809.0 $(821.5)$6,987.5 
Databases and content2,733.7 (889.7)1,844.0 2,681.0 (780.5)1,900.5 
Computer software828.2 (469.2)359.0 765.1 (422.2)342.9 
Other88.7 (45.9)42.8 88.8 (38.9)49.9 
Finite-lived intangible assets$11,429.0 $(2,399.5)$9,029.5 $11,343.9 $(2,063.1)$9,280.8 
Indefinite-lived intangible assets:
Trade names156.9 — 156.9 156.9 — 156.9 
Total intangible assets$11,585.9 $(2,399.5)$9,186.4 $11,500.8 $(2,063.1)$9,437.7 
Intangible amortization expense was $172.7 and $165.8 for the three months ended June 30, 2023, and 2022, respectively, and $339.4 and $331.6 for the six months ended June 30, 2023, and 2022, respectively.
Goodwill
The change in the carrying amount of goodwill by segment is shown below:
A&G
Segment
IP
Segment
LS&H
Segment
Consolidated Total
Balance as of December 31, 2022$1,109.8 $590.3 $1,176.4 $2,876.5 
Goodwill impairment(1)
 (3.0) (3.0)
Impact of foreign currency fluctuations(0.2)22.2  22.0 
Balance as of June 30, 2023$1,109.6 $609.5 $1,176.4 $2,895.5 
(1) Recorded in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information.

Note 7: Derivative Instruments
The Company has interest rate swap arrangements with counterparties to reduce its exposure to variability in cash flows relating to interest payments on its outstanding SOFR-based Term Loan arrangements (see Note 3 - Summary of Significant Accounting Policies for additional information). Our interest rate swap arrangements are subject to hedge accounting, by designating the interest rate swaps as hedges on applicable future quarterly interest payments. The following table provides a summary of the Company's interest rate swap arrangements by maturity date as of June 30, 2023:
15

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Notional ValueEffective DateMaturity DateFixed Rate
$48.9March 31, 2021September 29, 20231.640%
$48.9April 30, 2021September 29, 20231.640%
$100.0March 31, 2021March 31, 20240.401%
$100.0October 31, 2022March 31, 20240.421%
$150.0October 31, 2022March 31, 20240.445%
$384.1August 4, 2022October 31, 20262.809%
$384.1August 5, 2022October 31, 20263.010%
Changes in fair value are recorded in Accumulated other comprehensive income (loss) ("AOCI") in the Condensed Consolidated Balance Sheets and the amounts reclassified out of AOCI are recorded to Interest expense and amortization of debt discount, net in the Condensed Consolidated Statements of Operations.
The fair value of the interest rate swaps is recorded in Other current assets or Accrued expenses and other current liabilities and Other non-current assets or Other non-current liabilities in the Condensed Consolidated Balance Sheets, according to the duration of related cash flows. The fair value of the interest rate swaps was an asset balance of $44.4 and $49.5 as of June 30, 2023 and December 31, 2022, respectively. See Note 8 - Fair Value Measurements for additional information related to the fair value of these derivative instruments.
For additional information on our interest rate risk, see Item 3. Quantitative and Qualitative Disclosures about Market Risk, and see Note 9 - Debt for additional information on our outstanding Term Loan.
Foreign Currency Forward Contracts
The Company periodically enters into foreign currency contracts, which generally do not exceed 180 days in duration, to help manage the Company’s exposure to foreign exchange rate risks. The contracts are not designated as accounting hedges under the applicable sections of ASC 815, Derivatives and Hedging.
The Company accounts for these forward contracts at fair value and recognizes the associated realized and unrealized gains and losses in Other operating income, net in the Condensed Consolidated Statements of Operations. The Company recognized a loss (gain) from the mark to market adjustment of $2.9 and $(1.0), for the three months ended June 30, 2023 and 2022, respectively, and $(0.3) and $5.7 for the six months ended June 30, 2023 and 2022, respectively. The amounts disclosed for the three and six months ended June 30, 2022 were revised from the previously reported losses of $5.7 and $12.4, respectively. The principal amount of outstanding foreign currency contracts was $162.0 and $165.1 as of June 30, 2023 and December 31, 2022, respectively.
The total fair value of the forward contracts represented an asset balance of $1.3 and $0.8, and a liability balance of $0.6 and $0.4, as of June 30, 2023 and December 31, 2022, respectively, which are classified as Other current assets and Accrued expenses and other current liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 8 - Fair Value Measurements for additional information related to the fair value of derivative instruments.

Note 8: Fair Value Measurements
Assets and Liabilities Recorded at Fair Value on a Recurring Basis
The following table provides a summary of the Company’s assets and liabilities that were recognized at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:
16

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
June 30, 2023
Level 2Level 3Total
Fair Value
Assets
Forward currency contracts - current$1.3 $— $1.3 
Interest rate swaps - current13.4 — 13.4 
Interest rate swaps - non-current31.0 — 31.0 
Total$45.7 $— $45.7 
Liabilities
Forward currency contracts - current$0.6 $— $0.6 
Warrant liability - current— 19.2 19.2 
Total$0.6 $19.2 $19.8 
December 31, 2022
Level 2Level 3Total
Fair Value
Assets
Forward currency contracts - current$0.8 $— $0.8 
Interest rate swaps - current2.3 — 2.3 
Interest rate swaps - non-current47.2 — 47.2 
Total$50.3 $— $50.3 
Liabilities
Forward currency contracts - current$0.4 $— $0.4 
Warrant liability - non-current— 21.0 21.0 
Total$0.4 $21.0 $21.4 
There were no transfers of assets or liabilities between levels during the six months ended June 30, 2023 or year ended December 31, 2022.
Private Placement Warrants - The following table summarizes the changes in the Private Placement Warrants liability for the three and six months ended June 30, 2023 and 2022:
20232022
Balance as of January 1$21.0 $227.8 
Mark to market loss (gain) on financial instruments1.1 (100.4)
Exercise of Private Placement Warrants— — 
Balance as of March 31$22.1 $127.4 
Mark to market gain on financial instruments(2.9)(49.0)
Exercise of Private Placement Warrants— — 
Balance as of June 30$19.2 $78.4 
Non-Financial Assets Valued on a Non-Recurring Basis
The Company’s long-lived assets, including goodwill, indefinite-lived intangible and finite-lived intangible assets subject to amortization, are measured at fair value on a non-recurring basis. These assets are measured at cost but are written-down to fair value, if necessary, as a result of impairment.
17

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Finite-lived Intangible Assets - If a triggering event occurs, the Company determines the estimated fair value of finite-lived intangible assets by determining the present value of the expected cash flows. During the second quarter of 2023, the Company recorded an impairment charge of $132.2 in connection with intangible assets classified as Assets held-for-sale. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information.
Goodwill - Goodwill represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets resulting from business combinations. The Company evaluates its goodwill for impairment at the reporting unit level, defined as an operating segment or one level below an operating segment, annually as of October 1 or more frequently if impairment indicators arise in accordance with ASC Topic 350. The Company performs qualitative analysis of macroeconomic conditions, industry and market considerations, internal cost factors, financial performance, fair value history and other company specific events. If this qualitative analysis indicates that it is more likely than not that the estimated fair value is less than the book value for the respective reporting unit, the Company applies a one-step impairment test in which the Company determines whether the estimated fair value of the reporting unit is in excess of its carrying value. If the carrying value of the net assets assigned to the reporting unit exceeds the estimated fair value of the reporting unit, the Company performs the second step of the impairment test to determine the implied estimated fair value of the reporting unit’s goodwill. The Company determines the implied estimated fair value of goodwill by determining the present value of the estimated future cash flows for each reporting unit and comparing the reporting unit’s risk profile and growth prospects to selected, reasonably similar publicly traded companies. During the second quarter of 2023, the Company recorded an impairment charge of $3.0 in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 6 - Other Intangible Assets, net and Goodwill for additional information.

Note 9: Debt
The following table is a summary of the Company’s debt:
June 30, 2023December 31, 2022
TypeMaturityEffective
Interest
Rate
Carrying
Value
Effective
Interest
Rate
Carrying
Value
Senior Notes20294.875 %$921.4 4.875 %$921.4 
Senior Secured Notes20283.875 %921.2 3.875 %921.2 
Revolving Credit Facility20277.952 % 7.234 % 
Term Loan Facility 20268.217 %2,347.4 7.384 %2,497.4 
Senior Secured Notes20264.500 %700.0 4.500 %700.0 
Finance lease20366.936 %30.8 6.936 %31.3 
Total debt outstanding4,920.8 5,071.3 
Debt discounts and issuance costs(56.5)(65.3)
Current portion of long-term debt(1.1)(1.0)
Long-term debt$4,863.2 $5,005.0 
Financing Transactions
Senior Notes (2029) and Senior Secured Notes (2028)
The Company has $921.2 aggregate principal amount of its Senior Secured Notes due 2028 and $921.4 aggregate principal amount of its Senior Notes due 2029 bearing interest at a rate of 3.875% and 4.875% per annum, respectively, payable semi-annually to holders of record on June 30 and December 30 of each year. The first interest payment was paid in December 2021. Both of these series of Notes were issued by Clarivate Science Holdings Corporation (the "Issuer"), an indirect wholly-owned subsidiary of Clarivate.
18

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
The Senior Secured Notes due 2028 are secured on a first-lien pari passu basis with borrowings under the existing credit facilities and Senior Secured Notes due 2026. Both of these series of Notes are guaranteed on a joint and several basis by each of Clarivate’s indirect subsidiaries that is an obligor or guarantor under Clarivate’s existing credit facilities and Senior Secured Notes due 2026. The Senior Notes due 2029 are the Issuer’s and such guarantors’ unsecured obligations.

Senior Secured Notes (2026)
The Company has $700.0 aggregate principal amount of its Senior Secured Notes due 2026 bearing interest at a rate of 4.50% per annum, payable semi-annually to holders of record on May 1 and November 1 of each year. The first interest payment was paid in May 2020. The Senior Secured Notes due 2026 were issued by Camelot Finance S.A. (the "Lux Issuer"), an indirect wholly-owned subsidiary of Clarivate, and are secured on a first-lien pari passu basis with borrowings under the Credit Facilities and Senior Secured Notes due 2028. These Notes are guaranteed on a joint and several basis by each of Clarivate's indirect subsidiaries that is an obligor or guarantor under the Credit Facilities and are general senior secured obligations of the Lux Issuer and are secured on a first-priority basis by the collateral now owned or hereafter acquired by the Lux Issuer and each of the guarantors that secures the Issuer’s and such guarantor’s obligations under Clarivate's credit facilities (subject to permitted liens and other exceptions).
The Credit Facilities
The Company's Credit Facilities consist of a $750.0 Revolving Credit Facility with a $80.0 letter of credit sublimit, due 2027, and a $2,860.0 Term Loan Facility due 2026.
Revolving Credit Facility
As of June 30, 2023 and December 31, 2022, the Company had no outstanding balance on its Revolving Credit Facility. The facility provides for revolving loans, same-day borrowings and letters of credit pursuant to commitments in an aggregate principal amount of $750.0 with a letter of credit sublimit of $80.0. Proceeds of loans made under the Revolving Credit Facility may be borrowed, repaid and reborrowed prior to the maturity of the Revolving Credit Facility. Our ability to draw under the Revolving Credit Facility or issue letters of credit thereunder is conditioned upon, among other things, delivery of required notices, accuracy of the representations and warranties contained in the Credit Agreement and the absence of any default or event of default under the Credit Agreement.
As of June 30, 2023, letters of credit totaling $8.8 were collateralized by the Revolving Credit Facility, and, notwithstanding the Revolving Credit Facility, the Company had unsecured corporate guarantees outstanding of $13.6 and cash collateralized letters of credit of $3.6, which were not collateralized by the Revolving Credit Facility.
Term Loan Facility (2026)
The Company has a Term Loan Facility of $2,860.0 due 2026, which was fully drawn at closing. During the fourth quarter 2022, the Company made a $300.0 prepayment on its Term Loan Facility and prepayments of $150.0 during the six months ended June 30, 2023. Prior to the initial prepayment, the principal amount of the Term Loan Facility was repaid by the Company on the last business day of each March, June, September and December, in an amount equal to 0.25% of the aggregate original par principal amount of the initial term loans.
The carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value due to the short-term nature of the interest rate benchmark rates. The fair value of the fixed rate debt is estimated based on market observable data for debt with similar prepayment features. The fair value of the Company’s debt was $4,647.4 and $4,709.6 at June 30, 2023 and December 31, 2022, respectively, and is considered Level 2 under the fair value hierarchy.

Note 10: Revenue
Disaggregated Revenues
We disaggregate our revenues by segment (see Note 16 - Segment Information) and by transaction type based on revenue recognition pattern as follows:
19

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Subscription-based revenues are recurring revenues that are earned under annual, evergreen or multi-year contracts pursuant to which we license the right to use our products to our customers or provide maintenance services over a contractual term. Revenues from the sale of subscription data, maintenance services, and analytics solutions are recognized ratably over the contractual period.
Re-occurring revenues are earned under contracts for specific deliverables that are typically quoted on a product, data set or project basis and often derived from repeat customers. These contracts include either evergreen clauses, in which at least six month advance notice is required prior to cancellation, or the contract is for multiple years. Deliverables are usually received by the customer instantly or in a short period of time, at which time the revenues are recognized. The most significant component of our re-occurring revenues is our 'renewal' business within CPA Global.
Transactional and other revenues are earned under contracts for specific deliverables that are typically quoted on a product, data set or project basis and often derived from repeat customers, including customers that also generate subscription-based revenues. Transactional and other revenues may involve sales to the same customer on multiple occasions but with different products or services comprising the order. Other revenues relate to professional services including implementation for software and software as a service ("SaaS") subscriptions. These contracts vary in length from several months to years for multi-year projects. Revenue is recognized over time utilizing a reasonable measure of progress depicting the satisfaction of the related performance obligation. Other revenues also includes one-time perpetual archive license revenues.
The following table presents the Company’s revenues by transaction type based on revenue recognition pattern for the periods presented:
Three Months Ended June 30,
20232022
Subscription revenues$406.0 $407.4 
Re-occurring revenues111.0 112.0 
Transactional and other revenues151.8 168.0 
Deferred revenues adjustment (0.8)
Revenues, net$668.8 $686.6 
Six Months Ended June 30,
20232022
Subscription revenues$799.2 $811.2 
Re-occurring revenues218.7 226.5 
Transactional and other revenues280.0 311.7 
Deferred revenues adjustment (0.6)
Revenues, net$1,297.9 $1,348.8 
20

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Contract Balances
Balances, as of:Accounts receivable, netCurrent
deferred revenues
Non-current
deferred revenues
December 31, 2022$872.1 $947.5 $38.5 
June 30, 2023769.7 939.6 37.9 
Decrease$(102.4)$(7.9)$(0.6)
December 31, 2021$906.4 $1,030.4 $54.2 
June 30, 2022812.4 956.7 50.3 
Decrease$(94.0)$(73.7)$(3.9)
The Company recognized revenue of $588.9 during the six months ended June 30, 2023, attributable to deferred revenues recorded at the beginning of each such period. During the three months ended June 30, 2023, we revised the disclosure in this Note by $113.9 to decrease the revenue recognized that was included in the opening deferred revenue balance to $343.9 for the three months ended March 31, 2023. This correction did not have an impact on the accompanying Condensed Consolidated Balance Sheets or Statements of Operations. Those amounts primarily consisted of subscription revenues recognized ratably over the contractual term during the respective reporting periods.
Transaction Price Allocated to Remaining Performance Obligations
Revenue allocated to remaining performance obligations represents the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. Our most significant remaining performance obligations relate to contracts in which we license the right to use our products to our customers or provide maintenance services over the remaining contractual term, a majority of which are contracts with a duration of one year or less. As of June 30, 2023, approximately 90% of the aggregate transaction price allocated to remaining performance obligations are expected to be satisfied within one year.

Note 11: Shareholders’ Equity
As of June 30, 2023, there were unlimited shares of ordinary stock authorized and 676.1 million shares issued and outstanding, with no par value. The Company did not hold any shares as treasury shares as of June 30, 2023 and December 31, 2022. The Company’s ordinary shareholders are entitled to one vote per share.
MCPS Offering
In June 2021, concurrently with the June 2021 Ordinary Share Offering (see Note 1 - Background and Nature of Operations, in our Annual Report on Form 10-K), we completed a public offering of 14.4 million of our 5.25% Series A Mandatory Convertible Preferred Shares ("MCPS") (which included 1.9 million of our MCPS that the underwriters purchased pursuant to their option to purchase additional shares). Dividends on our mandatory convertible preferred shares are payable, as and if declared by our Board of Directors, at an annual rate of 5.25% of the liquidation preference of $100.00 per share. We may pay declared dividends on March 1, June 1, September 1 and December 1 of each year, commencing on September 1, 2021, and ending on, and including, June 1, 2024. Each of our convertible preferred shares has a liquidation preference of $100.00.
As of June 30, 2023, we accrued $6.2 of preferred share dividends within Accrued expenses and other current liabilities. While the dividends on the MCPS are cumulative, they will not be paid until declared by the Company’s Board of Directors. If the dividends are not declared, they will continue to accumulate until paid, due to a backstop contained in the agreement (even if never declared).
Treasury Shares
CPA Global Acquisition Shares - During the six months ended June 30, 2022, 41.7 thousand shares held in the Employee Benefit Trust ("EBT"), established for the CPA Global Equity Plan, were sold at an average net price per share of $15.01 to fund the payment to the respective employees. Given the original share value of $30.99 as of the date of the acquisition, an associated loss was recognized within the Condensed Consolidated Statement of Changes in Equity in the amount of $0.7 during the six months ended June 30, 2022. The CPA Global Equity Plan was terminated during the year ended December 31, 2022 after all remaining shares were sold and payments were made to respective employees.
21

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Share Repurchase Program and Share Retirements - In February 2022, the Company's Board of Directors approved the purchase of up to $1,000.0 of the Company's ordinary shares through open-market purchases, to be executed through December 31, 2023. During the six months ended June 30, 2022, the Company repurchased 10.7 million ordinary shares at an average price per share of $16.33 with a total carrying value of $175.0 all of which were subsequently retired at an average price at retirement of $15.61 and restored as authorized but unissued ordinary shares. Upon formal retirement and in accordance with ASC Topic 505, Equity, the Company reduced its ordinary shares account by the carrying amount of the treasury shares. Additionally, given the differences of the original repurchase share value and the value at the time of formal retirements, an associated loss was recognized within the Condensed Consolidated Statement of Changes in Equity in the amount of $7.7.
In May 2023, the Company's Board of Directors approved the extension of its share repurchase authorization through December 31, 2024, and reduced the authorization from $1,000.0 to $500.0. To enable the buybacks under the Board's authorization, the Company obtained shareholder approval on July 27, 2023 to permit it to conduct open-market purchases of up to 100.0 million of its ordinary shares from time to time as approved by the Board of Directors at a minimum purchase price of $1 per share and maximum purchase price of $35 per share. As of June 30, 2023, the Company had $500.0 of availability remaining under the Board's authorization.
Six Months Ended June 30,
20232022
Total number of shares repurchased— 10.7 
Average price paid per share$— $16.33 
Total
$— $175.0 
Total shares retired— 10.7 
Average price at retirement date$— $15.61 
Total
$— $167.3 
22

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Note 12: Share-based Compensation
The Company grants share-based awards under the Clarivate Plc 2019 Incentive Award Plan ("the Plan"). As of June 30, 2023, approximately 24.8 million of the Company’s ordinary shares were available for share-based awards. The Plan provides for the issuance of stock options, restricted stock units ("RSUs"), and performance share units ("PSUs").
Share-based compensation expense is recorded to the “Cost of revenues" and “Selling, general and administrative” line items on the accompanying Consolidated Statements of Operations. Total share-based compensation expense for the three and six months ended June 30, 2023 and 2022, comprised of the following:
Three Months Ended June 30, 2023
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$ $10.2 $0.1 $ $10.3 
Selling, general and administrative costs 16.2 4.0  20.2 
Total share-based compensation expense$ $26.4 $4.1 $ $30.5 
Six Months Ended June 30, 2023
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$ $23.0 $0.3 $ $23.3 
Selling, general and administrative costs1.9 32.9 13.6  48.4 
Total share-based compensation expense$1.9 $55.9 $13.9 $ $71.7 

Three Months Ended June 30, 2022
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$ $7.5 $0.1 $(0.2)$7.4 
Selling, general and administrative costs 12.6 0.9 0.8 14.3 
Total share-based compensation expense$ $20.1 $1.0 $0.6 $21.7 
Six Months Ended June 30, 2022
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$ $17.1 $0.3 $(0.6)$16.8 
Selling, general and administrative costs 28.8 1.9 0.9 31.6 
Total share-based compensation expense$ $45.9 $2.2 $0.3 $48.4 

The following table summarizes the Company’s existing share-based compensation awards program activity for the six months ended June 30, 2023, and 2022, respectively:
23

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Six Months Ended June 30, 2023
Stock OptionsRSUsPSUs
Balance at December 31, 20223.7 13.5 2.1 
Granted 5.6 1.5 
Exercised/Vested (2.5)(0.1)
Forfeited (0.9)(0.5)
Balance at June 30, 20233.7 15.7 3.0 
Total remaining unamortized compensation costs$ $97.6 $45.8 
Weighted average remaining service period0 years1.07 years2.21 years
Six Months Ended June 30, 2022
Stock OptionsRSUsPSUs
Balance at December 31, 20214.8 4.5 1.4 
Granted 4.5 0.9 
Exercised/Vested(0.2)(2.0) 
Forfeited(0.1)(0.4)(0.1)
Balance at June 30, 20224.5 6.6 2.2 
Total remaining unamortized compensation costs$ $72.1 $9.4 
Weighted average remaining service period0 years1.43 years1.69 years

Note 13: Income Taxes
We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period.
During the three months ended June 30, 2023, the income tax benefit of $35.3 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized, $33.0 tax benefit was associated with the impairment of intangible assets, and $17.1 tax benefit was related to the partial release of valuation allowance recorded against certain US tax attributes that are now considered realizable due to sufficient cumulative income and continued projections of future taxable income. During the three months ended June 30, 2022, the income tax provision of $10.5 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized.
During the six months ended June 30, 2023, the income tax benefit of $98.9 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized, $70.4 tax benefit was recorded on the settlement of an open tax dispute, $33.0 tax benefit was associated with the impairment of intangible assets, and $17.1 tax benefit was related to the partial release of valuation allowance recorded against certain US tax attributes that are now considered realizable due to sufficient cumulative income and continued projections of future taxable income. During the six months ended June 30, 2022, the income tax provision of $26.8 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized and tax expense on the mark to market gain on private warrants.

Note 14: Earnings Per Share
Basic net earnings per ordinary share from continuing operations (“EPS”) is calculated by taking Net income (loss) available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding for the applicable period. Diluted net EPS is computed by taking net earnings adjusted for the effect of the fair value of Private Placement Warrants
24

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
divided by the weighted average number of ordinary shares outstanding increased by the number of additional shares which have a dilutive effect.
Potential ordinary shares on a gross basis of 30.7 million and 9.7 million options, RSUs, PSUs, and Warrants related to the 2019 Incentive Award Plan were excluded from diluted EPS for the six months ended June 30, 2023 and 2022, respectively, as their inclusion would have been anti-dilutive or their performance metric was not met. Potential ordinary shares on a gross basis of 30.0 million and 10.1 million options, RSUs, PSUs, and Warrants related to the 2019 Incentive Award Plan were excluded from diluted EPS for the three months ended June 30, 2023 and 2022, respectively, as their inclusion would have been anti-dilutive or their performance metric was not met. See Note 11 - Shareholders’ Equity and Note 12 - Share-based Compensation for additional information.
The potential dilutive effect of our MCPS outstanding during the period was calculated using the if-converted method assuming the conversion as of the earliest period reported or at the date of issuance, if later. The resulting weighted-average ordinary shares of 55.3 million related to our MCPS are not included in the dilutive weighted-average ordinary shares outstanding calculation for the three and six months ended June 30, 2023, as their effect would be anti-dilutive.
The basic and diluted EPS computations for our ordinary shares are calculated as follows:
Three Months Ended June 30,
20232022
Basic EPS
Net (loss) income available to ordinary shareholders$(123.1)$62.4 
Dividends on preferred shares18.6 18.7 
Net (loss) income attributable to ordinary shares$(141.7)$43.7 
Basic weighted-average number of ordinary shares outstanding675.9 674.3 
Basic EPS$(0.21)$0.06 
Diluted EPS
Net (loss) income attributable to ordinary shares$(141.7)$43.7 
Change in fair value of private placement warrants (46.8)
Net loss attributable to ordinary shares, diluted$(141.7)$(3.1)
Denominator:
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic675.9 674.3 
Weighted-average effect of potentially dilutive shares to purchase ordinary shares  4.1 
Diluted weighted-average number of ordinary shares outstanding675.9 678.4 
Diluted EPS$(0.21)$0.00 
25

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Six Months Ended June 30,
20232022
Basic EPS
Net (loss) income available to ordinary shareholders$(79.6)$131.9 
Dividends on preferred shares37.4 37.4 
Net (loss) income attributable to ordinary shares$(117.0)$94.5 
Basic weighted-average number of ordinary shares outstanding675.4 678.3 
Basic EPS$(0.17)$0.14 
Diluted EPS
Net (loss) income attributable to ordinary shares$(117.0)$94.5 
Change in fair value of private placement warrants (141.7)
Net loss attributable to ordinary shares, diluted$(117.0)$(47.2)
Denominator:
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic675.4 678.3 
Weighted-average effect of potentially dilutive shares to purchase ordinary shares  4.9 
Diluted weighted-average number of ordinary shares outstanding675.4 683.2 
Diluted EPS$(0.17)$(0.07)


Note 15: Other Operating Expense (Income), Net
Other operating expense (income), net, consisted of the following for the three and six months ended June 30, 2023 and 2022:
Three Months Ended June 30,
20232022
Net foreign exchange loss (gain)11.7 (23.5)
Miscellaneous expense (income), net2.8 (1.1)
Other operating expense (income), net$14.5 $(24.6)

Six Months Ended June 30,
20232022
Gain on legal settlement(1)
(49.4) 
Net foreign exchange loss (gain)32.3 (43.9)
Miscellaneous (income) expense, net(0.4)5.6 
Other operating income, net$(17.5)$(38.3)
(1) Refer to Note 17 - Commitments and Contingencies for further information.

Note 16: Segment Information
26

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
The Chief Executive Officer is the Company’s Chief Operating Decision Maker (“CODM”). The CODM evaluates segment performance based primarily on revenue and Adjusted EBITDA. The CODM does not review assets by segment for the purposes of assessing performance or allocating resources.
Below is the overview of the product groups within each reportable segment. This structure enables a sharp focus on cross-selling opportunities within the markets we serve and provides substantial scale.
The A&G segment consists of our Academia & Government product group, which drives research excellence across institutions, empower researchers to tackle today’s global challenges, and help academic institutions and libraries improve operational efficiency and effectiveness.
The IP segment consists of our Patent Intelligence, Brand IP Intelligence, and IP Lifecycle Management product groups, which enable customers to establish, protect, and manage their intellectual property.
The LS&H segment consists of our Life Sciences & Healthcare product group, which includes products and solutions that provide insight and foresight across the drug and device lifecycle, empowering life science and healthcare organizations to create a healthier tomorrow.
Each of the three segments represent the segments for which discrete financial information is available and upon which operating results are regularly evaluated by the CODM in order to assess performance and allocate resources. The CODM evaluates performance based primarily on segment revenue and Adjusted EBITDA. Adjusted EBITDA represents net income (loss) before the provision for income taxes, depreciation and amortization, and interest expense adjusted to exclude acquisition and disposal-related transaction costs, losses on extinguishment of debt, share-based compensation, unrealized foreign currency remeasurement, transformational and restructuring expenses, acquisition-related adjustments to deferred revenues prior to the adoption of FASB ASU No. 2021-08 in 2021, non-operating income or expense, the impact of certain non-cash mark-to-market adjustments on financial instruments, legal settlements, impairments, and other items that are included in net income (loss) for the period that the Company does not consider indicative of its ongoing operating performance and certain unusual items impacting results in a particular period.
Revenues, net by segment
The following table summarizes revenue by reportable segment for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government$342.0 $332.7 $656.7 $644.5 
Intellectual Property216.3 238.4 425.4 480.2 
Life Sciences & Healthcare110.5 115.5 215.8 224.1 
Total Revenues, net$668.8 $686.6 $1,297.9 $1,348.8 

Adjusted EBITDA by segment
The following table presents segment profitability and a reconciliation to net income for the periods indicated:
27

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government$146.8 $122.9 $272.2 $227.4 
Intellectual Property100.1 107.8 194.7 225.4 
Life Sciences & Healthcare38.0 43.7 70.7 83.9 
Total Adjusted EBITDA$284.9 $274.4 $537.6 $536.7 
Benefit (provision) for income taxes35.3 (10.5)98.9 (26.8)
Depreciation and amortization(178.1)(175.6)(350.7)(352.0)
Interest expense and amortization of debt discount, net(73.0)(62.3)(146.6)(121.8)
Mark to market gain on financial instruments(1)
2.9 49.0 1.8 149.4 
Deferred revenues adjustment (0.8) (0.6)
Transaction related costs(2)
(0.7)(5.1)(2.4)(11.8)
Share-based compensation expense(30.5)(22.1)(71.7)(59.1)
Restructuring and lease impairments(3)
(12.2)(19.2)(21.6)(30.9)
Goodwill and intangible asset impairments(4)
(135.2) (135.2) 
Other(5)
(16.5)34.6 10.3 48.8 
Net (loss) income$(123.1)$62.4 $(79.6)$131.9 
Dividends on preferred shares(18.6)(18.7)(37.4)(37.4)
Net (loss) income attributable to ordinary shares$(141.7)$43.7 $(117.0)$94.5 
(1) Reflects mark-to-market adjustments on the Private Placement Warrants under ASC 815, Derivatives and Hedging. Refer to Note 8 - Fair Value Measurements for further information.
(2) Includes costs incurred to complete business combination transactions, including acquisitions, dispositions, and capital market activities and include advisory, legal, and other professional and consulting costs.
(3) Primarily reflects severance and related benefit costs related to approved restructuring programs. Refer to Note 19 - Restructuring and Lease Impairments for further information.
(4) Primarily includes the intangible assets impairment recorded during the three months ended June 30, 2023 further discussed in Note 4 - Assets Held for Sale and Divested Operations
(5) The current year periods primarily include net losses on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. The current year-to-date period was offset by a gain on legal settlement. The prior year periods include net gains on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. Refer to Note 15 - Other Operating Expense (Income), Net and Note 17 - Commitments and Contingencies for further information.

Note 17: Commitments and Contingencies
The Company does not have any recorded or unrecorded guarantees of the indebtedness of others.
Lawsuits and Legal Claims
The Company is engaged in various legal proceedings, claims, audits, and investigations that have arisen in the ordinary course of business. These matters may include among others, antitrust/competition claims, intellectual property infringement claims, employment matters, and commercial matters. The outcome of all of the matters against the Company is subject to future resolution, including the uncertainties of litigation.
From time to time, we are involved in litigation in the ordinary course of our business, including claims or contingencies that may arise related to matters occurring prior to our acquisition of businesses. At the present time, primarily because the matters are generally in early stages, we can give no assurance as to the outcome of any pending litigation to which we are currently a party, and we are unable to determine the ultimate resolution of these matters or the effect they may have on us.
Our best estimate of the Company's potential liability for the larger legal claims is approximately $4, which includes estimated legal costs and accrued interest. The recorded probable loss is an estimate and the actual costs arising from our litigation could be materially lower or higher. We have and will continue to vigorously defend ourselves against these
28

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
claims. We maintain appropriate levels of insurance, which we expect are likely to provide coverage for some of these liabilities or other losses that may arise from these litigation matters.
During the six months ended June 30, 2023, we reached settlement related to the potential liability for one of the larger legal claims, which was covered by insurance. We recognized a total gain on settlement of $49.4 which is included in Other operating expense (income), net in the Condensed Consolidated Statement of Operations.
Between January and March 2022, three putative securities class action complaints were filed in the United States District Court for the Eastern District of New York against Clarivate and certain of its executives and directors alleging that there were weaknesses in the Company’s internal controls over financial reporting and financial reporting procedures that it failed to disclose in violation of federal securities law. The complaints were consolidated into a single proceeding on May 18, 2022. On August 8, 2022, plaintiffs filed a consolidated amended complaint, seeking damages on behalf of a putative class of shareholders who acquired Clarivate securities between July 30, 2020, and February 2, 2022, and/or acquired Clarivate common or preferred shares in connection with offerings on June 10, 2021, or Clarivate common shares in connection with a September 13, 2021, offering. The amended complaint, like the prior complaints, references an error in the accounting treatment of an equity plan included in the Company’s 2020 business combination with CPA Global that was disclosed on December 27, 2021, and related restatements issued on February 3, 2022, of certain of the Company’s previously issued financial statements; the amended complaint also alleges that the Company and certain of its executives and directors made false or misleading statements relating to the Company’s product quality and expected organic revenues and organic growth rate, and that they failed to disclose significant known changes to the Company’s business model. Defendants moved to dismiss the amended complaint on October 7, 2022. Without deciding the motion, the court entered an order on June 23, 2023 allowing plaintiffs limited leave to amend, and plaintiffs filed an amended complaint on July 14, 2023. The Company intends to seek dismissal of the amended complaint. On June 7, 2022, a class action was filed in Pennsylvania state court in the Court of Common Pleas of Philadelphia asserting claims under the Securities Act of 1933, based on substantially similar allegations, with respect to alleged misstatements and omissions in the offering documents for two issuances of Clarivate ordinary shares in June and September 2021. The Company moved to stay this proceeding on August 19, 2022, and filed its preliminary objections to the state court complaint on October 21, 2022. Briefing on defendants' preliminary objections was completed on December 12, 2022, and the preliminary objections remain pending. On January 4, 2023, the court granted a partial stay of all proceedings until further court order after oral argument on the stay motion. Following oral argument on April 11, 2023, the court denied a further stay of the proceedings on April 17, 2023. Clarivate does not believe that the claims alleged in the complaints have merit and will vigorously defend against them. Given the early stage of the proceedings, we are unable to estimate the reasonably possible loss or range of loss, if any, arising from these matters.
Warrant Liabilities
Under Accounting Standards Codification 815, Derivatives and Hedging, ("ASC 815"), warrant instruments that do not meet the criteria to be considered indexed to an entity's own stock shall be initially classified as a liability at their estimated fair values, regardless of the likelihood that such instruments will ever be settled in cash. In periods subsequent to issuance, changes in the estimated fair value of the liabilities are reported through earnings. As of June 30, 2023, the Private Placement Warrants are set to expire within one year. Therefore, the remaining liability is included in Accrued expenses and other current liabilities on the Condensed Consolidated Balance Sheet as of June 30, 2023 (refer to Note 8 - Fair Value Measurements for additional information).

Contingent Liabilities
As of June 30, 2023 and December 31, 2022, there were no outstanding contingent liabilities.
MCPS Dividends
As noted in Note 11 - Shareholders’ Equity, dividends on our convertible preferred shares will be payable on a cumulative basis when, as and if declared by our Board of Directors, or an authorized committee of our Board of Directors, at an annual rate of 5.25% of the liquidation preference of $100.00 per share. Refer to Note 11 - Shareholders’ Equity for further details.

Note 18: Related Party Transactions
On December 1, 2021, Clarivate closed its acquisition of ProQuest from CIG, Atairos and certain other equity holders (the "Seller Group"). The aggregate consideration included $1,094.9 from the issuance of 46.9 million ordinary shares to the
29

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Seller Group. As part of the acquisition, and as a result, CIG is a related party to Clarivate. Clarivate assumed a Finance lease in which CIG is the Lessor as part of the acquisition. For the three and six months ended June 30, 2023, interest expense of $0.6 and $1.1, respectively, and amortization of the Finance lease right of use asset ("ROU") of $0.1 and $0.2, respectively, is reflected in the Condensed Consolidated Statements of Operations. The Finance lease ROU asset of $8.0 is presented within Property, Plant, and Equipment (see Note 5 - Property and Equipment, Net) and the corresponding lease liability of $30.8 is treated as an item of indebtedness (see Note 9 - Debt) within the Condensed Consolidated Balance Sheet.
Clarivate has a vendor and customer arrangement with an affiliate of one of our directors. The Company recognized revenues, net of $0.2 and $0.2 and incurred expenses of $1.3 and $1.2, respectively during the three months ended June 30, 2023 and 2022, related to the arrangement. During the six months ended June 30, 2023 and 2022, the Company recognized revenues, net of $0.4 and $0.4 and incurred expenses of $2.5 and $2.3, respectively, related to the arrangement. As of June 30, 2023 and December 31, 2022, the Company had no outstanding receivables and payables related to the arrangement.

Note 19: Restructuring and Lease Impairments
One Clarivate Program - During the second quarter of 2021, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings driver being from a reduction in workforce.
ProQuest Acquisition Integration Program - During the fourth quarter of 2021, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings driver being from a reduction in workforce.
Segment Optimization Program - During the second quarter of 2023, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings driver being from a reduction in workforce.
Other Restructuring Programs - During the fourth quarter of 2019 and throughout 2020, we engaged a strategic consulting firm to assist us in optimizing our structure and cost base, resulting in the implementation of several cost-saving and margin improvement programs designed to generate substantial incremental cash flows.
The following table summarizes the pre-tax charges by activity and program during the periods indicated:
30

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Severance and Related Benefit Costs:
One Clarivate Program$ $5.5 $ $11.1 
ProQuest Acquisition Integration Program7.6 7.7 16.9 12.0 
Segment Optimization Program2.3  2.3  
Other Restructuring Programs (1.1) (0.7)
Total Severance and Related Benefit Costs$9.9 $12.1 $19.2 $22.4 
Exit and Disposal Costs:
One Clarivate Program    
ProQuest Acquisition Integration Program$ $0.1 $0.1 $1.9 
Segment Optimization Program    
Other Restructuring Programs 0.2  0.1 
Total Exit and Disposal Costs$ $0.3 $0.1 $2.0 
Lease Abandonment Costs:
One Clarivate Program    
ProQuest Acquisition Integration Program 6.2  6.2 
Segment Optimization Program2.3  2.3  
Other Restructuring Programs 0.6  0.3 
Total Lease Abandonment Costs$2.3 $6.8 $2.3 $6.5 
Restructuring and Lease Impairment Costs$12.2 $19.2 $21.6 $30.9 
31

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
The following table summarizes the pre-tax charges by program and segment during the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government:
One Clarivate Program$ $3.2 $ $6.1 
ProQuest Acquisition Integration Program4.2 8.0 9.3 11.3 
Segment Optimization1.6  1.6  
Other Restructuring Programs 0.2   
Total Academia & Government$5.8 $11.4 $10.9 $17.4 
Intellectual Property:
One Clarivate Program$ $1.1 $ $3.0 
ProQuest Acquisition Integration Program1.9 4.0 4.6 5.9 
Segment Optimization1.4  1.4  
Other Restructuring Programs (0.4) (0.2)
Total Intellectual Property$3.3 $4.7 $6.0 $8.7 
Life Sciences & Healthcare:
One Clarivate Program$ $1.2 $ $2.0 
ProQuest Acquisition Integration Program1.5 2.0 3.1 2.9 
Segment Optimization1.6  1.6  
Other Restructuring Programs (0.1) (0.1)
Total Life Sciences & Healthcare$3.1 $3.1 $4.7 $4.8 
Restructuring and Lease Impairment Costs$12.2 $19.2 $21.6 $30.9 
The following table summarizes the activity relating to the restructuring reserves across each of Clarivate's cost-saving programs during the periods indicated:
Severance and
Related Benefit Costs
Exit, Disposal
and Abandonment Costs
Total
Reserve Balance as of December 31, 2022$11.5 $0.1 $11.6 
Expenses recorded19.2 2.4 21.6 
Payments made(23.4)(1.5)(24.9)
Noncash items(2.7)(0.8)(3.5)
Reserve Balance as of June 30, 2023$4.6 $0.2 $4.8 
Reserve Balance as of December 31, 2021$28.3 $0.7 $29.0 
Expenses recorded22.4 8.5 30.9 
Payments made(34.6)(2.7)(37.3)
Noncash items(2.6)(5.4)(8.0)
Reserve Balance as of June 30, 2022$13.5 $1.1 $14.6 

32

CLARIVATE PLC
Notes to the Condensed Consolidated Financial Statements (Unaudited)
(In millions, except option prices, per share data, ratios or as noted)
Note 20: Subsequent Events
Effective July 12, 2023, the Company entered into €100.0 of cross-currency swaps designated as hedges of euro denominated net investments in subsidiaries to mitigate FX exposure. The Company expects these swaps to qualify for hedge accounting.
Management has evaluated the impact of events that have occurred subsequent to June 30, 2023. Based on this evaluation, other than disclosed within these Condensed Consolidated Financial Statements and related notes, the Company has determined no other events were required to be recognized or disclosed.

33

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with our Annual Report on Form 10-K and the unaudited Condensed Consolidated Financial Statements, including the notes thereto, included elsewhere in this report. Certain statements in this section are forward-looking statements that involve risks and uncertainties, such as statements regarding our plans, objectives, expectations, and intentions. Our future results and financial condition may differ materially from those we currently anticipate as a result of the factors we describe under Item 1A. Risk Factors. Certain income statement amounts discussed herein are presented on an actual and on a constant currency basis. We calculate constant currency by converting the non-U.S. dollar income statement balances for the most current year to U.S. dollars by applying the average exchange rates of the preceding year. Certain amounts that appear in this section may not sum due to rounding.
Overview
We offer a collection of high quality, market leading information and analytic products and solutions through our Academia & Government ("A&G") segment, Intellectual Property (“IP”) segment, and Life Sciences & Healthcare ("LS&H") segment, which are also our reportable segments. Our A&G segment consists of our Academia & Government product group as well as Web of Science products. The A&G segment provides curated high-value, structured content, discovery solutions, and related software applications that are embedded into the workflows of our customers, which include libraries, universities and research institutions world-wide. Our IP segment consists of our patent, trademark, and IP management products and solutions. These products and solutions help manage customers' end-to-end portfolio of intellectual property from patents to trademarks across the entire IP lifecycle. The LS&H segment contains our products and solutions which serve the content and analytical needs of pharmaceutical and biotechnology companies across the drug development lifecycle, including content on discovery and preclinical research, competitive intelligence, regulatory information, and clinical trials.


34

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Factors Affecting the Comparability of Our Results of Operations
There have been no material changes to the factors affecting the comparability of our results of operations associated with our business previously disclosed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Factors Affecting the Comparability of Our Results of Operations section in our Annual Report on Form 10-K.
Risks and Uncertainties
As the conflict in Ukraine continues to evolve, we are closely monitoring the current and potential impact on our business, our people, and our clients. Given the levying of sanctions, regional instability, geopolitical shifts, and other potential adverse effects on macroeconomic conditions, security conditions, currency exchange, and financial markets, the short and long-term implications of Russia’s invasion of Ukraine are not possible to predict. We do not expect any direct impacts to our business to be material, but we are not currently able to predict any indirect impacts on the global economy and how those could negatively affect our business in the future. However, revenue growth in 2022 was slightly impacted by our decision to cease commercial operations in Russia in March 2022. We continue to monitor any evolving impacts of this conflict and its effects on the global economy and geopolitical landscape.

Key Performance Indicators
We regularly monitor the following key performance indicators to evaluate our business and trends, measure our performance, prepare financial projections and make strategic decisions. We include Revenue growth, Adjusted EBITDA, Adjusted EBITDA margin, Annualized Contract Value, Annual Renewal Rates, and Free Cash Flow as key performance indicators because they are a basis upon which our management assesses our performance, and we believe they reflect the underlying trends and indicators of our business by allowing management to focus on the most meaningful indicators of our continuous operational performance.
Adjusted EBITDA, Adjusted EBITDA margin, and Free Cash Flow are financial measures that are not prepared in accordance with U.S. generally accepted accounting principles (“non-GAAP”). Although we believe these measures may be useful to investors for the same reasons, these measures are not a substitute for GAAP financial measures or disclosures. For a reconciliation of our non-GAAP measures to the corresponding most closely related measures calculated in accordance with GAAP, see Certain Non-GAAP Measures below.
Organic revenue growth
We review year-over-year organic revenue growth in our segments as a key measure of our success in addressing customer needs. We also review year-over-year organic revenue growth by transaction type to help us identify and address broad changes in product mix, and by geography to help us identify and address broad changes and revenue trends by region. We measure organic revenue growth excluding acquisitions, disposals, and foreign currency impacts. We define these components as follows:
Organic: We define organic revenue growth as total revenue growth from continuing operations for all factors other than acquisitions, disposals, and foreign currency movements. We drive this type of revenue growth through pricing, up-selling and cross-selling efforts, securing new customer business, and the sale of new or enhanced product offerings.
Acquisitions: We define acquisition revenue as the revenue generated from acquired products and services from the date of acquisition to the first anniversary date of that acquisition. This type of growth comes as a result of our strategy of the pursuit of acquisition opportunities.
Disposals: We define disposals revenue as the revenue generated in the prior year comparative period from product lines, services, and/or businesses divested from the date of the sale in the current period presented or included within a disposal group.
Foreign Currency: We define the foreign currency impact on revenue as the difference between current revenue at current exchange rates and current revenue at the corresponding prior period exchange rates. Due to the significance of revenue transacted in foreign currencies, we believe that it is important to measure the impact of foreign currency movements on revenue.
35

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Adjusted EBITDA and Adjusted EBITDA margin
Adjusted EBITDA is presented because it is a basis upon which our management assesses our performance, and we believe it is useful for investors to understand the underlying trends of our operations. See Certain Non-GAAP Measures - Adjusted EBITDA and Adjusted EBITDA margin for important information on the limitations of Adjusted EBITDA and its reconciliation to our net loss under U.S. GAAP. Adjusted EBITDA represents net loss before provision for income taxes, depreciation and amortization, interest income and expense adjusted to exclude acquisition or disposal-related transaction costs (such costs include net income from continuing operations before provision for income taxes, depreciation and amortization, and interest income and expense from divestitures), share-based compensation, mandatory convertible preferred share dividend expense, unrealized foreign currency gains (losses), transformational and restructuring expenses, acquisition-related adjustments to deferred revenues prior to the adoption of FASB ASU No. 2021-08 in 2021, non-operating income or expense, the impact of certain non-cash, mark to market adjustments on financial instruments, legal settlements and other items that are included in net income for the period that the Company does not consider indicative of its ongoing operating performance, and certain unusual items impacting results in a particular period. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by Revenues, net plus the impact of the deferred revenue purchase accounting adjustments relating to acquisitions prior to 2021.
Annualized Contract Value
Annualized Contract Value (“ACV”), at a given point in time, represents the annualized value for the next 12 months of subscription-based client license agreements, assuming that all expiring license agreements during that period are renewed at their current price level. License agreements may cover more than one product and the standard subscription period for each license agreement typically runs for no less than 12 months. The renewal period for our subscriptions starts 90 days before the end of the current subscription period, during which customers must provide notice of whether they intend to renew or cancel the license agreement.
An initial subscription period for new customers may be for a term of less than 12 months, in certain circumstances. Most of our customers, however, opt to enter into a full 12-month initial subscription period, resulting in renewal periods spread throughout the calendar year. Customers that license more than one subscription-based product may, at any point during the renewal period, provide notice of their intent to renew only certain subscriptions within the license agreement and cancel other subscriptions, which we typically refer to as a downgrade. In other instances, customers may upgrade their license agreements by adding additional subscription-based products to the original agreement. Our calculation of ACV includes the impact of downgrades, upgrades, price increases, and cancellations that have occurred as of the reporting period. For avoidance of doubt, ACV does not include revenues associated with transactional and re-occurring revenues.
We monitor ACV because it represents a leading indicator of the potential subscription revenues that may be generated from our existing customer base over the upcoming 12-month period. Measurement of subscription revenues as a key operating metric is particularly relevant because a majority of our revenues are generated through subscription-based and re-occurring revenues, which accounted for 77.3% and 75.6% for the three months ended June 30, 2023 and 2022 and 78.4% and 76.9% for the six months ended June 30, 2023 and 2022, respectively. We calculate and monitor ACV for each of our segments and use the metric as part of our evaluation of our business and trends.
The amount of actual subscription revenues that we earn over any 12-month period are likely to differ from ACV at the beginning of that period, sometimes significantly. This may occur for numerous reasons, including subsequent changes in annual renewal rates, impact of price increases (or decreases), cancellations, upgrades and downgrades, and acquisitions and divestitures.
We calculate the ACV on a constant currency basis to exclude the effect of foreign currency fluctuations.
The following table presents ACV as of the dates indicated:
 June 30,Change
20232022
2023 vs. 2022(1)
Annualized Contract Value$1,567.2 $1,625.9 $(58.7)(3.6)%
(1) The change in ACV is primarily due to the divestiture of MarkMonitor in October 2022 and changes in foreign exchange rates, supplemented by organic ACV growth of 2.8% largely attributed to the impact of price increases.
36

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Annual Renewal Rates
Our revenues are primarily subscription based, which leads to high revenue predictability. Our ability to retain existing subscription customers is a key performance indicator that helps explain the evolution of our historical results and is a leading indicator of our revenues and cash flows for the subsequent reporting period.
“Annual renewal rate” is the metric we use to determine renewal levels by existing customers across all of our Segments, and is a leading indicator of renewal trends, which impact the evolution of our ACV and results of operations. We calculate the annual renewal rate for a given period by dividing (a) the annualized dollar value of existing subscription product license agreements that are renewed during that period, including the value of any product downgrades, by (b) the annualized dollar value of existing subscription product license agreements that come up for renewal in that period. “Open renewals,” which we define as existing subscription product license agreements that come up for renewal but are neither renewed nor canceled by customers during the applicable reposting period, are excluded from both the numerator and denominator of the calculation. We calculate the annual renewal rate to reflect the value of product downgrades but not the value of product upgrades upon renewal, because upgrades reflect the purchase of additional services.
The impact of upgrades, new subscriptions and product price increases is reflected in ACV, but not in annual renewal rates. Our annual renewal rates were 91.9% and 91.3% for the six months ended June 30, 2023 and 2022, respectively.

Free Cash Flow
We use free cash flow in our operational and financial decision-making and believe free cash flow is useful to investors because similar measures are frequently used by securities analysts, investors, ratings agencies and other interested parties to measure the ability of a company to service its debt. Our presentation of free cash flow should not be construed as a measure of liquidity or discretionary cash available to us to fund our cash needs, including investing in the growth of our business and meeting our obligations.
We define free cash flow as net cash provided by operating activities less capital expenditures. For further discussion on free cash flow, including a reconciliation to cash flows provided by operating activities, refer to Liquidity and Capital Resources - Cash Flows below.

Key Components of Our Results of Operations
There have been no material changes to the key components of our results of operations discussed in Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations to our Annual Report on Form 10-K for the year ended December 31, 2022.
37

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Results of Operations

Revenues, net
Total Revenue
Revenues, net of $668.8 for the three months ended June 30, 2023, decreased by $17.8, or 2.6%, from $686.6 for the three months ended June 30, 2022. On a constant currency basis, Revenues, net decreased by $23.9, or 3.5% for the three months ended June 30, 2023. Revenues, net of $1,297.9 for the six months ended June 30, 2023, decreased by $50.9, or 3.8%, from $1,348.8 for the six months ended June 30, 2022. On a constant currency basis, Revenues, net decreased by $44.1, or 3.3% for the six months ended June 30, 2023.
Revenue by Transaction Type
The following tables present the amounts of our subscription, re-occurring and transactional and other revenues for the periods indicated, as well as the drivers of the variances between periods, including as a percentage of such revenues.
Variance Increase/(Decrease)
Percentage of Factors Increase/(Decrease)
Three Months Ended June 30,
Total Variance (Dollars)
Total Variance (Percentage)
Acquisitions
Disposals(1)
FX Impact
Organic
(in millions, except percentages)20232022
Subscription revenues$406.0 $407.4 $(1.4)(0.3)%— %(4.4)%1.2 %2.9 %
Re-occurring revenues111.0 112.0 (1.0)(0.9)%— %— %0.7 %(1.6)%
Transactional and other revenues151.8 168.0 (16.2)(9.6)%— %(2.3)%0.2 %(7.5)%
Deferred revenues adjustment— (0.8)0.8 100.0 %100.0 %— %— %— %
Revenues, net$668.8 $686.6 $(17.8)(2.6)%0.1 %(3.2)%0.9 %(0.4)%
(1) Represents revenues from the MarkMonitor divestiture completed in October 2022 and from the assets held-for-sale disposal group (refer to Note 4 - Assets Held for Sale and Divested Operations for further information).
On a constant currency basis, subscription revenues decreased by $6.4, or 1.6%. Disposal subscription revenue reductions primarily relate to the MarkMonitor business divestiture. Organic subscription revenues increased primarily due to price increases, reflecting a trend consistent with the increase in our organic ACV between periods.
On a constant currency basis, re-occurring revenues decreased by $1.8, or 1.6%. Organic re-occurring revenues declined due to lower patent renewal volumes as a result of timing of the accelerated patent renewal payments in the prior year.
On a constant currency basis, transactional and other revenues decreased by $16.5, or 9.8%. Organic transactional and other revenues declined primarily due to lower LS&H real world data sales and IP patent search & analytics revenue.
Variance Increase/(Decrease)
Percentage of Factors Increase/(Decrease)
Six Months Ended June 30,
Total Variance (Dollars)
Total Variance (Percentage)
Acquisitions
Disposals(1)
FX Impact
Organic
(in millions, except percentages)20232022
Subscription revenues$799.2 $811.2 $(12.0)(1.5)%— %(4.4)%— %2.9 %
Re-occurring revenues218.7 226.5 (7.8)(3.4)%— %— %(1.8)%(1.7)%
Transactional and other revenues280.0 311.7 (31.7)(10.2)%— %(1.5)%(0.8)%(7.9)%
Deferred revenues adjustment— (0.6)0.6 100.0 %100.0 %— %— %— %
Revenues, net$1,297.9 $1,348.8 $(50.9)(3.8)%— %(3.0)%(0.5)%(0.3)%
(1) Represents revenues from the MarkMonitor divestiture completed in October 2022 and from the assets held-for-sale disposal group (refer to Note 4 - Assets Held for Sale and Divested Operations for further information).
On a constant currency basis, subscription revenues decreased by $11.6, or 1.4%. Disposal subscription revenue reductions primarily relate to the MarkMonitor business divestiture. Organic subscription revenues increased primarily due to price increases, reflecting a trend consistent with the increase in our ACV between periods.
38

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
On a constant currency basis, re-occurring revenues decreased by $3.8, or 1.7%. Organic re-occurring revenues declined due to lower patent renewal volumes as a result of timing of the accelerated patent renewal payments in the prior year.
On a constant currency basis, transactional and other revenues decreased by $29.3, or 9.4%. Organic transactional and other revenues declined primarily due to lower LS&H real world data sales and IP trademarks transactional volumes and search & analytics and patent filing revenue.
Revenue by Geography
The below tables present our revenues split by geographic region, separating the impacts of the deferred revenues adjustment:
Variance Increase/(Decrease)
Percentage of Factors Increase/(Decrease)
Three Months Ended June 30,
Total Variance (Dollars)
Total Variance (Percentage)
Acquisitions
Disposals(1)
FX Impact
Organic
(in millions, except percentages)
20232022
Americas361.2 384.5 (23.3)(6.1)%— %(4.2)%0.3 %(2.1)%
Europe/Middle East/Africa180.2 178.6 1.6 0.9 %— %(2.5)%1.4 %2.0 %
Asia Pacific127.4 124.3 3.1 2.5 %— %(0.8)%1.9 %1.4 %
Deferred revenues adjustment— (0.8)0.8 100.0 %100.0 %— %— %— %
Revenues, net$668.8 $686.6 $(17.8)(2.6)%0.1 %(3.2)%0.9 %(0.4)%
(1) Represents revenues from the MarkMonitor divestiture completed in October 2022 and from the assets held-for-sale disposal group (refer to Note 4 - Assets Held for Sale and Divested Operations for further information).
On a constant currency basis, Americas revenues decreased by $24.5, or 6.4%, with organic decline due to lower IP re-occurring patent renewal and transactional search & analytics revenues combined with lower LS&H real world data sales. On a constant currency basis, Europe/Middle East/Africa revenues decreased by $0.9, or 0.5%, with organic due to A&G subscription and IP re-occurring revenue. On a constant currency basis, Asia Pacific revenues increased by $0.7, or 0.6%, with organic growth led by A&G subscription revenue.
Variance Increase/(Decrease)
Percentage of Factors Increase/(Decrease)
Six Months Ended June 30,
Total Variance (Dollars)
Total Variance (Percentage)
Acquisitions
Disposals(1)
FX Impact
Organic
(in millions, except percentages)
20232022
Americas700.7 744.8 (44.1)(5.9)%— %(4.2)%(0.1)%(1.5)%
Europe/Middle East/Africa347.2 356.1 (8.9)(2.5)%— %(1.9)%(1.3)%0.8 %
Asia Pacific250.0 248.5 1.5 0.6 %— %(0.8)%(0.5)%1.9 %
Deferred revenues adjustment— (0.6)0.6 100.0 %100.0 %— %— %— %
Revenues, net$1,297.9 $1,348.8 $(50.9)(3.8)%— %(3.0)%(0.5)%(0.3)%
(1) Represents revenues from the MarkMonitor divestiture completed in October 2022 and from the assets held-for-sale disposal group (refer to Note 4 - Assets Held for Sale and Divested Operations for further information).
On a constant currency basis, Americas revenues decreased by $43.2, or 5.8%, with organic decline due to lower IP re-occurring patent renewal and transactional trademarks, search & analytics and patent filing revenues combined with lower LS&H real world data sales. On a constant currency basis, Europe/Middle East/Africa revenues decreased by $4.2, or 1.2%, with organic decline due to lower LS&H real world data sales and services revenue. On a constant currency basis, Asia Pacific revenues increased by $2.7, or 1.1%, with organic growth led by A&G and IP subscription revenue.
Revenue by Segment
The following tables and the discussions that follow present our revenues by segment for the periods indicated.
39

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Variance Increase/(Decrease)
Percentage of Factors Increase/(Decrease)

Three Months Ended June 30,
Total Variance (Dollars)
Total Variance (Percentage)
Acquisitions
Disposals(1)
FX Impact
Organic
(in millions, except percentages)20232022
Academia & Government$342.0 $332.7 $9.3 2.8 %— %— %1.0 %1.8 %
Intellectual Property216.3 239.2 (22.9)(9.6)%— %(9.1)%0.6 %(1.1)%
Life Sciences & Healthcare110.5 115.5 (5.0)(4.3)%— %— %1.0 %(5.4)%
Deferred revenues adjustment— (0.8)0.8 100.0 %100.0 %— %— %— %
Revenues, net$668.8 $686.6 $(17.8)(2.6)%0.1 %(3.2)%0.9 %(0.4)%
(1) Represents revenues from the MarkMonitor divestiture completed in October 2022 and from the assets held-for-sale disposal group (refer to Note 4 - Assets Held for Sale and Divested Operations for further information).
Academia & Government Segment: On a constant currency basis, revenues increased by $5.9, or 1.8%. Organic revenues, on a constant currency basis, increased primarily due to subscription revenues growth due to price increases and the benefit of net installations, partially offset by transaction revenues decline due to lower content aggregation revenue.
Intellectual Property Segment: On a constant currency basis, revenues decreased by $24.4, or 10.2%. Organic revenues, on a constant currency basis, declined primarily due to lower re-occurring patent renewal revenue because of timing of the accelerated patent renewal payments in the prior year and declines in transactional search & analytics.
Life Sciences & Healthcare Segment: On a constant currency basis, revenues decreased by $6.2, or 5.4%. Organic revenues, on a constant currency basis, declined primarily due to lower transactional real world data sales, partially offset by subscription revenues growth from price increases.
Variance Increase/(Decrease)
Percentage of Factors Increase/(Decrease)

Six Months Ended June 30,
Total Variance (Dollars)
Total Variance (Percentage)
Acquisitions
Disposals(1)
FX Impact
Organic
(in millions, except percentages)20232022
Academia & Government$656.7 $644.5 $12.2 1.9 %— %— %— %1.9 %
Intellectual Property425.4 480.8 (55.4)(11.5)%— %(8.4)%(1.4)%(1.7)%
Life Sciences & Healthcare215.8 224.1 (8.3)(3.7)%— %— %— %(3.7)%
Deferred revenues adjustment— (0.6)0.6 100.0 %100.0 %— %— %— %
Revenues, net$1,297.9 $1,348.8 $(50.9)(3.8)%— %(3.0)%(0.5)%(0.3)%
(1) Represents revenues from the MarkMonitor divestiture completed in October 2022 and from the assets held-for-sale disposal group (refer to Note 4 - Assets Held for Sale and Divested Operations for further information).
Academia & Government Segment: On a constant currency basis, revenues increased by $12.5, or 1.9%. Organic revenues, on a constant currency basis, increased primarily due to subscription revenues growth due to price increases and the benefit of net installations, partially offset by transaction revenues decline due to lower content aggregation revenue.
Intellectual Property Segment: On a constant currency basis, revenues decreased by $48.9, or 10.2%. Organic revenues, on a constant currency basis, declined primarily due to lower re-occurring patent renewal revenue because of timing of the accelerated patent renewal payments in the prior year and declines in transactional trademarks, search & analytics and patent filing revenue.
Life Sciences & Healthcare Segment: On a constant currency basis, revenues decreased by $8.3, or 3.7%. Organic revenues, on a constant currency basis, declined primarily due to lower transactional real world data sales, partially offset by subscription revenues growth from price increases and the benefit of net installations.

Operating Expenses
The following table presents certain of our operating expense line item amounts and their associated percentage of revenue:
40

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Three Months Ended June 30,Change 2023 vs. 2022Six Months Ended June 30,Change 2023 vs. 2022
(in millions, except percentages)20232022$%20232022$%
Cost of revenues$224.2$244.1$(19.9)(8.2)%$453.9$493.3$(39.4)(8.0)%
Selling, general and administrative costs192.9186.16.8 3.7 %387.7379.87.9 2.1 %
Total COR and SGA$417.1$430.2$(13.1)(3.0)%$841.6$873.1$(31.5)(3.6)%
Depreciation and amortization expense$178.1$175.6$2.51.4 %$350.7$352.0$(1.3)(0.4)%
As a percentage of revenue:
Total COR and SGA62.4 %62.7 %64.8 %64.7 %
Depreciation and amortization expense26.6 %25.6 %27.0 %26.1 %
Cost of revenues
On a constant currency basis, cost of revenues decreased by $17.9, or 7.3%, for the three months ended June 30, 2023. Cost of revenues as a percentage of revenues, net decreased by 2.1% to 33.5% for the three months ended June 30, 2023 compared to 35.6% for the three months ended June 30, 2022. The decrease for the three months ended June 30, 2023 was primarily attributed to the MarkMonitor business divestiture and due, in part, to a reduction in outside-service and people costs.
On a constant currency basis, cost of revenues decreased by $32.9, or 6.7%, for the six months ended June 30, 2023. Cost of revenues as a percentage of revenues, net decreased by 1.6% to 35.0% for the six months ended June 30, 2023, compared to 36.6% for the six months ended June 30, 2022. The decrease for the six months ended June 30, 2023 was primarily attributed to the MarkMonitor business divestiture and due, in part, to a reduction in outside-service and people costs.

Selling, general and administrative
On a constant currency basis, selling, general and administrative expense increased by $7.4, or 4.0%, for the three months ended June 30, 2023. Selling, general and administrative costs as a percentage of revenues, net increased by 1.7% to 28.8% for the three months ended June 30, 2023 compared to 27.1% for the three months ended June 30, 2022. The increase was primarily attributed to increased share-based compensation expense and expenses for legal claims and settlements. The increase was partially offset by a decrease in outside services.
On a constant currency basis, selling, general and administrative expense increased by $14.3, or 3.8%, for the six months ended June 30, 2023. Selling, general and administrative costs as a percentage of revenues, net increased by 1.7% to 29.9% for the six months ended June 30, 2023, compared to 28.2% for the six months ended June 30, 2022. The increase was primarily attributed to increased share-based compensation expense, increased net people related costs and expenses for legal claims and settlements. The increase was partially offset by a decrease in outside services.
Depreciation and Amortization
Depreciation and Amortization are relatively consistent for the three and six months ended June 30, 2023 and 2022. As a percentage of revenues, net, depreciation and amortization expense increased by 1.0% to 26.6% for the three months ended June 30, 2023 compared to 25.6% for the three months ended June 30, 2022. For the six months ended June 30, 2023, expressed as a percentage of revenues, net, depreciation and amortization expense increased by 0.9% to 27.0% compared to 26.1% for the six months ended June 30, 2022.
Restructuring and lease impairments
Three Months Ended June 30,Change 2023 vs. 2022Six Months Ended June 30,Change 2023 vs. 2022
20232022$%20232022$%
Restructuring and lease impairments$12.2 $19.2 $(7.0)(36.5)%$21.6 $30.9 $(9.3)(30.1)%

41

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
The decrease for the three and six months ended June 30, 2023, was primarily driven by the wind-down of expenses associated with the OneClarivate, CPA Global Acquisition Integration, and Operation Simplification and Optimization Programs. The decrease was partially offset by the Segment Optimization and ProQuest Acquisition Integration Programs. As of June 30, 2023, we are not expecting to incur any significant further costs under the former restructuring plans. See Note 19 - Restructuring and Lease Impairments for further information.
The following table summarizes the total costs incurred to date and expected costs to be incurred in a future period for each program.
Total Costs Incurred to DateCosts Expected to be Incurred in Future Periods
One Clarivate Program$36.7 $— 
ProQuest Acquisition Integration Program68.3 2.0 
Segment Optimization4.6 8.0 
Other Restructuring Programs:
CPA Global Acquisition Integration and Optimization Program128.1 — 
DRG Acquisition Integration Program7.3 — 
Operation Simplification and Optimization Program44.5 — 
Total Other Restructuring Programs$179.9 $— 
Goodwill and intangible asset impairments
The increase for the three and six months ended June 30, 2023 was primarily driven by the impairment charge discussed in Note 4 - Assets Held for Sale and Divested Operations.
Other operating expense (income), net
Three Months Ended June 30,Change 2023 vs. 2022Six Months Ended June 30,Change 2023 vs. 2022
20232022$%20232022$%
Other operating expense (income), net$14.5 $(24.6)$39.1 158.9 %$(17.5)$(38.3)$20.8 54.3 %
The fluctuations for the three and six months ended June 30, 2023, as compared to the three and six months ended June 30, 2022, respectively, were primarily driven by a net loss on foreign exchange re-measurement (as opposed to a net gain in the prior year periods), partially offset by a gain on legal settlement recorded during the six months ended June 30, 2023.
Mark to market gain on financial instruments
Three Months Ended June 30,Change 2023 vs. 2022Six Months Ended June 30,Change 2023 vs. 2022
20232022$%20232022$%
Mark to market gain on financial instruments$(2.9)$(49.0)$(46.1)(94.1)%$(1.8)$(149.4)$(147.6)(98.8)%

The Company accounts for its outstanding private placement warrants as liabilities at fair value on the balance sheet, which are subject to remeasurement at each balance sheet date and any change in fair value is recognized as of the end of each period for which earnings are reported. The change in fair value resulting in a decrease for the three and six months ended June 30, 2023 compared to the three and six months ended June 30, 2022 was driven by the change in the Company’s share price and its impact as an input to the Black-Scholes option valuation model.
Interest expense and amortization of debt discount, Net
42

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Three Months Ended June 30,Change 2023 vs. 2022Six Months Ended June 30,Change 2023 vs. 2022
20232022$%20232022$%
Interest expense and amortization of debt discount, net$73.0 $62.3 $10.7 17.2 %$146.6 $121.8 $24.8 20.4 %
The increase for the three and six months ended June 30, 2023 was primarily attributed to higher floating interest rates on borrowings under the Term Loan Facility, partially offset by debt prepayments and gains under our interest rate swap program.
Provision (benefit) for income taxes
Three Months Ended June 30,Change 2023 vs. 2022Six Months Ended June 30,Change 2023 vs. 2022
20232022$%20232022$%
(Benefit) provision for income taxes$(35.3)$10.5 $(45.8)(436.2)%$(98.9)$26.8 $(125.7)(469.0)%
The overall decrease in tax expense is primarily due to the $33.0 tax benefit recorded in the current quarter associated with the impairment of intangible assets and the $17.1 tax benefit recorded in the current quarter relating to the partial release of valuation allowance recorded against certain US tax attributes. The remaining decrease in tax expense for the six months ended June 30, 2022 relates to the $70.4 tax benefit recorded on the settlement of an open tax dispute. Both the three and six months ended June 30, 2023 are also impacted by the change in the mix of taxing jurisdictions in which pre-tax profits and losses were recognized. The effective tax rate for the three and six months ended June 30, 2023 may not be indicative of our effective tax rates for future periods.
Dividends on preferred shares
Three Months Ended June 30,Change 2023 vs. 2022Six Months Ended June 30,Change 2023 vs. 2022
20232022$%20232022$%
Dividends on preferred shares$18.6 $18.7 $(0.1)(0.5)%$37.4 $37.4 $— — %

Dividends on preferred shares are consistent for the three and six months ended June 30, 2023 and 2022. While the dividends on the MCPS are cumulative, they will not be paid until declared by the Company’s Board of Directors. If no dividends are declared and paid, they will continue to accumulate as the agreement contains a backstop to it being paid even if never declared by the Board.
43

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Certain Non-GAAP Measures
We include non-GAAP measures in this quarterly report, including Adjusted EBITDA, Adjusted EBITDA margin, and Free Cash Flow, because they are a basis upon which our management assesses our performance, and we believe they reflect the underlying trends and indicators of our business by allowing management to focus on the most meaningful indicators of our continuous operational performance.
Although we believe these measures are useful for investors for the same reasons, these measures are not a substitute for GAAP financial measures or disclosures. We provide reconciliations of these non-GAAP measures to the corresponding most closely related GAAP measure.
Adjusted EBITDA and Adjusted EBITDA margin
Adjusted EBITDA is presented because it is a basis upon which our management assesses our performance, and we believe it is useful for investors to understand the underlying trends of our operations. Adjusted EBITDA represents net income (loss) before the provision for income taxes, depreciation and amortization, and interest expense adjusted to exclude acquisition and disposal-related transaction costs, losses on extinguishment of debt, share-based compensation, unrealized foreign currency remeasurement, transformational and restructuring expenses, acquisition-related adjustments to deferred revenues prior to the adoption of FASB ASU No. 2021-08 in 2021, non-operating income or expense, the impact of certain non-cash mark-to-market adjustments on financial instruments, legal settlements, impairments, and other items that are included in net income (loss) for the period that the Company does not consider indicative of its ongoing operating performance and certain unusual items impacting results in a particular period. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by Revenues, net plus the impact of the deferred revenue purchase accounting adjustments relating to acquisitions prior to 2021.
Our presentation of Adjusted EBITDA and Adjusted EBITDA margin should not be construed as an inference that our future results will be unaffected by any of the adjusted items, or that our projections and estimates will be realized in their entirety or at all. In addition, because of these limitations, Adjusted EBITDA should not be considered as a measure of liquidity or discretionary cash available to us to fund our cash needs, including investing in the growth of our business and meeting our obligations.
The following table presents our calculation of Adjusted EBITDA for the three and six months ended June 30, 2023 and 2022, and reconciles these measures to our Net income (loss) for the same periods:
44

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Net (loss) income attributable to ordinary shares$(141.7)$43.7$(117.0)$94.5
Dividends on preferred shares18.618.737.437.4
Net (loss) income$(123.1)$62.4$(79.6)$131.9
(Benefit) provision for income taxes(35.3)10.5(98.9) 26.8
Depreciation and amortization178.1175.6350.7 352.0
Interest expense and amortization of debt discount, net73.062.3146.6 121.8
Deferred revenues adjustment0.8 0.6
Transaction related costs(1)
0.75.12.4 11.8
Share-based compensation expense30.522.171.7 59.1
Restructuring and lease impairments(2)
12.219.221.630.9
Goodwill and intangible asset impairments(3)
135.2135.2
Mark to market gain on financial instruments(4)
(2.9)(49.0)(1.8)(149.4)
Other(5)
16.5(34.6)(10.3) (48.8)
Adjusted EBITDA$284.9$274.4$537.6$536.7
Adjusted EBITDA margin42.6%39.9%41.4%39.8%
(1) Includes costs incurred to complete business combination transactions, including acquisitions, dispositions and capital market activities and include advisory, legal, and other professional and consulting costs.
(2) Primarily reflects severance and related benefit costs related to approved restructuring programs. Refer to Note 19 - Restructuring and Lease Impairments for further information.
(3) Primarily includes the intangible assets impairment recorded during the three months ended June 30, 2023 further discussed in Note 4 - Assets Held for Sale and Divested Operations
(4) Reflects mark-to-market adjustments on the Private Placement Warrants under ASC 815, Derivatives and Hedging. Refer to Note 8 - Fair Value Measurements for further information.
(5) The current year periods primarily include net losses on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. The current year-to-date period was offset by a gain on legal settlement. The prior year periods include net gains on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. Refer to Note 15 - Other Operating Expense (Income), Net and Note 17 - Commitments and Contingencies for further information.

Liquidity and Capital Resources
Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, capital expenditures, debt service, acquisitions, other commitments, and contractual obligations. Our principal sources of liquidity include cash from operating activities, cash and cash equivalents on our Consolidated Balance Sheets and amounts available under our revolving credit facility. We consider liquidity in terms of the sufficiency of these resources to fund our operating, investing and financing activities for a period of 12 months after the financial statement issuance date.
Our cash flows from operations are generated primarily from payments from our subscription and re-occurring transaction customers. As described above, the standard term of a subscription is typically 12 months. When a customer enters into a new subscription agreement, or submits a notice to renew their subscription, we typically invoice for the full amount of the subscription period, record the balance to deferred revenues, and ratably recognize the deferral throughout the subscription period. As a result, we experience cash flow seasonality throughout the year, with a heavier weighting of operating cash inflows occurring during the first half, and particularly first quarter, of the year, when most subscription invoices are sent, as compared to the second half of the year.
We require and will continue to need significant cash resources to, among other things, meet our debt service requirements, fund our working capital requirements, make capital expenditures (including product development), and expand our business through acquisitions. Based on our forecasts, we believe that cash flow from operations, available cash on hand and
45

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
available borrowing capacity under our revolving credit facility will be adequate to service debt, meet liquidity needs and fund necessary capital expenditures for at least the next 12 months. Our future capital requirements will depend on many factors, including the number of future acquisitions and the timing and extent of spending to support product development efforts. We could be required, or could elect, to seek additional funding through public or private equity or debt financings; however, additional funds may not be available on terms acceptable to us.
The below table summarizes our total liquidity for the periods presented:
Total LiquidityJune 30,December 31,
(in millions)20232022
Cash and cash equivalents$436.1 $348.8 
Additional availability under revolving credit facility(1)
741.2 740.5 
$1,177.3$1,089.3
(1) Net of letters of credit utilization of $8.8 and $9.5, respectively.
During the fourth quarter of 2022, the Company made a $300.0 prepayment on our Term Loan Facility and paid the $175.0 outstanding balance on its Revolving Credit Facility, which we had borrowed in November 2021 and used the net proceeds for general corporate purposes. As a result, the Company had no outstanding balance on its Revolving Credit Facility as of December 31, 2022 and June 30, 2023. Refer to Note 9 - Debt in Item 8. Financial Statements and Supplementary Data, for additional information related to outstanding borrowings.
On March 31, 2022, the Company’s direct and indirect subsidiaries that are borrowers or guarantors under the Credit Agreement dated as of October 31, 2019, (the "Credit Agreement") entered into an amendment thereto, pursuant to which the total revolving credit commitments thereunder were increased by $400.0 from $350.0 to $750.0 in the aggregate, and the maturity date for revolving credit commitments was extended to March 31, 2027, subject to a “springing” maturity date. Refer to Note 9 - Debt in Item 8. Financial Statements and Supplementary Data, for additional information related to the "springing" maturity date.
In February 2022, the Company's Board of Directors approved the purchase of up to $1,000.0 of the Company's ordinary shares through open-market purchases, to be executed through December 31, 2023. During the six months ended June 30, 2022, the Company repurchased 10.7 million ordinary shares with a total carrying value of $175.0 which were subsequently retired and restored as authorized but unissued ordinary shares. Upon formal retirement and in accordance with ASC Topic 505, Equity, the Company reduced its ordinary shares account by the carrying amount of the treasury shares. Additionally, given the differences of the original repurchase share value and the value at the time of formal retirements, an associated loss was recognized within the Consolidated Statement of Changes in Equity in the amount of $7.7. In May 2023, the Company's Board of Directors approved the extension of its share repurchase authorization through December 31, 2024, and reduced the authorization from $1,000.0 to $500.0. To enable the buybacks under the Board's authorization, the Company obtained shareholder approval on July 27, 2023 to permit it to conduct open-market purchases of up to 100.0 million of its ordinary shares from time to time as approved by the Board of Directors at a minimum purchase price of $1 per share and maximum purchase price of $35 per share. As of June 30, 2023, the Company had $500.0 of availability remaining under the Board's authorization.
Cash Flows
The following table discloses our consolidated cash flows provided by (used in) operating, investing, and financing activities for the periods presented:

46

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Six Months Ended June 30,
20232022
Net cash provided by operating activities$389.9 $164.6 
Net cash used in investing activities(107.5)(103.4)
Net cash used in financing activities(197.8)(239.4)
Effects of exchange rates1.7 (36.5)
Net increase (decrease) in cash and cash equivalents, and restricted cash$86.3 
 
$(214.7)
Net increase (decrease) in cash and cash equivalents$87.3 $(71.2)
Net decrease in restricted cash(1.0)(143.5)
Net increase (decrease) in cash and cash equivalents, and restricted cash$86.3 $(214.7)
Cash and cash equivalents, beginning of period$348.8 $430.9 
Restricted cash, beginning of period8.0 156.7 
Cash and cash equivalents, and restricted cash beginning of the year
$356.8 $587.6 
Cash and cash equivalents, end of period$436.1 $359.7 
Restricted cash, end of period7.0 13.2 
Cash and cash equivalents, and restricted cash end of the period
$443.1 $372.9 
Cash Flows Provided by Operating Activities
Net cash provided by operating activities consists of net income adjusted for non-cash items, such as depreciation and amortization, deferred income taxes, share-based compensation, restructuring and impairment, mark to market adjustments on financial instruments, deferred finance charges, and for changes in operating assets and liabilities.
The increase of $225.3 in net cash provided by operating activities for the six months ended June 30, 2023, was attributed to improved working capital results and the nonrecurring payments made from restricted cash in the prior year related to the CPA Global Equity Plan.
Cash Flows Used in Investing Activities
Net cash used in investing activities consists primarily of capital expenditures.
The $4.1 increase in cash used in investing activities for the six months ended June 30, 2023, was due to higher capital spending, primarily relating to capitalized costs associated with product and content development.
Cash Flows Used in Financing Activities
The $41.6 decrease in cash used in financing activities for the six months ended June 30, 2023, was primarily due to the $175.0 cash used for repurchases of our ordinary shares in the prior year period offset by $150.0 of prepayments on our Term Loan Facility during the six months ended June 30, 2023.
Free Cash Flow (non-GAAP measure)
The following table reconciles Free cash flow, which is a non-GAAP measure, to net cash provided by operating activities:
47

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Six Months Ended June 30,
20232022
Net cash provided by operating activities$389.9 $164.6 
Capital expenditures(116.9)(89.1)
Free cash flow$273.0 $75.5 
Free cash flow increased $197.5 for the six months ended June 30, 2023, compared to the prior year period, due to increased cash provided by operating activities, partially offset by increased capital expenditures.
Debt Profile
There have been no material changes to the debt profile associated with our business previously disclosed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity section in our Annual Report on Form 10-K for the year ended December 31, 2022, except as set forth below. The disclosures set forth below updates, and should be read together with the disclosures in the Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity - Debt Profile section, in our Annual Report on Form 10-K for the year ended December 31, 2022.
Term Loan Facility (2026)
During the six months ended June 30, 2023, the Company made prepayments of $150.0 on its Term Loan Facility.
On May 26, 2023, Camelot U.S. Acquisition LLC, a subsidiary of Clarivate Plc, entered into Amendment No. 5 to our Credit Agreement, dated as of October 31, 2019 to provide for the transition, with respect to the US dollar-denominated term loans thereunder, from a LIBOR based benchmark rate of interest to a Term SOFR based benchmark rate of interest, with certain credit spread adjustments and consequential amendments. The foregoing description of Amendment No. 5 to our Credit Agreement is qualified in its entirety by reference to the full text of the amendment, a copy of which is filed as an exhibit to this Quarterly Report on Form 10-Q.
The Credit Facilities
The Credit Facilities are secured by substantially all of our assets and the assets of all of our U.S. restricted subsidiaries and certain of our non-U.S. subsidiaries, including those that are or may be borrowers or guarantors under the Credit Facilities, subject to customary exceptions. The Credit Agreement governing the Credit Facilities contain customary events of default and restrictive covenants that limit us from, among other things, incurring certain additional indebtedness, issuing preferred stock, making certain restricted payments and investments, certain transfers or sales of assets, entering into certain affiliate transactions or incurring certain liens. These credit facilities limitations are subject to customary baskets, including certain limitations on debt incurrence and issuance of preferred stock, subject to compliance with a consolidated coverage ratio of Consolidated EBITDA (as defined in the credit facilities), to interest and other fixed charges on certain debt (as defined in the Credit Facilities) of 2.00 to 1.00. In addition, the Credit Facilities require us to comply with a springing financial covenant pursuant to which, as of the first quarter 2020, we must not exceed a total first lien net leverage ratio (as defined under the Credit Facilities) of 7.25 to 1.00, to be tested on the last day of any quarter only when more than 35% of the Revolving Credit Facility (excluding (i) non-cash collateralized, issued and undrawn letters of credit in an amount up to $20.0 and (ii) any cash collateralized letters of credit) is utilized at such date. As of June 30, 2023, our consolidated coverage ratio was 4.1 to 1.00 and our consolidated leverage ratio was 4.0 to 1.00. As of the date of this Report, we are in compliance with the covenants in the credit facilities.
The Credit Facilities provide that, upon the occurrence of certain events of default, our obligations thereunder may be accelerated, and the lending commitments terminated. Such events of default include payment defaults to the lenders, material inaccuracies of representations and warranties, covenant defaults, cross-defaults to other material indebtedness (including the Senior Secured Notes due 2026 and 2028 and Senior Notes due 2029), voluntary and involuntary bankruptcy proceedings, material money judgments, loss of perfection over a material portion of collateral, material ERISA/pension plan events, certain change of control events, and other customary events of default, in each case subject to threshold, notice and grace period provisions.
48

CLARIVATE PLC
Management’s Discussion and Analysis of Financial Condition and Results of Operations
(In millions, except share and per share data, option prices, ratios or as noted)
Commitments and Contingencies
Our contingent liabilities consist primarily of letters of credit and performance bonds and other similar obligations in the ordinary course of business.
Dividends on our mandatory convertible preferred shares are payable, as and if declared by our Board of Directors, at an annual rate of 5.25% of the liquidation preference of $100.00 per share. We may pay declared dividends in cash or, subject to certain limitations, in our ordinary shares, or in any combination of cash and ordinary shares, on March 1, June 1, September 1 and December 1 of each year, commencing on September 1, 2021, and ending on, and including, June 1, 2024. See Note 17 - Commitments and Contingencies in Item 1. Financial Statements and Supplementary Data, for additional information.
The Company is engaged in various legal proceedings and claims that have arisen in the ordinary course of business. We have taken what we believe to be adequate reserves related to the litigation and threatened claims. We maintain appropriate insurance policies in place, which are likely to provide some coverage for these liabilities or other losses that may arise from these litigation matters. See Note 17 - Commitments and Contingencies in Item 1. Financial Statements and Supplementary Data, for additional information.

Critical Accounting Policies, Estimates and Assumptions
There have been no material changes from the critical accounting policies, estimates, and assumptions previously disclosed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies, Estimates and Assumptions section in our Annual Report on Form 10-K for the year ended December 31, 2022.
Recently Issued and Adopted Accounting Pronouncements
For recently issued and adopted accounting pronouncements, see Note 3 - Summary of Significant Accounting Policies in Item 1. Financial Statements and Supplementary Data.

49

Item 3. Quantitative and Qualitative Disclosures About Market Risk
For information regarding our exposure to certain market risks, see “Item 7A. Quantitative and Qualitative Disclosures About Market Risk,” in the Form 10-K for the year ended December 31, 2022.
Foreign Currency Exchange Rate Risk
We are exposed to foreign currency exchange risk related to our transactions and our subsidiaries’ balances that are denominated in currencies other than the U.S. dollar, our functional currency. These currencies may continue to fluctuate, in either direction, especially as a result of central bank responses to inflation, concerns regarding future economic growth and other macroeconomic factors, and such fluctuations will affect financial statement line item comparability.
The following table presents the average of the quarterly weighted average exchange rates of the currencies that have the most significant impact on our business:
Rate for 1 USDThree Months Ended June 30,Six Months Ended June 30,
Currency:20232022Percentage Change20232022Percentage Change
GBP$0.80 $0.80 — %$0.81 $0.77 %
EUR0.92 0.94 (2)%0.93 0.92 %
JPY137.27 129.66 %134.80 123.02 10 %
Interest Rate Risk
Our interest rate risk arises primarily from our borrowings at floating interest rates. Borrowings under our credit facilities are subject to floating interest rates, plus a SOFR adjustment and a margin. As of June 30, 2023, we had $2,347.4 of floating rate debt outstanding under our Term Loan Facility. For our Term Loan Facility, the interest rate is one-month Term SOFR plus a SOFR adjustment of 0.11% (subject to a floor of 0.00% for $1,028.3 and 1.00% for $1,319.1), or Prime plus a margin of 2.25% per annum, as applicable depending on the borrowing. For borrowings under the revolving credit facility, the base interest rate is at Term SOFR, plus a 0.1% SOFR adjustment, plus 3.25% per annum (or 2.75% per annum, based on first lien leverage ratios) or Prime plus a margin of 2.25% per annum, as applicable depending on the borrowing. The interest rate margins under our credit facilities will decrease upon the achievement of certain first lien net leverage ratios (as the term is used in the Credit Agreement). Of the total debt outstanding under our credit facilities, we hedged $1,215.9 of our principal amount of our floating rate debt using interest rate swaps. As a result, $1,131.5 of our outstanding borrowings effectively bore interest at floating rates. A 0.125 basis point increase or decrease in the applicable base interest rate under our credit facilities would have an impact of $0.3 and $0.7 on our cash interest expense during the three and six months ended June 30, 2023.


Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Pursuant to Rules 13a-15(b) and 15d-15(b) under the Securities Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act as of the end of the period covered by this report. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of our controls and procedures relative to their costs.
Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2023, due to the material weakness in our internal control over financial reporting described below, our disclosure controls and procedures were not effective at the reasonable assurance level to ensure that the information required to be disclosed in the reports required to be filed or submitted under the Securities Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our
50

management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Notwithstanding the material weakness, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s condensed consolidated financial statements included in this Quarterly Report are fairly stated in all material respects in accordance with U.S. generally accepted accounting principles for each of the periods presented.
Material Weakness in Internal Control Over Financial Reporting
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. Management identified a material weakness as the Company did not design and maintain effective controls related to the preparation and review of the footnote disclosures included in the Company’s consolidated financial statements, including controls related to the completeness and accuracy of the underlying information used in the preparation of the footnote disclosures. The material weakness was determined to have existed as of December 31, 2022 and remains unremediated as of June 30, 2023, and resulted in immaterial misstatements of our footnote disclosures for the three month period ended March 31, 2023 and the year ended December 31, 2022. Additionally, if left unremediatated, this material weakness could result in additional misstatements of the footnote disclosures that would result in a material misstatement to the annual or interim financial statements that would not be prevented or detected.

Remediation Plan
Management is actively engaged in the planning for, and implementation of, remediation efforts to address the material weakness identified above. Our remediation plan includes the design and implementation of enhanced controls for the preparation of the footnotes to the financial statements, including control activities specifically related to the verification of the completeness and accuracy of the information used in the preparation of the footnote disclosures.
Changes in Internal Control Over Financial Reporting
There were no changes in Clarivate’s internal control over financial reporting during the second quarter 2023 that materially affected, or are reasonably likely to materially affect, internal control over financial reporting.

PART II. Other Information

Item 1. Legal Proceedings
From time to time, we are a party to various lawsuits, claims, and other legal proceedings that arise in the ordinary course of our business. While the outcomes of these matters are uncertain, management does not expect that the ultimate costs to resolve these matters will have a material adverse effect on our consolidated financial position, results of operations, or cash flows. For additional discussion of legal proceedings, see Item 1. Financial Statements and Supplementary Data - Notes to the Condensed Consolidated Financial Statements - Note 17 - Commitments and Contingencies in this Report.

Item 1A. Risk Factors
There have been no material changes to the risk factors associated with the business as previously disclosed in “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2022, except as set forth below. The risk factor set forth below updates, and should be read together with, the risk factors disclosed in “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2022.

We have identified a material weakness in our internal control over financial reporting and if we are not able to remediate the material weakness, or if we identify additional material weaknesses in the future or otherwise fail to design and maintain effective internal control over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent misstatements due to fraud or error.
Management identified a material weakness as the Company did not design and maintain effective controls related to the preparation and review of the footnote disclosures included in the Company’s consolidated financial statements, including controls related to the completeness and accuracy of the underlying information used in the preparation of the footnote disclosures. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial
51

reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis. We concluded that due to the material weakness, our disclosure controls and procedures were not effective at the reasonable assurance level to ensure that the information required to be disclosed in the reports required to be filed or submitted under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
If we fail to design and maintain effective internal control over financial reporting, there could be material misstatements in our consolidated financial statements that we may not be able to prevent or detect on a timely basis and fail to meet our reporting obligations, which would likely cause investors to lose confidence in our reported financial information. This could limit our access to capital markets, adversely affect our results of operations and lead to a decline in the trading price of the ordinary shares. Additionally, ineffective internal control over financial reporting could expose us to an increased risk of fraud or misappropriation of assets and subject us to potential delisting from the stock exchange on which we list or to other regulatory investigations and civil or criminal sanctions.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table sets forth the total number of shares repurchased, the average price paid per share, the total number of shares purchased as part of publicly announced programs, and the approximate dollar value of shares that may yet be purchased under the programs for each month during the three months ended June 30, 2023.

Period
Total Number of Shares Purchased(1)
Average Price Paid Per ShareTotal Number of Shares Purchased As Part of Publicly Announced Plans or Programs
Maximum Dollar Value of Shares That May Yet Be Purchased Under Plans or Programs(2)
April 1, 2023-April 30, 202391,069 $9.31 — $825 
May 1, 2023-May 31, 2023145,483 $8.18 — $500 
June 1, 2023-June 30, 202324,614 $9.25 — $500 
Total 261,166 — 
(1) Includes shares withheld to satisfy tax withholding obligations on behalf of employees that occur upon vesting and delivery of outstanding shares underlying stock options, restricted stock units and performance share units under the 2019 Incentive Award Plan.
(2) In May 2023, the Company's Board of Directors approved the extension of its share repurchase authorization through December 31, 2024, and reduced the authorization from $1,000.0 to $500.0. To enable the buybacks under the Board's authorization, the Company obtained shareholder approval on July 27, 2023 to permit it to conduct open-market purchases of up to 100.0 million of its ordinary shares from time to time as approved by the Board of Directors at a minimum purchase price of $1 per share and maximum purchase price of $35 per share. As of June 30, 2023, the Company had $500.0 of availability remaining under the Board's authorization.

Item 5. Other Information
During the quarter ended June 30, 2023, no director or officer (as defined in Rule 16a-1 under the Exchange Act) of the Company adopted or terminated a Rule 10b5-1 trading plan or adopted or terminated a non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408(a) of Regulation S-K).
As noted in Item 4. Controls and Procedures above, the Company determined that it did not design and maintain effective disclosure controls and procedures due to a material weakness in internal control over financial reporting related to the preparation and review of the footnote disclosures included in the consolidated financial statements, including controls related to the completeness and accuracy of the underlying information used in the preparation of the footnote disclosures. Based upon the foregoing, management and the Audit Committee of the Board of Directors concluded on August 5, 2023, that this control deficiency constitutes a material weakness that existed as of December 31, 2022 and March 31, 2023 and
52

remains unremediated as of June 30, 2023. As of the date of this filing, the Company has determined that this control deficiency has no material impact on the Company’s consolidated financial statements.
As a result, Management’s Report on Internal Control Over Financial Reporting included in Item 9A. Controls and Procedures of the Form 10-K for the fiscal year ended December 31, 2022 should no longer be relied upon. The Company expects to file an amendment to its Annual Report on Form 10-K (the “Form 10-K/A") for the fiscal year ended December 31, 2022 to include disclosures concerning this material weakness. In addition, the Form 10-K/A will include an amended report of our independent registered public accounting firm to reflect an adverse opinion related to the effectiveness of the Company’s internal control over financial reporting as of December 31, 2022. The Form 10-K/A will not contain any revision to the Company’s previously issued consolidated financial statements.

Item 6. Exhibits and Financial Statement Schedules
EXHIBIT INDEX
10.1*
31*
32*
101*
The following information from our Form 10-Q for the quarterly period ended June 30, 2023, formatted in Inline eXtensible Business Reporting Language: (i) Condensed Consolidated Statements of Comprehensive Income (unaudited), (ii) Condensed Consolidated Balance Sheets (unaudited), (iii) Condensed Statements of Operations, (iv) Condensed Consolidated Statements of Changes in Equity (unaudited), (v) Condensed Consolidated Statements of Cash Flows (unaudited), and (vi) the Notes to the Condensed Consolidated Financial Statements (unaudited).
104*
The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL
*    Filed herewith.

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in the City of London, United Kingdom on August 7, 2023.
CLARIVATE PLC
By:/s/ Jonathan M. Collins
Name: Jonathan M. Collins
Title: Executive Vice President & Chief Financial Officer

53
EX-10.1 2 exhibit101-q22023.htm EX-10.1 Document
Execution Version

AMENDMENT NO. 5 TO CREDIT AGREEMENT
This AMENDMENT NO. 5 (this “Amendment”), dated as of May 26, 2023, by and between Camelot U.S. Acquisition LLC, a limited liability company organized and established under the laws of Delaware, as Borrower Representative (the “Borrower Representative”) and Bank of America, N.A., as administrative agent and collateral agent (in such capacities, the “Administrative Agent”), relating to that certain Credit Agreement, dated as of October 31, 2019 (as amended by that certain Incremental Facility Amendment dated as of February 28, 2020, that certain Incremental Facility Amendment dated as of October 1, 2020, that certain Incremental Facility Amendment dated as of November 30, 2021, that certain Incremental Facility Amendment dated as of March 31, 2022 and as further amended, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Existing Credit Agreement” and, as amended hereby, the “Credit Agreement”), among Camelot UK Holdco Limited, a private limited liability company incorporated under the laws of England and Wales with registered number 10314173 (“Holdings”), the Borrower Representative, the other Borrowers party thereto, the several banks, financial institutions, institutional investors and other entities from time to time party thereto as Lenders and the Administrative Agent.
RECITALS:
WHEREAS, the Initial Term Loans and the Amendment No. 2 Incremental Term Loans under the Existing Credit Agreement incur or are permitted to incur interest, fees, commissions or other amounts based on LIBOR (as defined in the Existing Credit Agreement) in accordance with the terms of the Existing Credit Agreement;
WHEREAS, applicable parties under the Credit Agreement have determined, in accordance with Section 2.16(b) of the Existing Credit Agreement, that LIBOR for the Initial Term Loans and the Amendment No. 2 Incremental Term Loans should be replaced with a LIBOR Successor Rate (as defined in the Existing Credit Agreement) in accordance with the Existing Credit Agreement and, in connection therewith, the Administrative Agent has determined that certain LIBOR Successor Rate Conforming Changes (as defined in the Existing Credit Agreement) are necessary or advisable; and
WHEREAS, pursuant to Section 2.16(b) of the Existing Credit Agreement, this Amendment shall become effective without any further action or consent of any party to the Existing Credit Agreement so long as the Administrative Agent has not have received written objection from Lenders comprising the Required Lenders to the Adjustment (as defined in the Existing Credit Agreement) by 5:00 p.m. on the fifth Business Day after such posting of the Amendment by the Administrative Agent (the “Objection Deadline”).
NOW THEREFORE, the parties hereto therefore agree as follows:
Section 1. Defined Terms. Unless otherwise specifically defined herein, each term used herein that is defined in the Credit Agreement has the meaning assigned to such term in the Credit Agreement.
Section 2. Amendments to the Existing Credit Agreement. In accordance with the provisions of Section 11.1 of the Existing Credit Agreement, the parties hereto agree that:
(a)The Existing Credit Agreement shall be amended as set forth on Exhibit A hereto (with inserted text indicated in the following manner: inserted text and deleted text indicated in the following manner: deleted text) effective as of the Effective Date.
(b)Exhibits E and H to the Existing Credit Agreement, the Form of Prepayment Notice and the Form of Borrowing and Conversion/Continuation Request, respectively, are hereby amended and restated in their entirety as set forth on Exhibit B hereto.

    
    
    






Section 3. Representations and Warranties. The Borrower Representative represents and warrants to each other party hereto that (a) it has the organizational power and authority, and the legal right, to enter into, make, deliver and perform this Amendment, (b) it has taken all necessary organizational action to authorize the execution, delivery and performance of this Amendment, and (c) this Amendment has been duly executed and delivered on behalf of the Borrower Representative, and, upon execution, will constitute, a legal, valid and binding obligation of the Borrower Representative, enforceable against it in accordance with its terms, except as enforceability may be limited by any Legal Reservations.
Section 4. Conditions to the Effective Date. This Amendment shall become effective as of the first date (the “Effective Date”) when each of the following conditions shall have been satisfied (or waived by the Administrative Agent):
(a)the Administrative Agent shall have received an executed counterpart hereof from the Borrower Representative and the Administrative Agent;
(b)the Administrative Agent has not received, by the Objection Deadline, written notice of objection to such alternate rate of interest or the amendments to the Existing Credit Agreement as provided herein from the Required Lenders; and
(c)the Administrative Agent shall have received payment for all reasonable and documented invoiced out-of-pocket costs and expenses required to be paid or reimbursed under Section 11.9 of the Credit Agreement on or prior to the Effective Date, in each case to the extent invoiced to the Borrower Representative at least three (3) Business Days prior to the Effective Date.
For purposes of determining whether the conditions specified in this Section 3 have been satisfied on the date hereof, each party hereto shall, by execution and delivery of this Amendment, be deemed to have consented to, waived, approved or accepted, or to be satisfied with, the conditions set forth above.
Section 5. Governing Law; Submission to Jurisdiction; Waivers; Waiver of Jury Trial. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THAT WOULD REQUIRE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION. The provisions of Sections 11.14 and 11.18 of the Credit Agreement, as amended by this Amendment, are incorporated herein by reference, mutatis mutandis.
Section 6. Confirmation of Guarantees and Security Interests. By signing this Amendment, the Borrower Representative hereby confirms, on behalf of itself and the other Loan Parties, that the obligations of the Loan Parties under the Credit Agreement as modified or supplemented hereby and the other Loan Documents (i) are entitled to the benefits of the guarantees and the security interests set forth or created in the Guarantee, the Security Documents and the other Loan Documents, (ii) constitute “Obligations”, “Guarantor Obligations” or other similar term for purposes of the Credit Agreement, the Guarantee, the Security Documents and the other Loan Documents, (iii) notwithstanding the effectiveness of the terms hereof, the Guarantee, the Security Documents and the other Loan Documents, are, and shall continue to be, in full force and effect and are hereby ratified and confirmed in all respects. The Borrower Representative, on behalf of itself and the other Loan Parties, ratifies and confirms that all Liens granted, conveyed, or assigned to the Collateral Agent by each Loan Party pursuant to any Loan Document to which it is a party remain in full force and effect, are not released or reduced, and continue to secure full payment and performance of the Obligations as increased hereby.
Section 7. Counterparts. This Amendment may be executed by one or more of the parties to this Amendment on any number of separate counterparts, and all of said counterparts taken together
2
    





shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Amendment or any document or instrument delivered in connection herewith by facsimile transmission or electronic PDF shall be effective as delivery of a manually executed counterpart of this Amendment or such other document or instrument, as applicable.
Section 8. Miscellaneous.
(a)This Amendment shall constitute a “Loan Document” for all purposes of the Credit Agreement and the other Loan Documents. The provisions of this Amendment are deemed incorporated into the Credit Agreement as if fully set forth therein. The headings of this Amendment are for the purposes of reference only and shall not limit or otherwise affect the meaning hereof.
(b)This Amendment shall not constitute a novation of the Existing Credit Agreement or any other Loan Document.
Section 9. Severability. Any provision of this Amendment that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
Section 10. Transition to Term SOFR. Notwithstanding any other provision herein or in any other Loan Document, any Eurocurrency Loan (as defined in the Existing Credit Agreement) denominated in Dollars that is outstanding as of the Effective Date (each such Eurocurrency Loan, an “Existing LIBOR Loan”) shall continue until the end of the applicable Interest Period (as defined in the Existing Credit Agreement) for such Existing LIBOR Loan, and the provisions of the Existing Credit Agreement applicable thereto shall continue and remain in effect (notwithstanding the entry into this Amendment and the occurrence of the Effective Date) until the end of the applicable Interest Period for such Existing LIBOR Loan. Upon such date, such provisions shall have no further force or effect, and (i) unless a separate election has been delivered by the Borrower Representative to the Administrative Agent specifying a different Interest Period, each such Existing LIBOR Loan shall automatically convert to a Term SOFR Loan with an Interest Period of one month with no further action required by the Borrower Representative and (ii) the terms of the Credit Agreement (notwithstanding this Section 10) shall automatically apply to such Loans without any further action by any party; provided that, for the avoidance of doubt, at any time from and after the Effective Date, the Borrower Representative shall not be permitted to request a Borrowing of, conversion to, or continuation of, any Eurocurrency Loan denominated in Dollars; provided further that, as of the Effective Date, (i) Dollars shall not be considered a currency for which there is a published LIBOR rate and (ii) any outstanding request for a borrowing of new Eurocurrency Loans denominated in Dollars, or to continue an existing Eurocurrency Rate Loan denominated in Dollars, shall be deemed to be a request for a borrowing of, or a conversion to, a Term SOFR Loan without any further action by any party.
3
    




        
IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.
    
    BORROWER REPRESENTATIVE:

    CAMELOT U.S. ACQUISITION LLC
    

    By:                    
        Name:
        Title:


    




[Signature Page – Amendment No. 5]



    BANK OF AMERICA, N.A., as Administrative Agent
    

    By:                    
        Name:
        Title:
    
    

[Signature Page – Amendment No. 5]
        


Exhibit A

Credit Agreement

[See attached.]
    
    

    

EXHIBIT A
CREDIT AGREEMENT
among
CAMELOT UK HOLDCO LIMITED,
as Holdings,
CAMELOT UK BIDCO LIMITED,
as UK Holdco and a Revolving Borrower,
THE BORROWERS SET FORTH ON SCHEDULE 1.1G,
as the US Borrowers,
CAMELOT FINANCE S.A.,
as the Lux Borrower,
certain Restricted Subsidiaries from time to time designated hereunder as Additional Revolving Borrowers,
certain Restricted Subsidiaries from time to time party hereto as Subsidiary Guarantors,
the several Lenders and Issuing Lenders from time to time parties hereto,
and
BANK OF AMERICA, N.A.,
as Administrative Agent
dated as of October 31, 2019,
as amended by the Amendment No. 1 Incremental Facility Amendment dated as of February 28, 2020,
as amended by the Amendment No. 2 Incremental Facility Amendment dated as of October 1, 2020,
as amended by the Amendment No. 3 Incremental Facility Amendment dated as of November 30, 2021,
as amended by the Amendment No. 4 Incremental Facility Amendment dated as of March 31, 2022
and
as amended by Amendment No. 5 dated as of May 26, 2023
    

BofA Securities, Inc.,
Citibank, N.A.,
Goldman Sachs Bank USA,
JPMorgan Chase Bank, N.A.
and




    




RBC Capital Markets1
as Joint Lead Arrangers and Joint Bookrunners
Barclays Bank PLC
and
Morgan Stanley Senior Funding, Inc.
as Joint Bookrunners

Capital One, National Association
and
HSBC Bank USA, N.A.
as Co-Documentation Agents
1 RBC Capital Markets is the brand name for the capital markets activities of Royal Bank of Canada and its affiliates.
    



TABLE OF CONTENTS
Page
SECTION 1. DEFINITIONS
1.1    Defined Terms
1.2    General Interpretive Provisions
1.3    Accounting
1.4    Limited Condition Transactions
1.5    Currency Equivalents Generally
1.6    Change in Currency
1.7    Luxembourg Law Terms
1.8    Foreign Guarantor Provisions
1.9    Certain Calculations
1.10    Delaware LLC Divisions
1.11    Interest Rates
SECTION 2. AMOUNT AND TERMS OF COMMITMENTS
2.1    Term Commitments
2.2    Procedure for Borrowing Term Loans
2.3    Repayment of Term Loans
2.4    Revolving Commitments
2.5    Procedure for Borrowing of Revolving Loans
2.6    Swingline Commitment
2.7    Procedure for Swingline Borrowing; Refunding of Swingline Loans
2.8    Commitment Fees, etc
2.9    Termination or Reduction of Revolving Commitments
2.10    Optional Prepayments
2.11    Mandatory Prepayments and Commitment Reductions
2.12    Conversion and Continuation Options
2.13    Limitations on Eurocurrency Tranches and Term SOFR Tranches
2.14    Interest Rates and Payment Dates
2.15    Computation of Interest and Fees
2.16    Inability to Determine Interest Rate; Illegality
2.17    Pro Rata Treatment and Payments; Sharing of Payments by Lenders
2.18    Requirements of Law
2.19    Taxes
2.20    [Reserved]
2.21    Indemnity
2.22    Change of Lending Office
2.23    Replacement of Lenders
2.24    Evidence of Debt; Notes
2.25    Incremental Credit Extensions
2.26    Refinancing Amendments
2.27    Defaulting Lenders
2.28    Loan Modification Offers
2.29    Currency Equivalents
-i-
    


2.30    Additional Alternative Currencies
SECTION 3. LETTERS OF CREDIT
3.1    L/C Commitment
3.2    Procedure for Issuance of Letter of Credit
3.3    Fees and Other Charges
3.4    L/C Participations
3.5    Reimbursement Obligation of the Revolving Borrowers
3.6    Obligations Absolute
3.7    Letter of Credit Payments
3.8    Applications
3.9    Letter of Credit Amounts
3.10    Alternative Currency Letters of Credit
SECTION 4. REPRESENTATIONS AND WARRANTIES
4.1    Financial Condition
4.2    No Change
4.3    Existence; Compliance with Law
4.4    Power; Authorization; Enforceable Obligations
4.5    No Legal Bar
4.6    Litigation
4.7    Ownership of Property; Liens
4.8    Intellectual Property
4.9    Taxes
4.10    Federal Regulations
4.11    Employee Benefit Plans
4.12    Investment Company Act
4.13    Environmental Matters
4.14    Accuracy of Information, etc.
4.15    Security Documents
4.16    Solvency
4.17    Patriot Act; FCPA; OFAC; Sanctions
4.18    Beneficial Ownership Certificate
4.19    Use of Proceeds
4.20    Governing Law and Enforcement
4.21    Centre of Main Interests
SECTION 5. CONDITIONS PRECEDENT
5.1    Conditions to Closing Date
5.2    Conditions to Each Borrowing Date
SECTION 6. AFFIRMATIVE COVENANTS
6.1    Financial Statements
6.2    Certificates; Other Information
6.3    Payment of Taxes
6.4    Maintenance of Existence; Compliance with Law
6.5    Maintenance of Property; Insurance
6.6    Inspection of Property; Books and Records; Discussions
6.7    Notices
-ii-
    


6.8    Environmental Laws
6.9    Additional Collateral, etc.
6.10    Credit Ratings
6.11    Further Assurances
6.12    Designation of Unrestricted Subsidiaries
6.13    Employee Benefit Plans
6.14    Use of Proceeds
6.15    Post-Closing Matters
6.16    FCPA; OFAC; Sanctions
6.17    Centre of Main Interests
6.18    Transactions with Affiliates.
6.19    Lines of Business; Holding Company
6.20    Lux Borrower
SECTION 7. NEGATIVE COVENANTS
7.1    First Lien Net Leverage Ratio
7.2    Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock
7.3    Limitation on Restricted Payments
7.4    Dividend and Other Payment Restrictions Affecting Subsidiaries
7.5    Asset Sales
7.6    [Reserved]
7.7    Liens
7.8    Fundamental Changes
7.9    [Reserved]
7.10    Changes in Fiscal Periods
7.11    Negative Pledge Clauses
SECTION 8. GUARANTEE
8.1    The Guarantee
8.2    Obligations Unconditional
8.3    Reinstatement
8.4    No Subrogation
8.5    Remedies
8.6    Instrument for the Payment of Money
8.7    Continuing Guarantee
8.8    General Limitation on Guarantor Obligations
8.9    Release of Subsidiary Guarantors
8.10    Right of Contribution
8.11    Keepwell
8.12    Limitations
SECTION 9. EVENTS OF DEFAULT
9.1    Events of Default
9.2    [Reserved]
9.3    Action in Event of Default
9.4    Right to Cure
9.5    Application of Proceeds
-iii-
    


9.6    Clean-Up Period
SECTION 10. ADMINISTRATIVE AGENT
10.1    Appointment and Authority
10.2    Rights as a Lender
10.3    Exculpatory Provisions
10.4    Reliance by Administrative Agent
10.5    Delegation of Duties
10.6    Resignation and Removal of Administrative Agent
10.7    Non-Reliance on Administrative Agent, the Joint Lead Arrangers, the Incremental Facility Arrangers and the Other Lenders
10.8    No Other Duties, Etc.
10.9    Administrative Agent May File Proofs of Claim; Credit Bidding
10.10    Collateral and Guaranty Matters
10.11    Intercreditor Agreements
10.12    Withholding Tax Indemnity
10.13    Indemnification
10.14    Appointment of Incremental Arrangers, Refinancing Arrangers and Loan Modification Agents
10.15    Certain ERISA Matters
SECTION 11. MISCELLANEOUS
11.1    Amendments and Waivers
11.2    Notices
11.3    No Waiver; Cumulative Remedies
11.4    Survival of Representations and Warranties
11.5    Payment of Expenses
11.6    Successors and Assigns; Participations and Assignments
11.7    [Reserved]
11.8    Adjustments; Set-off
11.9    [Reserved]
11.10    Counterparts; Electronic Execution
11.11    Severability
11.12    Integration
11.13    Governing Law
11.14    Submission To Jurisdiction; Waivers
11.15    Acknowledgements
11.16    Acknowledgement and Consent to Bail-In of EEA Financial Institutions
11.17    Confidentiality
11.18    Waivers Of Jury Trial
11.19    USA Patriot Act Notification
11.20    Maximum Amount
11.21    Lender Action
11.22    No Fiduciary Duty
11.23    [Reserved]
11.24    Conduct of Business by the Lenders
11.25    Acknowledgment Regarding Any Supported QFCs
-iv-
    


SECTION 12. CO-BORROWER ARRANGEMENTS AND BORROWER REPRESENTATIVE
12.1    Addition of Additional Revolving Borrowers
12.2    Status of Borrowers
12.3    Resignation of Additional Revolving Borrowers
12.4    Appointment of Borrower Representative; Nature of Relationship
12.5    Powers
12.6    Employment of Agents
12.7    Execution of Loan Documents



SCHEDULES:
1.1A-1    Commitments
1.1A-2    L/C Sublimit
1.1B    Agreed Security Principles
1.1C    Foreign Security Documents
1.1D    Permitted Investments
1.1E    Permitted Liens
1.1F    Existing Swap Agreements
1.1G    US Borrowers
1.8    Foreign Guarantor Provisions
3.1    Existing Letters of Credit
4.9    Taxes
5.1(g)    Local Counsel Opinions
6.15    Post-Closing Undertakings
7.2    Permitted Indebtedness
11.2    Administrative Agent’s Office; Certain Addresses for Notices
EXHIBITS:
A-1    Form of US Pledge Agreement
A-2    Form of US Security Agreement
B    Form of Assignment and Assumption
C    Form of Compliance Certificate
C-1    Form of Exemption Certificate
C-2    Form of Exemption Certificate
C-3    Form of Exemption Certificate
C-4    Form of Exemption Certificate
D    [Reserved]
E    Form of Prepayment Notice
F-1    Form of Revolving Loan Note
F-2    Form of Swingline Loan Note
F-3    Form of Term Loan Note
G    Form of Guarantor Joinder Agreement
H    Form of Borrowing and Conversion/Continuation Request
I    Form of Solvency Certificate
J    [Reserved]
K    [Reserved]
L    Form of Swingline Borrowing Request
M    Form of Borrower Joinder

-v-
    


CREDIT AGREEMENT (this “Agreement”), dated as of October 31, 2019 and as amended by the Incremental Facility Amendment dated as of February 28, 2020 and the Incremental Facility Amendment dated as of October 1, 2020, among Camelot UK Holdco Limited, a private limited liability company incorporated under the laws of England and Wales with registered number 10314173 (“Holdings”), Camelot UK Bidco Limited, a private limited liability company incorporated under the laws of England and Wales with registered number 10267893 (“UK Holdco”), the borrowers listed on Schedule 1.1G hereto (collectively, the “US Borrowers”), Camelot Finance S.A., a public limited liability company (société anonyme) organized and established under the laws of the Grand Duchy of Luxembourg (“Luxembourg”), having its registered office at 14, rue Edward Steichen, L-2540 Luxembourg and registered with the Luxembourg Trade and Companies Register (the “Companies Register”) under number B 208514 (the “Lux Borrower” and, together with the US Borrowers, each a “Term Borrower” and, collectively, the “Term Borrowers”), certain Restricted Subsidiaries from time to time designated hereunder as Additional Revolving Borrowers (together with the Lux Borrower, UK Holdco and Camelot U.S. Acquisition LLC, a limited liability company organized and established under the laws of Delaware, each a “Revolving Borrower” and, collectively, the “Revolving Borrowers” and the Revolving Borrowers, together with the Term Borrowers, each a “Borrower” and, collectively, the “Borrowers”), the Subsidiary Guarantors from time to time party hereto (including through delivery of a Guarantor Joinder Agreement in accordance with the terms of this Agreement), the several banks, financial institutions, institutional lenders and other entities from time to time party hereto as lenders (the “Lenders”), the Issuing Lenders from time to time party hereto and Bank of America, N.A., as Administrative Agent.
W I T N E S S E T H:
WHEREAS, (i) certain of the Borrowers are party to that certain Credit Agreement originally dated as of October 3, 2016 (as amended, supplemented or otherwise modified, the “Existing Credit Agreement”) by and among, inter alios, Holdings, UK Holdco, certain of the Borrowers, certain Restricted Subsidiaries party thereto as Subsidiary Guarantors, the Lenders and Issuing Lenders party thereto and Credit Suisse AG, Cayman Islands Branch, as Administrative Agent and (ii) the Lux Borrower is party, as issuer, to that certain Indenture dated as of October 3, 2016 (as amended, supplemented or otherwise modified, the “Existing Senior Notes Indenture”) by and among, inter alios, the Lux Borrower, certain Restricted Subsidiaries party thereto as Subsidiary Guarantors and Wilmington Trust, National Association, as trustee, pursuant to which the Lux Borrower has issued those certain 7.875% Senior Notes due 2024 in an aggregate principal amount of $500,000,000 (the “Existing Senior Notes”);
WHEREAS, the Borrowers intend to effect the Closing Date Refinancing of the Existing Credit Agreement and the Existing Senior Notes Indenture;
WHEREAS, the Lux Borrower intends to issue $700,000,000 in aggregate principal amount of 4.50% senior secured notes of the Lux Borrower due 2026 (as substituted, replaced, extended, renewed, restated or refinanced, including any replacement or refinancing facility or indenture or other financing arrangement that increases or decreases the amount permitted to be borrowed or incurred thereunder or alters the maturity thereof and whether by the same or any other agent, lender or group of lenders and whether for the same or any other purpose, and any amendments, supplements, modifications, extensions, renewals, restatements, amendments and restatements or refundings thereof or any such indentures or facilities or other financing arrangement that replace or refinance such credit facility (or any subsequent replacement thereof), in each case to the extent permitted or not restricted by this Agreement, the “Senior Secured Notes”) pursuant to that certain Indenture dated as of the Closing Date (as amended, supplemented, substituted, replaced, extended, renewed, restated or refinanced or otherwise modified, the “Senior Secured Notes Indenture”) by and among, inter alios, the Lux Borrower, as issuer, the Restricted Subsidiaries party thereto as subsidiary guarantors and Wilmington Trust, National Association, as trustee;
WHEREAS, for the purposes described herein, the Lenders agreed to extend certain credit facilities consisting of (i) Term Loans made available to the Term Borrowers in an aggregate principal amount of $900,000,000 (the “Closing Date Term Loan Facility”) and (ii) Revolving Commitments (which Revolving Commitments include sub-facilities as set forth herein with respect to L/C
1
    



Commitments and Swingline Commitments) made available to the Revolving Borrowers in an aggregate principal amount of $250,000,000;
WHEREAS, the Borrowers intend that a portion of the proceeds of the Facilities and/or the Senior Secured Notes shall be used to satisfy, or to make a distribution or series of distributions to Camelot Holdings (Jersey) Limited (“Camelot Jersey”) or another applicable parent entity of UK Holdco in order to enable Camelot Jersey or such parent entity to satisfy, the obligations of Camelot Jersey pursuant to that certain Buyout Agreement dated as of August 21, 2019 by and among Camelot Jersey and Onex Partners IV LP, including the making of the “Buyout Payment” as defined therein (the transactions described in this paragraph, the “TRA Payment”);
WHEREAS, each Borrower agreed to guarantee the Obligations of each other Borrower (subject to certain limitations set forth in the Loan Documents and the Agreed Security Principles);
WHEREAS, each Borrower agreed to secure all of its respective Obligations by granting to the Collateral Agent, for the benefit of the Secured Parties, a lien on substantially all of its assets (subject to certain limitations set forth in the Loan Documents and the Agreed Security Principles); and
WHEREAS, Holdings and each Subsidiary Guarantor agreed to guarantee the Obligations of each Borrower and to secure their respective Obligations by granting to the Collateral Agent, for the benefit of the Secured Parties, a lien on substantially all of its assets (subject, in each case, to certain limitations set forth in the Loan Documents and the Agreed Security Principles).
NOW, THEREFORE, the parties hereto hereby agree as follows:
SECTION 1.
DEFINITIONS
1.aDefined Terms. As used in this Agreement (including the recitals hereof), the terms listed in this Section 1.1 shall have the respective meanings set forth in this Section 1.1.
ABR”: for any day a fluctuating rate per annum equal to the highest of (a) the Federal Funds Rate plus ½ of 1%, (b) the Prime Rate, and (c) Term SOFR with an Interest Period of one month plus 1.0%. If ABR is being used as an alternate rate of interest pursuant to Section 2.16 hereof, then to the extent affected, ABR shall be equal to the higher of clauses (a) and (b) above and shall be determined without reference to clause (c) above.
ABR Loans”: Loans the rate of interest applicable to which is based upon the ABR. All ABR Loans shall be denominated in Dollars.
Acceptable Intercreditor Agreement”: (a) the Initial Intercreditor Agreement, (b) an intercreditor or subordination agreement or arrangement the terms of which are consistent with market terms governing intercreditor arrangements for the sharing or subordination of liens or arrangements relating to the distribution of payments, as applicable, at the time the applicable agreement or arrangement is proposed to be established in light of the type of Indebtedness subject thereto (a “Market Intercreditor Agreement”) and (c) in the case of the Initial Intercreditor Agreement or in the event a Market Intercreditor Agreement has been entered into after the Closing Date, an intercreditor or subordination agreement or arrangement the terms of which are, taken as a whole, not materially less favorable to the Lenders than the terms of the Initial Intercreditor Agreement or such Market Intercreditor Agreement to the extent such agreement governs similar priorities, in each case of clause (b) or (c) as determined by the Borrower Representative and the Administrative Agent in good faith and as reasonably acceptable to the Administrative Agent.
Acceptable Price”: as defined in the definition of “Dutch Auction.”
Accepting Lenders”: as defined in Section 2.28(a).
2
    



Acquired Indebtedness”: with respect to any specified Person:
(i)Indebtedness of any other Person existing at the time such other Person is merged with or into or became a Restricted Subsidiary whether or not such Indebtedness is incurred in connection with, or in contemplation of, such other Person merging with or into, or becoming a Restricted Subsidiary; and
(ii)Indebtedness secured by a Lien encumbering any asset acquired by such specified Person;
provided that any Indebtedness of such Person that is extinguished, redeemed, defeased, retired or otherwise repaid at the time of or immediately upon consummation of the transaction pursuant to which such other Person becomes a Subsidiary of the specified Person will not be Acquired Indebtedness.
Additional Lender”: at any time, any bank, financial institution or institutional lender or other entity that agrees to provide any portion of any (a) Incremental Revolving Commitments, Additional/Replacement Revolving Commitments or Incremental Term Loans pursuant to an Incremental Amendment in accordance with Section 2.25 or (b) Permitted Credit Agreement Refinancing Debt pursuant to a Refinancing Amendment in accordance with Section 2.26; provided that (i) the Administrative Agent, each Issuing Lender and the Swingline Lender shall have consented (not to be unreasonably withheld, conditioned or delayed) to such Additional Lender if such consent would be required under Section 11.6(b) for an assignment of Loans or Revolving Commitments, as applicable, to such Additional Lender, (ii) the Borrower Representative shall have consented to such Additional Lender, (iii) if such Additional Lender is an Affiliated Lender, such Additional Lender must comply with the limitations and restrictions set forth in Section 11.6(b)(iv) and (iv) such Additional Lender will become a party to this Agreement.
Additional/Replacement Revolving Commitments”: as defined in Section 2.25(a).
Additional Revolving Borrowers”: Restricted Subsidiaries of UK Holdco from time to time designated by the Borrower Representative to the Administrative Agent as “borrowers” with respect to the Revolving Borrowings in accordance with Section 12, and “Additional Revolving Borrower” means any one of them.
Administrative Agent”: Bank of America, N.A., as the administrative agent for the Lenders under this Agreement and the other Loan Documents, together with any of its successors in such capacity.
Administrative Agent’s Office”: with respect to any currency, the Administrative Agent’s address and, as appropriate, account as set forth on Schedule 11.2 with respect to such currency, or such other address or account with respect to such currency as the Administrative Agent may from time to time notify to the Borrower Representative and the Lenders.
Affiliate”: with respect to any specified Person, any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For purposes of this definition, “control” (including, with correlative meanings, the terms “controlling”, “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise.
Affiliated Lender”: the Sponsor, any Debt Fund Affiliate or any Non-Debt Fund Affiliate.
Aggregate Exposure”: with respect to any Lender at any time, an amount equal to (a) until the Closing Date, the aggregate amount of such Lender’s Commitments at such time and (b) thereafter, the sum of (i) the aggregate then unpaid principal amount of such Lender’s Term Loans and (ii) the amount of such Lender’s Revolving Commitment then in effect or, if the Revolving Commitments have been terminated, the amount of such Lender’s Revolving Extensions of Credit then outstanding.
3
    



Aggregate Exposure Percentage”: with respect to any Lender at any time, the ratio (expressed as a percentage) of such Lender’s Aggregate Exposure at such time to the Aggregate Exposure of all Lenders at such time.
Agreed Currency”: Dollars or any Alternative Currency, as applicable.
Agreed Security Principles”: the principles set forth in Section 6.9(c) and the “Agreed Security Principles” set forth on Schedule 1.1B hereto.
Agreement”: as defined in the preamble hereto, as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms and conditions hereof.
Alternative Currency”: (i) (x) Euros, Australian Dollars and Sterling and (y) solely in the case of a Letter of Credit, Yen and Swiss Francs and (ii) subject to Section 2.30, any other currency.
Alternative Currency Letter of Credit”: as defined in Section 3.1.
Amendment No. 1 Effective Date”: February 28, 2020.
Amendment No. 1 Incremental Facility Amendment”: that certain Incremental Facility Amendment, dated as of February 28, 2020, among Holdings, the Borrowers, the Guarantors party thereto, the Amendment No. 1 Incremental Term Lenders and the Administrative Agent.
Amendment No. 1 Incremental Facility Arrangers”: Citibank, N.A., Goldman Sachs Bank USA, RBC Capital Markets, LLC, BofA Securities, Inc. and Barclays Bank PLC.
Amendment No. 1 Incremental Facility Transactions”: the “Incremental Facility Transactions” as defined in the Amendment No. 1 Incremental Facility Amendment.
Amendment No. 1 Incremental Term Commitment”: as to any Amendment No. 1 Incremental Term Lender, the obligation of such Amendment No. 1 Incremental Term Lender, if any, to make an Amendment No. 1 Incremental Term Loan to the Term Borrowers in a principal amount not to exceed the amount set forth under the heading “New Term Commitment” opposite such Amendment No. 1 Incremental Term Lender’s name on Schedule 1 to the Amendment No. 1 Incremental Facility Amendment The original aggregate principal amount of the Amendment No. 1 Incremental Term Commitments is $360,000,000 on the Amendment No. 1 Effective Date.
Amendment No. 1 Incremental Term Facility”: the Facility under which the Amendment No. 1 Incremental Term Loans are made available on the Amendment No. 1 Effective Date pursuant to the Amendment No. 1 Incremental Facility Amendment.
Amendment No. 1 Incremental Term Lenders”: the “New Term Lenders” as defined in the Amendment No. 1 Incremental Facility Amendment and their permitted successors and assigns.
Amendment No. 1 Incremental Term Loans”: the Term Loans made by the Amendment No. 1 Incremental Term Lenders to the Term Borrowers pursuant to Section 2.1(ii).
Amendment No. 2 Effective Date”: October 1, 2020.
Amendment No. 2 Incremental Facility Amendment”: that certain Incremental Facility Amendment, dated as of the Amendment No. 2 Effective Date, among Holdings, the Borrowers, the Guarantors party thereto, the Amendment No. 2 Incremental Term Lenders and the Administrative Agent.
Amendment No. 2 Incremental Facility Arrangers”: Citigroup Global Markets Inc., BofA Securities, Inc., RBC Capital Markets, LLC, Barclays Bank PLC, HSBC Securities (USA) Inc. and JPMorgan Chase Bank, N.A.
4
    



Amendment No. 2 Incremental Facility Transactions”: as defined in the Amendment No. 2 Incremental Facility Amendment.
Amendment No. 2 Incremental Term Commitment”: as to any Amendment No. 2 Incremental Term Lender, the obligation of such Amendment No. 2 Incremental Term Lender, if any, to make an Amendment No. 2 Incremental Term Loan to the Term Borrowers in a principal amount not to exceed the amount set forth under the heading “Amendment No. 2 Incremental Term Commitment” opposite such Amendment No. 2 Incremental Term Lender’s name on Schedule 1 to the Amendment No. 2 Incremental Facility Amendment. The original aggregate principal amount of the Amendment No. 2 Incremental Term Commitments is $1,600,000,000 on the Amendment No. 2 Effective Date.
Amendment No. 2 Incremental Term Facility”: the Facility under which the Amendment No. 2 Incremental Term Loans are made available on the Amendment No. 2 Effective Date pursuant to the Amendment No. 2 Incremental Facility Amendment.
Amendment No. 2 Incremental Term Lenders”: as defined in the Amendment No. 2 Incremental Facility Amendment and their permitted successors and assigns.
Amendment No. 2 Incremental Term Loans”: the Term Loans made by the Amendment No. 2 Incremental Term Lenders to the Term Borrowers pursuant to Section 2.1(iii).
Amendment No. 3 Effective Date”: November 30, 2021.
Amendment No. 3 Incremental Facility Amendment”: that certain Incremental Facility Amendment, dated as of the Amendment No. 3 Effective Date, among Holdings, the Borrowers, the Guarantors party thereto, the 2021 Incremental Revolving Lenders (as defined therein) party thereto, the Issuing Lenders party thereto and the Administrative Agent.
Amendment No. 3 Incremental Revolving Lenders”: the 2021 Incremental Revolving Lenders as defined in the Amendment No. 3 Incremental Facility Amendment.
Amendment No. 4 Effective Date”: March 31, 2022.
Amendment No. 4 Incremental Facility Amendment”: that certain Incremental Facility Amendment, dated as of the Amendment No. 4 Effective Date, among Holdings, the Borrowers, the Guarantors party thereto, the Amendment No. 4 Incremental Revolving Lenders party thereto, the Issuing Lenders party thereto and the Administrative Agent.
Amendment No. 4 Incremental Facility Arrangers”: BofA Securities, Inc., Citigroup Global Markets Inc., Goldman Sachs Bank USA, JPMorgan Chase Bank, N.A. and RBC Capital Markets, LLC.
Amendment No. 4 Incremental Revolving Lenders”: the 2022 Incremental Revolving Lenders as defined in the Amendment No. 4 Incremental Facility Amendment.
Amendment No. 5”: that certain Amendment, dated as of the Amendment No. 5 Effective Date, between the Borrower Representative and the Administrative Agent.
Amendment No. 5 Effective Date”: May 26, 2023.
Anti-Corruption Laws”: Laws relating to anti-bribery or anti-corruption (governmental or commercial), including, without limitation, Laws that prohibit the corrupt payment, offer, promise, receipt, request or authorization of the payment or transfer of anything of value (including gifts or entertainment), directly or indirectly, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the UK Bribery Act of 2010, any Law enacted in connection with, or arising under, the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, and any other Law of any foreign or domestic jurisdiction of similar effect or that relates to bribery or corruption.
5
    



Applicable Discount”: as defined in the definition of “Dutch Auction.”
Applicable Authority”: (a) with respect to Term SOFR, CME or any Governmental Authority having jurisdiction over the Administrative Agent or CME, and (b) with respect to any Alternative Currency, the applicable administrator for the Relevant Rate for such Alternative Currency or any Governmental Authority having jurisdiction over the Administrative Agent or such administrator.
Applicable Jurisdiction”: (i) with respect to the Revolving Facility and/or the Term Facility, the United States, Luxembourg and England and Wales, (ii) with respect to the Revolving Facility, Germany and Spain or (iii) any other jurisdiction approved by the Revolving Lenders or the Term Lenders, as applicable, and the Administrative Agent, in each case, acting reasonably and in good faith.
Applicable Margin”: with respect to:
(iii)any Revolving Loan, (i) initially, 3.25% per annum in the case of Eurocurrency Loans, Term SOFR Loans and Sterling Daily Rate Loans and 2.25% per annum in the case of ABR Loans and (ii) from and after the first Business Day immediately following the delivery to the Administrative Agent of a Compliance Certificate (pursuant to Section 6.2(c)), commencing with the first full fiscal quarter of UK Holdco ending after the Closing Date, wherein the First Lien Net Leverage Ratio is (A) greater than 4.50 to 1.00, 3.25% per annum in the case of Eurocurrency Loans, Term SOFR Loans and Sterling Daily Rate Loans and 2.25% per annum in the case of ABR Loans, (B) less than or equal to 4.50 to 1.00 and greater than 4.00 to 1.00, 3.00% per annum in the case of Eurocurrency Loans, Term SOFR Loans and Sterling Daily Rate Loans and 2.00% per annum in the case of ABR Loans, and (C) less than or equal to 4.00 to 1.00, 2.75% per annum in the case of Eurocurrency Loans, Term SOFR Loans and Sterling Daily Rate Loans and 1.75% per annum in the case of ABR Loans;
(iv)any Initial Term Loan (including the Amendment No. 1 Incremental Term Loans), (i) initially 3.25% per annum in the case of Term SOFR Loans and 2.25% per annum in the case of ABR Loans and (ii) from and after the first Business Day immediately following the delivery to the Administrative Agent of a Compliance Certificate (pursuant to Section 6.2(c)), commencing with the first full fiscal quarter of UK Holdco ending after the Closing Date, wherein the Total Net Leverage Ratio is (A) greater than 4.50 to 1.00, 3.25% per annum in the case of Term SOFR Loans and 2.25% per annum in the case of ABR Loans and (B) less than or equal to 4.50 to 1.00, 3.00% per annum in the case of Term SOFR Loans and 2.00% per annum in the case of ABR Loans;
(v)any Amendment No. 2 Incremental Term Loan, 3.00% per annum in the case of Term SOFR Loans and 2.00% per annum in the case of ABR Loans;
(vi)any Incremental Term Loan (other than the Amendment No. 1 Incremental Term Loans and the Amendment No. 2 Incremental Term Loans), the Applicable Margin shall be as set forth in the Incremental Amendment relating to the Incremental Term Commitment in respect of such Incremental Term Loan;
(vii)any Other Term Loan or any Other Revolving Loan, the Applicable Margin shall be as set forth in the Refinancing Amendment relating to such Loan; and
(viii)any Extended Term Loan or any Extended Revolving Loan, the Applicable Margin shall be as set forth in the Loan Modification Agreement relating to such Loan.
Any increase or decrease in the Applicable Margin resulting from a change in the First Lien Net Leverage Ratio or Total Net Leverage Ratio shall become effective as of the first Business Day immediately following the date a Compliance Certificate is delivered pursuant to Section 6.2(c); provided that the pricing level as set forth above in clause (a)(ii)(A) and (b)(ii)(A), as applicable, shall apply as of (x) the first Business Day after the date on which a Compliance Certificate was required to have been delivered but was not delivered, and shall continue to so apply to and including the date on which such Compliance Certificate is so delivered (and thereafter the pricing level otherwise determined in accordance with this definition shall apply) and (y) at the option of the Required Lenders, the first Business Day after an Event of Default under Section 9.1(a) shall have occurred and be continuing, and
6
    



shall continue to so apply to but excluding the date on which such Event of Default is cured or waived (and thereafter the pricing level otherwise determined in accordance with this definition shall apply).
In the event that any financial statements delivered pursuant to Section 6.1 or a Compliance Certificate delivered pursuant to Section 6.2(c) are shown to be inaccurate at any time that this Agreement is in effect and any Loans or Commitments are outstanding hereunder when such inaccuracy is discovered and such inaccuracy, if corrected, would have led to a higher Applicable Margin for any period (an “Applicable Period”) than the Applicable Margin applied for such Applicable Period, then (i) the Borrower Representative shall promptly (and in no event later than five (5) Business Days thereafter) deliver to the Administrative Agent a correct Compliance Certificate for such Applicable Period, (ii) the Applicable Margin shall be determined by reference to the corrected Compliance Certificate (but in no event shall the Lenders owe any amounts to the Borrowers) and (iii) the Borrower Representative shall pay to the Administrative Agent promptly upon demand (and in no event later than five (5) Business Days after demand) any additional interest owing as a result of such increased Applicable Margin for such Applicable Period, which payment shall be promptly applied by the Administrative Agent in accordance with the terms hereof. Notwithstanding anything to the contrary in this Agreement, any additional interest hereunder shall not be due and payable until demand is made for such payment pursuant to clause (iii) above and accordingly, any nonpayment of such interest as result of any such inaccuracy shall not constitute a Default (whether retroactively or otherwise), and no such amounts shall be deemed overdue (and no amounts shall accrue interest pursuant to Section 2.14(d)), at any time prior to the date that is five (5) Business Days following such demand.
Applicable Requirements”: in respect of any Indebtedness, Indebtedness that satisfies the following requirements:
(ix)other than Customary Bridge Financings and Indebtedness incurred pursuant to the Inside Maturity Basket, such Indebtedness does not mature prior to the Term Loan Maturity Date and does not have a Weighted Average Life to Maturity shorter than the remaining Weighted Average Life to Maturity of the Initial Term Loans or the Amendment No. 2 Incremental Term Loans determined at the time of incurrence;
(x)if such Indebtedness is secured by the Collateral, a Senior Representative acting on behalf of the holders of such Indebtedness has become party to an Acceptable Intercreditor Agreement (or any Acceptable Intercreditor Agreement has been amended or replaced in a manner reasonably acceptable to the Administrative Agent), which results in such Senior Representative having rights to share in the Collateral on a pari passu or junior basis, as applicable;
(xi)[reserved];
(xii)[reserved]; and
(xiii)the other terms and conditions of such Indebtedness (excluding pricing, fees, rate floors, premiums, optional prepayment or optional redemption provisions and financial covenants) are (i) taken as a whole, not materially less favorable to the Borrowers of such Indebtedness than those set forth in the Loan Documents (when taken as a whole) as determined by the Borrower Representative in good faith, (ii) customary for “high yield” notes of the type being incurred at the time of incurrence (it being agreed that such Indebtedness may be in the form of notes or a credit agreement) as determined by the Borrower Representative in good faith or (iii) then-current market terms (as determined by the Borrower Representative in good faith) for the applicable type of Indebtedness except in each case for covenants or other provisions contained in such Indebtedness that are applicable only after the Latest Maturity Date or added for the benefit of the existing Revolving Facility (in the case of revolving Indebtedness) or Term Facility (in the case of term Indebtedness); provided that, in the case of clause (iii), if such Indebtedness benefits from a financial covenant that is more restrictive than Section 7.1 of this Agreement, such financial covenant shall be either (A) conformed (or added) to the Loan Documents for the benefit of the Revolving Lenders pursuant to an amendment agreement between the Administrative Agent and the applicable Borrowers or (B) applicable only to periods after the Revolving Termination Date or otherwise reasonably satisfactory to the Administrative Agent
7
    



provided, further, that an Officer’s Certificate signed on behalf of the Borrower Representative delivered to the Administrative Agent at least five Business Days (or a shorter period acceptable to the Administrative Agent) prior to the incurrence of such Indebtedness, together with a reasonably detailed description of the material terms and conditions of such Indebtedness or drafts of the documentation relating thereto, stating that the Borrower Representative has determined in good faith that such terms and conditions satisfy the requirements of this definition, shall be conclusive evidence that such terms and conditions satisfy the requirements of this definition, unless the Administrative Agent notifies the Borrower Representative within such five Business Day period that it disagrees with such determination (including a reasonable description of the basis upon which it disagrees).
Applicable Security Jurisdiction”: with respect to any Loan Party organized under the laws of a Security Jurisdiction, each of (a) such Security Jurisdiction and (b) solely with respect to Equity Interests owned by such Loan Party, each other Security Jurisdiction in which any direct Subsidiary of such Loan Party that is a Loan Party is organized (it being understood that each Security Jurisdiction and its political subdivisions shall constitute a single Security Jurisdiction for purposes hereof).
Application”: an application, in such form as the applicable Issuing Lender may specify from time to time, requesting such Issuing Lender to issue a Letter of Credit.
Approved Commercial Bank”: a commercial bank with a consolidated combined capital surplus of at least $5,000,000,000.
Approved Electronic Communications”: as defined in Section 11.2.
Approved Fund”: as defined in Section 11.6(b)(ii).
Asset Sale”:
(a)the sale, conveyance, transfer or other disposition (whether in a single transaction or a series of related transactions) of property or assets (including by way of a Sale Leaseback Transaction) of UK Holdco or any Restricted Subsidiary (each referred to in this definition as a “disposition”); or
(b)the issuance or sale of Equity Interests of any Restricted Subsidiary (other than (1) directors’ qualifying shares or shares or interests required to be held by non-U.S. nationals or other third parties to the extent required by applicable law or (2) Preferred Stock or Disqualified Stock of a Restricted Subsidiary issued in compliance with Section 7.2), other than by any Restricted Subsidiary to UK Holdco or another Restricted Subsidiary (whether in a single transaction or a series of related transactions), in each case other than:
(i)a sale, exchange, transfer or other disposition of cash, Cash Equivalents or Investment Grade Securities or uneconomical, obsolete, damaged, unnecessary, surplus, unsuitable or worn out equipment or any sale or disposition of property or assets in connection with scheduled turnarounds, maintenance and equipment and facility updates or any disposition of inventory or goods (or other assets) held for sale or no longer used in the ordinary course of business;
(ii)the sale, conveyance, transfer or other disposition of all or substantially all of the assets of UK Holdco (on a consolidated basis) in a manner permitted pursuant to Section 7.8;
(iii)any Permitted Investment or Restricted Payment that is permitted to be made, and is made, under Section 7.3;
(iv)dispositions of assets, or sales or issuances of Equity Interests of any Restricted Subsidiary, with an aggregate Fair Market Value of (i) less than the greater of $15,000,000 and 5% of Consolidated EBITDA as of the most recently ended Reference Period in any single transaction or series of related transactions or (ii) less than the greater of $50,000,000 and 16% of Consolidated EBITDA as of the most recently ended Reference Period in the aggregate for all such other dispositions or issuances pursuant to this clause (ii) (and not excluded pursuant to another clause of this definition) in any fiscal
8
    



year, which amounts in the case of this clause (ii) if not used in any fiscal year may be carried forward to the next succeeding fiscal year;
(v)(i) any transfer or disposition of property or assets by a Restricted Subsidiary to UK Holdco or (ii) by UK Holdco or a Restricted Subsidiary to a Restricted Subsidiary;
(vi)sales of assets received by UK Holdco or any Restricted Subsidiary upon the foreclosure on a Lien;
(vii)any issuance or sale of Equity Interests in, or Indebtedness or other securities of, an Unrestricted Subsidiary;
(viii)the unwinding of any Hedging Obligations;
(ix)the sale, lease, assignment, license or sublease of inventory, equipment, accounts receivable, notes receivable or other current assets held for sale in the ordinary course of business or the conversion of accounts receivable into a notes receivable;
(x)the lease, assignment or sublease of any real or personal property in the ordinary course of business and dispositions to landlords of improvements made to leased real property pursuant to customary terms of leases entered into in the ordinary course of business;
(xi)a sale of accounts receivable and related assets of the type specified in the definition of “Receivables Financing” to a Receivables Subsidiary in a Qualified Receivables Financing or in factoring or similar transactions;
(xii)a transfer of accounts receivable and related assets of the type specified in the definition of “Receivables Financing” (or a fractional undivided interest therein) by a Receivables Subsidiary in a Qualified Receivables Financing;
(xiii)any financing transaction with respect to property built or acquired by UK Holdco or any Restricted Subsidiary, including Sale Leaseback Transactions permitted under this Agreement;
(xiv)any exchange of assets for assets (including a combination of assets and Cash Equivalents) related to a Similar Business of comparable or greater market value or usefulness to the business of UK Holdco and the Restricted Subsidiaries, as a whole, as determined in good faith by the Borrower Representative, which in the event of an exchange of assets with a Fair Market Value in excess of (i) the greater of $20,000,000 and 7% of Consolidated EBITDA as of the most recently ended Reference Period shall be evidenced by an Officer’s Certificate signed on behalf of the Borrower Representative and (ii) the greater of $30,000,000 and 10% of Consolidated EBITDA as of the most recently ended Reference Period shall be set forth in a resolution approved in good faith by at least a majority of the Board of Directors of the Borrower Representative (or any direct or indirect parent thereof);
(xv)the grant in the ordinary course of business of any license or sub-license of patents, trademarks, know-how and any other intellectual property;
(xvi)any sale or other disposition deemed to occur with creating, granting or perfecting a Lien not otherwise prohibited by this Agreement or the Loan Documents;
(xvii)the surrender or waiver of contract rights or settlement, release or surrender of a contract, tort or other litigation claim in the ordinary course of business;
(xviii)foreclosures, condemnations or any similar action on assets;
(xix)the sale (without recourse) of receivables (and related assets) pursuant to factoring arrangements entered into in the ordinary course of business;
9
    



(xx)sales, transfers and other dispositions of Investments in joint ventures to the extent required by, or made pursuant to, customary buy/sell arrangements between the joint venture parties set forth in joint venture arrangements and similar binding arrangements;
(xxi)transfers of property pursuant to a Recovery Event;
(xxii)the lapse, abandonment or other disposition of intellectual property rights in the ordinary course of business, which in the good faith determination of the Borrower Representative are no longer commercially reasonable to maintain or are not material to the conduct of the business of UK Holdco and the Restricted Subsidiaries taken as a whole; and
(xxiii)sales, transfers and other dispositions of assets that do not constitute Collateral having a Fair Market Value of not more than, in any fiscal year, the greater of $25,000,000 and 8% of Consolidated EBITDA as of the most recently ended Reference Period, which amounts if not used in any fiscal year may be carried forward to subsequent fiscal years (until so applied);
provided that, in each case of paragraphs (a) to (w) above, that if any asset subject to a disposal or transfer to any Loan Party is subject to a Lien created by any Security Document at the time of such disposal or transfer to any Loan Party, it shall be disposed of or transferred on the basis that it shall remain subject to, or otherwise become subject to equivalent, Liens under a Security Document immediately following such disposal (subject to the Collateral and Guarantee Principles and the Agreed Security Principles).
Assignee”: as defined in Section 11.6(b)(i).
Assignment and Assumption”: an Assignment and Assumption, substantially in the form of Exhibit B.
ASU”: as defined in Section 1.3(b).
Auction Purchase”: a purchase of Loans or Commitments pursuant to a Dutch Auction (x) in the case of a Permitted Auction Purchaser, in accordance with the provisions of Section 11.6(b)(iii) or (y) in the case of an Affiliated Lender, in accordance with the provisions of Section 11.6(b)(iv).
Auditors’ Determination”: as defined in Section 8.12(d).
Australian Dollars” or “A$”: the lawful currency of Australia.
Available Revolving Commitment”: as to any Revolving Lender at any time, an amount equal to the excess, if any, of (a) such Lender’s Revolving Commitment then in effect over (b) the aggregate Outstanding Amount of such Lender’s Revolving Extensions of Credit at such time.
Bail-In Action”: the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution.
Bail-In Legislation”: with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule.
Bank Levy”: (a) the UK bank levy as set out in the United Kingdom Finance Act 2011, (b) the bank levy imposed by the French Government under the “taxe bancaire de risque systémique” as set out in Article 235 ter ZE of the French tax code (Code Général des Impôts), (c) the bank levy imposed by the German Government under the Bank Restructuring Fund Regulation (Restrukturierungsfonds-Verordnung) which has been issued pursuant to the provisions of the Bank Restructuring Fund Act (Restrukturierungsfondsgesetz), (d) the bank levy imposed by the French Government under the “taxe pour le financement du fonds de soutien aux collectivités territoriales” as set out in Article 235 ter ZE bis of the French tax code (Code Général des Impôts) and (e) any other Tax of a similar nature in any
10
    



jurisdiction, which is imposed by reference to some or all of the assets, liabilities and/or equity of a financial institution or other entity carrying out financial transactions and which is in force or has been publicly announced at the Closing Date or (if applicable), in respect of any Lender, which becomes a party to this Agreement after the Closing Date, as at the date that Lender becomes a party to this Agreement.
Bankruptcy Code”: Title 11 of the United States Code entitled “Bankruptcy”, as now and hereinafter in effect, or any successor statute.
Basel III”: the Basel Committee on Banking Supervision’s (the “Committee”) revised rules relating to capital requirements set out in “Basel III: A global regulatory framework for more resilient banks and banking systems”, “Guidance for national authorities operating the countercyclical capital buffer” and “Basel III: International framework for liquidity risk measurement, standards and monitoring” published by the Committee in December 2010, “Revisions to the Basel II market risk framework” published by the Committee in February 2011, the rules for global systemically important banks contained in “Global systemically important banks: assessment methodology and the additional loss absorbency requirement – Rules text” published by the Committee in November 2011, as amended, supplemented or restated, and any further guidance or standards published by the Committee in connection with these rules.
BBSY”: as set forth in the definition of Eurocurrency Rate.
Beneficially Own”: as defined within the meaning of Rules 13d-3 and 13d-5 under the Exchange Act; “Beneficial Ownership” shall have a correlative meaning.
Beneficial Ownership Certification”: a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.
Beneficial Ownership Regulation”: 31 C.F.R § 1010.230.
Benefit Plan”: any of (a) an “employee benefit plan” (as defined in ERISA) that is subject to Title I of ERISA, (b) a “plan” as defined in and subject to Section 4975 of the Code or (c) any Person whose assets include (for the purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such “employee benefit plan” or “plan”.
Benefited Lender”: as defined in Section 11.8(a).
BHC Act Affiliate” of a party means an “affiliate” (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.
Board”: the Board of Governors of the Federal Reserve System of the United States (or any successor).
Board of Directors”: as to any Person, the board of directors or managers, sole member, managing member or other governing body, as applicable, of such Person (or, if such Person is a partnership, the board of directors or other governing body of the general partner of such Person) or any duly authorized committee thereof.
Borrower” or “Borrowers”: as defined in the preamble hereto.
Borrower DTTP Filing” means an HM Revenue & Customs’ Form DTTP2, duly completed and filed by the relevant UK Borrower, which:
(a)    where it relates to a UK Treaty Lender that is a Lender on the Closing Date, contains the scheme reference number and jurisdiction of tax residence stated opposite that Lender's name in Schedule 1.1A-1, and is filed with HM Revenue & Customs within 30 days of the date on which that UK Borrower becomes a Borrower; or
11
    



(b)    where it relates to a UK Treaty Lender that is not a party to this Agreement on the Closing Date, contains the scheme reference number and jurisdiction of tax residence stated in respect of that Lender in the relevant Assignment and Assumption, Incremental Amendment or Refinancing Amendment pursuant to which such Lender becomes a party hereto or as otherwise notified to the UK Borrower in writing within 15 days of the relevant UK Treaty Lender becoming a party to this Agreement and:
(i)    where the UK Borrower is a Borrower as at the relevant assignment date or the date on which the Incremental Revolving Loans described in the relevant Incremental Amendment take effect or the date on which the relevant Refinancing Amendment take effect (as applicable) is filed with HM Revenue & Customs within 30 days of that date; or
(ii)    where the UK Borrower is not a Borrower as at the relevant assignment date or the date on which the Incremental Revolving Loans described in the relevant Incremental Amendment take effect or the date on which the relevant Refinancing Amendment take effect (as applicable) is filed with HM Revenue & Customs within 30 days of the date on which that UK Borrower becomes a Borrower.
Borrower Joinder”: a joinder agreement, in substantially the form of Exhibit M hereto or otherwise reasonably acceptable to the Administrative Agent, pursuant to which an Additional Revolving Borrower agrees to become an obligor in respect of the Revolving Facility under this Agreement.
Borrower Representative”: as defined in Section 12.4.
Borrowing” a Revolving Borrowing, a Swingline Borrowing or a Term Borrowing, as the context may require.
Borrowing Date”: any Business Day specified by any Borrower as a date on which such Borrower requests the relevant Lenders to make Loans hereunder.
Borrowing Request”: a certificate duly executed by a Responsible Officer substantially in the form of Exhibit H.
Business”: as defined in Section 4.13(b).
Business Day”: any day other than a Saturday, Sunday or other day on which commercial banks are authorized to close under the Laws of, or are in fact closed in, the state where the Administrative Agent’s Office with respect to Obligations denominated in Dollars is located and:
(a) [reserved];
(b) if such day relates to any interest rate settings as to a Eurocurrency Loan denominated in Euro, any fundings, disbursements, settlements and payments in Euro in respect of any such Eurocurrency Loan, or any other dealings in Euro to be carried out pursuant to this Agreement in respect of any such Eurocurrency Loan, means a TARGET Day;
(c) if such day relates to any interest rate settings as to a Eurocurrency Loan denominated in a currency other than Euro, means any such day on which dealings in deposits in the relevant currency are conducted by and between banks in the London or other applicable offshore interbank market for such currency;
(d) if such day relates to any interest rate settings as to a Sterling Daily Rate Loan denominated in Sterling, means a day other than a day banks are closed for general business in London because such day is a Saturday, Sunday or a legal holiday under the laws of the United Kingdom; and
(e) if such day relates to any fundings, disbursements, settlements and payments in a currency other than Euro in respect of a Eurocurrency Loan denominated in a currency other than Euro, or any
12
    



other dealings in any currency other than Euro to be carried out pursuant to this Agreement in respect of any such Eurocurrency Loan (other than any interest rate settings), means any such day on which banks are open for foreign exchange business in the principal financial center of the country of such currency.
Camelot Jersey”: as defined in the preamble hereto.
Cancellation” or “Cancelled”: the cancellation, termination and forgiveness by a Permitted Auction Purchaser of all Loans, Commitments and related Obligations acquired in connection with an Auction Purchase or other acquisition of Term Loans, which cancellation shall be consummated as described in Section 11.6(b)(iii)(C) and the definition of “Eligible Assignee.”
Capital Expenditures”: for any period, with respect to any Person, the aggregate of all expenditures by such Person or any Restricted Subsidiary thereof during such period for the acquisition or leasing (pursuant to a capital lease) of fixed or capital assets or additions to equipment (including replacements, capitalized repairs and improvements during such period) that, in conformity with GAAP, are required to be included as capital expenditures in the consolidated statement of cash flows of UK Holdco and the Restricted Subsidiaries.
Capital Stock”: (1) in the case of a corporation or a company, corporate stock or share capital; (2) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock; (3) in the case of an exempted company, shares; (4) in the case of a partnership or limited liability company, partnership or membership interests (whether general or limited); and (5) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person.
Capitalized Lease Obligations”: at the time any determination thereof is to be made, the amount of the liability in respect of a capital lease that would at such time be required to be capitalized and reflected as a liability on a balance sheet (excluding the footnotes thereto) in accordance with GAAP.
Captive Insurance Subsidiary”: any direct or indirect Subsidiary of UK Holdco that bears financial risk or exposure relating to insurance or reinsurance activities and any segregated accounts associated with any such Person.
Cash Collateral”: as defined in the definition of “Collateralize.”
Cash Collateral Account” means a blocked, non-interest bearing deposit account of one or more of the Loan Parties at Bank of America, N.A. or another commercial bank in the name of the Administrative Agent and under the sole dominion and control of the Administrative Agent, and otherwise established in a manner satisfactory to the Administrative Agent.
Cash Collateralize”: as defined in Section 3.2(b).
Cash Contribution Amount”: the aggregate amount of cash contributions made to the capital of UK Holdco or any Restricted Subsidiary described in the definition of “Contribution Indebtedness.”
Cash Equivalents”:
(a)Dollars, Alternative Currencies and other local currencies held by UK Holdco and the Restricted Subsidiaries from time to time in the ordinary course of business in connection with any business conducted by such Person in such jurisdiction;
(b)securities issued or directly and fully guaranteed or insured by the government of the United States, Canada, any country that is a member of the European Union, Switzerland or the United Kingdom or any agency or instrumentality thereof in each case with maturities not exceeding two years from the date of acquisition;
13
    



(c)certificates of deposit, time deposits and eurodollar time deposits with maturities of one year or less from the date of acquisition, and bankers’ acceptances, in each case with maturities not exceeding one year from the date of acquisition, and overnight bank deposits, in each case with any commercial bank having capital and surplus in excess of $250,000,000, in the case of U.S. banks, and $100,000,000 (or the foreign currency equivalent thereof), in the case of non-U.S. banks, and whose long-term debt is rated with an Investment Grade Rating by Moody’s or S&P (or reasonably equivalent ratings of another internationally recognized ratings agency);
(d)repurchase obligations for underlying securities of the types described in clauses (2) and (3) above entered into with any financial institution meeting the qualifications specified in clause (3) above;
(e)commercial paper issued by a corporation (other than an Affiliate of Holdings) rated at least “P-1/A-1” or the equivalent thereof by Moody’s or S&P (or reasonably equivalent ratings of another internationally recognized ratings agency) and in each case maturing within one year after the date of acquisition;
(f)readily marketable direct obligations issued by any state or commonwealth of the United States of America, Canada, any country that is a member of the European Union, the United Kingdom or Switzerland or any political subdivision of the foregoing having one of the two highest rating categories obtainable from either Moody’s or S&P (or reasonably equivalent ratings of another internationally recognized ratings agency) in each case with maturities not exceeding two years from the date of acquisition;
(g)Indebtedness or Preferred Stock issued by Persons (other than the Sponsors or any of their respective Affiliates) with a rating of “A” or higher from S&P or “A-2” or higher from Moody’s in each case with maturities not exceeding two years from the date of acquisition;
(h)investment funds investing at least 95% of their assets in securities of the types described in clauses (1) through (7) above; and
(i)instruments equivalent to those referred to in clauses (1) through (7) above denominated in Alternative Currencies or any other currency comparable in credit quality and tenor to those referred to above and customarily used by corporations for cash management purposes in any jurisdiction outside the United States to the extent reasonably required in connection with (a) any business conducted by any Restricted Subsidiary organized in such jurisdiction or (b) any Investment in the jurisdiction where such Investment is made.
Cash Management Agreement”: any agreement to provide Cash Management Services.
Cash Management Obligations”: all obligations, including guarantees thereof, of any Group Member to a Cash Management Provider in respect of Cash Management Services.
Cash Management Provider”: any Person that (a) as of the Closing Date or as of the date it enters into any Cash Management Agreement, is the Administrative Agent, a Joint Lead Arranger, an Incremental Facility Arranger, a Lender or an Affiliate of the foregoing, in its capacity as a counterparty to such Cash Management Agreement or (b) as of the date it enters into any Cash Management Agreement is designated in writing by the Borrower Representative with the consent of the Administrative Agent (not to be unreasonably withheld, conditioned or delayed) with respect to specified Cash Management Services and that has appointed the Collateral Agent as its collateral agent in a manner reasonably acceptable to the Collateral Agent; provided that none of the Administrative Agent, a Joint Lead Arranger, an Incremental Facility Arranger, a Lender or an Affiliate of the foregoing described in the preceding clause (a) shall cease to be Cash Management Provider by reason of ceasing to be the Administrative Agent, a Joint Lead Arranger, an Incremental Facility Arranger, a Lender or an Affiliate of the foregoing, as applicable.
Cash Management Services”: any cash management facilities or services, including (i) treasury, netting, cash pooling, automated payment, depositary and overdraft services and automated clearinghouse
14
    



transfer of funds and (ii) purchase cards, credit or debit cards, electronic funds transfer, automated clearinghouse arrangements or similar services.
CFC”: any “controlled foreign corporation” within the meaning of Section 957 of the Code that is a direct or indirect Subsidiary of a US Subsidiary that is a “United States person” within the meaning of Section 957(c) of the Code.
Change in Law”: the occurrence, after the Closing Date, of any of the following: (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority; provided that notwithstanding anything herein to the contrary, (x) the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act and the European Capital Requirements Directive IV and in each case all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III and/or CRD IV, shall in each case be deemed to be a “Change in Law”, regardless of the date enacted, adopted or issued.
Change of Control”: at any time, (a) the sale, lease or transfer, in one or a series of related transactions, of all or substantially all the assets of UK Holdco and its Restricted Subsidiaries, taken as a whole, to a Person other than any of the Permitted Holders, (b) the Borrower Representative becomes aware (by way of a report or any other filing pursuant to Section 13(d) of the Exchange Act, proxy, vote, written notice or otherwise) of the acquisition by any Person or group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision), including any group acting for the purpose of acquiring, holding or disposing of securities (within the meaning of Rule 13d-5(b)(1) under the Exchange Act), other than any of the Permitted Holders, in a single transaction or in a related series of transactions, by way of merger, consolidation or other business combination or purchase of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any successor provision), of more than 50% of the total voting power of the Voting Stock of UK Holdco, or any direct or indirect parent of UK Holdco that holds directly or indirectly an amount of Voting Stock of UK Holdco such that UK Holdco is a Subsidiary of such holding company, (c) Holdings shall fail to Beneficially Own, directly or indirectly, Capital Stock of UK Holdco representing 100% of the total voting power represented by the issued and outstanding Capital Stock of UK Holdco, (d) UK Holdco shall fail to Beneficially Own, directly or indirectly, Capital Stock of the Lux Borrower representing 100% of the total voting power represented by the issued and outstanding Capital Stock of the Lux Borrower, (e) UK Holdco shall fail to Beneficially Own, directly or indirectly, Capital Stock of any US Borrower representing 100% of the total voting power represented by the issued and outstanding Capital Stock of such US Borrower; provided that any Disposition of a Borrower (including, for the avoidance of doubt, pursuant to Section 7.8) that is not prohibited under the terms of this Agreement shall not constitute a “Change of Control” or (f) a “change of control” or similar event shall occur under the Senior Secured Notes or other Indebtedness of any Group Member the outstanding principal amount of which exceeds $125,000,000 in the aggregate.
Class”: (a) with respect to Commitments or Loans, those of such Commitments or Loans that have the same terms and conditions and (b) with respect to Lenders, those of such Lenders that have Commitments or Loans of a particular Class. For the avoidance of doubt, (i) the Closing Date Term Loans and the Amendment No. 1 Incremental Term Loans shall constitute the same Class of Term Loans and (ii) the Amendment No. 2 Incremental Term Loans shall constitute a separate Class of Term Loans.
Clean-Up Period”: with respect to any Permitted Acquisition or any other Permitted Clean-Up Investment, the period from the date of the consummation of such Permitted Acquisition or Permitted Clean-Up Investment until the date that is 90 days after such closing date.
Closing Date”: October 31, 2019.
Closing Date Refinancing”: as defined in Section 5.1(c).
15
    



Closing Date Term Loan Facility”: as defined in the preamble hereto.
Closing Date Term Loans”: has the meaning assigned to such term in the definition of “Initial Term Loan”.
CME”: CME Group Benchmark Administration Limited.
Code”: the Internal Revenue Code of 1986, as amended from time to time (except as indicated otherwise with respect to the definition of FATCA).
Collateral”: all of the assets and property of the Loan Parties and any other Person, now owned or hereafter acquired, whether real, personal or mixed, upon which a Lien is purported to be created by any Security Document; provided, however, that the Collateral shall not include any Excluded Assets.
Collateral Agent”: Bank of America, N.A., as the sole and exclusive collateral agent for the Secured Parties under this Agreement and the other Loan Documents, together with any of its successors in such capacity.
Collateral and Guarantee Principles”: as defined in Section 6.9(c).
Collateralize”: to (i) pledge and deposit with or deliver to the Administrative Agent, for the benefit of the Issuing Lenders and the Lenders, as collateral for the L/C Obligations, cash or deposit account balances (“Cash Collateral”) pursuant to documentation in form and substance reasonably satisfactory to the Administrative Agent or (ii) issue back to back letters of credit for the benefit of the Issuing Lenders in a form and substance reasonably satisfactory to the Administrative Agent, in each case, in an amount not less than 100% of the outstanding L/C Obligations.
Commitment”: as to any Lender, the sum of the Term Commitment and the Revolving Commitment of such Lender.
Commitment Fee”: as defined in Section 2.8(a).
Commitment Fee Rate”: initially, 0.50% per annum, and from and after the first Business Day immediately following the delivery to the Administrative Agent of a Compliance Certificate (pursuant to Section 6.2(c)), commencing with the Compliance Certificate delivered in respect of the first full fiscal quarter of UK Holdco ending after the Closing Date, wherein the First Lien Net Leverage Ratio is (x) greater than 4.50 to 1.00, 0.50% per annum and (y) less than or equal to 4.50 to 1.00, 0.375% per annum.
Commodity Exchange Act”: the Commodity Exchange Act (7 U.S.C. § 1 et seq.), as amended from time to time, and any successor statute.
Commonly Controlled Entity”: an entity, whether or not incorporated, that is under common control with Holdings or any Borrower within the meaning of Section 4001 of ERISA or is part of a group that includes Holdings or any Borrower and that is treated as a single employer under Section 414 of the Code.
Compliance Certificate”: a certificate duly executed by a Responsible Officer substantially in the form of Exhibit C or as otherwise reasonably agreed by the Administrative Agent.
Conforming Changes”: (a) with respect to the Revolving Facility, with respect to the use, administration of or any conventions associated with SOFR, SONIA Rate or any proposed Revolving Facility Successor Rate for an Agreed Currency or Term SOFR, as applicable, any conforming changes to the definition of “ABR”, “SOFR”, “SONIA Rate”, “Term SOFR” and “Interest Period”, timing and frequency of determining rates or making payments of interest and other technical administrative or operational matters (including, for the avoidance of doubt, the definitions of “Business Day” and “US Government Securities Business Day”, timing of borrowing requests or prepayment, conversion or continuation notices and length of lookback periods) as may be appropriate, in the discretion of the
16
    



Administrative Agent (in consultation with the Borrower Representative), to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate exists, in such other manner of administration as the Administrative Agent (in consultation with the Borrower Representative) determines is reasonably necessary in connection with the administration of this Agreement and any other Loan Document) and (b) with respect to the Term Loans, with respect to the use, administration of or any conventions associated with SOFR, any proposed Term Loan Successor Rate or Term SOFR, as applicable, any conforming changes to the definition of “ABR”, “SOFR”, “Term SOFR” and “Interest Period”, timing and frequency of determining rates or making payments of interest and other technical administrative or operational matters (including, for the avoidance of doubt, the definitions of “Business Day” and “US Government Securities Business Day”, timing of borrowing requests or prepayment, conversion or continuation notices and length of lookback periods) as may be appropriate, in the discretion of the Administrative Agent (in consultation with the Borrower Representative), to reflect the adoption and implementation of such applicable rate(s) and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such rate exists, in such other manner of administration as the Administrative Agent (in consultation with the Borrower Representative) determines is reasonably necessary in connection with the administration of this Agreement and any other Loan Document).
Consolidated Cash Interest Expense”: with respect to UK Holdco and its Restricted Subsidiaries for any period, (a) consolidated cash interest expense of UK Holdco and its Restricted Subsidiaries for such period, (i) including the cash interest component of Capitalized Lease Obligations (regardless of whether accounted for as interest expense under GAAP) and (ii) excluding (A) amortization, accretion or accrual of deferred financing fees, original issue discount, debt issuance costs, discounted liabilities, commissions, fees and expenses, (B) any expense arising from any bridge, commitment, structuring and/or other financing fee (including fees and expenses associated with the Transactions and agency and trustee fees), (C) any expense resulting from the discounting of any Indebtedness in connection with the application of recapitalization or purchase accounting in connection with the Transactions or any acquisition, (D) fees and expenses associated with any Asset Sales, acquisitions, Investments, issuances of Capital Stock or Indebtedness (in each case, whether or not consummated), (E) costs associated with obtaining, or breakage costs in respect of, any Hedge Agreement or any other derivative instrument other than any interest rate Hedge Agreement or interest rate derivative instrument with respect to Indebtedness, (F) any “additional interest” or “penalty interest” with respect to any securities, taxes or failure to timely comply with registration rights obligations, (G) interest expense with respect to Indebtedness of any Parent Holding Company of UK Holdco appearing on the balance sheet of UK Holdco solely by reason of push-down accounting under GAAP, (H) any payments with respect to make-whole, prepayment or repayment premiums or other breakage costs of any Indebtedness, (I) any interest expense attributable to the exercise of appraisal rights or other rights of dissenting shareholders and the settlement of any claims or actions (whether actual, contingent or potential) with respect thereto in connection with any acquisition or Investment permitted hereunder, (J) any lease, rental or other expense in connection with a lease obligation that is not a Capitalized Lease Obligation and (K) any non-cash interest expense attributable to any movement in the mark to market valuation of Hedging Obligations or any other derivative instruments and/or any payment obligation in respect of any Hedging Obligation or other derivative instrument other than any interest rate Hedging Obligation or interest rate derivative instrument with respect to Indebtedness minus (b) cash interest income for such period.
For purposes of this definition, interest expense shall be calculated after giving effect to net payments and receipts (if any) pursuant to interest rate Hedging Obligations with respect to Indebtedness.
Consolidated Current Assets”: at any date, all amounts (other than cash and Cash Equivalents) that would, in conformity with GAAP, be set forth opposite the caption “total current assets” (or any like caption) on a consolidated balance sheet of UK Holdco and its Restricted Subsidiaries at such date.
Consolidated Current Liabilities”: at any date, all amounts that would, in conformity with GAAP, be set forth opposite the caption “total current liabilities” (or any like caption) on a consolidated
17
    



balance sheet of UK Holdco and its Restricted Subsidiaries at such date, but excluding (a) the current portion of any Funded Debt of UK Holdco and its Restricted Subsidiaries and (b) without duplication of clause (a) above, all Indebtedness consisting of Loans to the extent otherwise included therein.
Consolidated EBITDA”: with respect to UK Holdco and its Restricted Subsidiaries for any period, the Consolidated Net Income of UK Holdco and its Restricted Subsidiaries for such period:
(j)increased (without duplication) by:
(i)provision for Taxes based on income or profits or capital, including, without limitation, state, franchise and similar Taxes and foreign withholding Taxes of such Person paid or accrued during such period deducted (and not added back) in computing Consolidated Net Income and payroll taxes related to stock compensation costs, including (i) an amount equal to the amount of Tax distributions actually made to the holders of Capital Stock of such Person or any direct or indirect parent of such Person in respect of such period in accordance with Section 7.3(b)(xii) which shall be included as though such amounts had been paid as income Taxes directly by such Person and (ii) penalties and interest related to such taxes or arising from any tax examinations; plus
(ii)consolidated Fixed Charges of UK Holdco and its Restricted Subsidiaries for such period (including (x) bank fees and (y) costs of surety bonds in connection with financing activities, in each case, to the extent included in Fixed Charges), together with items excluded from the definition of “Consolidated Interest Expense” pursuant to clauses (1)(q) through (1)(z) thereof, in each case, to the extent the same was deducted (and not added back) in calculating such Consolidated Net Income; plus
(iii)Consolidated Non-Cash Charges of UK Holdco and its Restricted Subsidiaries for such period to the extent such non-cash charges were deducted (and not added back) in computing Consolidated Net Income; plus
(iv)[reserved]; plus
(v)[reserved]; plus
(vi)any other non-cash charges, including any write offs or write downs, reducing Consolidated Net Income for such period (provided that if any such non-cash charges represent an accrual or reserve for potential cash items in any future period, the cash payment in respect thereof in such future period shall be subtracted from Consolidated EBITDA to such extent, and excluding amortization of a prepaid cash item that was paid in a prior period); plus
(vii)the amount of any minority interest expense consisting of Subsidiary income attributable to minority equity interests of third parties in any non-Wholly Owned Subsidiary of UK Holdco deducted (and not added back) in such period in calculating Consolidated Net Income; plus
(viii)the amount of management, monitoring, consulting, transaction and advisory fees (including termination fees) and related expenses and indemnities paid or accrued in such period to the Sponsors pursuant to the Management Agreement to the extent deducted (and not added back) in computing Consolidated Net Income; plus
(ix)pro forma adjustments, including the “run rate” cost savings, operating expense reductions, operational improvements, restructuring charges and expenses and synergies (“Expected Cost Savings”) that are expected (in good faith) to be realized as a result of actions taken or with respect to which substantial steps are expected to be taken within 24 months after the date of any acquisition, disposition, divestiture, restructuring or other transaction or the implementation of a cost savings or other similar initiative (any such event or initiative, a “Cost Saving Initiative”), as applicable (calculated on a Pro Forma Basis as though such Expected Cost Savings had been realized on the first day of such period and as if such Expected Cost Savings were realized during the entirety of such period), net of the amount of actual benefits realized during such period from such actions; provided that (A) such actions or substantial steps with respect thereto are expected in the good faith determination of the Borrower Representative to be taken within 24 months after the consummation or implementation of the applicable
18
    



Cost Saving Initiative, which is expected to result in Expected Cost Savings and (B) no Expected Cost Savings shall be added pursuant to this defined term to the extent duplicative of any expenses or charges otherwise added to Consolidated EBITDA, whether through a pro forma adjustment or otherwise, for such period (which adjustments may be incremental to, but without duplication for, pro forma adjustments made pursuant to the definition of “Pro Forma Basis”); plus
(x)[reserved]; plus
(xi)the amount of loss or discount on sale of receivables and related assets to the Receivables Subsidiary or otherwise in connection with a Receivables Financing, to the extent deducted (and not added back) in computing Consolidated Net Income; plus
(xii)(i) any costs or expenses incurred by UK Holdco or any of its Restricted Subsidiaries pursuant to any management equity plan or stock option plan or any other management or employee benefit plan, trust, scheme or agreement or any stock subscription or shareholder agreement, any pension plan (including any post-employment benefit scheme which has been agreed with the relevant pension trustee), including any deferred compensation arrangement, or any accelerated vesting of awards and (ii) payments made to optionholders in connection with, or as a result of, any distribution being made to equityholders, which payments are being made to compensate such optionholders as though they were equityholders at the time of, and entitled to share in, such distribution, in each case to the extent permitted hereunder; plus
(xiii)for purposes of determining compliance with the maximum First Lien Net Leverage Ratio required under Section 7.1, the Cure Amount, if any, received by UK Holdco for such period and permitted to be included in Consolidated EBITDA pursuant to Section 9.4; plus
(xiv)the Tax effect of any items excluded from the calculation of Consolidated Net Income pursuant to clauses (1), (3), (4) and (8) of the definition thereof; plus
(xv)to the extent not already otherwise included herein, adjustments and add-backs made in calculating “Standalone Adjusted EBITDA” for the twelve months ended June 30, 2019 as set forth in the Offering Memorandum in respect of the Senior Secured Notes; plus
(xvi)earn-out, non-compete and contingent consideration obligations (including to the extent accounted for as bonuses, compensation or otherwise) and adjustments thereof and purchase price adjustments incurred in connection with any permitted acquisition or other Investment permitted hereunder and paid or accrued during such period; plus
(xvii)[reserved]; plus
(xviii)“run rate” pro forma adjustments, from the first day of the applicable period, for the aggregate amount of Consolidated EBITDA projected by the Borrower Representative in good faith to result from binding contracts entered into; provided that the aggregate amount of addbacks made pursuant to this clause (r) in any period shall not exceed an amount equal to 10% of Consolidated EBITDA for such period (after giving effect to such addbacks) as of any date of determination; plus
(xix)any other adjustments, exclusions and add-backs that are consistent with Regulation S-X of the Securities Act of 1933, as amended;
(k)decreased by (without duplication) non-cash gains increasing Consolidated Net Income of UK Holdco and its Restricted Subsidiaries for such period, excluding any non-cash gains to the extent they represent the reversal of an accrual or reserve for a potential cash item that reduced Consolidated EBITDA in any prior period; and
(l)increased (by losses) or decreased (by gains) by (without duplication) the application of FASB Interpretation No. 45 (Guarantees) and/or Accounting Standards Codification Topic 810.
19
    



Notwithstanding the foregoing, Consolidated EBITDA (a) for the fiscal quarter ended September 30, 2018, shall be deemed to be $79,347,000, (b) for the fiscal quarter ended December 31, 2018, shall be deemed to be $82,351,000, (c) for the fiscal quarter ended March 31, 2019, shall be deemed to be $67,650,000 and (d) for the fiscal quarter ended June 30, 2019, shall be deemed to be $86,620,000, as may be subject to add-backs and adjustments (without duplication) pursuant to clauses (1)(i) and (r) above and the definition of “Pro Forma Basis” for the applicable period.
Consolidated First Lien Indebtedness”: as of any date of determination, the aggregate principal amount of Consolidated Total Indebtedness that is secured by a Lien on any asset of UK Holdco or any of its Restricted Subsidiaries that constitutes Collateral ranking pari passu with the Liens securing the Obligations; provided that “Consolidated First Lien Indebtedness” shall be calculated, without duplication, after netting the Netted Amounts from the amount of Consolidated Total Indebtedness so secured.
Consolidated Interest Expense”: with respect to any Person for any period, the sum, without duplication, of
(m)consolidated interest expense of such Person and its Restricted Subsidiaries for such period, to the extent such expense was deducted (and not added back) in computing Consolidated Net Income (including (a) amortization of original issue discount resulting from the issuance of Indebtedness at less than par, (b) all commissions, discounts and other fees and charges owed with respect to letters of credit or bankers acceptances, (c) non-cash interest payments (but excluding any non-cash interest expense attributable to the movement in the mark to market valuation of Hedging Obligations or other derivative instruments pursuant to GAAP and any payment obligation in respect of any Hedging Obligation or other derivative instrument other than any interest rate Hedging Obligation or interest rate derivative instrument with respect to Indebtedness), (d) the interest component of Capitalized Lease Obligations and (e) net payments and receipts (if any) pursuant to interest rate Hedging Obligations with respect to Indebtedness, and excluding (q) any interest expense attributable to the exercise of appraisal rights or other rights of dissenting shareholders and the settlement of any claims or actions (whether actual, contingent or potential) with respect thereto in connection with any acquisition or Investment permitted hereunder, (r) interest expense with respect to Indebtedness of any Parent Holding Company appearing on the balance sheet solely by reason of push-down accounting under GAAP, (s) fees and expenses associated with any Asset Sales, acquisitions, Investments, issuances of Capital Stock or Indebtedness (in each case, whether or not consummated), (t) any expense resulting from the discounting of any Indebtedness in connection with the application of recapitalization or purchase accounting in connection with the Transactions or any acquisition, (u) any “additional interest” or “penalty interest” with respect to any securities, taxes or failure to comply with registration rights obligations, (v) any accretion or accrued interest of discounted liabilities, (w) amortization of deferred financing fees, debt issuance costs, commissions, discounts, fees and expenses, (x) any expensing of bridge, commitment and other financing fees, cost of surety bonds, charges owed with respect to letters of credit, bankers’ acceptances or similar facilities, (y) commissions, discounts, yield and other fees and charges (including any interest expense) related to any Receivables Financing and (z) any payments with respect to make-whole, prepayment or repayment premiums or other breakage costs of any Indebtedness); plus
(n)consolidated capitalized interest of such Person and its Restricted Subsidiaries for such period, whether paid or accrued; less
(o)interest income for such period;
provided that, for purposes of calculating Consolidated Interest Expense, no effect shall be given to the discount and/or premium resulting from the bifurcation of derivatives under FASB ASC 815 and related interpretations as a result of the terms of the Indebtedness to which such Consolidated Interest Expense relates.
Notwithstanding the foregoing, any additional changes arising from (i) the application of Accounting Standards Codification Topic 480-10-25-4 “Distinguishing Liabilities from Equity—Overall—Recognition” to any series of Preferred Stock other than Disqualified Stock or (ii) the application of
20
    



Accounting Standards Codification Topic 470-20 “Debt—Debt with Conversion Options—Recognition,” in each case, shall be disregarded in the calculation of Fixed Charges.
Consolidated Net Income”: with respect to UK Holdco and its Restricted Subsidiaries for any period, the aggregate of the Net Income of UK Holdco and its Restricted Subsidiaries for such period, on a consolidated basis, and otherwise determined in accordance with GAAP; provided, however, that, without duplication:
(p)any after-Tax effect of (i) extraordinary, one-time, infrequent, non-recurring, non-operating or unusual gains, losses, income or expenses (including all fees and expenses relating thereto) (including costs and expenses relating to the Transactions), in each case as determined by the Borrower Representative in good faith and (ii) restructuring charges (including tax restructuring charges), charges attributable to operating expense reductions and/or synergies and/or similar initiatives and/or programs, accruals or reserves and business optimization expense, including any such costs incurred in connection with acquisitions after the Closing Date (including entry into new market/channels and new service or product offerings) and costs related to the closure, reconfiguration and/or consolidation of facilities and costs to relocate employees, facilities opening costs, integration, transition and transaction costs, retention charges, severance, relocation costs, contract termination costs, recruiting and signing, retention or completion bonuses and expenses, one time compensation charges, future lease commitments, systems establishment costs, conversion costs and excess pension charges, consulting fees, expenses attributable to the implementation of costs savings initiatives, cost rationalization programs and other new initiatives, costs associated with tax projects/audits, payments and curtailments or modifications to pension and post-retirement employee benefit plans, costs relating to rights fee arrangements and early terminations thereof, costs relating to strategic initiatives, costs attributable to new contracts or projects, costs of software, new systems, intellectual property, information technology or accounting developments or improvements, costs relating to project startups or new operations and corporate development costs and costs consisting of professional consulting or other fees relating to any of the foregoing, in each case shall be excluded,
(q)the cumulative effect of a change in accounting principles and changes as a result of the adoption or modification of accounting policies during such period, whether effected through a cumulative effect adjustment or a retroactive application in each case in accordance with GAAP, shall be excluded (except that, if the Borrower Representative determines in good faith that the cumulative effects thereof are not material to the interests of the Lenders, the effects of any change in any such principles or policies may be included in any subsequent period after the fiscal quarter in which such change, adoption or modification was made),
(r)any net after-Tax effect of income or loss from disposed, abandoned or discontinued assets, properties or operations and any net after-Tax gains or losses on disposal of disposed, abandoned, transferred, closed or discontinued assets, properties or operations shall be excluded, in each case excluding, at the option of the Borrower Representative, assets, properties and operations pending disposal, abandonment, transfer, closure or discontinuation, as applicable, in each case so long as such assets, properties or operations are classified as discontinued under GAAP,
(s)any net after-Tax effect of gains or losses (including all fees and expenses relating thereto) attributable to business dispositions or asset dispositions or the sale or other disposition of any Capital Stock of any Person, or of returned or surplus assets, other than in the ordinary course of business, as determined in good faith by the Borrower Representative, shall be excluded,
(t)the Net Income for such period of any Person that is not a Subsidiary, or is an Unrestricted Subsidiary, or that is accounted for by the equity method of accounting (other than a Borrower or a Guarantor), shall be excluded; provided that the Consolidated Net Income of UK Holdco shall be increased by the amount of dividends or distributions or other payments that are actually paid in cash or Cash Equivalents (or to the extent converted into cash or Cash Equivalents) to the referent Person or a Restricted Subsidiary thereof in respect of such period,
(u)solely for the purpose of the definition of Excess Cash Flow and determining the amount available for Restricted Payments under Section 7.3(a)(3)(A), the Net Income for such period of any
21
    



Restricted Subsidiary (other than any Loan Party) shall be excluded to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary of its Net Income is not at the date of determination permitted without any prior governmental approval (which has not been obtained) or, directly or indirectly, by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule, or governmental regulation applicable to that Restricted Subsidiary or its stockholders, unless such restriction with respect to the payment of dividends or similar distributions has been legally waived, provided that Consolidated Net Income of UK Holdco will be increased by the amount of dividends or other distributions or other payments actually paid in cash or Cash Equivalents (or to the extent converted into cash or Cash Equivalents) to UK Holdco or any of its Restricted Subsidiaries in respect of such period, to the extent not already included therein,
(v)effects of adjustments (including the effects of such adjustments pushed down to UK Holdco and its Restricted Subsidiaries) in any line item in such Person’s consolidated financial statements (including, but not limited to, any step-ups with respect to re-valuing assets and liabilities) pursuant to GAAP and related authoritative pronouncements resulting from the application in accordance with GAAP of purchase accounting in relation to any investment, acquisition, merger or consolidation (or reorganization or restructuring) that is consummated after the Closing Date or the depreciation, amortization or write-off of any amounts thereof, net of taxes, shall be excluded,
(w)any net after-Tax income (loss) from the early extinguishment of (i) Indebtedness, (ii) Hedging Obligations or (iii) other derivative instruments shall be excluded,
(x)any impairment charge or expense, asset write-off or write-down, including impairment charges or asset write-offs or write-downs related to intangible assets, long-lived assets or investments in debt and equity securities or as a result of a change in law or regulations, in each case, pursuant to GAAP and the amortization of intangibles arising pursuant to GAAP shall be excluded,
(y)any non-cash compensation charge or expense, including any such charge arising from grants of stock appreciation or similar rights, phantom equity, stock options, restricted stock or other rights, and any cash charges associated with the rollover, acceleration or payout of Equity Interests by management of UK Holdco or any of its direct or indirect parent companies, including any expense resulting from the application of Statement of Financial Accounting Standards No. 123R shall be excluded, provided that any subsequent settlement in cash shall reduce Consolidated Net Income for the period in which such payment occurs,
(z)any fees and expenses or other charges (including any make-whole premium or penalties) incurred during such period, or any amortization thereof for such period, in connection with the Transactions, any acquisition, Investment, recapitalization, disposition, Asset Sale, issuance or repayment of Indebtedness, equity offering, refinancing transaction or amendment or modification of any debt instrument (in each case, (i) including any such transactions consummated prior to the Closing Date, (ii) whether or not such transaction is undertaken but not completed, (iii) if unsuccessful, whether or not such transaction is permitted by this Agreement (if such transaction would have been permitted if successful) and (iv) including any such transaction incurred by any direct or indirect parent company of UK Holdco) and any charges or non-recurring merger costs incurred during such period as a result of any such transaction shall be excluded,
(aa)accruals and reserves that are established and not reversed within 12 months after the Closing Date that are so required to be established as a result of the Transactions (or within 12 months after the closing of any acquisition that are so required to be established as a result of such acquisition) in accordance with GAAP shall be excluded,
(ab)[reserved],
(ac)any charges resulting from the application of Accounting Standards Codification Topic 805 “Business Combinations,” Accounting Standards Codification Topic 350 “Intangibles—Goodwill and Other,” Accounting Standards Codification Topic 360-10-35-15 “Impairment or Disposal of Long-Lived Assets,” Accounting Standards Codification Topic 480-10-25-4 “Distinguishing Liabilities from
22
    



Equity—Overall—Recognition” or Accounting Standards Codification Topic 820 “Fair Value Measurements and Disclosures” shall be excluded,
(ad)non-cash interest expense resulting from the application of Accounting Standards Codification Topic 470-20 “Debt—Debt with Conversion Options—Recognition” shall be excluded,
(ae)any non-cash interest expense and non-cash interest income, in each case to the extent there is no associated cash disbursement or receipt, as the case may be, before the maturity date of the Initial Term Loans, shall be excluded;
(af)the net after-Tax effect of carve-out related items (including, without limitation, elimination of duplicative costs (including with respect to transaction services agreements) and costs and expenses related to information and technology systems establishment or modification), in each case in connection with acquisitions and investments permitted hereunder, shall be excluded;
(ag)the following items shall be excluded:
(i)any net unrealized gain or loss (after any offset) resulting in such period from (i) Hedging Obligations, (ii) the application of Accounting Standards Codification Topic 815 “Derivatives and Hedging” and/or (iii) any ineffectiveness recognized in earnings related to qualifying hedge transactions or the fair value of changes therein recognized in earnings for derivatives that do not qualify as hedge transactions, in respect of Hedging Obligations;
(ii)any net foreign exchange gains or losses (whether or not realized) resulting from the impact of foreign currency changes on the valuation of assets and liabilities on the consolidated balance sheet of UK Holdco and its Restricted Subsidiaries (in each case, including currency re-measurements of Indebtedness, any net loss or gain resulting from hedge arrangements for currency exchange or any other currency related risk and any translation of assets and liabilities denominated in a foreign currency); and
(ah)any fee, loss, charge, expense, cost, accrual or reserve associated with and/or payment of any actual or prospective legal settlement, fine, judgment or order shall be excluded.
Solely for purposes of calculating Consolidated EBITDA, the Net Income of UK Holdco and its Restricted Subsidiaries shall be calculated without deducting the income attributable to the minority equity interests of third parties in any non-Wholly Owned Restricted Subsidiary except to the extent (without duplication) of dividends declared or paid in respect of such period or any prior period on the shares of Capital Stock of such Restricted Subsidiary held by such third parties.
In addition, to the extent not already accounted for in the Consolidated Net Income of UK Holdco and its Restricted Subsidiaries, notwithstanding anything to the contrary in the foregoing, Consolidated Net Income shall include (i) the amount of proceeds received during such period from business interruption insurance in respect of insured claims for such period, (ii) the amount of proceeds as to which the Borrower Representative has determined there is reasonable evidence it will be reimbursed by the insurer in respect of such period from business interruption insurance (with a deduction for any amount so added back to the extent denied by the applicable carrier in writing within 180 days or not so reimbursed within 365 days) and (iii) reimbursements of any expenses and charges that are covered by indemnification, insurance or other reimbursement provisions in connection with any acquisition, permitted Investment, Recovery Event or any sale, conveyance, transfer or other disposition of assets permitted hereunder.
Notwithstanding the foregoing, (x) for the purpose of Section 7.3 only (other than clauses (a)(3)(E) and (a)(3)(F) therein), there shall be excluded from Consolidated Net Income any income arising from any sale or other disposition of Restricted Investments made by UK Holdco and its Restricted Subsidiaries, any repurchases and redemptions of Restricted Investments from UK Holdco and its Restricted Subsidiaries, any repayments of loans and advances which constitute Restricted Investments by UK Holdco or any of its Restricted Subsidiaries, any sale of the stock of an Unrestricted Subsidiary or any distribution or dividend from an Unrestricted Subsidiary, in each case only to the extent such amounts increase the amount of Restricted Payments permitted under such covenant pursuant to clauses (a)(3)(E)
23
    



and (a)(3)(F) therein and (y) for the purpose of the definition of Excess Cash Flow only, there shall be excluded the income (or deficit) of any Person accrued prior to the date it becomes a Restricted Subsidiary or is merged into or consolidated with UK Holdco or any Restricted Subsidiary thereof.
Consolidated Non-Cash Charges”: with respect to UK Holdco and its Restricted Subsidiaries for any period, the aggregate depreciation, amortization (including amortization of intangibles, deferred financing fees, debt issuance costs, commissions, fees and expenses, expensing of any bridge, commitment or other financing fees, the non-cash portion of interest expense resulting from the reduction in the carrying value under purchase accounting of UK Holdco’s or any Restricted Subsidiary’s outstanding Indebtedness and commissions, discounts, yield and other fees and charges but excluding amortization of prepaid cash expenses that were paid in a prior period), non-cash impairment, non-cash compensation, non-cash rent and other non-cash expenses of UK Holdco and its Restricted Subsidiaries reducing Consolidated Net Income of UK Holdco and its Restricted Subsidiaries for such period on a consolidated basis and otherwise determined in accordance with GAAP; provided that if any non-cash charges referred to in this definition represent an accrual or reserve for potential cash items in any future period, the cash payment in respect thereof in such future period shall be subtracted from Consolidated EBITDA in such future period to such extent paid.
Consolidated Secured Indebtedness”: as of any date of determination, the aggregate principal amount of Consolidated Total Indebtedness that is secured by a Lien on any asset of UK Holdco or any of its Restricted Subsidiaries that constitutes Collateral; provided that “Consolidated Secured Indebtedness” shall be calculated, without duplication, after netting the Netted Amounts from the amount of Consolidated Total Indebtedness so secured.
Consolidated Total Indebtedness”: as of any date of determination, the aggregate principal amount of Indebtedness described in clauses (a)(i), (a)(ii) (excluding, for the avoidance of doubt, surety bonds, performance bonds and similar instruments) and (a)(iv) of the definition of “Indebtedness” of UK Holdco and the Restricted Subsidiaries outstanding on such date, determined on a consolidated basis, to the extent required to be recorded on a balance sheet in accordance with GAAP, including, without duplication, the outstanding principal amount of the Term Loans; provided, that the amount of revolving Indebtedness under this Agreement and any other revolving credit facility shall be computed based upon the period-ending value of such Indebtedness during the applicable period; provided, further, that Consolidated Total Indebtedness shall not include (x) Indebtedness in respect of any Qualified Receivables Financing permitted pursuant to Section 7.2, any Hedging Obligations or any obligations that are non-recourse to UK Holdco and its Restricted Subsidiaries or (y) obligations in respect of letters of credit (including Letters of Credit) or bankers’ acceptances, except to the extent of unreimbursed amounts thereunder; provided, further, that “Consolidated Total Indebtedness”, “Consolidated First Lien Indebtedness” and “Consolidated Secured Indebtedness” shall in each case (but without duplication) be calculated for all purposes hereunder (i) net of the Unrestricted Cash Amount and (ii) to exclude any obligation, liability or indebtedness if, upon or prior to the maturity thereof, the applicable Person has irrevocably deposited with the proper Person in trust or escrow the necessary funds (or evidences of indebtedness) for the payment, redemption or satisfaction of such obligation, liability or indebtedness, and thereafter such funds and evidences of such obligation, liability or indebtedness or other security so deposited are not included in the calculation of the Unrestricted Cash Amount (clauses (i) and (ii), the “Netted Amounts”).
Consolidated Working Capital”: at any date, the excess of Consolidated Current Assets on such date over Consolidated Current Liabilities on such date.
Consolidated Working Capital Adjustment”: for any period on a consolidated basis, the amount (which may be a negative number) by which Consolidated Working Capital as of the beginning of such period exceeds (or is less than (in which case the Consolidated Working Capital Adjustment will be a negative number)) Consolidated Working Capital as of the end of such period.
Contingent Obligations”: with respect to any Person, any obligation of such Person guaranteeing any leases, dividends or other obligations that do not constitute Indebtedness (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, including, any obligation of such Person, whether or not contingent:
24
    



(ai)to purchase any such primary obligation or any property constituting direct or indirect security therefor,
(aj)to advance or supply funds:
(i)for the purchase or payment of any such primary obligation; or
(ii)to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor; or
(ak)to purchase property, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation against loss in respect thereof.
Contractual Obligation”: as to any Person, any provision of any security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound.
Contribution Indebtedness”: Indebtedness, Preferred Stock or Disqualified Stock of UK Holdco or any Restricted Subsidiary in an aggregate principal amount not greater than 100% of the aggregate amount of contributions (including the proceeds of any sale of Capital Stock other than Disqualified Stock) in the form of cash, and the Fair Market Value of contributions of Cash Equivalents, marketable securities or other property (in each case other than Excluded Contributions, any contributions received in connection with the exercise of the Cure Right or any such cash contributions that have been used to make a Restricted Payment), made to the equity capital of UK Holdco or any Restricted Subsidiary (other than from UK Holdco or a Restricted Subsidiary) after the Closing Date.
Control”: the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise. “Controlling” and “Controlled” have meanings correlative thereto.
Cost Saving Initiative”: as defined in clause (1)(i) of the definition of “Consolidated EBITDA.”
Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
CRD IV”: (i) Regulation (EU) No 575/2013 of the European Parliament of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms; and (ii) Directive 2013/36/EU of the European Parliament and of the Council of 26 June 2013 on access to the activity of credit institutions and the prudential supervision of credit institutions and investment firms, amending Directive 2002/87/EC and repealing Directives 2006/48/EC and 2006/49/EC; or any law, rules or guidance by which either of them is implemented.
CTA 2009” means the United Kingdom Corporation Tax Act 2009.
Cure Amount”: as defined in Section 9.4(a).
Cure Period”: as defined in Section 9.4(a).
Cure Right”: as defined in Section 9.4(a).
Customary Bridge Financings”: customary bridge facilities that automatically convert into or are exchanged for permanent financing that do not provide (i) an earlier final maturity date than the Latest Maturity Date of the Initial Term Loans or the Amendment No. 2 Incremental Term Loans or (ii) a shorter Weighted Average Life to Maturity than the remaining Weighted Average Life to Maturity of the
25
    



Initial Term Loans or the Amendment No. 2 Incremental Term Loans, in each case determined at the time such facility is incurred.
Daily Simple SOFR”: with respect to any applicable determination date, the SOFR published on such date on the Federal Reserve Bank of New York’s website (or any successor source).
Debt Fund Affiliate”: an Affiliate of any Sponsor (other than Holdings and any of its Subsidiaries) that is a bona fide debt fund or an investment vehicle that is engaged in the making, purchasing, holding or otherwise investing in commercial loans, bonds and similar extensions of credit in the ordinary course of business with respect to which any Sponsor and its Affiliates (other than Debt Fund Affiliates) do not directly or indirectly possess the power to direct or cause the direction of the investment policies of such entity.
Debtor Relief Laws”: the Bankruptcy Code of the United States, the United Kingdom Insolvency Act 1986 and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief Laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.
Declined Proceeds”: as defined in Section 2.11(f).
Default”: any of the events specified in Section 9.1, whether or not any requirement for the giving of notice, the lapse of time, or both, has been satisfied.
Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
Delaware Divided LLC” means a Delaware LLC which has been formed upon the consummation of a Delaware LLC Division.
Delaware LLC” means any limited liability company organized or formed under the laws of the State of Delaware.
Delaware LLC Division” means the statutory division of any Delaware LLC limited liability company into two or more Delaware LLCs limited liability companies pursuant to Section 18-217 of the Delaware Limited Liability Company Act or a comparable provision of any other requirement of Law.
Defaulting Lender”: any Lender that (a) has refused (whether verbally or in writing) to fund (and has not retracted such refusal), or has failed to fund, any portion of the Term Loans, Revolving Loans, participations in L/C Obligations or participations in Swingline Loans required to be funded by it hereunder (collectively, its “Funding Obligations”) within two (2) Business Days of the date required to be funded by such Lender hereunder unless such Lender notifies the Administrative Agent and the Borrower Representative in writing that such failure is the result of such Lender’s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing), (b) has notified the Administrative Agent or the Borrower Representative in writing that it does not intend to (or will not be able to) satisfy such Funding Obligations or has made a public statement to that effect with respect to its Funding Obligations or generally under other agreements in which it commits to extend credit (unless such writing or public statement relates to such Lender’s obligation to fund a Loan hereunder and states that such position is based on such Lender’s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has otherwise failed to pay over to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within two (2) Business Days of the date when due, (d) has failed, within three (3) Business Days after written request by the Administrative Agent, to confirm in a manner reasonably satisfactory to the Administrative Agent that it will comply with its Funding Obligations; provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (d) upon the Administrative Agent’s receipt of such confirmation, or (e) has, or has a direct or indirect parent company that has, (i) admitted in writing that it is insolvent or that it is not able to pay its
26
    



debts as they become due, (ii) become the subject of a proceeding under any Debtor Relief Law, (iii) had a receiver, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or a substantial part of its assets or a custodian appointed for it, (iv) is or becomes subject to a forced liquidation, (v) makes a general assignment for the benefit of creditors or is otherwise adjudicated as, or determined by any Governmental Authority having regulatory authority over such person or its assets to be insolvent or bankrupt, (vi) taken any action in furtherance of, or indicated its consent to, approval of or acquiescence in any such proceeding or appointment or action or (vii) become the subject of a Bail-In Action or any other similar proceeding or process; provided that a Lender shall not be a Defaulting Lender under this clause (e) solely by virtue of the ownership or acquisition of any equity interest in that Lender or the existence of an Undisclosed Administration in respect of that Lender (or, in such any case, any direct or indirect parent company thereof) by a Governmental Authority so long as such ownership interest or Undisclosed Administration does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender.
Defaulting Lender Fronting Exposure”: at any time there is a Defaulting Lender, (a) with respect to any Issuing Lender, such Defaulting Lender’s Pro Rata Share of the Outstanding Amount of L/C Obligations of such Issuing Lender other than L/C Obligations as to which such Defaulting Lender’s participation obligation has been reallocated to other Lenders or Cash Collateralized in accordance with the terms hereof, and (b) with respect to any Swingline Lender, such Defaulting Lender’s Pro Rata Share of Swingline Loans other than Swingline Loans as to which such Defaulting Lender’s participation obligation has been reallocated to other Lenders or Cash Collateralized in accordance with the terms hereof.
Designated Non-cash Consideration”: the Fair Market Value of non-cash consideration received by UK Holdco or any of its Restricted Subsidiaries in connection with an Asset Sale that is determined by the Borrower Representative to be Designated Non-cash Consideration, less the amount of Cash Equivalents received in connection with a subsequent sale of or collection on such Designated Non-cash Consideration.
Designated Preferred Stock”: Preferred Stock of UK Holdco or any direct or indirect parent of UK Holdco, as applicable (other than Disqualified Stock), that is issued for cash (other than to UK Holdco or any of the Restricted Subsidiaries or an employee stock ownership plan or trust established by UK Holdco or any of its Subsidiaries) and is so designated as Designated Preferred Stock, pursuant to an Officer’s Certificate signed on behalf of the Borrower Representative, on the issuance date thereof, the cash proceeds of which are excluded from the calculation set forth in Section 7.3(a)(3).
Disposition”: with respect to any property (including Capital Stock of UK Holdco or any Restricted Subsidiary), any sale, lease, Sale Leaseback Transaction, assignment, conveyance, transfer or other disposition thereof (including by merger or consolidation or amalgamation and excluding the granting of a Lien permitted hereunder) and any issuance of Capital Stock of any Restricted Subsidiary. The terms “Dispose” and “Disposed of” shall have correlative meanings.
Disqualified Lender”: (i) each bank, financial institution, other institutional lenders and investors and other entities identified on a list made available to the Administrative Agent and the Joint Lead Arrangers on or prior to the date of the engagement letter entered into with the Joint Lead Arrangers and (ii) each competitor of UK Holdco or any of its Subsidiaries that is in the same or a similar line of business as UK Holdco and its Subsidiaries identified by name and designated in writing from time to time to the Administrative Agent and (iii) as to any entity referenced in clause (ii) above (the “Primary Disqualified Lender”), any of such Primary Disqualified Lender’s Affiliates clearly identifiable as such solely on the basis of its name, but excluding any Affiliate that is primarily engaged in, or that advises bona fide debt funds, or other investment vehicles that are engaged in, making, purchasing, holding or otherwise investing in commercial loans, bonds and similar extensions of credit or securities in the ordinary course and with respect to which the Primary Disqualified Lender does not, directly or indirectly, possess the power to direct or cause the direction of such entity; provided that any Person that is a Lender and subsequently becomes a Disqualified Lender (but was not a Disqualified Lender on the
27
    



Closing Date or at the time it became a Lender) shall be deemed to not be a Disqualified Lender hereunder. The list of Disqualified Lenders shall be held by the Administrative Agent and made available to Lenders (including in connection with the sale of a participation interest pursuant to Section 11.6(c)) upon request.
Disqualified Stock”: with respect to any Person, any Capital Stock of such Person that, by its terms (or by the terms of any security into which it is convertible or for which it is redeemable or exchangeable, in each case at the option of the holder thereof), or upon the happening of any event:
(al)matures or is mandatorily redeemable (other than as a result of a change of control, asset sale or casualty event), pursuant to a sinking fund obligation or otherwise,
(am)is convertible or exchangeable for Indebtedness or Disqualified Stock, or
(an)is redeemable at the option of the holder thereof,
in whole or in part, in each case prior to 91 days after the maturity date of the Initial Term Facility (other than as a result of a change of control, asset sale or casualty event to the extent permitted under clause (1) above); provided, however, that only the portion of Capital Stock that so matures or is mandatorily redeemable, is so convertible or exchangeable or is so redeemable at the option of the holder thereof prior to such date shall be deemed to be Disqualified Stock; provided, further, however, that if such Capital Stock is issued to any plan for the benefit of employees of UK Holdco or its Subsidiaries or by any such plan to such employees, such Capital Stock shall not constitute Disqualified Stock solely because it may be required to be repurchased by UK Holdco or any Restricted Subsidiary in order to satisfy applicable statutory or regulatory obligations; provided, further, however, that any Capital Stock held by any future, current or former employee, director, manager or consultant (or their respective trusts, estates, investment funds, investment vehicles or immediate family members), of UK Holdco, any of its Subsidiaries, any of its direct or indirect parent companies or any other entity in which UK Holdco or a Restricted Subsidiary has an Investment and is designated in good faith as an “affiliate” by the Board of Directors of the Borrower Representative (or the compensation committee thereof), in each case pursuant to any stockholders’ agreement, management equity plan, stock option plan or any other management or employee benefit plan or agreement shall not constitute Disqualified Stock solely because it may be required to be repurchased by UK Holdco or any Restricted Subsidiary; provided, further, however, that any class of Capital Stock of such Person that by its terms authorizes such Person to satisfy its obligations thereunder by delivery of Capital Stock that is not Disqualified Stock shall not be deemed to be Disqualified Stock.
Dollar Amount”: at any time:
(i)with respect to any Loan denominated in Dollars, the principal amount thereof then outstanding (or in which such participation is held); and
(ii)with respect to any Loan denominated in an Alternative Currency, the principal amount thereof then outstanding in the relevant Alternative Currency, converted to Dollars in accordance with Section 1.5.
Dollars” and “$”: dollars in lawful currency of the United States.
DPTA”: as defined in Section 8.12(d).
Dutch Auction”: one or more purchases (each, a “Purchase”) by a Permitted Auction Purchaser or an Affiliated Lender (either, a “Purchaser”) of Term Loans; provided that, each such Purchase is made on the following basis:
(iii)(i) the Purchaser will notify the Administrative Agent in writing (a “Purchase Notice”) (and the Administrative Agent will deliver such Purchase Notice to each relevant Lender) that such Purchaser wishes to make an offer to purchase from each Term Lender and/or each Lender with respect to
28
    



any Class of Term Loans on an individual tranche basis Term Loans, in an aggregate principal amount as is specified by such Purchaser (the “Term Loan Purchase Amount”) with respect to each applicable tranche, subject to a range or minimum discount to par expressed as a price at which range or price such Purchaser would consummate the Purchase (the “Offer Price”) of such Term Loans to be purchased (it being understood that different Offer Prices and/or Term Loan Purchase Amounts, as applicable, may be offered with respect to different tranches of Term Loans and, in such an event, each such offer will be treated as a separate offer pursuant to the terms of this definition); provided that the Purchase Notice shall specify that each Return Bid (as defined below) must be submitted by a date and time to be specified in the Purchase Notice, which date shall be no earlier than the second Business Day following the date of the Purchase Notice and no later than the fifth Business Day following the date of the Purchase Notice and (ii) the Term Loan Purchase Amount specified in each Purchase Notice delivered by such Purchaser to the Administrative Agent shall not be less than $10,000,000 in the aggregate;
(iv)such Purchaser will allow each Lender holding the Class of Term Loans subject to the Purchase Notice to submit a notice of participation (each, a “Return Bid”) which shall specify (i) one or more discounts to par of such Lender’s tranche or tranches of Term Loans subject to the Purchase Notice expressed as a price (each, an “Acceptable Price”) (but in no event will any such Acceptable Price be greater than the highest Offer Price for the Purchase subject to such Purchase Notice) and (ii) the principal amount of such Lender’s tranches of Term Loans at which such Lender is willing to permit a purchase of all or a portion of its Term Loans to occur at each such Acceptable Price (the “Reply Amount”);
(v)based on the Acceptable Prices and Reply Amounts of the Term Loans as are specified by the Lenders, such Purchaser will determine the applicable discount (the “Applicable Discount”), which will be either, as applicable, (i) the lowest Acceptable Price at which such Purchaser can complete the Purchase for the entire Term Loan Purchase Amount or (ii) in the event that the aggregate Reply Amounts relating to such Purchase Notice are insufficient to allow such Purchaser to complete a purchase of the entire Term Loan Purchase Amount, the highest Acceptable Price that is less than or equal to the Offer Price;
(vi)such Purchaser shall purchase Term Loans from each Lender with one or more Acceptable Prices that are equal to or less than the Applicable Discount at the Applicable Discount (such Term Loans being referred to as “Qualifying Loans” and such Lenders being referred to as “Qualifying Lenders”), subject to clauses (e), (f), (g) and (h) below;
(vii)such Purchaser shall purchase the Qualifying Loans offered by the Qualifying Lenders at the Applicable Discount; provided that if the aggregate principal amount required to purchase the Qualifying Loans would exceed the Term Loan Purchase Amount, such Purchaser shall purchase Qualifying Loans ratably based on the aggregate principal amounts of all such Qualifying Loans tendered by each such Qualifying Lender;
(viii)the Purchase shall be consummated pursuant to and in accordance with Section 11.6(b) and, to the extent not otherwise provided herein, shall otherwise be consummated pursuant to procedures (including as to timing, rounding and minimum amounts, Interest Periods, and other notices by such Purchaser) reasonably acceptable to the Administrative Agent (provided that, subject to the proviso of clause (g) of this definition, such Purchase shall be required to be consummated no later than five Business Days after the time that Return Bids are required to be submitted by Lenders pursuant to the applicable Purchase Notice);
(ix)upon submission by a Lender of a Return Bid, subject to the foregoing clause (f), such Lender will be irrevocably obligated to sell the entirety or its pro rata portion (as applicable pursuant to clause (e) above) of the Reply Amount at the Applicable Discount plus accrued and unpaid interest through the date of purchase to such Purchaser pursuant to Section 11.6(b) and as otherwise provided herein; provided that as long as no Return Bids have been submitted each Purchaser may rescind its Purchase Notice by notice to the Administrative Agent; and
(x)purchases by a Permitted Auction Purchaser of Qualifying Loans shall result in the immediate Cancellation of such Qualifying Loans.
29
    



EBITDA”: for any period for any Person, the aggregate (without double counting) earnings before interest, tax, depreciation and amortization attributable to such Person for such period (calculated on the same basis as Consolidated EBITDA mutatis mutandis but on an unconsolidated basis and excluding intercompany items (other than intercompany profit margins), as applicable).
ECF Percentage”: 50%; provided that the ECF Percentage shall be reduced to (i) 25% if the First Lien Net Leverage Ratio as of the last day of the most recently ended Reference Period is less than or equal to 4.50 to 1.00 and greater than 4.00 to 1.00 and (ii) 0% if the First Lien Net Leverage Ratio as of the last day of the most recently ended Reference Period is less than or equal to 4.00 to 1.00; provided that the ECF Percentage shall be determined on the date of required prepayment in respect of Excess Cash Flow and giving pro forma effect to such prepayment and to any other repayment or prepayment at or prior to the time such prepayment in respect of Excess Cash Flow is due.
EEA Financial Institution”: (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a Subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.
EEA Member Country”: any of the member states of the European Union, Iceland, Liechtenstein, and Norway.
EEA Resolution Authority”: any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having the responsibility for the resolution of any EEA Financial Institution.
Effective Yield”: as to any Indebtedness, the effective yield applicable thereto calculated by the Administrative Agent in consultation with the Borrower Representative in a manner consistent with generally accepted financial practices, taking into account (a) interest rate margins, (b) interest rate floors (subject to the proviso set forth below), (c) any amendment to the relevant interest rate margins and interest rate floors prior to the applicable date of determination and (d) original issue discount and upfront or similar fees (based on an assumed four-year average life to maturity or lesser remaining average life to maturity), but excluding (i) any advisory, arrangement, commitment, consent, structuring, success, underwriting, ticking, unused line fees, amendment fees and/or any similar fees payable in connection therewith (regardless of whether any such fees are paid to or shared in whole or in part with any lender) and (ii) any other fee that is not paid directly by the Borrower Representative generally to all relevant lenders ratably (or, if only one lender (or affiliated group of lenders) is providing such Indebtedness, are fees of the type not customarily shared with lenders generally); provided, that with respect to any Indebtedness that includes a “SOFR floor” or “Base Rate floor”, that (A) to the extent that the “Term SOFR” (for an Interest Period of three months) or “Base Rate” (in each case without giving effect to any floor specified in the definitions thereof on the date on which the Effective Yield is being calculated) is less than such floor, the amount of such difference will be deemed added to the interest rate margin applicable to such Indebtedness for purposes of calculating the Effective Yield and (B) to the extent that the “Term SOFR” (for an Interest Period of three months) or “Base Rate” (in each case, without giving effect to any floor specified in the definitions thereof) is greater than such floor, the floor will be disregarded in calculating the Effective Yield.
Eligible Assignee”: (a) any Lender, any Affiliate of a Lender and any Approved Fund (any two or more Approved Funds with respect to a particular Lender being treated as a single Eligible Assignee for all purposes hereof), and (b) any commercial bank, insurance company, financial institution, investment or mutual fund or other entity that is an “accredited investor” (as defined in Regulation D under the Securities Act) and which extends credit or buys commercial loans in the ordinary course; provided that “Eligible Assignee” (x) shall include (i) Debt Fund Affiliates and Affiliated Lenders, subject to the provisions of Section 11.6(b)(iv) and (ii) Permitted Auction Purchasers, subject to the provisions of Section 11.6(b)(iii), and solely to the extent that such Permitted Auction Purchasers purchase or acquire Term Loans pursuant to a Dutch Auction or open market purchase permitted hereunder and effect a Cancellation immediately upon such contribution, purchase or acquisition pursuant
30
    



to documentation reasonably satisfactory to the Administrative Agent and (y) shall not include any Disqualified Lender, any natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of, one or more natural persons) or any Term Borrower, Holdings or any of their Affiliates (other than as set forth in this definition).
EMU Legislation”: the legislative measures of the European Council for the introduction of, changeover to or operation of a single or unified European currency.
Environmental Laws”: any and all foreign, Federal, state, local or municipal laws, rules, orders, regulations, statutes, ordinances, codes, decrees, legally binding requirements of any Governmental Authority or other Requirements of Law (including common law) regulating, relating to or imposing liability or standards of conduct concerning the release, transportation, generation, use, handling, treatment, storage or disposal of Materials of Environmental Concern, human health and safety with respect to exposure to Materials of Environmental Concern, and protection or restoration of the environment.
Equity Interests”: Capital Stock and all warrants, options or other rights to acquire Capital Stock (but excluding any debt security that is convertible into, or exchangeable for, Capital Stock).
ERISA”: the Employee Retirement Income Security Act of 1974, as amended from time to time.
EU Bail-In Legislation Schedule”: the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.
EU Lender”: in respect of a Spanish Borrower, a Lender which (a) is resident for Tax purposes in a member state of the European Union (other than Spain) acting directly or through a permanent establishment located in another a member state of the European Union (other than Spain), provided that it does not act in respect of the Loan through a permanent establishment located in Spain or in a jurisdiction other than a member state of the European Union; and (b) does not obtain the relevant income through a state or territory treated as a tax haven pursuant to Spanish laws and regulations (currently set out in Royal Decree 1080/1991, of 5 July -Real Decreto 1080/1991, de 5 de julio-, as amended or restated).
EURIBOR”: as set forth in the definition of Eurocurrency Rate.
Eurocurrency Loans”: Loans that bear interest at a rate based on clauses (a) and (b) of the definition of “Eurocurrency Rate.”
Eurocurrency Rate”: for any Interest Period,
(xi)with respect to the Revolving Facility, in the case of any Eurocurrency Loan denominated in Euros, the rate per annum equal to the Euro Interbank Offered Rate (“EURIBOR”), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) on the day that is two TARGET Days preceding the first day of such Interest Period with a term equivalent to such Interest Period;
(xii)with respect to the Revolving Facility, in the case of any Eurocurrency Loan denominated in Australian dollars, the rate per annum equal to the Bank Bill Swap Reference Bid Rate (“BBSY”) or a comparable or successor rate, which rate is approved by the Administrative Agent in consultation with the Borrower Representative, as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at or about 10:30 a.m. (Melbourne, Australia time) on the Rate Determination Date with a term equivalent to such Interest Period; and
(xiii)with respect to the Revolving Facility, in the case of any Eurocurrency Loan denominated in any Alternative Currency (other than Euros, Sterling and Australian Dollars), the rate per annum as designated with respect to such Alternative Currency at the time such Alternative Currency is approved
31
    



by the Administrative Agent and the Revolving Lenders or Issuing Lenders, as applicable, pursuant to Section 2.30(a).
provided that the Eurocurrency Rate shall be no less than  zero for all purposes of this Agreement.
Eurocurrency Tranche”: the collective reference to Eurocurrency Loans under a particular Facility the then current Interest Periods with respect to all of which begin on the same date and end on the same later date (whether or not such Loans shall originally have been made on the same day).
Euros”, “EUR” and “”: the single currency of the Participating Member States; provided, that if any member state or states ceases to have such single currency as its lawful currency (such member state(s) being the “Exiting State(s)”), EUR, Euro and € shall, for the avoidance of doubt, mean for all purposes the single currency adopted and retained as the lawful currency of the remaining member states and shall not include any successor currency introduced by the Exiting State(s).
Event of Default”: any of the events specified in Section 9.1; provided that any requirement for the giving of notice, the lapse of time, or both, has been satisfied.
Excess Cash Flow”: for any Excess Cash Flow Period, the excess, if positive, of
(xiv)the sum, without duplication, of
(1)Consolidated Net Income for such Excess Cash Flow Period,
(2)the amount of Consolidated Non-Cash Charges deducted in arriving at such Consolidated Net Income, but excluding any such Consolidated Non-Cash Charges representing an accrual or reserve for a potential cash item in any future period,
(3)the Consolidated Working Capital Adjustment for such Excess Cash Flow Period,
(4)the aggregate net amount of non-cash loss on the Disposition of property by UK Holdco and the Restricted Subsidiaries during such Excess Cash Flow Period (other than sales in the ordinary course of business), to the extent deducted in arriving at such Consolidated Net Income,
(5)the amount of Tax expense in excess of the amount of Taxes paid in cash during such Excess Cash Flow Period to the extent such Tax expense was deducted in determining Consolidated Net Income for such period, and
(6)cash receipts in respect of Swap Agreements during such Excess Cash Flow Period to the extent not otherwise included in Consolidated Net Income, over
(xv)the sum, without duplication, of
(1)the amount of all non-cash credits included in arriving at such Consolidated Net Income (but excluding any non-cash credit to the extent representing a reversal of an accrual or reserve described in clause (a)(ii)),
(2)[reserved],
(3)[reserved],
(4)to the extent not deducted in determining Consolidated Net Income, Permitted Tax Distributions and Taxes of any Group Member that were paid in cash with respect to such Excess Cash Flow Period,
32
    



(5)all mandatory prepayments of the Term Loans pursuant to Section 2.11 made during such Excess Cash Flow Period as a result of any Asset Sale or Recovery Event, but only to the extent that such Asset Sale or Recovery Event resulted in a corresponding increase in Consolidated Net Income,
(6)[reserved],
(7)to the extent not funded with the proceeds of Indebtedness (other than Indebtedness under the Revolving Facility or any other revolving credit facility), the aggregate amount of all regularly scheduled principal amortization payments of Funded Debt made on their due date during such Excess Cash Flow Period (including payments in respect of Capitalized Lease Obligations to the extent not deducted in the calculation of Consolidated Net Income),
(8)to the extent not funded with the proceeds of Indebtedness (other than Indebtedness under the Revolving Facility or any other revolving credit facility), the aggregate amount of all optional prepayments, repurchases and redemptions of Indebtedness (other than (x) the Loans and other such amounts deducted from the amount of Excess Cash Flow required to be prepaid pursuant to Section 2.11(b) and (y) in respect of any revolving credit facility to the extent there is not an equivalent permanent reduction in commitments thereunder) made during the Excess Cash Flow Period,
(9)the aggregate net amount of non-cash gains on the Disposition of property by UK Holdco and the Restricted Subsidiaries during such Excess Cash Flow Period (other than sales of inventory in the ordinary course of business), to the extent included in arriving at such Consolidated Net Income,
(10)[reserved],
(11)any cash payments that are made during such Excess Cash Flow Period and have the effect of reducing an accrued liability that was not accrued during such period,
(12)the amount of Taxes paid in cash during such Excess Cash Flow Period to the extent they exceed the amount of Tax expense deducted in determining Consolidated Net Income for such period,
(13)[reserved],
(14)the aggregate amount of any premium, make-whole or penalty payments actually paid in cash by UK Holdco and any Restricted Subsidiary during such period that are required to be made in connection with any prepayment or satisfaction and discharge of Indebtedness,
(15)cash expenditures in respect of Swap Agreements during such fiscal year to the extent not deducted in arriving at such Consolidated Net Income,
(16)the amount of cash payments made in respect of pensions and other post-employment benefits in such period to the extent not deducted in arriving at such Consolidated Net Income,
(17)the amount of cash and Cash Equivalents subject to cash collateral or other deposit arrangements made with respect to Letters of Credit or Swap Agreements; provided, that if such cash and Cash Equivalents cease to be subject to those arrangements, such amount shall be added back to Excess Cash Flow for the subsequent Excess Cash Flow Period when such arrangements cease,
(18)a reserve established by UK Holdco or any Restricted Subsidiary in good faith in respect of deferred revenue that any Group Member generated during such Excess Cash Flow Period; provided that, to the extent all or any portion of such deferred revenue is not returned to customers during the immediately succeeding Excess Cash Flow Period or otherwise included in the
33
    



Consolidated Net Income in the immediately subsequent year, such deferred revenue shall be added back to Excess Cash Flow for such subsequent Excess Cash Flow Period,
(19)cash payments by UK Holdco and its Restricted Subsidiaries in respect of long-term liabilities to the extent not deducted in arriving at such Consolidated Net Income; provided that no such payments are with respect to long-term liabilities with an Affiliate of UK Holdco (or are guaranteed by an Affiliate of UK Holdco), and
(20)amounts added to Consolidated Net Income pursuant to clauses (1), (3), (4) and (11) of the definition of “Consolidated Net Income” and, without duplication, any other loss, expense, accrual, reserve or charge excluded in the calculation of “Consolidated Net Income” paid or payable in cash.
In no event shall Excess Cash Flow be calculated on a Pro Forma Basis.
Excess Cash Flow Application Date”: as defined in Section 2.11(b).
Excess Cash Flow Period”: each fiscal year of UK Holdco beginning with the fiscal year ending December 31, 2020.
Exchange Act”: the Securities Exchange Act of 1934, as amended from time to time, and any successor statute.
Exchange Rate”: on any day with respect to any Alternative Currency, the Administrative Agent’s spot rate of exchange for the purchase of such Alternative Currency with Dollars in the London foreign exchange market at approximately 11:00 a.m. (London time) on such day.
Excluded Assets”: with respect to any Loan Party (as it relates to clauses (ii), (iii) and (ix), to the extent the UCC or United States Law is applicable to the relevant asset): (i) fee owned real property and all leasehold property (and, for the avoidance of doubt, in no event shall landlord lien waivers, estoppels and collateral access letters be required to be delivered with respect to any such leasehold property), (ii) any vehicles and other assets subject to certificates of title (other than to the extent perfection of the security interest in such assets is accomplished solely by the filing of a UCC financing statement), (iii) chattel paper, letter of credit rights and tort claims (other than to the extent perfection of the security interest therein is accomplished solely by the filing of a UCC financing statement), (iv) any assets the granting of a security interest in which (1) is prohibited or restricted by Law (including restrictions in respect of margin stock and financial assistance, fraudulent conveyance, preference, thin capitalization or other similar laws or regulations), (2) requires government or third-party consents that have not been obtained or would violate the terms of any contract or trigger termination pursuant to a “change of control” provision; provided that such contracts were not entered into in contemplation of the release of Collateral or the creation of an Excluded Asset (after giving effect to the applicable anti-assignment provisions of the UCC or other applicable Law, the granting or assignment of which is expressly deemed effective under the UCC or other applicable Law notwithstanding any applicable prohibition); provided, that there shall be no requirement to use efforts to procure the relevant consents or (3) could reasonably be expected to result in material adverse accounting, regulatory or Tax consequences as determined by the Borrower Representative in good faith in consultation with the Administrative Agent, (v) (A) any margin stock and (B) Equity Interests in an Excluded Subsidiary (other than a CFC or a FSHCO), (vi) any assets where the cost, burden or difficulty of obtaining a security interest in, or perfection of a security interest in, such assets exceeds the practical benefit to the Secured Parties afforded thereby (as reasonably determined by the Borrower Representative), (vii) any governmental or regulatory licenses or state or local franchises, charters, consents, permits and authorizations, to the extent a security interest in any such license, franchise, charter, consent, permit or authorization is prohibited or restricted thereby, (viii) any general intangible, lease, license, agreement or similar arrangement or any property subject thereto (including pursuant to a purchase money security interest or similar arrangement) to the extent that a grant of a security interest therein would violate or invalidate such general intangible, lease, license or agreement or purchase money arrangement or create a right of termination in favor of any other party thereto (other than the Loan Parties) after giving effect to the applicable anti-assignment provisions of the UCC or other applicable law, the assignment of which is expressly deemed effective under the
34
    



UCC or other applicable law notwithstanding such prohibition, (ix) any cash and Cash Equivalents (other than proceeds of Collateral as to which perfection of the security interest in such proceeds is accomplished solely by the filing of a UCC financing statement), deposit and securities accounts (including securities entitlements and related assets) and any other assets requiring perfection through control agreements or perfection by “control” (other than in respect of certificated equity interests in the Borrowers, the Guarantors and material wholly-owned Restricted Subsidiaries thereof required to be pledged pursuant to the Security Documents), (x) any intent-to-use trademark application prior to the filing and acceptance by the United States Patent and Trademark Office of a “Statement of Use” or “Amendment to Allege Use” with respect thereto, to the extent, if any, that, and solely during the period, if any, in which, the grant of a security interest therein would impair the validity or enforceability of such intent-to-use trademark application, or any registration issuing therefrom, under applicable federal law, (xi) any assets of any Excluded Subsidiary, (xii) any property subject to a capital lease, purchase money security interest or, in the case of property of a Loan Party acquired after the Closing Date, pre-existing secured indebtedness not incurred in anticipation of the acquisition by the applicable Loan Party, to the extent that the granting of a security interest in such property would be prohibited under the terms of such capital lease, purchase money financing or secured indebtedness, (xiii) [reserved], (xiv) any Equity Interests of a CFC or of a FSHCO, other than 65% of the total outstanding voting Equity Interests and 100% of the total outstanding non-voting Equity Interests of such CFC or FSHCO that, in each case, are directly owned by a Loan Party, (xv) receivables and related assets (A) sold to any Receivables Subsidiary or (B) otherwise sold, pledged, factored, contributed or disposed of in connection with any Qualified Receivables Financing or other factoring arrangement not prohibited hereunder, (xvi) any assets which are subject to a security interest in respect of Acquired Indebtedness and such security interest constitutes a Permitted Lien, (xvii) any Rule 3-16 Capital Stock and (xviii) any asset excluded by the Collateral and Guarantee Principles or the Agreed Security Principles.
Excluded Contributions”: the net cash proceeds and Cash Equivalents or Fair Market Value of assets or property received by or contributed to UK Holdco or its Restricted Subsidiaries after the Closing Date (other than (i) such amounts provided by or contributed to UK Holdco or its Restricted Subsidiaries from or by any Restricted Subsidiary and (ii) Permitted Cure Securities) from:
(i)contributions to its common or preferred equity capital, and
(ii)the sale (other than to UK Holdco or a Restricted Subsidiary or management equity plan or stock option plan or any other management or employee benefit plan or agreement) of Capital Stock (other than Refunding Capital Stock, Disqualified Stock and Designated Preferred Stock) of UK Holdco or any direct or indirect parent,
in each case designated as Excluded Contributions pursuant to an Officer’s Certificate signed on behalf of the Borrower Representative on or about the date such capital contributions are made or the date such Capital Stock is sold, as the case may be, the proceeds of which are excluded from the calculation set forth in Section 7.3(a)(3).
Excluded ECP Guarantor”: in respect of any Swap Obligation, any Loan Party that is not a Qualified ECP Guarantor at the time such Swap Obligation is incurred.
Excluded Subsidiary”: any Subsidiary of UK Holdco that is, at any time of determination, (i) not a Wholly Owned Subsidiary, provided that such Subsidiary shall cease to be an Excluded Subsidiary at the time such Subsidiary becomes a Wholly Owned Subsidiary, (ii) a special purpose securitization vehicle (or similar special purpose entity), including any Receivables Subsidiary created pursuant to a transaction permitted under this Agreement, (iii) a joint venture, (iv) a not-for-profit Subsidiary, (v) a Captive Insurance Subsidiary, Immaterial Subsidiary or broker-dealer Subsidiary, (vi) organized under the laws of any jurisdiction other than a Security Jurisdiction, (vii) a CFC, (viii) a FSHCO, (ix) a Subsidiary of a CFC or of a FSHCO, (x) an Unrestricted Subsidiary, (xi) any Subsidiary for which the providing of a guarantee could reasonably be expected (A) to result in any violation or breach of, or conflict with, fiduciary duties of such subsidiary’s officers, directors or managers or (B) to result in material adverse regulatory or Tax consequences, as determined by the Borrower Representative in good faith in consultation with the Administrative Agent, (xii) any Subsidiary that is prohibited or restricted by (A) applicable requirements of Law or (B) any contractual obligation, in each case from guaranteeing the
35
    



Obligations or which would require governmental (including regulatory) or third-party consent, approval, license or authorization in order to provide such guarantee (including under any financial assistance, corporate benefit, thin capitalization, capital maintenance, liquidity maintenance or similar legal principles), unless such consent, approval, license or authorization has been obtained, it being understood that neither Holdings nor any of its Subsidiaries shall have any obligation to obtain any such consent, approval, license or authorization, (xiii) any Subsidiary in respect of which the Borrower Representative determines in consultation with the Administrative Agent that the cost, burden, difficulty or consequence of providing a guarantee is excessive in relation to the benefit to the Lenders of the security to be afforded thereby or the value of such guarantee or (xiv) any Subsidiary to the extent excluded by the application of the Collateral and Guarantee Principles or the Agreed Security Principles. Notwithstanding the foregoing, the Borrower Representative may from time to time, upon notice to the Administrative Agent, elect to cause any Subsidiary that would otherwise be an Excluded Subsidiary to become a Subsidiary Guarantor (but shall have no obligation to do so), subject to the satisfaction of guarantee and collateral requirements consistent with the Security Documents delivered on the Closing Date (giving effect, as applicable, to the Collateral and Guarantee Principles or the Agreed Security Principles) or otherwise reasonably acceptable to the Borrower Representative and the Administrative Agent (which shall include, in the case of a Foreign Subsidiary, guarantee and collateral requirements customary under local law, including customary local limitations). The Borrower Representative may subsequently elect to release any such Subsidiary as a Subsidiary Guarantor at any time in its sole discretion (it being understood that such release shall be subject to (A) UK Holdco or its applicable Restricted Subsidiary having capacity to make hereunder, and being deemed to make hereunder, an Investment in such Subsidiary after such release and (B) such Subsidiary having capacity to incur hereunder, and being deemed to incur hereunder, any Indebtedness or Liens after such release).
Excluded Swap Obligation”: any obligation (a “Swap Obligation”) of any Excluded ECP Guarantor to pay or perform under any agreement, contract or transaction that constitutes a “swap” within the meaning of section 1a(47) of the Commodity Exchange Act, if, and to the extent that, all or a portion of the Guarantee of such Guarantor of, or the grant by such Guarantor of a security interest to secure, such Swap Obligation (or any Guarantee thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor’s failure for any reason not to constitute an “eligible contract participant” as defined in the Commodity Exchange Act.
Existing Letter of Credit”: as defined in Section 3.1(c).
Existing Senior Notes”: as defined in the preamble hereto.
Existing Senior Notes Indenture”: as defined in the preamble hereto.
Existing Swap Agreement”: each Swap Agreement listed on Schedule 1.1F.
Expected Cost Savings”: as defined in clause (1)(i) of the definition of “Consolidated EBITDA.”
Export Control Laws”: such export-control Laws as are administered or enforced by the U.S. Government, the European Union, or other export control authority with jurisdiction over any Loan Party, or any subsidiary or joint venture thereof, including, without limitation, the Export Administration Regulations, the International Traffic in Arms Regulations, and the European Union Dual Use Regulation (Council Regulation EC 428/2009 (as amended)).
Extended Revolving Commitments”: one or more Classes of extended Revolving Commitments that result from a Permitted Amendment.
Extended Revolving Loans”: the Revolving Loans made pursuant to any Extended Revolving Commitment or otherwise extended pursuant to a Permitted Amendment.
Extended Term Commitments”: one or more Classes of extended Term Commitments hereunder that result from a Permitted Amendment.
36
    



Extended Term Loans”: one or more classes of extended Term Loans that result from a Permitted Amendment.
Facility”: (a) any Term Facility (including the Closing Date Term Loan Facility, the Amendment No. 1 Incremental Term Facility and the Amendment No. 2 Incremental Term Facility) and (b) any Revolving Facility, as the context may require.
Fair Market Value”: with respect to any Investment, asset, property or transaction, the price which could be negotiated in an arm’s length, free market transaction, for cash, between a willing seller and a willing and able buyer, neither of whom is under undue pressure or compulsion to complete the transaction (as determined in good faith by the Borrower Representative).
FATCA”: as defined in Section 2.19(a).
Federal Funds Rate”: for any day, the rate per annum equal to the weighted average of the rates on overnight Federal funds transactions, as published by the Federal Reserve Bank of New York on the Business Day next succeeding such day; provided that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day as so published on the next succeeding Business Day, and (b) if no such rate is so published on such next succeeding Business Day, the Federal Funds Rate for such day shall be the average rate charged to Bank of America, N.A. on such day on such transactions as determined by the Administrative Agent.
Fee Letter”: the Fee Letter dated October 20, 2019 by and among Clarivate Analytics plc, the Joint Lead Arrangers and the other parties thereto, as amended, restated, modified or supplemented from time to time in accordance with the terms thereof.
Fee Payment Date”: (a) the last Business Day of each March, June, September and December (commencing on December 31, 2019), (b) the Revolving Termination Date and (c) the date the Total Revolving Commitments are reduced to zero.
Financial Compliance Date”: any date on which the aggregate Outstanding Amount of all Revolving Loans, Swingline Loans and undrawn L/C Obligations (excluding (i) non-Collateralized, issued and undrawn L/C Obligations in an amount up to $20,000,000 and (ii) Collateralized Letters of Credit) of the Revolving Borrowers exceeds 35% of the Revolving Commitments as of such date.
Financial Covenant Event of Default”: as defined in Section 9.3(b).
First Lien Net Leverage Ratio”: as of any date of determination for the most recently ended Reference Period or the Reference Period otherwise specified herein, the ratio of (a) Consolidated First Lien Indebtedness on such day, to (b) Consolidated EBITDA, in each case of UK Holdco and its Restricted Subsidiaries, calculated on a Pro Forma Basis for such period.
First Priority Refinancing Revolving Facility”: as defined in the definition of “Permitted First Priority Refinancing Debt.”
First Priority Refinancing Term Facility”: as defined in the definition of “Permitted First Priority Refinancing Debt.”
Fixed Amount”: as defined in Section 1.9(b).
Fixed Charges”: with respect to UK Holdco and the Restricted Subsidiaries for any period, the sum of:
(a)Consolidated Interest Expense of UK Holdco and its Restricted Subsidiaries for such period; and
37
    



(b)all cash dividend payments (excluding items eliminated in consolidation) on any series of Preferred Stock or Disqualified Stock of UK Holdco and the Restricted Subsidiaries;
provided, however, that, notwithstanding the foregoing, any charges arising from (i) the application of Accounting Standards Codification Topic 480-10-25-4 “Distinguishing Liabilities from Equity—Overall—Recognition” to any series of Preferred Stock other than Disqualified Stock or (ii) the application of Accounting Standards Codification Topic 470-20 “Debt—Debt with Conversion Options—Recognition,” in each case, shall be disregarded in the calculation of Fixed Charges.
Foreign Plan”: any pension plan, benefit plan, fund or other similar program established, maintained or contributed to by a Loan Party or any Subsidiary of a Loan Party primarily for the benefit of individuals residing outside the United States (other than plans, funds or similar programs that are maintained exclusively by a Governmental Authority), and which is required to be funded through a trust or other funding vehicle and is not subject to ERISA or the Code.
Foreign Benefit Plan Event”: with respect to any Foreign Plan, (a) the existence of unfunded liabilities in excess of the amount permitted under any applicable law, or in excess of the amount that would be permitted absent a waiver from a Governmental Authority, (b) the failure to make the required contributions or payments, under any applicable law or the terms of the Foreign Plan, on or before the due date for such contributions or payments, (c) the receipt of a notice by a Governmental Authority relating to the intention to terminate any such Foreign Plan or to appoint a trustee or similar official to administer any such Foreign Plan, (d) the incurrence of any liability by a Loan Party or any of Subsidiary of a Loan Party on account of the complete or partial termination of such Foreign Plan or the complete or partial withdrawal of any participating employer therein, (e) the occurrence of any transaction that could result in a Loan Party or any Subsidiary of a Loan Party incurring, or the imposition on a Loan Party or any Subsidiary of a Loan Party of, any fine, excise tax or penalty resulting from any noncompliance with applicable law or (f) any other event or condition with respect to a Foreign Plan that could result in liability of a Loan Party or any Subsidiary of a Loan Party.
Foreign Guarantor Provisions”: the Foreign Guarantor Provisions set forth on Schedule 1.8.
Foreign Loan Party”: any Loan Party that is not a US Loan Party.
Foreign Subsidiary”: any Subsidiary of Holdings that is not a US Subsidiary.
Forms”: as defined in Section 2.19(j).
FRB”: the Board of Governors of the Federal Reserve System of the United States.
FSHCO”: any Subsidiary of Holdings, substantially all the assets of which consist of Equity Interests of one or more CFCs or other FSHCOs.
Funded Debt”: as to any Person, all Indebtedness described in clauses (1)(a), (1)(b) (excluding, for the avoidance of doubt, surety bonds, performance bonds and similar instruments) and (1)(d) of the definition of “Indebtedness” of such Person that matures more than one year from the date of its creation or matures within one year from such date but is renewable or extendible, at the option of such Person, to a date more than one year from such date or arises under a revolving credit or similar agreement that obligates the lender or lenders to extend credit during a period of more than one year from such date, including all current maturities and current sinking fund payments in respect of such Indebtedness whether or not required to be paid within one year from the date of its creation and, in the case of the Borrowers, Indebtedness in respect of the Loans.
Funding Default”: as defined in Section 2.17(d).
Future Guarantor”: as defined in Section 8.12(g).
38
    



GAAP”: generally accepted accounting principles in the United States of America that are in effect from time to time; provided, that GAAP shall be construed, and all computations of amounts and ratios referred to in this Agreement shall be made, in accordance with the interpretive provisions set forth in Section 1 of this Agreement; provided, further, that (A) if any change in GAAP or in the application thereof or any change as a result of the adoption or modification of accounting policies (including the conversion to IFRS as described below or any change in the methodology of calculating reserves for returns, rebates and other chargebacks) is implemented or takes effect after the date of delivery of any financial statements required to be delivered under this Agreement and/or there is any change in the functional currency reflected in such financial statements or (B) if UK Holdco or its applicable direct or indirect parent company elects or is required to report under IFRS, UK Holdco or the Required Lenders may request by written notice to the Administrative Agent to amend the relevant affected provisions of this Agreement to eliminate the effect of such change in accounting principles or change as a result of the adoption or modification of accounting policies occurring after the Closing Date in GAAP or IFRS, as applicable, or in the application thereof on the operation of such provision, regardless of whether any such notice is given before or after such change in GAAP or IFRS, as applicable, or in the application thereof, and in such case, (x) the Borrower Representative and the Administrative Agent shall negotiate in good faith to enter into an amendment of the relevant affected provisions (it being understood that no amendment or similar fee shall be payable to the Administrative Agent or any Lender in connection therewith) to preserve the original intent thereof in light of the applicable change or election, as the case may be and (y) such provision shall be interpreted on the basis of GAAP or IFRS, as applicable, as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance with this definition. Any consent required from the Administrative Agent with respect to the foregoing shall not be unreasonably withheld, conditioned or delayed. At any time after the Closing Date, the Borrower Representative or its applicable direct or indirect parent company may elect to apply IFRS accounting principles in lieu of GAAP, or vice versa, and upon such election, references herein to GAAP shall thereafter be construed to mean IFRS, or vice versa, as applicable (except as otherwise provided in this Agreement); provided, that any calculation or determination in this Agreement that requires the application of GAAP for periods that include fiscal quarters ended prior to the application of IFRS will remain as previously calculated or determined in accordance with GAAP and vice versa. For the avoidance of doubt, solely making an election (without any other action) referred to in this definition will not (1) be treated as an Incurrence of Indebtedness or (2) have the effect of rendering impermissible any payment, Investment or other action made prior to the date of such election pursuant to Section 7.3 or any Incurrence of Indebtedness prior to the date of such election pursuant to Section 7.2 if such payment, Investment, Incurrence or other action was permitted under this Agreement on the date made, incurred or taken, as the case may be.
German Borrower”: an Additional Revolving Borrower resident for tax purposes in Germany.
German Collateral”: as defined in Section 10.1(c).
“German GmbH & Co. KG Guarantor”: as defined in Section 8.12(d).
German GmbH Guarantor”: as defined in Section 8.12(d).
German Guarantor”: as defined in Section 8.12(d).
German Qualifying Lender”: a Lender which is beneficially entitled to interest payable to that Lender in respect of any amounts hereunder and is:
(a)    resident for tax purposes in Germany;
(b)    lending through a Facility Office in Germany to which the relevant interest payment is effectively attributable for tax purposes; or
(c)    a German Treaty Lender.
German Treaty”: as defined in the definition of “German Treaty State”.
39
    



German Treaty Lender”: a Lender which (a) is treated as a resident of a German Treaty State for the purposes of the German Treaty and (b) does not carry on a business in Germany through a permanent establishment with which that Lender’s participation in the Loan is effectively connected.
German Treaty State”: a jurisdiction having a double taxation agreement with Germany (a “German Treaty”) which makes provision for full exemption from tax imposed by Germany on interest.
Global Intercompany Note”: a note in such form as may be reasonably agreed between the Borrower Representative and the Administrative Agent.
Governmental Approval”: any consent, authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority.
Governmental Authority”: any nation, or any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank, administrative tribunal or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies exercising such powers or functions, such as the European Union or the European Central Bank) and any group or body charged with setting financial accounting or regulatory capital rules or standards (including, without limitation, the Financial Accounting Standards Board, the Bank for International Settlements or the Basel Committee on Banking Supervision or any successor or similar authority to any of the foregoing).
Group Member”: the collective reference to Holdings, the Borrowers and UK Holdco and its Restricted Subsidiaries.
guarantee”: as to any Person, a guarantee (other than by endorsement of negotiable instruments for collection in the ordinary course of business), direct or indirect, in any manner (including letters of credit and reimbursement agreements in respect thereof), of all or any part of any Indebtedness of another Person.
Guarantee”: as defined in Section 8.2.
Guarantee Obligation”: as to any Person (the “guaranteeing person”), any obligation (including obligations arising by way of parallel debt), including a reimbursement, counterindemnity or similar obligation, of the guaranteeing person that guarantees or in effect guarantees, or which is given to induce the creation of a separate obligation by another Person (including any bank under any letter of credit) that guarantees or in effect guarantees, any Indebtedness (the “primary obligations”) of any other third Person (the “primary obligor”) in any manner, whether directly or indirectly, including any obligation of the guaranteeing person, whether or not contingent, (a) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (b) to advance or supply funds (i) for the purchase or payment of any such primary obligation or (ii) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (c) to purchase property, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (d) otherwise to assure or hold harmless the owner of any such primary obligation against loss in respect thereof; provided, however, that the term Guarantee Obligation shall not include endorsements of instruments for deposit or collection in the ordinary course of business. The amount of any Guarantee Obligation of any guaranteeing person shall be deemed to be the lower of (a) an amount equal to the stated or determinable amount of the primary obligation in respect of which such Guarantee Obligation is made and (b) the maximum amount for which such guaranteeing person may be liable pursuant to the terms of the instrument embodying such Guarantee Obligation, unless such primary obligation and the maximum amount for which such guaranteeing person may be liable are not stated or determinable, in which case the amount of such Guarantee Obligation shall be such guaranteeing person’s maximum reasonably anticipated liability in respect thereof as determined by the Borrower Representative in good faith.
Guaranteed Loan Party”: as defined in Section 8.12(d).
40
    



Guaranteed Obligations”: as defined in Section 8.1(b).
Guarantor Joinder Agreement”: an agreement substantially in the form of Exhibit G or in such other form reasonably approved by the Administrative Agent.
Guarantors”: the collective reference to Holdings, the Borrowers (other than with respect to a Borrower’s own obligations or obligations with respect to which it is jointly and severally liable) and the Subsidiary Guarantors (in each case, except to the extent released in accordance with this Agreement).
Hedging Obligations”: with respect to any Person, the obligations of such Person under Swap Agreements.
Holding Company”: in relation to a company or corporation, any other company or corporation in respect of which it is a Subsidiary.
Holdings”: as defined in the preamble hereto.
Honor Date”: as defined in Section 3.5.
IFRS”: International Financial Reporting Standards (formerly International Accounting Standards) as issued by the International Accounting Standards Board and its predecessor as in effect from time to time.
Immaterial Subsidiary”: each Subsidiary which, as of the most recently ended Reference Period, contributed five percent (5%) or less of Consolidated EBITDA for such period; provided that, if at any time the aggregate amount of EBITDA attributable to all Subsidiaries that are Immaterial Subsidiaries exceeds ten percent (10%) of Consolidated EBITDA for any such period, the Borrower Representative (or, in the event the Borrower Representative has failed to do so within 30 days, the Administrative Agent) shall designate sufficient Subsidiaries to eliminate such excess, and such designated Subsidiaries shall no longer constitute Immaterial Subsidiaries under this Agreement.
Incremental Amendment”: as defined in Section 2.25(c), and including, for the avoidance of doubt, the Amendment No. 1 Incremental Facility Amendment and the Amendment No. 2 Incremental Facility Amendment.
Incremental Arranger”: as defined in Section 2.25(a).
Incremental Equivalent Debt”: as defined in Section 7.2(b)(vi).
Incremental Facility”: any Class of Incremental Term Commitments or Revolving Commitment Increases and the extensions of credit made thereunder, as the context may require.
Incremental Facility Arrangers”: collectively, the Amendment No. 1 Incremental Facility Arrangers, the Amendment No. 2 Incremental Facility Arrangers and the Amendment No. 4 Incremental Facility Arrangers.
Incremental Facility Closing Date”: as defined in Section 2.25(c).
Incremental Lender”: an Incremental Term Lender or Incremental Revolving Lender, as the context may require.
Incremental Loan”: any Class of Incremental Term Loans or Incremental Revolving Loans, as the context may require.
Incremental Revolving Lender”: as defined in Section 2.25(a).
Incremental Revolving Loans”: as defined in Section 2.25(a).
41
    



Incremental Term Commitments”: as defined in Section 2.25(a).
Incremental Term Lender”: as defined in Section 2.25(a).
Incremental Term Loan Maturity Date”: the date on which an Incremental Term Loan matures as set forth in the Incremental Amendment relating to such Incremental Term Loan.
Incremental Term Loans”: as defined in Section 2.25(a).
Incremental Term Percentage”: as to any Incremental Term Lender at any time, the percentage which such Lender’s Incremental Term Commitments then constitutes of the aggregate Incremental Term Commitments then outstanding.
Incremental Yield Differential”: as defined in Section 2.25(a)(vii).
Incur”: with respect to any Indebtedness, issue, assume, guarantee, incur or otherwise become liable for; provided, however, that any Indebtedness or Capital Stock of a Person existing at the time such person becomes a Subsidiary (whether by merger, consolidation, acquisition or otherwise) shall be deemed to be Incurred by such Person at the time it becomes a Subsidiary.
Incurrence-Based Amount”: as defined in Section 1.9(b).
Indebtedness”: with respect to any Person:
(i)the principal and premium (if any) of any Indebtedness of such Person, whether or not contingent, (i) in respect of borrowed money, (ii) evidenced by bonds, notes, debentures or similar instruments or letters of credit or bankers’ acceptances (or, without duplication, reimbursement agreements in respect thereof), (iii) representing the deferred and unpaid purchase price of any property, asset or business, except (x) any such balance that constitutes a trade payable, accrued expense or similar obligation to a trade creditor and (y) any acquisition earn-out obligations, (iv) in respect of Capitalized Lease Obligations or (v) representing any Hedging Obligations, other than Hedging Obligations that are incurred in the normal course of business and not for speculative purposes, and that do not increase the Indebtedness of the obligor outstanding at any time other than as a result of fluctuations in interest rates, commodity prices or foreign currency exchange rates or by reason of fees, indemnities and compensation payable thereunder, if and to the extent that any of the foregoing Indebtedness (other than letters of credit and Hedging Obligations) would appear as a liability on a balance sheet (excluding the footnotes thereto) of such Person prepared in accordance with GAAP, provided that Indebtedness of any direct or indirect parent of UK Holdco appearing upon the balance sheet of UK Holdco solely by reason of push-down accounting under GAAP shall be excluded;
(ii)to the extent not otherwise included, any obligation of such Person to be liable for, or to pay, as obligor, guarantor or otherwise, the obligations described in clause (a) of another Person (other than by endorsement of negotiable instruments for collection in the ordinary course of business); and
(iii)to the extent not otherwise included, obligations described in clause (a) of another Person secured by a Lien on any asset owned by such Person (whether or not such Indebtedness is assumed by such Person); provided, however, that the amount of such Indebtedness will be the lesser of (i) the Fair Market Value of such asset at such date of determination, and (ii) the amount of such Indebtedness of such other Person;
provided that (a) Contingent Obligations incurred in the ordinary course of business, (b) obligations under or in respect of Receivables Financings, (c) Other Obligations associated with other post-employment benefits and pension plans, (d) any operating leases as such an instrument would be determined in accordance with GAAP prior to the issuance of the ASU, (e) in connection with the purchase by UK Holdco or any Restricted Subsidiary of any business, post-closing payment adjustments to which the seller may be entitled to the extent such payment is determined by a final closing balance sheet or such payment depends on the performance of such business after the closing until 30 days after any such
42
    



obligation becomes contractually due and payable, (f) deferred or prepaid revenues, (g) any Capital Stock (other than Disqualified Stock), (h) purchase price holdbacks in respect of a portion of the purchase price of an asset to satisfy warranty or other unperformed obligations of the respective seller, and (i) premiums payable to, and advance commissions or claims payments from, insurance companies, shall not constitute Indebtedness.
Indemnitee”: as defined in Section 11.5.
Indemnified Liabilities”: as defined in Section 11.5.
Independent Financial Advisor”: an accounting, appraisal or investment banking firm or consultant, in each case of nationally recognized standing that is, in the good faith determination of Holdings or its direct or indirect parent, qualified to perform the task for which it has been engaged.
Initial Intercreditor Agreement”: the Intercreditor Agreement, dated as of the Closing Date, among Holdings, UK Holdco, the other Borrowers and the other Guarantors party thereto, Bank of America, N.A., as Credit Agreement Collateral Agent (as defined therein) for the Credit Agreement Secured Parties referred to therein, Wilmington Trust, National Association, as Initial Notes Collateral Agent (as defined therein) for the Notes Secured Parties referred to therein, and each additional Authorized Representative (as defined therein) from time to time party thereto for the Additional First Lien Secured Parties (as defined therein).
Initial Term Commitment”: any Term Commitment outstanding as of the Closing Date and any Amendment No. 1 Incremental Term Commitment.
Initial Term Lender”: any Lender which holds an Initial Term Loan or an Initial Term Commitment.
Initial Term Loan”: (1) prior to the Amendment No. 1 Effective Date, a Loan made pursuant to Section 2.1(i) on the Closing Date (such Loans, the “Closing Date Term Loans”) and (2) from and after the Amendment No. 1 Effective Date, collectively, the Closing Date Term Loans and the Amendment No. 1 Incremental Term Loans.
Inside Maturity Basket”: Incremental Term Loans, Incremental Equivalent Debt, Permitted Credit Agreement Refinancing Debt, Refinancing Indebtedness or other Indebtedness in an aggregate principal amount outstanding not exceeding the greater of $250,000,000 and 75% of Consolidated EBITDA as of the most recently ended Reference Period (as selected by the Borrower Representative).
Insolvency”: with respect to any Multiemployer Plan, the condition that such Plan is insolvent within the meaning of Section 4245 of ERISA.
Insolvent”: pertaining to a condition of Insolvency.
Intellectual Property Security Agreements”: collectively, the US Intellectual Property Security Agreements and each other intellectual property security agreement or intellectual property security agreement supplement executed and delivered pursuant to Section 6.9, Section 6.11 or Schedule 1.1C (as such schedule may be amended or supplemented from time to time in accordance with the Agreed Security Principles), in each case as amended, restated, supplemented, replaced or otherwise modified from time to time in accordance with its terms.
Intercreditor Agreements”: the Initial Intercreditor Agreement and/or any Acceptable Intercreditor Agreement entered into after the Closing Date, as the context may require or permit.
Interest Coverage Ratio”: as of any date of determination for the most recently ended Reference Period or the Reference Period otherwise specified herein, the ratio of (a) Consolidated EBITDA for such period to (b) Consolidated Cash Interest Expense for such period. Unless otherwise specified herein,
43
    



“Interest Coverage Ratio” shall be a reference to the Interest Coverage Ratio for the most recently ended Reference Period.
Interest Payment Date”: (a) as to any ABR Loan (including any Swingline Loan), the last Business Day of each March, June, September and December (commencing on December 31, 2019) and the final maturity date of such Loan, (b) as to any Eurocurrency Loan or Term SOFR Loan having an Interest Period of three months or less, the last day of such Interest Period, (c) as to any Eurocurrency Loan or Term SOFR Loan having an Interest Period longer than three months, each day that is three months, or a whole multiple thereof, after the first day of such Interest Period and the last day of such Interest Period, (d) as to any Eurocurrency Loan or Term SOFR Loan (except in the case of the repayment or prepayment of all Loans or, as to any Revolving Loan, the Revolving Termination Date or such earlier date on which the Revolving Commitments are terminated), the date of any repayment or prepayment made in respect thereof, (e) as to any Sterling Daily Rate Loan, the last Business Day of each month and (f) as to any Swingline Loan, the last Business Day of each March, June, September and December (commencing on December 31, 2019), and the Revolving Termination Date.
Interest Period”: (a) as to any Eurocurrency Loan, the period commencing on the borrowing, continuation or conversion date, as the case may be, with respect to such Eurocurrency Loan and ending (i) one, two, three or six (in each case, subject to availability) months thereafter or (ii) if approved by all Lenders under the relevant Facility, twelve months thereafter, one week thereafter or such other period as all relevant Lenders shall agree, in each case as selected by the Borrower Representative in its irrevocable notice of borrowing, continuation or conversion, substantially in the form of Exhibit H, or such other form as may be approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative; provided that all of the foregoing provisions relating to Interest Periods are subject to the following:
(1)if any Interest Period would otherwise end on a day that is not a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless the result of such extension would be to carry such Interest Period into another calendar month in which event such Interest Period shall end on the immediately preceding Business Day;
(2)the Borrower Representative may not select an Interest Period under any Revolving Facility that would extend beyond the Revolving Termination Date and the Borrowers (with respect to the Term Loans other than the Incremental Term Loans) and the Borrowers (with respect to the Incremental Term Loans) may not select an Interest Period under the Term Facility beyond the date final payment is due on the Term Loans;
(3)any Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of a calendar month;
(4)if the Borrower Representative shall fail to specify the Interest Period in any notice of borrowing of, conversion to, or continuation of, Eurocurrency Loans, the Borrower Representative shall be deemed to have selected an Interest Period of one month; and
(5)the Borrower Representative shall be permitted to select an Interest Period of one week on no more than ten (10) instances per annum; and
(b)    as to any Term SOFR Loan, the period commencing on the date such Term SOFR Loan is disbursed or converted to or continued as a Term SOFR Loan, as applicable, and ending on the date that is one month, three months or six months thereafter, as selected by the Borrower Representative in its irrevocable notice of borrowing, continuation or conversion, substantially in the form of Exhibit H, or such other form as may be approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative; provided, that:
44
    



(i)    any Interest Period that would otherwise end on a day that is not a Business Day shall be extended to the next succeeding Business Day unless such Business Day falls in another calendar month, in which case such Interest Period shall end on the immediately preceding Business Day;
(ii)    any Interest Period pertaining to a Term SOFR Loan that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of the calendar month at the end of such Interest Period;
(iii)    if the Borrower Representative shall fail to specify the Interest Period in any notice of borrowing of, conversion to, or continuation of, Term SOFR Loans, the Borrower Representative shall be deemed to have selected an Interest Period of one month; and
(iv)    no Interest Period shall extend beyond the Revolving Termination Date applicable to such Loan.
Investment Grade Rating”: a rating equal to or higher than Baa3 (or the equivalent) by Moody’s or BBB- (or the equivalent) by S&P, or an equivalent rating by any other Rating Agency.
Investment Grade Securities”:
(a)securities issued or directly and fully guaranteed or insured by the government or any agency or instrumentality thereof (other than Cash Equivalents) of the U.S., Canada, any country that is a member of the European Union, the United Kingdom, Japan or Switzerland;
(b)securities that have an Investment Grade Rating;
(c)investments in any fund that invests at least 95% of its assets in investments of the type described in clauses (1) and (2) which fund may also hold immaterial amounts of cash pending investment and/or distribution; and
(d)corresponding instruments in countries other than the United States customarily utilized for high quality investments.
Investments”: with respect to any Person, all investments by such Person in other Persons (including Affiliates) in the form of loans (including guarantees), advances or capital contributions (excluding accounts receivable, trade credit and advances or extensions of credit to customers and vendors and commission, travel and similar advances to officers, directors, employees and consultants made in the ordinary course of business) and purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities issued by any other Person. For purposes of the definition of “Unrestricted Subsidiary” and Section 7.3:
(e)“Investments” shall include the portion (proportionate to UK Holdco’s direct or indirect equity interest in such Subsidiary) of the Fair Market Value of the net assets of a Subsidiary of UK Holdco at the time that such Subsidiary is designated an Unrestricted Subsidiary; provided, however, that upon a redesignation of such Subsidiary as a Restricted Subsidiary, UK Holdco shall be deemed to continue to have a permanent “Investment” in an Unrestricted Subsidiary equal to an amount (if positive) equal to:
(i)UK Holdco’s direct or indirect “Investment” in such Subsidiary at the time of such redesignation less
(ii)the portion (proportionate to UK Holdco’s equity interest in such Subsidiary) of the Fair Market Value of the net assets of such Subsidiary at the time of such redesignation;
45
    



(f)any property transferred to or from an Unrestricted Subsidiary shall be valued at its Fair Market Value at the time of such transfer, in each case as determined in good faith by the Borrower Representative; and
(g)the amount of any Investment shall be the original cost of such Investment, plus the cost of any addition thereto that otherwise constitutes an Investment, without any adjustments for increases or decreases in value, or write-ups, write-downs or write-offs with respect thereto, but giving effect to any repayments of principal in the case of any Investment in the form of a loan and any return of capital or return on Investment in the case of any equity Investment (whether as a distribution, dividend, redemption or sale).
For the avoidance of doubt, a guarantee by UK Holdco or a Restricted Subsidiary of the obligations of another Person (the “primary obligor”) shall not be deemed to be an Investment by UK Holdco or such Restricted Subsidiary in the primary obligor to the extent that such obligations of the primary obligor are in favor of UK Holdco or any Restricted Subsidiary, and in no event shall (x) a guarantee of an operating lease or other business contract of UK Holdco or any Restricted Subsidiary or (y) intercompany indebtedness among UK Holdco and the Restricted Subsidiaries made in the ordinary course of business and having a term not exceeding 364 days be deemed an Investment.
IRS”: as defined in Section 11.6(c)(i).
Issuer Documents”: with respect to any Letter of Credit, the application form, and any other document, agreement and instrument entered into by any Issuing Lender and a Borrower (or any Subsidiary) or in favor of such Issuing Lender and relating to such Letter of Credit.
Issuing Lender”: (i) each Revolving Lender as of the Closing Date or in each case any of their respective affiliates, each in its capacity as issuer of any Letter of Credit, (ii) each Amendment No. 3 Incremental Revolving Lender or in each case any of their respective affiliates, each in its capacity as issuer of any Letter of Credit, (iii) each Amendment No. 4 Incremental Revolving Lender or in each case any of their respective affiliates, each in its capacity as issuer of any Letter of Credit, and (iv) such other Revolving Lenders or Affiliates of Revolving Lenders that are reasonably acceptable to the Administrative Agent and the Borrower Representative that agrees pursuant to an agreement with and in form and substance reasonably satisfactory to the Administrative Agent and the Borrower Representative, to be bound by the terms hereof applicable to such Issuing Lender.
ITA 2007” means the United Kingdom Income Tax Act 2007.
Joint Bookrunners”: collectively, the Joint Bookrunners listed on the cover page hereof.
Joint Lead Arrangers”: collectively, the Joint Lead Arrangers listed on the cover page hereof.
Junior Indebtedness”: third party Subordinated Indebtedness for borrowed money of UK Holdco or any of its Restricted Subsidiaries that is a Loan Party in an aggregate outstanding principal amount exceeding the greater of $125,000,000 and 39% of Consolidated EBITDA as of the most recently ended Reference Period.
Latest Maturity Date”: at any date of determination, the latest maturity or expiration date applicable to any Loan or Commitment hereunder at such time, including the latest maturity or expiration date of any Incremental Term Loans, Other Term Loan, any Other Term Commitment, any Other Revolving Loan or any Other Revolving Commitment.
Laws”: collectively, all international, foreign, federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of law.
46
    



LCT Election”: as defined in Section 1.4.
LCT Test Date”: as defined in Section 1.4.
L/C Advance”: with respect to each L/C Participant, such L/C Participant’s funding of its participation in any Letter of Credit in accordance with Section 3.4(a).
L/C Borrowing”: an extension of credit resulting from a drawing under any Letter of Credit which has not been reimbursed on the date when made or Refinanced as a Revolving Borrowing.
L/C Commitment”: $80,000,000.
L/C Credit Extension”: with respect to any Letter of Credit, the issuance thereof or extension of the expiry date thereof, or the renewal or increase of the amount thereof.
L/C Obligations”: at any time, an amount equal to the sum of (a) the aggregate then undrawn and unexpired amount of the then outstanding Letters of Credit and (b) the aggregate amount of drawings under Letters of Credit that have not then been reimbursed pursuant to Section 3.5. For purposes of computing the amount available to be drawn under any Letter of Credit, the amount of such Letter of Credit shall be determined in accordance with Section 3.9 and, if on any date of determination a Letter of Credit has expired by its terms but any amount may still be drawn thereunder by reason of the operation of Rule 3.14 of the ISP, such Letter of Credit shall be deemed to be “outstanding” in the amount so remaining available to be drawn.
L/C Participants”: the collective reference to all the Revolving Lenders other than each Issuing Lender.
L/C Sublimit”: with respect to any Issuing Lender, (i) the amount set forth opposite the name of such Issuing Lender on Schedule 1.1A-2 or (ii) such other amount specified in the agreement by which such Issuing Lender becomes an Issuing Lender hereunder.
Legal Reservations”:
(h)the principle that enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law);
(i)the time barring of claims under any applicable law (including the Limitation Acts) of any Relevant Jurisdiction, the possibility that an undertaking to assume liability for or indemnify a person against non-payment of stamp duty may be void and defenses of set-off or counterclaim;
(j)the principle that in certain circumstances Liens granted by way of fixed charge may be re-characterized as a floating charge or that Liens purported to be constituted as an assignment may be re-characterized as a charge;
(k)the principle that additional interest imposed pursuant to any relevant agreement may be held to be unenforceable on the grounds that it is a penalty and therefore void;
(l)the principle that a court may not give effect to an indemnity for legal costs incurred by an unsuccessful litigant;
(m)the principle that the creation or purported creation of a Lien over any contract or agreement which is subject to a prohibition on transfer, assignment or charging may be void, ineffective or invalid and may give rise to a breach of the contract or agreement over which a Lien has purportedly been created;
(n)similar principles, rights and defenses under the laws of any Relevant Jurisdiction; and
47
    



(o)any other matters which are set out as qualifications or reservations as to matters of law of general application in the legal opinions delivered pursuant to this Agreement.
Lenders”: as defined in the preamble hereto; provided that, unless the context otherwise requires, each reference herein to the Lenders shall be deemed to include the Issuing Lenders.
Letter of Credit Expiration Date”: the day that is three Business Days prior to the scheduled Revolving Termination Date (or, if such day is not a Business Day, the immediately preceding Business Day).
Letters of Credit”: as defined in Section 3.1(a).
Lien”: any mortgage, deed of trust, pledge, hypothecation, collateral assignment, deposit arrangement, encumbrance, lien (statutory or other), charge or other security interest or any preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any capital lease having substantially the same economic effect as any of the foregoing).
Limitation Acts” means the Limitation Act 1980 and the Foreign Limitation Periods Act 1984, in each case of England and the Prescription and Limitation (Scotland) Act 1973 of Scotland.
Limited Condition Transaction”: any transaction, any acquisition or other Investment permitted hereunder (including by way of merger, amalgamation or consolidation), any assumption or incurrence of Indebtedness or issuance of Preferred Stock or Disqualified Stock, any Asset Sale or any Restricted Payment, by UK Holdco or one or more of the Restricted Subsidiaries.
Loan”: any loan made or maintained by any Lender pursuant to this Agreement.
Loan Documents”: this Agreement, any Intercreditor Agreement, the Notes, the Security Documents, any Refinancing Amendment, any Incremental Amendment (including the Amendment No. 1 Incremental Facility Amendment and the Amendment No. 2 Incremental Facility Amendment), any Loan Modification Agreement, any Borrower Joinder and any other document designated as a “Loan Document” by the Administrative Agent and the Borrower Representative from time to time.
Loan Modification Agent”: as defined in Section 2.28(a).
Loan Modification Agreement”: as defined in Section 2.28(b).
Loan Modification Offer”: as defined in Section 2.28(a).
Loan Note Instrument (Notes)”: the Loan Note Instrument constituting $700,000,000 Principal Amount Floating Rate Unsecured Loan Notes Due dated as of the Closing Date, issued by UK Holdco, as amended, novated, supplemented, restated, extended, amended and restated or otherwise modified from time to time.
Loan Note Instrument (Term Loans)”: the Loan Note Instrument constituting up to $900 Principal Amount Floating Rate Unsecured Loan Notes Due 2026 (with an initial issuance on the Closing Date in a principal amount of $493,000,000) dated as of the Closing Date, issued by UK Holdco, as amended, novated, supplemented, restated, extended, amended and restated or otherwise modified from time to time.
Loan Note Instruments”: the collective reference to the Loan Note Instrument (Notes) and the Loan Note Instrument (Term Loans).
Loan Parties”: the collective reference to the Borrowers and the Guarantors.
48
    



London Banking Day”: any day on which dealings in Dollar deposits are conducted by and between banks in the London interbank market.
Lux Borrower”: as defined in the recitals hereto.
Luxembourg Borrower”: any Borrower whose registered office/place of central administration is in Luxembourg and whose centre of main interests (as that term is used in Article 3(1) of Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast)) is in Luxembourg.
Luxembourg Exempt Lender”: in relation to a Luxembourg Borrower, a Lender which is (otherwise than by reason of being a Luxembourg Treaty Lender) able to receive interest from that Borrower without a deduction or withholding for, or on account of, Tax imposed by Luxembourg.
Luxembourg Guarantor”: any Guarantor whose registered office/place of central administration is in Luxembourg and whose centre of main interests (as that term is used in Article 3(1) of Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast)) is in Luxembourg.
Luxembourg Loan Party”: any Loan Party whose registered office/place of central administration is in Luxembourg and whose centre of main interests (as that term is used in Article 3(1) of Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast)) is in Luxembourg.
Luxembourg Qualifying Lender”: in respect of amounts payable by any Luxembourg Borrower, a Lender which is beneficially entitled to interest payable to that Lender in respect of a Loan or Letter of Credit and is (i) lending through (A) an entity tax resident in Luxembourg, or (B) a permanent establishment in Luxembourg to which the relevant interest payment is effectively attributable for tax purposes, (ii) a Luxembourg Exempt Lender or (iii) a Luxembourg Treaty Lender.
Luxembourg Treaty”: as defined in the definition of “Luxembourg Treaty State”.
Luxembourg Treaty Lender”: a Lender which (i) is treated as a resident of a Luxembourg Treaty State for the purposes of the Luxembourg Treaty, (ii) does not carry on a business in Luxembourg through a permanent establishment with which that Lender's participation in the Loan or Letter of Credit is effectively connected and (iii) fulfils any other conditions which must be fulfilled under the relevant Luxembourg Treaty and the laws of Luxembourg to obtain exemption from taxation imposed by Luxembourg on interest.
Luxembourg Treaty State”: a jurisdiction having a double taxation agreement with Luxembourg which makes provision for full exemption from tax imposed by Luxembourg on interest (a “Luxembourg Treaty”).
Majority Facility Lenders”: (a) with respect to any Revolving Facility, the Majority Revolving Lenders with respect to such Revolving Facility and (b) with respect to any Term Facility, the Majority Term Lenders with respect to such Term Facility.
Majority Revolving Lenders”: at any time with respect to any Revolving Facility, (i) prior to the termination of all Revolving Commitments with respect to such Revolving Facility, non-Defaulting Lenders holding more than 50% of the Total Revolving Commitments and (ii) after the termination of all the Revolving Commitments with respect to such Revolving Facility, non-Defaulting Lenders holding more than 50% of the Total Revolving Extensions of Credit with respect to such Revolving Facility.
Majority Term Lenders”: at any time with respect to any Term Facility, Term Lenders that are non-Defaulting Lenders having Term Loans and unused and outstanding Term Commitments with respect to such Term Facility representing more than 50% of the sum of all Term Loans outstanding and unused and outstanding Term Commitments with respect to such Term Facility at such time.
49
    



Management Agreement”: one or more management services or consulting services agreements, entered into prior to the Closing Date between UK Holdco or any direct or indirect parent company or any Restricted Subsidiary and the Sponsors and any other beneficial owner in the equity in the Borrower Representative or any direct or indirect parent company of the Borrower Representative.
Management Determination”: as defined in Section 8.12(d).
Management Investor”: any Person who is a director, officer or otherwise a member of management of UK Holdco, any of its Restricted Subsidiaries or any of UK Holdco’s direct or indirect parent companies on the Closing Date.
Margin Stock”: as set forth in Regulation U of the Board of Governors of the United States Federal Reserve System, or any successor thereto.
Market Capitalization”: on any date of determination, an amount equal to (a) the total number of then issued and outstanding shares of common Capital Stock of Holdings or its applicable direct or indirect parent entity multiplied by (b) the arithmetic mean of the closing prices per share of such common shares of Capital Stock on the principal securities exchange on which such common Capital Stock are traded for the 30 consecutive trading days immediately preceding such date.
Market Intercreditor Agreement”: as defined in the definition of “Acceptable Intercreditor Agreement.”
Master Agreement”: as defined in the definition of “Qualified Counterparty.”
Material Adverse Effect”: a material adverse effect on (a) the business, assets, liabilities, operations, financial condition or operating results of UK Holdco and the Restricted Subsidiaries taken as a whole, (b) the ability of the Loan Parties (taken as a whole) to perform their payment obligations under the Loan Documents or (c) the material rights, remedies and benefits available to, or conferred upon, the Administrative Agent, any Lender or any Secured Party hereunder or under any other Loan Document (taken as a whole).
Material Restricted Subsidiary”: at any date, a Restricted Subsidiary which is a Material Subsidiary.
Material Subsidiary”: at any date, a Subsidiary which is not an Immaterial Subsidiary.
Materials of Environmental Concern”: any chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, any petroleum or petroleum products, asbestos, polychlorinated biphenyls, lead or lead-based paints or materials, radon, toxic molds or fungus, and urea-formaldehyde insulation, in each case, that are regulated pursuant to Environmental Law.
Maximum Amount”: as defined in Section 11.20(a).
MFN Provision”: as defined in Section 2.25(a)(iv).
Minimum Extension Condition”: as defined in Section 2.28(c).
Moody’s”: Moody’s Investors Service, Inc., or any successor to the rating agency business thereof.
Multiemployer Plan”: a Plan that is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.
Net Assets”: as defined in Section 8.12(d).
50
    



Net Cash Proceeds”: (a) in connection with any Asset Sale, any Recovery Event or any other sale of assets, the proceeds thereof actually received in the form of cash and Cash Equivalents (including any such proceeds received by way of deferred payment of principal pursuant to a note or installment receivable or purchase price adjustment receivable or otherwise, but only as and when received), net of (i) attorneys’ fees, accountants’ fees, investment banking fees, and other bona fide fees, costs and expenses actually incurred in connection therewith, (ii) amounts required to be applied to the repayment of Indebtedness secured by a Lien expressly permitted hereunder on any asset that is the subject of such Asset Sale, Recovery Event or other sale of assets (other than any Lien pursuant to a Security Document), (iii) Taxes paid and the Borrower Representative’s reasonable and good faith estimate of income, franchise, sales, and other applicable Taxes required to be paid by any Group Member in connection with such Asset Sale, Recovery Event or other sale of assets, (iv) a reasonable reserve for any indemnification payments (fixed or contingent) attributable to the seller’s indemnities and representations and warranties to the purchaser in respect of such Asset Sale, Recovery Event or other sale of assets owing by any Group Member in connection therewith and which are reasonably expected to be required to be paid; provided that to the extent such indemnification payments are not made and are no longer reserved for, such reserve amount shall constitute Net Cash Proceeds, (v) cash escrows to any Group Member from the sale price for such Asset Sale, Recovery Event or other sale of assets; provided that any cash released from such escrow shall constitute Net Cash Proceeds upon such release, (vi) in the case of a Recovery Event, costs of preparing assets for transfer upon a taking or condemnation, (vii) other customary fees and expenses actually incurred in connection therewith and net of Taxes paid or reasonably estimated to be payable as a result thereof (after taking into account the reduction in Tax liability resulting from any available operating losses and net operating loss carryovers, Tax credits, and Tax credit carry forwards, and similar Tax attributes or deductions and any Tax sharing arrangements) and (viii) in the case of any Asset Sale, Recovery Event or any other sale of assets by a non-Wholly Owned Subsidiary, the pro rata portion of the Net Cash Proceeds thereof (calculated without regard to this clause (viii)) attributable to any minority interest and not available for distribution to or for the account of UK Holdco or a Wholly-Owned Restricted Subsidiary as a result thereof, and (b) in connection with any issuance or sale of Capital Stock or any incurrence or issuance of Indebtedness, the cash proceeds received from any such issuance or incurrence, net of attorneys’ fees, investment banking fees, accountants’ fees, underwriting discounts and commissions and other bona fide fees and expenses actually incurred in connection therewith.
Net Income”: with respect to any Person, the net income (loss) attributable to such Person, determined in accordance with GAAP and before any reduction in respect of Preferred Stock dividends.
Net Short Lender” has the meaning set forth in Section 11.1(b)(xi).
Netted Amounts”: as defined in the definition of “Consolidated Total Indebtedness.”
Non-Debt Fund Affiliate”: any Affiliate of Holdings other than (i) Holdings, the Borrowers or any Subsidiary of Holdings or the Borrowers, (ii) any Debt Fund Affiliate and (iii) any natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of, one or more natural persons).
Non-Excluded Taxes”: as defined in Section 2.19(a).
Non-Guarantor Subsidiary”: any Subsidiary that is not a Subsidiary Guarantor.
Non-U.S. Lender”: as defined in Section 2.19(j).
Note”: a Term Loan Note, a Revolving Loan Note or a Swingline Loan Note.
Notice of Intent to Cure”: an Officer’s Certificate signed on behalf of the Borrower Representative delivered to the Administrative Agent, with respect to each period of four consecutive fiscal quarters for which a Cure Right will be exercised, on or before the date the financial statements required under Section 6.1(a) or (b) were required to have been delivered, which Officer’s Certificate shall contain a computation of the applicable Event of Default and notice of intent to cure such Event of Default through the issuance of Permitted Cure Securities as contemplated under Section 9.4.
51
    



Obligations”: the unpaid principal of and interest on (including interest accruing after the maturity of the Loans or the maturity of Cash Management Obligations and interest accruing after the filing of any petition in bankruptcy, or the commencement of any insolvency, reorganization or like proceeding, relating to any Borrower or any Guarantor, whether or not a claim for post-filing or post-petition interest is allowed in such proceeding) the Loans, and all other obligations and liabilities (including obligations arising by way of parallel debt) of any Borrower or any other Loan Party or, in the case of Specified Cash Management Agreements and Specified Swap Agreements, any Restricted Subsidiary (including, in each case of the foregoing, with respect to guarantees) to the Administrative Agent, any Lender or any other Secured Party, whether direct or indirect, absolute or contingent, due or to become due, or now existing or hereafter incurred, which may arise under, out of, or in connection with, this Agreement, or any other Loan Document or any other document made, delivered or given in connection herewith or therewith or any Specified Swap Agreement (other than, in the case of any Excluded ECP Guarantor, any Excluded Swap Obligations arising thereunder) or any Specified Cash Management Agreement, whether on account of principal, interest, reimbursement obligations, fees, indemnities, costs, expenses (including all fees, charges and disbursements of counsel to the Administrative Agent or to any Lender that are required to be paid by any Borrower or any Guarantor pursuant to any Loan Document), guarantee obligations or otherwise.
OFAC”: the U.S. Department of the Treasury’s Office of Foreign Assets Control.
Offer Price”: as defined in the definition of “Dutch Auction.”
Officer’s Certificate”: a certificate signed on behalf of the Borrower Representative or any other Group Member by any Responsible Officer thereof.
OID”: with respect to any Term Loan or Revolving Facility (or repricing thereof), or any Incremental Term Loan or Revolving Commitment Increase, as the case may be, the amount of any original issue discount or upfront fees (which shall be deemed to constitute a like amount of original issue discount), but excluding any arrangement, structuring, commitment or other fees payable in connection therewith that are not shared with all Lenders in the primary syndication thereof, which excluded fees shall not be included and equated to the interest rate.
Organizational Document”: (i) relative to each Person that is a corporation or company, its charter and its by-laws or memorandum and articles of association (or similar documents), (ii) relative to each Person that is a limited liability company, its certificate of formation and its operating agreement (or similar documents), (iii) relative to each Person that is a limited partnership, its certificate of formation or registration and its limited partnership agreement (or similar documents), (iv) relative to each Person that is a general partnership, its partnership agreement (or similar document), (v) relative to each Person that is an exempted limited partnership, its exempted limited partnership agreement, (vi) relative to each Person that is an exempted company, its memorandum and articles of association and (vii) relative to any Person that is any other type of entity, such documents as shall be comparable to the foregoing.
Other Applicable Indebtedness”: as defined in Section 2.11(i).
Other Guarantor”: as defined in Section 8.12(f).
Other Obligations”: any principal, interest, premium, penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and bankers’ acceptances), damages and other liabilities payable under the documentation governing any Indebtedness.
Other Revolving Commitments”: one or more Classes of revolving credit commitments hereunder or extended Revolving Commitments hereunder that result from a Refinancing Amendment.
Other Revolving Facility Relevant Rate Successor Rate”: as defined in Section 2.16(c).
Other Revolving Loans”: the Revolving Loans made pursuant to any Other Revolving Commitment.
52
    



Other Taxes”: any and all present or future stamp or documentary taxes or any other excise or property taxes, charges or similar levies (including any penalties, interest and additional amounts with respect thereto) arising from any payment made hereunder or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document.
Other Term Commitments”: one or more Classes of term loan commitments hereunder that result from a Refinancing Amendment.
Other Term Loans”: one or more Classes of Term Loans that result from a Refinancing Amendment.
Outstanding Amount”: (a) with respect to the Term Loans, Revolving Loans and Swingline Loans on any date, the Dollar Amount of the aggregate outstanding principal amount thereof on such date after giving effect to any borrowings and prepayments or repayments of Term Loans, Revolving Loans (including any refinancing of outstanding unpaid drawings under Letters of Credit or L/C Credit Extensions as a Revolving Borrowing) and Swingline Loans, as the case may be, occurring on such date and (b) with respect to any L/C Obligations on any date, the Dollar Amount of the aggregate outstanding amount thereof on such date after giving effect to any L/C Credit Extension occurring on such date and any other changes thereto as of such date, including as a result of any reimbursements of outstanding unpaid drawings under any Letters of Credit (including any refinancing of outstanding unpaid drawings under Letters of Credit or L/C Credit Extensions as a Revolving Borrowing) or any reductions in the maximum amount available for drawing under Letters of Credit taking effect on such date.
Overnight Rate”: for any day, (a) with respect to any amount denominated in Dollars, the greater of (i) the Federal Funds Rate and (ii) an overnight rate determined by the Administrative Agent, the Issuing Lender, or the Swingline Lender, as the case may be, in accordance with banking industry rules on interbank compensation, and (b) with respect to any amount denominated in an Alternative Currency, the rate of interest per annum at which overnight deposits in the applicable Alternative Currency, in an amount approximately equal to the amount with respect to which such rate is being determined, would be offered for such day by a branch or Affiliate of Bank of America, N.A. in the applicable offshore interbank market for such currency to major banks in such interbank market.
Parent Holding Company”: any direct or indirect parent entity of Holdings which holds directly or indirectly 100% of the Equity Interest of Holdings and which does not hold Equity Interests in any other Person (except for any other Parent Holding Company).
Participant”: as defined in Section 11.6(c).
Participant Register”: as defined in Section 11.6(c).
Participating Member State”: any member state of the European Union that has the euro as its lawful currency in accordance with legislation of the European Union relating to Economic and Monetary Union.
Patriot Act”: USA PATRIOT Improvement and Reauthorization Act, Pub. L. 109-177 (signed into law March 9, 2009), as amended.
PBGC”: the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA (or any successor).
Perfection Requirements”: the making or procuring of appropriate registrations, filings, endorsements, stampings and intimation and/or the taking of control, possession or of other actions in accordance with local laws and/or notifications of the Security Documents and/or the Liens created thereunder.
Permitted Acquisition”: as defined in clause (23) of the definition of “Permitted Investments.”
53
    



Permitted Amendment”: an amendment to this Agreement and the other Loan Documents, effected in connection with a Loan Modification Offer pursuant to Section 2.28, providing for an extension of the maturity date applicable to the Loans and/or Commitments of the Accepting Lenders and, in connection therewith, (a) a change to the Applicable Margin with respect to the Loans and/or Commitments of the Accepting Lenders, (b) a change to the fees payable to, or the inclusion of new fees to be payable to, the Accepting Lenders and/or (c) any other changes permitted by the terms of Section 2.28.
Permitted Asset Swap”: the substantially concurrent purchase and sale or exchange of Related Business Assets or a combination of Related Business Assets and cash or Cash Equivalents between UK Holdco or any of the Restricted Subsidiaries and another Person; provided that any cash or Cash Equivalents received must be applied in accordance with Section 7.5.
Permitted Auction Purchaser”: any Borrower or Holdings.
Permitted Clean-Up Investment”: any Investment referred to in clauses (3), (9), (21) and (23) of the definition of “Permitted Investments.”
Permitted Credit Agreement Refinancing Debt”: (a) Permitted First Priority Refinancing Debt, (b) Permitted Second Priority Refinancing Debt, (c) Permitted Unsecured Refinancing Debt or (d) Indebtedness incurred or Other Revolving Commitments obtained pursuant to a Refinancing Amendment, in each case, issued, incurred or otherwise obtained (including by means of the extension or renewal of existing Indebtedness) in exchange for, or to extend, renew, replace or Refinance, in whole or part, existing Term Loans, outstanding Revolving Loans or (in the case of Other Revolving Commitments obtained pursuant to a Refinancing Amendment) Revolving Commitments hereunder (including any successive Permitted Credit Agreement Refinancing Debt) (any such extended, renewed, replaced or Refinanced Term Loans, Revolving Loans or Revolving Commitments, “Refinanced Credit Agreement Debt”); provided that (i) such extending, renewing or refinancing Indebtedness (including, if such Indebtedness includes or relates to any Other Revolving Commitments, the unused portion of such Other Revolving Commitments) is in an original aggregate principal amount (or accreted value, if applicable) not greater than the aggregate principal amount (or accreted value, if applicable) of the Refinanced Credit Agreement Debt (and, in the case of Refinanced Credit Agreement Debt consisting, in whole or in part, of unused Revolving Commitments or Other Revolving Commitments, the amount thereof) plus an amount equal to unpaid and accrued interest and premium thereon plus other reasonable and customary fees and expenses (including upfront fees and original issue discount), (ii) in the case of Other Revolving Commitments and Other Revolving Loans, there shall be no required repayment thereof (other than in connection with a voluntary reduction of commitments or availability thereunder) prior to the maturity thereof, and (iii) such Refinanced Credit Agreement Debt shall be repaid, defeased or satisfied and discharged, and all accrued interest, fees and premiums (if any) in connection therewith shall be paid, on the date such Permitted Credit Agreement Refinancing Debt is issued, incurred or obtained; provided that to the extent that such Refinanced Credit Agreement Debt consists, in whole or in part, of Revolving Commitments or Other Revolving Commitments (or Revolving Loans or Other Revolving Loans incurred pursuant to any Revolving Commitments or Other Credit Revolving Commitments), such Revolving Commitments or Other Revolving Commitments, as applicable, shall be terminated, and all accrued fees in connection therewith shall be paid, on the date such Permitted Credit Agreement Refinancing Debt is issued, incurred or obtained.
Permitted Cure Securities”: any Qualified Equity Interest in Holdings.
Permitted First Priority Refinancing Debt”: any secured Indebtedness incurred by any Borrower or Subsidiary Guarantor in the form of one or more series of senior secured notes or senior secured term loans (each, a “First Priority Refinancing Term Facility”) or one or more senior secured revolving credit facilities (each, a “First Priority Refinancing Revolving Facility”); provided that (i) such Indebtedness is secured by the Collateral on a pari passu basis (but without regard to the control of remedies) with the Obligations, (ii) such Indebtedness constitutes Permitted Credit Agreement Refinancing Debt in respect of Term Loans (including portions of Classes of Term Loans, Other Term Loans or Incremental Term Loans) or outstanding Revolving Loans and (iii) such Indebtedness complies with the Permitted Refinancing Requirements; provided that an Officer’s Certificate signed on behalf of the Borrower
54
    



Representative delivered to the Administrative Agent at least five (5) Business Days (or such shorter period acceptable to the Administrative Agent) prior to the incurrence of such Indebtedness, together with a reasonably detailed description of the material terms and conditions of such Indebtedness or drafts of the documentation relating thereto, stating that the Borrower Representative has determined in good faith that such terms and conditions satisfy the requirement of this definition shall be conclusive evidence that such terms and conditions satisfy such requirement unless the Administrative Agent notifies the Borrower Representative within such five (5) Business Day period that it disagrees with such determination (including a reasonable description of the basis upon which it disagrees)). Permitted First Priority Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.
Permitted Holders”: (i) the Sponsors, (ii) the Management Investors, (iii) any Person that has no material assets other than the Capital Stock of UK Holdco and, directly or indirectly, holds or acquires 100% of the total voting power of the Voting Stock of Holdings or any direct or indirect Parent Holding Company, and of which no other Person or group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision), other than any Permitted Holder specified in clause (i) above, holds more than 50% of the total voting power of the Voting Stock thereof, (iv) any other beneficial owner in the equity in Holdings or any direct or indirect Parent Holding Company as of the Closing Date and (v) any group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision) the members of which include any Permitted Holder specified in clauses (i), (iii) or (iv) above and that, directly or indirectly, hold or acquire beneficial ownership of the Voting Stock of Holdings or any direct or indirect Parent Holding Company or of a Permitted Holder specified in clause (iii) above (a “Permitted Holder Group”), so long as no Person or other “group” (other than a Permitted Holder or group of Permitted Holders specified in clauses (i), (iii) and (iv) above) beneficially owns more than 50% on a fully diluted basis of the Voting Stock held by the Permitted Holder Group.
Permitted Investments”:
(p)any Investment in UK Holdco or any Restricted Subsidiary;
(q)any Investment in Cash Equivalents or Investment Grade Securities;
(r)(x) any Investment by UK Holdco or any Restricted Subsidiary in a Person if as a result of such Investment (a) such Person becomes a Restricted Subsidiary, or (b) such Person, in one transaction or a series of related transactions, is merged, consolidated or amalgamated with or into, or transfers or conveys all or substantially all of its assets to, or is liquidated into, UK Holdco or a Restricted Subsidiary and (y) any Investment held by such Person; provided that such Investment was not acquired by such Person in contemplation of such acquisition, merger, consolidation or transfer;
(s)any Investment in securities or other assets, including earnouts or similar obligations, not constituting Cash Equivalents or Investment Grade Securities and received in connection with an Asset Sale made pursuant to Section 7.5 or any other disposition of assets not constituting an Asset Sale;
(t)any Investment (x) existing on the Closing Date (in the case of any individual Investment in excess of $5,000,000, to be set forth on Schedule 1.1D), (y) made pursuant to binding commitments in effect on the Closing Date (in the case of any individual Investment in excess of $5,000,000, to be set forth on Schedule 1.1D) and (z) that replaces, Refinances, refunds, renews or extends any Investment described under either of the immediately preceding clauses (x) or (y), provided that any such Investment is in an amount that does not exceed the amount replaced, Refinanced, refunded, renewed or extended except to the extent required by the terms of such Investment on the Closing Date;
(u)loans and advances to, and guarantees of Indebtedness of, employees of UK Holdco (or any of its direct or indirect parent companies) or a Restricted Subsidiary not in excess of the greater of $20,000,000 and 7% of Consolidated EBITDA as of the most recently ended Reference Period outstanding at any one time, in the aggregate;
(v)any Investment acquired by UK Holdco or any of the Restricted Subsidiaries (a) in exchange for any other Investment or accounts receivable held by UK Holdco or any such Restricted
55
    



Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of UK Holdco of such other Investment or accounts receivable, (b) in good faith settlement of delinquent obligations of, and other disputes with, Persons who are not Affiliates or (c) as a result of a foreclosure by UK Holdco or any of the Restricted Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default;
(w)Hedging Obligations permitted under Section 7.2(b)(xii);
(x)additional Investments by UK Holdco or any of the Restricted Subsidiaries having an aggregate Fair Market Value, taken together with all other Investments made pursuant to this clause (9) that are at the time outstanding, not to exceed the greater of $250,000,000 and 77% of Consolidated EBITDA as of the most recently ended Reference Period; provided, however, for the avoidance of doubt, that if any Investment pursuant to this clause (9) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (1) above and shall cease to have been made pursuant to this clause (9) for so long as such Person continues to be a Restricted Subsidiary;
(y)loans and advances to (or guarantees of Indebtedness of) future, present or former officers, directors, employees and consultants for business related travel expenses (including entertainment expense), moving and relocation expenses, Tax advances, payroll advances and other similar expenses, in each case Incurred in the ordinary course of business or consistent with past practice or to fund such Person’s purchase or other acquisition for value of Equity Interests of UK Holdco or any direct or indirect parent company thereof under compensation plans approved by the Board of Directors of UK Holdco (or any direct or indirect parent company thereof) in good faith;
(z)Investments the payment for which consists of Equity Interests of Holdings (other than Disqualified Stock) or any direct or indirect parent of Holdings, as applicable; provided, however, that such Equity Interests will not increase the amount available for Restricted Payments under Section 7.3(a)(3);
(aa)any transaction to the extent it constitutes an Investment that is permitted by and made in accordance with the provisions of Section 6.18 (except transactions described in clauses (b)(ii), (b)(v), (b)(ix)(B), (b)(xxiii) and (b)(xxiv) therein);
(ab)Investments consisting of the licensing or contribution of intellectual property pursuant to joint marketing arrangements with other Persons;
(ac)guarantees issued in accordance with Section 7.2 and Section 6.9;
(ad)Investments consisting of purchases and acquisitions of inventory, supplies, materials and equipment (including without limitation prepayments to suppliers in the ordinary course of business) or purchases of contract rights or licenses or leases of intellectual property, in each case in the ordinary course of business;
(ae)any Investment in a Receivables Subsidiary or any Investment by a Receivables Subsidiary in any other Person in connection with a Qualified Receivables Financing, including Investments of funds held in accounts permitted or required by the arrangements governing such Qualified Receivables Financing or any related Indebtedness; provided, however, that any Investment in a Receivables Subsidiary is in the form of a Purchase Money Note, contribution of additional receivables or an equity interest;
(af)Investments resulting from the receipt of non-cash consideration in an Asset Sale received in compliance with Section 7.5 or any disposition of assets not constituting an Asset Sale;
(ag)(x) Investments in joint ventures of UK Holdco or any of its Restricted Subsidiaries existing on the Closing Date, (y) additional Investments in joint ventures in an aggregate amount not to exceed the greater of $150,000,000  and 47% of Consolidated EBITDA as of the most recently ended
56
    



Reference Period at any one time outstanding and (z) additional Investments in Similar Businesses in an aggregate amount not to exceed the greater of $150,000,000 and 47% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding; provided, however, that, for the avoidance of doubt, if any Investment pursuant to this clause (18) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (1) above and shall cease to have been made pursuant to this clause (18) for so long as such Person continues to be a Restricted Subsidiary;
(ah)Investments of a Restricted Subsidiary acquired after the Closing Date or of an entity merged into or consolidated with a Restricted Subsidiary in a transaction that is not prohibited by Section 7.8 after the Closing Date to the extent that such Investments were not made in contemplation of such acquisition, merger or consolidation and were in existence on the date of such acquisition, merger or consolidation;
(ai)advances, loans, rebates and extensions of credit (including the creation of receivables) to suppliers, customers and vendors, and performance guarantees, in each case in the ordinary course of business;
(aj)the acquisition of assets or Capital Stock solely in exchange for the issuance of common equity securities of Holdings or a Restricted Subsidiary (or any direct or indirect parent of Holdings);
(ak)Investments by Lux Company Borrower in UK Holdco evidenced by each Loan Note Instrument; and
(al)acquisitions by UK Holdco or any Restricted Subsidiary of the majority of the Capital Stock of Persons or of assets constituting a division or business unit of, or all or substantially all of the assets of, a Person (each a “Permitted Acquisition”); provided that (i) no Specified Event of Default has occurred or is continuing at the applicable time of determination, (ii) UK Holdco and its Restricted Subsidiaries will be in compliance with Section 6.19(a) after giving effect to such Permitted Acquisition, (iii) any Person acquired shall become, and any Person acquiring assets shall be, a Restricted Subsidiary (unless designated as an Unrestricted Subsidiary) and (iv) UK Holdco or such Restricted Subsidiary, as applicable, shall take, and shall cause such Person to take, all actions required under Section 6.9 in connection therewith.
Permitted Liens”: with respect to any Group Member:
(am)pledges or deposits by such Person in connection with workmen’s compensation, employment or unemployment insurance and other types of social security legislation, employee source deductions, goods and services Taxes, sales Taxes, municipal Taxes, corporate Taxes and pension fund obligations or good faith deposits, prepayments or cash pledges to secure bids, tenders, contracts (other than for the payment of Indebtedness) or leases, subleases, licenses, sublicenses or similar agreements to which such Person is a party, performance and return of money bonds and other similar obligations incurred in the ordinary course of business, or deposits to secure public or statutory obligations of such Person or deposits of cash or government bonds to secure surety, stay, customs or appeal bonds or statutory bonds to which such Person is a party, or deposits as security for contested Taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business;
(an)Liens imposed by law, such as landlords’, carriers’, warehousemen’s, materialmen’s, repairmen’s, construction contractors’ and mechanics’ and other like Liens, in each case for sums not overdue for a period of more than 30 days (other than with respect to Subsidiaries formed in Germany) or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which such Person shall then be proceeding with an appeal or other proceedings for review if adequate reserves with respect thereto are being maintained in accordance with GAAP (or, in the case of any Foreign Subsidiary, the accounting principles applicable in the relevant jurisdiction);
57
    



(ao)Liens for Taxes, assessments or other governmental charges (i) not overdue for more than 60 days or (ii) which are being contested in good faith by appropriate proceedings if (a) adequate reserves with respect thereto are being maintained on the books of such Person in accordance with GAAP (or, in the case of any Foreign Subsidiary, the accounting principles applicable in the relevant jurisdiction) or (b) they are immaterial to UK Holdco and its Restricted Subsidiaries taken as a whole;
(ap)Liens in favor of issuers of performance, surety, bid, indemnity, warranty, release, appeal or similar bonds or with respect to other regulatory requirements, or letters of credit or bankers’ acceptances issued, and completion guarantees provided for, in each case pursuant to the request of and for the account of such Person in the ordinary course of its business;
(aq)survey exceptions, encumbrances, leases, subleases, encroachments, protrusions, easements or reservations of, or rights of others for, sublicenses, licenses, rights-of-way, servitudes, sewers, electric lines, drains, telegraph and telephone and cable television lines, and other similar purposes, or zoning, building codes or other restrictions (including, without limitation, defects or irregularities in title and similar encumbrances) as to the use of real properties or Liens incidental to the conduct of the business of such Person or to the ownership of its properties which were not Incurred in connection with Indebtedness and which, in each case, do not in the aggregate materially impair their use in the operation of the business of such Person taken as a whole;
(ar)Liens incurred to secure Other Obligations in respect of Indebtedness or other obligations permitted to be Incurred pursuant to Section 7.2(b)(i), (b)(ii), (b)(iv), (b)(vi) (to the extent contemplated to be secured by the terms thereof), (b)(vii), (b)(xv), (b)(xvi) or (b)(xxii) (to the extent contemplated to be secured by the terms thereof); provided that, (A) in the case of Section 7.2(b)(vii), such Lien extends only to the assets and/or Capital Stock, the acquisition, purchase, lease, construction, design, installation, repair, replacement or improvement of which is financed thereby and any income or profits thereof; provided that individual financings provided by a lender may be cross collateralized to other financings provided by such lender or its Affiliates, (B) in the case of Section 7.2(b)(vi) such Indebtedness complies with the Applicable Requirements, (C) in the case of Section 7.2(b)(xv), such guarantee may only be subject to Liens to the extent the underlying Indebtedness may be subject to any Liens and (D) in the case of any Liens securing Refinancing Indebtedness Incurred pursuant to Section 7.2(b)(xvi), such Lien relates only to Refinancing Indebtedness that (x) is secured by Liens on all or a portion of the same assets or the same categories or types of assets as the assets (plus improvements, accessions, proceeds or dividends or distributions in respect thereof, or replacements of any thereof) that secured the Indebtedness being refinanced or (y) extends, replaces, refunds, refinances, renews or defeases Indebtedness incurred or Disqualified Stock or Preferred Stock issued under Section 7.2(b)(iii) (solely to the extent such Indebtedness was secured by a Lien prior to such refinancing);
(as)Liens (i) securing the Obligations and (ii) existing on the Closing Date (in the case of any Lien securing obligations in excess of $5,000,000, to be set forth on Schedule 1.1E);
(at)Liens on assets, property or shares of stock of a Person at the time such Person becomes a Restricted Subsidiary; provided, however, that such Liens are not created or incurred in connection with, or in contemplation of, such other Person becoming such a Restricted Subsidiary; provided, further, however, that such Liens may not extend to any other property owned by UK Holdco or any Restricted Subsidiary (other than the proceeds or products of such assets, property or shares of stock or improvements thereon or replacements, accessions or additions thereto, it being understood that individual financings of the type permitted under Section 7.2(b)(vii) provided by any lender may be cross-collateralized to other financings of such type provided by such lender or its affiliates);
(au)Liens on assets or on property at the time UK Holdco or any Restricted Subsidiary acquired such assets or property, including any acquisition by means of a merger or consolidation with or into UK Holdco or any Restricted Subsidiary; provided, however, that such Liens are not created or incurred in connection with, or in contemplation of, such acquisition; provided, further, however, that the Liens may not extend to any other assets or property owned by UK Holdco or any Restricted Subsidiary (other than the proceeds or products of such assets or property or shares of stock or improvements thereon or replacements, accessions or additions thereto, it being understood that individual financings of the type
58
    



permitted under Section 7.2(b)(vii) provided by any lender may be cross-collateralized to other financings of such type provided by such lender or its affiliates);
(av)Liens securing Indebtedness or other obligations of UK Holdco or a Restricted Subsidiary owing to UK Holdco or another Restricted Subsidiary permitted to be Incurred pursuant to Section 7.2;
(aw)Liens securing Hedging Obligations not entered into for speculative purposes;
(ax)Liens on specific items of inventory or other goods and proceeds of any Person securing such Person’s obligations in respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods;
(ay)leases, licenses, subleases and sublicenses of assets (including, without limitation, real property and intellectual property rights) in the ordinary course of business which do not materially interfere with the ordinary conduct of the business of UK Holdco or any Restricted Subsidiaries;
(az)Liens arising from UCC financing statement filings (or similar filings in any other jurisdiction) regarding operating leases or consignments entered into by UK Holdco and its Restricted Subsidiaries in the ordinary course of business and precautionary or purported Liens evidenced by the filing of UCC financing statement filings (or similar filings in any other jurisdiction);
(ba)Liens in favor of UK Holdco or any Restricted Subsidiary;
(bb)Liens on accounts receivable and related assets of the type specified in the definition of “Receivables Financing” incurred in connection with a Qualified Receivables Financing;
(bc)(A) pledges and deposits made in the ordinary course of business to secure liability to insurance carriers, insurance companies and brokers and (B) Liens on insurance policies and the proceeds thereof securing the financing of the premiums with respect thereto;
(bd)Liens on the Equity Interests and Indebtedness of, and the assets of, Unrestricted Subsidiaries and joint ventures that are not Restricted Subsidiaries;
(be)grants of software and other technology licenses in the ordinary course of business;
(bf)judgment and attachment Liens not giving rise to an Event of Default and notices of lis pendens and associated rights related to litigation being contested in good faith by appropriate proceedings and for which adequate reserves have been made;
(bg)Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods entered into in the ordinary course of business;
(bh)Liens incurred to secure Cash Management Services in the ordinary course of business;
(bi)Liens on equipment of UK Holdco or any Restricted Subsidiary granted in the ordinary course of business to UK Holdco’s or such Restricted Subsidiary’s client at which such equipment is located;
(bj)Liens to secure any refinancing, refunding, extension, renewal or replacement (or successive refinancings, refundings, extensions, renewals or replacements) as a whole, or in part, of any Indebtedness secured by any Lien referred to in clauses (6), (7), (8), (9), (10), (11) and (15) of this definition of “Permitted Liens;” provided, however, that (x) such new Lien shall be limited to all or part of the same property that secured the original Lien (plus proceeds or products of such property or improvements on such property), and (y) the Indebtedness secured by such Lien at such time is not increased to any amount greater than the sum of (A) the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clauses (6), (7), (8), (9), (10), (11) and (15) of this definition of “Permitted Liens” at the time the original Lien became a Permitted Lien under this
59
    



Agreement, and (B) an amount necessary to pay accrued and unpaid interest, any fees and expenses, including any premium and defeasance costs, related to such refinancing, refunding, extension, renewal or replacement;
(bk)other Liens securing obligations which obligations do not exceed the greater of $250,000,000 and 77% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding; provided that, at the election of the Borrower Representative with respect to any such Liens on Collateral, the holders of such obligations (or a representative thereof) shall be party to an Acceptable Intercreditor Agreement that provides that such obligations are secured on a junior lien basis to the Obligations hereunder;
(bl)[reserved];
(bm)Liens on receivables and related assets including proceeds thereof being sold in factoring arrangements entered into in the ordinary course of business;
(bn)Liens that are contractual rights of set-off (i) relating to the establishment of depository relations with banks not given in connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts of UK Holdco or any of its Restricted Subsidiaries to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business of UK Holdco and its Restricted Subsidiaries or (iii) relating to purchase orders and other agreements entered into with customers of UK Holdco or any of its Restricted Subsidiaries in the ordinary course of business;
(bo)Liens encumbering reasonable customary initial deposits and margin deposits and similar Liens attaching to commodity trading accounts or other brokerage accounts incurred in the ordinary course of business and not for speculative purposes;
(bp)Liens deemed to exist in connection with Investments in repurchase agreements permitted under Section 7.2; provided that such Liens do not extend to any assets other than those assets that are the subject of such repurchase agreement;
(bq)restrictions on dispositions of assets to be disposed of pursuant to merger agreements, stock or asset purchase agreements and similar agreements;
(br)customary options, put and call arrangements, rights of first refusal and similar rights relating to Investments in joint ventures, partnerships and similar investment vehicles;
(bs)any amounts held by a trustee in the funds and accounts under an indenture securing any revenue bonds issued for the benefit of UK Holdco or any of its Restricted Subsidiaries;
(bt)Liens (i) in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods in the ordinary course of business or (ii) on specific items of inventory or other goods and proceeds of any Person securing such Person’s obligations in respect of bankers’ acceptances or letters of credit issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods in the ordinary course of business;
(bu)Liens not given in connection with the issuance of Indebtedness for borrowed money (i) of a collection bank arising under Section 4-210 of the UCC (or similar provisions in any other jurisdiction) on items in the course of collection; (ii) attaching to a commodity trading account in the ordinary course of business; and (iii) in favor of a banking or other financial institution arising as a matter of law or under customary general terms and conditions encumbering deposits or other funds maintained with a financial institution (including the right of set-off) and which are within the general parameters customary in the banking industry (including, without limitation, any Lien arising by entering into standard banking arrangements (AGB-Banken oder AGB-Sparkassen) in Germany);
60
    



(bv)(i) Liens solely on any cash earnest money deposits made in connection with any letter of intent or purchase agreement in connection with an Investment permitted hereunder and (ii) Liens on advances of cash or Cash Equivalents in favor of the seller of any property to be acquired in an Investment permitted hereunder to be applied against the purchase price for such Investment;
(bw)customary Liens on deposits required in connection with the purchase of property, equipment and inventory, in each case incurred in the ordinary course of business;
(bx)Liens on cash, Cash Equivalents or other property arising in connection with the defeasance, discharge, repayment or redemption of Indebtedness; provided that such defeasance, discharge, repayment or redemption is permitted hereunder;
(by)Liens on property or assets under construction (and related rights) in favor of a contractor or developer or arising from progress or partial payments by a third party relating to such property or assets;
(bz)Liens given to a public utility or any municipality or governmental authority when required by such utility or authority in connection with the operations of UK Holdco or a Restricted Subsidiary thereof in the ordinary course of business; provided that such Liens do not materially interfere with the operations of UK Holdco and its Restricted Subsidiaries, taken as a whole;
(ca)Liens on assets or Equity Interests of Non-Guarantor Subsidiaries, provided such Liens secure obligations of Non-Guarantor Subsidiaries that are otherwise permitted hereunder and such Liens only encumber assets or Equity Interests of such Non-Guarantor Subsidiaries;
(cb)Liens arising out of or deemed to exist in connection with any financing transaction of the type described in clause (m) of the definition of “Asset Sale;”
(cc)(i) pledges, deposits or Liens arising as a matter of law in the ordinary course of business in connection with workers’ compensation schemes, payroll Taxes, unemployment insurance and other social security legislation and (ii) pledges and deposits in the ordinary course of business securing liability for reimbursement or indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing property, casualty or liability insurance to UK Holdco or any Restricted Subsidiary (including, without limitation, any Liens Incurred pursuant to Section 8a of the German Old Age Employees Part Time Act (Altersteilzeitgesetz) or Section 7e of the Fourth Book of the German Social Code (Sozialgesetzbuch IV)); and
(cd)Liens on assets not constituting Collateral securing obligations in an aggregate amount not to exceed the greater of $10,000,000 and 3% of Consolidated EBITDA as of the most recently ended Reference Period.
For purposes of this definition, the term “Indebtedness” shall be deemed to include interest on such Indebtedness.
Permitted Refinancing Requirements”: with respect to any Indebtedness incurred by any Borrower or Subsidiary Guarantor to Refinance, in whole or part, any other Indebtedness (such other Indebtedness, “Refinanced Debt”):
(i)with respect to all such Indebtedness:
(1)the other terms and conditions of such Indebtedness (excluding pricing, fees, rate floors and optional prepayment or redemption terms) are not materially more restrictive on the Group Members than those applicable to the Refinanced Debt (except for (x) financial covenants or other covenants or provisions applicable only to periods after the Latest Maturity Date at the time of such Refinancing, as may be agreed by the Borrower Representative and the providers of such Indebtedness, (y) then-prevailing market terms for the applicable type of Indebtedness (as determined by the Borrower Representative in good faith); provided that if such Indebtedness includes a financial covenant that is
61
    



more restrictive than Section 7.1 of this Agreement, such financial covenant shall be either (A) conformed (or added) to the Loan Documents for the benefit of the Revolving Lenders pursuant to an amendment agreement between the Administrative Agent and the applicable Borrowers or (B) applicable only to periods after the Revolving Termination Date or otherwise reasonably satisfactory to the Administrative Agent or (z) terms that are conformed (or added) to the Loan Documents for the benefit of the applicable Lender pursuant to an amendment between the Administrative Agent and the applicable Borrowers);
(2)if such Indebtedness is guaranteed, it is not guaranteed by any Restricted Subsidiary other than a Loan Party; and
(3)the proceeds of such Indebtedness are applied, substantially concurrently with the incurrence thereof, to the prepayment (or satisfaction and discharge) of the outstanding amount (and, if such Indebtedness constitutes Refinancing Revolving Debt, reductions of the Revolving Commitments) of the Refinanced Debt in accordance with its terms;
(ii)if such Indebtedness constitutes Refinancing Revolving Debt, such Indebtedness does not mature (or require commitment reductions or amortization) prior to the final stated maturity date of the Refinanced Debt;
(iii)if such Indebtedness constitutes Refinancing Term Debt (other than Customary Bridge Financing):
(1)in the case of Refinancing Term Debt, other than Refinancing Term Debt incurred pursuant to the Inside Maturity Basket, such Indebtedness (A) does not mature prior to the maturity date of the Refinanced Debt and (B) does not have a Weighted Average Life to Maturity shorter than the remaining Weighted Average Life to Maturity of the Refinanced Debt determined at the time of incurrence; and
(2)[reserved]; and
(iv)if such Indebtedness is secured:
(1)such Indebtedness is not secured by any assets other than the Collateral (it being understood that such Indebtedness shall not be required to be secured by all of the Collateral); provided that Indebtedness that may be incurred by Non-Guarantor Subsidiaries pursuant to Section 7.2 may be secured by assets of Non-Guarantor Subsidiaries; and
(2)to the extent secured by Collateral, a Senior Representative acting on behalf of the providers of such Indebtedness shall have become party to an Acceptable Intercreditor Agreement (or, if applicable, the Initial Intercreditor Agreement shall have been amended or replaced in a manner reasonably acceptable to the Administrative Agent), which results in such Senior Representative having rights to share in the Collateral as provided in the definition of Permitted First Priority Refinancing Debt, in the case of a First Priority Refinancing Revolving Facility or a First Priority Refinancing Term Facility, or in the definition of Permitted Second Priority Refinancing Debt, in the case of a Second Priority Refinancing Revolving Facility or a Second Priority Refinancing Term Facility.
Permitted Second Priority Refinancing Debt”: any secured Indebtedness incurred by any Borrower or Subsidiary Guarantor in the form of one or more series of second lien secured notes or second lien secured term loans (each, a “Second Priority Refinancing Term Facility”) or one or more revolving credit facilities (each, a “Second Priority Refinancing Revolving Facility”); provided that (i) such Indebtedness is secured by the Collateral on a second lien, subordinated basis (with respect to liens only) to the Obligations and the obligations in respect of any Permitted First Priority Refinancing Debt, (ii) such Indebtedness constitutes Permitted Credit Agreement Refinancing Debt in respect of Term Loans (including portions of Classes of Term Loans, Other Term Loans or Incremental Term Loans) or outstanding Revolving Loans and (iii) such Indebtedness complies with the Permitted Refinancing Requirements; provided that an Officer’s Certificate signed on behalf of the Borrower Representative delivered to the Administrative Agent at least five Business Days (or such shorter period acceptable to the Administrative Agent) prior to the incurrence of such Indebtedness, together with a reasonably detailed
62
    



description of the material terms and conditions of such Indebtedness or drafts of the documentation relating thereto, stating that the Borrower Representative has determined in good faith that such terms and conditions satisfy the requirement of this definition shall be conclusive evidence that such terms and conditions satisfy such requirement unless the Administrative Agent notifies the Borrower Representative within such five Business Day period that it disagrees with such determination (including a reasonable description of the basis upon which it disagrees)). Permitted Second Priority Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.
Permitted Tax Distributions”: payments made pursuant to Section 7.3(b)(xii).
Permitted Unsecured Refinancing Debt”: any unsecured Indebtedness incurred by any Borrower or Subsidiary Guarantor in the form of one or more series of senior unsecured notes or term loans (each, an “Unsecured Refinancing Term Facility”) or one or more revolving credit facilities (each, an “Unsecured Refinancing Revolving Facility”); provided that (i) such Indebtedness constitutes Permitted Credit Agreement Refinancing Debt in respect of Term Loans (including portions of Classes of Term Loans, Other Term Loans or Incremental Term Loans) or outstanding Revolving Loans and (ii) such Indebtedness complies with the Permitted Refinancing Requirements; provided that an Officer’s Certificate signed on behalf of the Borrower Representative delivered to the Administrative Agent at least five Business Days (or such shorter period acceptable to the Administrative Agent) prior to the incurrence of such Indebtedness, together with a reasonably detailed description of the material terms and conditions of such Indebtedness or drafts of the documentation relating thereto, stating that the Borrower Representative has determined in good faith that such terms and conditions satisfy the requirement of this definition shall be conclusive evidence that such terms and conditions satisfy such requirement unless the Administrative Agent notifies the Borrower Representative within such five Business Day period that it disagrees with such determination (including a reasonable description of the basis upon which it disagrees)). Permitted Unsecured Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.
Person”: any natural person, corporation, limited partnership, exempted limited partnership, exempted company, general partnership, limited liability company, limited liability partnership, joint venture, association, joint stock company, trust, bank trust company, land trust, business trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity whether legal or not.
Plan”: at a particular time, any employee benefit plan that is subject to Title IV of ERISA and in respect of which Holdings or a Commonly Controlled Entity is (or, if such plan were terminated at such time, would under Section 4069 of ERISA be deemed to be) an “employer” as defined in Section 3(5) of ERISA.
Platform”: as defined in Section 6.2(a).
Preferred Stock”: any Equity Interest with preferential right of payment of dividends or redemptions upon liquidation, dissolution, or winding up.
Previously Designated Unrestricted Subsidiary”: as defined in Section 6.12.
Prime Rate”: the rate set by the Administrative Agent based upon various factors including the Administrative Agent’s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate. Any change in such prime rate announced by the Administrative Agent shall take effect at the opening of business on the day specified in the public announcement of such change.
Private Lender Information”: any information and documentation that is not Public Lender Information.
Pro Forma Basis”: with respect to any Reference Period (i) if, during such Reference Period (or after such Reference Period and prior to the date of determination), UK Holdco or any Restricted Subsidiary shall have made any Disposition (or discontinued any operations) of at least a division of a
63
    



business unit, the Consolidated EBITDA for such Reference Period shall be reduced by an amount equal to the Consolidated EBITDA (if positive) attributable to the property that is the subject of such Disposition or discontinuation for such Reference Period or increased by an amount equal to the Consolidated EBITDA (if negative) attributable thereto for such Reference Period (for the avoidance of doubt, including (without duplication) pro forma adjustments, if any, to the extent set forth in the definition of Consolidated EBITDA);
(3)if, during such Reference Period (or after such Reference Period and prior to the date of determination), UK Holdco or any Restricted Subsidiary shall have made an Investment or acquisition of assets, in each case constituting at least a division of a business unit of, or all or substantially all of the assets of, any Person (whether by way of merger, asset acquisition, acquisition of Capital Stock or otherwise), Consolidated EBITDA for such Reference Period shall be calculated after giving pro forma effect thereto as if such Investment or acquisition occurred on the first day of such Reference Period (for the avoidance of doubt, including (without duplication) pro forma adjustments, if any, to the extent set forth in the definition of Consolidated EBITDA);
(4)if, during such Reference Period (or after such Reference Period and prior to the date of determination), the Borrower Representative shall have designated any Restricted Subsidiary as an Unrestricted Subsidiary, or designated any Unrestricted Subsidiary as a Restricted Subsidiary, Consolidated EBITDA and the Interest Coverage Ratio for such Reference Period shall be calculated after giving pro forma effect thereto as if such designation occurred on the first day of such Reference Period;
(5)if, during such Reference Period (or after such Reference Period and prior to the date of determination), UK Holdco or any Restricted Subsidiary shall have Incurred or shall have repaid, retired or extinguished any Indebtedness (other than Indebtedness under any revolving credit facility unless such Indebtedness has been permanently repaid, retired or extinguished (and the commitments thereunder terminated) and not replaced), or issued or redeemed any Disqualified Stock or Preferred Stock, then the Interest Coverage Ratio shall be calculated giving pro forma effect to such Incurrence, repayment, retirement, extinguishment, issuance or redemption, as if the same had occurred on the first day of the applicable Reference Period;
(6)if, after such Reference Period and prior to the date of determination, UK Holdco or any Restricted Subsidiary shall have Incurred or shall have repaid, retired or extinguished any Indebtedness (other than Indebtedness under any revolving credit facility unless such Indebtedness has been permanently repaid, retired or extinguished (and the commitments thereunder terminated) and not replaced), or issued or redeemed any Disqualified Stock or Preferred Stock, then the First Lien Net Leverage Ratio, the Secured Net Leverage Ratio and the Total Net Leverage Ratio shall be calculated giving pro forma effect to such Incurrence, repayment, retirement, extinguishment, issuance or redemption, as if the same had occurred on the last day of such Reference Period; and
(7)if, during such Reference Period (or after such Reference Period and prior to the date of determination), UK Holdco or any Restricted Subsidiary shall have initiated any Cost Saving Initiative, the applicable Expected Cost Savings shall be calculated on a pro forma basis as though such Expected Cost Savings had been realized on the first day of such Reference Period and as if such Expected Cost Savings were realized in full during the entirety of such Reference Period;
provided that, solely for purposes of calculating (x) quarterly compliance with Section 7.1 and (y) the First Lien Net Leverage Ratio for purposes of the definitions of “Applicable Margin” and “Commitment Fee Rate”, in each case, the date of the required calculation shall be the last day of the Reference Period, and no transaction occurring after the end of the Reference Period shall be taken into account in determining any such calculation made on a Pro Forma Basis.
For purposes of this Agreement, whenever pro forma effect is to be given to any pro forma event, the pro forma calculations shall be made in good faith by a responsible financial or accounting officer of the Borrower Representative. Any such pro forma calculation shall include, without duplication, adjustments appropriate to reflect cost savings, operating expense reductions, restructuring charges and
64
    



expenses and synergies reasonably expected to result from the applicable event to the extent set forth in the definition of “Consolidated EBITDA”.
If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the interest on such Indebtedness shall be calculated as if the rate in effect on the applicable calculation date had been the applicable rate for the entire period (taking into account any Hedging Obligations applicable to such Indebtedness).
The term “Disposition” in this definition shall not include dispositions of inventory and other ordinary course dispositions of property.
Properties”: as defined in Section 4.13(a).
Pro Rata Share”: with respect to (i) any Revolving Facility, and each Revolving Lender’s share of such Revolving Facility, at any time a fraction (expressed as a percentage), the numerator of which is the amount of the Revolving Commitments of such Revolving Lender under such Revolving Facility at such time and the denominator of which is the amount of the aggregate Revolving Commitments under such Revolving Facility at such time; provided that if such Revolving Commitments have been terminated, then the Pro Rata Share of each Revolving Lender shall be determined based on the Pro Rata Share of such Revolving Lender under such Revolving Facility immediately prior to such termination and after giving effect to any subsequent assignments made pursuant to the terms hereof, (ii) any Term Facility, and each Term Lender and such Term Lender’s share of all Term Commitments or Term Loans under such Term Facility, at any time a fraction (expressed as a percentage), the numerator of which is the amount of the Term Commitments of such Term Lender under such Term Facility at such time and the denominator of which is the amount of the aggregate Term Commitments under such Term Facility at such time; provided that if any Term Loans are outstanding under such Term Facility, then the Pro Rata Share of each Term Lender shall be a fraction (expressed as a percentage), the numerator of which is the amount of the Term Loans of such Term Lender under such Term Facility at such time and the denominator of which is the amount of the aggregate Term Loans at such time; provided, further, that if all Term Loans under such Term Facility have been repaid, then the Pro Rata Share of each Term Lender under such Term Facility shall be determined based on the Pro Rata Share of such Term Lender under such Term Facility immediately prior to such repayment, and (iii) with respect to each Lender and all Loans and Outstanding Amounts at any time a fraction (expressed as a percentage), the numerator of which is the Outstanding Amount with respect to Loans and Commitments of such Lender at such time (plus such Lender’s obligation to purchase participations in undrawn Letters of Credit) and the denominator of which is the Outstanding Amount (in aggregate) plus the amount of all Lenders’ obligations to purchase participations in undrawn Letters of Credit at such time; provided that if all Outstanding Amounts have been repaid or terminated, then the Pro Rata Share of each Lender shall be determined based on the Pro Rata Share of such Lender immediately prior to such termination and after giving effect to any subsequent assignments made pursuant to the terms hereof.
PTE” means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.
Public Lender”: as defined in Section 6.2(a).
Public Lender Information”: information and documentation that is either exclusively (i) of a type that would be publicly available if Holdings and its respective Subsidiaries were public reporting companies or (ii) not material or inside information with respect to Holdings and its respective Subsidiaries or any of their respective securities for purposes of foreign, United States Federal and state securities laws.
Purchase”: as defined in the definition of “Dutch Auction.”
Purchase Money Note”: a promissory note of a Receivables Subsidiary evidencing a line of credit, which may be irrevocable, from UK Holdco or any of its Subsidiaries to a Receivables Subsidiary in connection with a Qualified Receivables Financing, which note is intended to finance that portion of the purchase price that is not paid by cash or a contribution of equity.
65
    



Purchase Notice”: as defined in the definition of “Dutch Auction.”
Purchaser”: as defined in the definition of “Dutch Auction.”
QFC”: has the meaning assigned to the term “qualified financial contract” in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).
Qualified Counterparty”: (i) in the case of a Specified Swap Agreement that is an Existing Swap Agreement, any counterparty thereto, (ii) in the case of a Specified Swap Agreement that is in effect on the Closing Date, the Administrative Agent, a Joint Lead Arranger, a Lender or an Affiliate of the foregoing, in its capacity as a counterparty to such Specified Swap Agreement, (iii) in the case of a Specified Swap Agreement entered into after the Closing Date, the Administrative Agent, a Joint Lead Arranger, an Incremental Facility Arranger, a Lender or an Affiliate of the foregoing, in each case at the time of entry into such agreement, in its capacity as a counterparty to such Specified Swap Agreement and (iv) any other Person from time to time designated in writing by the Borrower Representative with the consent of the Administrative Agent (not to be unreasonably withheld, delayed or conditioned) and that has appointed the Collateral Agent as its collateral agent in a manner reasonably acceptable to the Collateral Agent; provided that none of the Administrative Agent, a Joint Lead Arranger, an Incremental Facility Arranger, a Lender or an Affiliate of the foregoing described in the preceding clauses (ii) and (iii) shall cease to be Qualified Counterparties by reason of ceasing to be the Administrative Agent, a Joint Lead Arranger, an Incremental Facility Arranger, a Lender or an Affiliate of the foregoing, as applicable.
Qualified ECP Guarantor”: in respect of any Swap Obligation, any Loan Party that has total assets exceeding $10,000,000 (or total assets exceeding such other amount so that such Loan Party is an “eligible contract participant” as defined in the Commodity Exchange Act) at the time such Swap Obligation is incurred.
Qualified Equity Interests”: any Capital Stock that is not a Disqualified Stock.
Qualified Receivables Financing”: any Receivables Financing of a Receivables Subsidiary that meets the following conditions: (1) the Borrower Representative shall have determined in good faith that such Qualified Receivables Financing (including financing terms, covenants, termination events and other provisions) is in the aggregate economically fair and reasonable to Borrower Representative and the Receivables Subsidiary, (2) all sales of accounts receivable and related assets to the Receivables Subsidiary are made at Fair Market Value (as determined in good faith by the Borrower Representative), and (3) the financing terms, covenants, termination events and other provisions thereof shall be market terms at the time the receivables financing is first introduced (as determined in good faith by the Borrower Representative and it being understood that such terms, covenants, termination events and other provisions may subsequently be modified so long as such modifications are on market terms at the time of any such modification) and may include Standard Securitization Undertakings. The grant of a security interest in any accounts receivable of UK Holdco or any Restricted Subsidiary (other than a Receivables Subsidiary) to secure any Indebtedness shall not be deemed a Qualified Receivables Financing.
Qualified Reporting Subsidiary” as defined in Section 6.1.
Rate Determination Date” means two (2) Business Days prior to the commencement of the applicable Interest Period (or such other day as is generally treated as the rate fixing day by market practice in the applicable interbank market, as determined by the Administrative Agent (in consultation with the Borrower Representative); provided that to the extent such market practice is not administratively feasible for the Administrative Agent, the Rate Determination Date shall be such other day as is reasonably determined by the Administrative Agent (in consultation with the Borrower Representative).
Rating Agency”: S&P, Moody’s or any other nationally recognized rating agency selected by the Borrower Representative and approved by the Administrative Agent in writing.
Ratio Debt”: as defined in Section 7.2(a).
66
    



Realizable Assets”: as defined in Section 8.12(d).
Recalculation”: as defined in Section 3.10(a).
Receivables Fees”: distributions or payments made directly or by means of discounts with respect to any participation interest issued or sold in connection with, and other fees paid to a Person that is not a Restricted Subsidiary in connection with, any Receivables Financing.
Receivables Financing”: any transaction or series of transactions that may be entered into by UK Holdco or any Subsidiary of UK Holdco pursuant to which UK Holdco or any of its Subsidiaries may sell, convey or otherwise transfer to (a) a Receivables Subsidiary (in the case of a transfer by UK Holdco or any of its Subsidiaries), and (b) any other Person (in the case of a transfer by a Receivables Subsidiary), or may grant a security interest in, any accounts receivable (whether now existing or arising in the future) of UK Holdco or any of its Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and all guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts receivable and other assets which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable and any Hedging Obligations entered into by UK Holdco or any such Subsidiary in connection with such accounts receivable.
Receivables Repurchase Obligation”: any obligation of a seller of receivables in a Qualified Receivables Financing to repurchase receivables arising as a result of a breach of a representation, warranty or covenant or otherwise, including as a result of a receivable or portion thereof becoming subject to any asserted defense, dispute, off-set or counterclaim of any kind as a result of any action taken by, any failure to take action by or any other event relating to the seller.
Receivables Subsidiary”: a Wholly Owned Restricted Subsidiary of UK Holdco (or another Person formed for the purposes of engaging in a Qualified Receivables Financing with UK Holdco in which UK Holdco or any Subsidiary of UK Holdco makes an Investment and to which UK Holdco or any Subsidiary of UK Holdco transfers accounts receivable and related assets) which engages in no activities other than in connection with the financing of accounts receivable of UK Holdco and its Subsidiaries, all proceeds thereof and all rights (contractual or other), collateral and other assets relating thereto, and any business or activities incidental or related to such business, and which is designated by the Borrower Representative as a Receivables Subsidiary and:
(i)no portion of the Indebtedness or any other obligations (contingent or otherwise) of which (i) is guaranteed by UK Holdco or any other Restricted Subsidiary of UK Holdco (excluding guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to Standard Securitization Undertakings), (ii) is recourse to or obligates UK Holdco or any other Restricted Subsidiary of UK Holdco in any way other than pursuant to Standard Securitization Undertakings, or (iii) subjects any property or asset of UK Holdco or any other Restricted Subsidiary of UK Holdco, directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to Standard Securitization Undertakings,
(ii)with which neither UK Holdco nor any other Restricted Subsidiary of UK Holdco has any material contract, agreement, arrangement or understanding other than on terms which UK Holdco reasonably believe to be no less favorable to UK Holdco or such Restricted Subsidiary than those that might be obtained at the time from Persons that are not Affiliates of UK Holdco, and
(iii)to which neither UK Holdco nor any other Restricted Subsidiary of UK Holdco has any obligation to maintain or preserve such entity’s financial condition or cause such entity to achieve certain levels of operating results.
Any such designation by the Borrower Representative shall be evidenced to the Administrative Agent by delivering to the Administrative Agent an Officer’s Certificate signed on behalf of the Borrower Representative certifying that such designation complied with the foregoing conditions.
67
    



Receiver”: any receiver and manager or administrative receiver (or an equivalent officer in any jurisdiction) of the whole or any part of the Collateral.
Reclassifiable Item”: as defined in Section 1.9(c).
Recovery Event”: any settlement of or payment in respect of any property or casualty insurance claim or any condemnation, eminent domain or similar proceeding relating to any asset of any Group Member.
Reference Period”: (a) for purposes of determining actual compliance with Section 7.1, the period beginning on the first day of the most recently completed period of four consecutive fiscal quarters for which the financial statements and certificates required by Section 6.1(a) or (b), as the case may be, have been or were required to have been delivered and ending on the last day of such four consecutive fiscal quarter period and (b) for any other purpose, the period beginning on the first day of the most recently completed period of four consecutive fiscal quarters for which the financial statements and certificates required by Section 6.1(a) or (b), as the case may be, have been or were required to have been delivered or, if earlier, are internally available and, in each case, ending on the last day of such four consecutive fiscal quarter period; it being understood and agreed that prior to the first delivery (or required delivery) of financial statements under Section 6.1(a) or (b), as the case may be, “Reference Period” means the period of four consecutive fiscal quarters most recently ended for which financial statements are available.
Refinance”: in respect of any Indebtedness, to refinance, discharge, redeem, replace, defease, refund, extend, renew or repay any Indebtedness with the proceeds of other Indebtedness, or to issue other Indebtedness, in exchange or replacement for, such Indebtedness in whole or in part; “Refinanced” and “Refinancing” shall have correlative meanings.
Refinanced Credit Agreement Debt”: as defined in the definition of “Permitted Credit Agreement Refinancing Debt.”
Refinanced Debt”: as defined in the definition of “Permitted Refinancing Requirements.”
Refinancing Amendment”: an amendment to this Agreement executed by each of (a) the Borrower Representative and any applicable Borrower, (b) the Administrative Agent and (c) each Additional Lender and Lender that agrees to provide any portion of the Permitted Credit Agreement Refinancing Debt being incurred pursuant thereto, in accordance with Section 2.26.
Refinancing Arranger”: any Person (who may be the Administrative Agent, if it so agrees) that is not an Affiliate of any Borrower appointed by the Borrower Representative, after consultation with the Administrative Agent, as the arranger of any Permitted Credit Agreement Refinancing Debt.
Refinancing Revolving Debt”: any First Priority Refinancing Revolving Facility, Second Priority Refinancing Revolving Facility or Unsecured Refinancing Revolving Facility.
Refinancing Term Debt”: Indebtedness under any First Priority Refinancing Term Facility, Second Priority Refinancing Term Facility or Unsecured Refinancing Term Facility.
Refunding Capital Stock”: as defined in Section 7.3(b)(ii).
Register”: as defined in Section 11.6(b)(vi).
Registered Equivalent Notes”: with respect to any notes originally issued in a Rule 144A or other private placement transaction under the Securities Act of 1933 (or pursuant to similar rules in any jurisdiction outside of the United States), substantially identical notes (having the same Guarantees) issued in a dollar-for-dollar exchange therefor pursuant to an exchange offer registered with the SEC (or any securities regulator outside of the United States).
68
    



Regulated Bank”: an Approved Commercial Bank that is (i) a U.S. depository institution the deposits of which are insured by the Federal Deposit Insurance Corporation; (ii) a corporation organized under section 25A of the U.S. Federal Reserve Act of 1913; (iii) a branch, agency or commercial lending company of a foreign bank operating pursuant to approval by and under the supervision of the Board under 12 CFR part 211; (iv) a non-U.S. branch of a foreign bank managed and controlled by a U.S. branch referred to in clause (iii); or (v) any other U.S. or non-U.S. depository institution or any branch, agency or similar office thereof supervised by a bank regulatory authority in any jurisdiction.
Regulation U”: Regulation U of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.
Regulation X”: Regulation X of the Board as from time to time in effect and all official rulings and interpretations thereunder or thereof.
Reimbursement Obligation”: the obligation of the Revolving Borrowers or the Borrower Representative (on behalf of any Revolving Borrower) to reimburse the Issuing Lenders pursuant to Section 3.5 for amounts drawn under Letters of Credit.
Reinvestment Deferred Amount”: with respect to any Reinvestment Event, the aggregate Net Cash Proceeds received by any Loan Party in connection therewith that are subject to prepayment in accordance with Section 2.11(c) but not applied to prepay the Term Loans pursuant to Section 2.11(c) as a result of the determination by the Borrower Representative to reinvest such Net Cash Proceeds.
Reinvestment Event”: as defined in Section 2.11(c).
Reinvestment Prepayment Amount”: with respect to any Reinvestment Event, the Reinvestment Deferred Amount relating thereto less any amount expended prior to the relevant Reinvestment Prepayment Date to acquire, replace, reconstruct or repair assets useful in the business of UK Holdco and the Restricted Subsidiaries or in connection with a Permitted Acquisition or other Investment permitted hereunder.
Reinvestment Prepayment Date”: with respect to any Reinvestment Event, the earlier of (a) the date occurring 450 days after such Reinvestment Event (or, if later, 180 days after the date UK Holdco or a Restricted Subsidiary has entered into a binding commitment to reinvest the Net Cash Proceeds of such Reinvestment Event prior to the expiration of such 450 day period) and (b) the date on which the Borrower Representative shall have notified the Administrative Agent in writing that it has determined not to acquire, replace, reconstruct or repair assets useful in the business of UK Holdco and the Restricted Subsidiaries or in connection with a Permitted Acquisition or other Investment permitted hereunder.
Related Business Assets”: assets (other than cash or Cash Equivalents) used or useful in a Similar Business; provided that any assets received by UK Holdco or a Restricted Subsidiary in exchange for assets transferred by UK Holdco or a Restricted Subsidiary will not be deemed to be Related Business Assets if they consist of securities of a Person, unless upon receipt of the securities of such Person, such Person would become a Restricted Subsidiary.
Related Parties”: with respect to any Person, such Person’s Affiliates and the partners, directors, officers, employees, agents and advisors of such Person and of such Person’s Affiliates.
Relevant Governmental Body”: the Federal Reserve Board and/or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and/or the Federal Reserve Bank of New York or any successor thereto.
Relevant Jurisdiction”: in relation to a Loan Party:
(iv)the jurisdiction under whose laws that Loan Party is incorporated or organized as at the Closing Date or as at the date on which that Loan Party becomes party to this Agreement (as the case may be);
69
    



(v)any jurisdiction where it conducts its business; and
(vi)any jurisdiction where any asset subject to or intended to be subject to the Liens to be created by it is situated.
Relevant Rate”: with respect to the Revolving Facility, with respect to any Loan or L/C Credit Extension denominated in (a), Sterling, SONIA Rate (b) Dollars, Term SOFR, (c) Euros, EURIBOR, (d) Australian dollars, BBSY and (e) any Alternative Currency other than Sterling, Euros and Australian Dollars, the benchmark rate as designated with respect to such Alternative Currency at the time such Alternative Currency is approved by the Administrative Agent and the Revolving Lenders or Issuing Lenders, as applicable, pursuant to Section 2.30(a).
Reply Amount”: as defined in the definition of “Dutch Auction.”
Reportable Event”: any of the events set forth in Section 4043(c) of ERISA, other than those events as to which the thirty day notice period is waived under subsections .27, .28, .29, .30, .31, .32, .34 or .35 of PBGC Reg. § 4043.
Repricing Indebtedness”: as defined in the definition of “Repricing Transaction.”
Repricing Premium”: as defined in Section 2.10(c).
Repricing Transaction”: other than in the context of a transaction involving a Change of Control, the financing of any Significant Acquisition or any Transformative Disposition (i) the repayment, prepayment, refinancing, substitution or replacement of all or a portion of the Initial Term Loans or the Amendment No. 2 Incremental Term Loans with the incurrence of any broadly syndicated pari passu secured term loan “B” credit facility denominated in the same currency (“Repricing Indebtedness”) and having an Effective Yield that is less than the Effective Yield of the Initial Term Loans or Amendment No. 2 Incremental Term Loans, as applicable and (ii) any amendment, waiver, consent or modification to this Agreement that would reduce the Effective Yield of the Initial Term Loans or the Amendment No. 2 Incremental Term Loans; provided that the primary purpose (as determined by the Borrower Representative in good faith) of such repayment, prepayment, refinancing, substitution, replacement, amendment, waiver, consent or modification was to reduce the Effective Yield of the Initial Term Loans or the Amendment No. 2 Incremental Term Loans, as applicable.
Required Lenders”: at any time, non-Defaulting Lenders holding more than 50% of (a) until the Closing Date, the Commitments then in effect and (b) thereafter, the sum of (i) the aggregate Outstanding Amount of all Term Loans at such time, (ii) the Total Incremental Term Commitments then in effect and (iii) the Total Revolving Commitments then in effect or, if the Revolving Commitments have been terminated, the Total Revolving Extensions of Credit at such time.
Requirement of Law”: as to any Person, any law, treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.
Responsible Officer”: the chief executive officer, representative, director, manager, president, vice president, executive vice president, chief financial officer, treasurer or assistant treasurer, secretary or assistant secretary, an authorized signatory, an attorney-in-fact (to the extent empowered by the board of directors/managers of Holdings, UK Holdco or the Borrower Representative), or other similar officer of a Loan Party (or of its general partner, managing member or sole member, if applicable) of the applicable Loan Party, but in any event, with respect to financial matters, the chief financial officer, treasurer, controller or comptroller (or other officer or director with equivalent duties), and solely for purposes of notices given pursuant to Section 2, any other officer or employee of the applicable Loan Party so designated by any of the foregoing officers in a notice to the Administrative Agent or any other officer or employee of the applicable Loan Party designated in or pursuant to an agreement between the applicable Loan Party and the Administrative Agent.
70
    



Restricted”: when referring to cash or Cash Equivalents of UK Holdco and the Restricted Subsidiaries, means that such cash or Cash Equivalents appear (or would be required to appear) as “restricted” on the consolidated balance sheet of UK Holdco.
Restricted Debt Payments”: as defined in Section 7.3(a)(iii).
Restricted Investment”: an Investment other than a Permitted Investment.
Restricted Payments”: as defined in Section 7.3(a)(iv). The amount of any Restricted Payment (other than in cash), other than any Restricted Investment, shall be the Fair Market Value on the applicable date of determination of the assets or securities proposed to be transferred or issued pursuant to such Restricted Payment.
Restricted Subsidiary”: any Subsidiary of UK Holdco other than any Unrestricted Subsidiary; provided, however, that upon a Subsidiary ceasing to be an Unrestricted Subsidiary, such Subsidiary shall be included in the definition of “Restricted Subsidiary”.
Retained Declined Proceeds”: as defined in Section 2.11(f).
Retired Capital Stock”: as defined in Section 7.3(b)(ii).
Return Bid”: as defined in the definition of “Dutch Auction.”
Revolving Borrower”: as defined in the recitals hereto.
Revolving Borrowing”: a borrowing consisting of simultaneous Revolving Loans of the same Type and, in the case of Eurocurrency Loans and Term SOFR Loans, having the same Interest Period made by each of the Revolving Lenders.
Revolving Commitment”: as to any Lender, the obligation of such Lender, if any, to make Revolving Loans and participate in Swingline Loans and Letters of Credit in an aggregate principal and/or face amount not to exceed the amount set forth under the heading “Revolving Commitment” opposite such Lender’s name on Schedule 1.1A-1 or in the Assignment and Assumption, Refinancing Amendment or Incremental Amendment pursuant to which such Lender became a party hereto, as applicable, as the same may be changed from time to time pursuant to the terms hereof. The original amount of the Total Revolving Commitments is the Dollar Amount of $250,000,000.
Revolving Commitment Increase”: as defined in Section 2.25(a).
Revolving Commitment Increase Lender”: as defined in Section 2.25(d).
Revolving Commitment Period”: the period from and including the Closing Date to but excluding the Revolving Termination Date.
Revolving Excess”: as defined in Section 2.11(e).
Revolving Extensions of Credit”: as to any Revolving Lender at any time to an amount equal to the sum of (a) the aggregate Outstanding Amount of all Revolving Loans held by such Lender at such time, (b) such Lender’s Revolving Percentage of the aggregate Outstanding Amount of all L/C Obligations at such time and (c) such Lender’s Revolving Percentage of the aggregate Outstanding Amount of all Swingline Loans at such time.
Revolving Facility”: any Class of Revolving Commitments and the extensions of credit made thereunder, as the context may require.
Revolving Facility Scheduled Unavailability Date”: as defined in Section 2.16(c)(ii)(2).
71
    



Revolving Facility Successor Rate”: as defined in Section 2.16(c).
Revolving Facility Term SOFR Replacement Date”: as defined in Section 2.16(c).
Revolving Facility Term SOFR Successor Rate”: as defined in Section 2.16(c).
Revolving Lender”: each Lender that has a Revolving Commitment or that holds Revolving Loans.
Revolving Loan Note”: a promissory note substantially in the form of Exhibit F-1.
Revolving Loans”: as defined in Section 2.4(a).
Revolving Percentage”: as to any Revolving Lender at any time, the percentage which such Lender’s Revolving Commitment then constitutes of the Total Revolving Commitments or, at any time after the Revolving Commitments shall have expired or terminated, the percentage which the aggregate Outstanding Amount of such Lender’s Revolving Loans at such time constitutes of the aggregate Outstanding Amount all Revolving Loans at such time; provided that in the event that the Revolving Loans are paid in full prior to the reduction to zero of the Total Revolving Extensions of Credit, the Revolving Percentages shall be determined in a manner designed to ensure that the other outstanding Revolving Extensions of Credit shall be held by the Revolving Lenders on a comparable basis.
Revolving Termination Date”: the earlier of (i) the fifth anniversary of the Amendment No. 4 Effective Date and (ii) the date (the “Springing Maturity Date”) that is 90 days prior to the scheduled final maturity date of (x) any Initial Term Loans (including Amendment No. 1 Term Loans) or Amendment No. 2 Term Loans or (y) the Senior Secured Notes, in each case that are outstanding as of the Amendment No. 4 Effective Date; provided that the Springing Maturity Date shall apply only to the extent that such Indebtedness referenced in the foregoing clauses (x) or (y) has not been Refinanced or extended such that the final maturity date thereof is no earlier than the date that is 90 days after the fifth anniversary of the Amendment No. 4 Effective Date.
Rule 3-16 Capital Stock”: the Capital Stock (or any portion thereof) of any Subsidiary of Holdings to the extent the granting of a security interest thereon would create the requirement for Holdings or any direct or indirect parent company thereof to file separate financial statements of such Subsidiary with the SEC (or any other governmental authority) pursuant to Rule 3-10 or 3-16 of Regulation S-X under the Securities Act (or any successor regulation) or any other requirement of law in effect from time to time.

S&P”: Standard & Poor’s Financial Services LLC, a subsidiary of The McGraw-Hill Companies, Inc. and any successor to the rating agency business thereof.

Sale Leaseback Transaction”: any arrangement with any Person or Persons, whereby in contemporaneous or substantially contemporaneous transactions UK Holdco or any Restricted Subsidiary sells substantially all of its right, title and interest in any property and, in connection therewith, UK Holdco or a Restricted Subsidiary acquires, leases or licenses back the right to use all or a material portion of such property.
Sanctioned Country”: as defined in Section 4.17(c).
Sanctioned Person”: (a) any Person listed in any Sanctions Laws-related list of designated persons maintained by OFAC (including the designation as a “specially designated national” or “blocked person”), the U.S. Department of State, the United Nations Security Council, the European Union, the United Kingdom or any EU member state, and (b) any Person owned 50% or more by any such Person or Persons.
Sanctions Laws”: the laws and regulations administered or enforced by the U.S. Government (including OFAC or the U.S. Department of State), the United Nations Security Council, Canada, the European Union, the United Kingdom and any other relevant sanctions authority.
72
    



SEC”: the Securities and Exchange Commission, any successor thereto and any analogous Governmental Authority.
Second Priority Refinancing Revolving Facility”: as defined in the definition of “Permitted Second Priority Refinancing Debt.”
Second Priority Refinancing Term Facility”: as defined in the definition of “Permitted Second Priority Refinancing Debt.”
Secured Net Leverage Ratio”: as of any date of determination for the most recently ended Reference Period or the Reference Period otherwise specified herein, the ratio of (a) Consolidated Secured Indebtedness on such day, to (b) Consolidated EBITDA, in each case of UK Holdco and its Restricted Subsidiaries, calculated on a Pro Forma Basis for such period.
Secured Parties”: the collective reference to the Administrative Agent, the Lenders (including each Issuing Lender in its capacity as such), any Receiver and, so long as any Obligations (other than in respect of Specified Cash Management Agreements and Specified Swap Agreements) are outstanding, any Qualified Counterparties and any Cash Management Providers.
Securities Act”: the Securities Act of 1933, as amended from time to time, and any successor statute.
Security Agreements”: collectively, the US Security Agreement, the US Pledge Agreement and each other security agreement and security agreement supplement executed and delivered pursuant to Section 5.1(a), Section 6.9, Section 6.11, Section 6.15 or Schedule 1.1C (as such schedule may be amended or supplemented from time to time in accordance with the Agreed Security Principles), in each case as amended, restated, supplemented, replaced or otherwise modified from time to time in accordance with its terms.
Security Documents”: the collective reference to each Security Agreement, each Intellectual Property Security Agreement, those certain foreign security and pledge agreements listed on Schedule 1.1C (as such schedule may be amended or supplemented from time to time in accordance with the Agreed Security Principles), collateral assignments, security agreement supplements, security agreements, pledge agreements or other similar agreements delivered to the Administrative Agent pursuant to Section 5.1(a), Section 6.9, Section 6.11 or Section 6.15, and each of the other agreements, instruments or documents that creates or purports to create a Lien to secure the Obligations.
Security Jurisdiction”: each of (a) the United States, any State thereof and the District of Columbia, (b) England and Wales, (c) Luxembourg (solely with respect to the Lux Borrower) and (d) any other jurisdiction in which any Borrower is organized (solely with respect to such Borrower).
Senior Secured Notes”: as defined in the preamble hereto.
Senior Secured Notes Indenture”: as defined in the preamble hereto.
Senior Representative”: with respect to any series of Permitted First Priority Refinancing Debt or Permitted Second Priority Refinancing Debt or any other series of Indebtedness, the trustee, administrative agent, collateral agent, security agent or similar agent under the indenture or agreement pursuant to which such Indebtedness is issued, incurred or otherwise obtained, as the case may be, and each of their successors in such capacities.
Significant Acquisition”: an acquisition the result of which is that Consolidated EBITDA, determined on a Pro Forma Basis after giving effect thereto, is equal to or greater than 125.0% of Consolidated EBITDA as of the most recently ended Reference Period immediately prior to the consummation of such Permitted Acquisition, in each case with respect to UK Holdco and the Restricted Subsidiaries based on the most recently ended Reference Period.
73
    



Significant Subsidiary”: at any date of determination, each Restricted Subsidiary that would be a “Significant Subsidiary” within the meaning of Rule 1-02 under the Securities Act as such rule is in effect on the Closing Date.
Similar Business”: any business, service or other activity engaged in by UK Holdco, any of the Restricted Subsidiaries, or any direct or indirect parent on the Closing Date and any business or other activities that are reasonably similar, ancillary, complementary or related to, or a reasonable extension, development or expansion of, the businesses in which UK Holdco and the Restricted Subsidiaries are engaged on the Closing Date.
Single Employer Plan”: any Plan that is subject to Title IV of ERISA, but that is not a Multiemployer Plan.
SOFR”: (a) other than with respect to the Revolving Facility, with respect to any day, the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark (or a successor administrator) on the Federal Reserve Bank of New York’s website (or any successor source) and, in each case, that has been selected or recommended by the Relevant Governmental Body; and (b) with respect to the Revolving Facility, the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator).
SOFR Adjustment”: (a) with respect to Daily Simple SOFR, in the case of the Revolving Facility, 0.10% (10 basis points) per annum; and (b) with respect to Term SOFR, (i) in the case of Term Loans, 0.11448% (11.448 basis points) for an Interest Period of one month’s duration, 0.26161% (26.161 basis points) for an Interest Period of three month’s duration and 0.42826% (42.826 basis points) for an Interest Period of six months’ duration and (ii) in the case of the Revolving Facility, 0.10% (10 basis points) per annum for an Interest Period of one month’s duration, 0.10% (10 basis points) per annum for an Interest Period of three months’ duration, and 0.25% (25 basis points) per annum for an Interest Period of six months’ duration.
Solvency Certificate”: a certificate duly executed by a Responsible Officer substantially in the form of Exhibit I.
Solvent”: with respect to any Person and its Subsidiaries on a consolidated basis, means that as of any date of determination, (a) the sum of the fair value of the assets of such Person will, as of such date, exceed the sum of all debts of such Person as of such date, (b) the present fair saleable value of the assets of such Person will, as of such date, be greater than the amount that will be required to pay the probable liability on existing debts of such Person as such debts become absolute and matured, (c) such Person will not have, as of such date, an unreasonably small amount of capital with which to conduct any business in which it is or is about to become engaged and (d) such Person does not intend to incur, or believe or reasonably should believe that it will incur, debts beyond its ability to pay as they mature. For purposes of this definition, (i) “debt” means liability on a “claim” and (ii) “claim” means any (x) right to payment, whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, subordinated, secured or unsecured or (y) right to an equitable remedy for breach of performance if such breach gives rise to a right to payment, whether or not such right to an equitable remedy is reduced to judgment, fixed, contingent, matured or unmatured, disputed, undisputed, secured or unsecured. For purposes of this definition, the amount of any contingent, unliquidated and disputed claim and any claim that has not been reduced to judgment at any time shall be computed as the amount that, in light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability irrespective of whether such liabilities meet the criteria for accrual under the Financial Accounting Standards Board Statement of Financial Accounting Standards No. 5.
SONIA Rate”: with respect to any applicable determination date, the Sterling Overnight Index Average Reference Rate published on the fifth Business Day preceding such date on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time); provided however that if such determination date is not a Business Day, SONIA Rate means such rate that applied on the first Business Day immediately prior thereto.
74
    



SONIA Adjustment” means, with respect to the SONIA Rate, 0.0326% per annum.
Spain”: the Kingdom of Spain.
Spanish Borrower”: a Borrower resident for tax purposes in Spain.
Spanish Guarantor”: a Guarantor resident for tax purposes in Spain.
Spanish Loan Party”: any Loan Party incorporated or organized under the laws of Spain, whose registered office/place of central administration is in Spain and whose centre of main interest (as that term is used in Article 3(1) of the regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 (recast)) is in Spain.
Spanish Qualifying Lender”: in respect of a Spanish Borrower, a Lender which is beneficially entitled to interest payable to that Lender in respect of any amounts hereunder and which is (a) a financial institution (entidad de crédito o establecimiento financiero de crédito) resident for tax purposes in Spain as identified in paragraph (c) of article 61 of Spanish Royal Decree 634/2015, of 10 July (Real Decreto 634/2015, de 10 de julio), as amended or restated; (b) a Spanish tax resident securitisation fund as identified in paragraph (k) of article 61 of Spanish Royal Decree 634/2015, of 11 July (Real Decreto 634/2015, de 10 de julio), as amended or restated; (c) a permanent establishment in Spain of a non-Spanish financial institution, as identified in the second paragraph of article 8.1 of Spanish Royal Decree 1776/2004, of 30 July (Real Decreto 1776/2004, de 30 de julio), as amended or restated; (d) an EU Lender; or (e) a Spanish Treaty Lender.
Spanish Tax Deduction”: a deduction or withholding for, or on account of, Tax imposed by Spain from an interest payment under a Loan Document.
Spanish Treaty Lender”: in respect of a Spanish Borrower, a Lender which (a) is treated as a resident of a Spanish Treaty State for the purposes of such Spanish Treaty; (b) does not carry on a business in Spain through a permanent establishment with which that Lender’s participation in the Loan is effectively connected; and (c) fulfils any other procedural conditions which must be fulfilled under the Spanish Treaty by residents of that Spanish Treaty State for such residents to obtain full exemption from taxation on interest imposed by Spain, subject to the completion of procedural formalities.
Spanish Treaty State”: a jurisdiction having a double taxation agreement (including, but not limited to, any protocol, exchange of letters, memorandum of understanding, mutual agreement or any other agreement executed between the Governmental Authority of such jurisdiction and Spain in connection with or under the provisions of such double taxation agreement) with Spain (a “Spanish Treaty”) which makes provision for full exemption from tax imposed by Spain on interest.
Specified Cash Management Agreement”: any Cash Management Agreement entered into by any Group Member, on the one hand, and any Cash Management Provider, on the other hand.
Specified Class”: as defined in Section 2.28(a).
Specified Event of Default”: any Event of Default set forth under Section 9.1(a) or, with respect to a Borrower, 9.1(g).
Specified Swap Agreement”: any (i) Existing Swap Agreement and (ii) Swap Agreement entered into by any Group Member, on the one hand, and any Qualified Counterparty (at the time entered into) on the other hand (unless otherwise designated by the Borrower Representative).
Sponsors”: (i) Onex Corporation, Onex Partners IV LP, Onex Partners Manager LP and/or one or more other investment funds advised, managed or controlled by Onex Corporation, and (ii) Baring Private Equity Asia GP VI, L.P. and the investment fund managed and controlled by it, and, in each case (whether individually or as a group), their Affiliates and any investment funds that have granted to the
75
    



foregoing control in respect of their investment in UK Holdco and/or any of the Restricted Subsidiaries of UK Holdco, but, in any event, excluding any of their respective portfolio companies.
Standard Securitization Undertakings”: representations, warranties, covenants, indemnities and guarantees of performance entered into by UK Holdco or any Subsidiary of UK Holdco which the Borrower Representative has determined in good faith to be customary in a Receivables Financing including, without limitation, those relating to the servicing of the assets of a Receivables Subsidiary, it being understood that any Receivables Repurchase Obligation shall be deemed to be a Standard Securitization Undertaking.
Stated Maturity Date” means, with respect to any security, the date specified in such security as the fixed date on which the final payment of principal of such security is due and payable, including pursuant to any mandatory redemption provision (but excluding any provision providing for the repurchase of such security at the option of the holder thereof upon the happening of any contingency beyond the control of the issuer unless such contingency has occurred).
Sterling”, “GBP” and “£”: the lawful currency of the United Kingdom.
Sterling Daily Rate”: for any day, with respect to any Loans or any other credit extension denominated in Sterling, a rate per annum equal to the SONIA Rate for such day determined pursuant to the definition thereof plus the SONIA Adjustment; provided that if the Sterling Daily Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement.
Sterling Daily Rate Loan”: a Loan that bears interest at a rate based on the definition of “Sterling Daily Rate”.
Subject Subsidiary”: as defined in Section 6.12.
Subordinated Indebtedness”: (a) with respect to any Borrower, any Indebtedness of any Borrower which is by its terms contractually subordinated in right of payment to the Loans, and (b) with respect to any Guarantor, any Indebtedness of such Guarantor which is by its terms contractually subordinated in right of payment to its Guarantee.
Subsidiary”: with respect to any Person (1) any corporation, partnership, limited liability company, unlimited liability company, association, joint venture or other business entity (other than a partnership, joint venture or limited liability company) of which more than 50% of the total voting power of shares of stock or other ownership interests entitled (without regard to the occurrence of any contingency) to vote in the election of the Person or Persons (whether directors, managers, trustees or other Persons performing similar functions) having the power to direct or cause the direction of the management and policies thereof at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, (2) any partnership, joint venture or limited liability company of which (x) more than 50% of the capital accounts, distribution rights, total equity and voting interests or general and limited partnership interests, as applicable, are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof, whether in the form of membership, general, special or limited partnership interests or otherwise, and (y) such Person or any Subsidiary of such Person is a controlling general partner or otherwise controls such entity and (3) any Person that is consolidated in the consolidated financial statements of the specified Person in accordance with GAAP. Unless otherwise qualified, all references to a “Subsidiary” or to “Subsidiaries” in this Agreement shall refer to a Subsidiary or Subsidiaries of Holdings.
Subsidiary Guarantor”: the collective reference to each Restricted Subsidiary that is party to the Loan Documents as guarantors of the Obligations, except to the extent released in accordance with this Agreement.
Swap Agreement”: any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing
76
    



indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions; provided that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of UK Holdco or any of its Subsidiaries shall be a Swap Agreement.
Swap Obligation”: as defined in the definition of “Excluded Swap Obligation.”
Swingline Borrowing”: a borrowing consisting of simultaneous Swingline Loans of the same Type.
Swingline Commitment”: the obligation of the Swingline Lender to make Swingline Loans in Dollars pursuant to Section 2.6 in an aggregate principal amount at any one time outstanding not to exceed $25,000,000.
Swingline Lender”: Bank of America, N.A. and/or any other Lender under the Revolving Facility approved by the Borrower Representative and the Administrative Agent that agrees in writing to act in such capacity.
Swingline Loan Note”: a promissory note substantially in the form of Exhibit F-2.
Swingline Loans”: as defined in Section 2.6(a).
Swingline Participation”: as defined in Section 2.6(a).
Swiss Francs”: the lawful currency of Switzerland.
TARGET2”: the Trans-European Automated Real-time Gross Settlement Express Transfer payment system which utilizes a single shared platform and which was launched on November 19, 2007.
“TARGET Day”: any day on which TARGET2 (or, if such payment system ceases to be operative, such other payment system, if any, determined by the Administrative Agent to be a suitable replacement) is open for the settlement of payments in Euro.
Taxes”: as defined in Section 2.19(a).
Term Borrowers”: as defined in the preamble hereto.
Term Borrowing”: a borrowing consisting of simultaneous Term Loans of the same Type.
Term Commitment”: as to any Lender, (i) the obligation of such Lender on the Closing Date, if any, to make a Closing Date Term Loan to the Term Borrowers in a principal amount not to exceed the amount set forth under the heading “Term Commitment” opposite such Lender’s name on Schedule 1.1A-1, (ii) the Incremental Term Commitments, if any, issued after the Closing Date pursuant to Section 2.25 (including, without limitation, the Amendment No. 1 Incremental Term Commitments and Amendment No. 2 Incremental Term Commitments) or (iii) Other Term Commitments, if any, issued after the Closing Date pursuant to a Refinancing Amendment entered into pursuant to Section 2.26. The aggregate principal amount of the Term Commitments as of the Closing Date is $900,000,000. With respect to the Amendment No. 1 Incremental Term Facility only, the aggregate principal amount of the Amendment No. 1 Incremental Term Commitments as of the Amendment No. 1 Effective Date is $360,000,000. With respect to the Amendment No. 2 Incremental Term Facility only, the aggregate principal amount of the Amendment No. 2 Incremental Term Commitments as of the Amendment No. 2 Effective Date is $1,600,000,000.
Term Facility”: any Class of Term Loans, as the context may require.
77
    



Term Lenders”: each Lender that holds a Term Commitment (including any Initial Term Commitment or Amendment No. 2 Incremental Term Commitment) or that holds a Term Loan (including any Initial Term Loan or Amendment No. 2 Incremental Term Loan).
Term Loan”: an Initial Term Loan (including the Amendment No. 1 Incremental Term Loans), an Amendment No. 2 Incremental Term Loan, an Other Term Loan or an Incremental Term Loan, as the context requires.
Term Loan Maturity Date”: the seventh anniversary of the Closing Date.
Term Loan Note”: a promissory note substantially in the form of Exhibit F-3, as it may be amended, supplemented or otherwise modified from time to time.
Term Loan Purchase Amount”: as defined in the definition of “Dutch Auction.”
Term Loan Scheduled Unavailability Date”: as defined in Section 2.16(b)(ii).
Term Percentage”: as to any Term Lender at any time, the percentage which such Lender’s Term Commitment then constitutes of the aggregate Term Commitments (or, at any time after the Closing Date, the percentage which the aggregate Outstanding Amount of such Lender’s Term Loans at such time constitutes of the aggregate Outstanding Amount of all Term Loans at such time).
Term SOFR”:
(vii)for any Interest Period with respect to a Term SOFR Loan, the rate per annum equal to the Term SOFR Screen Rate two US Government Securities Business Days prior to the commencement of such Interest Period with a term equivalent to such Interest Period; provided that if the rate is not published prior to 11:00 a.m. on such determination date, then “Term SOFR” means the Term SOFR Screen Rate on the first US Government Securities Business Day immediately prior thereto, in each case plus the SOFR Adjustment for such Interest Period; and
(viii)for any interest calculation with respect to an ABR Loan on any date, (i) with respect to Term Loans, the rate per annum equal to the Term SOFR Screen Rate two US Government Securities Business Days prior to such date with a term of one month commencing that day; provided that if the rate is not published prior to 11:00 a.m. on such determination date, then Term SOFR means the Term SOFR Screen Rate on the first US Government Securities Business Day immediately prior thereto, in each case, plus the SOFR Adjustment for such term and (ii) with respect to Revolving Facility, the rate per annum equal to the Term SOFR Screen Rate with a term of one month commencing that day,
provided that if the Term SOFR determined in accordance with the foregoing clauses (a) or (b) would otherwise be less than such amount, “Term SOFR” shall be deemed to be (i) 1.00% per annum for purposes of the Amendment No. 2 Incremental Term Loans and (ii) zero for all other purposes of this Agreement.
Term SOFR Loan”: a Loan that bears interest at a rate determined by reference to clause (a) of the definition of “Term SOFR”.
Term SOFR Screen Rate”: the forward-looking SOFR term rate administered by CME (or any successor administrator satisfactory to the Administrative Agent) and published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time).
Term SOFR Tranche”: the collective reference to Term SOFR Loans under a particular Facility the then current Interest Periods with respect to all of which begin on the same date and end on the same later date (whether or not such Loans shall originally have been made on the same day).
78
    



Termination Date”: the date on which all Commitments have been terminated and the principal of and interest on each Loan, all fees and all other expenses or amounts payable under any Loan Document shall have been paid in full (other than contingent indemnification and reimbursement obligations for which no claim has been made) and all Letters of Credit have been canceled, have expired or have been Collateralized or back-stopped by a letter of credit or otherwise in a manner reasonably satisfactory to the relevant Issuing Lender or deemed reissued under another agreement in a manner reasonably satisfactory to the Administrative Agent and the relevant Issuing Lender.
Total Net Leverage Ratio”: as of any date of determination for the most recently ended Reference Period or the Reference Period otherwise specified herein, the ratio of (a) Consolidated Total Indebtedness on such day, to (b) Consolidated EBITDA, in each case of UK Holdco and its Restricted Subsidiaries, calculated on a Pro Forma Basis for such period.
Total Incremental Term Commitments”: at any time, the aggregate Dollar Amount of the Incremental Term Commitments then in effect.
Total Revolving Commitments”: at any time, the aggregate Dollar Amount of the Revolving Commitments then in effect.
Total Revolving Extensions of Credit”: at any time, the aggregate Outstanding Amount of the Revolving Extensions of Credit of the Revolving Lenders at such time.
TRA Payment”: as defined in the preamble hereto.
Transactions”: (a) the issuance and sale of the Senior Secured Notes on or prior to the Closing Date, (b) the execution and delivery of the Loan Documents to be entered into on the Closing Date and the funding of the Loans on the Closing Date, (c) the Closing Date Refinancing, (d) the TRA Payment and (e) the payment of fees and expenses incurred in connection with the foregoing.
Transferee”: any Assignee or Participant.
Transformative Disposition”: any Asset Sale or other disposition by UK Holdco or any Restricted Subsidiary that is either (a) not permitted by the terms of this Agreement immediately prior to the consummation of such Asset Sale or other disposition or (b) if permitted by the terms of this Agreement immediately prior to the consummation of such Asset Sale or other disposition, would not provide UK Holdco and its Restricted Subsidiaries with a durable capital structure following such consummation, as determined by the Borrower Representative acting in good faith.
Type”: as to any Loan, its nature as an ABR Loan, a Sterling Daily Rate Loan, a Term SOFR Loan or a Eurocurrency Loan.
UK Borrower”: UK Holdco and/or an Additional Revolving Borrower incorporated in the United Kingdom.
UK Holdco”: as defined in the preamble hereto.
UK Non-Bank Lender”: (a) where a Revolving Lender or a Swingline Lender becomes a party to this Agreement on the Closing Date, a Revolving Lender or a Swingline Lender listed as a UK Non-Bank Lender in Schedule 1.1A-1, and (b) where a Revolving Lender or a Swingline Lender becomes a party to this Agreement after the Closing Date, a Revolving Lender or a Swingline Lender which gives a UK Tax Confirmation in the Assignment and Assumption, Incremental Amendment or Refinancing Amendment pursuant to which such Lender becomes a party hereto.
UK Qualifying Lender”: (a) a Revolving Lender or a Swingline Lender which is beneficially entitled to interest payable to that Lender in respect of an advance under a Loan Document that is a Revolving Loan or a Swingline Loan (as applicable) and is (i) a Revolving Lender or Swingline Lender (as applicable) (A) which is a bank (as defined for the purpose of section 879 of the ITA 2007) making an
79
    



advance under a Loan Document that is a Revolving Loan or a Swingline Loan (as applicable) and is within the charge to United Kingdom corporation tax as respects any payments of interest made in respect of that advance or would be within such charge as respects such payments apart from section 18A of the CTA 2009; or (B) in respect of an advance made under a Loan Document that is a Revolving Loan or a Swingline Loan (as applicable) by a person that was a bank (as defined for the purpose of section 879 of the ITA 2007) at the time that that advance was made and within the charge to United Kingdom corporation tax as respects any payments of interest made in respect of that advance; or (ii) a Revolving Lender or a Swingline Lender which is: (A) a company resident in the United Kingdom for United Kingdom tax purposes, or (B) a partnership each member of which is (x) a company so resident in the United Kingdom or (y) a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings into account in computing its chargeable profits (within the meaning of section 19 of the CTA 2009) the whole of any share of interest payable in respect of that advance that falls to it by reason of Part 17 of the CTA 2009, or (C) a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings into account interest payable in respect of that advance in computing the chargeable profits (within the meaning of section 19 of the CTA 2009) of that company; or (iii) a UK Treaty Lender, or (b) a Revolving Lender or a Swingline Lender which is a building society (as defined for the purposes of section 880 ITA) making an advance under a Loan Document that is a Revolving Loan or a Swingline Loan (as applicable).
UK Tax Confirmation”: a confirmation in writing by a Revolving Lender or a Swingline Lender that the person beneficially entitled to interest payable to that Revolving Lender or Swingline Lender in respect of an advance under a Loan Document that is a Revolving Loan or a Swingline Loan (as applicable) is either (a) a company resident in the United Kingdom for United Kingdom tax purposes or (b) a partnership each member of which is (i) a company so resident in the United Kingdom or (ii) a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings into account in computing its chargeable profits (within the meaning of section 19 of the CTA 2009) the whole of any share of interest payable in respect of that advance that falls to it by reason of Part 17 of the CTA 2009 or (c) a company not so resident in the United Kingdom which carries on a trade in the United Kingdom through a permanent establishment and which brings into account interest payable in respect of that advance in computing the chargeable profits (within the meaning of section 19 of the CTA 2009) of that company.
UK Tax Deduction”: a deduction or withholding for, or on account of, Tax imposed by the United Kingdom from a payment under a Loan Document.
UK Treaty”: meaning assigned to such term in the definition of “UK Treaty State”.
UK Treaty Lender”: a Revolving Lender or a Swingline Lender which is (i) treated as a resident of a UK Treaty State for the purposes of the relevant Treaty, (ii) does not carry on a business in the United Kingdom through a permanent establishment with which that Lender’s participation in the Loan is effectively connected, and (iii) fulfills any other conditions which must be fulfilled under the relevant Treaty to obtain full exemption from Tax imposed by the United Kingdom on payments of interest.
UK Treaty State”: a jurisdiction having a double taxation agreement (a “Treaty”) with the United Kingdom (a “UK Treaty”) which makes provision for full exemption from Tax imposed by the United Kingdom on interest.
Undisclosed Administration”: in relation to a Lender or its direct or indirect parent company the appointment of an administrator, provisional liquidator, conservator, receiver, trustee, custodian or other similar official by a supervisory authority or regulator under or based on the law in the country where such Lender is subject to home jurisdiction supervision if applicable law requires that such appointment is not to be publicly disclosed.
Uniform Commercial Code” or “UCC”: the Uniform Commercial Code (or any similar or equivalent legislation) as in effect from time to time in any applicable jurisdiction.
United Kingdom” or “UK”: the United Kingdom of Great Britain and Northern Ireland.
80
    



United States”: the United States of America.
Unrestricted”: when referring to cash or Cash Equivalents, means that such cash or Cash Equivalents are not Restricted.
Unrestricted Cash Amount”: on any date of determination, an amount equal to the sum of (a) the Unrestricted cash and Cash Equivalents and (b) cash and Cash Equivalents restricted in favor of the Administrative Agent, the collateral agent in respect of the Senior Secured Notes or any other administrative agent or collateral agent in respect of Obligations secured on a pari passu basis with the Obligations, so long as the holders of such other Obligations do not have the benefit of a control agreement or other equivalent method of perfection (unless (i) the Administrative Agent or Collateral Agent also has the benefit of a control agreement or other equivalent method of perfection or (ii) such holders are bound by an Acceptable Intercreditor Agreement), in each case of UK Holdco and its Restricted Subsidiaries on such date.
Unrestricted Subsidiary”: (i) any Subsidiary of UK Holdco designated by the Borrower Representative as an Unrestricted Subsidiary pursuant to Section 6.12 subsequent to the Closing Date, (ii) any Subsidiary of an Unrestricted Subsidiary and (iii) each Receivables Subsidiary designated by the Borrower Representative as an Unrestricted Subsidiary pursuant to Section 6.12 subsequent to the Closing Date. For the avoidance of doubt, no Borrower may be designated as an Unrestricted Subsidiary at any time, and no Additional Revolving Borrower may be designated as an Unrestricted Subsidiary unless it shall have ceased to be an Additional Revolving Borrower pursuant to Section 12.3 prior to the effectiveness of such designation as an Unrestricted Subsidiary.
Unsecured Refinancing Revolving Facility”: as defined in the definition of “Permitted Unsecured Refinancing Debt.”
Unsecured Refinancing Term Facility”: as defined in the definition of “Permitted Unsecured Refinancing Debt.”
US Borrowers”: as defined in the recitals hereto.
US Government Securities Business Day”: any Business Day, except any Business Day on which any of the Securities Industry and Financial Markets Association, the New York Stock Exchange or the Federal Reserve Bank of New York is not open for business because such day is a legal holiday under the federal laws of the United States or the laws of the State of New York, as applicable.
US Intellectual Property Security Agreements”: collectively, each of the intellectual property security agreements among the Loan Parties party thereto and the Administrative Agent, in each case substantially in the applicable form attached to the US Security Agreement.
US Loan Party”: any Loan Party organized under the laws of the United States, any state within the United States or the District of Columbia.
US Pledge Agreement”: the US Pledge Agreement dated as of the Closing Date among the Loan Parties party thereto and the Administrative Agent, substantially in the form of Exhibit A-1.
US Security Agreement”: the US Security Agreement dated as of the Closing Date among the Loan Parties party thereto and the Administrative Agent, substantially in the form of Exhibit A-2.
US Subsidiary”: any Subsidiary of UK Holdco organized under the laws of the United States, any state within the United States or the District of Columbia.
VAT”: (a) any tax imposed in compliance with the Council Directive of 28 November 2006 on the common system of value added tax (EC Directive 2006/112); and (b) any other tax of a similar nature, whether imposed in a member state of the European Union in substitution for, or levied in addition to, such tax referred to in paragraph (a), or imposed elsewhere.
81
    



Voting Stock”: with respect to any Person as of any date, the Capital Stock of such Person that is at the time entitled to vote in the election of the Board of Directors of such Person.
Weighted Average Life to Maturity”: when applied to any Indebtedness, Disqualified Stock or Preferred Stock, as the case may be, at any date, the quotient obtained by dividing (1) the sum of the products of the number of years from the date of determination to the date of each successive scheduled principal payment of such Indebtedness or redemption or similar payment with respect to such Disqualified Stock or Preferred Stock multiplied by the amount of such payment, by (2) the sum of all such payments; provided that the effect of any prepayment shall be disregarded in making such calculation.
Wholly Owned Restricted Subsidiary”: any Wholly Owned Subsidiary that is a Restricted Subsidiary.
Wholly Owned Subsidiary”: any Person means a Subsidiary of such Person 100% of the outstanding Capital Stock or other ownership interests of which (other than directors’ qualifying shares or shares or interests required to be held by foreign nationals or other third parties to the extent required by applicable law) shall at the time be owned by such Person or by one or more Wholly Owned Subsidiaries of such Person.
Write-Down and Conversion Powers”: with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule.
1.bGeneral Interpretive Provisions.
(i)Unless otherwise specified therein, all terms defined in this Agreement shall have the defined meanings when used in the other Loan Documents or any certificate or other document made or delivered pursuant hereto or thereto.
(ii)As used herein and in the other Loan Documents, and any certificate or other document made or delivered pursuant hereto or thereto, (i) accounting terms not defined in Section 1.1 and accounting terms partly defined in Section 1.1, to the extent not defined, shall have the respective meanings given to them under GAAP, (ii) the words “include”, “includes” and “including” shall be deemed to be followed by the phrase “without limitation”, (iii) the word “incur” shall be construed to mean incur, create, issue, assume or become liable in respect of (and the words “incurred” and “incurrence” shall have correlative meanings), (iv) the words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, Capital Stock, securities, revenues, accounts, real property, leasehold interests and contract rights, (v) the term “consolidated” with respect to any Person refers to such Person consolidated with the Restricted Subsidiaries, and excludes from such consolidation any Unrestricted Subsidiary as if such Unrestricted Subsidiary were not an Affiliate of such Person, (vi) references to agreements or other Contractual Obligations (including any of the Loan Documents) shall, unless otherwise specified, be deemed to refer to such agreements or Contractual Obligations as amended, novated, supplemented, restated, extended, amended and restated or otherwise modified from time to time, (vii) any reference to any Law in any Loan Document shall include all statutory and regulatory provisions consolidating, amending, replacing, supplementing, superseding or interpreting such Law, (viii) a debt instrument includes any equity or hybrid instrument to the extent characterized as indebtedness and (ix) the words “ordinary course of business” or “ordinary course” shall, with respect to any Person, be deemed to refer to items or actions that are consistent with industry practice or norms of such Person’s industry or such Person’s past practice (it being understood that the sale of accounts receivable (and related assets) pursuant to supply-chain, factoring or reverse factoring arrangements entered into by UK Holdco and its Restricted Subsidiaries shall be deemed to be in the ordinary course of business so long as such accounts receivable (and related assets) are sold for cash in an amount not less than 95% of the face amount thereof).
82
    



(iii)The words “hereof”, “herein” and “hereunder” and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement, and clause, paragraph, Section, Schedule and Exhibit references are to this Agreement unless otherwise specified.
(iv)The meanings given to terms defined herein shall be equally applicable to both the singular and plural forms of such terms.
(v)Unless otherwise specified, all references herein to times of day shall be references to New York City time (daylight or standard, as applicable).
(vi) Any financial ratios required to be maintained by the Borrowers pursuant to this Agreement shall be calculated by dividing the appropriate component by the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down to the nearest number (with a rounding-up if there is no nearest number).
(vii)Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the stated amount of such Letter of Credit in effect at such time; provided, however, that with respect to any Letter of Credit that, by its terms or the terms of any Issuer Document related thereto, provides for one or more automatic increases in the stated amount thereof, the amount of such Letter of Credit shall be deemed to be the maximum stated amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum stated amount is in effect at such time.
1.cAccounting.
(i)For purposes of all financial definitions and calculations in this Agreement, including the determination of Excess Cash Flow (i) there shall be excluded for any period the effects of purchase accounting (including the effects of such adjustments pushed down to UK Holdco and the Restricted Subsidiaries) in component amounts required or permitted by GAAP and related authoritative pronouncements (including the effects of such adjustments pushed down to UK Holdco and the Restricted Subsidiaries), as a result of the Transactions, any acquisition consummated prior to the Closing Date, any Permitted Acquisitions or other investments permitted hereunder, or the amortization or write-off of any amounts thereof and (ii) effect shall not be given to (A) any election under Accounting Standards Codification 825-10-25 (previously referred to as Statement of Financial Accounting Standards 159) (or any other Accounting Standards Codification, International Accounting Standard or Financial Accounting Standard having a similar result or effect) to value any Indebtedness or other liabilities of UK Holdco or any Subsidiary at “fair value,” as defined therein, (B) any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification, International Accounting Standard or Financial Accounting Standard having a similar result or effect) to value any such Indebtedness in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full stated principal amount thereof or (C) the application of Accounting Standards Codification 480, 815, 805 and 718 (to the extent these pronouncements under Accounting Standards Codification 718 result in recording an equity award as a liability on the consolidated balance sheet of UK Holdco and its Restricted Subsidiaries in the circumstance where, but for the application of the pronouncements, such award would have been classified as equity). Any calculation or determination in this Agreement that requires the application of GAAP across multiple quarters need not be calculated or determined using the same accounting standard for each constituent quarter.
(ii)Notwithstanding anything to the contrary contained in this Agreement or in the definition of “Capitalized Lease Obligation”, unless the Borrower Representative elects otherwise, all obligations of any Person that are or would have been treated as operating leases for purposes of GAAP prior to the issuance by the Financial Accounting Standards Board on February 25, 2016 of an Accounting Standards Update (the “ASU”) shall continue to be accounted for as operating leases (and not be treated as financing or capital lease obligations or Indebtedness) for purposes of all financial definitions, calculations and deliverables under this Agreement or any other Loan Document (including the calculation of Consolidated Net Income and Consolidated EBITDA) (whether or not such operating lease obligations were in effect on such date) notwithstanding the fact that such obligations are required in accordance with
83
    



the ASU or any other change in accounting treatment or otherwise (on a prospective or retroactive basis or otherwise) to be treated as or to be re-characterized as financing or capital lease obligations or otherwise accounted for as liabilities in financial statements.
(iii)Interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a responsible financial or accounting officer of the Borrower Representative to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP. Interest on any Indebtedness under a revolving credit facility computed on a pro forma basis may be computed based upon the average daily balance of such Indebtedness during the applicable period. Interest on Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a eurocurrency interbank offered rate, or other rate, shall be deemed to have been based upon the rate actually chosen, or, if none, then based upon such optional rate chosen as the Borrower Representative may designate.
1.dLimited Condition Transactions Notwithstanding anything to the contrary herein (including in connection with any calculation that is made on a Pro Forma Basis), in connection with any action being taken in connection with a Limited Condition Transaction, for purposes of:
(i)determining compliance with any provision of this Agreement which (i) requires the calculation of any financial ratio or test (including the First Lien Net Leverage Ratio, Secured Net Leverage Ratio, Total Net Leverage Ratio and Interest Coverage Ratio), (ii) requires the absence of any Default or Event of Default (or any type of Default or Event of Default) and/or (iii) requires the accuracy of any representation or warranty; or
(ii)determining compliance with any basket or other condition set forth in this Agreement (including baskets measured as a percentage of Consolidated EBITDA);
in each case, at the option of the Borrower Representative (the Borrower Representative’s election to exercise such option in connection with any Limited Condition Transaction, a “LCT Election”), the date of determination of whether any such action is permitted hereunder shall be deemed to be (A) in the case of any acquisition or other Investment (including by way of merger, amalgamation or consolidation), any Asset Sale or any assumption or incurrence of Indebtedness or issuance of Preferred Stock or Disqualified Stock, or any transaction relating thereto, the date (or on the basis of the financial statements for the most recently ended Reference Period at the time) of entry into a binding letter of intent or the definitive agreements for such Limited Condition Transaction (or, solely in connection with an acquisition (including by way of merger, amalgamation or consolidation) to which the United Kingdom City Code on Takeovers and Mergers applies, the date on which a “Rule 2.7 Announcement” of a firm intention to make an offer is made), (B) in the case of any Restricted Debt Payment, at the time (or on the basis of the financial statements for the most recently ended Reference Period at the time) of delivery of notice with respect to such Restricted Debt Payment or (C) in the case of any other Restricted Payment, at the time (or on the basis of the financial statements for the most recently ended Reference Period at the time) of the declaration of such Restricted Payment (the applicable date determined pursuant to clause (A), (B) or (C), the “LCT Test Date”), and if, after giving effect to the Limited Condition Transaction and the other transactions to be entered into in connection therewith (including any incurrence of Indebtedness and the use of proceeds thereof) and, at the election of the Borrower Representative, any other Limited Condition Transaction that has not been consummated but with respect to which the Borrower Representative has made an LCT Election, on a Pro Forma Basis as if they had occurred at the beginning of the most recently completed Reference Period ending prior to the LCT Test Date, UK Holdco or the Restricted Subsidiaries would have been permitted to take such action on the relevant LCT Test Date in compliance with such ratio, test, basket or condition, such ratio, test, basket or condition shall be deemed to have been complied with. For the avoidance of doubt, if the Borrower Representative has made an LCT Election and any of the ratios, tests, baskets or conditions for which compliance was determined or tested as of the LCT Test Date are exceeded as a result of fluctuations in any such ratio, test, basket or condition, including due to fluctuations in Consolidated EBITDA at or prior to the consummation of the relevant transaction or action, such baskets, tests, ratios and conditions will not be deemed to have been exceeded as a result of such fluctuations. The provisions of this Section 1.4 shall also apply in respect of the incurrence of any Incremental Facility.
84
    



1.eCurrency Equivalents Generally.
(i)Any amount specified in this Agreement (other than in Sections 2, 3, 10 and 11 or as set forth in clause (b) of this Section) or any of the other Loan Documents to be in Dollars shall also include the equivalent of such amount in any currency other than Dollars, such equivalent amount to be determined at the rate of exchange quoted by the Reuters World Currency Page for the Alternative Currency at 11:00 a.m. (London time) on such day (or, in the event such rate does not appear on any Reuters World Currency Page, by reference to such other publicly available service for displaying exchange rates as may be agreed upon by the Administrative Agent and the Borrower Representative, or, in the absence of such agreement, such rate shall instead be the arithmetic average of the spot rates of exchange of the Administrative Agent in the market where its foreign currency exchange operations in respect of such currency are then being conducted, at or about 11:00 a.m. (New York City time) on such date for the purchase of Dollars for delivery two Business Days later); provided that the determination of any Dollar Amount shall be made in accordance with Section 2.29; provided that if any basket is exceeded solely as a result of fluctuations in applicable currency exchange rates after the last time such basket was utilized, such basket will not be deemed to have been exceeded solely as a result of such fluctuations in currency exchange rates.
(ii)For purposes of determining the First Lien Net Leverage Ratio, the Secured Net Leverage Ratio and the Total Net Leverage Ratio, amounts denominated in a currency other than Dollars will be converted to Dollars for the purposes of (A) testing the covenant set forth in Section 7.1, at the exchange rate used in preparing the applicable financial statements as of the last day of the fiscal quarter for which such measurement is being made and (B) otherwise, at the option of the Borrower Representative, the Exchange Rate as of the date of calculation or at the exchange rate used in preparing the applicable financial statements, and at the option of the Borrower Representative in each case will, in the case of Indebtedness, reflect the currency translation effects, determined in accordance with GAAP, of Swap Agreements permitted hereunder for currency exchange risks with respect to the applicable currency in effect on the date of determination of the Dollar Amount of such Indebtedness.
1.fChange in Currency.
(i)Each obligation of any Loan Party to make a payment denominated in the national currency unit of any member state of the European Union that adopts the Euro as its lawful currency after the Closing Date shall be redenominated into Euro at the time of such adoption (in accordance with the EMU Legislation). If, in relation to the currency of any such member state, the basis of accrual of interest expressed in this Agreement in respect of that currency shall be inconsistent with any convention or practice in the London interbank market for the basis of accrual of interest in respect of the Euro, such expressed basis shall be replaced by such convention or practice with effect from the date on which such member state adopts the Euro as its lawful currency; provided that if any Borrowing in the currency of such member state is outstanding immediately prior to such date, such replacement shall take effect, with respect to such Borrowing, at the end of the then current Interest Period.
(ii)Each provision of this Agreement shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify in consultation with the Borrower Representative to be appropriate to reflect the adoption of the Euro by any member state of the European Union and any relevant market conventions or practices relating to the Euro.
(iii)Each provision of this Agreement also shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify in consultation with the Borrower Representative to be appropriate to reflect a change in currency of any other country and any relevant market conventions or practices relating to the change in currency.
1.gLuxembourg Law Terms.
Without prejudice to the generality of any provision of this Agreement, in this Agreement where it relates to a Luxembourg Loan Party, a reference to: (a) a winding-up, administration or dissolution includes, without limitation, bankruptcy (faillite), insolvency, voluntary and judicial liquidation (liquidation volontaire et judiciare), composition with creditors (concordat préventif de la
85
    



faillite), moratorium or reprieve from payment (sursis de paiement), controlled management (gestion contrôlée), or fraudulent conveyance (action paulienne), general settlement with creditors, reorganization or similar laws affecting the rights of creditors generally; (b) a receiver, administrative receiver, administrator, trustee, custodian, sequestrator, conservator or similar officer includes, without limitation, a juge délégué, commissaire, juge-commissaire, mandatair ad hoc, administrateur, proviso ire, liquidateur or curateur; (c) a lien or security interest includes any hypothèque, nantissement, gage, privilège, sûreté réelle, droit de rétention, and any type of security in rem (sûreté réelle) or agreement or arrangement having a similar effect and any transfer of title by way of security; (d) a person being unable to pay its debts includes that person being in a state of cessation de paiements; (e) creditors process means an executory attachment (saisie exécutoire) or conservatory attachment (saisie conservatoire); (f) a guarantee includes any garantie which is independent from the debt to which it relates and excludes any suretyship (cautionnement) within the meaning of Articles 2011 and seq. of the Luxembourg Civil Code; (g) by-laws or constitutional documents includes its up-to-date (restated) articles of association (statuts coordonnés) and (h) a director or a manager includes an administrateur and a gérant.
1.hForeign Guarantor Provisions. This Agreement and all of the other Loan Documents shall be subject in all respects to the Foreign Guarantor Provisions set forth in Schedule 1.8 (as may be supplemented pursuant to Section 11.1 or as otherwise agreed to by the Administrative Agent).
1.iCertain Calculations.
(i)For purposes of determining the permissibility of any action, change, transaction or event that requires a calculation of any financial ratio or financial test (including Section 7.1 hereof, any First Lien Net Leverage Ratio test, any Secured Net Leverage Ratio test, any Total Net Leverage Ratio test and/or any Interest Coverage Ratio test) and/or the amount of Consolidated EBITDA or Consolidated Net Income, and irrespective of any use of the expression “at any one time outstanding” (or any similar expression), such financial ratio, financial test or amount shall, subject to Section 1.4, be calculated at the time such action is taken, such change is made, such transaction is consummated or such event occurs, as the case may be, and no Default or Event of Default shall be deemed to have occurred solely as a result of a change in such financial ratio, financial test or amount occurring after the time such action is taken, such change is made, such transaction is consummated or such event occurs, as the case may be.
(ii)Notwithstanding anything to the contrary herein, unless the Borrower Representative otherwise notifies the Administrative Agent, with respect to any amount incurred or transaction entered into (or consummated) in reliance on a provision of this Agreement that does not require compliance with a financial ratio or financial test (including any First Lien Net Leverage Ratio test, any Secured Net Leverage Ratio test, any Total Net Leverage Ratio test and/or any Interest Coverage Ratio test) (any such amount, including any amount drawn under the Revolving Facility or any other permitted revolving facility and any cap expressed as a percentage of Consolidated Net Income or Consolidated EBITDA, a “Fixed Amount”) substantially concurrently with any amount Incurred or transaction entered into (or consummated) in reliance on a provision of this Agreement that requires compliance with a financial ratio or financial test (including any First Lien Net Leverage Ratio test, any Secured Net Leverage Ratio test, any Total Net Leverage Ratio test and/or any Interest Coverage Ratio test) (any such amount, an “Incurrence-Based Amount”), it is understood and agreed that (i) the incurrence of the Incurrence-Based Amount shall be calculated first without giving effect to any Fixed Amount but giving full pro forma effect to the use of proceeds of such Fixed Amount and the related transactions and (ii) the incurrence of the Fixed Amount shall be calculated thereafter. Unless the Borrower Representative elects otherwise, the Borrowers shall be deemed to have used amounts under an Incurrence-Based Amount then available to the Borrowers prior to utilization of any amount under a Fixed Amount then available to the Borrowers.
(iii)For purposes of determining compliance at any time with Sections 7.2, 7.3, 7.5 and 7.7, in the event that any Indebtedness, Preferred Stock, Disqualified Stock, Lien, Restricted Payment, Investment or disposition or portion thereof, as applicable, at any time meets the criteria of more than one of the categories of transactions or items permitted pursuant to any clause of such Sections 7.2 (other than Section 7.2(b)(i) in the case of Indebtedness incurred on the Closing Date), 7.3, 7.5 or 7.7 (other than pursuant to clause (6) of the definition of “Permitted Liens” as it relates to Section 7.2(b)(i) and clause (7)(i) of the definition of “Permitted Liens”) (each of the foregoing, including the categories and items set
86
    



forth in component definitions thereof, a “Reclassifiable Item”), the Borrower Representative, in its sole discretion, may, from time to time, divide, classify or reclassify such Reclassifiable Item (or portion thereof) under one or more clauses (or component definitions) of each such Section and will only be required to include such Reclassifiable Item (or portion thereof) in any one category; provided that, upon delivery of any financial statements pursuant to Section 6.1(a) or (b) following the initial incurrence or making of any such Reclassifiable Item, if such Reclassifiable Item could, based on such financial statements, have been incurred or made in reliance on any “ratio-based” basket or exception, such Reclassifiable Item shall automatically be reclassified as having been incurred or made under such “ratio-based” basket or exception (in each case, subject to any other applicable provision of such “ratio-based” basket or exception); provided, further, that Indebtedness shall be reclassified only to the extent that any Lien in respect thereof would be permitted after such reclassification and any concurrent reclassification of such Lien. It is understood and agreed that any Indebtedness, Preferred Stock, Disqualified Stock, Lien, Restricted Payment, Investment, disposition and/or Affiliate Transaction need not be permitted solely by reference to one category under the applicable covenant, but may instead be permitted in part under any combination thereof or under any other available exception.
(iv)Notwithstanding anything to the contrary herein, but subject to Sections 1.4 and 1.9(a) and (c), all financial ratios and tests (including the Total Net Leverage Ratio, the First Lien Net Leverage Ratio, the Secured Net Leverage Ratio and the Interest Coverage Ratio) and the amount of Consolidated Net Income and Consolidated EBITDA (other than, for the avoidance of doubt, for purposes of calculating Excess Cash Flow) contained in this Agreement that are calculated with respect to any Reference Period shall be calculated with respect to such Reference Period on a Pro Forma Basis.
(v)For purposes of determining compliance with Section 7.2 or Section 7.7, if any Indebtedness, Preferred Stock, Disqualified Stock or Lien is created or Incurred in reliance on a basket measured by reference to a percentage of Consolidated EBITDA, and any refinancing or replacement thereof would cause the percentage of Consolidated EBITDA to be exceeded if calculated based on the Consolidated EBITDA on the date of such refinancing or replacement, such percentage of Consolidated EBITDA will be deemed not to be exceeded so long as the principal amount of such refinancing or replacement Indebtedness, Preferred Stock, Disqualified Stock or other obligation does not exceed an amount sufficient to repay the principal amount of such Indebtedness, Preferred Stock, Disqualified Stock or other obligation being refinanced or replaced, except by an amount equal to (x) the amount necessary to pay accrued and unpaid interest, fees, underwriting discounts and expenses, including any premium and defeasance costs Incurred in connection with such refinancing or replacement, (y) any existing commitments unutilized thereunder and (z) additional amounts permitted to be Incurred under Section 7.2.
1.jDelaware LLC Divisions. For all purposes under the Loan Documents, in connection with any Delaware LLC Division: (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a Delaware Divided LLC, then it shall be deemed to have been transferred from the original Person to the Delaware Divided LLC, and (b) if a Delaware Divided LLC comes into existence, such Delaware Divided LLC shall be deemed to have been organized on the first date of its existence by the holders of its Equity Interests at such time.
1.kInterest Rates. The Administrative Agent does not warrant, nor accept responsibility, nor shall the Administrative Agent have any liability with respect to the administration, submission or any other matter related to any reference rate referred to herein or with respect to any rate (including, for the avoidance of doubt, the selection  of such rate and any related spread or other adjustment) that is an alternative or replacement for or successor to any such rate (including, without limitation, any Term Loan Successor Rate or Revolving Facility Term SOFR Successor Rate) (or any component of any of the foregoing) or the effect of any of the foregoing, or of any Conforming Changes. The Administrative Agent and its affiliates or other related entities may engage in transactions or other activities that affect any reference rate referred to herein, or any alternative, successor or replacement rate (including, without limitation, any Term Loan Successor Rate or Revolving Facility Term SOFR Successor Rate) (or any component of any of the foregoing) or any related spread or other adjustments thereto, in each case, in a manner adverse to any Borrower.  The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any reference rate referred to herein or any alternative, successor or replacement rate (including, without limitation, any Term Loan Successor Rate or Revolving Facility
87
    



Term SOFR Successor Rate) (or any component of any of the foregoing), in each case pursuant to the terms of this Agreement, and shall have no liability to any Borrower, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or other action or omission related to or affecting the selection, determination, or calculation of any rate (or component thereof) provided by any such information source or service.
SECTION 2.
AMOUNT AND TERMS OF COMMITMENTS
2.aTerm Commitments. (i) Subject to the terms and conditions hereof, each Term Lender (other than the Amendment No. 1 Incremental Term Lenders and the Amendment No. 2 Incremental Term Lenders) severally agrees to make a single Term Loan to the Term Borrowers on the Closing Date in Dollars and in an amount not to exceed the amount of the Term Commitment of such Lender on the Closing Date, (ii) subject to the terms and conditions set forth in the Amendment No. 1 Incremental Facility Amendment, each Amendment No. 1 Incremental Term Lender severally agrees to make a single Term Loan to the Incremental Borrowers (as defined in the Amendment No. 1 Incremental Facility Amendment) on the Amendment No. 1 Effective Date in Dollars and in an amount not to exceed the amount of the Amendment No. 1 Incremental Term Commitment of such Amendment No. 1 Incremental Term Lender on the Amendment No. 1 Effective Date and (iii) subject to the terms and conditions set forth in the Amendment No. 2 Incremental Facility Amendment, each Amendment No. 2 Incremental Term Lender severally agrees to make a single Amendment No. 2 Incremental Term Loan to the Incremental Borrowers (as defined in the Amendment No. 2 Incremental Facility Amendment) on the Amendment No. 2 Effective Date in Dollars and in an amount not to exceed the amount of the Amendment No. 2 Incremental Term Commitment of such Amendment No. 2 Incremental Term Lender on the Amendment No. 2 Effective Date. Term Loans may from time to time be Eurocurrency Loans or ABR Loans, as determined by the Borrower Representative and notified to the Administrative Agent in accordance with Sections 2.2 and 2.12. The Term Borrowing on the Closing Date shall consist of Term Loans made simultaneously by the Term Lenders in accordance with their respective Term Commitments. The Term Commitments (excluding any Incremental Term Commitments or Other Term Commitments) shall automatically terminate at 11:59 p.m. (New York City time) on the Closing Date. The Amendment No. 1 Incremental Term Commitments shall automatically terminate at 11:59 p.m. (New York City time) on the Amendment No. 1 Effective Date. The Amendment No. 2 Incremental Term Commitments shall automatically terminate at 11:59 p.m. (New York City time) on the Amendment No. 2 Effective Date. Amounts borrowed under this Section 2.1 and repaid or prepaid may not be reborrowed.
2.bProcedure for Borrowing Term Loans. The Borrower Representative (on behalf of the Borrowers under any Term Facility) shall give the Administrative Agent irrevocable notice, substantially in the form of Exhibit H or such other form as may be approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative (which notice must be received by the Administrative Agent no later than (A) 11:00 a.m. (New York City time), one Business Day prior to the anticipated Closing Date and the Amendment No. 1 Effective Date, as applicable, and two Business Days (or such shorter period as may be agreed by the Administrative Agent) prior to the anticipated Amendment No. 2 Effective Date, as applicable, (which shall be a Business Day), in the case of ABR Loans and (B) 11:00 a.m. (New York City time), three Business Days prior to the anticipated Closing Date, Amendment No. 1 Effective Date or Amendment No. 2 Effective Date, as applicable, in the case of Eurocurrency Loans, in each case or such shorter period as the Administrative Agent shall agree) requesting that the Initial Term Lenders make the Closing Date Term Loans on the Closing Date, that the Amendment No. 1 Incremental Term Lenders make the Amendment No. 1 Incremental Term Loans on the Amendment No. 1 Effective Date or that the Amendment No. 2 Incremental Term Lenders make the Amendment No. 2 Incremental Term Loans on the Amendment No. 2 Effective Date, as applicable, and specifying (i) the amount to be borrowed, (ii) the Type of Loans, (iii) the applicable Interest Period, and (iv) instructions for remittance of the Term Loans to be borrowed. If the Borrower fails to specify the Type of Closing Date Term Loans, Amendment No. 1 Incremental Term Loans or Amendment No. 2 Incremental Term Loans, as applicable, they shall be made as ABR Loans. Notwithstanding the foregoing, such notices may be conditioned on the occurrence of the Closing Date, the Amendment No. 1 Effective Date or the Amendment No. 2 Effective Date, as
88
    



applicable, or, with respect to Incremental Term Loans, may be conditioned on the occurrence of any transaction utilizing such Incremental Term Loans. Upon receipt of such notice the Administrative Agent shall promptly notify each Term Lender thereof. Not later than 1:00 p.m. (New York City time) on the Closing Date, the Amendment No. 1 Effective Date or the Amendment No. 2 Effective Date, as applicable, each such Term Lender shall make available to the Administrative Agent at the Administrative Agent’s Office an amount in immediately available funds equal to the Term Loan or Term Loans to be made by such Lender. Such borrowing will then be made available to the Term Borrowers by the Administrative Agent crediting such account or by wire transfer as is designated in writing to the Administrative Agent by the Borrower Representative (or as otherwise directed by the Borrower Representative), with the aggregate of the amounts made available to the Administrative Agent by the Term Lenders and in like funds as received by the Administrative Agent.
2.cRepayment of Term Loans.
(i)The principal amount of the Initial Term Loans of each Initial Term Lender shall be repaid by the Term Borrowers (i) on the last Business Day of each March, June, September and December (commencing on March 31, 2020), in an amount equal to 0.25% of the aggregate Outstanding Amount of the Initial Term Loans (including the Amendment No. 1 Incremental Term Loans) on the Amendment No. 1 Effective Date (which payments shall be reduced as a result of the application of prepayments in accordance with the order of priority set forth in Section 2.17(b)) and (ii) on the Term Loan Maturity Date, in an amount equal to the aggregate Outstanding Amount on such date, together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment.
(ii)The principal amount of the Amendment No. 2 Incremental Term Loans of each Amendment No. 2 Incremental Term Lender shall be repaid by the Term Borrowers (i) on the last Business Day of each March, June, September and December (commencing on March 31, 2021), in an amount equal to 0.25% of the aggregate Outstanding Amount of the Amendment No. 2 Incremental Term Loans on the Amendment No. 2 Effective Date (which payments shall be reduced as a result of the application of prepayments in accordance with the order of priority set forth in Section 2.17(b)) and (ii) on the Term Loan Maturity Date, in an amount equal to the aggregate Outstanding Amount on such date, together in each case with accrued and unpaid interest on the principal amount to be paid to but excluding the date of such payment.
(iii)To the extent not previously paid, (i) each Incremental Term Loan shall be due and payable on the Incremental Term Loan Maturity Date applicable to such Incremental Term Loan, (ii) each Other Term Loan shall be due and payable on the maturity date thereof as set forth in the Refinancing Amendment applicable thereto and (iii) each Extended Term Loan shall be due and payable on the maturity date thereof as set forth in the Permitted Amendment applicable thereto together, in each case, with accrued and unpaid interest on the principal amount to be paid to but excluding the date of payment.
(iv)The Obligations of the Term Borrowers as Borrowers of the Term Loans, whether on account of principal, interest, fees or otherwise, are joint and several.
(v)For the avoidance of doubt, effective as of the Amendment No. 1 Effective Date, (i) the Amendment No. 1 Incremental Term Loans made on the Amendment No. 1 Effective Date in accordance with the Amendment No. 1 Incremental Facility Amendment shall constitute for all purposes of this Agreement, a Term Loan made pursuant to this Agreement; provided that, pursuant to the Amendment No. 1 Incremental Facility Amendment, the Amendment No. 1 Incremental Term Loans shall constitute “Initial Term Loans” for all purposes of this Agreement and all provisions of this Agreement applicable to Initial Term Loans shall be applicable to the Amendment No. 1 Incremental Term Loans, (ii) the Amendment No. 1 Incremental Term Commitment shall constitute a “Term Commitment” for all purposes of this Agreement, and all provisions of this Agreement applicable to Term Commitments shall be applicable to the Amendment No. 1 Incremental Term Commitments and (iii) the Closing Date Term Loans and the Amendment No. 1 Incremental Term Loans (X) shall constitute Term Loans of the same Class for all purposes of this Agreement, (Y) shall mature and shall become due and payable on the Term Loan Maturity Date and (Z) shall be repaid in quarterly installments in accordance with Section 2.3(a).
89
    



(vi)For the avoidance of doubt, effective as of the Amendment No. 2 Effective Date, (i) the Amendment No. 2 Incremental Term Loans made on the Amendment No. 2 Effective Date in accordance with the Amendment No. 2 Incremental Facility Amendment shall constitute for all purposes of this Agreement, Term Loans made pursuant to this Agreement, (ii) the Amendment No. 2 Incremental Term Commitments shall constitute “Term Commitments” for all purposes of this Agreement, and all provisions of this Agreement applicable to Term Commitments shall be applicable to the Amendment No. 2 Incremental Term Commitments and (iii) the Amendment No. 2 Incremental Term Loans (X) shall mature and shall become due and payable on the Term Loan Maturity Date and (Y) shall be repaid in quarterly installments in accordance with Section 2.3(b).
2.dRevolving Commitments.
(i)Subject to the terms and conditions hereof, each Revolving Lender severally agrees to make revolving credit loans (“Revolving Loans”) to the Revolving Borrowers in Dollars or in one or more Alternative Currencies from time to time on any Business Day during the Revolving Commitment Period in an aggregate principal amount which, when added to such Lender’s Revolving Percentage of the sum of (i) the aggregate Outstanding Amount of L/C Obligations at such time and (ii) the aggregate Outstanding Amount of the Swingline Loans at such time, does not exceed the amount of such Lender’s Revolving Commitment. During the Revolving Commitment Period the Revolving Borrowers may use the Revolving Commitments by borrowing, repaying or prepaying the Revolving Loans in whole or in part, and reborrowing, all in accordance with the terms and conditions hereof. The Revolving Loans (other than Revolving Loans denominated in Dollars or Sterling) may from time to time be Eurocurrency Loans or, with respect to Revolving Loans denominated in Dollars, Term SOFR Loans or ABR Loans, as determined by the applicable Revolving Borrower and notified to the Administrative Agent in accordance with Sections 2.5 and 2.12. Revolving Loans denominated in Sterling shall be Sterling Daily Rate Loans.
(ii)The Revolving Borrowers shall repay all outstanding Revolving Loans on the Revolving Termination Date, together with accrued and unpaid interest on the Revolving Loans, to but excluding the date of payment.
2.eProcedure for Borrowing of Revolving Loans. The Revolving Borrowers may borrow under the Revolving Commitments during the Revolving Commitment Period on any Business Day, provided that the Borrower Representative (on behalf of the Revolving Borrowers) shall give the Administrative Agent irrevocable notice (which notice must be received by the Administrative Agent prior to (a) 1:00 p.m. (New York City time), three Business Days prior to the requested Borrowing Date, in the case of Term SOFR Loans, Eurocurrency Loans denominated in Euros and Sterling Daily Rate Loans denominated in Sterling or 1:00 p.m. (New York City time), four Business Days prior to the requested Borrowing Date, in the case of Eurocurrency Loans denominated in Australian Dollars, or (b) 10:00 a.m. (New York City time), on the requested Borrowing Date, in the case of ABR Loans), specifying (i) the amount and Type of Revolving Loans to be borrowed, (ii) the currency in which the Revolving Loans to be borrowed are to be denominated, (iii) the requested Borrowing Date, (iv) in the case of Eurocurrency Loans or Term SOFR Loans, the respective amounts of each such Type of Loan and the respective lengths of the initial Interest Period therefor and (v) instructions for remittance of the applicable Loans to be borrowed; provided, however, that if the Borrower Representative (on behalf of the Revolving Borrowers) wishes to request (x) Eurocurrency Loans having an Interest Period other than one, two, three or six months in duration as provided in the definition of “Interest Period” or (y) Term SOFR Loans having an Interest Period other than one, three or six months in duration as provided in the definition of “Interest Period,” the applicable notice must be received by the Administrative Agent not later than 11:00 a.m. (New York City time) seven Business Days prior to the requested date of such Borrowing, whereupon the Administrative Agent shall give prompt notice to the Lenders of such request and determine whether the requested Interest Period is acceptable to all of them. Not later than 11:00 a.m. (New York City time) four Business Days before the requested date of such Borrowing, in the case of Term SOFR Loans or Eurocurrency Loans denominated in Euros, or five Business Days before the requested date of such Borrowing, in the case of Eurocurrency Loans denominated in Australian Dollars, the Administrative Agent shall notify the Borrower Representative (on behalf of the Revolving Borrowers) (which notice may be by telephone) whether or not the requested Interest Period has been consented to by all the Lenders. Each borrowing under the Revolving Commitments shall be in an amount equal to (x) in the case of ABR Loans, $1,000,000 or a whole multiple of $500,000 in excess
90
    



thereof and (y) in the case of Eurocurrency Loans, Term SOFR Loans or Sterling Daily Rate Loans, as applicable, (1) if denominated in Dollars, $1,000,000 or a whole multiple of $500,000 in excess thereof, (2) if denominated in Euros, €1,000,000 or a whole multiple of €500,000 in excess thereof, (3) if denominated in Sterling, £500,000 or a whole multiple of £250,000 in excess thereof or (4) if denominated in Australian Dollars, A$1,000,000 or a whole multiple of A$500,000 in excess thereof (or, if the then aggregate Available Revolving Commitments of the Lenders are less than the Dollar Amount of any of the foregoing, such lesser amount); provided that the Swingline Lender may request, on behalf of the Revolving Borrowers, borrowings under the Revolving Commitments that are ABR Loans in other amounts pursuant to Section 2.7. Upon receipt of any such notice from the Borrower Representative, the Administrative Agent shall promptly notify each Revolving Lender thereof. Each Revolving Lender will make the amount of its pro rata share of each borrowing available to the Administrative Agent at the Administrative Agent’s Office for the applicable currency for the account of the Revolving Borrower designated in the applicable notice of Borrowing prior to 1:00 p.m. (New York City time) for Borrowings denominated in Dollars and prior to 8:00 a.m. (New York City time) for Borrowings denominated in an Alternative Currency on the Borrowing Date requested by the applicable Revolving Borrower in funds immediately available to the Administrative Agent. Such borrowing will then be made available to the applicable Revolving Borrower by the Administrative Agent crediting such account or by wire transfer as is designated in writing to the Administrative Agent by the Borrower Representative (on behalf of the applicable Revolving Borrower), with the aggregate of the amounts made available to the Administrative Agent by the Revolving Lenders and in like funds as received by the Administrative Agent.
2.fSwingline Commitment.
(i)Subject to the terms and conditions hereof and in reliance upon the agreements of the other Lenders set forth in this Section 2.6, the Swingline Lender agrees to make a portion of the credit otherwise available to the Revolving Borrowers under the Revolving Commitments from time to time during the Revolving Commitment Period by making swingline loans in Dollars (“Swingline Loans”) to the Revolving Borrowers; provided that (i) the aggregate Outstanding Amount of Swingline Loans at any time shall not exceed the Swingline Commitment then in effect (notwithstanding that the aggregate Outstanding Amount of Swingline Loans at any time, when aggregated with the Outstanding Amount of the Swingline Lender’s other Revolving Loans, may exceed the Swingline Commitment then in effect), (ii) the Revolving Borrowers shall not request, and the Swingline Lender shall not make, any Swingline Loan if, after giving effect to the making of such Swingline Loan, the aggregate amount of the Available Revolving Commitments of the Lenders would be less than zero and (iii) no Revolving Borrower shall use the proceeds of any Swingline Loan to refinance any outstanding Swingline Loan (whether borrowed by it or another Revolving Borrower). During the Revolving Commitment Period, the Revolving Borrowers may use the Swingline Commitment by borrowing, repaying and reborrowing, all in accordance with the terms and conditions hereof. Swingline Loans shall be ABR Loans only. Immediately upon the making of a Swingline Loan, each Revolving Lender shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from the Swingline Lender a risk participation in such Swingline Loan (each a “Swingline Participation”) in an amount equal to the product of such Revolving Lender’s Revolving Percentage of such Swingline Loan.
(ii)The Revolving Borrowers shall repay to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earliest to occur of (i) the date ten Business Days after such Loan is made and (ii) the Revolving Termination Date.
2.gProcedure for Swingline Borrowing; Refunding of Swingline Loans.
(i)Swingline Borrowings. Whenever a Revolving Borrower desires that the Swingline Lender make a Swingline Loan, the Borrower Representative (on behalf of the applicable Revolving Borrower) shall give the Swingline Lender irrevocable facsimile notice (which facsimile notice must be received by the Swingline Lender not later than 1:00 p.m. (New York City time) on the proposed Borrowing Date) confirmed promptly in writing substantially in the form of Exhibit L or such other form as approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent) (a “Swingline Loan Notice”), appropriately completed and signed by a Responsible Officer of the Borrower Representative, specifying (i) the amount to be borrowed and (ii) the requested Borrowing Date (which shall be a Business Day
91
    



during the Revolving Commitment Period). Promptly after receipt by the Swingline Lender of any Swingline Loan Notice, the Swingline Lender will confirm with the Administrative Agent (by telephone or in writing) that the Administrative Agent has also received such Swingline Loan Notice and, if not, the Swingline Lender will notify the Administrative Agent (by telephone or in writing) of the contents thereof. Each borrowing under the Swingline Commitment shall be in an amount equal to $1,000,000 or a whole multiple of $500,000 in excess thereof. Unless the Swingline Lender has received notice (by telephone or in writing) from the Administrative Agent (including at the request of any Revolving Lender) prior to 2:00 p.m. on the date of the proposed Swingline Borrowing (A) directing the Swingline Lender not to make such Swingline Loan as a result of the limitations set forth in the first proviso to the first sentence of Section 2.6(a), or (B) that one or more of the applicable conditions specified in Section 5.2 is not then satisfied, then, subject to the terms and conditions hereof, the Swingline Lender will, not later than 3:00 p.m. on the borrowing date specified in such Swingline Loan Notice, make the amount of its Swingline Loan available to the Borrower Representative (or the applicable Revolving Borrower specified in the notice of Borrowing) in an amount in immediately available funds equal to the amount of the Swingline Loan to be made by the Swingline Lender by crediting such account on the books of the Swingline Lender in immediately available funds or by wire transfer as is designated in writing to the Swingline Lender by the Borrower Representative
(ii)Refinancing of Swingline Loans.
(1)The Swingline Lender at any time in its sole and absolute discretion may request, on behalf of the Borrower Representative (which hereby irrevocably authorizes the Swingline Lender to so request on its behalf), that each Revolving Lender make an ABR Revolving Loan to the Borrower Representative in an amount equal to such Revolving Lender’s Revolving Percentage of the amount of all Swingline Loans then outstanding. Such request shall be made in writing (which written request shall be deemed to be a Borrowing Request for purposes hereof) and in accordance with the requirements of Section 2.4, without regard to the minimum and multiples specified therein for the principal amount of ABR Loans, but subject to the unutilized portion of the Revolving Commitments and the conditions set forth in Section 5.2. The Swingline Lender shall furnish the Borrower Representative with a copy of the applicable Borrowing Request promptly after delivering such notice to the Administrative Agent. Each Revolving Lender shall make an amount equal to its Revolving Percentage of the amount specified in such Borrowing Request available to the Administrative Agent in immediately available funds (and the Administrative Agent may apply Cash Collateral available with respect to the applicable Swingline Loan) for the account of the Swingline Lender at the Administrative Agent’s office not later than 1:00 p.m. on the day specified in such Borrowing Request, whereupon, subject to Section 2.7(b)(ii), each Revolving Lender that so makes funds available shall be deemed to have made an ABR Loan to the applicable Borrower in such amount. The Administrative Agent shall remit the funds so received to the Swingline Lender.
(2)If for any reason the Swingline Loan cannot be refinanced by such a Revolving Loan in accordance with Section 2.7(b)(i), the request for ABR Loans submitted by the Swingline Lender as set forth herein shall be deemed to be a request by the Swingline Lender that each of the Revolving Lenders fund its Swingline Participation in the relevant Swingline Loans, and each Revolving Lender’s payment to the Administrative Agent for the account of the Swingline Lender pursuant to Section 2.7(b)(i) shall be deemed payment in respect of each such Revolving Lender’s Swingline Participations in the Outstanding Amount of all Swingline Loans.
(3)If any Revolving Lender fails to make available to the Administrative Agent for the account of the Swingline Lender any amount required to be paid by such Lender pursuant to the foregoing provisions of this Section 2.7(b) by the time specified in Section 2.7(b)(i), the Swingline Lender shall be entitled to recover from such Lender (acting through the Administrative Agent), on demand, such amount with interest thereon for the period from the date such payment is required to the date on which such payment is immediately available to the Swingline Lender at a rate per annum equal to the greater of the Federal Funds Rate and a rate determined by the Swingline Lender in accordance with banking industry rules on interbank compensation, plus any administrative, processing or similar fees customarily charged by the Swingline Lender in connection with the foregoing. If such Lender pays such amount (with interest and fees as aforesaid), the amount so paid shall constitute such Lender’s Revolving Loan included in the relevant Revolving Loan or funded Swingline Participation in the
92
    



relevant Swingline Loan, as the case may be. A certificate of the Swingline Lender submitted to any Lender (through the Administrative Agent) with respect to any amounts owing under this clause (iii) shall be conclusive absent manifest error.
(4)Each Revolving Lender’s obligation to make Revolving Loans or to purchase and fund its Swingline Participations in Swingline Loans pursuant to this Section 2.7(b) shall be absolute and unconditional and shall not be affected by any circumstance, including (A) any setoff, counterclaim, recoupment, defense or other right which such Lender may have against the Swingline Lender, any Borrower or any other Person for any reason whatsoever, (B) the occurrence or continuance of a Default, or (C) any other occurrence, event or condition, whether or not similar to any of the foregoing; provided, however, that each Revolving Lender’s obligation to make Revolving Loans pursuant to this Section 2.7(b) is subject to the conditions set forth in Section 5.2. No such funding of Swingline Participations shall relieve or otherwise impair the obligation of the applicable Borrower to repay Swingline Loans, together with interest as provided herein.
(iii)Repayment of Swingline Participations.
(1)At any time after any Revolving Lender has purchased and funded its Swingline Participations in one or more Swingline Loans, if the Swingline Lender receives any payment on account of such Swingline Loan, the Swingline Lender will distribute to such Revolving Lender its Revolving Percentage thereof in the same funds as those received by the Swingline Lender.
(2)If any payment received by the Swingline Lender in respect of principal or interest on any Swingline Loan is required to be returned by the Swingline Lender (including pursuant to any settlement entered into by the Swingline Lender in its discretion), each Revolving Lender shall pay to the Swingline Lender its Revolving Percentage thereof on demand of the Administrative Agent, plus interest thereon from the date of such demand to the date such amount is returned, at a rate per annum equal to the Federal Funds Rate. The Administrative Agent will make such demand upon the request of the Swingline Lender. The obligations of the Lenders under this clause shall survive the payment in full of the Obligations and the termination of this Agreement.
(iv)Interest for the Account of the Swingline Lender. The Swingline Lender shall be responsible for invoicing the Borrowers for interest on the Swingline Loans. Until each Revolving Lender funds its Revolving Loan or risk participation pursuant to this Section 2.7 to fund its Swingline Participations, interest in respect of such Revolving Percentage shall be solely for the account of the Swingline Lender.
(v)Payments Directly to the Swingline Lender. The Borrowers shall make all payments of principal and interest in respect of the Swingline Loans directly to the Swingline Lender.
(vi)Revolving Defaulting Lenders. Notwithstanding anything to the contrary contained in Sections 2.6 and 2.7 or elsewhere in this Agreement, (i) the Swingline Lender shall not be obligated to make any Swingline Loan at a time when a Revolving Lender is a Defaulting Lender unless the Swingline Lender has entered into arrangements reasonably satisfactory to it and the Borrower Representative to eliminate the Swingline Lender’s risk with respect to the Defaulting Lender’s or Defaulting Lenders’ participation in such Swingline Loans, including by cash collateralizing such Defaulting Lender’s or Defaulting Lenders’ Pro Rata Share of the aggregate Outstanding Amount of Swingline Loans at such time and (ii) the Swingline Lender shall not make any Swingline Loan after it has received written notice from any Borrower, any other Loan Party or the Required Lenders stating that a Default or an Event of Default exists and is continuing until such time as the Swingline Lender shall have received written notice (A) of rescission of all such notices from the party or parties originally delivering such notice or notices or (B) of the waiver of such Default or Event of Default in accordance with Section 11.1.
2.hCommitment Fees, etc.
(i)The Revolving Borrowers agree to pay to the Administrative Agent for the account of each Revolving Lender, in accordance with its Revolving Percentage, a commitment fee (the “Commitment Fee”) equal to the Commitment Fee Rate times the actual daily unutilized amount of the
93
    



Total Revolving Commitments, subject to adjustment as provided in Section 2.25. The Commitment Fee shall accrue at all times during the Revolving Commitment Period, including at any time during which one or more of the conditions in Section 5 is not satisfied, and shall be due and payable in arrears on each applicable Fee Payment Date. The Commitment Fee shall be calculated quarterly in arrears, and if there is any change in the Commitment Fee Rate during any quarter, the actual daily amount shall be computed and multiplied by the Commitment Fee Rate separately for each period during such quarter that such Commitment Fee Rate was in effect.
(ii)The Borrowers agree to pay to the Administrative Agent, the Joint Lead Arrangers (and their respective affiliates) and the Incremental Facility Arrangers (and their respective affiliates) the fees in the amounts and on the dates set forth in any fee agreements (including the Fee Letter) with such Persons and to perform any other obligations contained therein.
2.iTermination or Reduction of Revolving Commitments. The Borrower Representative (on behalf of the Revolving Borrowers) shall have the right, upon not less than two Business Days’ notice (to the extent there are no Revolving Loans outstanding at such time) or not less than three Business Days’ notice (in any other case) to the Administrative Agent, to terminate the Revolving Commitments or, from time to time, to reduce the amount of the Revolving Commitments. Any termination or reduction of Revolving Commitments pursuant to this Section 2.9 shall be accompanied by prepayment of the Revolving Loans and/or Swingline Loans to the extent, if any, that the Total Revolving Extensions of Credit exceed the amount of the Total Revolving Commitments as so reduced; provided that if the aggregate Outstanding Amount of Revolving Loans and Swingline Loans at such time is less than the amount of such excess (because L/C Obligations constitute a portion thereof), the Borrower Representative shall, to the extent of the balance of such excess, Collateralize outstanding Letters of Credit, in each case, in a manner reasonably satisfactory to the Administrative Agent. Any such reduction shall be in an amount equal to $1,000,000 or a whole multiple thereof or, if less than $1,000,000, the amount of the Revolving Commitments, or a whole multiple thereof, and shall reduce permanently the Revolving Commitments then in effect; provided, further, that if any such notice of termination of the Revolving Commitments indicates that such termination is to be made in connection with a Refinancing of the Facilities or in connection with the consummation of any other event, such notice of termination may be revoked if such Refinancing or other event is not consummated and any Term SOFR Loan that was the subject of such notice shall be continued as an ABR Loan. Each prepayment of the Loans under this Section 2.9 (except in the case of Revolving Loans that are ABR Loans (to the extent all Revolving Loans are not being prepaid) and Swingline Loans) shall be accompanied by accrued interest to the date of such prepayment on the amount prepaid.
2.jOptional Prepayments.
(i)The Borrowers may at any time and from time to time prepay the Loans, in whole or in part, in each case, without premium or penalty, upon irrevocable notice, substantially in the form of Exhibit E or such other form as may be approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative (on behalf of the Borrowers), which notice must be received by the Administrative Agent (i) no later than 1:00 p.m. (New York City time) three Business Days prior to the prepayment date, in the case of Term SOFR Loans, Eurocurrency Loans denominated in Euros or Sterling Daily Rate Loans, (ii) no later than 1:00 p.m. (New York City time) four Business Days prior to the prepayment date, in the case of Eurocurrency Loans denominated in Australian Dollars, and (iii) no later than 1:00 p.m. (New York City time) on the prepayment date, in the case of ABR Loans; provided that if a Eurocurrency Loan is prepaid on any day other than the last day of the Interest Period applicable thereto, the Borrowers shall also pay any amounts owing pursuant to Section 2.21; provided, further, that if such notice of prepayment indicates that such prepayment is to be funded with the proceeds of a Refinancing of the Facilities or is conditioned upon the consummation of any other transaction or event, such notice of prepayment may be revoked if such Refinancing or other transaction or event is not consummated and any Term SOFR Loan that was the subject of such notice shall be continued as an ABR Loan. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. If any such notice is given, the amount specified in such notice shall be due and payable on the date specified therein, together with (except in the case of Revolving Loans that are ABR Loans and Swingline Loans, other than in
94
    



connection with a repayment of all Loans) accrued interest to such date on the amount prepaid. Partial prepayments of Term Loans and Revolving Loans shall be in an aggregate principal amount of (x) in the case of ABR Loans, $1,000,000 or a whole multiple of $500,000 in excess thereof, (y) in the case of Term SOFR Loans, $1,000,000 or a whole multiple of $500,000 in excess thereof and (z) in the case of (1) Eurocurrency Loans denominated in Euro, €1,000,000 or a whole multiple of €500,000 in excess thereof, (2) Sterling Daily Rate Loans, £500,000 or a whole multiple of £250,000 in excess thereof or (3) Eurocurrency Loans denominated in Australian Dollars, A$1,000,000 or a whole multiple of A$500,000 in excess thereof. Partial prepayments of Swingline Loans shall be in an aggregate principal amount of $1,000,000 or a whole multiple of $500,000 in excess thereof.
(ii)Notwithstanding anything herein to the contrary, in the event that, on or prior to the date that is six months after the Closing Date, any Borrower (x) makes any prepayment of Initial Term Loans with the proceeds of any Repricing Transaction described under clause (i) of the definition of Repricing Transaction with respect to Initial Term Loans, or (y) effects any amendment of this Agreement resulting in a Repricing Transaction with respect to Initial Term Loans under clause (ii) of the definition of Repricing Transaction, the Borrowers shall on the date of such prepayment or amendment, as applicable, pay to each Initial Term Lender (I) in the case of such clause (x), 1.00% of the principal amount of the Initial Term Loans so prepaid and (II) in the case of such clause (y), 1.00% of the aggregate amount of the Initial Term Loans affected by such Repricing Transaction and outstanding on the effective date of such amendment (an “Initial Term Repricing Premium”).
(iii)Notwithstanding anything herein to the contrary, in the event that, on or prior to the date that is six months after the Amendment No. 2 Effective Date, any Borrower (x) makes any prepayment of Amendment No. 2 Incremental Term Loans with the proceeds of any Repricing Transaction described under clause (i) of the definition of Repricing Transaction with respect to Amendment No. 2 Incremental Term Loans, or (y) effects any amendment of this Agreement resulting in a Repricing Transaction with respect to Amendment No. 2 Incremental Term Loans under clause (ii) of the definition of Repricing Transaction, the Borrowers shall on the date of such prepayment or amendment, as applicable, pay to each Amendment No. 2 Incremental Term Lender (I) in the case of such clause (x), 1.00% of the principal amount of the Amendment No. 2 Incremental Term Loans so prepaid and (II) in the case of such clause (y), 1.00% of the aggregate amount of the Amendment No. 2 Incremental Term Loans affected by such Repricing Transaction and outstanding on the effective date of such amendment (an “Amendment No. 2 Repricing Premium” and together with the Initial Term Repricing Premium, a “Repricing Premium”).
2.kMandatory Prepayments and Commitment Reductions.
(i)If any Indebtedness shall be incurred by any Group Member (other than any Indebtedness permitted to be incurred by any such Person in accordance with Section 7.2), concurrently with, and as a condition to closing of such transaction, an amount equal to 100% of the Net Cash Proceeds thereof shall be applied on the date of such issuance or incurrence toward the prepayment of the Term Loans as set forth in clause (g) of this Section 2.11.
(ii)Subject to clauses (d) and (i) of this Section 2.11, if, for any Excess Cash Flow Period, there shall be Excess Cash Flow, an amount equal to (i) the ECF Percentage for such period of such Excess Cash Flow over (ii) in each case at the option of the Borrower Representative and to the extent not funded with (x) the proceeds of Indebtedness constituting “long term indebtedness” (or a comparable caption) under GAAP (other than Indebtedness in respect of any revolving credit facility) or (y) the proceeds of Permitted Cure Securities applied pursuant to Section 9.4, the aggregate amount of (1) all Purchases by any Permitted Auction Purchaser (determined as the par value of the Loans purchased by such Permitted Auction Purchaser) pursuant to a Dutch Auction or open market purchase permitted hereunder, (2) voluntary prepayments of Term Loans and Revolving Loans (but, in the case of Revolving Loans, only to the extent of a concurrent and permanent reduction in the Revolving Commitments), (3) optional prepayments, purchases and redemptions and buybacks (with credit given to the par value of the loans or notes repurchased) by UK Holdco and the Restricted Subsidiaries of other Indebtedness that is secured by a Lien ranking pari passu (determined without regard to the control of remedies) with the Lien securing the Obligations (but, in the case of revolving indebtedness, only to the extent of a concurrent and permanent reduction in the revolving commitments), (4) payments by UK Holdco and the Restricted Subsidiaries in cash on account of Capital Expenditures, (5) payments by UK Holdco and the Restricted
95
    



Subsidiaries in cash on account of acquisitions or other Investments permitted hereunder (including any earn-out payments) and (6) Restricted Payments made in cash pursuant to Section 7.3(a), (b)(iv), (b)(v), (b)(vi), (b)(viii), (b)(x), (b)(xii), (b)(xiii), (b)(xix) and (b)(xxi), in each case, made during, or committed to be made within 12 months of the end of, the Excess Cash Flow Period (provided, however, that if any payment committed to be made is not actually made in cash within such period, such amount shall be added back to Excess Cash Flow for the subsequent Excess Cash Flow Period) or, at the option of the Borrower Representative, after the Excess Cash Flow Period and prior to the Excess Cash Flow Application Date, shall, on the relevant Excess Cash Flow Application Date, be applied toward the prepayment of the Term Loans as set forth in clause (g) of this Section 2.11, provided that no such prepayment shall be made if the Excess Cash Flow for any Excess Cash Flow Period is less than $10,000,000 (and, if Excess Cash Flow exceeds such amount, only such excess shall be subject to prepayment). Each such prepayment shall be made on a date (an “Excess Cash Flow Application Date”) no later than 10 Business Days after the date on which the financial statements of UK Holdco referred to in Section 6.1(a), for the fiscal year with respect to which such prepayment is made, are required to be delivered to the Lenders.
(iii)Subject to clauses (d) and (i) of this Section 2.11, if, on any date, UK Holdco or any Restricted Subsidiary shall receive Net Cash Proceeds from any Asset Sale or any Recovery Event in excess of (i) the greater of $2,000,000 and 0.7% of Consolidated EBITDA as of the most recently ended Reference Period in any single transaction or series of related transactions and (ii) with respect to all other Net Cash Proceeds not excluded pursuant to the preceding clause (i), the greater of $5,000,000 and 1.6% of Consolidated EBITDA as of the most recently ended Reference Period for all such Net Cash Proceeds in any fiscal year, then, unless the Borrower Representative has determined in good faith that such Net Cash Proceeds shall be reinvested in its business (a “Reinvestment Event”), an aggregate amount equal to 100% of such Net Cash Proceeds shall be applied within five Business Days of such date to prepay outstanding Term Loans in accordance with this Section 2.11; provided that, notwithstanding the foregoing, on each Reinvestment Prepayment Date, an amount equal to the Reinvestment Prepayment Amount with respect to any Asset Sale or Recovery Event, shall be applied to prepay the outstanding Term Loans as set forth in Section 2.11(g).
(iv)Notwithstanding anything to the contrary in this Agreement (including clauses (b) and (c) above), to the extent that the Borrower Representative has determined in good faith that (i) any of or all the Net Cash Proceeds of any Asset Sale or Recovery Event by a Subsidiary or Excess Cash Flow attributable to Subsidiaries (or branches of Subsidiaries) are prohibited or delayed by applicable local law from being repatriated to the relevant Borrower(s) (including as a result of financial assistance and corporate benefit restrictions and fiduciary and statutory duties of the relevant directors), (ii) such repatriation would present a material risk of liability for the applicable Subsidiary or its directors or officers (or gives rise to a material risk of breach of fiduciary or statutory duties by any director or officers) or (iii) in the case of Foreign Subsidiaries, such repatriation or any distribution of the relevant amounts would reasonably be expected to result in material adverse Tax consequences, the portion of such Net Cash Proceeds or Excess Cash Flow so affected will not be required to be applied to repay Loans at the times set forth in this Section 2.11 but may be retained by the applicable Subsidiary or branch (the Borrowers hereby agreeing to cause the applicable Subsidiary or branch to promptly take commercially reasonable actions to permit such repatriation without violating applicable local law or incurring material adverse Tax consequences); provided, that for a period of 360 days from receipt of such Net Cash Proceeds, if such repatriation becomes permitted under such applicable local law, would not present a material risk as described in clause (ii) above, or no such material adverse Tax consequences would result from such distribution, as the case may be, such distribution will be promptly effected and such distributed Net Cash Proceeds will be promptly (and in any event not later than 10 Business Days after such distribution) applied (net of additional Taxes payable or reserved against as a result thereof) to the repayment of Term Loans pursuant to this Section 2.11.
(v)In the event the aggregate Outstanding Amount of Revolving Loans, L/C Obligations and Swingline Loans at any time exceeds (the “Revolving Excess”) the Total Revolving Commitments then in effect, the Revolving Borrowers shall immediately (or, if such Revolving Excess results solely from a Recalculation, within 2 Business Days) repay Swingline Loans and Revolving Loans and Collateralize Letters of Credit to the extent necessary to remove such Revolving Excess.
96
    



(vi)The Borrower Representative shall deliver to the Administrative Agent notice, substantially in the form of Exhibit E or such other form as may be approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative (on behalf of the Borrowers), of each prepayment required under this Section 2.11, which notice must be received by the Administrative Agent not less than three Business Days (or such shorter time as the Administrative Agent shall reasonably agree) prior to the date such prepayment shall be made. The Administrative Agent will promptly notify each applicable Lender of such notice. Each such Lender may reject all of its Pro Rata Share of any prepayment pursuant to clause (b) or (c) above (such declined amounts, the “Declined Proceeds”) by providing written notice (each, a “Rejection Notice”) to the Administrative Agent and the Borrower Representative no later than 12:00 p.m. (New York City time), two Business Days after the date of such Lender’s receipt of such notice from the Administrative Agent. If a Lender fails to deliver a Rejection Notice to the Administrative Agent within the time frame specified above such failure will be deemed an acceptance of such prepayment. Any Declined Proceeds may be retained by the Borrowers (such retained amount, the “Retained Declined Proceeds”). The Borrower Representative shall deliver to the Administrative Agent, at the time of each prepayment required under this Section 2.11, an Officer’s Certificate setting forth in reasonable detail the calculation of the amount of such prepayment.
(vii)Amounts to be applied in connection with any mandatory prepayments made pursuant to this Section 2.11 shall be applied to the prepayment of the Term Loans in accordance with Section 2.17(b). The application of any prepayment of Loans pursuant to this Section 2.11 shall be made on a pro rata basis regardless of Type. Each prepayment of the Loans under this Section 2.11 (except in the case of Revolving Loans that are ABR Loans (to the extent all Revolving Loans are not being prepaid) and Swingline Loans) shall be accompanied by accrued interest to the date of such prepayment on the amount prepaid.
(viii)Notwithstanding any of the other provision of this Section 2.11, if any prepayment of Eurocurrency Loans or Term SOFR Loans is required to be made under this Section 2.11 other than on the last day of the Interest Period applicable thereto, the applicable Borrower may, in its sole discretion, deposit the amount of any such prepayment otherwise required to be made thereunder with the Administrative Agent, to be held as security for the obligations of the applicable Borrower to make such prepayment pursuant to a cash collateral agreement to be entered into on terms reasonably satisfactory to the Administrative Agent until the last day of such Interest Period, at which time the Administrative Agent shall be authorized (without any further action by or notice to or from any Borrower or any other Loan Party) to apply such amount to the prepayment of such Eurocurrency Loans or Term SOFR Loans in accordance with this Section 2.11 (determined as of the date such prepayment was required to be originally made); provided that such unpaid Eurocurrency Loans or Term SOFR Loans shall continue to bear interest in accordance with Section 2.15 until such unpaid Eurocurrency Loans or Term SOFR Loans have been prepaid. Upon the occurrence and during the continuance of any Event of Default, the Administrative Agent shall also be authorized (without any further action by or notice to or from any Borrower or any other Loan Party) to apply such amount to the prepayment of the applicable Eurocurrency Loans or Term SOFR Loans in accordance with this Section 2.11 (determined as of the date such prepayment was required to be originally made). Notwithstanding anything to the contrary contained in this Agreement, any amounts held by the Administrative Agent pursuant to this clause (h) pending application to any Eurocurrency Loans or Term SOFR Loans shall be held and applied to the satisfaction of such Eurocurrency Loans or Term SOFR Loans prior to any other application of such property as may be provided for herein.
(ix)Notwithstanding the foregoing provisions of this Section 2.11, at the Borrower Representative’s option, outstanding Indebtedness that is secured by the Collateral on a pari passu basis (determined without regard to the control of remedies) with the Obligations hereunder (“Other Applicable Indebtedness”) may share, on the terms set forth below, in any mandatory prepayment of the Term Loans pursuant to Section 2.11(b) and/or (c), and the amount of any such prepayment required to be made hereunder shall be reduced accordingly. Any Net Cash Proceeds or Excess Cash Flow may be applied to Other Applicable Indebtedness only to (and not in excess of) the extent to which a mandatory prepayment in respect of such Asset Sale, Recovery Event or Excess Cash Flow is required under the terms of such Other Applicable Indebtedness (with any remaining Net Cash Proceeds or Excess Cash Flow applied to
97
    



prepay outstanding Term Loans in accordance with the terms hereof), unless such application would result in the holders of Other Applicable Indebtedness receiving in excess of their pro rata share (determined on the basis of the aggregate Outstanding Amount of Term Loans and Other Applicable Indebtedness at such time) of such Net Cash Proceeds relative to Term Lenders, in which case such Net Cash Proceeds may only be applied to Other Applicable Indebtedness on a pro rata basis with outstanding Term Loans. To the extent the holders of Other Applicable Indebtedness decline to have such indebtedness repurchased, repaid or prepaid with any such Net Cash Proceeds or Excess Cash Flow, the declined amount of such Net Cash Proceeds or Excess Cash Flow shall promptly (and, in any event, within 10 Business Days after the date of such rejection) be applied to prepay Term Loans in accordance with the terms hereof (to the extent such Net Cash Proceeds or Excess Cash Flow would otherwise have been required to be applied if such Other Applicable Indebtedness was not then outstanding)
2.lConversion and Continuation Options.
(i)The Borrower Representative may elect from time to time to convert Term SOFR Loans to ABR Loans by giving the Administrative Agent prior irrevocable notice of such election telephonically (provided that each telephonic notice is confirmed promptly in writing), substantially in the form of Exhibit H or such other form as approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative (on behalf of the Borrowers), no later than 1:00 p.m. (New York City time), three Business Days prior to the proposed conversion date. The Borrower Representative may elect from time to time to convert ABR Loans to Term SOFR Loans by giving the Administrative Agent prior irrevocable notice of such election telephonically (provided that each telephonic notice is confirmed promptly in writing), substantially in the form of Exhibit H or such other form as approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative (on behalf of the Borrowers), no later than 1:00 p.m. (New York City time), on the third Business Day preceding the proposed conversion date (which notice shall specify the length of the initial Interest Period therefor and the Class of the Loans); provided, however, that if the Borrower Representative wishes to request Eurocurrency Loans or Term SOFR Loans having an Interest Period other than one, two (other than with respect to Term SOFR Loans), three or six months in duration as provided in the definition of “Interest Period,” the applicable notice must be received by the Administrative Agent not later than 11:00 a.m. (New York City time) seven Business Days prior to the requested date of such Borrowing conversion, whereupon the Administrative Agent shall give prompt notice to the Lenders of such request and determine whether the requested Interest Period is approved by all of them. Not later than 11:00 a.m. (New York City time), four Business Days before the requested date of such Borrowing conversion, the Administrative Agent shall notify the Borrower Representative (which notice may be by telephone) whether or not the requested Interest Period has been consented to by all the Lenders; provided, further that, upon notice from the Administrative Agent to the Borrower Representative at the direction of the Required Lenders, no ABR Loan may be converted into a Term SOFR Loan when any Event of Default has occurred and is continuing. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof.
(ii)Any Eurocurrency Loan or Term SOFR Loan may be continued as such upon the expiration of the then current Interest Period with respect thereto by the Borrower Representative (on behalf of the Borrowers) giving irrevocable notice (which notice shall specify the Class of Loans) to the Administrative Agent telephonically (provided that each telephonic notice is confirmed promptly in writing), substantially in the form of Exhibit H or such other form as approved by the Administrative Agent (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent), appropriately completed and signed by a Responsible Officer of the Borrower Representative, no later than 12:00 p.m. (New York City time) on the third Business Day preceding the proposed continuation date in the case of Term SOFR Loans or Eurocurrency Loans denominated in Euros or 12:00 p.m. (New York City time) on the fourth Business Day preceding the proposed continuation date, in the case of Eurocurrency Loans denominated in Australian Dollars; provided, however, that if the Borrower Representative wishes to request Eurocurrency Loans or Term SOFR Loans having an Interest Period other than one, two (other than with respect to Term SOFR Loans), three or six months in duration as provided in the definition of “Interest Period,” the applicable
98
    



notice must be received by the Administrative Agent not later than 11:00 a.m. (New York City time) seven Business Days prior to the requested date of such Borrowing continuation, whereupon the Administrative Agent shall give prompt notice to the Lenders of such request and determine whether the requested Interest Period is acceptable to all of them. Not later than 11:00 a.m. (New York City time), three Business Days before the requested date of such Borrowing continuation, in the case of Term SOFR Loans or Eurocurrency Loans denominated in Euros or 11:00 p.m. (New York City time) four Business Days before the requested date of such Borrowing continuation, in the case of Eurocurrency Loans denominated in Australian Dollars, the Administrative Agent shall notify the Borrower Representative (which notice may be by telephone) whether or not the requested Interest Period has been consented to by all the Lenders; provided, further that, to the extent the Required Lenders provide written notice thereof to the Borrower Representative, no Eurocurrency Loan or Term SOFR Loan may be continued as such when any Event of Default has occurred and is continuing; provided, further, that with respect to Term SOFR Loans, if continuation is not permitted pursuant to the preceding proviso, such Loans shall be automatically converted to ABR Loans on the last day of such then expiring Interest Period. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof.
(iii)If the Borrower Representative fails to give a timely notice requesting continuation or conversion from one Type of Loan to another, then the applicable Loans shall, subject to the final proviso to the preceding clause (b), be (i) in the case of ABR Loans, continued as ABR Loans or (ii) in the case of Eurocurrency Loans or Term SOFR Loans, continued as Eurocurrency Loans or Term SOFR Loans, as applicable, with an Interest Period of one month.
2.mLimitations on Eurocurrency Tranches and Term SOFR Tranches. Notwithstanding anything to the contrary in this Agreement, all borrowings, conversions and continuations of Eurocurrency Loans or Term SOFR Loans and all selections of Interest Periods shall be in such amounts and be made pursuant to such elections so that, after giving effect thereto, (a) the aggregate principal amount of the Term SOFR Loans comprising each Term SOFR Tranche shall be equal to $5,000,000 or a whole multiple of $1,000,000 in excess thereof, (b) the aggregate principal amount of the Eurocurrency Loans denominated in Euros comprising each Eurocurrency Tranche shall be equal to €5,000,000 or a whole multiple of €1,000,000 in excess thereof, (c) the aggregate principal amount of the Eurocurrency Loans denominated in Australian Dollars comprising each Eurocurrency Tranche shall be equal to A$5,000,000 or a whole multiple of A$1,000,000 in excess thereof and (d) (i) in the case of Term Loans, no more than five Eurocurrency Tranches shall be outstanding at any one time and (ii) in the case of Revolving Loans, no more than 10 Eurocurrency Tranches shall be outstanding at any one time.
2.nInterest Rates and Payment Dates.
(i)(i) Each Eurocurrency Loan shall bear interest for each day during each Interest Period with respect thereto at a rate per annum equal to the Eurocurrency Rate determined for such day plus the Applicable Margin, and (ii) each Term SOFR Loan shall bear interest for each day during each Interest Period with respect thereto at a rate per annum equal to Term SOFR determined for such Interest Period plus the Applicable Margin.
(ii)Each ABR Loan shall bear interest at a rate per annum equal to the ABR plus the Applicable Margin.
(iii)Each Sterling Daily Rate Loan shall bear interest for each day outstanding at a rate per annum equal to the Sterling Daily Rate determined for such day plus the Applicable Margin.
(iv)(i) If all or a portion of the principal amount of any Loan or Reimbursement Obligation shall not be paid when due (whether at the stated maturity, by acceleration or otherwise), such overdue amount shall bear interest at a rate per annum equal to the rate that would otherwise be applicable thereto pursuant to the foregoing provisions of this Section plus 2% and (ii) if all or a portion of (x) any interest payable on any Loan or Reimbursement Obligation, (y) any Commitment Fee or (z) any other amount payable hereunder or under any other Loan Document shall not be paid when due (whether at the stated maturity, by acceleration or otherwise), such overdue amount shall bear interest at a rate per annum equal to the rate then applicable to ABR Loans under the relevant Facility plus 2% (or, in the case of any such other amounts that do not relate to a particular Facility, the rate then applicable to ABR Loans under the
99
    



Revolving Facility plus 2%), in each case, with respect to clauses (i) and (ii) above, from the date of such non-payment until such amount is paid in full (as well after as before judgment).
(v)Interest shall be payable in arrears on each Interest Payment Date, provided that interest accruing pursuant to Section 2.14(d) shall be payable from time to time on demand.
(vi)Interest on each Loan shall be payable in the currency in which each Loan was made.
2.oComputation of Interest and Fees.
(i)Interest and fees payable pursuant hereto shall be calculated on the basis of a 360-day year for the actual days elapsed, except that, with respect to Sterling Daily Rate Loans and ABR Loans, the interest thereon shall be calculated on the basis of a 365- (or 366-, as the case may be) day year for the actual days elapsed or, in any case where the practice in the relevant market differs, in accordance with that market practice. The Administrative Agent shall as soon as practicable notify the Borrower Representative and the relevant Lenders of each determination of a Eurocurrency Rate or Term SOFR. Any change in the interest rate on a Loan resulting from a change in the ABR, the Sterling Daily Rate or the Eurocurrency Reserve Percentage shall become effective as of the opening of business on the day on which such change becomes effective. The Administrative Agent shall as soon as practicable notify the Borrower Representative and the relevant Lenders of the effective date and the amount of each such change in interest rate. In computing interest on any Loan, the date of the making of such Loan or the first day of an Interest Period applicable to such Loan or, with respect to an ABR Loan being converted from a Eurocurrency Loan or a Term SOFR Loan, the date of conversion of such Eurocurrency Loan or Term SOFR Loan to such ABR Loan, as the case may be, shall be included, and the date of payment of such Loan or the expiration date of an Interest Period applicable to such Loan or, with respect to an ABR Loan being converted to a Eurocurrency Loan or a Term SOFR Loan, the date of conversion of such ABR Loan to such Eurocurrency Loan or Term SOFR Loan, as the case may be, shall be excluded; provided that if a Loan is repaid on the same day on which it is made, one day’s interest shall be paid on that Loan.
(ii)Each determination of an interest rate by the Administrative Agent pursuant to any provision of this Agreement shall be conclusive and binding on the Borrowers and the Lenders in the absence of manifest error. The Administrative Agent shall, at the request of the Borrower Representative, deliver to the Borrower Representative a statement showing the quotations used by the Administrative Agent in determining any interest rate pursuant to Section 2.14.
2.pInability to Determine Interest Rate; Illegality.
(i)Other than with respect to the Revolving Facility, if prior to the first day of any Interest Period (i) the Administrative Agent or the Majority Facility Lenders in respect of the relevant Facility shall have determined (which determination shall be conclusive and binding upon the Borrowers) that, by reason of circumstances affecting the relevant market, adequate and reasonable means do not exist for ascertaining Term SOFR for such Interest Period (and the circumstances described in Section 2.16(b) do not apply), or (ii) the Administrative Agent shall have received notice from the Majority Facility Lenders in respect of the relevant Facility that Term SOFR determined or to be determined for such Interest Period will not adequately and fairly reflect the cost to such Lenders (as conclusively certified by such Lenders) of making or maintaining their affected Loans during such Interest Period, as applicable, then the Administrative Agent shall give telecopy or telephonic notice thereof to the Borrower Representative and the relevant Lenders as soon as practicable thereafter. Thereafter, (x) the obligation of the Lenders to make or maintain Term SOFR Loans, or convert ABR Loans to Term SOFR Loans, as applicable, shall be suspended and (y) in the event of a determination described in the preceding sentence with respect to the Term SOFR component of the ABR, the utilization of the Term SOFR component in determining the ABR shall be suspended, in each case until the Administrative Agent (upon the instruction of the Majority Facility Lenders) revokes such notice. Upon receipt of such notice, the Borrower Representative (on behalf of the Borrowers) may revoke any pending request for a Borrowing of, conversion to or continuation of Term SOFR Loans (to the extent of the affected Term SOFR or Interest Periods) or, failing that, the Borrower Representative will be deemed to have converted such request into a request for a Borrowing of ABR Loans (subject to the foregoing clause (y)) in the amount specified therein.
100
    



(ii)Other than with respect to the Revolving Facility, notwithstanding anything to the contrary in this Agreement or any other Loan Document, if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Borrower Representative or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower Representative) that the Borrower Representative or Required Lenders (as applicable) have determined, that:
(1)adequate and reasonable means do not exist for ascertaining Term SOFR for any requested Interest Period, including, without limitation, because the Term SOFR Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary; or
(2)the administrator of the Term SOFR Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent has made a public statement identifying a specific date after which Term SOFR or the Term SOFR Screen Rate shall no longer be made available, or used for determining the interest rate of loans; provided that, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent that will continue to provide Term SOFR after such specific date (such specific date, the “Term Loan Scheduled Unavailability Date”); or
(3)syndicated loans currently being executed, or that include language similar to that contained in this Section 2.16, are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace Term SOFR,
then, reasonably promptly after such determination by the Administrative Agent or receipt by the Administrative Agent of such notice, as applicable, the Administrative Agent and the Borrower Representative may amend this Agreement solely for the purpose of replacing Term SOFR in accordance with this Section 2.16 with an alternative alternate benchmark rate giving due consideration to any evolving or then existing convention for similar U.S. dollar denominated syndicated credit facilities for such alternative benchmark and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar U.S. dollar denominated syndicated credit facilities for such benchmark, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated (any such proposed rate, a “Term Loan Successor Rate”), and any such amendment shall become effective at 5:00 p.m. on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, in the case of any amendments in connection with a Term Loan Successor Rate prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.
Such Term Loan Successor Rate shall be applied in a manner consistent with market practice; provided that to the extent such market practice is not administratively feasible for the Administrative Agent, such Term Loan Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent in consultation with the Borrower Representative.
If no Term Loan Successor Rate has been determined and the circumstances under clause (i) above exist or the Term Loan Scheduled Unavailability Date has occurred (as applicable), the Administrative Agent will promptly so notify the Borrower Representative and each Lender.  Thereafter, (x) the obligation of the Lenders to make or maintain Term SOFR Loans shall be suspended (to the extent of the affected Term SOFR Loans or Interest Periods), and (y) the Term SOFR component shall no longer be utilized in determining ABR.  Upon receipt of such notice, the Borrower Representative (on behalf of the Borrowers) may revoke any pending request for a Borrowing of, conversion to or continuation of Term SOFR Loans (to the extent of the affected Term SOFR Loans or Interest Periods) or, failing that, with respect to a pending request for Loans denominated in Dollars, the Borrower Representative will be deemed to have converted such request into a request for a Borrowing of ABR Loans (subject to the foregoing clause (y)) in the amount specified therein, and any outstanding Term SOFR Loans shall be deemed to have been converted to ABR Loans at the end of the extant Interest Period.
Notwithstanding anything else herein, any definition of Term Loan Successor Rate shall provide that in no event shall such Term Loan Successor Rate be less than zero for purposes of this Agreement.
101
    



In connection with the implementation of a Term Loan Successor Rate, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement; provided that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Lenders reasonably promptly after such amendment becomes effective.
(iii)With respect to the Revolving Facility,
(1)if prior to (x) the commencement of any Interest Period for any Borrowing of Term SOFR Loans, (y) any relevant date of determination of the interest rate with respect to any Revolving Loans denominated in an Alternative Currency or (z) a conversion of ABR Loans to Term SOFR Loans or a continuation of any of such Term SOFR Loans, as applicable, (I) the Administrative Agent determines (which determination shall be conclusive absent manifest error) that (A) no Revolving Facility Successor Rate for the Relevant Rate for the applicable Agreed Currency has been determined in accordance with Section 2.16(c)(ii) and the circumstances under Section 2.16(c)(ii)(1) or the Revolving Facility Scheduled Unavailability Date has occurred with respect to such Relevant Rate (as applicable), or (B) adequate and reasonable means do not otherwise exist for determining the Relevant Rate for the applicable Agreed Currency for any determination date(s) or requested Interest Period, as applicable, with respect to a proposed Term SOFR Loan, a Revolving Loan denominated in an Alternative Currency or the determination of the Term SOFR component of the ABR in connection with an existing or proposed ABR Loan, or (II) the Administrative Agent reasonably determines, or is advised by the Required Lenders, that for any reason the Relevant Rate with respect to a proposed Loan denominated in an Agreed Currency for any requested Interest Period or determination date(s) does not adequately and fairly reflect the cost to such Lenders of funding such Loan, the Administrative Agent will promptly so notify the Borrower Representative and each Lender. Thereafter, (x) the obligation of the Lenders to make or maintain Term SOFR Loans or Revolving Loans denominated in the relevant Alternative Currency, or to convert ABR Loans to Term SOFR Loans, as the case may be, shall be suspended (to the extent of the affected Term SOFR Loans or Revolving Loans, as the case may be, or Interest Periods), and (y) in the event of a determination described in the preceding sentence with respect to the Term SOFR component of the ABR, the utilization of the Term SOFR component in determining the ABR shall be suspended, in each case until the Administrative Agent (or, in the case of a determination by the Required Lenders described in Section 2.16(c)(i)(II), until the Administrative Agent upon instruction of the Required Lenders) revokes such notice. Upon receipt of such notice, (A) the Borrower Representative may revoke any pending request for a Borrowing of, conversion to or continuation of Term SOFR Loans or Revolving Loans denominated in the relevant Alternative Currency, as the case may be (to the extent of the affected Term SOFR Loans or Revolving Loans, as the case may be, or Interest Periods), or, failing that, will be deemed to have converted such request with respect to any Loan denominated in Dollars in the Dollar Amount of the amount specified therein into a request for a Borrowing of ABR Loans in the amount specified therein and (B) (i) any outstanding Term SOFR Loans shall be deemed to have been converted to ABR Loans at the end of the extant Interest Period and (ii) any outstanding affected Revolving Loan denominated in the relevant Alternative Currency, at the Borrower Representative’s option, will either (1) be converted into a Borrowing of ABR Loans in the Dollar Amount of the amount of such outstanding Alternative Currency immediately or (2) be prepaid in full within three Business Days; provided that, in the case of a Revolving Loan denominated in an Alternative Currency, if no election is made by the Borrower Representative by the date that is three Business Days after receipt by the Borrower Representative of such notice, the Borrower Representative will be deemed to have elected clause (1) above.
(2)Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Borrower Representative or the Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower Representative) that the Borrower Representative or the Required Lenders (as applicable) have determined, that:
(a)adequate and reasonable means do not exist for ascertaining the Relevant Rate for an Agreed Currency because either (x) none of the one month, three
102
    



month and six month interest periods of such Relevant Rate (including any forward-looking term rate thereof) is or (y) the Relevant Rate is not, in either case, available or published on a current basis and such circumstances are unlikely to be temporary; or
(b)the Applicable Authority (or any successor administrator thereof), in each case acting in such capacity, has made a public statement identifying a specific date after which all tenors of the Relevant Rate for an Agreed Currency (including any forward-looking term rate thereof) or the Relevant Rate shall or will no longer be made available, or permitted to be used for determining the interest rate of loans denominated in such Agreed Currency, or shall or will otherwise cease, provided, that, in each case, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent, in consultation with the Borrower Representative, that will continue to provide such interest period(s) of the Relevant Rate or the Relevant Rate itself, in either case, for such Agreed Currency after such specific date (the latest date on which all tenors of the Relevant Rate or such Relevant Rate itself, in either case, for such Agreed Currency (including any forward-looking term rate thereof) are no longer available permanently or indefinitely, the “Revolving Facility Scheduled Unavailability Date”);
or if the events or circumstances of the type described in Section 2.16(c)(ii)(1) or (2) have occurred with respect to the Revolving Facility Successor Rate for the relevant Agreed Currency then in effect, then, (x) with respect to Term SOFR, on a date and time determined by the Administrative Agent, in consultation with the Borrower Representative (any such date, the “Revolving Facility Term SOFR Replacement Date”), which date shall be at the end of an Interest Period or on the relevant interest payment date, as applicable, for interest calculated and, solely with respect to clause (2) above, no later than the Revolving Facility Scheduled Unavailability Date, Term SOFR will be replaced hereunder and under any Loan Document with Daily Simple SOFR plus the SOFR Adjustment for any payment period for interest calculated that can be determined by the Administrative Agent, in each case, without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document (the “Revolving Facility Term SOFR Successor Rate”), and (y) with respect to any other Relevant Rate (or if Daily Simple SOFR is not available on or prior to the Revolving Facility Term SOFR Replacement Date), reasonably promptly after such determination by the Administrative Agent or receipt by the Administrative Agent of such notice, as applicable, the Administrative Agent and the Borrower Representative may amend this Agreement to replace the Relevant Rate for an Agreed Currency or any then current Revolving Facility Successor Rate for an Agreed Currency in accordance with this Section 2.16 with an alternate benchmark rate giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the U.S. and denominated in such Agreed Currency for such alternative benchmarks, and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar credit facilities syndicated and agented in the U.S. and denominated in such Agreed Currency for such benchmarks, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent, in consultation with the Borrower Representative, from time to time in its reasonable discretion and may be periodically updated (and any such proposed rate, including for the avoidance of doubt, any adjustment thereto, an “Other Revolving Facility Relevant Rate Successor Rate” and together with the Revolving Facility Term SOFR Successor Rate, a “Revolving Facility Successor Rate”), and any such amendment shall become effective at 5:00 p.m. on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all relevant Lenders and the Borrower Representative unless, in the case of any amendments in connection with an Other Revolving Facility Relevant Rate Successor Rate, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.
If the relevant Revolving Facility Successor Rate is Daily Simple SOFR plus the SOFR Adjustment, all interest payments will be payable on a quarterly basis.
The Administrative Agent will promptly (in one or more notices) notify the Borrower Representative and each relevant Lender of the implementation of any Revolving Facility Successor Rate.
103
    



Any Revolving Facility Successor Rate shall be applied in a manner consistent with market practice; provided, that to the extent such market practice is not administratively feasible for the Administrative Agent, such Revolving Facility Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent in consultation with the Borrower Representative.
Notwithstanding anything else herein, if at any time any Revolving Facility Successor Rate as so determined would otherwise be less than 0.00% per annum, the Revolving Facility Successor Rate will be deemed to be 0.00% per annum, for the purposes of this Agreement and the other Loan Documents.
In connection with the implementation of a Revolving Facility Successor Rate, the Administrative Agent, in consultation with the Borrower Representative, will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement; provided that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower Representative and the Lenders reasonably promptly after such amendment becomes effective.
(3)For purposes of this Section 2.16(c), those Lenders that either have not made, or do not have an obligation under this Agreement to make, the relevant Loans in the relevant Alternative Currency shall be excluded from any determination of Required Lenders.
(iv)Notwithstanding any other provision of this Agreement, if any Change in Law shall make it unlawful for any Lender to make or maintain any Eurocurrency Loan, Term SOFR Loan or Sterling Daily Rate Loan or to give effect to its obligations as contemplated hereby with respect to any Eurocurrency Loan, Term SOFR Loan or Sterling Daily Rate Loan, then, by written notice to the Borrower Representative and to the Administrative Agent:
(1)any obligation of such Lender to make or continue Eurocurrency Loans, Term SOFR Loans or Sterling Daily Rate Loans, as the case may be, in the affected currency or currencies or to convert ABR Loans to Term SOFR Loans shall be suspended and
(2)if such notice asserts the illegality of such Lender making or maintaining ABR Loans the interest rate on which is determined by reference to the Term SOFR component of the ABR, the interest rate on which ABR Loans of such Lender, shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Term SOFR component of the ABR,
in each case of clauses (i) and (ii) until such Lender notifies the Administrative Agent and the Borrower Representative that the circumstances giving rise to such determination no longer exist.
Upon receipt of such notice, the Borrowers shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or, (I) if applicable and such Loans are denominated in Dollars, convert all of such Lender’s affected Term SOFR Loans to ABR Loans (the interest rate on which ABR Loans of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the Term SOFR component of the ABR) or (II) if applicable and such Loans are denominated in an Alternative Currency, the interest rate with respect to such Loans shall be determined by an alternative rate mutually acceptable to the Borrowers and the Lenders, either on the last day of the Interest Period therefor, if such Lender may lawfully continue to maintain such Eurocurrency Loans or Term SOFR Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such Eurocurrency Loans or Term SOFR Loans or in the case of any Sterling Daily Rate Loans. In the event any Lender shall exercise its rights under paragraphs (i) or (ii) of this clause (d), all payments and prepayments of principal that would otherwise have been applied to repay the Eurocurrency Loans, Term SOFR Loans or Sterling Daily Rate Loans that would have been made by such Lender or the converted Eurocurrency Loans or Term SOFR Loans of such Lender shall instead be applied to repay the ABR Loans (if applicable) made by such Lender in lieu of, or resulting from the conversion of, such Eurocurrency Loans, Term SOFR Loans or Sterling Daily Rate Loans. For purposes of this clause (d), a notice to the Borrower Representative by any Lender shall be effective as to each Eurocurrency Loan or Term SOFR Loan made by such Lender, if lawful, on the last day of the Interest Period then applicable to
104
    



such Eurocurrency Loan or Term SOFR Loan; in all other cases, such notice shall be effective on the date of receipt by the Borrower Representative.
2.qPro Rata Treatment and Payments; Sharing of Payments by Lenders.
(i)Each borrowing by the Borrowers from the Lenders hereunder, each payment by any Borrower on account of any Commitment Fee and any reduction of the Commitments of the Lenders shall be made pro rata according to the respective Term Percentages, Incremental Term Percentages or Revolving Percentages, as the case may be, of the relevant Lenders.
(ii)Except as expressly set forth herein, each payment (including each prepayment) on account of principal of and interest on the Term Loans shall be made pro rata to the Term Lenders according to the respective Outstanding Amount of the Term Loans then held by the Term Lenders. The amount of each optional prepayment of the Term Loans made pursuant to Section 2.10 shall be applied as directed by the Borrower Representative in the notice described in Section 2.10 and, if no direction is given by the Borrower, in the direct order of maturity. The amount of each mandatory prepayment of the Term Loans pursuant to Section 2.11 (other than any such prepayment pursuant to Section 2.11(b)) shall be applied as directed by the Borrower Representative in the notice described in Section 2.11 and, if no direction is given by the Borrower Representative, in the direct order of maturity. The amount of each mandatory prepayment of the Term Loans pursuant to Section 2.11(b) shall be applied in the direct order of maturity or as otherwise directed by the Borrower Representative. Except as expressly set forth herein, each payment (including each prepayment) by the Revolving Borrowers on account of principal of and interest on the Revolving Loans shall be made pro rata to the Revolving Lenders according to the respective Outstanding Amount of the Revolving Loans then held by the Revolving Lenders.
(iii)Each payment or prepayment of the principal of, and interest on, any Loans shall be made in the relevant currency in which such Loans are denominated (even if the applicable Borrower is required to convert currency to do so). All payments (including prepayments) to be made by the Borrowers hereunder and denominated in Dollars, whether on account of principal, interest, fees or otherwise, shall be made without setoff or counterclaim and shall be made prior to 10:00 a.m. (New York City time) on the due date thereof to the Administrative Agent at the applicable Administrative Agent’s Office, for the account of the Lenders, in Dollars and in immediately available funds. All payments (including prepayments) to be made by the Borrowers hereunder and denominated in an Alternative Currency, whether on account of principal, interest, fees or otherwise, shall be made without setoff or counterclaim and shall be made prior to 8:00 a.m. (New York City time) on the due date thereof to the Administrative Agent at the applicable Administrative Agent’s Office, for the account of the Lenders, in the applicable Alternative Currency and in immediately available funds. If, for any reason, any Borrower is prohibited by any Law from making any required payment hereunder in an Alternative Currency, such Borrower shall make such payment in Dollars in the Dollar Amount of the Alternative Currency payment amount. Any payments received after such time shall be deemed to be received on the next Business Day at the Administrative Agent’s sole discretion, and any applicable interest or fee shall continue to accrue. The Administrative Agent shall distribute such payments to the Lenders promptly upon receipt in like funds as received. Except as otherwise provided hereunder, if any payment hereunder (other than payments on the Eurocurrency Loans or Term SOFR Loans) becomes due and payable on a day other than a Business Day, such payment shall be required on the immediately preceding Business Day. If any payment on a Eurocurrency Loan or Term SOFR Loan becomes due and payable on a day other than a Business Day, the maturity thereof shall be extended to the next succeeding Business Day unless the result of such extension would be to extend such payment into another calendar month, in which event such payment shall be made on the immediately preceding Business Day. In the case of any extension of any payment of principal pursuant to the preceding two sentences, interest thereon shall be payable at the then applicable rate during such extension.
(iv)Unless the Administrative Agent shall have been notified in writing by any Lender prior to the time of any Borrowing that such Lender will not make the amount that would constitute its share of such Borrowing available to the Administrative Agent, the Administrative Agent may assume that such Lender is making such amount available to the Administrative Agent, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrowers a corresponding amount. If such amount is not made available to the Administrative Agent by the required time on the Borrowing Date
105
    



therefor (a “Funding Default”), such Lender shall pay to the Administrative Agent, on demand, such amount with interest thereon, at a rate equal to the greater of (i) the Overnight Rate and (ii) a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation, for the period until such Lender makes such amount immediately available to the Administrative Agent. A certificate of the Administrative Agent submitted to any Lender with respect to any amounts owing under this paragraph shall be conclusive in the absence of manifest error. If such Lender’s share of such borrowing is not made available to the Administrative Agent by such Lender within three Business Days after such Borrowing Date, the Administrative Agent shall also be entitled to recover such amount with interest thereon at the rate per annum applicable to ABR Loans under the relevant Facility, on demand, from the Borrowers. Nothing herein shall be deemed to relieve any Lender from its obligation to fulfill its Commitment or to prejudice any rights which the Administrative Agent or the Borrowers may have against any Lender as a result of any default by such Lender hereunder.
(v)Unless the Administrative Agent shall have been notified in writing by the Borrower Representative prior to the date of any payment due to be made by the Borrowers hereunder that the Borrowers will not make such payment to the Administrative Agent, the Administrative Agent may assume that the Borrowers are making such payment, and the Administrative Agent may, but shall not be required to, in reliance upon such assumption, make available to the Lenders their respective pro rata shares of a corresponding amount. If such payment is not made to the Administrative Agent by the Borrowers within three Business Days after such due date, the Administrative Agent shall be entitled to recover, on demand, from each Lender to which any amount which was made available pursuant to the preceding sentence, such amount with interest thereon at the rate per annum equal to the daily Overnight Rate. Nothing herein shall be deemed to limit the rights of the Administrative Agent or any Lender against the Borrowers.
(vi)If any Lender makes available to the Administrative Agent funds for any Loan to be made by such Lender as provided in the foregoing provisions of this Section 2 and such funds are not made available to the applicable Borrower by the Administrative Agent because the conditions to the applicable Loan set forth in Section 5 are not satisfied or waived in accordance with the terms hereof, the Administrative Agent shall return such funds (in like funds as received from such Lender) to such Lender, without interest.
(vii)The obligations of the Lenders hereunder to make Term Loans and Revolving Loans, to fund participations in Letters of Credit and Swingline Loans and to make payments pursuant to Section 10.13 are several and not joint. The failure of any Lender to make any Loan, to fund any such participation or to make any payment under Section 10.13 on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so on such date, and no Lender shall be responsible for the failure of any other Lender to so make its Loan, to purchase its participation or to make its payment under Section 10.13.
(viii)Nothing herein shall be deemed to obligate any Lender to obtain the funds for any Loan in any particular place or manner or to constitute a representation by any Lender that it has obtained or will obtain the funds for any Loan in any particular place or manner.
2.rRequirements of Law.
(i)Subject to clause (c) of this Section 2.18, if any Change in Law shall (i) subject any Lender to any Tax of any kind whatsoever with respect to this Agreement, any Letter of Credit, any Application or any Eurocurrency Loan, Sterling Daily Rate Loan or Term SOFR Loan made by it, or change the basis of Taxation of payments to such Lender in respect thereof (except for (x) any Non-Excluded Taxes or Other Taxes (each of which is provided for in Section 2.19), (y) any Taxes described in clauses (i) through (vii) of the second sentence of Section 2.19(a) and (z) any Taxes which would have been compensated for under Section 2.19(a), Section 2.19(f) or Section 2.19(g) but were not so compensated because an exclusion in Section 2.19(b), Section 2.19(c), Section 2.19(d), Section 2.19(e) or Section 2.19(h) applied), (ii) impose, modify or hold applicable any reserve, special deposit, compulsory loan or similar requirement against assets held by, deposits or other liabilities in or for the account of, advances, loans or other extensions of credit by, or any other acquisition of funds by, any office of such Lender that is not otherwise included in the determination of the Eurocurrency Rate, Sterling Daily Rate
106
    



or Term SOFR or (iii) impose on such Lender any other condition (for the avoidance of doubt, other than Taxes), and the result of any of the foregoing is to increase the cost to such Lender by an amount that such Lender reasonably deems to be material, of making, converting into, continuing or maintaining Eurocurrency Loans, Sterling Daily Rate Loans or Term SOFR Loans or issuing or participating in Letters of Credit, or to reduce any amount receivable hereunder in respect thereof, then, in any such case, the Borrowers shall promptly pay such Lender, upon its demand, any additional amounts necessary to compensate such Lender for such increased cost or reduced amount receivable. If any Lender becomes entitled to claim any additional amounts pursuant to this paragraph, it shall promptly notify the Borrower Representative (with a copy to the Administrative Agent) of the event by reason of which it has become so entitled.
(ii)Subject to clause (c) of this Section 2.18, if any Lender shall have determined that compliance by such Lender (or any corporation controlling such Lender) with any Change in Law regarding capital adequacy or liquidity shall have the effect of reducing the rate of return on such Lender’s or such corporation’s capital as a consequence of its obligations hereunder or under or in respect of any Loans or Letters of Credit to a level below that which such Lender or such corporation could have achieved but for such Change in Law (taking into consideration such Lender’s or such corporation’s policies with respect to capital adequacy or liquidity) by an amount reasonably deemed by such Lender to be material, then from time to time, after submission by such Lender to the Borrower Representative (with a copy to the Administrative Agent) of a written request therefor (setting forth in reasonable detail the basis for calculating the additional amounts owed to such Lender under this Section 2.18(b)), the Borrowers shall pay to such Lender such additional amount or amounts as will compensate such Lender or such corporation for such reduction.
(iii)Notwithstanding anything to the contrary in this Agreement (including clauses (a) and (b) above), reimbursement pursuant to this Section 2.18 for (A) increased costs arising from any market disruption (i) shall be limited to circumstances generally affecting the banking market and (ii) may only be requested by Lenders representing the Majority Facility Lenders with respect to the applicable Facility and (B) increased costs because of any Change in Law resulting from clause (i) or (ii) of the proviso to the definition of “Change in Law” may only be requested by a Lender imposing such increased costs on borrowers similarly situated to the Borrowers under syndicated credit facilities comparable to those provided hereunder. A certificate as to any additional amounts payable pursuant to this Section submitted by any Lender to the Borrower Representative (with a copy to the Administrative Agent) shall be conclusive in the absence of manifest error. The Borrowers shall pay such Lender the additional amount shown as due on any such certificate promptly after, and in any event within, 10 Business Days of, receipt thereof. Notwithstanding anything to the contrary in this Section, the Borrowers shall not be required to compensate a Lender pursuant to this Section for any amounts incurred more than nine months prior to the date that such Lender notifies the Borrower Representative of such Lender’s intention to claim compensation therefor; provided that, if the circumstances giving rise to such claim have a retroactive effect, then such nine-month period shall be extended to include the period of such retroactive effect. The obligations of the Borrowers pursuant to this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.
2.sTaxes.
(i)Except where required under applicable law, all payments made by the Loan Parties under any Loan Document shall be made free and clear of, and without deduction or withholding for or on account of, any present or future taxes, levies, imposts, duties, charges, fees, deductions or withholdings, including any penalties, interest and additional amounts with respect thereto, now or hereafter imposed, levied, collected, withheld or assessed by any Governmental Authority (collectively, “Taxes”). Subject to Section 2.19(b), Section 2.19(c), Section 2.19(d), Section 2.19(e) and Section 2.19(h) below, if any applicable law requires any Taxes, excluding (i) Taxes imposed on or measured by net income and franchise Taxes (which franchise Taxes are imposed in lieu of net income Taxes) imposed on or with respect to the Administrative Agent or any Lender as a result of a present or former connection between the Administrative Agent or such Lender and the jurisdiction of the Governmental Authority imposing such Tax or any political subdivision or taxing authority thereof or therein (other than any such connection arising solely from the Administrative Agent or such Lender having executed, delivered or performed its obligations or received a payment under, or enforced, this Agreement or any other Loan
107
    



Document), (ii) branch profits Taxes imposed on the Administrative Agent or any Lender by the United States of America or any similar Tax imposed by any other jurisdiction described in clause (i) above, (iii) United States withholding Taxes to the extent imposed pursuant to a Requirement of Law (or official interpretation or administration thereof) in effect at the time the relevant Lender becomes a party to this Agreement (or designates a new lending office) except to the extent that such Lender (or its assignor, if any) would have been entitled at the time of designation of a new lending office (or assignment, if any) to receive additional amounts from the Borrowers with respect to such Taxes pursuant to this clause (a), (iv) Taxes that are attributable to a Lender’s failure to comply with the requirements of clauses (j), (k), (l), (o), (q) or (u) of this Section 2.19, (v) Taxes imposed by sections 1471 through 1474 of the Code as in existence on the Closing Date (and any amended or successor versions of such provisions that are substantively comparable and not materially more onerous to comply with), any current or future U.S. treasury regulations thereunder and official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and fiscal, tax or regulatory legislation, rules or official practices adopted pursuant to any intergovernmental agreement, treaty or convention entered into in connection with the foregoing (“FATCA”), (vi) any Bank Levy and (vii) any withholding taxes applicable pursuant to the Luxembourg law of December 23, 2005 (such non-excluded taxes, levies, imposts, duties, charges, fees, deductions or withholdings, including any penalties, interest, and additional amounts with respect thereto, the “Non-Excluded Taxes”), or Other Taxes to be withheld from any amounts payable by the Loan Parties to the Administrative Agent or any Lender hereunder, the amounts so payable to the Administrative Agent or such Lender shall be increased to the extent necessary to yield to the Administrative Agent or such Lender (after making all required withholdings in respect of Non-Excluded Taxes and Other Taxes) an amount equal to the sum it would have received had no such withholding been made. Within 30 days of a Loan Party making a payment subject to any deduction or withholding as mentioned in this Section 2.19(a), the Loan Party making such payment shall deliver to the Administrative Agent as agent for the relevant Lender or Lenders evidence reasonably satisfactory to that Lender that the relevant deduction or withholding has been made and (as applicable) any appropriate payment has been made to the relevant taxing authority.
(ii)A payment by a German Borrower shall not be increased pursuant to Section 2.19(a) by reason of a withholding or deduction for, or on account of, Taxes imposed by Germany if on the date on which the payment falls due (i) the payment could have been made to the Lender without a withholding or deduction if the Lender had been a German Qualifying Lender, but on that date that Lender is not or has ceased to be a German Qualifying Lender other than as a result of any change after the date it became a Lender under this Agreement in (or in the interpretation, administration, or application of) any law or German Treaty, or any published practice or published concession of any relevant taxing authority or (ii) the relevant Lender is a German Treaty Lender and the Loan Party making the payment is able to demonstrate that the payment could have been made to the Lender, without the withholding or deduction had that Lender complied with its obligations under Section 2.19(k) below.
(iii)A payment by a Loan Party (other than in respect of an amount due in respect of a Term Loan) shall not be increased pursuant to Section 2.19(a) by reason of a UK Tax Deduction if on the date on which the payment falls due:
(1)the payment could have been made to the relevant Lender without a UK Tax Deduction if the Lender had been a UK Qualifying Lender, but on that date that Lender is not or has ceased to be a UK Qualifying Lender other than as a result of any change after the date it became a Lender under this Agreement in (or in the interpretation, administration, or application of) any law or Treaty, or any published practice or published concession of any relevant taxing authority;
(2)the relevant Lender is a UK Qualifying Lender solely by virtue of clause (a)(ii) of the definition of UK Qualifying Lender and (A) an officer of H.M. Revenue & Customs has given (and not revoked) a direction (a “Direction”) under section 931 of the ITA 2007 which relates to the payment and that Lender has received from the UK Borrower a certified copy of that Direction and (B) the payment could have been made to the Lender without any UK Tax Deduction if that Direction had not been made;
(3)the relevant Lender is a UK Qualifying Lender solely by virtue of clause (a)(ii) of the definition of UK Qualifying Lender and (A) the relevant Lender has not given a UK Tax
108
    



Confirmation to the UK Borrower and (B) the payment could have been made to the relevant Lender without any UK Tax Deduction if the Lender had given a UK Tax Confirmation to the UK Borrower, on the basis that the UK Tax Confirmation would have enabled the UK Borrower to have formed a reasonable belief that the payment was an “excepted payment” for the purpose of section 930 of the ITA 2007; or
(4)the relevant Lender is a UK Treaty Lender and the Loan Party making the payment is able to demonstrate that the payment could have been made to the Lender without the UK Tax Deduction had that Lender complied with its obligations under Section 2.19(k) (subject to Section 2.19(l)) or Section 2.19(m) as applicable.
(iv)A payment by a Loan Party in respect of an amount due from a Spanish Borrower shall not be increased pursuant to Section 2.19(a) by reason of a Spanish Tax Deduction if on the date on which the payment falls due:
(i)    the payment could have been made to the relevant Lender without a Spanish Tax Deduction if the Lender had been a Spanish Qualifying Lender, but on that date that Lender is not or has ceased to be a Spanish Qualifying Lender other than as a result of any change after the date it became a Lender under this Agreement in (or in the interpretation, administration or application of) any law or Spanish Treaty, or any published practice or published concession of any relevant taxing authority;
(ii)    the relevant Lender is a Spanish Qualifying Lender under paragraphs (d) or (e) of the definition of “Spanish Qualifying Lender” and the payment could have been made to that Lender without a Spanish Tax Deduction had the relevant Lender complied with its obligations under Section 2.19(k) or 2.19(u), as applicable.
(v)A payment by a Luxembourg Borrower shall not be increased pursuant to Section 2.19(a) by reason of a withholding or deduction for, or on account of, Taxes imposed by Luxembourg if on the date on which the payment falls due (i) the payment could have been made to the Lender without a withholding or deduction if the Lender had been a Luxembourg Qualifying Lender, but on that date that Lender is not or has ceased to be a Luxembourg Qualifying Lender other than as a result of any change after the date it became a Lender under this Agreement in (or in the interpretation, administration, or application of) any law or Luxembourg Treaty, or any published practice or published concession of any relevant taxing authority or (ii) the relevant Lender is a Luxembourg Treaty Lender and the Loan Party making the payment is able to demonstrate that the payment could have been made to the Lender, without the withholding or deduction had that Lender complied with its obligations under Section 2.19(k) below.
(vi)The Borrowers shall indemnify the Administrative Agent and each Lender within 10 Business Days after written demand therefor (which written demand shall be made no later than 180 days after the earlier of (1) the date on which the Administrative Agent or the applicable Lender, as the case may be, received written demand for payment of the applicable Non-Excluded Taxes or Other Taxes from the relevant Governmental Authority or (2) the date on which the Administrative Agent or the applicable Lender, as the case may be, paid the applicable Non-Excluded Taxes or Other Taxes; provided, that failure or delay on the part of the Administrative Agent or the applicable Lender, as the case may be, to make such written demand shall not constitute a waiver of the right of the Administrative Agent or the applicable Lender, as the case may be, to demand indemnity and reimbursement for such Non-Excluded Taxes or Other Taxes, except to the extent that such failure or delay results in prejudice to the Borrowers) for the full amount of any Non-Excluded Taxes or Other Taxes imposed on or with respect to any payment made by any Loan Party under any Loan Document (including Non-Excluded Taxes and Other Taxes imposed or asserted on or attributable to amounts payable under this Section 2.19 paid by such Person and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Non-Excluded Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority, but excluding Non-Excluded Taxes to the extent compensated under Section 2.19(a) or Taxes to the extent that such Taxes would have been compensated for by Section 2.19(a) or Section 2.19(g) but were not so compensated because one of the exclusions in Section 2.19(b), Section 2.19(c), Section 2.19(d), Section 2.19(e), Section 2.19(g) or Section 2.19(h) applied). A certificate stating the amount of such payment or liability and setting forth in reasonable detail the calculation thereof delivered to the Borrower Representative by a Lender (with a copy to the
109
    



Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender shall be conclusive absent manifest error. Statements payable by any Borrower pursuant to this Section 2.19 shall be submitted to the Borrower Representative at the address specified under Section 11.2.
(vii)Without duplication of clauses (a) or (f) above, the Borrowers shall pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law, except for any Luxembourg Taxes payable due to the registration of a Loan Document with the Administration de l’Enregistrement, des Domaines et de la TVA in Luxembourg within the same circumstances as referred to under Section 2.19(h)(i) and (ii) below.
(viii)A payment shall not be required to be made by a Loan Party pursuant to Section 2.19(a), Section 2.19(f) or Section 2.19(g) for, or on account of, Other Taxes where (i) such Other Taxes are imposed with respect to an assignment or transfer of any Lender’s rights or any participation or sub-contract by a Lender (other than in the course of primary syndication, pursuant to Section 2.23 (other than Section 2.23(c)) or after a Default), or (ii) such Other Taxes derive from the voluntary registration of a Loan Document by or on behalf of the Administrative Agent or any Lender where such registration is not required to maintain, preserve, establish or enforce the rights of the Administrative Agent or that Lender under a Loan Document.
(ix)Whenever any Non-Excluded Taxes or Other Taxes are payable by the Borrowers, as promptly as possible thereafter the Borrowers shall send to the Administrative Agent for its own account or for the account of the relevant Lender, as the case may be, (A) where that payment is in connection with a UK Tax Deduction, a statement under section 975 of the ITA 2007 or other evidence reasonably satisfactory to the Administrative Agent that the UK Tax Deduction has been made or (as applicable) any appropriate payment paid to HM Revenue & Customs, or (B) in any other case, a certified copy of an original official receipt received by the Borrowers showing payment thereof, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.
(x)Each Lender (or Assignee) that is not a “United States person” as defined in Section 7701(a)(30) of the Code (a “Non-U.S. Lender”) shall deliver to the Borrower Representative (on behalf of the applicable Borrowers) and the Administrative Agent two copies of either U.S. Internal Revenue Service Form W-8BEN, Form W-8BEN-E or Form W-8ECI, or, in the case of a Non-U.S. Lender claiming exemption from U.S. federal withholding tax under Section 871(h) or 881(c) of the Code with respect to payments of “portfolio interest”, a statement substantially in the form of Exhibit C-1 and a Form W-8BEN, Form W-8BEN-E, or any subsequent versions thereof or successors thereto, properly completed and duly executed by such Non-U.S. Lender claiming complete exemption from, or a reduced rate of, U.S. federal withholding tax on all payments by the Borrowers under this Agreement and the other Loan Documents; provided that, in the case of a Non-U.S. Lender that is not the beneficial owner, such Non-U.S. Lender shall deliver to the Borrower Representative (on behalf of the applicable Borrowers) and the Administrative Agent two executed copies of U.S. Internal Revenue Service Form W-8IMY, accompanied by Form W-8ECI, Form W-8BEN, Form W-8BEN-E, a statement substantially in the form of Exhibit C-2 or Exhibit C-3, Form W-9, and/or other certification documents from each beneficial owner, as applicable (in each case, or any subsequent versions thereof or successors thereto); provided, further, that if the Non-U.S. Lender is a partnership and one or more direct or indirect partners of such Non-U.S. Lender are claiming exemption from U.S. federal withholding tax under Section 871(h) or 881(c) of the Code with respect to payments of “portfolio interest”, such Non-U.S. Lender may provide a statement substantially in the form of Exhibit C-4 on behalf of each such direct or indirect partner). Any Lender (or Assignee) that is not a Non-U.S. Lender shall deliver to the Borrower Representative (on behalf of the applicable Borrowers) and the Administrative Agent two copies of U.S. Internal Revenue Service Form W-9, or any subsequent versions thereof or successors thereto, properly completed and duly executed by such Person claiming complete exemption from backup withholding on all payments by the Borrowers under this Agreement and the other Loan Documents. The Administrative Agent shall deliver to the Borrower Representative (on behalf of the applicable Borrowers) with respect to any Revolving Loan made to a US Loan Party, and with respect to any Term Loan, a duly completed U.S. Internal Revenue Service Form W-9 (or, in the case of a successor Administrative Agent that is not organized in the United States, a duly executed U.S. Internal Revenue Service Form W-8IMY (y)(A) certifying that such Administrative Agent is a qualified intermediary, within the meaning of Treasury Regulation Section
110
    



1.1441-1(e)(5)(ii) (or any successor thereto) and (B) assuming primary responsibility for U.S. federal income tax withholding with respect to payments to be received by it on behalf of the Lenders or (z) evidencing its agreement with the Borrowers to be treated as a United States person with respect to payments on such Loans for U.S. federal income tax purposes in accordance with Treasury Regulation 1.1441-1(b)(2)(iv)(A) (or any successor thereto)). The forms and certification referenced in the previous three sentences (the “Forms”) shall be delivered by the Administrative Agent and each Lender on or before the date it becomes a party to this Agreement. In addition, the Administrative Agent and each Lender shall deliver the Forms promptly upon the obsolescence or invalidity of any Forms previously delivered by the Administrative Agent and such Lender and upon the written request of the Borrower Representative or the Administrative Agent. The Administrative Agent and each Lender shall promptly notify the Borrower Representative (on behalf of the applicable Borrowers) at any time it determines that it is no longer in a position to provide any previously delivered Form to the Borrower Representative (or any other form or certification adopted by the U.S. taxing authorities for such purpose). Notwithstanding any other provision of this paragraph (j), the Administrative Agent and each Lender shall not be required to deliver any Form pursuant to this paragraph (j) that the Administrative Agent and such Lender is not legally able to deliver.
(xi)The Administrative Agent and each Lender that is entitled to an exemption from or reduction of withholding tax (other than U.S. federal withholding Tax) under the law of the jurisdiction in which a Loan Party is resident for tax purposes, or any treaty to which such jurisdiction is a party, with respect to payments under any Loan Document (including, for the avoidance of doubt, a Luxembourg Treaty Lender, a German Treaty Lender, a Spanish Treaty Lender and a UK Treaty Lender) shall (subject, in the case of a UK Treaty Lender with respect to an exemption from or reduction of a UK Tax Deduction, to Section 2.19(l)) (i) cooperate in completing any procedural formalities necessary for a Loan Party making a payment to that Lender or the Administrative Agent to obtain authorization to make that payment without a withholding or deduction for, or on account of, Tax, and (ii) deliver to the Borrower Representative (on behalf of the applicable Borrowers) (with a copy to the Administrative Agent), at the time or times reasonably requested by the Borrower Representative (on behalf of the applicable Borrowers) or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law or any treaty as will permit such payments to be made without withholding or deduction for, or on account of, Tax or at a reduced rate, provided that the Administrative Agent or such Lender, as applicable, is legally entitled to complete such procedural formalities or complete, execute and deliver such documentation and in the Administrative Agent’s or such Lender’s judgment, as applicable, such completion of such procedural formalities or such completion, execution or submission of such documentation would not materially prejudice the legal or commercial position of the Administrative Agent and such Lender.
(xii)A UK Treaty Lender which becomes (i) a party to this Agreement on the Closing Date that (x) holds a passport under the HM Revenue & Customs DT Treaty Passport scheme and (y) wishes such scheme to apply to this Agreement, shall confirm its scheme reference number and its jurisdiction of tax residence opposite its name in Schedule 1.1A; or (ii) a Lender hereunder after the Closing Date that (x) holds a passport under the HM Revenue & Customs DT Treaty Passport scheme and (y) wishes such scheme to apply to this Agreement, shall provide its scheme reference number and its jurisdiction of tax residence in the relevant Assignment or Assumption, Refinancing Amendment or Incremental Amendment pursuant to which such Lender becomes a party hereto or otherwise in writing to the UK Borrower within 15 days of it become a party to this Agreement, and having done so, such UK Treaty Lender shall have satisfied its obligation under clause (k) above in respect of a UK Tax Deduction.
(xiii)If a UK Treaty Lender has confirmed its scheme reference number and its jurisdiction of tax residence in accordance with clause (l) above and
(1)a UK Borrower making a payment to that Lender has not made a Borrower DTTP Filing in respect of that Lender; or
(2)a UK Borrower making a payment to that Lender has made a Borrower DTTP Filing in respect of that Lender but:
111
    



(a)such Borrower DTTP Filing has been rejected by HM Revenue & Customs; or
(b)HM Revenue & Customs has not given that UK Borrower authority to make payments to that Lender without a Tax Deduction within 60 days of the date of the Borrower DTTP Filing,
and in each case, the UK Borrower has notified that UK Treaty Lender in writing of either (1) or (2) above, then such UK Treaty Lender and the UK Borrower shall co-operate in completing any additional procedural formalities necessary for that UK Borrower to obtain authorization to make that payment without a UK Tax Deduction.
(3)If a UK Treaty Lender has not confirmed its scheme reference number and jurisdiction of tax residence in accordance with clause (l) above, no Loan Party shall make a Borrower DTTP Filing or file any other form relating to the HM Revenue & Custom DT Treaty Passport scheme in respect of that UK Treaty Lender's Commitment(s) or its participation in any Loan unless the UK Treaty Lender otherwise agrees.
(4)A Loan Party shall, promptly on making a Borrower DTTP Filing, deliver a copy of such Borrower DTTP Filing to the Administrative Agent for delivery to the relevant UK Treaty Lender.
(5)A UK Non-Bank Lender which becomes a party to this Agreement on the Closing Date gives a UK Tax Confirmation to the UK Borrower by entering into this Agreement. A UK Non-Bank Lender shall promptly notify the UK Borrower and the Administrative Agent if there is any change in the position from that set out in the UK Tax Confirmation.
(xiv)If the Administrative Agent or any Lender determines, in its sole discretion exercised in good faith, that it has received a refund (whether in the form of cash or as a credit against, or as a reduction of, a tax liability) of any Non-Excluded Taxes or Other Taxes as to which it has been indemnified by the Loan Parties or with respect to which the Loan Parties have paid additional amounts pursuant to this Section 2.19, it shall pay over such refund to the relevant Loan Party (but only to the extent of indemnity payments made, or additional amounts paid, by the Loan Parties under this Section 2.19 with respect to the Non-Excluded Taxes or Other Taxes giving rise to such refund), net of all out-of-pocket expenses of the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund); provided that the relevant Loan Party, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to the Loan Parties (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (n), in no event will the Administrative Agent or any Lender be required to pay any amount to the Loan Parties pursuant to this paragraph (n) the payment of which would place the Administrative Agent or such Lender in a less favorable net after-Tax position than it would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. This paragraph (n) shall not be construed to require the Administrative Agent or any Lender to make available its tax returns (or any other information relating to its taxes which it deems confidential) to the Borrower Representative or any other Person.
(xv)If a payment made to the Administrative Agent or a Lender under any Loan Document would be subject to United States federal withholding Tax imposed by FATCA if the Administrative Agent or such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), the Administrative Agent and such Lender shall deliver to the Borrower Representative (on behalf of the applicable Borrowers) and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower Representative (on behalf of the applicable Borrowers) or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the
112
    



Borrower Representative (on behalf of the applicable Borrowers) or the Administrative Agent as may be necessary for any Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that the Administrative Agent or such Lender has complied with the Administrative Agent’s or such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this paragraph (o), “FATCA” shall include any amendments made to FATCA after the Closing Date.
(xvi)Each Lender which becomes a party to this Agreement after the Closing Date (a “New Lender”) shall indicate in the Assignment and Assumption, Refinancing Amendment or Incremental Amendment pursuant to which such Lender will became a party hereto, which of the following categories it falls in: (i) in relation to a Luxembourg Borrower (a) not a Luxembourg Qualifying Lender, (b) a Luxembourg Qualifying Lender (other than a Luxembourg Treaty Lender), or (c) a Luxembourg Treaty Lender; (ii) in relation to a UK Borrower (a) not a UK Qualifying Lender, (b) a UK Qualifying Lender (other than a UK Treaty Lender), or (c) a UK Treaty Lender; (iii) in relation to a German Borrower (a) not a German Qualifying Lender, (b) a German Qualifying Lender (other than a German Treaty Lender), or (c) a German Treaty Lender; and (iv) in relation to a Spanish Borrower (a) not a Spanish Qualifying Lender, (b) a Spanish Qualifying Lender (other than a Spanish Treaty Lender or an EU Lender), (c) an EU Lender; or (d) a Spanish Treaty Lender. If a New Lender fails to indicate its status in accordance with this Section 2.19(p) then such New Lender shall be treated for the purposes of this Agreement as if it was not a Luxembourg Qualifying Lender, not a UK Qualifying Lender, not a German Qualifying Lender or not at Spanish Qualifying Lender, as applicable, until such time as it notifies the Administrative Agent which category applies (and the Administrative Agent upon receipt of such notification, shall inform the Borrower Representative). For the avoidance of doubt, an Assignment and Assumption, Refinancing Amendment or Incremental Amendment shall not be invalidated by any failure of a Lender to comply with this Section 2.19(p).
(xvii)Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify the Borrower Representative (on behalf of the applicable Borrowers) and the Administrative Agent in writing of its legal inability to do so.
(xviii)Without limiting any other provisions of this Agreement, each Lender that would not qualify for a complete exemption from withholding Taxes with respect to payments made under any Loan Document at the time such Lender becomes a party to this Agreement, shall consider in good faith, but not be required, to take actions, including assigning any of its Commitments and Loans to an affiliate of such Lender, so as to reasonably limit any obligations of the Loan Parties under this Section 2.19.
(xix)The agreements in this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.
(xx)VAT.
(1)All amounts expressed to be payable under any Loan Document by any party to this Agreement to a Lender which (in whole or in part) constitute the consideration for any supply for VAT purposes are deemed to be exclusive of any VAT which is chargeable on that supply and, accordingly, subject to clause (ii) below, if VAT is or becomes chargeable on any supply made by any Lender to any party to this Agreement under any Loan Document and such Lender is required to account to the relevant tax authority for the VAT, that party must pay to such Lender (in addition to and at the same time as paying any other consideration for such supply) an amount equal to the amount of the VAT (and such Lender must promptly provide an appropriate VAT invoice to that party).
(2)If VAT is or becomes chargeable on any supply made by any Lender (the “Supplier”) to any other Lender (the “Recipient”) under any Loan Document, and any party other than the Recipient (the “Relevant Party”) is required by the terms of any Loan Document to pay an amount equal to the consideration for that supply to the Supplier (rather than being required to reimburse or indemnify the Recipient in respect of that consideration):
113
    



(a)(where the Supplier is the person required to account to the relevant tax authority for the VAT) the Relevant Party must also pay to the Supplier (at the same time as paying that amount) an additional amount equal to the amount of the VAT. The Recipient must (where this clause (1) applies) promptly pay to the Relevant Party an amount equal to any credit or repayment the Recipient receives from the relevant tax authority which the Recipient reasonably determines relates to the VAT chargeable on that supply; and
(b)(where the Recipient is the person required to account to the relevant tax authority for the VAT) the Relevant Party must promptly, following demand from the Recipient, pay to the Recipient an amount equal to the VAT chargeable on that supply but only to the extent that the Recipient reasonably determines that it is not entitled to credit or repayment from the relevant tax authority in respect of that VAT.
(3)Where any Loan Document requires any party to this Agreement to reimburse or indemnify a Lender for any cost or expense, that party shall reimburse or indemnify (as the case may be) such Lender for the full amount of such cost or expense, including such part thereof as represents VAT, save to the extent that such Lender reasonably determines that it is entitled to credit or repayment in respect of such VAT from the relevant tax authority.
(4)Any reference in this Section 2.19(t) to any party shall, at any time when such party is treated as a member of a group for VAT purposes, include (where appropriate and unless the context otherwise requires) a reference to the representative member of such group at such time (the term “representative member” to have the same meaning as in the Value Added Tax Act 1994 or in the relevant legislation of any other jurisdiction having implemented Council Directive 2006/112/EC on the common system of value added tax).
(5)In relation to any supply made by a Lender to any party to this Agreement under any Loan Document, if reasonably requested by such Lender, that party must promptly provide such Lender with details of that party's VAT registration and such other information as is reasonably requested in connection with such Lender's VAT reporting requirements in relation to such supply.
(u)    Each (i) Spanish Qualifying Lender under paragraphs (d) or (e) of the definition of “Spanish Qualifying Lender” and (ii) Lender who is not resident for tax purposes in Spain but is entitled to the benefits of a Spanish Treaty providing for a reduction of a Spanish Tax Deduction applicable on interest shall, as soon as reasonably practicable after the date on which it becomes a Party to this Agreement, and in any event before any payment is due or made, whichever comes first, deliver to the Spanish Borrower through the Administrative Agent a certificate of tax residence (or the specific form or documentation required under the relevant Spanish Treaty) duly issued by the competent tax authorities of that Lender’s jurisdiction of tax residence evidencing such Lender as resident for tax purposes in that jurisdiction and, if a Spanish Treaty Lender or a Lender entitled to the benefits of a Spanish Treaty, evidencing such Lender as resident for tax purposes in that jurisdiction and declaring that it is entitled to the benefits of the relevant Spanish Treaty. Each such Lender shall be required to deliver a new certificate of tax residence each time the existing certificate expires in accordance with the Spanish laws and regulations.
For purposes of this Section 2.19, the term Lender shall include any Issuing Lender or Swingline Lender.
2.t[Reserved].
2.uIndemnity. The Borrowers agree to indemnify each Lender for, and to hold each Lender harmless from, any loss or expense that such Lender may sustain or incur as a consequence of (a) default by any Borrower in making a borrowing of, conversion into or continuation of Eurocurrency Loans, Sterling Daily Rate Loans or Term SOFR Loans after the Borrower Representative has given a notice requesting the same in accordance with the provisions of this Agreement, (b) default by the Borrowers in making any prepayment of or conversion from Eurocurrency Loans, Sterling Daily Rate Loans or Term SOFR Loans after the Borrower Representative has given a notice thereof in accordance with the
114
    



provisions of this Agreement or (c) the making of a prepayment of Eurocurrency Loans or Term SOFR Loans on a day that is not the last day of an Interest Period with respect thereto. Such indemnification may include an amount equal to the excess, if any, of (i) the amount of interest that would have accrued on the amount so prepaid, or not so borrowed, reduced, converted or continued, for the period from the date of such prepayment or of such failure to borrow, reduce, convert or continue to the last day of such Interest Period (or, in the case of a failure to borrow, reduce, convert or continue, the Interest Period that would have commenced on the date of such failure) in each case at the applicable rate of interest or other return for such Loans provided for herein (excluding, however, the Applicable Margin included therein, if any) over (ii) the amount of interest (as reasonably determined by such Lender) that would have accrued to such Lender on such amount by placing such amount on deposit for a comparable period with leading banks in the interbank eurocurrency market; provided that the foregoing shall not apply in respect of the Revolving Facility in the case of any benchmark rate that is not an interbank eurocurrency rate. A certificate as to any amounts payable pursuant to this Section submitted to the Borrower Representative by any Lender shall be conclusive in the absence of manifest error. This covenant shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.
2.vChange of Lending Office.
(i)Each Lender agrees that, upon the occurrence of any event giving rise to the operation of Sections 2.18 or 2.19 with respect to such Lender, it will, if requested by the Borrower Representative, use reasonable efforts (subject to overall policy considerations of such Lender) to designate another lending office for any Loans affected by such event with the object of avoiding the consequences of such event; provided that such designation is made on terms that, in the sole judgment of such Lender, cause such Lender and its lending office(s) to suffer no economic, legal or regulatory disadvantage (with respect to which such Lender is not reimbursed), and provided, further, that nothing in this Section shall affect or postpone any of the obligations of the Borrowers or the rights of any Lender pursuant to Sections 2.18 or 2.19.
(ii)Subject to clause (a) above, and without prejudice to the rights and obligations (but subject to the terms and requirements) in Section 2.19, each Borrower agrees that each Lender may, at its option, make any Loan available to any Borrower by causing any foreign or domestic branch or Affiliate of such Lender to make such Loan, and that any exercise of such option shall not shall affect or postpone any of the obligations of the Borrowers or the rights of any Lender pursuant to this Agreement (except to the extent that, for the avoidance of doubt, the exercise of such option changes such Lender’s status as a UK Qualifying Lender, a German Qualifying Lender, a Spanish Qualifying Lender or a Luxembourg Qualifying Lender for the purposes of Section 2.19).
2.wReplacement of Lenders. The Borrowers shall be permitted to replace, or, notwithstanding Section 2.17, prepay the applicable Loans and terminate the applicable Commitments (on a non pro rata basis among Lenders generally), of any Lender (a) where a Loan Party is obligated to pay additional amounts or indemnity payments under Section 2.19, (b) that requests reimbursement for amounts owing pursuant to Sections 2.16 or 2.18, (c) that becomes a Defaulting Lender or otherwise defaults in its obligation to make Loans hereunder or (d) that has not consented to a proposed change, waiver, discharge or termination of the provisions of this Agreement as contemplated by Section 11.1 that requires the consent of all Lenders or all Lenders under a particular Facility or each Lender affected thereby and which has been approved by the Required Lenders as provided in Section 11.1, with a Lender or Eligible Assignee; provided that (i) such replacement does not conflict with any Requirement of Law, (ii) in the case of clause (a) or (b), prior to any such replacement, such Lender shall have taken no action under Section 2.22 sufficient to eliminate the continued need for payment of amounts owing pursuant to Sections 2.16, 2.18 or 2.19, (iii)  the replacement financial institution or other Eligible Assignee shall purchase, or the applicable Borrowers shall repay, all Loans and other amounts (or, in the case of clause (d) as it relates to provisions affecting a particular Facility, Loans or other amounts owing under such Facility) owing to such replaced Lender on or prior to the date of replacement, (iv) the Borrowers shall be liable to such replaced Lender under Section 2.21 if any Eurocurrency Loan or Term SOFR Loan owing to such replaced Lender shall be purchased other than on the last day of the Interest Period relating thereto, (v) in the case of any replacement, the replacement financial institution or other Eligible Assignee, if not already a Lender, shall be reasonably satisfactory to the Administrative Agent, (vi) in the case of any replacement, the replaced Lender shall be deemed to have made such replacement in
115
    



accordance with the provisions of Section 11.6, (vii) until such time as such replacement or prepayment and termination shall be consummated, the Borrowers shall pay all additional amounts (if any) required pursuant to Sections 2.16, 2.182.19(a) or 2.19(f), as the case may be, and (viii) any such replacement or prepayment and termination shall not be deemed to be a waiver of any rights that the Borrowers, the Administrative Agent or any other Lender shall have against the replaced Lender. Upon any such assignment, such replaced Lender shall no longer constitute a “Lender” for purposes hereof (or, in the case of clause (d) as it relates to provisions affecting a particular Facility, a Lender under such Facility); provided that any rights of such replaced Lender to indemnification hereunder shall survive as to such replaced Lender. Each Lender, the Administrative Agent and the Borrowers agree that in connection with the replacement of a Lender and upon payment to such replaced Lender of all amounts required to be paid under this Section 2.23, the Administrative Agent and the Borrowers shall be authorized, without the need for additional consent from such replaced Lender, to execute an Assignment and Assumption on behalf of such replaced Lender, and any such Assignment and Assumption so executed by the Administrative Agent or the Borrowers and, to the extent required under Section 11.6, the Borrowers, the Swingline Lender and each Issuing Lender, shall be effective for purposes of this Section 2.23 and Section 11.6. Notwithstanding anything to the contrary in this Section 2.23, in the event that a Lender which holds Loans or Commitments under more than one Facility does not agree to a proposed amendment, supplement, modification, consent or waiver which requires the consent of all Lenders under a particular Facility, the Borrowers shall be permitted to replace or, notwithstanding Section 2.17, prepay the applicable Loans and terminate the applicable Commitments of the non-consenting Lender with respect to the affected Facility and may, but shall not be required to, replace such Lender with respect to any unaffected Facilities.
2.xEvidence of Debt; Notes. The Loans and other credit extensions hereunder made by each Lender shall be evidenced by one or more accounts or records maintained by such Lender in the ordinary course of business. The Administrative Agent shall maintain the Register in accordance with Section 11.6(b)(vi). The accounts or records maintained by each Lender shall be conclusive absent manifest error of the amount of the Loans and other credit extensions hereunder made by the Lenders to the Borrowers and the interest and payments thereon. Any failure to so record or any error in doing so shall not, however, limit or otherwise affect the joint and several obligation of the Borrowers hereunder to pay any amount owing with respect to the Obligations. In the event of any conflict between the accounts and records maintained by any Lender and the Register, the Register shall control in the absence of manifest error. If so requested by any Lender by written notice to the Borrower Representative (with a copy to the Administrative Agent), the applicable Borrowers shall execute and deliver to such Lender (and/or, if applicable and if so specified in such notice, to any Person who is an assignee of such Lender pursuant to Section 11.6) (promptly after the Borrower Representative’s receipt of such notice) a Note or Notes to evidence such Lender’s Loans in addition to such accounts or records. Each Lender may attach schedules to its Note and endorse thereon the date, Type (if applicable), amount and maturity of its Loans and payments with respect thereto.
2.yIncremental Credit Extensions.
Subject to the terms of this Section 2.25:
(i)A Borrower or Subsidiary Guarantor may, at any time or from time to time after the Closing Date, by notice from the Borrower Representative to the Administrative Agent (whereupon the Administrative Agent shall promptly deliver a copy to each of the Lenders) and the Person appointed by the Borrower Representative to arrange an Incremental Facility (such Person, who may be the Administrative Agent, if it so agrees, or any other Person appointed by the Borrower Representative, the “Incremental Arranger”), request one or more additional tranches of term loans and/or one or more increases to the amount of any Class of Term Loans then outstanding (the commitments thereof, the “Incremental Term Commitments”, the loans thereunder, the “Incremental Term Loans”, and a Lender making such loans, an “Incremental Term Lender”) and/or one or more additional tranches of revolving loans (the “Additional/Replacement Revolving Commitments”) and/or one or more increases in the amount of the Revolving Commitments of any Class (each such increase, a “Revolving Commitment Increase”, the loans thereunder and under any Additional/Replacement Revolving Commitments, the “Incremental Revolving Loans”, and a Lender making a commitment to provide such Incremental Revolving Loans, an “Incremental Revolving Lender”); provided that the Borrowers and Subsidiary
116
    



Guarantors may incur Incremental Term Commitments that are intended to be fungible with the Initial Term Loans on no more than five occasions prior to the initial Term Loan Maturity Date unless the Administrative Agent otherwise agrees; provided, further, that:
(1)after giving effect to any such Additional/Replacement Revolving Commitments, any such Revolving Commitment Increase and any such Incremental Term Loans, the aggregate amount of such Additional/Replacement Revolving Commitments, Revolving Commitment Increases and Incremental Term Loans shall not exceed an amount equal to the sum of (x) an unlimited amount at any time so long as the First Lien Net Leverage Ratio on a Pro Forma Basis (but without giving effect to the cash proceeds of such Incremental Term Loans or of any Incremental Revolving Loans incurred pursuant to such Revolving Commitment Increase or such Additional/Replacement Revolving Commitments remaining on the balance sheet) as of the most recently ended Reference Period (calculated assuming that such Revolving Commitment Increase or Additional/Replacement Revolving Commitment is fully drawn throughout such period) does not exceed the greater of (A) 5.00 to 1.00 and (B) if incurred to finance an acquisition or other Investment permitted hereunder, the First Lien Net Leverage Ratio as of the most recently ended Reference Period, plus (y) the amount of all prior voluntary prepayments, loan buybacks (with credit given to the principal amount thereof) and commitment reductions of Term Loans, Revolving Loans, Incremental Loans, Indebtedness incurred pursuant to Section 7.2(b)(vi) that is secured by a Lien on the Collateral on a pari passu basis with the Obligations and Permitted Credit Agreement Refinancing Debt and Refinancing Indebtedness previously applied to the permanent repayment of any of the foregoing and the amount of any prepayments made to any Lender pursuant to Section 2.23, with any replacement of a Lender pursuant thereto being deemed, solely for this purpose, to constitute a prepayment (in each case to the extent not funded with the proceeds of long-term Indebtedness (except Indebtedness under one or more revolving credit or similar facilities) or the proceeds of Permitted Cure Securities applied pursuant to Section 9.4 and, with respect to any prepayment or commitment reduction of or in respect of revolving loans, to the extent accompanied by a permanent reduction in such revolving commitments) less the aggregate principal amount of Indebtedness incurred under Section 7.2(b)(vi)(y), plus (z) an amount equal to the greater of $325,000,000 and 100% of Consolidated EBITDA on a Pro Forma Basis as of the most recently ended Reference Period (and after giving effect to any acquisition or other transaction consummated concurrently therewith) less the aggregate outstanding principal amount of Indebtedness incurred under Section 7.2(b)(vi)(z) (provided that, for the avoidance of doubt, the amount available to the Borrowers pursuant to clauses (y) and (z) above shall be available at all times and shall not be subject to any ratio test described in foregoing clause (x)); provided that, for the avoidance of doubt, if the applicable Borrower incurs Incremental Term Loans, Additional/Replacement Revolving Commitments or a Revolving Commitment Increase under clause (x) above on the same date that it incurs indebtedness under clauses (y) or (z) above, then the First Lien Net Leverage Ratio will be calculated with respect to such incurrence under clause (x) without regard to any incurrence of indebtedness under clauses (y) or (z) above. Unless the Borrower Representative elects otherwise, any Incremental Term Loans, Additional/Replacement Revolving Commitments or Revolving Commitment Increase shall be deemed incurred first under clause (x) above, with the balance incurred under clauses (y) and (z) above. The Borrower Representative may designate any Incremental Arranger of any Incremental Facility with such titles under the Incremental Facility as Borrower Representative may deem appropriate.
(2)the Incremental Term Loans and Incremental Revolving Loans shall rank pari passu in right of payment and of security with the other Loans and Commitments hereunder;
(3)any Additional/Replacement Revolving Commitments shall not mature earlier than the Revolving Termination Date and shall not have amortization or scheduled mandatory commitment reductions (other than at the maturity thereof) and all other material terms (other than pricing, maturity, upfront, arrangement, structuring, underwriting, ticking, consent, amendment and other fees, participation in mandatory prepayments or commitment reductions and immaterial terms, which shall be determined by the Borrower Representative) shall (x) be substantially consistent with the existing Revolving Facility or (y) be reasonably satisfactory to the Administrative Agent (it being understood that if any financial maintenance covenant or other more favorable provision (other than pricing, maturity, upfront, arrangement, structuring, underwriting, ticking, consent, amendment and other fees, participation in mandatory prepayments or commitment reductions and immaterial terms) is added for the benefit of any Additional/Replacement Revolving Commitments, no consent shall be required from the Administrative Agent or any Lender to the extent that such financial maintenance covenant or such other
117
    



provision is (i) also added for the benefit of any then-existing Revolving Facility, in which case such terms may be incorporated into this Agreement (or any other applicable Loan Document) for the benefit of the Revolving Facility without further amendment or consent requirements or (ii) only applicable after the Revolving Termination Date);
(4)other than Customary Bridge Financings and Indebtedness incurred pursuant to the Inside Maturity Basket, the Incremental Term Loans shall have a Weighted Average Life to Maturity no shorter than the remaining Weighted Average Life to Maturity of the Initial Term Loans and the Amendment No. 2 Incremental Term Loans determined at the time of incurrence and shall not mature earlier than the Term Loan Maturity Date;
(5)subject to clause (iv) above, the interest rates and the amortization schedule applicable to any such Incremental Term Loans shall be determined by the Borrower Representative and the applicable Incremental Term Lenders;
(6)no Event of Default shall exist on the Incremental Facility Closing Date with respect to any Incremental Amendment entered into in connection therewith (and after giving effect to any Incremental Term Loans and/or Incremental Revolving Loans made thereunder); provided, however, that in connection with a Limited Condition Transaction, the absence of an Event of Default shall be tested on the date specified in Section 1.4;
(7)with respect to any Dollar denominated Incremental Term Loans in the form of broadly syndicated term “B” loans, if the all-in-yield (whether in the form of interest rate margins, including interest rate floors (subject to clause (1) of the first proviso in this clause (vii)), upfront fees or OID (with any OID being equated to interest margin based on an assumed four-year life to maturity)) with respect to the Incremental Term Loans made thereunder paid by any Borrower to all lenders generally (as determined by the Borrower Representative and the applicable Incremental Arranger) (but excluding any arrangement, commitment, ticking, structuring or other similar fees payable in connection therewith, which shall not be included and equated to interest rate) with respect to the Incremental Term Loans made thereunder exceeds the all-in yield (after giving effect to interest rate margins (including the interest rate floors (subject to clause (1) of the first proviso in this clause (vii)) and OID (equated to interest based on an assumed four-year life to maturity or, if shorter, the remaining life to maturity thereof) paid by any Borrower to all lenders generally (computed in a manner consistent with the foregoing) with respect to the Initial Term Loans or the Amendment No. 2 Incremental Term Loans, as applicable, that are denominated in the same currency as such Incremental Term Loans, as the case may be, after giving effect to any increase or repricing thereof that has theretofore become effective (it being understood that if any such repricing was effected as a refinancing tranche, the OID applicable to the refinanced loans shall be taken into account), by more than 50 basis points (the amount of such excess above 50 basis points being referred to herein as the “Incremental Yield Differential”), then, upon the effectiveness of such Incremental Amendment, the Applicable Margin then in effect for such Initial Term Loans or Amendment No. 2 Incremental Term Loans, as applicable, denominated in the same currency shall automatically be increased by the Incremental Yield Differential (this clause (vii), after giving effect to the final proviso to this clause (vii), the “MFN Provision”); provided, (1) if the Incremental Term Loans include an interest-rate floor greater than the interest rate floor applicable to such Term Loans, the differential between such interest rate floors shall be equated to the interest rate margins for purposes of determining whether an increase to the Applicable Margin shall be required, but only to the extent an increase in the interest rate floor applicable to such Term Loans would cause an increase in the Applicable Margin, and in such case either the interest rate floor or the Applicable Margin (at the election of the Borrower Representative) applicable to such Term Loans shall be increased to the extent of such differential between interest rate floors and (2) any Incremental Term Loans that constitute fixed-rate Indebtedness shall be swapped to a floating rate on a customary matched-maturity basis; provided further that the MFN Provision shall not apply to (A) any Incremental Term Loans having an aggregate principal amount not exceeding the greater of $250,000,000 and 75% of Consolidated EBITDA as of the most recently ended Reference Period (as selected by the Borrower Representative), (B) Incremental Term Loans scheduled to mature on or after the date that is one year after the Term Loan Maturity Date as of the Closing Date, (C) Incremental Term Loans incurred after the date that is 18 months after the Closing Date (or, solely in the case of Amendment No. 2 Incremental Term Loans, after the date that is 6 months
118
    



after the Amendment No. 2 Effective Date) or (D) Incremental Term Loans incurred in connection with an acquisition or other Investment permitted hereunder;
(8)the Incremental Term Loans, Additional/Replacement Revolving Commitments and Revolving Commitment Increases may be denominated in Dollars, any Alternative Currency and any other currency acceptable to the Incremental Arranger and the applicable Incremental Term Lenders or Incremental Revolving Lenders, as the case may be;
(9)no Incremental Term Loans, Additional/Replacement Revolving Commitments and Revolving Commitment Increases may be secured by any assets other than the Collateral and no Incremental Term Loans and Revolving Commitment Increases shall be guaranteed by any person other than the Borrowers and the Guarantors;
(10)any Incremental Term Loans may provide for the ability to participate (A) on a pro rata basis or non-pro rata basis in any voluntary prepayment of Term Loans made pursuant to Section 2.10(a) and (B) on a pro rata or less than pro rata basis (but not on a greater than pro rata basis, other than in the case of prepayment with proceeds of Indebtedness refinancing such Incremental Term Loans) in any mandatory prepayment of Term Loans required pursuant to Section 2.11;
(11)except as otherwise required or permitted by the foregoing, all other terms of any Incremental Term Loans shall be as agreed between the applicable Borrowers and the Incremental Term Lenders; provided that if such Incremental Term Loans benefit from a financial covenant that is more restrictive than Section 7.1 of this Agreement, such financial covenant shall be either (A) conformed (or added) to the Loan Documents for the benefit of the Revolving Lenders pursuant to an amendment agreement between the Administrative Agent and the applicable Borrowers or (B) applicable only to periods after the Revolving Termination Date or otherwise reasonably satisfactory to the Administrative Agent; and
(xii)    no Additional/Replacement Revolving Commitments may be provided by an Affiliate of UK Holdco.
(ii)The Revolving Commitment Increases shall be treated substantially the same as the Revolving Commitments being increased, and shall be considered to be part of the Class of Revolving Facility being increased (it being understood that (x) if required to consummate the provision of Revolving Commitment Increases, the pricing, interest rate margins, rate floors and facility fees on the Class of Revolving Commitments being increased may be increased and additional upfront or similar fees may be payable to the lenders providing the Revolving Commitment Increase (without any requirement to pay such fees to any existing Revolving Lenders or the requirement to obtain the consent of any Lender) and (y) other terms that are more favorable to the lenders providing the Revolving Commitment Increase may be incorporated into this Agreement (or any other applicable Loan Document) for the benefit of the Class of Revolving Commitments being increased without the need for the consent of any Lender). Each notice from the Borrower Representative to the Administrative Agent and the Incremental Arranger pursuant to Section 2.25(a) shall set forth the requested amount and principal proposed terms of the relevant Incremental Term Loans, Additional/Replacement Revolving Commitments or Revolving Commitment Increase.
(iii)Incremental Term Loans may be made, and Additional/Replacement Revolving Commitments and Revolving Commitment Increases may be provided, by any existing Lender or any Additional Lender (provided that no existing Lender shall be obligated to provide any portion of any Incremental Facility), in each case on terms permitted in this Section 2.25, and, to the extent not permitted in this Section 2.25, all terms and documentation with respect to any Incremental Term Loan, Additional/Replacement Revolving Commitments or Revolving Commitment Increase which relate to provisions of a mechanical (including with respect to the Collateral and currency mechanics) or administrative nature, shall in each case be reasonably satisfactory to the Administrative Agent; provided that the Administrative Agent shall not be required to execute, accept or acknowledge any Incremental Amendment (as defined below) or related documentation which contains (by express language or omission) any material deviation from the terms of this Section 2.25. Commitments in respect of Incremental Term Loans, Additional/Replacement Revolving Commitments and Revolving Commitment
119
    



Increases shall become Commitments (or in the case of a Revolving Commitment Increase to be provided by an existing Revolving Lender, an increase in such Lender’s applicable Revolving Commitment) under this Agreement pursuant to an amendment (an “Incremental Amendment”) to this Agreement and, as appropriate, the other Loan Documents, executed by the Borrower Representative, each Lender agreeing to provide such Commitment, if any, each Additional Lender, if any, and, in the case of an Incremental Facility incurred by a Subsidiary Guarantor, such Subsidiary Guarantor (it being understood and agreed that any such Subsidiary Guarantor shall be organized in an Applicable Jurisdiction). The Incremental Amendment may, without the consent of any other Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Incremental Arranger and the Borrower Representative, to effect the provisions of this Section (including (i) any amendments that are not adverse to the interests of any Lender that are made to effectuate changes necessary to enable any Incremental Term Loans that are intended to be fungible with an existing Class of Term Loans to be fungible with such Term Loans, which shall include any amendments to Section 2.3 that do not reduce the ratable amortization received by each Lender thereunder and (ii) any amendments that are reasonably necessary to account for any Subsidiary Guarantor as a Borrower, in each case without the need for any further consent); provided that any terms relating to provisions of an operational nature (including with respect to the Collateral and currency mechanics) or administrative nature shall be reasonably satisfactory to the Administrative Agent). Notwithstanding anything in Section 5.2 to the contrary, the effectiveness of any Incremental Amendment and the occurrence of any credit event (including the making (but not the conversion or continuation) of a Loan and the issuance, increase in the amount, or extension of a Letter of Credit thereunder) pursuant to such Incremental Amendment shall be subject solely to the satisfaction of such conditions as the parties thereto shall agree and the conditions set forth in this Section 2.25 (the effective date of any such Incremental Amendment, an “Incremental Facility Closing Date”). The Borrowers will use the proceeds of the Incremental Term Loans, Additional/Replacement Revolving Commitments and Revolving Commitment Increases for any purpose not prohibited by this Agreement.
(iv)Upon each Revolving Commitment Increase pursuant to this Section, each Revolving Lender immediately prior to such increase will automatically and without further act be deemed to have assigned to each Lender providing a portion of the Revolving Commitment Increase (each a “Revolving Commitment Increase Lender”) in respect of such increase, and each such Revolving Commitment Increase Lender will automatically and without further act be deemed to have assumed, a portion of such Revolving Lender’s participations hereunder in outstanding Letters of Credit and Swingline Loans such that, after giving effect to each such deemed assignment and assumption of participations, the percentage of the aggregate outstanding (i) participations hereunder in Letters of Credit and (ii) participations hereunder in Swingline Loans held by each Revolving Lender (including each such Revolving Commitment Increase Lender) will equal the percentage of the aggregate Revolving Commitments of all Revolving Lenders represented by such Revolving Lender’s Revolving Commitment and if, on the date of such increase, there are any Revolving Loans outstanding, such Revolving Loans shall on or prior to the effectiveness of such Revolving Commitment Increase either be prepaid from the proceeds of additional Revolving Loans made hereunder or assigned to a Revolving Commitment Increase Lender (in each case, reflecting such increase in Revolving Commitments, such that Revolving Loans are held ratably in accordance with each Revolving Lender’s Pro Rata Share, after giving effect to such increase), which prepayment or assignment shall be accompanied by accrued interest on the Revolving Loans being prepaid and any costs incurred by any Lender in accordance with Section 2.21 (it being understood that the foregoing provisions shall apply only to an increase in the amount of the Revolving Commitments of any Class and not to any additional tranches of Revolving Loans). The Administrative Agent and the Lenders hereby agree that the minimum borrowing, pro rata borrowing and pro rata payment requirements contained elsewhere in this Agreement shall not apply to the transactions effected pursuant to the immediately preceding sentence. For the avoidance of doubt, this Section 2.25(d) shall apply only to such Class of Revolving Commitments that are the same Class as the Incremental Revolving Loans and shall not apply to any other Class of Revolving Loans.
(v)Notwithstanding anything to the contrary herein, this Section 2.25 shall supersede any provisions in Sections 2.17, 5.2 or 11.1 to the contrary and Section 2.17 shall be deemed to be amended to implement any Incremental Amendment.
120
    



(vi)If the Incremental Arranger is not the Administrative Agent, the actions authorized to be taken by the Incremental Arranger herein shall be done in consultation with the Administrative Agent and, with respect to the preparation of any documentation necessary or appropriate to carry out the provisions of this Section 2.25 (including amendments to this Agreement and the other Loan Documents), any comments to such documentation reasonably requested by the Administrative Agent shall be reflected therein.
2.zRefinancing Amendments.
(i)At any time after the Closing Date, a Borrower or Subsidiary Guarantor may obtain, from any Lender or any Additional Lender, Permitted Credit Agreement Refinancing Debt in respect of (1) all or any portion of the Term Loans then outstanding under this Agreement (which for purposes of this clause (1) will be deemed to include any then outstanding Other Term Loans) or (2) all or any portion of the Revolving Loans (or unused Revolving Commitments) under this Agreement (which for purposes of this clause (2) will be deemed to include any then outstanding Other Revolving Loans and Other Revolving Commitments), in the form of (x) Other Term Loans or Other Term Commitments or (y) Other Revolving Loans or Other Revolving Commitments, as the case may be, in each case pursuant to a Refinancing Amendment; provided that such Permitted Credit Agreement Refinancing Debt:
(1)shall not be permitted to rank senior in right of payment or security to the other Loans and Commitments hereunder;
(2)will have such pricing, premiums, optional prepayment terms and financial covenants as may be agreed by the Borrower Representative and the Lenders thereof;
(3)(x) with respect to any Other Revolving Loans or Other Revolving Commitments, will have a maturity date that is not prior to the maturity date of Revolving Loans (or unused Revolving Commitments) being Refinanced and (y) other than Customary Bridge Financings and Indebtedness incurred pursuant to the Inside Maturity Basket, with respect to any Other Term Loans or Other Term Commitments, will have a maturity date that is not prior to the maturity date of, and will have a Weighted Average Life to Maturity that is not shorter than, the remaining Weighted Average Life to Maturity of the Term Loans being Refinanced determined at the time of incurrence;
(4)subject to clause (ii) above, will have terms and conditions that are (i) substantially identical to, or, taken as a whole, not materially more favorable to the Lenders or Additional Lenders providing such Permitted Credit Agreement Refinancing Debt than, the Refinanced Debt (as determined by the Borrower Representative in good faith), (ii) then-current market terms (as determined by the Borrower Representative in good faith at the time of incurrence or issuance (or the obtaining of a commitment with respect thereto)) for the applicable type of Indebtedness; provided that if such Permitted Credit Agreement Refinancing Debt benefits from a financial covenant that is more restrictive than Section 7.1 of this Agreement, such financial covenant shall be either (A) conformed (or added) to the Loan Documents for the benefit of the Revolving Lenders pursuant to an amendment agreement between the Administrative Agent and the applicable Borrowers or (B) applicable only to periods after the Revolving Termination Date or otherwise reasonably satisfactory to the Administrative Agent or (iii) reasonably acceptable to the Administrative Agent (it being understood that if any financial maintenance covenant or other more favorable provision is added for the benefit of any Permitted Credit Agreement Refinancing Debt, no consent shall be required from the Administrative Agent or any Lender to the extent that such financial maintenance covenant or other provision is (i) also added for the benefit of the Refinanced Debt, in which case such terms may be incorporated into this Agreement (or any other applicable Loan Document) for the benefit of the Refinanced Debt without further amendment or consent requirements or (ii) only applicable after the maturity of the Refinanced Debt);
(5)the proceeds of such Permitted Credit Agreement Refinancing Debt shall be applied, substantially concurrently with the incurrence thereof, to the prepayment of outstanding Term Loans or reduction of Revolving Commitments being so Refinanced (and repayment of Revolving Loans outstanding thereunder); and
121
    



(6)shall not be secured by any assets other than the Collateral and shall not be guaranteed by any person other than the Borrowers and the Guarantors.
The effectiveness of any Refinancing Amendment shall be subject to the satisfaction on the date thereof of each of the conditions set forth in Section 5.2 (unless waived by the Lenders providing such Permitted Credit Agreement Refinancing Debt) and, to the extent reasonably requested by the Refinancing Arranger, receipt by the Refinancing Arranger of legal opinions, board resolutions, officers’ certificates and/or reaffirmation agreements consistent with those delivered on the Closing Date under Section 5.1 (other than changes to such legal opinions resulting from a change in law, change in facts or changes to counsel’s form of opinion). Any Refinancing Amendment may provide for the issuance of Letters of Credit for the account of the Borrower Representative or any Restricted Subsidiary, pursuant to any Other Revolving Commitments established thereby, in each case on terms substantially equivalent to the terms applicable to Letters of Credit under the Revolving Commitments subject to the approval of the Issuing Lenders.
(ii)The Refinancing Arranger shall promptly notify each Lender as to the effectiveness of each Refinancing Amendment. Each of the parties hereto hereby agrees that, upon the effectiveness of any Refinancing Amendment, this Agreement shall be deemed amended to the extent (but only to the extent) necessary to reflect the existence and terms of the Permitted Credit Agreement Refinancing Debt incurred pursuant thereto (including any amendments necessary to treat the Loans and Commitments subject thereto as Other Term Loans, Other Revolving Loans, Other Revolving Commitments and/or Other Term Commitments).
(iii)Any Refinancing Amendment may, without the consent of any other Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of Refinancing Arranger and the Borrower Representative, in consultation with the Administrative Agent, to effect the provisions of this Section. In addition, if so provided in the relevant Refinancing Amendment and with the consent of each Issuing Lender, participations in Letters of Credit expiring on or after the then-existing Revolving Termination Date shall be reallocated on such date from Lenders holding Revolving Commitments to Lenders holding extended revolving commitments in accordance with the terms of such Refinancing Amendment; provided, however, that such participation interests shall, upon receipt thereof by the relevant Lenders holding revolving commitments, be deemed to be participation interests in respect of such revolving commitments and the terms of such participation interests (including the commission applicable thereto) shall be adjusted accordingly.
(iv)Notwithstanding anything to the contrary in this Agreement, this Section 2.26 shall supersede any provisions in Sections 2.17 or 11.1 to the contrary and the Borrowers and the Administrative Agent may amend Section 2.17 to implement any Refinancing Amendment.
(v)If the Refinancing Arranger is not the Administrative Agent, the actions authorized to be taken by the Refinancing Arranger herein shall be done in consultation with the Administrative Agent and, with respect to the preparation of any documentation necessary or appropriate to carry out the provisions of this Section 2.26 (including amendments to this Agreement and the other Loan Documents), any comments to such documentation reasonably requested by the Administrative Agent shall be reflected therein.
2.aaDefaulting Lenders.
(i)Adjustments. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a Defaulting Lender, then, until such time as that Lender is no longer a Defaulting Lender, to the extent permitted by applicable law:
(1)Waivers and Amendments. Such Defaulting Lender’s right to approve or disapprove any amendment, waiver or consent with respect to this Agreement shall be restricted as set forth in the definitions of “Required Lenders”, “Majority Revolving Lenders” and “Majority Term Lenders” and otherwise as set forth in Section 11.1.
122
    



(2)Reallocation of Payments. Any payment of principal, interest, fees or other amounts received by the Administrative Agent for the account of such Defaulting Lender (whether voluntary or mandatory, at maturity, pursuant to Section 9 or otherwise, and including any amounts made available to the Administrative Agent by such Defaulting Lender pursuant to Section 11.8), shall be applied at such time or times as may be determined by the Administrative Agent as follows: first, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder; second, in the case of a Revolving Lender, to the payment on a pro rata basis of any amounts owing by such Defaulting Lender to the Issuing Lenders and the Swingline Lender hereunder; third, as the Borrowers may request (so long as no Default or Event of Default exists), to the funding of any Loan in respect of which such Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent; fourth, in the case of a Revolving Lender, if so determined by the Administrative Agent and the Borrowers, to be held in a non-interest bearing deposit account and released in order to satisfy obligations of such Defaulting Lender to fund Loans under this Agreement; fifth, to the payment of any amounts owing to the Lenders, the Issuing Lenders or the Swingline Lender as a result of any judgment of a court of competent jurisdiction obtained by any Lender, such Issuing Lender or the Swingline Lender against such Defaulting Lender as a result of such Defaulting Lender’s breach of its obligations under this Agreement; sixth, so long as no Default or Event of Default exists, to the payment of any amounts owing to the Borrowers as a result of any judgment of a court of competent jurisdiction obtained by the Borrowers against such Defaulting Lender as a result of such Defaulting Lender’s breach of its obligations under this Agreement; and seventh, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction; provided that if such payment is a payment of the principal amount of any Loans or L/C Advances and such Lender is a Defaulting Lender under clause (a) of the definition thereof, such payment shall be applied solely to pay the relevant Loans of, and L/C Advances owed to, the relevant non-Defaulting Lenders on a pro rata basis prior to being applied pursuant to Section 3.2(b). Any payments, prepayments or other amounts paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender or to post Cash Collateral pursuant to Section 3.2(b) shall be deemed paid to and redirected by such Defaulting Lender, and each Lender irrevocably consents hereto.
(3)Certain Fees. Such Defaulting Lender shall not be entitled to receive or accrue Letter of Credit fees, any commitment fee pursuant to Section 2.8(a) or any default interest pursuant to Section 2.14(d) for any period during which that Lender is a Defaulting Lender (and the Borrowers shall not be required to pay any such fee or interest that otherwise would have been required to have been paid to such Defaulting Lender).
(4)Reallocation of Applicable Percentages to Reduce Fronting Exposure. During any period in which there is a Defaulting Lender, for purposes of computing the amount of the obligation of each non-Defaulting Lender to acquire, Refinance or fund participations in Swingline Loans and Letters of Credit pursuant to Sections 2.7 and 3.4, respectively, the “Pro Rata Share” of each non-Defaulting Lender shall be computed without giving effect to the Revolving Commitment of such Defaulting Lender; provided that the aggregate obligation of each non-Defaulting Lender to acquire, Refinance or fund participations in Letters of Credit and Swingline Loans shall not exceed the positive difference, if any, of (1) the Revolving Commitment of such non-Defaulting Lender minus (2) the aggregate principal amount of the Revolving Loans of such Lender. In the event non-Defaulting Lenders’ obligations to acquire, Refinance or fund participations in Letters of Credit are increased as a result of a Defaulting Lender, then all Letter of Credit fees that would have been paid to such Defaulting Lender shall be paid to such non-Defaulting Lenders ratably in accordance with such increase of such non-Defaulting Lender’s obligations to acquire, Refinance or fund participations in Letters of Credit.
(ii)Defaulting Lender Cure. If the Borrower Representative, the Administrative Agent, the Swingline Lender and each Issuing Lender agree in writing that a Defaulting Lender should no longer be deemed to be a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any cash collateral), such Lender will, to the extent applicable, purchase that portion of outstanding Loans of the other Lenders or take such other actions as the Administrative Agent may determine to be necessary to cause the Loans and funded and unfunded participations in Letters of Credit and Swingline Loans to be held on a pro rata basis by the Lenders in accordance with their Pro Rata Share (without giving effect to Section 2.27(a)(iv)), whereupon such
123
    



Lender will cease to be a Defaulting Lender; provided that no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of the Borrowers while such Lender was a Defaulting Lender; and provided, further, that except to the extent otherwise expressly agreed by the affected parties and subject to Section 11.16, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender’s having been a Defaulting Lender.
(iii)No Release. Subject to Section 11.16, the provisions hereof attributable to Defaulting Lenders shall not release or excuse any Defaulting Lender from failure to perform its obligations hereunder.
2.abLoan Modification Offers.
(i)The Borrowers may, on one or more occasions, by written notice from the Borrower Representative to the Administrative Agent, make one or more offers (each, a “Loan Modification Offer”) to all the Lenders of one or more Classes on the same terms to each such Lender (each Class subject to such a Loan Modification Offer, a “Specified Class”) to make one or more Permitted Amendments pursuant to procedures reasonably specified by any Person that is not an Affiliate of any Borrower appointed by the Borrower Representative, after consultation (and, with respect to any documentation requiring execution of the Administrative Agent in its capacity as such, with the consent of the Administrative Agent, not to be unreasonably withheld, delayed or conditioned) with the Administrative Agent, as agent under such Loan Modification Agreement (as defined below) (such Person (who may be the Administrative Agent, if it so agrees), the “Loan Modification Agent”) and reasonably acceptable to the Borrower Representative; provided that (i) any such offer shall be made by the Borrowers to all Lenders of the Specified Class on a pro rata basis, (ii) [reserved], (iii) any applicable Minimum Extension Condition shall be satisfied unless waived by the Borrower Representative and (iv) in the case of any Permitted Amendment relating to the Revolving Commitments, each Issuing Lender and the Swingline Lender shall have approved such Permitted Amendment to the extent its commitment to issue Letters of Credit or make Swingline Loans, as applicable, is extended. Such notice shall set forth (i) the terms and conditions of the requested Permitted Amendment and (ii) the date on which such Permitted Amendment is requested to become effective (which shall not be less than 5 Business Days nor more than 45 Business Days after the date of such notice, unless otherwise agreed to by the Loan Modification Agent); provided that, notwithstanding anything to the contrary, assignments and participations of Specified Classes shall be governed by the same or, at the Borrower Representative’s discretion, more restrictive assignment and participation provisions than those set forth in Section 11.6. Permitted Amendments shall become effective only with respect to the Loans and Commitments of the Lenders of the Specified Class that accept the applicable Loan Modification Offer (such Lenders, the “Accepting Lenders”) and, in the case of any Accepting Lender, only with respect to such Lender’s Loans and Commitments of such Specified Class as to which such Lender’s acceptance has been made. No Lender shall have any obligation to accept any Loan Modification Offer.
(ii)A Permitted Amendment shall be effected pursuant to an amendment to this Agreement (a “Loan Modification Agreement”) executed and delivered by the Borrower Representative and any other applicable Borrower, each applicable Accepting Lender and the Loan Modification Agent. The Loan Modification Agent shall promptly notify each Lender as to the effectiveness of each Loan Modification Agreement. Each Loan Modification Agreement may, without the consent of any Lender other than the applicable Accepting Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the opinion of the Loan Modification Agent and the Borrower Representative, to give effect to the provisions of this Section 2.28, including any amendments necessary to treat the applicable Loans and/or Commitments of the Accepting Lenders as a new “Class” of loans and/or commitments hereunder; provided that (x) no Loan Modification Agreement may provide for (i) any Class resulting from a Loan Modification Agreement to be secured by any Collateral or other assets of any Group Member that does not also secure the Loans and (ii) so long as any Loans are outstanding, any mandatory prepayment provisions that do not also apply to the Loans of the Specified Class on a pro rata basis or greater than pro rata basis (or, with respect to prepayments made with proceeds of Permitted Credit Agreement Refinancing Debt, on a pro rata basis, less than pro rata basis or greater than pro rata basis), (y) in the case of any Loan Modification Offer relating to Revolving Commitments or Revolving Loans, except as otherwise agreed to by each Issuing Lender, (i) the
124
    



allocation of the participation exposure with respect to any then-existing or subsequently issued Letter of Credit as between the commitments of such new “Class” and the remaining Revolving Commitments shall be made on a ratable basis as between the commitments of such new “Class” and the remaining Revolving Commitments and (ii) the Revolving Termination Date may not be extended without the prior written consent of each Issuing Lender whose commitment to issue Letters of Credit is extended and (z) the terms and conditions of the applicable Loans and/or Commitments of the Accepting Lenders (excluding pricing, fees, rate floors and optional prepayment or redemption terms) shall be substantially identical or (taken as a whole) shall be no more favorable to the Accepting Lenders than those applicable to the Specified Class (except for (1) financial covenants or other covenants or provisions applicable only to periods after the Latest Maturity Date at the time of such Loan Modification Offer, as may be agreed by the Borrower Representative and the Accepting Lenders, (2) any terms that are confirmed (or added) to the Loan Documents for the benefit of the lenders of the Specified Class pursuant to such Loan Modification Agreement and (3) pricing, premiums and fees).
(iii)Subject to Section 2.28(b), the Borrowers may at their election specify as a condition (a “Minimum Extension Condition”) to consummating any such Loan Modification Agreement that a minimum amount (to be determined and specified in the relevant Loan Modification Offer in the Borrowers’ sole discretion and may be waived by the Borrowers) of Loans of any or all applicable Classes be extended.
(iv)Notwithstanding anything to the contrary in this Agreement, this Section 2.28 shall supersede any provisions in Sections 2.17 or 11.1 to the contrary and the Borrowers and the Administrative Agent may amend Section 2.17 to implement any Loan Modification Agreement.
(v)If the Loan Modification Agent is not the Administrative Agent, the actions authorized to be taken by the Loan Modification Agent herein shall be done in consultation with the Administrative Agent and, with respect to the preparation of any documentation necessary or appropriate to carry out the provisions of this Section 2.28 (including amendments to this Agreement and the other Loan Documents), any comments to such documentation reasonably requested by the Administrative Agent shall be reflected therein.
2.acCurrency Equivalents.
The Administrative Agent shall determine the Dollar Amount of each Revolving Loan denominated in an Alternative Currency and L/C Obligation in respect of Letters of Credit denominated in an Alternative Currency (i) for Revolving Loans, as of the first day of each Interest Period applicable thereto, (ii) upon the issuance and increase of any Letter of Credit denominated in an Alternative Currency, (iii) as of the end of each fiscal quarter of UK Holdco and (iv) from time to time in its discretion, and shall promptly notify the Borrower Representative, the Revolving Borrowers and the Revolving Lenders of each Dollar Amount so determined by it. Each such determination shall be based on the Exchange Rate on the date of the related Borrowing request for purposes of the initial such determination for any Revolving Loan.
2.adAdditional Alternative Currencies.
(i)The Borrower Representative (on behalf of any Additional Revolving Borrower) may from time to time request that Revolving Loans be made and/or Letters of Credit be issued in a currency other than those specifically listed in the definition of “Alternative Currency”; provided that such requested currency is a lawful currency that is readily available and freely transferable and convertible into Euros. In the case of any such request with respect to the making of Revolving Loans, such request shall be subject to the approval of the Administrative Agent and the Revolving Lenders; and, in the case of any such request with respect to the issuance of Letters of Credit, such request shall be subject to the approval of the Administrative Agent and the applicable Issuing Lender.
(ii)Any such request shall be made to the Administrative Agent not later than 11:00 a.m. (New York City time) fifteen Business Days prior to the date of the desired Borrowing (or such other time or date as may be agreed by the Administrative Agent and, in the case of any such request pertaining to Letters of Credit, the relevant Issuing Lender, in its or their sole discretion). In the case of any such
125
    



request pertaining to Revolving Loans, the Administrative Agent shall promptly notify each Revolving Lender thereof and in the case of any such request pertaining to Letters of Credit, the Administrative Agent shall promptly notify the relevant Issuing Lender. Each such Revolving Lender (in the case of any such request pertaining to Revolving Loans) or the Issuing Lender (in the case of a request pertaining to Letters of Credit) shall notify the Administrative Agent, not later than 11:00 a.m. (New York City time), ten Business Days after receipt of such request whether it consents, in its sole discretion, to the making of Revolving Loans or the issuance of Letters of Credit, as the case may be, in the requested currency.
(iii)Any failure by any Revolving Lender or any Issuing Lender, as the case may be, to respond to such request within the time period specified in the preceding paragraph (b) shall be deemed to be a refusal by such Revolving Lender or Issuing Lender, as the case may be, to permit Revolving Loans to be made or Letters of Credit to be issued in such requested currency. If the Administrative Agent and all the Revolving Lenders that would be obligated to make Revolving Loans denominated in such requested currency consent to making Revolving Loans in such requested currency, the Administrative Agent shall so notify the Borrower Representative and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Borrowings of Revolving Loans; and if the Administrative Agent and the relevant Issuing Lender consent to the issuance of Letters of Credit in such requested currency, the Administrative Agent shall so notify the Borrower Representative and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Letter of Credit issuances. The benchmark rate of interest, and any matter relating thereto, with respect to any additional “Alternative Currency” established pursuant to this Section 2.30 shall be as determined by the Administrative Agent, UK Holdco and the affected Revolving Lenders and Issuing Lenders. If the Administrative Agent shall fail to obtain the requisite consent to any request for an additional currency under this Section 2.30, the Administrative Agent shall promptly so notify the Borrower Representative.
(iv)The Administrative Agent will have the right, in consultation with the Borrower Representative, to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document; provided that with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such Conforming Changes to the Borrower Representative and the Lenders reasonably promptly after such amendment becomes effective.

SECTION 3.
LETTERS OF CREDIT
3.aL/C Commitment.
(i)Subject to the terms and conditions hereof, each Issuing Lender, in reliance on the agreements of the other Revolving Lenders set forth in Section 3.4(a), agrees to issue standby letters of credit and, to the extent agreed to by an Issuing Lender, bank guarantees and commercial letters of credit providing for the payment of cash upon the honoring of a presentation thereunder (collectively with the Existing Letters of Credit, “Letters of Credit”) for the account of UK Holdco or the account of any of the Restricted Subsidiaries (provided that the Borrower Representative shall be an applicant, and be fully and unconditionally liable, with respect to each Letter of Credit issued for the account of a Restricted Subsidiary) on any Business Day prior to the date that is thirty (30) days prior to the Revolving Termination Date in such form as may be approved from time to time by the Issuing Lenders; provided that no Issuing Lender shall have any obligation to issue any Letter of Credit if, after giving effect to such issuance, (i) the L/C Obligations would exceed the L/C Commitment, (ii) the aggregate Dollar Amount of the Available Revolving Commitments would be less than zero or (iii) the L/C Obligation of such Issuing Lender would exceed its L/C Sublimit. Each Letter of Credit shall (i) be denominated in Dollars or one or more Alternative Currencies (any Letter of Credit denominated in an Alternative Currency, an “Alternative Currency Letter of Credit”); provided that Royal Bank of Canada, Barclays Bank PLC, Morgan Stanley Senior Funding, Inc., JPMorgan Chase Bank, N.A. and their respective affiliates shall not be required to issue Alternative Currency Letters of Credit without their consent; (ii) have a stated amount
126
    



acceptable to the relevant Issuing Lender, (iii) expire no later than the earlier of (x) unless otherwise agreed by the applicable Issuing Lender, the first anniversary of its date of issuance, and (y) the date that is 3 Business Days prior to the Revolving Termination Date, provided that any Letter of Credit with the consent of the applicable Issuing Lender may provide for the renewal or extension thereof for additional one-year periods or such longer periods of time as may be agreed by the Issuing Lender (which shall in no event extend beyond the date referred to in clause (y) above, except to the extent the L/C Obligations under such Letter of Credit have been Cash Collateralized); provided, further, that the Issuing Lenders shall not renew or extend any such Letter of Credit if it has received written notice (or otherwise has knowledge) that an Event of Default has occurred and is continuing or any of the conditions set forth in Section 5.2 are not satisfied prior to the date of the decision to renew or extend such Letter of Credit) and (iv) be otherwise reasonably acceptable in all respects to the Issuing Lenders. Unless otherwise directed by the Issuing Lenders, the Borrower Representative shall not be required to make a specific request to an Issuing Lender for any such extension. Once any Letter of Credit has been issued that may be extended automatically pursuant to the foregoing, the Revolving Lenders shall be deemed to have authorized (but may not require) the Issuing Lenders to permit the extension of such Letter of Credit, including to the date that is 3 Business Days prior to the Revolving Termination Date. All Existing Letters of Credit shall be deemed to have been issued pursuant hereto, and from and after the Closing Date shall be subject to and governed by the terms and conditions hereof. Existing Letters of Credit shall constitute utilization of the Revolving Commitments. Notwithstanding anything herein to the contrary, in no event shall Goldman Sachs Bank USA or any other Issuing Lender be required to issue Letters of Credit other than standby letters of credit.
(ii)No Issuing Lender shall at any time be obligated to issue any Letter of Credit (i) if such issuance would conflict with, or cause such Issuing Lender or any L/C Participant to exceed any limits imposed by, any applicable Requirement of Law or if such issuance would conflict with one or more policies of the Issuing Lender applicable to the issuance by it of letters of credit generally, (ii) if any order, judgment or decree of any Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain such Issuing Lender from issuing such Letter of Credit, or any Requirement of Law applicable to such Issuing Lender or any request or directive (whether or not having the force of law) from any Governmental Authority with jurisdiction over such Issuing Lender shall prohibit, or request that such Issuing Lender refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon such Issuing Lender with respect to such Letter of Credit any restriction, reserve or capital requirement (for which such Issuing Lender is not otherwise compensated hereunder) not in effect on the Closing Date, or shall impose upon such Issuing Lender any unreimbursed loss, cost or expense which was not applicable on the Closing Date and which such Issuing Lender in good faith deems material to it or (iii) as otherwise provided in Section 3.2(b) below.
(iii)Subject to the terms and conditions hereof, (i) Letters of Credit may be issued on the Closing Date to backstop or replace letters of credit outstanding on the Closing Date or (ii) all letters of credit issued for the account of the Borrower Representative or any Restricted Subsidiary and outstanding on the Closing Date and issued by an entity that is an Issuing Lender under this Agreement, which, by its execution of this Agreement, has agreed to act as an Issuing Lender hereunder and listed on Schedule 3.1 (each, an “Existing Letter of Credit”) shall automatically be continued hereunder on the Closing Date by the applicable Issuing Lender, and as of the Closing Date the Revolving Lenders shall acquire a participation therein as if such Existing Letter of Credit were issued hereunder, and each such Existing Letter of Credit shall be deemed a Letter of Credit for all purposes of this Agreement as of the Closing Date without any further action by the Borrower Representative.
(iv)Subject to the terms and conditions hereof, any letter of credit issued for the account of a Person that becomes a Restricted Subsidiary after the Closing Date pursuant to a Permitted Acquisition or other Investment, in each case that is (x) outstanding on the date of such acquisition and (y) issued by an entity that is an Issuing Lender under this Agreement shall, at the request of the Borrower Representative and with the consent of such Issuing Lender in its sole discretion, be deemed to be a “Letter of Credit” for all purposes of this Agreement as of the date of such acquisition; provided that (i) such Letter of Credit would otherwise be permitted to be issued under this Section 3 at such time (provided that such Letter of Credit may be in another currency agreed by the Administrative Agent and such Issuing Lender, and such Letter of Credit shall be deemed an “Alternative Currency Letter of Credit” hereunder) and (ii) the Borrower Representative, the Administrative Agent and such Issuing Lender shall have entered into an
127
    



acknowledgment reasonably acceptable to each party thereto confirming that such letters of credit shall be treated as having been issued hereunder.
3.bProcedure for Issuance of Letter of Credit.
(i)The Borrower Representative may from time to time on any Business Day occurring from (or, in the case of any Letter of Credit permitted to be issued on the Closing Date, prior to) the Closing Date until the Revolving Termination Date request that an Issuing Lender issue a Letter of Credit by delivering to the relevant Issuing Lender, with a copy to the Administrative Agent, at its address for notices specified herein an Application therefor, completed to the satisfaction of such Issuing Lender, and such other certificates, documents and other papers and information as such Issuing Lender may request. Promptly upon receipt of any Application, the relevant Issuing Lender will confirm with the Administrative Agent that the Administrative Agent has received a copy of the Application, and if not, will furnish the Administrative Agent with a copy thereof. Unless such Issuing Lender has received written notice from the Administrative Agent or the Borrower Representative, at least two Business Days prior to the requested date of issuance, or one Business Day prior to the requested date of amendment, as appropriate, of the applicable Letter of Credit, that one or more of the conditions contained in Section 5 shall not then be satisfied, then, subject to the terms and conditions hereof, such Issuing Lender will process such Application and the certificates, documents and other papers and information delivered to it in connection therewith in accordance with its customary procedures and shall promptly issue the Letter of Credit requested thereby (but in no event shall any Issuing Lender be required to issue any Letter of Credit (a) earlier than (i) five Business Days, in the case of standby Letters of Credit or similar agreements or (ii) to the extent an Issuing Lender agrees to issue bank guarantees or commercial Letters of Credit, or similar agreements, such period of time as is acceptable to such Issuing Lender, or (b) later than 10 Business Days (or in each case such shorter period as may be agreed to by an Issuing Lender in any particular instance) after, its receipt of the Application therefor and all such other certificates, documents and other papers and information relating thereto) by issuing the original of such Letter of Credit to the beneficiary thereof or as otherwise may be agreed to by the Issuing Lenders and the Borrower Representative. Each Issuing Lender shall furnish a copy of such Letter of Credit to the Borrower Representative and the Administrative Agent promptly following the issuance thereof. The Administrative Agent shall promptly furnish to the Revolving Lenders notice of the issuance of each Letter of Credit (including the amount thereof).
(ii)Cash Collateral. (i) If an Issuing Lender has honored any full or partial drawing request under any Letter of Credit and such drawing has resulted in an L/C Borrowing and the conditions set forth in Section 5.2 to a Revolving Borrowing cannot then be met, (ii) if, as of the Letter of Credit Expiration Date, any Letter of Credit may for any reason remain outstanding and partially or wholly undrawn, (iii) if any Event of Default occurs and is continuing and the Administrative Agent or the Required Lenders, as applicable, require the Revolving Borrowers to Cash Collateralize the L/C Obligations pursuant to Section 9.3 or (iv) an Event of Default set forth under Section 9.1(g) occurs and is continuing, then the Revolving Borrowers shall Cash Collateralize the then Outstanding Amount of all L/C Obligations (in an amount equal to such Outstanding Amount determined as of the date of such L/C Borrowing or the Letter of Credit Expiration Date, as the case may be), and shall do so not later than 2:00 p.m. (New York City time) on (x) in the case of the immediately preceding clauses (i) through (iii), (1) if the Borrower Representative receives notice thereof prior to 11:00 a.m. (New York City time), on any Business Day, on the Business Day immediately following receipt of such notice or (2) if the Borrower Representative receives notice thereof after 11:00 a.m. (New York City time), on any Business Day, on the second Business Day immediately following receipt of such notice and (y) in the case of the immediately preceding clause (iv), the Business Day on which an Event of Default set forth under Section 9.1(g) occurs or, if such day is not a Business Day, the Business Day immediately succeeding such day. At any time that there shall exist a Defaulting Lender, if any Defaulting Lender Fronting Exposure remains outstanding (after giving effect to Section 2.27(a)(iv)), then promptly upon the request of the Administrative Agent, each Issuing Lender or the Swingline Lender, the Revolving Borrowers shall Cash Collateralize the Defaulting Lender Fronting Exposure and deliver to the Administrative Agent Cash Collateral in an amount sufficient to cover such Defaulting Lender Fronting Exposure (after giving effect to any Cash Collateral provided by the Defaulting Lender); provided that if any Defaulting Lender Fronting Exposure is not Cash Collateralized in accordance with the foregoing to the reasonable satisfaction of the Issuing Lenders, the Issuing Lenders shall have no obligation to issue new Letters of
128
    



Credit or to extend, renew or amend existing Letters of Credit to the extent Letter of Credit exposure would exceed the commitments of the non-Defaulting Lenders. For purposes hereof, “Cash Collateralize” means to pledge and deposit with or deliver to the Administrative Agent, for the benefit of the relevant Issuing Lender and the Lenders, as collateral for the L/C Obligations, Cash Collateral pursuant to documentation in form and substance reasonably satisfactory to the Administrative Agent and the relevant Issuing Lender (which documents are hereby consented to by the Lenders). Derivatives of such term have corresponding meanings. The Revolving Borrowers hereby grant to the Administrative Agent, for the benefit of the Issuing Lenders and the Lenders, a security interest in all such cash, deposit accounts and all balances therein and all proceeds of the foregoing. Cash Collateral shall be maintained in a Cash Collateral Account and may be invested in readily available Cash Equivalents. If at any time the Administrative Agent reasonably determines that any funds held as Cash Collateral are subject to any right or claim of any Person other than the Administrative Agent (on behalf of the Secured Parties) or that the total amount of such funds is less than the aggregate Outstanding Amount of all L/C Obligations (or in the case of Cash Collateral provided with regard to Defaulting Lender Fronting Exposure, such amount of Defaulting Lender Fronting Exposure), the Revolving Borrowers will, forthwith upon demand by the Administrative Agent, pay to the Administrative Agent, as additional funds to be deposited and held in a Cash Collateral Account as aforesaid, an amount equal to the excess of (a) such aggregate Outstanding Amount over (b) the total amount of funds, if any, then held as Cash Collateral that the Administrative Agent reasonably determines to be free and clear of any such right and claim. Upon the drawing of any Letter of Credit for which funds are on deposit as Cash Collateral, such funds shall be applied, to the extent permitted under applicable Law, to reimburse the relevant Issuing Lender. To the extent the amount of any Cash Collateral exceeds the then Outstanding Amount of such L/C Obligations and so long as no Event of Default has occurred and is continuing, the excess shall be refunded to the Revolving Borrowers.
3.cFees and Other Charges.
(i)The Revolving Borrowers will pay a fee on the actual aggregate daily undrawn and unexpired amount of all outstanding Letters of Credit (as described in Section 3.9 hereof) at a per annum rate equal to the Applicable Margin then in effect with respect to Term SOFR Loans under the Revolving Facility, less the amount of fronting fee referred to in the next sentence, shared ratably among the Revolving Lenders and payable quarterly in arrears on each applicable Fee Payment Date after the issuance date. In addition, the Revolving Borrowers shall pay to the applicable Issuing Lender for its own account a fronting fee which shall be the greater of $500 per annum (solely to the extent invoiced and to the extent Letters of Credit issued by such Issuing Lender are outstanding in the applicable period) and 0.125% per annum (or such lower fee as applicable Issuing Lender may agree) on the actual aggregate daily undrawn and unexpired amount of all such Issuing Lender’s Letters of Credit amounts (as described in Section 3.9 hereof) outstanding during the applicable period, payable quarterly in arrears on each applicable Fee Payment Date after the issuance date.
(ii)In addition to the foregoing fees, the Revolving Borrowers shall pay or reimburse such Issuing Lender for such normal and customary costs and expenses as are incurred or charged by the Issuing Lender in issuing, negotiating, effecting payment under, amending or otherwise administering any Letter of Credit. Such costs and expenses shall be due and payable on demand and nonrefundable.
3.dL/C Participations.
(i)The Issuing Lenders irrevocably agree to grant and hereby grant to each L/C Participant, and, to induce the Issuing Lenders to issue Letters of Credit, each L/C Participant irrevocably agrees to accept and purchase and hereby accepts and purchases from the Issuing Lenders, on the terms and conditions set forth below, for such L/C Participant’s own account and risk an undivided interest equal to such L/C Participant’s Revolving Percentage in the Issuing Lenders’ obligations and rights under and in respect of each Letter of Credit and the amount of each draft paid by an Issuing Lender thereunder. Each L/C Participant agrees with the Issuing Lenders that, if a draft is paid under any Letter of Credit for which an Issuing Lender is not reimbursed in full by the Revolving Borrowers in accordance with the terms of this Agreement, such L/C Participant shall pay to such Issuing Lender upon demand at such Issuing Lender’s address for notices specified herein an amount equal to such L/C Participant’s Revolving Percentage of the amount of such draft, or any part thereof, that is not so reimbursed. Each L/C
129
    



Participant’s obligation to pay such amount shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such L/C Participant may have against any Issuing Lender, the Revolving Borrowers, any other Group Member or any other Person for any reason whatsoever, (ii) the occurrence or continuance of a Default or an Event of Default or the failure to satisfy any of the other conditions specified in Section 5, (iii) any adverse change in the condition (financial or otherwise) of the Borrower Representative and the Restricted Subsidiaries, (iv) any breach of this Agreement or any other Loan Document by the Borrowers, any other Loan Party or any other L/C Participant or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing.
(ii)If any amount required to be paid by any L/C Participant to an Issuing Lender pursuant to Section 3.4(a) in respect of any unreimbursed portion of any payment made by such Issuing Lender under any Letter of Credit is paid to such Issuing Lender within three Business Days after the date such payment is due, such L/C Participant shall pay to such Issuing Lender on demand an amount equal to the product of (i) such amount, times (ii) the daily Overnight Rate during the period from and including the date such payment is required to the date on which such payment is immediately available to the Issuing Lenders, times (iii) a fraction the numerator of which is the number of days that elapse during such period and the denominator of which is 360. If any such amount required to be paid by any L/C Participant pursuant to Section 3.4(a) is not made available to an Issuing Lender by such L/C Participant within three Business Days after the date such payment is due, such Issuing Lender shall be entitled to recover from such L/C Participant, on demand, such amount with interest thereon calculated from such due date at the rate per annum applicable to ABR Loans under the Revolving Facility. A certificate of an Issuing Lender submitted to any L/C Participant with respect to any amounts owing under this Section shall be conclusive in the absence of manifest error.
(iii)Whenever, at any time after an Issuing Lender has made payment under any Letter of Credit and has received from any L/C Participant its pro rata share of such payment in accordance with Section 3.4(a), an Issuing Lender receives any payment related to such Letter of Credit (whether directly from the Borrower Representative or otherwise, including proceeds of collateral applied thereto by such Issuing Lender), or any payment of interest on account thereof, such Issuing Lender will distribute to such L/C Participant its pro rata share thereof; provided, however, that in the event that any such payment received by such Issuing Lender shall be required to be returned by such Issuing Lender, such L/C Participant shall return to such Issuing Lender the portion thereof previously distributed by such Issuing Lender to it.
3.eReimbursement Obligation of the Revolving Borrowers. Upon receipt from the beneficiary of any Letter of Credit of any notice of a drawing under such Letter of Credit, the applicable Issuing Lender shall promptly notify the Borrower Representative and the Administrative Agent thereof. If any drawing is paid under any Letter of Credit, the Revolving Borrowers shall reimburse the Issuing Lenders for the amount of (a) the drawing so paid and (b) any fees, charges or other costs or expenses incurred by such Issuing Lender in connection with such payment, not later than 3:00 p.m. (New York City time) on (x) if such notice of drawing is received (i) in the case of any drawing in any Alternative Currency, prior to 11:00 a.m. (London time) or (ii) in the case of any drawing in Dollars, prior to 11:00 a.m. (New York time), in each case, on the first Business Day following the date such drawing is paid by the Issuing Lenders and (y) otherwise, the second Business Day following the date such drawing is paid by the Issuing Lenders (the “Honor Date”). Each such payment shall be made to an Issuing Lender at its address for notices referred to herein in the currency in which the applicable Letter of Credit is denominated and in immediately available funds. If the Revolving Borrowers fail to reimburse an Issuing Lender on the Honor Date, interest shall be payable on any such amounts from the date on which the relevant drawing is paid until payment in full at the rate set forth in (x) until the second Business Day next succeeding the date of the relevant notice, Section 2.14(b) and (y) thereafter, Section 2.14(d).
3.fObligations Absolute. The Revolving Borrowers’ obligations under this Section 3 shall be absolute and unconditional under any and all circumstances and irrespective of any setoff, counterclaim or defense to payment that the Borrowers may have or have had against the Issuing Lenders, any beneficiary of a Letter of Credit or any other Person (it being understood that this provision shall not preclude the ability of the Borrowers to bring any claim for damages against any such Person who has acted with gross negligence or willful misconduct, as determined in a final and non-appealable decision of
130
    



a court of competent jurisdiction). The Borrowers also agree with the Issuing Lenders that the Issuing Lenders shall not be responsible for, and the Revolving Borrowers’ Reimbursement Obligations under Section 3.5 shall not be affected by, among other things, the validity or genuineness of documents or of any endorsements thereon, even though such documents shall in fact prove to be invalid, fraudulent or forged, or any dispute between or among the Revolving Borrowers and any beneficiary of any Letter of Credit or any other party to which such Letter of Credit may be transferred or any claims whatsoever of the Revolving Borrowers against any beneficiary of such Letter of Credit or any such transferee. The Issuing Lenders shall not be liable for any error, omission, interruption or delay in transmission, dispatch or delivery of any message or advice, however transmitted, in connection with any Letter of Credit, except for errors or omissions found by a final and non-appealable decision of a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of the Issuing Lenders. The Revolving Borrowers agree that any action taken or omitted by the Issuing Lenders under or in connection with any Letter of Credit or the related drafts or documents, if done in the absence of gross negligence or willful misconduct (as determined in a final and non-appealable decision of a court of competent jurisdiction), shall be binding on the Revolving Borrowers and shall not result in any liability of the Issuing Lenders to the Revolving Borrowers.
3.gLetter of Credit Payments. If any draft shall be presented for payment under any Letter of Credit, the applicable Issuing Lender shall promptly notify the Borrower Representative of the date and amount thereof. The responsibility of the applicable Issuing Lender to the Borrower Representative in connection with any draft presented for payment under any Letter of Credit shall, in addition to any payment obligation expressly provided for in such Letter of Credit, be limited to determining that the documents (including each draft) delivered under such Letter of Credit in connection with such presentment are in conformity with such Letter of Credit.
3.hApplications. To the extent that any provision of any Application related to any Letter of Credit, or any other agreement submitted by the Borrower Representative to, or entered into by the Borrower Representative with, the Issuing Lenders or any other Person relating to any Letter of Credit, is inconsistent with the provisions of this Section 3, the provisions of this Section 3 shall control.
3.iLetter of Credit Amounts. Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the stated amount of such Letter of Credit in effect at such time; provided, however, that with respect to any Letter of Credit that, by its terms (or the terms of any applicable Application or other document, agreement or instrument entered into by the applicable Issuing Lender and the Borrower Representative (or Restricted Subsidiary, if applicable) or in favor of the applicable Issuing Lender and relating to such Letter of Credit) provides for one or more automatic increases in the stated amount thereof, the amount of such Letter of Credit shall be deemed to be the maximum stated amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum stated amount is in effect at such time.
3.jAlternative Currency Letters of Credit.
(i)With respect to any Alternative Currency Letter of Credit, the applicable Issuing Lender shall not later than the second Business Day of each month, recalculate the Dollar Amount of the L/C Obligations under such Letter of Credit by notionally converting into Dollars the Outstanding Amount of such L/C Obligations in accordance with Section 1.5(a) (a “Recalculation”) and promptly deliver such Recalculation to the Administrative Agent.
(ii)Each Issuing Lender shall provide the Administrative Agent with prompt notice (and in any event within one Business Day) of any issuance, increase, decrease, extension and/or termination of any Alternative Currency Letter of Credit;
(iii)Each Issuing Lender shall provide the Administrative Agent with a consolidated list of all outstanding Alternative Currency Letters of Credit not later than 9:00 a.m. (New York time), two Business Days prior to the last Business Day of each March, June, September and December.
(iv)The Administrative Agent shall use reasonable efforts to provide Letter of Credit fee invoices in connection with any Alternative Currency Letters of Credit on the applicable Fee Payment
131
    



Date (or within five Business Days thereafter). Any discrepancies in fee calculations will be adjusted in the subsequent Fee Payment Date.
SECTION 4.
REPRESENTATIONS AND WARRANTIES
To induce the Administrative Agent and the Lenders to enter into this Agreement and to make the Loans and issue or participate in the Letters of Credit, each Loan Party (but with respect to Holdings, solely as set forth herein) hereby jointly and severally represents and warrants to the Administrative Agent and each Lender, solely to the extent required by Section 5 hereof, that:
4.aFinancial Condition.
(i)[Reserved].
(ii)The unaudited consolidated balance sheet at June 30, 2019 and related unaudited combined statements of operations, comprehensive income (loss), changes in equity and cash flows related to Clarivate Analytics plc and its combined Subsidiaries for the six months ended June 30, 2019 present fairly in all material respects the financial condition of Clarivate Analytics plc and its combined Subsidiaries as at such applicable date, and the results of its operations and its combined stockholder’s equity and cash flows for the six months then ended. All such financial statements, including the related schedules and notes thereto, have been prepared in all material respects in accordance with GAAP applied consistently throughout the periods involved.
(iii)The audited consolidated balance sheet at December 31, 2018 and related combined statements of operations, comprehensive income (loss), changes in equity and cash flows related to Clarivate Analytics plc for the fiscal year ended December 31, 2018, in each case reported on by and accompanied by an unqualified report as to going concern or scope of audit from PricewaterhouseCoopers LLP, present fairly in all material respects the combined financial condition of Clarivate Analytics plc and its combined Subsidiaries as at such applicable date, and the combined results of its operations and its combined stockholder’s equity and cash flows for the respective fiscal year then ended. All such financial statements, including the related schedules and notes thereto, have been prepared in all material respects in accordance with GAAP applied consistently throughout the periods involved (except as approved by the aforementioned firm of accountants and disclosed therein).
4.bNo Change. Since December 31, 2018, there has been no development or event that has had or could reasonably be expected to have a Material Adverse Effect.
4.cExistence; Compliance with Law. Each Group Member (a) is duly organized (or where applicable in the relevant jurisdiction, registered or incorporated), validly existing and (where applicable in the relevant jurisdiction) in good standing under the laws of the jurisdiction of its organization, registration or incorporation, as the case may be, (b) has the power and authority to own and operate its property, to lease the property it operates as lessee and to conduct the business in which it is currently engaged and (c) is in compliance with all Requirements of Law, except in the case of clauses (a) (as it relates to good standing and Group Members other than Holdings, UK Holdco and the Borrowers), (b) and (c) above, to the extent that the failure to comply therewith would not, in the aggregate, reasonably be expected to have a Material Adverse Effect.
4.dPower; Authorization; Enforceable Obligations.
(i)Each Loan Party has the corporate or other organizational power and authority, and the legal right, to enter into, make, deliver and perform the Loan Documents to which it is a party and, in the case of the Borrowers, to obtain extensions of credit hereunder. Each Loan Party has taken all necessary corporate or other organizational action to authorize the execution, delivery and performance of the Loan Documents to which it is a party and, in the case of the Borrowers, to authorize the extensions of credit on the terms and conditions of this Agreement.
132
    



(ii)No Governmental Approval or consent or authorization of, filing with, notice to or other act by or in respect of, any other Person is required in connection with the extensions of credit hereunder or with the execution, delivery, performance and validity or (under the laws of England and Wales or Luxembourg) to make admissible this Agreement or any of the Loan Documents in in the courts of England and Wales or Luxembourg, except (i) Governmental Approvals, consents, authorizations, filings and notices that have been obtained or made and are in full force and effect, (ii) the filings referred to in Section 4.15, (iii) the Perfection Requirements and (iv) as would not reasonably be expected to result in a Material Adverse Effect.
(iii)Each Loan Document has been duly executed and delivered on behalf of each applicable Loan Party. This Agreement constitutes, and each other Loan Document upon execution will constitute, a legal, valid and binding obligation of each applicable Loan Party, enforceable against each such Loan Party in accordance with its terms, except as enforceability may be limited by any Legal Reservations.
4.eNo Legal Bar. The execution, delivery and performance of this Agreement and the other Loan Documents, the issuance of Letters of Credit, the borrowings and guarantees hereunder and the use of the proceeds thereof (i) will not violate (x) any Requirement of Law, (y) any Contractual Obligation of Holdings or any Group Member that is material to Holdings and its Subsidiaries, taken as a whole, or (z) the Organizational Documents of any Loan Party, in the case of clauses (x) and (y), except as would not reasonably be expected to result in a Material Adverse Effect and (ii) will not result in, or require, the creation or imposition of any Lien on any of their respective properties or revenues pursuant to any Requirement of Law, any such Organizational Documents or any such Contractual Obligation (other than the Liens created by the Security Documents and Permitted Liens).
4.fLitigation. No litigation, suit or proceeding of or before any arbitrator or Governmental Authority is pending or, to the knowledge of any Loan Party, threatened in writing by or against any Group Member or against any of their respective properties, assets or revenues that would reasonably be expected to have a Material Adverse Effect.
4.gOwnership of Property; Liens. Each Group Member has title in fee simple to, or a valid leasehold interest in, all its real property, and good title to, or a valid leasehold interest in, all its other property, and none of such property is subject to any Lien except as permitted by Section 7.7 and except where the failure to have such title or other interest would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
4.hIntellectual Property. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Group Members own, or are licensed to use, all intellectual property necessary for the conduct in all material respects of the business of UK Holdco and the Restricted Subsidiaries, taken as a whole, as currently conducted. No material claim has been asserted and is pending by any Person challenging or questioning any Group Member’s use of any intellectual property or the validity or effectiveness of any Group Member’s intellectual property or alleging that the conduct of any Group Member’s business infringes or violates the rights of any Person, nor does UK Holdco or any other Loan Party know of any valid basis for any such claim except for such claims that would not reasonably be expected to impair or interfere in any material respect with the operations of the business conducted by UK Holdco and the Restricted Subsidiaries, taken as a whole, or result in a Material Adverse Effect.
4.iTaxes. Except as set forth on Schedule 4.9 or as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (i) each Group Member has filed or caused to be filed all Tax returns that are required to be filed and has paid all Taxes shown to be due and payable on said returns or on any assessments made against it or any of its property by any Governmental Authority (other than any amount or validity of which are currently being contested in good faith by appropriate proceedings and with respect to which reserves in conformity with GAAP (or, in the case of any Foreign Subsidiary, the accounting principles applicable in the relevant jurisdiction) have been provided on the books of the relevant Group Member); and (ii) no tax Lien (other than any Liens for Taxes not yet due and payable) has been filed, and, to the knowledge of any of the Group Members, no claim is being asserted, with respect to any such Tax, fee or other charge.
133
    



4.jFederal Regulations. No Group Member is engaged principally, or as one of its important activities, in the business of extending credit for the purpose, whether immediate, incidental or ultimate, of buying or carrying Margin Stock, and no part of the proceeds of any Loans, and no other extensions of credit hereunder, will be used for the purpose of buying or carrying Margin Stock in a manner or for any purpose that violates the provisions of Regulation U and Regulation X.
4.kEmployee Benefit Plans. Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i) neither a Reportable Event nor a failure to meet the minimum funding standards of Section 412 or 430 of the Code or Section 302 or 303 of ERISA has occurred during the five-year period prior to the date on which this representation is made or deemed made with respect to any Plan, (ii) each Plan has been operated and maintained in compliance in all respects with applicable Law, including the applicable provisions of ERISA and the Code, and the governing documents for such Plan, (iii) no termination of a Single Employer Plan has occurred, and no Lien in favor of the PBGC or a Plan has arisen, during such five-year period, (iv) the present value of all accrued benefits under each Single Employer Plan (based on those assumptions used to fund such Plan) did not, as of the last annual valuation date prior to the date on which this representation is made or deemed made, exceed the value of the assets of such Plan allocable to such accrued benefits by a material amount, (v) neither UK Holdco nor any Commonly Controlled Entity has had a complete or partial withdrawal from any Multiemployer Plan that has resulted or could reasonably be expected to result in a material liability under ERISA, (vi) no such Multiemployer Plan is Insolvent, (vii) each Foreign Plan has been operated and maintained in compliance in all respects with applicable law and the governing documents for such plan and (viii) no Foreign Benefit Plan Event has occurred during the five-year period prior to the date on which this representation is made or deemed made with respect to any Foreign Plan.
4.lInvestment Company Act. No Loan Party is registered or required to be registered as an “investment company”, under the Investment Company Act of 1940, as amended.
4.mEnvironmental Matters. Except as, in the aggregate, would not reasonably be expected to have a Material Adverse Effect:
(i)the facilities and real properties currently owned, leased or operated by any Group Member (the “Properties”) do not contain, and (to the knowledge of the Group Members) have not previously contained, any Materials of Environmental Concern in amounts or concentrations or under circumstances that constitute or (to the knowledge of the Group Members) constituted a violation of any Environmental Law;
(ii)no Group Member has received any written notice of violation, alleged violation, non-compliance, liability or potential liability regarding environmental matters or compliance with Environmental Laws with regard to any of the Properties or the business operated by any Group Member (the “Business”), nor does any Group Member have knowledge that any such notice is being threatened;
(iii)Materials of Environmental Concern have not been released, generated, treated, stored or disposed of at, or transported from, the Properties in violation of, or in a manner that is reasonably expected to give rise to liability under, any Environmental Law;
(iv)no judicial proceeding or governmental or administrative action is pending or, to the knowledge of any Group Member, threatened, under any Environmental Law to which any Group Member is or, to the knowledge of the Group Member, will be named as a party with respect to the Properties or the Business, nor are there any consent decrees or other decrees, consent orders, administrative orders or other orders, or other judicial requirements outstanding under any Environmental Law with respect to the Properties or the Business;
(v)the Properties and all operations at the Properties are in compliance, and (to the knowledge of the Group Members) have in the past five years been in compliance, with all applicable Environmental Laws;
134
    



(vi)to the knowledge of the Group Members, there are no past or present conditions, events, circumstances, facts, or activities that would reasonably be expected to give rise to any liability or other obligation for any Group Member under any Environmental Laws; and
(vii)no Group Member has assumed any liability of any other Person under Environmental Laws.
4.nAccuracy of Information, etc. No statement or information concerning any Group Member or the Business contained in this Agreement, any other Loan Document, or any other document, certificate or written statement furnished by or on behalf of any Loan Party to the Administrative Agent or the Lenders, or any of them (except for projections, pro forma financial information and information of a general economic or industry nature), for use in connection with the transactions contemplated by this Agreement or the other Loan Documents, when taken as a whole and when taken together with any public filings made by UK Holdco or a parent entity thereof, contained, as of the date such statement, information, document or certificate was so furnished and after giving effect to all supplements and updates thereto, any untrue statement of a material fact or omitted to state a material fact necessary to make the statements contained herein or therein not materially misleading in light of the circumstances under which such statements were made. The projections and pro forma financial information, taken as a whole, contained in the materials referenced above are based upon good faith estimates and assumptions believed by management of the Borrower Representative to be reasonable at the time made and as of the Closing Date (with respect to such projections and pro forma financial information delivered prior to the Closing Date), it being recognized by the Lenders that such financial information as it relates to future events is not to be viewed as fact, forecasts and projections are subject to uncertainties and contingencies, actual results during the period or periods covered by such financial information may differ from the projected results set forth therein by a material amount and no assurance can be given that any forecast or projections will be realized.
4.oSecurity Documents.
(i)Each of the Security Documents is effective to create in favor of the Administrative Agent, for the benefit of the Secured Parties, a legal, valid and, subject to any Legal Reservations, enforceable security interest in the Collateral described therein and proceeds thereof, subject to the relevant Perfection Requirements under applicable laws and as set forth in this Agreement and/or the other relevant Loan Documents (including the Collateral and Guarantee Principles, the Agreed Security Principles and the Intercreditor Agreement).
(ii)Subject to the Collateral and Guarantee Principles, the Agreed Security Principles and the Perfection Requirements and only to the extent such Liens are intended to be created by the relevant Security Documents and required to be perfected under the Loan Documents, the Liens created by the Security Documents constitute fully perfected (or the equivalent under applicable law) first priority Liens (subject to Permitted Liens) so far as possible under relevant law on, and security interests in all right, title and interest of the grantors in such Collateral in each case free and clear of any Liens other than Liens permitted hereunder.
4.pSolvency. As of the Closing Date (and after giving effect to the consummation of the Transactions to occur on the Closing Date), Holdings and its Subsidiaries, on a consolidated basis, after giving effect to the Transactions and the incurrence of all Indebtedness and obligations being incurred in connection herewith and therewith and the other transactions contemplated hereby and thereby, are Solvent.
4.qPatriot Act; FCPA; OFAC; Sanctions.
(i)To the extent applicable, the Loan Parties and each of their Subsidiaries are in compliance in all material respects with U.S. and non-U.S. Laws relating to anti-money laundering including, without limitation, the Patriot Act.
(ii)The Loan Parties and each of their Subsidiaries are in compliance in all material respects with all applicable Anti-Corruption Laws.
135
    



(iii)None of the Loan Parties, nor any of their Subsidiaries or respective officers or directors, nor, to the knowledge of the Loan Parties, any employee or agent of the Loan Parties or any of their Subsidiaries is a Sanctioned Person. No Group Member is located, organized or resident in a country or territory that is the subject of comprehensive territorial Sanctions Laws (a “Sanctioned Country”) as of the Closing Date.
(iv)The Loan Parties will not, directly or indirectly, use the proceeds of any Loans, or lend, contribute or otherwise make available such proceeds to any Subsidiary (or any joint ventures of the Loan Parties or any of their Subsidiaries), joint venture partner or other Person, to fund any activities of or business with any Sanctioned Person, or in any country or territory, that, at the time of such funding, is a Sanctioned Person or a Sanctioned Country, or in any other manner that will result in a violation by any Person (including any Person participating in any Loan transaction, whether as a Lender, advisor, or otherwise) of Sanctions Laws or applicable Anti-Corruption Laws; provided that the obligations in this clause (d) shall in no event be interpreted or applied in such a manner that the obligations hereunder would result in any Loan Party, any of its Subsidiaries or any Secured Party (or any director, officer or employee thereof) violating under any anti-boycott or blocking law, regulation or statute that is in force from time to time and applicable to such entity or person (including, without limitation, Council Regulation (EC) 2271/96).
(v)The representations and warranties contained in this Section 4.17 (A) made by any Restricted Subsidiary resident in Germany (Inländer) within the meaning of section 2 paragraph 15 of the German Foreign Trade Act (Außenwirtschaftsgesetz), are only made to the extent such relevant representation and/or warranty does not result in a violation of or conflict with section 7 of the German Foreign Trade Ordinance (Außenwirtschaftsverordnung) or any similar anti-boycott statute, and (B) given by any Loan Party to any Lender resident in Germany (Inländer) within the meaning of section 2 para. 15 of the German Foreign Trade Act (Außenwirtschaftsgesetz) are made only to the extent that any Lender resident in Germany (Inländer) within the meaning of section 2 para. 15 of the German Foreign Trade Act (Außenwirtschaftsgesetz) would be permitted to make such representation and warranties pursuant to section 7 of the German Foreign Trade Ordinance (Außenwirtschaftsverordnung).
4.rBeneficial Ownership Certificate. As of the Closing Date, the information included in the Beneficial Ownership Certification, if applicable, is true and correct in all material respects.
4.sUse of Proceeds. The Borrowers will (a) use the proceeds of the Closing Date Term Loans and the Revolving Loans incurred on the Closing Date to finance a portion of the Transactions (including paying any fees, commissions and expenses associated therewith), (b) use the proceeds of the Amendment No. 1 Incremental Term Loans incurred on the Amendment No. 1 Effective Date to finance a portion of the Amendment No. 1 Incremental Facility Transactions (including paying any fees, commissions and expenses associated therewith), (c) use the proceeds of the Amendment No. 2 Incremental Term Loans incurred on the Amendment No. 2 Effective Date to finance a portion of the Amendment No. 2 Incremental Facility Transactions (including paying any fees, commissions and expenses associated therewith) and (d) will use the proceeds of all other Borrowings to finance the working capital needs of UK Holdco and the Restricted Subsidiaries and for general corporate purposes of UK Holdco and the Restricted Subsidiaries (including without limitation capital expenditures, acquisitions, Investments and Restricted Payments permitted hereunder).
4.tGoverning Law and Enforcement. Subject to the Legal Reservations and Perfection Requirements, (i) the choice of governing law of the Loan Documents to which each Loan Party is a party will be recognized and enforced in its Relevant Jurisdiction and (ii) any judgment obtained in relation to a Loan Document to which each Loan Party is a party in the jurisdiction of the governing law of that Loan Document will be recognized and enforced in its Relevant Jurisdiction.
4.uCentre of Main Interests. On the Closing Date, for the purposes of Regulation (EU) No. 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast) (the “Regulation”), the centre of main interest (as that term is used in Article 3(1) of the Regulation) of each Loan Party that is incorporated in a member state of the European Union or England & Wales is situated in its jurisdiction of incorporation and it has no “establishment” (as that term is used in Article 2(h) of that Regulation) in any other jurisdiction.
136
    



Notwithstanding anything herein or in any other Loan Document to the contrary, no officer of Holdings or any Group Member shall have any personal liability in connection with the representations and warranties and other certifications in this Agreement or any other Loan Document.
SECTION 5.
CONDITIONS PRECEDENT
5.aConditions to Closing Date. The agreement of each Lender to make the initial extension of credit requested to be made by it under this Agreement on the Closing Date is subject to the satisfaction, prior to or substantially concurrently with the making of such extension of credit on the Closing Date, of the following conditions precedent:
(i)Loan Documents. The Administrative Agent shall have received:
(1)this Agreement, executed and delivered by Holdings, the Borrowers, each Guarantor and each Person listed on Schedule 1.1A-1;
(2)the US Security Agreement, executed and delivered by the Loan Parties party thereto;
(3)the Intellectual Property Security Agreements, executed and delivered by the Loan Parties party thereto;
(4)each other Security Document as required pursuant to Schedule 1.1C, executed and delivered by the Loan Parties party thereto;
(5)each Note, executed and delivered by the Borrowers in favor of each Lender requesting the same;
(6)the Loan Note Instrument (Notes), executed and delivered by UK Holdco;
(7)the Loan Note Instrument (Term Loans), executed and delivered by UK Holdco; and
(8)a Borrowing Request, executed and delivered by the Borrower Representative.
(ii)[Reserved].
(iii)Closing Date Refinancing. Substantially contemporaneously with the funding of the Facilities, (i) the principal, accrued and unpaid interest, fees, premium, if any, and other amounts (other than (x) obligations not then due and payable or that by their terms survive the termination thereof and (y) certain existing letters of credit, bank guarantees, bankers’ acceptances and similar documents and instruments outstanding under the Existing Credit Agreement that on the Closing Date will be grandfathered into, or backstopped by, the Revolving Facility or cash collateralized in a manner satisfactory to the issuing banks thereof) under the Existing Credit Agreement will be repaid in full and all commitments to extend credit thereunder will be terminated and any security interests and guarantees in connection therewith shall be terminated and/or released (or arrangements for such repayment, termination and release shall have been made) and (ii) the Existing Senior Notes issued under the Existing Senior Notes Indenture will be redeemed (with a notice of redemption, which may be conditional upon closing of the Transactions, being delivered (and deposit of cash in an amount sufficient to redeem the Existing Senior Notes in full being made) on or prior to the Closing Date) and be irrevocably defeased or satisfied and discharged on or prior to the Closing Date in accordance with the terms of the Existing Senior Notes Indenture (together, the “Closing Date Refinancing”).
(iv)[Reserved].
137
    



(v)Fees. The Lenders and the Administrative Agent shall have received all fees required to be paid on or prior to the Closing Date, and all reasonable out-of-pocket expenses required to be paid on the Closing Date for which reasonably detailed invoices have been presented (including the reasonable, fees and expenses of legal counsel to the Administrative Agent) to the Borrower Representative at least three Business Days prior to the Closing Date (or such later date as the Borrower Representative may reasonably agree), which amounts may be offset against the proceeds of the Facilities.
(vi)Closing Certificate; Certified Certificate of Incorporation; Good Standing Certificates. The Administrative Agent shall have received (i) an Officer’s Certificate of or on behalf of each Loan Party, dated the Closing Date, in form and substance reasonably acceptable to the Administrative Agent, with appropriate insertions and attachments, including copies of resolutions of the Board of Directors and/or similar governing bodies of each Loan Party approving and authorizing the execution, delivery and performance of the Loan Documents to which it is a party and, in the case of the Borrowers, the borrowings hereunder, certified organizational authorizations (if required by applicable law or customary for market practice in the relevant jurisdiction), incumbency certifications, the certificate of incorporation or other similar Organizational Documents of each Loan Party certified by the relevant authority of the jurisdiction of organization, registration or incorporation of such Loan Party (only where customary in the applicable jurisdiction) and bylaws or other similar Organizational Documents of each Loan Party certified by a Responsible Officer as being in full force and effect on the Closing Date, (ii) a good standing certificate (to the extent such concept exists in the relevant jurisdictions) for each Loan Party from its jurisdiction of organization, registration or incorporation and (iii) in relation to the Lux Borrower, (A) an up-to-date electronic certified true and complete excerpt of the Companies Register dated no earlier than one Business Day prior to the Closing Date, (B) a solvency certificate dated as of the Closing Date (signed by a director or authorized signatory) that it is not subject to nor, as applicable, does it meet or threaten to meet the criteria of bankruptcy (faillite), insolvency, voluntary or judicial liquidation (liquidation volontaire ou judiciaire), composition with creditors (concordat préventif de faillite), controlled management (gestion contrôlée), reprieve from payment (sursis de paiement), general settlement with creditors, reorganization or similar laws affecting the rights of creditors generally and no application has been made or is to be made by its director or, as far as it is aware, by any other Person for the appointment of a commissaire, juge-commissaire, liquidateur, curateur or similar officer pursuant to any voluntary or judicial insolvency, winding-up, liquidation or similar proceedings, (C) an up-to-date electronic certified true and complete certificate of non-registration of judgments (certificat de non-inscription d’une décision judiciaire), issued by the Companies Register no earlier than one Business Day prior to the Closing Date and reflecting the situation no more than two Business Days prior to the Closing Date certifying that, as of the date of the day immediately preceding such certificate, the Lux Borrower has not been declared bankrupt (en faillite), and that it has not applied for general settlement or composition with creditors (concordat préventif de la faillite), controlled management (gestion contrôlée), or reprieve from payment (sursis de paiement), judicial liquidation (liquidation judiciaire) or the appointment of a temporary administrator (administrateur provisoire), such other proceedings listed at Article 13, items 2 to 12 and Article 14 of the Luxembourg Act dated December 19, 2002 on the Register of Commerce and Companies, on Accounting and on Annual Accounts of the Companies (as amended from time to time) (and which include foreign court decisions as to faillite, concordat or analogous procedures according to Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast) and (D) an electronic certified copy of the resolution of its directors (or similar body) approving the Loan Documents to which it is party and approving the execution, delivery and performance of, and authorizing named persons to sign the Loan Documents to which it is party and any documents to be delivered by it under any of the same.
(vii)Legal Opinions. The Administrative Agent shall have received the executed legal opinion of Davis Polk & Wardwell LLP, special New York counsel to the Loan Parties, and executed legal opinions of each local counsel to the Loan Parties or the Administrative Agent, as applicable, set forth on Schedule 5.1(g), each of which shall be in form and substance reasonably satisfactory to the Administrative Agent (provided that counsel to the Administrative Agent shall provide such opinions to the extent customary in any applicable jurisdiction).
(viii)Pledged Stock; Stock Powers; Pledged Notes. Subject to the last paragraph of this Section 5.1, the Administrative Agent shall have received (i) the certificates representing the shares of Capital Stock (to the extent certificated) pledged or otherwise required to be delivered pursuant to the
138
    



Security Documents to be entered into on the Closing Date (to the extent required to be delivered pursuant to such Security Documents and the Agreed Security Principles), together with (where applicable in the relevant jurisdiction) an undated stock power or other equity transfer form for each such certificate executed or endorsed in blank by a duly authorized signatory of the pledgor thereof and (ii) certificates evidencing the Loan Note Instruments.
(ix)Filings, Registrations and Recordings. Subject to the last paragraph of this Section 5.1, each document (including any Uniform Commercial Code financing statement) required by the Security Documents or under law or reasonably requested by the Administrative Agent to be filed, registered or recorded in order to create in favor of the Administrative Agent, for the benefit of the Secured Parties, a perfected Lien on the Collateral described therein, prior and superior in right to any other Person (other than Permitted Liens), shall have been executed and delivered to the Administrative Agent in proper form for filing, registration or recordation (other than, with respect to any security interest granted by a Loan Party incorporated in England and Wales, registrations with the Companies House in England and Wales, which shall be effected within 21 days of creating a security interest granted by a Loan Party incorporated in England and Wales).
(x)Solvency Certificate. The Administrative Agent shall have received a Solvency Certificate, which shall certify that Holdings and its Subsidiaries on a consolidated basis are, and will after giving effect to the Transactions and the other transactions contemplated hereby be, Solvent.
(xi)Patriot Act; Beneficial Ownership Regulation. The Administrative Agent and the Lenders (to the extent reasonably requested in writing at least 10 Business Days prior to the Closing Date) shall have received, at least three Business Days prior to the Closing Date, all documentation and other information about Holdings, UK Holdco and the Borrowers that the Administrative Agent reasonably determines to be required by Governmental Authorities under applicable “know your customer” and anti-money-laundering rules and regulations, including without limitation the Patriot Act and Beneficial Ownership Regulation.
(xii)Representations and Warranties. Each of the representations and warranties made by any Loan Party in or pursuant to the Loan Documents shall be true and correct in all material respects (except where such representations and warranties are already qualified by materiality, in which case such representation and warranty shall be accurate in all respects) on and as of the Closing Date.
Notwithstanding the foregoing, to the extent any Collateral or any security interest therein (other than Collateral with respect to which a lien or security interest may be perfected by (w) intellectual property security filings with the United States Patent and Trademark Office or the United States Copyright Office, (x) the filing of a financing statement under the Uniform Commercial Code, (y) the delivery of any promissory note or certificate evidencing the Loan Note Instruments, together with undated note powers, and (z) the delivery of any stock certificates, if any, together with undated stock powers executed in blank, by (I) Holdings, with respect to the Borrowers only and (II) with respect to all material wholly-owned restricted subsidiaries formed in the United States, in each case to the extent required by the Security Documents) is not provided or perfected on the Closing Date after the Borrowers’ use of commercially reasonable efforts to do so or cannot be provided or perfected without undue burden or expense, the provision and/or perfection of such security interests in such Collateral shall not constitute a condition precedent to the availability of any Facility on the Closing Date, but shall be required to be provided and/or perfected within 120 days after the Closing Date (or such later date as the Administrative Agent may agree in its reasonable discretion).
5.bConditions to Each Borrowing Date. Subject to the final paragraph of this Section 5.2, the agreement of each Lender to make any extension of credit requested to be made by it on any date is subject to the satisfaction of the following conditions precedent:
(i)Representations and Warranties. Each of the representations and warranties made by any Loan Party in or pursuant to the Loan Documents shall be true and correct in all material respects (except where such representations and warranties are already qualified by materiality, in which case such representation and warranty shall be accurate in all respects) on and as of such date as if made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date, in
139
    



which case such representations and warranties shall have been true and correct in all material respects (except where such representations and warranties are already qualified by materiality, in which case such representation and warranty shall be accurate in all respects) as of such earlier date.
(ii)No Default. No Default or Event of Default shall have occurred and be continuing on such date or after giving effect to the extensions of credit requested to be made on such date.
(iii)Notice. The Administrative Agent and, if applicable, the Issuing Lenders or the Swingline Lender, shall have received notice from the Borrower Representative, which, if in writing, may be in the form of a Borrowing Request.
Each borrowing by, and each issuance, renewal, extension, increase or amendment of a Letter of Credit on behalf of, the Revolving Borrowers hereunder shall constitute a representation and warranty by the Revolving Borrowers as of the date of such extension of credit that the conditions contained in this Section 5.2 have been satisfied.
Notwithstanding the foregoing, (x) the conditions set forth in clauses (a) and (b) of this Section 5.2 shall be qualified during the Clean-Up Period by the provisions of Section 9.6, (y) this Section 5.2 shall be subject to Section 1.4 in all respects and (z) the conditions in this Section 5.2 shall not apply in respect of any Incremental Facility, Refinancing Amendment or Permitted Amendment (which shall instead by governed by the relevant conditions applicable to each of the foregoing in accordance with this Agreement).
SECTION 6.
AFFIRMATIVE COVENANTS
Each Borrower and (solely with respect to Sections 6.1, 6.2, 6.3, 6.4, 6.6, 6.9, 6.11, 6.14, 6.16 and 6.19) Holdings hereby jointly and severally agree that, until the Termination Date, each Borrower and (solely with respect to Sections 6.1, 6.2, 6.3, 6.4, 6.6, 6.9, 6.11, 6.14, 6.16 and 6.19) Holdings will, and will cause each of its Restricted Subsidiaries to:
6.aFinancial Statements. Furnish to the Administrative Agent (who shall promptly furnish to each Lender):
(i)as soon as available, but in any event within 90 days after the last day of each fiscal year of UK Holdco, a copy of the audited consolidated balance sheet of UK Holdco and its consolidated Subsidiaries as at the end of such year and the related audited consolidated statements of income and of cash flows for such year, setting forth in each case in comparative form the figures for the previous year and accompanied by an opinion of PricewaterhouseCoopers LLP or other independent certified public accountants of recognized national standing, which opinion shall not be subject to qualification as to scope or contain any “going concern” qualification or exception other than with respect to or resulting from (i) the maturity of any Loans under this Agreement, the Senior Secured Notes or any other Indebtedness or (ii) any potential inability to satisfy any financial covenant on a future date or for a future period (provided that delivery within the time periods specified above of copies of the Annual Report on Form 10-K or Form 20-F of UK Holdco (or any direct or indirect parent company thereof) filed with the SEC (or the equivalent documents filed with a comparable agency in any applicable non-U.S. jurisdiction, provided such documents contain substantially the same scope of information as would be set forth in a Form 10-K or Form 20-F) shall be deemed to satisfy the requirements of this Section 6.1(a)); and
(ii)as soon as available, but in any event within 45 days after the last day of the first three fiscal quarters of each fiscal year of UK Holdco, the unaudited consolidated balance sheet of UK Holdco and its consolidated Subsidiaries as at the end of such quarter and the related unaudited consolidated statements of income and of cash flows for such quarter and the portion of the fiscal year through the end of such quarter, setting forth in each case in comparative form the figures for the previous year, certified by a Responsible Officer as fairly stating in all material respects the financial position of UK Holdco and its consolidated Subsidiaries in accordance with GAAP for the period covered thereby (subject to normal year-end audit adjustments and the absence of footnotes) (provided that delivery within the time periods specified above of copies of the Quarterly Report on Form 10-Q or a Report of Foreign Private Issuer on
140
    



Form 6-K (that includes substantially the same information as was included in Clarivate Holdings Limited’s Form 6-K dated May 15, 2019) of UK Holdco (or any direct or indirect parent company thereof) filed with the SEC (or the equivalent documents filed with a comparable agency in any applicable non-U.S. jurisdiction, provided such documents contain substantially the same scope of information as would be set forth in Form 10-Q or the aforementioned 6-K) shall be deemed to satisfy the requirements of this Section 6.1(b)).
All such consolidated financial statements shall be prepared (except as otherwise provided below) in all material respects in accordance with GAAP applied consistently (except to the extent any such inconsistent application of GAAP has been approved by such accountants (in the case of clause (a) above) or officer (in the case of clause (b) above), as the case may be, and disclosed in reasonable detail therein) consistently throughout the periods reflected therein and with prior periods (subject, in the case of quarterly financial statements, to normal year-end audit adjustments and the absence of footnotes), and all such financial statements shall include a presentation of Consolidated EBITDA.
Notwithstanding the foregoing, the obligations in Section 6.1(a) and Section 6.1(b) may be satisfied by furnishing, at the option of the Borrower Representative, the applicable financial statements or, as applicable, forecasts of (I) any predecessor or successor of UK Holdco or any entity meeting the requirements of clause (II) or (III) of this paragraph, (II) any other wholly-owned Restricted Subsidiary that, together with its consolidated Restricted Subsidiaries, constitutes substantially all of the assets of UK Holdco and its consolidated Subsidiaries (a “Qualified Reporting Subsidiary”) or (III) any Parent Holding Company, provided that to the extent such information relates to a Qualified Reporting Subsidiary or a Parent Holding Company, (x) such information is accompanied by consolidating information (which need not be audited) that explains in reasonable detail the differences between the information relating to such Qualified Reporting Subsidiary or such Parent Holding Company, on the one hand, and the information relating to UK Holdco and its Restricted Subsidiaries on a standalone basis, on the other hand and (y) solely in the case of a Qualified Reporting Subsidiary, neither such Parent Holding Company nor any Subsidiary of such Parent Holding Company (other than Holdings or such Qualified Reporting Subsidiary and its Subsidiaries) shall have any material assets or liabilities.

Notwithstanding the foregoing, in the event that UK Holdco or any Parent Holding Company of UK Holdco is or becomes a public reporting company and files a Form 10-K or Form 20-F (or other equivalent document), or Form 10-Q or Form 6-K (or other equivalent document), as contemplated pursuant to clauses (a) and (b) above, respectively, then UK Holdco shall satisfy the delivery requirements under this Section 6.1 upon the filing of such reports with the SEC or other securities commission or stock exchange; provided that if a Parent Holding Company of UK Holdco files such reports with the SEC or other securities commission or stock exchange, such Parent Holding Company of UK Holdco provides the consolidating information set forth in this paragraph. 

For the avoidance of doubt, any financial statements or other reports delivered pursuant to this Section 6.1 (A) shall not be required to comply with Section 302, Section 404 or Section 906 of the Sarbanes-Oxley Act of 2002, or related Items 307 or 308 of Regulation S-K promulgated by the SEC, or Item 10(e) of Regulation S-K (with respect to any non-GAAP financial measures contained therein), (B) shall not be required to contain the separate financial information for any Loan Parties contemplated by Rule 3-05, Rule 3-09, Rule 3-10 or Rule 3-16 of Regulation S-X promulgated by the SEC (other than the consolidating information contemplated by the immediately preceding paragraph), (C) shall not be required to comply with Items 402, 405, 406, 407 and 601 of Regulation S-K promulgated by the SEC, (D) shall not be required to contain any exhibit (including any financial statements that would be required to be filed as an exhibit) and (E) shall not be required to comply with rules or regulations promulgated by the SEC concerning Extensible Business Reporting Language (XBRL).

6.bCertificates; Other Information. Furnish to the Administrative Agent (who shall promptly furnish to each Lender) or, in the case of clause (g), to the relevant Lender:
(i)promptly upon the request of the Administrative Agent, in connection with the delivery of any financial statements or other information pursuant to Section 6.1 or this Section 6.2, confirmation of whether such statements or information contains any Private Lender Information. The Borrowers and
141
    



each Lender acknowledge that certain of the Lenders may be “public-side” Lenders (Lenders that do not wish to receive material non-public information with respect to the Borrowers, Holdings, their respective Subsidiaries or their securities) (the “Public Lenders”) and, if documents or notices required to be delivered pursuant to Section 6.1 or this Section 6.2 or otherwise are being distributed through IntraLinks/IntraAgency, SyndTrak or another relevant website or other information platform (the “Platform”), any document or notice that Borrower Representative has indicated contains Private Lender Information shall not be posted on that portion of the Platform designated for such public-side Lenders, provided that if Borrower Representative has not indicated whether a document or notice delivered pursuant to Section 6.1 or this Section 6.2 contains Private Lender Information, the Administrative Agent reserves the right to post such document or notice solely on that portion of the Platform designated for Lenders who wish to receive material nonpublic information with respect to the Borrowers, Holdings, their respective Subsidiaries or their respective securities;
(ii)[reserved];
(iii)concurrently with the delivery of any financial statements pursuant to Section 6.1, (i) an Officer’s Certificate of Borrower Representative stating that such Responsible Officer has obtained no knowledge of any Default or Event of Default except as specified in such certificate, (ii) (x) a Compliance Certificate containing all information and calculations reasonably necessary for determining the Applicable Margin and, to the extent that a Financial Compliance Date occurred on the last day of the period covered by such financial statements, compliance by UK Holdco with the provisions of Section 7.1 of this Agreement as of the last day of the fiscal quarter or fiscal year of UK Holdco, as the case may be (and, with respect to each annual financial statement commencing with the annual financial statements for the fiscal year of UK Holdco ending December 31, 2020, the amount, if any, of Excess Cash Flow for such fiscal year together with the calculation thereof in reasonable detail), and (y) to the extent not previously disclosed to the Administrative Agent, a description of any change in the jurisdiction of organization of any Loan Party, and (iii) certifying a list of names of all Unrestricted Subsidiaries (if any) (or certifying as to any changes to such list since the delivery of the last such certificate) and that each Subsidiary set forth on such list individually qualifies as an Unrestricted Subsidiary;
(iv)[reserved];
(v)simultaneously with the delivery of each set of consolidated financial statements referred to in Sections 6.1(a) and (b) above, a narrative discussion and analysis of the financial condition and results of operations of UK Holdco and its Restricted Subsidiaries for such fiscal quarter or fiscal year, as applicable, and for the period from the beginning of the then current fiscal year to the end of such fiscal quarter (or for the entire such fiscal year most recently ended in the case of such discussion and analysis given after the end of such fiscal year), as compared to the comparable periods of the previous year (provided that delivery within the time periods specified above of copies of the Quarterly Report on Form 10-Q or Foreign Private Issuer Report on Form 6-K and Annual Report on Form 10-K or 20-F, as applicable, of UK Holdco (or any direct or indirect parent company thereof) filed with the SEC (or the equivalent documents filed with a comparable agency in any applicable non-U.S. jurisdiction, provided such documents contain substantially the same scope of information as would be set forth in equivalent U.S. documents) shall be deemed to satisfy the requirements of this Section 6.2(e));
(vi)promptly, copies of all financial statements and reports that UK Holdco and its Restricted Subsidiaries send generally to the holders of any class of their debt securities or public equity securities, acting in such capacity, and, within five days after the same are filed, copies of all financial statements and reports that UK Holdco or any Qualified Reporting Subsidiary filed with the SEC (or the equivalent documents filed with a comparable agency in any applicable non-U.S. jurisdiction, provided such documents contain substantially the same information as would be set forth in equivalent U.S. documents); provided that the obligations in this clause (f) shall be deemed to be satisfied if such financial statements and reports are publicly available;
(vii)promptly following any Lender’s request therefor, all documentation and other information that such Lender reasonably requests in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering or terrorist financing rules and regulations, including the Patriot Act and Beneficial Ownership Regulation;
142
    



(viii)to the extent equivalent conference calls are required pursuant to the terms of the Senior Secured Notes, quarterly, at a time mutually agreed with the Administrative Agent that is promptly after the delivery of the information required pursuant to clause (a) and (b) above, but in no event earlier than is required with respect to the Senior Secured Notes, participate in a conference call for Lenders to discuss the financial condition and results of operations of UK Holdco and its Subsidiaries for the most recently-ended period for which financial statements have been or were required to have been delivered; and
(ix)as promptly as reasonably practicable from time to time following the Administrative Agent’s request therefor, such other information regarding the operations, business affairs and financial condition of any Group Member, or compliance with the terms of any Loan Document, as the Administrative Agent may reasonably request.
Nothing in this Agreement or in any other Loan Document shall require any Loan Party to provide information (i) that constitutes non-financial trade secrets or non-financial proprietary information, (ii) in respect of which disclosure is prohibited by applicable Laws, (iii) that is subject to attorney-client or similar privilege or constitutes attorney work product or (iv) in respect of which Holdings, a Borrower or any Restricted Subsidiary owes confidentiality obligations to any third party (provided such confidentiality obligations were not entered into in contemplation of the requirements of this Agreement).
6.cPayment of Taxes. Pay, discharge or otherwise satisfy at or before maturity or before they become delinquent, as the case may be, all its Tax obligations of whatever nature, except (i) where the failure to do so would not reasonably be expected to have a Material Adverse Effect or (ii) where the amount or validity thereof is currently being contested in good faith by appropriate proceedings and reserves in conformity with GAAP (or, in the case of any Foreign Subsidiary, the accounting principles applicable in the relevant jurisdiction) with respect thereto have been provided on the books of UK Holdco or the relevant Group Member.
6.dMaintenance of Existence; Compliance with Law.
(i)(i) Preserve, renew and keep in full force and effect its organizational existence and (ii) take all reasonable action to maintain or obtain all Governmental Approvals and all other all rights, privileges and franchises, in each case necessary or desirable in the normal conduct of its business, except, in each case, as otherwise permitted by Section 7.5 or 7.8 or by the Security Documents and except, other than in the case of clause (i) with respect to Holdings, UK Holdco and the Lux Borrower, to the extent that failure to do so would not reasonably be expected to have a Material Adverse Effect;
(ii)comply with all Requirements of Law except to the extent that failure to comply therewith would not, in the aggregate, reasonably be expected to have a Material Adverse Effect; provided that the requirements set forth in this Section 6.4, as they pertain to compliance by any Foreign Subsidiary with Sanctions are subject to and limited by any Requirement of Law applicable to such Foreign Subsidiary in its relevant local jurisdiction; and
(iii)comply with all Governmental Approvals except to the extent that failure to do so would not reasonably be expected to have a Material Adverse Effect.
6.eMaintenance of Property; Insurance. (a) Keep all material tangible property useful and reasonably necessary in its business in good working order and condition, ordinary wear and tear and casualty and condemnation excepted, except to the extent the failure to do so would not reasonably be expected to have a Material Adverse Effect, (b) maintain all the rights, licenses, permits, privileges, franchises, patents, copyrights, trademarks and trade names material to the conduct of its business, except to the extent the failure to do so would not reasonably be expected to have a Material Adverse Effect or as otherwise permitted by the Loan Documents and (c) maintain with insurance companies that the Borrower Representative believes (in the good faith judgment of the management of the Borrower Representative) are financially sound and responsible at the time the relevant coverage is placed or renewed insurance in at least such amounts (after giving effect to any self-insurance which the Borrower Representative believes (in the good faith judgment of management of the Borrower Representative) is
143
    



reasonable and prudent in light of the size and nature of its business) and against at least such risks (and with such risk retentions) as the Borrower Representative believes (in the good faith judgment of management of the Borrower Representative) is reasonable and prudent in light of the size and nature of its business (it being agreed that in any event flood insurance shall not be required except to the extent required by applicable Law).
6.fInspection of Property; Books and Records; Discussions. (a) Keep proper books of records and account containing entries of all material financial transactions and matters involving the assets and business of UK Holdco and its Restricted Subsidiaries that are full, true and correct in all material respects and permit the preparation of consolidated financial statements in accordance with GAAP and (b) permit, at the Borrowers’ expense, representatives of the Administrative Agent to visit and inspect any of its properties and examine and make abstracts from any of its books and records at any reasonable time during normal business hours, upon reasonable prior written notice, and as often as may reasonably be desired and to discuss the business, operations, properties and financial and other condition of the Group Members with officers and employees of the Group Members and with their independent certified public accountants; provided that (i) in no event shall there be more than one such visit for the Administrative Agent and its representatives as a group per calendar year except during the continuance of an Event of Default and (ii) the Borrowers shall have the right to be present during any discussions with accountants. Notwithstanding anything to the contrary in this Section 6.6 or Section 6.2(i), none of the Group Members will be required to disclose, permit the inspection, examination or making copies or abstracts of, or discuss any document, information or other matter that (a) constitutes non-financial trade secrets or non-financial proprietary information, (b) in respect of which disclosure to the Administrative Agent or any Lender (or their respective representatives or contractors) is prohibited by Law or any binding agreement (other than any agreement with another Group Member or any Affiliate thereof), (c) is subject to attorney-client or similar privilege or constitutes attorney work product, (d) in respect of which Holdings, a Borrower or any Restricted Subsidiary owes confidentiality obligations to any third party (provided such confidentiality obligations were not entered into in contemplation of the requirements of this Agreement).
6.gNotices. Promptly give notice to the Administrative Agent (who shall promptly furnish to each Lender) of:
(i)the occurrence of any Default or Event of Default;
(ii)the following events where there is any reasonable likelihood of the imposition of liability on any Borrower as a result thereof that would be reasonably expected to have a Material Adverse Effect, promptly and in any event within 30 days after the Borrower Representative knows or has reason to know thereof:  the occurrence of any Reportable Event with respect to any Plan, a failure to make any required contribution to a Plan in a material amount, the creation of any Lien on the assets of any Loan Party in favor of the PBGC or a Plan or any withdrawal from, or the termination or Insolvency of, any Multiemployer Plan that would result in the imposition of a material withdrawal liability; and
(iii)any development or event that has had or would reasonably be expected to have a Material Adverse Effect.
Each notice pursuant to this Section 6.7 shall be accompanied by a statement of a Responsible Officer of the Borrower Representative setting forth details of the occurrence referred to therein and stating what action the relevant Group Member proposes to take with respect thereto.
6.hEnvironmental Laws.
(i)Comply with, and take commercially reasonably action to ensure compliance by all tenants and subtenants, if any, with, all applicable Environmental Laws, and obtain and comply with and maintain, and take commercially reasonably action to ensure that all tenants and subtenants obtain and comply with and maintain, any and all licenses, approvals, notifications, registrations or permits required by applicable Environmental Laws, except where the failure to do so would not reasonably be expected to result in a Material Adverse Effect.
144
    



(ii)Conduct and complete all investigations, studies, sampling and testing, and all remedial, removal and other actions, required under Environmental Laws and promptly comply with all lawful orders and directives of all Governmental Authorities regarding Environmental Laws, except where the failure to do so would not reasonably be expected to result in a Material Adverse Effect, provided that no such actions shall be required to be undertaken to the extent that the applicable Group Member is contesting such action, order or directive in good faith and by proper proceedings, and appropriate reserves are being maintained with respect to such circumstances in accordance with GAAP.
(iii)In the event that any Group Member shall fail timely to commence or cause to be commenced or fail diligently to prosecute to completion such actions, or fail to contest such action, order or directive in good faith, as provided in Section 6.8(b), allow the Administrative Agent (at its election) to cause such actions to be performed, and reasonably promptly pay all reasonable costs and expenses (including reasonable attorneys’ and consultants’ fees, charges and disbursements) incurred by the Administrative Agent in connection therewith, provided that the Administrative Agent shall not have the right to cause such actions to be performed for any underlying matter which would not reasonably be expected to result in a Material Adverse Effect.
6.iAdditional Collateral, etc.
(i)If any additional Restricted Subsidiary is formed or acquired after the Closing Date (including any Unrestricted Subsidiary that is designated as a Restricted Subsidiary), unless such Subsidiary is an Excluded Subsidiary, the Borrowers will, on or prior to the latest of (i) 60 days after such formation or acquisition, (ii) the date on which financial statements are required to be delivered pursuant to Section 6.1(a) or (b), as applicable, with respect to the fiscal quarter in which such Restricted Subsidiary was formed or acquired and (iii) such later date as the Administrative Agent shall reasonably agree, cause such Restricted Subsidiary to execute and to deliver to the Administrative Agent (1) a Guarantor Joinder Agreement, (2) subject to the Agreed Security Principles, applicable Security Documents substantially similar to other Loan Parties organized in the same jurisdiction or, if at such time there are no other Loan Parties in such jurisdiction, in respect of substantially all of its assets (other than any Excluded Assets) to the extent customary under applicable Law (as determined by the Borrower Representative and the Administrative Agent in good faith) and (3) if reasonably requested by the Administrative Agent, legal opinions relating to the matters described above, which opinions shall be in form and substance reasonably satisfactory to the Administrative Agent.
(ii)[Reserved].
(iii)Notwithstanding anything to the contrary in this Agreement or any other Loan Document, (i) in no event shall control agreements or perfection by control or similar arrangements be required with respect to any Collateral (including deposit or securities accounts), other than in respect of (x) delivery of the certificated Equity Interests in UK Holdco, the Borrowers and material wholly-owned Restricted Subsidiaries thereof to the extent constituting Collateral and required to be pledged and delivered pursuant to the Security Documents and (y) delivery of any intercompany notes (other than the Global Intercompany Note) and other promissory notes held by a Borrower or a Guarantor that constitute Collateral evidencing debt for borrowed money in a principal amount of at least $25,000,000 to the extent required to be pledged and delivered pursuant to the Security Documents, (ii) in no event shall Collateral include any Excluded Assets unless the Borrower Representative so elects, (iii) in no event shall entry into any source code escrow arrangements or the registration of any intellectual property be required, (iv) no perfection actions shall be required, nor shall the Administrative Agent or Collateral Agent be authorized to take any perfection or other actions, other than (A) with respect to US Loan Parties, (1) filings pursuant to the UCC in the office of the secretary of state (or similar central filing office) of the relevant state(s), (2) filings in the United States Copyright Office or the United States Patent and Trademark Office with respect to intellectual property and (3) subject to the Intercreditor Agreements, delivery to the Administrative Agent to be held in its possession of Collateral consisting of certificated Equity Interests, intercompany notes and other promissory notes described in clause (i) above and (B) the actions required by the applicable Security Documents to the extent consistent with the “Agreed Security Principles” set forth on Schedule 1.1B, (v) (A) no actions in any jurisdiction other than an Applicable Security Jurisdiction, or required by the laws of any jurisdiction other than an Applicable Security Jurisdiction, shall be required to be taken, nor shall the Administrative Agent or the Collateral Agent be
145
    



authorized to take any such action, to create any security interests in assets located or titled outside of an Applicable Security Jurisdiction (including any Equity Interests of Subsidiaries organized under the laws of a jurisdiction other than an Applicable Security Jurisdiction) or to perfect or make enforceable any security interests in any such assets (it being understood that there shall be no security agreements or pledge agreements governed under the laws of any jurisdiction other than an Applicable Security Jurisdiction and all guarantee agreements shall be governed under the laws of the State of New York) and (B) the Security Documents shall be consistent with the “Agreed Security Principles” set forth on Schedule 1.1B and (vi) no Loan Party shall be required to seek any landlord lien waiver, estoppel, warehouseman waiver or other collateral access or similar letter or agreement (this paragraph, the “Collateral and Guarantee Principles”).
6.jCredit Ratings. Use commercially reasonable efforts to maintain at all times a credit rating by each of S&P and Moody’s in respect of the Facilities provided for under this Agreement and a corporate rating by S&P and a corporate family rating by Moody’s for UK Holdco, Holdings or any Parent Holding Company (it being understood that there shall be no requirement to maintain any specific credit rating).
6.kFurther Assurances. At any time or from time to time upon the reasonable request of the Administrative Agent, at the expense of the Borrowers, promptly execute, acknowledge and deliver such further documents and do such other acts and things as the Administrative Agent may reasonably request in order to effect fully the purposes of the Loan Documents. In furtherance and not in limitation of the foregoing, the Loan Parties shall take such actions as the Administrative Agent may reasonably request from time to time (including the execution and delivery of guaranties, security agreements, pledge agreements, stock powers, financing statements and other documents, the filing or recording of any of the foregoing, and the delivery of stock certificates and other collateral with respect to which perfection is obtained by possession, in each case to the extent required by the applicable Security Documents) to ensure that the Obligations are guaranteed by the Guarantors, on a first priority basis (subject to Permitted Liens) and are secured by substantially all of the assets (other than those assets, including Excluded Assets, specifically excluded by the terms of this Agreement and the other Loan Documents) of the Loan Parties, in each case subject to the Agreed Security Principles.
6.lDesignation of Unrestricted Subsidiaries. The Borrower Representative may at any time after the Closing Date designate any Restricted Subsidiary as an Unrestricted Subsidiary and subsequently re-designate any Unrestricted Subsidiary as a Restricted Subsidiary, if other than for purposes of designating a Restricted Subsidiary as an Unrestricted Subsidiary that is a Receivables Subsidiary in connection with the establishment of a Qualified Receivables Financing (i) the Interest Coverage Ratio of UK Holdco and the Restricted Subsidiaries for the most recently ended Reference Period preceding such designation or re-designation, as applicable, would have been, on a Pro Forma Basis, at least the lesser of (x) 2.00 to 1.00 and (y) the Interest Coverage Ratio as of the most recently ended Reference Period and (ii) no Event of Default has occurred and is continuing or would result therefrom. The designation of any Restricted Subsidiary as an Unrestricted Subsidiary after the Closing Date shall constitute an Investment by the applicable Loan Party or Restricted Subsidiary therein at the date of designation in an amount equal to the Fair Market Value of the applicable Loan Party’s or Restricted Subsidiary’s investment therein; provided that if any subsidiary (a “Subject Subsidiary”) being designated as an Unrestricted Subsidiary has a subsidiary that was previously designated as an Unrestricted Subsidiary (the “Previously Designated Unrestricted Subsidiary”) in compliance with the provisions of this Agreement, the Investment of such Subject Subsidiary in such Previously Designated Unrestricted Subsidiary shall not be taken into account, and shall be excluded, in determining whether the Subject Subsidiary may be designated as an Unrestricted Subsidiary hereunder. The designation of any Unrestricted Subsidiary as a Restricted Subsidiary shall constitute (x) the incurrence at the time of designation of Indebtedness or Liens of such Subsidiary existing at such time, and (y) a return on any Investment by the applicable Loan Party or Restricted Subsidiary in Unrestricted Subsidiaries pursuant to the preceding sentence in an amount equal to the Fair Market Value at the date of such designation of such Loan Party’s or Restricted Subsidiary’s Investment in such Subsidiary. For the avoidance of doubt, neither a Borrower nor UK Holdco shall be permitted to be an Unrestricted Subsidiary. At any time a Subsidiary is designated as an Unrestricted Subsidiary hereunder, the Borrower Representative shall cause such Subsidiary to be designated as an Unrestricted Subsidiary (or any similar applicable term) under the Senior Secured Notes.
146
    



6.mEmployee Benefit Plans. (i) Maintain, and cause each Commonly Controlled Entity to maintain, all Plans that are presently in existence or may, from time to time, come into existence, in compliance with the terms of any such Plan, ERISA, the Code and all other applicable laws, except to the extent the failure to do so would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; and (ii) maintain, or cause to be maintained, all Foreign Plans that are presently in existence or may, from time to time, come into existence, in compliance with the terms of any such Foreign Plan and all applicable laws, except to the extent the failure to do so would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
6.nUse of Proceeds. The Borrowers will only use the proceeds of the Loans in accordance with Sections 4.17(d) and 4.19.
6.oPost-Closing Matters. The Borrower Representative will, and will cause each of the Restricted Subsidiaries to, take each of the actions set forth on Schedule 6.15 within the time period prescribed therefor on such schedule (as such time period may be extended by the Administrative Agent).
6.pFCPA; OFAC; Sanctions. The Loan Parties agree to maintain policies, procedures, and internal controls reasonably designed to ensure compliance with the Sanctions Laws, the Export Control Laws and the applicable Anti-Corruption Laws, provided that the obligations in this Section 6.16 shall in no event be interpreted or applied in such a manner that the obligations hereunder would result in any Loan Party or any of its Subsidiaries in each case resident in the United Kingdom, Luxembourg, Spain or Germany or any Secured Party resident in the European Union (or any director, officer or employee thereof) violating any anti-boycott or blocking law, regulation or statute that is in force from time to time and applicable to such entity or person (including, without limitation, Council Regulation (EC) 2271/96).
6.qCentre of Main Interests. No Loan Party whose jurisdiction of incorporation is in a member state of the European Union or England & Wales shall do anything to change the location of its centre of main interests for the purposes of the Regulation (as defined in Section 4.21); provided that in respect of Loan Parties other than UK Holdco, Holdings and the Lux Borrower, such change of location shall be permitted if it would not be expected that such change would be materially adverse to the interests of the Lenders (taken as a whole).
6.rTransactions with Affiliates..
(i)UK Holdco shall make, and shall ensure that its Restricted Subsidiaries make, only those payments to, or sales, leases, transfers or other dispositions of any of its properties or assets to, or purchases of property or assets from, or enter into or make or amend any transaction or series of transactions, contracts, agreements, understandings, loans, advances or guarantees with, or for the benefit of, any Affiliate of UK Holdco involving aggregate consideration in excess of the greater of $25,000,000 and 8% of Consolidated EBITDA as of the most recently ended Reference Period (each of the foregoing, an “Affiliate Transaction”), that are not materially less favorable to UK Holdco or the relevant Restricted Subsidiary than those that could have been obtained in a comparable transaction by UK Holdco or such Restricted Subsidiary with an unrelated Person.
(ii)Notwithstanding clause (a), the following Affiliate Transactions shall be permitted:
(1)(A) transactions between or among Holdings, UK Holdco and/or any of the Restricted Subsidiaries (or an entity that becomes a Restricted Subsidiary as a result of such transaction), (B) [reserved] and (C) any merger or consolidation between or among UK Holdco and/or any direct parent company of UK Holdco, provided that such parent company shall have no material liabilities and no material assets other than cash, Cash Equivalents and the Capital Stock of UK Holdco and such merger or consolidation is otherwise in compliance with the terms of this Agreement and effected for a bona fide business purpose; provided, that upon giving effect to such merger or consolidation, the surviving Person shall be (or shall immediately become) a Loan Party and otherwise comply with the requirements of Section 6.9, and 100% of the Capital Stock of such surviving Person shall be pledged to the Administrative Agent in accordance with the terms of the Loan Documents;
147
    



(2)(A) Restricted Payments permitted by Section 7.3 (including any payments that are exceptions to the definition of Restricted Payments set forth in Section 7.3(a)(i) through (iv)) and (B) Permitted Investments;
(3)transactions pursuant to compensatory, benefit and incentive plans and agreements with officers, directors, managers or employees of UK Holdco (or any direct or indirect parent thereof) or any of the Restricted Subsidiaries approved by a majority of the Board of Directors of UK Holdco (or any direct or indirect parent thereof) in good faith;
(4)the payment of reasonable and customary fees and reimbursements paid to, and indemnity and similar arrangements provided on behalf of, former, current or future officers, directors, managers, employees or consultants of UK Holdco or any Restricted Subsidiary or any direct or indirect parent of UK Holdco;
(5)transactions in which UK Holdco or any of the Restricted Subsidiaries, as the case may be, delivers to the Administrative Agent a letter from an Independent Financial Advisor stating that such transaction is fair to UK Holdco or such Restricted Subsidiary from a financial point of view or meets the requirements of clause (a) of this Section 6.18;
(6)payments, loans or advances to employees or consultants or guarantees in respect thereof (or cancellation of loans, advances or guarantees) for bona fide business purposes in the ordinary course of business;
(7)any agreement, instrument or arrangement as in effect as of the Closing Date or any transaction contemplated thereby, or any amendment thereto (so long as any such amendment is not disadvantageous to Lenders in any material respect when taken as a whole as compared to the applicable agreement as in effect on the Closing Date as determined by the Borrower Representative in good faith);
(8)the existence of, or the performance by UK Holdco or any of the Restricted Subsidiaries of its obligations under, the terms of any stockholders or similar agreement (including any registration rights agreement or purchase agreement related thereto) to which it is a party as of the Closing Date, and any amendment thereto or similar transactions, agreements or arrangements which it may enter into thereafter; provided, however, that the existence of, or the performance by UK Holdco or any of the Restricted Subsidiaries of its obligations under, any future amendment to any such existing transaction, agreement or arrangement or under any similar transaction, agreement or arrangement entered into after the Closing Date shall only be permitted by this clause (viii) to the extent that the terms of any such existing transaction, agreement or arrangement together with all amendments thereto, taken as a whole, or new transaction, agreement or arrangement are not otherwise more disadvantageous to the Lenders in any material respect when taken as a whole as compared to the original transaction, agreement or arrangement as in effect on the Closing Date as determined by the Borrower Representative in good faith;
(9)(A) transactions with customers, clients, suppliers or purchasers or sellers of goods or services, in each case in the ordinary course of business and otherwise in compliance with the terms of this Agreement, which are fair to UK Holdco and the Restricted Subsidiaries in the reasonable determination of the Borrower Representative, and are on terms at least as favorable as might reasonably have been obtained at such time from an unaffiliated party or (B) transactions with joint ventures or Unrestricted Subsidiaries entered into in the ordinary course of business;
(10)any transaction effected as part of a Qualified Receivables Financing;
(11)the sale or issuance of Equity Interests (other than Disqualified Stock) of UK Holdco to Holdings (or a successor direct parent of UK Holdco);
(12)[reserved];
148
    



(13)payments by UK Holdco or any of the Restricted Subsidiaries to the Sponsors made for any financial advisory, financing, underwriting or placement services or in respect of other investment banking activities, including, without limitation, in connection with acquisitions or divestitures, which payments are approved by a majority of the Board of Directors of UK Holdco or any direct or indirect parent of UK Holdco in good faith;
(14)any contribution to the capital of UK Holdco or any Restricted Subsidiary;
(15)transactions permitted by, and complying with, the provisions of Section 7.5 or Section 7.8;
(16)[reserved];
(17)pledges of Equity Interests of Unrestricted Subsidiaries;
(18)any employment agreements, option plans and other similar arrangements entered into by UK Holdco or any of the Restricted Subsidiaries with employees or consultants in the ordinary course of business;
(19)the issuances of securities or other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding of, employment arrangements, stock option and stock ownership plans or similar employee benefit plans approved by the Board of Directors of UK Holdco or any direct or indirect parent of UK Holdco or of a Restricted Subsidiary, as appropriate, in good faith;
(20)the entering into of any tax sharing agreement or arrangement and any payments permitted by Section 7.3(b)(xii) or, with respect to franchise or similar Taxes, by Section 7.3(b)(xiii)(1);
(21)transactions to effect the Transactions, including the making of the TRA Payment;
(22)any employment, consulting, service or termination agreement, or customary indemnification arrangements, entered into by UK Holdco or any of the Restricted Subsidiaries with current, former or future officers and employees of UK Holdco or any of its Restricted Subsidiaries and the payment of compensation to officers and employees of UK Holdco or any of its respective Restricted Subsidiaries (including amounts paid pursuant to employee benefit plans, employee stock option or similar plans), in each case in the ordinary course of business;
(23)transactions with a Person that is an Affiliate of UK Holdco solely because UK Holdco, directly or indirectly, owns Equity Interests in, or controls, such Person entered into in the ordinary course of business;
(24)transactions with Affiliates solely in their capacity as holders of Indebtedness or Equity Interests of UK Holdco or any of its Subsidiaries, so long as such transaction is with all holders of such class (and there are such non-Affiliate holders) and such Affiliates are treated no more favorably than all other holders of such class generally;
(25)any agreement that provides customary registration rights to the equity holders of UK Holdco or any direct or indirect parent of UK Holdco and the performance of such agreements;
(26)payments to and from and transactions with any joint venture in the ordinary course of business; provided such joint venture is not controlled by an Affiliate (other than a Restricted Subsidiary) of UK Holdco; and
149
    



(27)transactions between UK Holdco or any of its Restricted Subsidiaries and any Person that is an Affiliate thereof solely due to the fact that a director of such Person is also a director of UK Holdco or any direct or indirect parent of UK Holdco; provided, however, that such director abstains from voting as a director of UK Holdco or such direct or indirect parent of UK Holdco, as the case may be, on any matter involving such other Person.
6.sLines of Business; Holding Company.
(i)Holdings and UK Holdco will, and will permit the Restricted Subsidiaries to, enter into only those businesses that are Similar Businesses. UK Holdco will not issue any Capital Stock other than to Holdings.
(ii)Holdings will ensure that its only material liabilities and material assets are, and that it will only conduct, transact or otherwise engage in any material business or operations, as follows: (i) Holdings’ ownership of the Equity Interests of UK Holdco and activities incidental thereto, (ii) the entry into, and the performance of its obligations with respect to, the Loan Documents, the Senior Secured Notes and other Indebtedness that has been guaranteed by, or is otherwise considered Indebtedness of, any Borrower or any of the Restricted Subsidiaries Incurred in accordance with Section 7.2; (iii) the consummation of the Transactions; (iv) the performing of activities (including, without limitation, cash management activities) and the entry into documentation with respect thereto, in each case, permitted by this Agreement for Holdings to enter into and perform; (v) the payment of dividends and distributions (and other activities in lieu thereof permitted by this Agreement), the making of contributions to the capital of its Subsidiaries and Guarantees of Indebtedness permitted to be incurred hereunder and the Guarantees of other obligations not constituting Indebtedness; (vi) the maintenance of its legal existence (including the ability to incur fees, costs and expenses relating to such maintenance and performance of activities relating to its officers, directors, managers and employees and those of its Subsidiaries); (vii) the performing of activities in preparation for and consummating any public offering of its common stock or any other issuance or sale of its Equity Interests (other than Disqualified Stock) including converting into another type of legal entity; (viii) the participation in Tax, accounting and other administrative matters as a member of any consolidated or similar group including UK Holdco, including compliance with applicable Laws and legal, Tax and accounting matters related thereto and activities relating to its officers, directors, managers and employees; (ix) the holding of any cash and Cash Equivalents (but not operating any property); (x) the entry into and performance of its obligations with respect to contracts and other arrangements, including the providing of indemnification to officers, managers, directors and employees; (xi) establishing and maintaining bank accounts; (xii) guaranteeing ordinary course obligations incurred by any of the Restricted Subsidiaries; (xiii) engaging in any activities incidental to compliance with the provisions of the Securities Act and the Exchange Act and similar laws and regulations of other jurisdictions and the rules of securities exchanges, in each case, as applicable to companies with listed equity or debt securities, as well as activities incidental to investor relations, shareholder meetings and reports to shareholders or debt-holders; and (xiv) any activities incidental to the foregoing. Holdings will cause UK Holdco to, and UK Holdco will, at all times remain a Wholly Owned Subsidiary of Holdings.
6.tLux Borrower.
(i)The Lux Borrower (and any successor permitted under Section 6.18(b) and Section 7.8(a)) will ensure its only material liabilities and material assets are, and that it will only conduct, transact or otherwise engage in any material business or operations, as follows: (i) [reserved], (ii) the entry into, and the performance of its obligations under and with respect to the Loan Documents, the Senior Secured Notes Indenture and related documents and documentation relating to any Indebtedness or Investments permitted by the Loan Documents; (iii) the entry into, and the performance of its obligations under the Loan Note Instruments or any future similar instruments; (iv) the consummation of the Transactions; (v) the performing of activities (including, without limitation, cash management activities) and the entry into documentation with respect thereto, in each case, specifically and expressly contemplated by this Agreement for Lux Borrower to enter into and perform or incidental to such performance; (vi) the maintenance of its legal existence (including the ability to incur fees, costs and expenses relating to such maintenance and performance of activities relating to its officers, directors, managers and employees); (vii) the participation in Tax, accounting and other administrative matters as a member of any consolidated or
150
    



similar group including Holdings, including compliance with applicable Laws and legal, Tax and accounting matters related thereto and activities relating to its officers, directors, managers and employees; (viii) the holding of any cash and Cash Equivalents (but not operating any property); (ix) the entry into and performance of its obligations with respect to contracts and other arrangements, including the providing of indemnification to officers, managers, directors and employees; (x) establishing and maintaining bank accounts (and granting security, charges and other liens thereon to secure the Obligations and other Indebtedness or obligation permitted to be secured thereby); (xi) engaging in any activities incidental to compliance with the provisions of the Securities Act and the Exchange Act and similar laws and regulations of other jurisdictions and the rules of securities exchanges, in each case, as applicable to companies with listed equity or debt securities, as well as activities incidental to investor relations, shareholder meetings and reports to shareholders or debt-holders; and (xii) any activities incidental to the foregoing.
(ii)The Lux Borrower will only issue Capital Stock to UK Holdco. The Lux Borrower will not undertake any action that will require the Lux Borrower to register as an ‘‘investment company’’ or an entity “controlled by an investment company” as defined in the US Investment Company Act of 1940, as amended and the rules and regulations thereunder.
SECTION 7.
NEGATIVE COVENANTS
Each Borrower hereby jointly and severally agrees that, until the Termination Date, such Borrower will, and will cause the Restricted Subsidiaries to, comply with this Section 7.
7.aFirst Lien Net Leverage Ratio. UK Holdco shall not, without the written consent of the Majority Revolving Lenders, permit the First Lien Net Leverage Ratio on a Pro Forma Basis as at the last day of any period of four consecutive fiscal quarters of UK Holdco commencing with the fiscal quarter ending March 31, 2020 (but only if the last day of such fiscal quarter constitutes a Financial Compliance Date) to exceed 7.25 to 1.00.
7.bLimitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock.
(i)(i) UK Holdco will not, and will not permit any of the Restricted Subsidiaries to, directly or indirectly, Incur any Indebtedness (including Acquired Indebtedness) or issue any shares of Disqualified Stock; and (ii) UK Holdco will not permit any of the Restricted Subsidiaries to issue any shares of Preferred Stock; provided, however, that UK Holdco and any of the Restricted Subsidiaries may Incur Indebtedness (including Acquired Indebtedness) or issue shares of Disqualified Stock and any of the Restricted Subsidiaries may issue shares of Preferred Stock, in each case, if either (A) the Interest Coverage Ratio for the most recently ended Reference Period is at least 2.00 to 1.00 or (B) the Total Net Leverage Ratio for the most recently ended Reference Period does not exceed 6.50 to 1.00 (any such debt incurred pursuant to this proviso, “Ratio Debt”), in each case determined on a Pro Forma Basis; provided, further, however, that the aggregate principal amount of Indebtedness (excluding Acquired Indebtedness not Incurred in connection with or in contemplation of the applicable merger, acquisition or other similar transaction) that may be Incurred and Disqualified Stock or Preferred Stock that may be issued pursuant to this clause (a) by Restricted Subsidiaries that are not Borrowers or Guarantors, taken together with the principal amount of all such Indebtedness Incurred and Disqualified Stock or Preferred Stock issued by Restricted Subsidiaries that are not Borrowers or Guarantors outstanding pursuant to paragraph (1) of the final proviso to clause (b)(vi) and the final proviso to clause (b)(xxii)(x) of this Section 7.2, shall not exceed the greater of $125,000,000 and 39% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding.
(ii)The limitations set forth in Section 7.2(a) shall not apply to (collectively, “Permitted Debt”):
(1)Indebtedness Incurred pursuant to this Agreement, any other Loan Document or any Loan Note Instrument (including any Indebtedness incurred pursuant to Section 2.25, 2.26 or 2.28);
151
    



(2)the Incurrence by the Borrowers and the Guarantors of Indebtedness represented by the Senior Secured Notes issued on the Closing Date (not including any additional notes) and the guarantees, as applicable;
(3)Indebtedness existing on the Closing Date (other than Indebtedness described in Section 7.2(b)(i) and (ii)) (in the case of any individual item of Indebtedness in a principal amount in excess of $5,000,000, to be set forth on Schedule 7.2);
(4)Permitted First Priority Refinancing Debt and Permitted Second Priority Refinancing Debt;
(5)Permitted Unsecured Refinancing Debt;
(6)Indebtedness, Disqualified Stock or Preferred Stock (“Incremental Equivalent Debt”) not to exceed an amount equal to the sum of (x) an unlimited amount at any time so long as (A) in the case of Indebtedness that is secured by a Lien on the Collateral on a pari passu basis with the Obligations, the First Lien Net Leverage Ratio for the most recently ended Reference Period does not exceed 5.00 to 1.00, (B) in the case of Indebtedness that is secured by a Lien on the Collateral other than on a pari passu basis with the Obligations, the Secured Net Leverage Ratio for the most recently ended Reference Period does not exceed 6.50 to 1.00 or (C) in the case of Indebtedness that is unsecured or is secured by a Lien on assets that do not constitute Collateral, and in the case of Disqualified Stock or Preferred Stock, either (1) the Total Net Leverage Ratio for the most recently ended Reference Period does not exceed 6.50 to 1.00 or (2) the Interest Coverage Ratio for the most recently ended Reference Period is at least 2.00 to 1.00, in each case on a Pro Forma Basis (but without giving effect to the cash proceeds of any such Indebtedness remaining on the balance sheet and calculated assuming that any such Indebtedness is fully drawn throughout such period), plus (y) the amount of all prior voluntary prepayments, loan buybacks (with credit given to the principal amount thereof) and commitment reductions of Term Loans, Revolving Loans, Incremental Loans, Indebtedness incurred pursuant to this Section 7.2(b)(vi) that is secured by a Lien on the Collateral on a pari passu basis with the Obligations and Permitted Credit Agreement Refinancing Debt and Refinancing Indebtedness previously applied to the permanent repayment of any of the foregoing and the amount of any prepayments made to any Lender pursuant to Section 2.23, with any replacement of a Lender pursuant thereto being deemed, solely for this purpose, to constitute a prepayment (in each case, to the extent not funded with the proceeds of long-term Indebtedness (except Indebtedness under one or more revolving credit or similar facilities) or the proceeds of Permitted Cure Securities applied pursuant to Section 9.4 and, with respect to any prepayment or commitment reduction of or in respect of revolving loans, to the extent accompanied by a permanent reduction in such revolving commitments) (minus the aggregate principal amount of Indebtedness Incurred under Section 2.25(a)(i)(y)), plus (z) an amount equal to the greater of $325,000,000 and 100% of Consolidated EBITDA on a Pro Forma Basis as of the most recently ended Reference Period (and after giving effect to any acquisition or other transaction consummated concurrently therewith) (minus the aggregate outstanding principal amount of Indebtedness Incurred under Section 2.25(a)(i)(z)) (provided that, for the avoidance of doubt, the amount available to the Borrowers pursuant to clauses (y) and (z) above shall be available at all times and shall not be subject to any ratio test described in foregoing clause (x) above), which amount may be secured on a pari passu or junior basis; provided, that:
(a)the principal amount of such Indebtedness (excluding Acquired Indebtedness not Incurred in connection with or in contemplation of the applicable merger, acquisition or other similar transaction) that may be Incurred and Disqualified Stock or Preferred Stock that may be issued pursuant to this clause (vi) by Restricted Subsidiaries that are not Borrowers or Guarantors, shall not exceed the greater of $125,000,000 and 39% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding (minus the outstanding principal amount of such Indebtedness Incurred by Restricted Subsidiaries that are not Borrowers or Guarantors pursuant to the second proviso to clause (a) and the final proviso to clause (b)(xxii)(x) of this Section 7.2);
(b)the Applicable Requirements shall have been satisfied;
152
    



(c)no Indebtedness under this clause (vi) may be Incurred at any time that an Event of Default has occurred and is continuing (unless such Indebtedness is used to finance, in whole or in part, a Limited Condition Transaction, in which case the absence of an Event of Default shall be tested on the date specified in Section 1.4);
(d)any such Indebtedness in the form of Dollar denominated broadly syndicated term “B” loans Incurred under this clause (vi) that is secured by a Lien on the Collateral on a pari passu basis with the Obligations shall be subject to the MFN Provision set forth in Section 2.25(a)(vii) (giving effect to all exceptions thereto, mutatis mutandis for Incremental Equivalent Debt);
(e)[reserved]; and
(f)(A) for the avoidance of doubt, if the applicable Borrower incurs Indebtedness under clause (x) above on the same date that it incurs Indebtedness under clauses (y) or (z) above, then the applicable incurrence ratio will be calculated with respect to such incurrence under clause (x) without regard to any incurrence of Indebtedness under clauses (y) or (z) and (B) unless the applicable Borrower elects otherwise, any Indebtedness incurred pursuant to this clause (vi) shall be deemed incurred first under clause (x) above, with the balance incurred under clauses (y) and (z) above.
(7)Indebtedness (including, without limitation, Capitalized Lease Obligations, mortgage financings or purchase money obligations) Incurred by UK Holdco or any of the Restricted Subsidiaries, Disqualified Stock issued by UK Holdco or any of the Restricted Subsidiaries and Preferred Stock issued by any Restricted Subsidiaries to finance all or any part of the acquisition, purchase, lease, construction, design, installation, repair, replacement or improvement of property (real or personal), plant or equipment or other fixed or capital assets used or useful in the business of UK Holdco or the Restricted Subsidiaries or in a Similar Business (whether through the direct purchase of assets or the Capital Stock of any Person owning such assets) in an aggregate principal amount, including all Indebtedness Incurred to renew, refund, Refinance, replace, defease or discharge any Indebtedness Incurred pursuant to this clause (vii), not to exceed the greater of $150,000,000 and 47% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding (minus amounts incurred and outstanding under clause (xvi) in respect of Indebtedness originally incurred under this clause (vii)); provided, that Capitalized Lease Obligations incurred by UK Holdco or any Restricted Subsidiary pursuant to this clause (vii) in connection with a Sale Leaseback Transaction shall not be subject to the foregoing limitation so long as the proceeds of such Sale Leaseback Transaction are used by UK Holdco or such Restricted Subsidiary to permanently repay outstanding loans under any credit agreement, debt facility or other Indebtedness secured by a Lien on the assets subject to such Sale Leaseback Transaction;
(8)Indebtedness (x) in respect of any bankers’ acceptance, bank guarantees, discounted bill of exchange or the discounting or factoring of receivables, warehouse receipt or similar facilities, and reinvestment obligations related thereto, entered into in the ordinary course of business and (y) constituting reimbursement obligations with respect to letters of credit issued in the ordinary course of business, including letters of credit in respect of workers’ compensation claims, or other Indebtedness with respect to reimbursement type obligations regarding workers’ compensation claims; provided, however, that upon the drawing of such letters of credit or the Incurrence of such Indebtedness, such obligations are reimbursed within 45 days following such drawing;
(9)Indebtedness arising from agreements of UK Holdco or a Restricted Subsidiary providing for indemnification, adjustment of purchase price, earnout or similar obligations, in each case, Incurred in connection with the acquisition or disposition of any business, assets or a Subsidiary of UK Holdco in accordance with the terms of this Agreement, other than guarantees of Indebtedness Incurred by any Person acquiring all or any portion of such business, assets or Subsidiary for the purpose of financing such acquisition;
153
    



(10)shares of Preferred Stock of a Restricted Subsidiary issued to UK Holdco or another Restricted Subsidiary; provided that any subsequent issuance or transfer of any Capital Stock or any other event that results in any Restricted Subsidiary that holds such shares of Preferred Stock of another Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such shares of Preferred Stock (except to UK Holdco or another Restricted Subsidiary) shall be deemed, in each case, to be an issuance of shares of Preferred Stock;
(11)Indebtedness or Disqualified Stock of (a) a Restricted Subsidiary to UK Holdco or (b) UK Holdco or any Restricted Subsidiary to any Restricted Subsidiary; provided that if UK Holdco or a Guarantor Incurs such Indebtedness to a Restricted Subsidiary that is not a Borrower or a Guarantor, such Indebtedness is, on and from the date that is 120 days following the Closing Date (or such later date as the Administrative Agent may agree in its reasonable discretion), subordinated in right of payment to the Loans or the Guarantee of such Guarantor, as the case may be; provided, further, that any subsequent issuance or transfer of any Capital Stock or any other event that results in any Restricted Subsidiary lending such Indebtedness or Disqualified Stock, as applicable, ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such Indebtedness or Disqualified Stock, as applicable (except to UK Holdco or another Restricted Subsidiary) shall be deemed, in each case, to be an Incurrence of such Indebtedness or Disqualified Stock, as applicable;
(12)Hedging Obligations that are Incurred in the ordinary course of business (and not for speculative purposes) or in connection with the Transactions: (1) for the purpose of fixing or hedging interest rate risk with respect to any Indebtedness that is permitted by the terms of this Agreement to be outstanding; (2) for the purpose of fixing or hedging currency exchange rate risk; or (3) for the purpose of fixing or hedging commodity price risk with respect to any commodity purchases;
(13)obligations (including reimbursement obligations with respect to letters of credit and bank guarantees) in respect of performance, bid, appeal and surety bonds and completion guarantees provided by UK Holdco or any Restricted Subsidiaries;
(14)Indebtedness, Disqualified Stock or Preferred Stock in an aggregate principal amount or liquidation preference that, when aggregated with the principal amount or liquidation preference of all other Indebtedness, Disqualified Stock and Preferred Stock then outstanding and Incurred pursuant to this clause (xiv), does not exceed the greater of $250,000,000 and 77% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding (minus amounts incurred and outstanding under clause (xvi) in respect of Indebtedness originally incurred under this clause (xiv));
(15)any guarantee by UK Holdco or any of the Restricted Subsidiaries of Indebtedness or other obligations of UK Holdco or any of the Restricted Subsidiaries so long as the Incurrence of such Indebtedness or other obligations by UK Holdco or such Restricted Subsidiary is permitted under the terms of this Agreement; provided that if such Indebtedness is by its express terms subordinated in right of payment to the Loans or the Guarantee of any Guarantor, any such guarantee of such Guarantor with respect to such Indebtedness shall be subordinated in right of payment to the Loans and the Guarantees, substantially to the same extent as such Indebtedness is subordinated to the Loans or any relevant Guarantees, as applicable;
(16)the Incurrence by UK Holdco or any of the Restricted Subsidiaries of Indebtedness or Disqualified Stock or Preferred Stock of a Restricted Subsidiary that serves to refund, Refinance, replace or defease any Indebtedness, Disqualified Stock or Preferred Stock Incurred as permitted under clause (a) of this Section 7.2 and clauses (b)(i), (b)(ii), (b)(iii), (b)(vi), (b)(vii), (b)(xiv), (b)(xvi), (b)(xix), (b)(xxii), (b)(xxvii) and (b)(xxx), of this Section 7.2 or any Indebtedness, Disqualified Stock or Preferred Stock Incurred to so refund or Refinance such Indebtedness, Disqualified Stock or Preferred Stock, including any additional Indebtedness, Disqualified Stock or Preferred Stock Incurred to pay accrued and unpaid interest, fees and expenses, including any premium and defeasance costs in connection therewith (subject to the following proviso, “Refinancing Indebtedness”) prior to its respective maturity; provided, however, that such Refinancing Indebtedness:
154
    



(a)other than with respect to Indebtedness incurred pursuant to Section 7.2(a), revolving Indebtedness and Customary Bridge Financings and other than with respect to Indebtedness incurred pursuant to the Inside Maturity Basket, has a Weighted Average Life to Maturity at the time such Refinancing Indebtedness is Incurred which is not less than the shorter of (x) the remaining Weighted Average Life to Maturity of the Indebtedness being refunded or Refinanced and (y) the remaining Weighted Average Life to Maturity of the Senior Secured Notes;
(b)other than with respect to Indebtedness incurred pursuant to Section 7.2(a), Customary Bridge Financings and other than with respect to Indebtedness incurred pursuant to the Inside Maturity Basket, has a Stated Maturity which is no earlier than the earlier of (x) the Stated Maturity of the Indebtedness being refunded or Refinanced and (y) the Stated Maturity of the Senior Secured Notes;
(c)to the extent such Refinancing Indebtedness Refinances (x) Subordinated Indebtedness, such Refinancing Indebtedness is Subordinated Indebtedness, or (y) Disqualified Stock or Preferred Stock, such Refinancing Indebtedness is Disqualified Stock or Preferred Stock;
(d)is Incurred in an aggregate principal amount (or if issued with original issue discount an aggregate issue price) that is equal to or less than the sum of (x) the aggregate principal amount (or if issued with original issue discount, the aggregate accreted value) then outstanding of the Indebtedness being Refinanced plus (y) the amount necessary to pay accrued and unpaid interest, fees, underwriting discounts and expenses, including any premium and defeasance costs Incurred in connection with such Refinancing plus (z) an amount not exceeding the amount otherwise able to be Incurred pursuant to this Section 7.2 (it being understood that such amount shall constitute utilization of the applicable basket or exception to this Section 7.2); and
(e)shall not include (x) Indebtedness, Disqualified Stock or Preferred Stock of a Subsidiary that is not a Guarantor that Refinances Indebtedness, Disqualified Stock or Preferred Stock of UK Holdco; (y) Indebtedness, Disqualified Stock or Preferred Stock of a Subsidiary that is not a Guarantor that Refinances Indebtedness, Disqualified Stock or Preferred Stock of a Guarantor; or (z) Indebtedness, Disqualified Stock or Preferred Stock of UK Holdco or a Restricted Subsidiary that Refinances Indebtedness, Disqualified Stock or Preferred Stock of an Unrestricted Subsidiary;
(17)Indebtedness arising from (x) Cash Management Services and (y) the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business, provided that, in the case of this (y), such Indebtedness is extinguished within ten Business Days of its Incurrence;
(18)Indebtedness of UK Holdco or any Restricted Subsidiary supported by a letter of credit or bank guarantee issued pursuant to this Agreement, in a principal amount not in excess of the stated amount of such letter of credit or bank guarantee;
(19)Contribution Indebtedness;
(20)Indebtedness of UK Holdco or any Restricted Subsidiary consisting of (x) the financing of insurance premiums or (y) take-or-pay obligations contained in supply arrangements;
(21)Indebtedness Incurred by a Receivables Subsidiary in a Qualified Receivables Financing that is not recourse to UK Holdco or any Restricted Subsidiary other than a Receivables Subsidiary (except for Standard Securitization Undertakings);
(22)(x) Indebtedness, Disqualified Stock or Preferred Stock of UK Holdco or any of the Restricted Subsidiaries Incurred to finance an acquisition or other Investment or (y) Acquired
155
    



Indebtedness of UK Holdco or any of the Restricted Subsidiaries not Incurred in connection with or in contemplation of the applicable merger, acquisition or other similar transaction; provided that, in the case of clause (x), after giving effect to the transactions that result in the Incurrence or issuance thereof, on a Pro Forma Basis, either (A) UK Holdco would be permitted to Incur at least $1.00 of additional Indebtedness as Ratio Debt or (B) (1) in the case of Indebtedness that is secured by a Lien on the Collateral on a pari passu basis with the Obligations, the First Lien Net Leverage Ratio on a Pro Forma Basis does not exceed the First Lien Net Leverage Ratio as of the most recently ended Reference Period, (2) in the case of Indebtedness that is secured by a Lien on the Collateral other than on a pari passu basis with the Obligations, the Secured Net Leverage Ratio on a Pro Forma Basis does not exceed the Secured Net Leverage Ratio as of the most recently ended Reference Period or (3) in the case of Indebtedness that is unsecured or is secured by a Lien on assets that do not constitute Collateral, and in the case of Disqualified Stock or Preferred Stock, either (x) the Total Net Leverage Ratio on a Pro Forma Basis does not exceed the Total Net Leverage Ratio as of the most recently ended Reference Period or (y) the Interest Coverage Ratio on a Pro Forma Basis is no less than the Interest Coverage Ratio as of the most recently ended Reference Period; provided, that the aggregate principal amount of Indebtedness Incurred by Restricted Subsidiaries which are not Borrowers or Guarantors under the preceding clause (xxii)(x) shall not exceed the greater of $125,000,000 and 39% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding (minus the amount of such Indebtedness Incurred by Restricted Subsidiaries that are not Borrowers or Guarantors outstanding pursuant to the second proviso of clause (a) and paragraph (1) of the final proviso to clause (b)(vi) of this Section 7.2);
(23)Indebtedness Incurred by UK Holdco or any Restricted Subsidiary to the extent that the net proceeds thereof are promptly deposited to defease or to satisfy and discharge the Senior Secured Notes;
(24)Guarantees (A) Incurred in the ordinary course of business in respect of obligations of (or to) suppliers, customers, franchisees, lessors and licensees that, in each case, are non-Affiliates or (B) otherwise constituting Investments permitted under this Agreement;
(25)Indebtedness issued by UK Holdco or any of the Restricted Subsidiaries to current or former employees, directors, managers and consultants thereof, their respective estates, spouses or former spouses, in each case to finance the purchase or redemption of Equity Interests of UK Holdco or any direct or indirect parent company of UK Holdco to the extent permitted by Section 7.3(b)(iv);
(26)Indebtedness owed on a short-term basis of no longer than 30 days to banks and other financial institutions Incurred in the ordinary course of business of UK Holdco and the Restricted Subsidiaries with such banks or financial institutions that arises in connection with ordinary banking arrangements to manage cash balances of UK Holdco and the Restricted Subsidiaries;
(27)Indebtedness Incurred by joint ventures of UK Holdco or any of the Restricted Subsidiaries (or by UK Holdco or any of the Restricted Subsidiaries on behalf of any such joint venture) or guarantees of the foregoing, and Indebtedness of Restricted Subsidiaries that are Non-Guarantor Subsidiaries, in an aggregate principal amount that does not exceed the greater of $175,000,000 and 54% of Consolidated EBITDA as of the most recently ended Reference Period at any one time outstanding (minus amounts incurred and outstanding under clause (xvi) in respect of Indebtedness originally incurred under this clause (xxvii));
(28)customer deposits and advance payments received in the ordinary course of business from customers for goods purchased in the ordinary course of business;
(29)Indebtedness Incurred pursuant to Sale Leaseback Transactions; and
(30)Indebtedness, Disqualified Stock or Preferred Stock of UK Holdco or a Restricted Subsidiary Incurred to finance or assumed in connection with an acquisition of any assets (including Capital Stock), business or Person in an aggregate principal amount or liquidation preference that does not exceed the greater of $30,000,000 and 10% of Consolidated EBITDA as of the most
156
    



recently ended Reference Period, at any one time outstanding (minus amounts Incurred and outstanding under (clause (xvi) in respect of Indebtedness originally Incurred under this clause (xxx)).
(iii)For purposes of determining compliance with this Section 7.2, with respect to Indebtedness Incurred, re-borrowings of amounts previously repaid pursuant to “cash sweep” provisions or any similar provisions that provide that Indebtedness is deemed to be repaid daily (or otherwise periodically) shall only be deemed for purposes of this Section 7.2 to have been Incurred on the date such Indebtedness was first Incurred and not on the date of any subsequent re-borrowing thereof. Accrual of interest, the accretion of accreted value, the amortization of original issue discount, the payment of interest in the form of additional Indebtedness with the same terms, the payment of dividends on Disqualified Stock or Preferred Stock in the form of additional shares of Disqualified Stock or Preferred Stock of the same class, the accretion of liquidation preference and increases in the amount of Indebtedness outstanding solely as a result of fluctuations in the exchange rate of currencies will not be deemed to be an Incurrence of Indebtedness, Disqualified Stock or Preferred Stock for purposes of this Section 7.2. For the avoidance of doubt, the outstanding principal amount of any particular Indebtedness shall be counted only once. Guarantees of, or obligations in respect of letters of credit relating to, Indebtedness that is otherwise included in the determination of a particular amount of Indebtedness shall not be included in the determination of such amount of Indebtedness, provided that the Incurrence of the Indebtedness represented by such guarantee or letter of credit, as the case may be, was in compliance with this Section 7.2.
(iv)For purposes of determining compliance with any Dollar-denominated restriction on the Incurrence of Indebtedness, the Dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was Incurred, in the case of term debt, or first committed or first Incurred (whichever yields the lower Dollar-equivalent amount), in the case of revolving credit debt; provided that if such Indebtedness is Incurred to Refinance other Indebtedness denominated in a foreign currency, and such refinancing would cause the applicable Dollar-denominated restriction to be exceeded if calculated at the relevant currency exchange rate in effect on the date of such refinancing, such Dollar-denominated restriction shall be deemed not to have been exceeded so long as the principal amount of such refinancing Indebtedness does not exceed the principal amount of such Indebtedness being Refinanced (plus an amount not exceeding the amount otherwise able to be Incurred pursuant to this Section 7.2, it being understood that such amount shall constitute utilization of the applicable basket or exception to this Section 7.2).
7.cLimitation on Restricted Payments.
(i)UK Holdco will not, and will not permit any of the Restricted Subsidiaries to, directly or indirectly:
(1)declare or pay any dividend or make any distribution on account of UK Holdco’s or any of its Restricted Subsidiaries’ Equity Interests, including any payment made in connection with any merger or consolidation involving UK Holdco (other than dividends, payments or distributions (A) payable solely in Equity Interests (other than Disqualified Stock) of UK Holdco or to UK Holdco and the Restricted Subsidiaries; or (B) by a Restricted Subsidiary so long as, in the case of any dividend or distribution payable on or in respect of any class or series of securities issued by a Restricted Subsidiary other than a Wholly Owned Restricted Subsidiary, UK Holdco or a Restricted Subsidiary receives at least its pro rata share of such dividend or distribution in accordance with its Equity Interests in such class or series of securities);
(2)purchase or otherwise acquire or retire for value any Equity Interests of UK Holdco or any direct or indirect parent of UK Holdco;
(3)make any principal payment on, or redeem, repurchase, defease or otherwise acquire or retire for value, in each case prior to any scheduled repayment or scheduled maturity, any Junior Indebtedness (other than the payment, redemption, repurchase, defeasance, acquisition or retirement of (A) Junior Indebtedness in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year of the date of such payment, redemption,
157
    



repurchase, defeasance, acquisition or retirement and (B) Indebtedness permitted under Section 7.2(b)(xi)) (any such payments, redemptions, repurchases, defeasances, acquisitions or retirements for value, “Restricted Debt Payments”); or
(4)make any Restricted Investment;
(all such payments and other actions set forth in clauses (i) through (iv) above, other than any of the exceptions set forth therein, being collectively referred to as “Restricted Payments”), unless at the applicable time of determination:
(a)(x) solely in the case of a Restricted Payment (other than a Restricted Investment or a Restricted Debt Payment) that is made in reliance on clause (3)(A) below, no Event of Default shall have occurred and be continuing or would occur as a consequence thereof and (y) solely in the case of a Restricted Debt Payment that is made in reliance on clause (3)(A) below, no Specified Event of Default shall have occurred and be continuing or would occur as a consequence thereof;
(b)[reserved]; and
(c)such Restricted Payment, together with the aggregate amount of all other Restricted Payments made by UK Holdco and the Restricted Subsidiaries after the Closing Date (including Restricted Payments permitted by clause (b)(i), but excluding all other Restricted Payments permitted by clause (b) of this Section 7.3), is less than the sum of, without duplication,
(i)50% of the Consolidated Net Income of UK Holdco for the period (taken as one accounting period) from the first day of the fiscal quarter in which the Closing Date occurs to the end of UK Holdco’s most recently ended Reference Period at the applicable time of determination; provided that this clause (A) shall in no event be less than zero, plus
(ii)100% of the aggregate net proceeds, including cash and the Fair Market Value of assets other than cash, received by UK Holdco after the Closing Date from the issue or sale of Equity Interests of UK Holdco or any direct or indirect parent of UK Holdco (excluding (without duplication) any Cure Amount, Refunding Capital Stock, Designated Preferred Stock, Cash Contribution Amount, Excluded Contributions and Disqualified Stock), including Equity Interests issued upon conversion of Indebtedness or upon exercise of warrants or options (other than an issuance or sale to a Restricted Subsidiary or an employee stock ownership plan or trust established by UK Holdco or any of its Subsidiaries), plus
(iii)100% of the aggregate amount of contributions to the capital of UK Holdco received in cash and the Fair Market Value of property other than cash after the Closing Date (other than Excluded Contributions, Refunding Capital Stock, Designated Preferred Stock, Disqualified Stock and the Cash Contribution Amount), plus
(iv)the principal amount of any Indebtedness, or the liquidation preference or maximum fixed repurchase price, as the case may be, of any Disqualified Stock, of
158
    



UK Holdco or any Restricted Subsidiary thereof issued after the Closing Date (other than any Indebtedness or Disqualified Stock issued to UK Holdco or any Restricted Subsidiary) that has been converted into or exchanged for Equity Interests in UK Holdco (other than Disqualified Stock) or any direct or indirect parent of UK Holdco, plus
(v)100% of the aggregate amount received by UK Holdco or any Restricted Subsidiary in cash and the Fair Market Value of property other than cash received by UK Holdco or any Restricted Subsidiary from:
(1)the sale or other disposition (other than to UK Holdco or a Restricted Subsidiary) of Restricted Investments made by UK Holdco and the Restricted Subsidiaries and from repurchases and redemptions of such Restricted Investments from UK Holdco and the Restricted Subsidiaries by any Person (other than UK Holdco or any of its Restricted Subsidiaries) and from repayments of loans or advances which constituted Restricted Investments (other than in each case to the extent that the Restricted Investment was made pursuant to clause (b)(vii) of this Section 7.3),
(2)the sale (other than to UK Holdco or a Restricted Subsidiary) of the Capital Stock of an Unrestricted Subsidiary of Holdings, or
(3)any distribution or dividend from any Unrestricted Subsidiary of Holdings (to the extent such distribution or dividend is not already included in the calculation of Consolidated Net Income); plus
(vi)in the event any Unrestricted Subsidiary of UK Holdco has been redesignated as a Restricted Subsidiary or has been merged or consolidated with or into, or transfers or conveys its assets to, or is liquidated into, UK Holdco or a Restricted Subsidiary, in each case after the Closing Date, the Fair Market Value of the Investment of UK Holdco or its applicable Restricted Subsidiary in such Unrestricted Subsidiary at the time of such redesignation, combination or transfer (or of the assets transferred or conveyed, as applicable), after deducting any Indebtedness associated with such Unrestricted Subsidiary so designated or combined or any Indebtedness associated with the assets so transferred or conveyed (other than in each case to the extent that the designation of such Subsidiary as an Unrestricted Subsidiary was made pursuant to clause (b)(vii) of this Section 7.3 or constituted a Permitted Investment); plus
(vii)the aggregate amount of Retained Declined Proceeds; plus
159
    



(viii)the greater of $100,000,000 and 31% of Consolidated EBITDA as of the most recently ended Reference Period.
(ii)The provisions of Section 7.3(a) will not prohibit:
(1)the payment of any dividend or distribution or consummation of any redemption within 60 days after the date of declaration thereof or the giving of a redemption notice related thereto, if at the date of declaration or notice such payment would have complied with the provisions of this Agreement;
(2)(A) the redemption, repurchase, defeasance, exchange, retirement or other acquisition of any Equity Interests (“Retired Capital Stock”) of UK Holdco or any direct or indirect parent of UK Holdco or any Restricted Subsidiary or Junior Indebtedness of UK Holdco or any Restricted Subsidiary, in exchange for, or out of the proceeds of a sale (other than to UK Holdco or a Restricted Subsidiary) of, Equity Interests of UK Holdco or any direct or indirect parent of UK Holdco to the extent contributed to UK Holdco or any Restricted Subsidiary or contributed to the equity capital of UK Holdco or any Restricted Subsidiary (other than any Disqualified Stock or any Equity Interests sold to UK Holdco or any Restricted Subsidiary of UK Holdco or to an employee stock ownership plan or any trust established by UK Holdco or any of its Restricted Subsidiaries) (collectively, including any such contributions, “Refunding Capital Stock”); (B) if immediately prior to the retirement of Retired Capital Stock, the declaration and payment of dividends thereon was permitted under clause (vi) of this Section 7.3(b), the declaration and payment of dividends on the Refunding Capital Stock (other than Refunding Capital Stock the proceeds of which were used to redeem, repurchase, defease, retire or otherwise acquire any Equity Interests of any direct or indirect parent company of UK Holdco) in an aggregate amount per year no greater than the aggregate amount of dividends per annum that were declarable and payable on such Retired Capital Stock immediately prior to such retirement; and (C) the declaration and payment of accrued dividends on the Retired Capital Stock out of the proceeds of the sale (other than to UK Holdco or a Restricted Subsidiary) (made within 90 days of such redemption, repurchase, defeasance, exchange, retirement, or other acquisition) (other than to a Restricted Subsidiary of UK Holdco or to an employee stock ownership plan or any trust established by UK Holdco or any of its Restricted Subsidiaries) of Refunding Capital Stock;
(3)the prepayment, redemption, repurchase, defeasance, exchange or other acquisition or retirement of Junior Indebtedness of UK Holdco or any Restricted Subsidiary (x) constituting Acquired Indebtedness not Incurred in connection with or in contemplation of the applicable merger, acquisition or other similar transaction or (y) made by exchange for, or out of the proceeds of the sale (made within 90 days of such prepayment, redemption, repurchase, defeasance, exchange, or other acquisition) of, new Indebtedness of UK Holdco or a Restricted Subsidiary that is incurred in accordance with Section 7.2 so long as, in the case of this clause (y):
(a)the principal amount (or accreted value, if applicable) of such new Indebtedness does not exceed the principal amount (or accreted value, if applicable) of the Junior Indebtedness being so prepaid, redeemed, repurchased, defeased, exchanged, acquired or retired for value (plus accrued and unpaid interest, fees, underwriting discounts and expenses, including any premium and defeasance costs, required to be paid under the terms of the instrument governing the Junior Indebtedness being so prepaid, redeemed, repurchased, defeased, exchanged, acquired or retired plus any fees and expenses Incurred in connection therewith, including reasonable tender premiums);
(b)if such Junior Indebtedness was subordinated to the Facilities or the related Guarantee, as the case may be, such new Indebtedness must be subordinated to the Facilities or the related Guarantee at least to the same extent as such Junior Indebtedness so prepaid, purchased, exchanged, redeemed, repurchased, defeased, exchanged, acquired or retired;
160
    



(c)other than with respect to Indebtedness incurred pursuant to the Inside Maturity Basket, such Indebtedness has a final scheduled maturity date no earlier than the earlier of (x) the final scheduled maturity date of the Junior Indebtedness being so prepaid, redeemed, repurchased, defeased, exchanged, acquired or retired or (y) the Latest Maturity Date; and
(d)other than in respect of revolving Indebtedness and Indebtedness incurred pursuant to the Inside Maturity Basket, such Indebtedness has a Weighted Average Life to Maturity that is not less than the lesser of (x) the remaining Weighted Average Life to Maturity of the Junior Indebtedness being so prepaid, redeemed, repurchased, defeased, acquired or retired at the time of incurrence or (y) the remaining Weighted Average Life to Maturity of the latest maturing Term Loans;
(4)the purchase, retirement, redemption or other acquisition (or dividends to UK Holdco or any other direct or indirect parent of UK Holdco to finance any such purchase, retirement, redemption or other acquisition) for value of Equity Interests of UK Holdco or any direct or indirect parent of UK Holdco held by any future, present or former employee, director or consultant of UK Holdco or any direct or indirect parent of UK Holdco or any Subsidiary of UK Holdco or their estates or the beneficiaries of such estates pursuant to any management equity plan or stock option plan or any other management or employee benefit plan or other similar agreement or arrangement; provided, however, that the aggregate amounts paid under this clause (iv) do not exceed the greater of $30,000,000 and 10% of Consolidated EBITDA as of the most recently ended Reference Period in any calendar year (with unused amounts in any calendar year being carried over to succeeding calendar years); provided, further, however, that such amount in any calendar year may be increased by an amount not to exceed:
(a)the cash proceeds received after the Closing Date by UK Holdco, any direct or indirect parent of UK Holdco and the Restricted Subsidiaries from the sale of Equity Interests (other than Disqualified Stock) of UK Holdco or any direct or indirect parent of UK Holdco (to the extent contributed to UK Holdco or any Restricted Subsidiary) to members of management, directors or consultants of UK Holdco and the Restricted Subsidiaries (provided that the amount of such cash proceeds utilized for any such repurchase, retirement, other acquisition or dividend will not increase the amount available for Restricted Payments under clause (a)(3) of this Section 7.3); plus
(b)the cash proceeds of key man life insurance policies received after the Closing Date by UK Holdco, any direct or indirect parent of UK Holdco (to the extent contributed to UK Holdco or any Restricted Subsidiary) and the Restricted Subsidiaries;
(provided that the Borrower Representative may elect to apply all or any portion of the aggregate increase contemplated by clauses (1) and (2) above in any calendar year); in addition, cancellation of Indebtedness owing to UK Holdco or any of its Restricted Subsidiaries from any current, former or future officer, director or employee (or any permitted transferees thereof) of UK Holdco or any of the Restricted Subsidiaries (or any direct or indirect parent company thereof), in connection with a repurchase of Equity Interests of UK Holdco (or any direct or indirect parent company thereof) from such Persons will be deemed not to constitute a Restricted Payment for purposes of this Section 7.3 or any other provisions of this Agreement;
(5)the declaration and payment of dividends or distributions to holders of any class or series of Disqualified Stock of UK Holdco or any of the Restricted Subsidiaries and any Preferred Stock of any Restricted Subsidiaries issued or Incurred in accordance with Section 7.2;
(6)(A) the declaration and payment of dividends or distributions to holders of any class or series of Designated Preferred Stock (other than Disqualified Stock) issued after the Closing Date, (B) the declaration and payment of dividends to any direct or indirect parent of UK Holdco, the proceeds of which will be used to fund the payment of dividends to holders of any class or series of Designated Preferred Stock (other than Disqualified Stock) of any direct or indirect parent of UK Holdco issued after the Closing Date; and (C) the declaration and payment of dividends on Refunding Capital
161
    



Stock that is Preferred Stock in excess of the dividends declarable and payable thereon pursuant to clause (b)(ii) of this Section 7.3; provided, however, that (x) for the most recently ended Reference Period preceding the date of issuance of such Designated Preferred Stock or the declaration of such dividends on Refunding Capital Stock that is Preferred Stock, after giving effect to such issuance (and the payment of dividends or distributions) on a Pro Forma Basis, UK Holdco would be permitted to Incur at least $1.00 of additional Ratio Debt pursuant to Section 7.2(a) and (y) the aggregate amount of dividends declared and paid pursuant to this clause (vi) does not exceed the net cash proceeds actually received by UK Holdco from any such sale of Designated Preferred Stock (other than Disqualified Stock issued after the Closing Date and securities issued in connection with the Cure Right);
(7)Investments in Unrestricted Subsidiaries having an aggregate Fair Market Value, taken together with all other Investments made pursuant to this clause (vii) that are at that time outstanding, not to exceed the greater of $100,000,000 and 31% of Consolidated EBITDA as of the most recently ended Reference Period, at any one time outstanding;
(8)the payment of dividends on UK Holdco’s common stock (or the payment of dividends to any direct or indirect parent of UK Holdco to fund the payment by any direct or indirect parent of UK Holdco of dividends on such entity’s common stock) of up to the sum of (A) 6.00% per annum of the net proceeds received by or contributed to UK Holdco or its applicable direct or indirect parent as a result of the initial public offering of UK Holdco’s publicly listed parent or any future public offering of UK Holdco’s publicly listed parent’s common stock and (B) 2.00% per annum of the Market Capitalization of Holdings or its applicable direct or indirect parent;
(9)Restricted Payments in an amount equal to the amount of Excluded Contributions made;
(10)other Restricted Payments in an aggregate amount not to exceed the greater of $150,000,000 and 47% of Consolidated EBITDA as of the most recently ended Reference Period;
(11)the distribution, as a dividend or otherwise, of shares of Capital Stock of, or other securities of, or Indebtedness owed to, UK Holdco or a Restricted Subsidiary by, Unrestricted Subsidiaries;
(12)any payments pursuant to a tax sharing agreement between UK Holdco and any other Person or a Restricted Subsidiary and any other Person with which UK Holdco or any Restricted Subsidiary files a consolidated tax return or with which UK Holdco or any Restricted Subsidiary is part of a group for tax purposes or any tax advantageous group contribution made pursuant to applicable legislation; provided, however, that any such tax sharing agreement or arrangement and payment does not permit or require payments in excess of the amounts of Tax that would be payable by UK Holdco or the Subsidiaries on a stand-alone basis;
(13)the payment of dividends, other distributions or other amounts to, or the making of loans to any direct or indirect parent of UK Holdco, in the amount required for such entity to:
(a)pay amounts equal to the amounts required for any direct or indirect parent of UK Holdco to pay fees and expenses (including franchise, capital stock, minimum and other similar taxes) required to maintain its corporate existence, customary salary, bonus and other benefits payable to, and indemnities provided on behalf of, officers and employees of UK Holdco or any direct or indirect parent of UK Holdco, if applicable, and general corporate operating and overhead expenses (including legal, accounting and other professional fees and expenses) of any direct or indirect parent of UK Holdco, if applicable, in each case to the extent such fees, expenses, salaries, bonuses, benefits and indemnities are attributable to the ownership or operation of UK Holdco, if applicable, and its Subsidiaries;
(b)pay, if applicable, amounts equal to amounts required for any direct or indirect parent of UK Holdco, if applicable, to pay interest and/or principal on
162
    



Indebtedness the proceeds of which have been contributed to UK Holdco or any Restricted Subsidiary and that has been guaranteed by, or is otherwise considered Indebtedness of, UK Holdco or any of the Restricted Subsidiaries Incurred in accordance with Section 7.2; and
(c)pay fees and expenses Incurred by any direct or indirect parent related to any equity or debt offering of such parent (whether or not successful);
(14)(i) repurchases of Equity Interests deemed to occur upon exercise of stock options or warrants if such Equity Interests represent a portion of the exercise price of such options or warrants and (ii) in connection with the withholding of a portion of the Equity Interests granted or awarded to a director or an employee to pay for the taxes payable by such director or employee upon such grant or award;
(15)purchases of receivables pursuant to a Receivables Repurchase Obligation in connection with a Qualified Receivables Financing and the payment or distribution of Receivables Fees;
(16)[reserved];
(17)the payment, purchase, redemption, defeasance or other acquisition or retirement for value of Junior Indebtedness, Disqualified Stock or Preferred Stock of UK Holdco and the Restricted Subsidiaries in connection with a “change of control” (as defined in the documentation governing such Junior Indebtedness, Disqualified Stock or Preferred Stock) or an Asset Sale that is permitted under Section 7.5 and the other terms of this Agreement; provided that, prior to such payment, purchase, redemption, defeasance or other acquisition or retirement for value, (x) in the case of a change of control, no Event of Default shall have occurred and be continuing under Section 9.1(l) or the Commitments shall have been terminated and the full amount of all Obligations (other than contingent indemnification and reimbursement obligations for which no claim has been made) shall have been indefeasibly paid in full in cash or (y) in the case of an Asset Sale, UK Holdco (or a third party to the extent permitted by this Agreement) has applied such amounts in accordance with Section 2.11, as the case may be;
(18)any joint venture that is not a Restricted Subsidiary may make Restricted Payments required or permitted to be made pursuant to the terms of the joint venture arrangements to holders of its Equity Interests;
(19)any Restricted Payments made in connection with the consummation of the Transactions including the making of the TRA Payment;
(20)the payment of cash in lieu of the issuance of fractional shares of Equity Interests upon exercise or conversion of securities exercisable or convertible into Equity Interests of UK Holdco;
(21)payments or distributions, in the nature of satisfaction of dissenters’ rights, pursuant to or in connection with a consolidation, merger or transfer of assets that complies with the provisions of this Agreement applicable to mergers, consolidations and transfers of all or substantially all the property and assets of UK Holdco and its Subsidiaries;
(22)the prepayment, redemption, repurchase, defeasance, exchange, retirement or other acquisition of any Junior Indebtedness of UK Holdco or any Restricted Subsidiary or any direct or indirect parent of UK Holdco (including dividends made to effectuate such prepayment, redemption, repurchase, defeasance, exchange, retirement or other acquisition), in an aggregate amount not to exceed the greater of $50,000,000 and 16% of Consolidated EBITDA as of the most recently ended Reference Period in the aggregate;
(23)unlimited Restricted Payments; provided, that (x) in the case of any Restricted Investment, the Total Net Leverage Ratio, on a Pro Forma Basis as of the most recently ended
163
    



Reference Period, does not exceed 5.25 to 1.00 or (y) in the case of any other Restricted Payment, the Total Net Leverage Ratio, on a Pro Forma Basis as of the most recently ended Reference Period, does not exceed 4.75 to 1.00;
provided, however, that at the applicable time of determination in respect of any Restricted Payment permitted under clause (b)(x) and (b)(xxiii)(y) of this Section 7.3, no Event of Default shall have occurred and be continuing or would occur as a consequence thereof.
7.dDividend and Other Payment Restrictions Affecting Subsidiaries. UK Holdco will not, and will not permit any Restricted Subsidiary that is not a Borrower or a Guarantor to, directly or indirectly create or otherwise cause to become effective any consensual encumbrance or consensual restriction on the ability of any Restricted Subsidiary that is not a Borrower or a Guarantor to:
(i)(i) pay dividends or make any other distributions to UK Holdco or any of the Restricted Subsidiaries (1) on its Capital Stock or (2) with respect to any other interest or participation in, or measured by, its profits; or (ii) pay any Indebtedness owed to UK Holdco or any of the Restricted Subsidiaries;
(ii)make loans or advances to UK Holdco or any of the Restricted Subsidiaries; or
(iii)sell, lease or transfer any of its properties or assets to UK Holdco or any of the Restricted Subsidiaries;
except in each case for such encumbrances or restrictions existing under or by reason of:
(a)contractual encumbrances or restrictions in effect or entered into or existing on the Closing Date, including pursuant to this Agreement, Hedging Obligations and the other documents relating to the Transactions;
(b)this Agreement, the Loan Documents, the Senior Secured Notes, any additional notes permitted to be Incurred under the Senior Secured Notes Indenture and, in each case, any guarantees thereof;
(c)applicable law or any applicable rule, regulation or order;
(d)any agreement or other instrument of a Person acquired by UK Holdco or any Restricted Subsidiary which was in existence at the time of such acquisition or at the time it merges with or into UK Holdco or any Restricted Subsidiary or assumed in connection with the acquisition of assets from such Person (but not created in contemplation thereof), which encumbrance or restriction is not applicable to any Person, or the properties or assets of any Person and its Subsidiaries, other than the Person, or the property or assets of the Person and its Subsidiaries, so acquired or the property or assets so assumed;
(e)contracts or agreements for the sale of assets, including customary restrictions with respect to a Restricted Subsidiary imposed pursuant to an agreement entered into for the sale or disposition of all or substantially all the Capital Stock or assets of such Restricted Subsidiary;
(f)Indebtedness secured by a Lien that is otherwise permitted to be Incurred pursuant to Sections 7.2 and 7.7 that limit the right of the debtor to dispose of the assets securing such Indebtedness;
(g)restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business;
164
    



(h)customary provisions in joint venture, operating or other similar agreements, asset sale agreements and stock sale agreements in connection with the entering into of such transaction;
(i)purchase money obligations for property acquired and Capitalized Lease Obligations in the ordinary course of business that impose restrictions of the nature described in clause (c) of this Section 7.4 on the property so acquired;
(j)customary provisions contained in leases, licenses, contracts and other similar agreements entered into in the ordinary course of business (including leases or licenses of intellectual property) that impose restrictions of the type described in clause (c) of this Section 7.4 on the property subject to such lease, license, contract or agreement;
(k)any encumbrance or restriction of a Receivables Subsidiary effected in connection with a Qualified Receivables Financing; provided, that such restrictions apply only to such Receivables Subsidiary;
(l)other Indebtedness, Disqualified Stock or Preferred Stock of UK Holdco or any Restricted Subsidiary that is Incurred subsequent to the Closing Date pursuant to Section 7.2; provided that either (A) such encumbrances and restrictions contained in any agreement or instrument will not materially affect the Borrowers’ ability to make anticipated principal or interest payment on the Loans (as determined by the Borrower Representative in good faith) or (B) such encumbrances and restrictions are not materially more restrictive, taken as a whole, than those contained in the Senior Secured Notes Indenture (with respect to other indentures) or this Agreement (with respect to other credit agreements);
(m)any Restricted Investment not prohibited by Section 7.3 and any Permitted Investment;
(n)arising or agreed to in the ordinary course of business, not relating to any Indebtedness, and that do not, individually or in the aggregate, detract from the value of property or assets of UK Holdco or any Restricted Subsidiary in any manner material to UK Holdco or any Restricted Subsidiary;
(o)existing under, by reason of or with respect to Refinancing Indebtedness; provided that the encumbrances and restrictions contained in the agreements governing that Refinancing Indebtedness are not materially more restrictive, taken as a whole, than those contained in the agreements governing the Indebtedness being Refinanced (as determined by the Borrower Representative in good faith);
(p)restrictions or conditions contained in any trading, netting, operating, construction, service, supply, purchase, sale or other agreement to which UK Holdco or any of the Restricted Subsidiaries is a party entered into in the ordinary course of business; provided that such agreement prohibits the encumbrance of solely the property or assets of UK Holdco or such Restricted Subsidiary that are the subject of such agreement, the payment rights arising thereunder or the proceeds thereof and does not extend to any other asset or property of UK Holdco or such Restricted Subsidiary or the assets or property of any other Restricted Subsidiary; and
(q)any encumbrances or restrictions of the type referred to in clauses (a), (b) and (c) of this Section 7.4 imposed by any amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings of the contracts, instruments or obligations referred to in clauses (1) through (16) above; provided that such amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings are, in the good faith judgment of the Borrower Representative, not materially more restrictive when taken as a whole with
165
    



respect to such dividend and other payment restrictions than those contained in the dividend or other payment restrictions prior to such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing.
For purposes of determining compliance with this Section 7.4, (i) the priority of any Preferred Stock in receiving dividends or liquidating distributions prior to dividends or liquidating distributions being paid on common stock shall not be deemed a restriction on the ability to make distributions on Capital Stock and (ii) the subordination of loans or advances made to UK Holdco or a Restricted Subsidiary to other Indebtedness Incurred by UK Holdco or such Restricted Subsidiary shall not be deemed a restriction on the ability to make loans or advances.
7.eAsset Sales. UK Holdco will not, and will not permit any of the Restricted Subsidiaries to, cause or make an Asset Sale, unless:
(i)UK Holdco or any of the Restricted Subsidiaries, as the case may be, receives consideration at the time of such Asset Sale at least equal to the Fair Market Value (as determined in good faith by the Borrower Representative) of the Equity Interests issued or assets sold or otherwise disposed of;
(ii)[reserved]; and
(iii)except in the case of a Permitted Asset Swap, at least 75% of the consideration therefor received by UK Holdco or such Restricted Subsidiary, as the case may be, when taken together with the consideration for all other Asset Sales pursuant to this Section 7.5 since the Closing Date (on a cumulative basis), is in the form of cash or Cash Equivalents, provided, however, that in the case of Asset Sales involving the disposition of non-core assets (as determined by the Borrower Representative in its good faith judgment provided the value of such non-core assets does not exceed 50% of the consideration payable in connection with such acquisition) acquired as part of any acquisition after the Closing Date, only 50% of the consideration therefor, when taken together with the consideration for all other Asset Sales pursuant to this proviso since the Closing Date, must be in the form of cash or Cash Equivalents; provided, further, that the amount of:
(1)any liabilities (as shown on UK Holdco’s or such Restricted Subsidiary’s most recent balance sheet or in the notes thereto or, if Incurred, increased or decreased subsequent to the date of such balance sheet, such liabilities that would have been reflected in UK Holdco’s or such Restricted Subsidiary’s balance sheet or in the notes thereto if such incurrence, increase or decrease had taken place on the date of such balance sheet, as reasonably determined in good faith by the Borrower Representative) of UK Holdco or any Restricted Subsidiary (other than liabilities that are by their terms subordinated to the Obligations) that are assumed by the transferee (or a third party on behalf of the transferee) of any such assets or Equity Interests pursuant to an agreement that releases or indemnifies UK Holdco or such Restricted Subsidiary (or a third party on behalf of the transferee), as the case may be, from further liability;
(2)any notes or other obligations or other securities or assets received by UK Holdco or such Restricted Subsidiary from such transferee that are converted by UK Holdco or such Restricted Subsidiary into cash within 180 days of the receipt thereof (to the extent of the cash received);
(3)any Designated Non-cash Consideration received by UK Holdco or any of the Restricted Subsidiaries in such Asset Sale having an aggregate Fair Market Value, taken together with all other Designated Non-cash Consideration received pursuant to this clause (iii) that is at that time outstanding, not to exceed the greater of $75,000,000 and 24% of Consolidated EBITDA as of the most recently ended Reference Period, at the time of the receipt of such Designated Non-cash Consideration (with the Fair Market Value of each item of Designated Non-cash Consideration being measured at the time received and without giving effect to subsequent changes in value);
(4)Indebtedness of any Restricted Subsidiary that is no longer a Restricted Subsidiary as a result of such Asset Sale, to the extent that UK Holdco and each other Restricted Subsidiary are released from any Guarantee of such Indebtedness in connection with such Asset Sale; and
166
    



(5)consideration consisting of Indebtedness of UK Holdco or any Guarantor received from Persons who are not UK Holdco or a Restricted Subsidiary,
shall each be deemed to be Cash Equivalents for the purposes of this Section 7.5;
After UK Holdco’s or any Restricted Subsidiary’s receipt of the Net Cash Proceeds of any Asset Sale pursuant to clauses (a) to (c) above, UK Holdco or such Restricted Subsidiary shall apply the Net Cash Proceeds from such Asset Sale if and to the extent required by Section 2.11(c).
7.f[Reserved].
7.gLiens. UK Holdco will not, and will not permit any of the Restricted Subsidiaries to, create or incur any Lien (other than Permitted Liens) that secures obligations under any Indebtedness on any asset or property of UK Holdco or any Restricted Subsidiary.
7.hFundamental Changes. UK Holdco will not, nor will it permit any of the Restricted Subsidiaries to, directly or indirectly merge, dissolve, liquidate, amalgamate, consolidate with or into another Person, or Dispose of (whether in one transaction or in a series of transactions) all or substantially all of its assets (whether now owned or hereafter acquired) to or in favor of any Person, except that:
(i)(i) any Restricted Subsidiary (other than any Borrower) may merge, amalgamate or consolidate with (1) any US Borrower (including a merger the purpose of which is to reorganize such US Borrower into a new jurisdiction in any State of the United States); provided that such US Borrower shall be the continuing or surviving Person or the surviving Person shall expressly assume the obligations of such US Borrower pursuant to documents reasonably acceptable to the Administrative Agent, (2) the Lux Borrower; provided that the Lux Borrower shall be the continuing or surviving Person, or (3) any one or more other Restricted Subsidiaries and (ii) any Borrower may merge, amalgamate or consolidate with any other Borrower; provided that, in the case of a merger, amalgamation or consolidation with the Lux Borrower, if the surviving Person is not the Lux Borrower such surviving Person shall be subject to Section 6.20(a); provided that (y) when any Additional Revolving Borrower is merging, amalgamating or consolidating with another Restricted Subsidiary that is not another Additional Revolving Borrower or a Loan Party then either (A) the Additional Revolving Borrower shall be the continuing or surviving Person and resident in its jurisdiction of incorporation or (B) (I) the Additional Revolving Borrower shall cease to be a Borrower under this Agreement in accordance with Section 12.3, (II) to the extent constituting an Investment, such Investment must be an Investment permitted hereunder and (III) to the extent constituting a Disposition, such Disposition must be permitted hereunder and (z) when any Guarantor is merging with another Restricted Subsidiary that is not a Loan Party (A) the Guarantor shall be the continuing or surviving Person or (B) (I) to the extent constituting an Investment, such Investment must be an Investment permitted hereunder and (II) to the extent constituting a Disposition, such Disposition must be permitted hereunder;
(ii)(i) any Restricted Subsidiary that is not a Loan Party may merge, amalgamate or consolidate with or into any other Restricted Subsidiary that is not a Loan Party and (ii) any Restricted Subsidiary may liquidate or dissolve, or any Borrower or any Restricted Subsidiary may (if the validity, perfection and priority of the Liens securing the Obligations is not adversely affected thereby) change its legal form if the Borrower Representative determines in good faith that such action is in the best interest of UK Holdco and its Subsidiaries and is not disadvantageous to the Lenders in any material respect (it being understood that in the case of any dissolution of a Restricted Subsidiary that is (A) an Additional Revolving Borrower, such Subsidiary shall at or before the time of such dissolution cease to be an Additional Revolving Borrower under this Agreement in accordance with Section 12.3 or (B) a Guarantor, such Subsidiary shall at or before the time of such dissolution transfer its assets to another Restricted Subsidiary that is a Guarantor unless such Disposition of assets is permitted hereunder; and in the case of any change in legal form, a Restricted Subsidiary that is an Additional Revolving Borrower or a Guarantor will remain an Additional Revolving Borrower or Guarantor unless such Additional Revolving Borrower or Guarantor is otherwise permitted to cease being an Additional Revolving Borrower or Guarantor hereunder);
167
    



(iii)any Restricted Subsidiary (other than any Borrower) may Dispose of all or substantially all of its assets (upon voluntary liquidation or otherwise) to any Borrower or to any Restricted Subsidiary; provided that if the transferor in such a transaction is (A) an Additional Revolving Borrower, then such Subsidiary shall cease to be an Additional Revolving Borrower under this Agreement in accordance with Section 12.3 or (B) a Guarantor, then (i) the transferee must either be a Borrower or a Guarantor and (ii) to the extent constituting an Investment, such Investment must be an Investment permitted hereunder; provided, further, that any US Borrower may Dispose of all or substantially all of its assets (upon voluntary liquidation or otherwise) to any other Loan Party;
(iv)any Restricted Subsidiary may merge, amalgamate or consolidate with, or dissolve into, any other Person in order to effect an Investment permitted hereunder; provided that (i) the continuing or surviving Person shall, to the extent subject to the terms hereof, have complied with the requirements of Section 6.9, (ii) to the extent constituting an Investment, such Investment must be an Investment permitted hereunder, (iii) to the extent constituting a Disposition, such Disposition must be permitted hereunder and (iv) to the extent such Restricted Subsidiary is an Additional Revolving Borrower, it shall cease to be an Additional Revolving Borrower in accordance with Section 12.3;
(v)UK Holdco, the Borrowers and the other Restricted Subsidiaries may consummate the Transactions;
(vi)subject to clause (a) above, any Restricted Subsidiary (excluding any Borrower other than any US Borrower) may merge, dissolve, liquidate, amalgamate, consolidate with or into another Person in order to effect a Disposition permitted pursuant to Section 7.5; provided that if such Restricted Subsidiary is an Additional Revolving Borrower, it shall cease to be an Additional Revolving Borrower in accordance with Section 12.3; and
(vii)any Investment permitted hereunder may be structured as a merger, consolidation or amalgamation,
provided, in each case, that if any asset subject to a disposal or transfer to, or merger, amalgamation or consolidation with, or dissolution into, any other Loan Party pursuant to this Section 7.8 is subject to a Lien created by any Security Document at the time of such disposal or transfer to, or merger, amalgamation or consolidation with, or dissolution into, such other Loan Party, it shall be disposed of or transferred on the basis that it shall remain subject to, or otherwise become subject to equivalent, Liens under a Security Document immediately following such disposal (subject to the Agreed Security Principles).
7.i[Reserved].
7.jChanges in Fiscal Periods. UK Holdco will not permit the fiscal year of UK Holdco to end on a day other than December 31 or change UK Holdco’s method of determining fiscal quarters except upon written notice to the Administrative Agent whereupon the Borrower Representative and the Administrative Agent will, and are hereby authorized, without the consent of any other Secured Party or other Person, to make such adjustments to this Agreement as are reasonably necessary to reflect such change in fiscal year or method of determining fiscal quarters.
7.kNegative Pledge Clauses. UK Holdco will not, and will not permit any of the Restricted Subsidiaries that is a Loan Party to, enter into or suffer to exist or become effective any agreement that prohibits or limits the ability of UK Holdco or any Group Member that is a Loan Party to create, incur, assume or suffer to exist any Lien upon any of its property or revenues that constitutes Collateral, whether now owned or hereafter acquired, to secure its obligations under the Loan Documents to which it is a party other than (a) this Agreement and the other Loan Documents, (b) any agreements evidencing or governing any purchase money Liens or Capitalized Lease Obligations otherwise permitted hereby (in which case, any prohibition or limitation shall only be effective against the assets financed thereby), (c) customary restrictions on the assignment of leases, licenses and contracts entered into in the ordinary course of business, (d) any agreement in effect at the time any Person becomes a Restricted Subsidiary; provided that such agreement was not entered into in contemplation of such Person becoming a Restricted Subsidiary, (e) customary restrictions and conditions contained in agreements relating to the sale of a
168
    



Restricted Subsidiary (or the assets of a Restricted Subsidiary) pending such sale; provided that such restrictions and conditions apply only to the Restricted Subsidiary that is to be sold (or whose assets are to be sold) and such sale is permitted hereunder), (f) restrictions and conditions existing on the Closing Date and any amendments or modifications thereto so long as such amendment or modification, taken as a whole, does not expand the scope of any such restriction or condition in any material respect as determined by the Borrower Representative in good faith, (g) restrictions under agreements evidencing or governing or otherwise relating to Indebtedness of Non-Guarantor Subsidiaries permitted under Section 7.2; provided that such Indebtedness is only with respect to the assets of Non-Guarantor Subsidiaries, (h) customary provisions in joint venture agreements, limited liability company operating agreements, partnership agreements, stockholders agreements and other similar agreements, (i) restrictions contained in agreements governing the Senior Secured Notes and (j) restrictions contained in agreements governing Indebtedness, Preferred Stock or Disqualified Stock permitted by Section 7.2 that (x) are not materially more restrictive, taken as a whole, than the restrictions contained in this Agreement (as determined by the Borrower Representative in good faith) or (y) will not materially impair the Borrowers’ obligation or ability to make any payments required hereunder (as determined by the Borrower Representative in good faith).
SECTION 8.
GUARANTEE
8.aThe Guarantee. (a) [Reserved].
(i)Each Guarantor hereby jointly and severally guarantees, as a primary obligor and not as a surety, to each Secured Party and their respective successors and assigns, the prompt payment in full when due (whether at stated maturity, by required prepayment, declaration, demand, by acceleration or otherwise) of (1) the principal of and interest (including any interest, fees, costs or charges that would accrue but for the provisions of the Bankruptcy Code after any bankruptcy or insolvency petition under the Bankruptcy Code or any similar law of any other jurisdiction) on (i) the Loans made by the Lenders to, including the Loans represented by the Notes held by each Lender of, any Borrower, (ii) the Incremental Loans made by the Incremental Term Lenders or Incremental Revolving Lenders to any Borrower, (iii) the Other Term Loans and Other Revolving Loans made by any lender thereof, and (iv) the Notes held by each Lender of any Borrower and (2) all other Obligations from time to time owing to the Secured Parties by any Loan Party or, in the case of Specified Cash Management Agreements and Specified Swap Agreements, any Restricted Subsidiary (such obligations under clauses (1) and (2) being herein collectively called the “Guaranteed Obligations” and the “Guarantor Obligations”). Each Guarantor hereby jointly and severally agrees that, if any Borrower, Loan Party or, in the case of Specified Cash Management Agreements and Specified Swap Agreements, Restricted Subsidiary shall fail to pay in full when due (whether at stated maturity, by acceleration or otherwise) any of the Guaranteed Obligations, such Guarantor will promptly pay the same in cash, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the Guaranteed Obligations, the same will be promptly paid in full when due (whether at extended maturity, by acceleration or otherwise) in accordance with the terms of such extension or renewal.
8.bObligations Unconditional.
(i)The obligations of the Guarantors under Section 8.1 shall constitute a guaranty of payment (and not of collection) and to the fullest extent permitted by applicable Requirements of Law, are absolute, irrevocable and unconditional, joint and several, irrespective of the value, genuineness, validity, regularity or enforceability of the Guaranteed Obligations under this Agreement, the Notes, if any, or any other agreement or instrument referred to herein or therein, or any substitution, release or exchange of any other guarantee of or security for any of the Guaranteed Obligations, and, in each case, irrespective of any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge or defense of a surety by any Guarantor (except for payment in full). Without limiting the generality of the foregoing, it is agreed that the occurrence of any one or more of the following shall not alter or impair the liability of any Guarantor hereunder, which shall, in each case, remain absolute, irrevocable and unconditional under any and all circumstances as described above:
169
    



(1)at any time or from time to time, without notice to any Guarantor, the time for any performance of or compliance with any of the Guarantor Obligations shall be extended, or such performance or compliance shall be waived;
(2)any of the acts mentioned in any of the provisions of this Agreement or the Notes, if any, or any other agreement or instrument referred to herein or therein shall be done or omitted;
(3)the maturity of any of the Guarantor Obligations shall be accelerated, or any of the Guarantor Obligations shall be amended in any respect, or any right under the Loan Documents or any other agreement or instrument referred to herein or therein shall be amended or waived in any respect or any other guarantee of any of the Guarantor Obligations or any security therefor shall be released or exchanged in whole or in part or otherwise dealt with;
(4)any Lien or security interest granted to, or in favor of, the Issuing Lenders or any Lender or the Administrative Agent or Collateral Agent as security for any of the Guarantor Obligations shall fail to be valid or perfected or entitled to the expected priority;
(5)the release of any other Guarantor pursuant to Section 8.9, 10.10 or otherwise; or
(6)except for the payment in full of the Guarantor Obligations, any other circumstance whatsoever which may or might in any manner or to any extent vary the risk of any Guarantor as an obligor in respect of the Guarantor Obligations or which constitutes, or might be construed to constitute, an equitable or legal discharge of any Borrower or any Guarantor for the Guarantor Obligations, or of such Guarantor under the Guarantee or of any security interest granted by any Guarantor, whether in a proceeding under any Debtor Relief Law or in any other instance.
(b)    Each of the Guarantors hereby expressly waives diligence, presentment, demand of payment, marshaling, protest and all notices whatsoever, and any requirement that any Secured Party exhaust any right, power or remedy or proceed against any Borrower under this Agreement or the Notes, if any, or any other agreement or instrument referred to herein or therein, or against any other person under any other guarantee of, or security for, any of the Guarantor Obligations. Each of the Guarantors waive any and all notice of the creation, renewal, extension, waiver, termination or accrual of any of the Guarantor Obligations and notice of or proof of reliance by any Secured Party upon the guarantee made under this Section 8 (this “Guarantee”) or acceptance of the Guarantee, and the Guarantor Obligations, and any of them, shall conclusively be deemed to have been created, contracted or incurred in reliance upon the Guarantee, and all dealings between the Borrowers and the Secured Parties shall likewise be conclusively presumed to have been had or consummated in reliance upon the Guarantee. The Guarantee shall be construed as a continuing, absolute, irrevocable and unconditional guarantee of payment without regard to any right of offset with respect to the Guarantor Obligations at any time or from time to time held by the Secured Parties and the obligations and liabilities of the Guarantors hereunder shall not be conditioned or contingent upon the pursuit by the Secured Parties or any other person at any time of any right or remedy against any Borrower or against any other person which may be or become liable in respect of all or any part of the Guarantor Obligations or against any collateral security or guarantee therefor or right of offset with respect thereto. The Guarantee shall remain in full force and effect and be binding in accordance with and to the extent of its terms upon the Guarantors and the successors and assigns thereof, and shall inure to the benefit of the applicable Lenders, and their respective successors and assigns, notwithstanding that from time to time during the term of this Agreement there may be no Guarantor Obligations outstanding.
8.cReinstatement. The obligations of the Guarantors under this Section 8 shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of the Borrowers or any other Loan Party in respect of the Guarantor Obligations is rescinded or must be otherwise restored by any holder of any of the Guarantor Obligations, whether as a result of any proceedings in bankruptcy or reorganization or otherwise.
170
    



8.dNo Subrogation. Each Guarantor hereby agrees that until the payment and satisfaction in full in cash of all Guarantor Obligations (other than contingent indemnification and reimbursement obligations for which no claim has been made) and the expiration and termination of the Commitments under this Agreement, it shall waive any claim and shall not exercise any right or remedy, direct or indirect, arising by reason of any performance by it of its Guarantee, whether by subrogation, right of contribution or otherwise, against any Borrower or any other Guarantor of any of the Guarantor Obligations or any security for any of the Guarantor Obligations.
8.eRemedies. Each Guarantor jointly and severally agrees that, as between the Guarantors and the Lenders, the obligations of each Borrower under this Agreement and the Notes, if any, may be declared to be forthwith due and payable as provided in Section 9 (and shall be deemed to have become automatically due and payable in the circumstances provided in Section 9) for purposes of Section 8.1, notwithstanding any stay, injunction or other prohibition preventing such declaration (or such obligations from becoming automatically due and payable) as against any Borrower or any Guarantor and that, in the event of such declaration (or such obligations being deemed to have become automatically due and payable, or the circumstances occurring where Section 9 provides that such obligations shall become due and payable), such obligations (whether or not due and payable by any Borrower) shall forthwith become due and payable by the Guarantors for purposes of Section 8.1.
8.fInstrument for the Payment of Money. Each Guarantor hereby acknowledges that the Guarantee constitutes an instrument for the payment of money, and consents and agrees that any Lender or the Administrative Agent, at its sole option, in the event of a dispute by such Guarantor in the payment of any moneys due hereunder, shall have the right to bring a motion-action under New York CPLR Section 3213.
8.gContinuing Guarantee. The Guarantee made by the Guarantors is a continuing guarantee of payment, and shall apply to all Guaranteed Obligations whenever arising.
8.hGeneral Limitation on Guarantor Obligations. In any action or proceeding involving any federal, state, provincial or territorial, corporate, limited partnership or limited liability company law, or any applicable state, federal or foreign bankruptcy, insolvency, reorganization or other law affecting the rights of creditors generally, if the obligations of any Guarantor under Section 8.1 would otherwise be held or determined to be void, voidable, invalid or unenforceable, or subordinated to the claims of any other creditors, on account of the amount of its liability under Section 8.1, then, notwithstanding any other provision to the contrary, the amount of such liability of such Guarantor shall, without any further action by such Guarantor, any Loan Party or any other Person, be automatically limited and reduced to the highest amount (after giving effect to the right of contribution established in Section 8.10) that is valid and enforceable and not subordinated to the claims of other creditors as determined in such action or proceeding. To effectuate the foregoing, the Administrative Agent and the Guarantors hereby irrevocably agree that the Guarantor Obligations of each Guarantor in respect of the Guarantee at any time shall be limited to the maximum amount as will result in the Guarantor Obligations of such Guarantor with respect thereto not constituting a fraudulent transfer or conveyance after giving full effect to the liability under such Guarantee and its related contribution rights but before taking into account any liabilities under any other guarantee by such Guarantor. For purposes of the foregoing, all guarantees of such Guarantor other than its Guarantee will be deemed to be enforceable and payable after the Guarantee. To the fullest extent permitted by applicable law, this Section 8.8 shall be for the benefit solely of creditors and representatives of creditors of each Guarantor and not for the benefit of such Guarantor or the holders of any Equity Interest in such Guarantor.
8.iRelease of Subsidiary Guarantors. A Subsidiary Guarantor or a Borrower shall be automatically released from its obligations hereunder in the event that all the Capital Stock of such Subsidiary Guarantor or Borrower shall be sold, transferred or otherwise disposed of to a Person other than a Loan Party in a transaction permitted by this Agreement. In connection with any such release of a Guarantor or Borrower, the Administrative Agent shall execute and deliver to the Borrower Representative, at the Borrower Representative’s expense, all UCC termination statements and other documents that the Borrower Representative shall reasonably request to evidence such release.
171
    



8.jRight of Contribution. Each Guarantor hereby agrees that to the extent that a Guarantor shall have paid more than its proportionate share of any payment made hereunder, such Subsidiary Guarantor shall be entitled to seek and receive contribution from and against any other Guarantor hereunder which has not paid its proportionate share of such payment. Each Guarantor’s right of contribution shall be subject to the terms and conditions of Section 8.4. The provisions of this Section 8.10 shall in no respect limit the obligations and liabilities of any Guarantor to the Administrative Agent and the other Secured Parties, and each Guarantor shall remain liable to the Administrative Agent and the other Secured Parties for the full amount guaranteed by such Guarantor hereunder. Notwithstanding the foregoing, no Excluded ECP Guarantor shall have any obligations or liabilities to any Guarantor, the Administrative Agent or any other Secured Party with respect to Excluded Swap Obligations.
8.kKeepwell. Each Qualified ECP Guarantor hereby jointly and severally absolutely, unconditionally and irrevocably undertakes to provide such funds or other support as may be needed from time to time by each other Loan Party to honor all of its obligations under the Guarantee in respect of Swap Obligations (provided, however, that each Qualified ECP Guarantor shall only be liable under this Section 8.11 for the maximum amount of such liability that can be hereby incurred without rendering its obligations under this Section 8.11, or otherwise under the Guarantee, as it relates to such Loan Party, voidable under applicable law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations of each Qualified ECP Guarantor under this Section 8.11 shall remain in full force and effect until the termination and release of all Obligations in accordance with the terms of this Agreement. Each Qualified ECP Guarantor intends that this Section 8.11 constitute, and this Section 8.11 shall be deemed to constitute, a “keepwell, support, or other agreement” for the benefit of each other Loan Party for all purposes of Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.
8.lLimitations.
(i)Limitations in Luxembourg.
(1)Notwithstanding anything to the contrary contained in this Agreement or in any other Loan Document, the aggregate obligations of a Luxembourg Guarantor in respect of the obligations of a Group Member which is not a direct or indirect subsidiary of such Luxembourg Guarantor shall be limited at any time to an aggregate amount not exceeding 90% of the greater of:
(a)an amount equal to the sum of the Luxembourg Guarantor’s Net Assets (Capitaux Propres), as referred to in annex I to the grand-ducal regulation dated 18 December 2015 defining the form and content of the presentation of balance sheet and profit and loss account, and enforcing the Luxembourg law dated 19 December 2002 on the register of commerce and companies, accounting and companies annual accounts, as amended (the “Regulation”) and its subordinated debt (dettes subordonnées), as reflected in the financial information of the Luxembourg Guarantor available to the Secured Parties as at the Closing Date or (as applicable) as at the date of its accession as a Guarantor, including, without limitation, its most recently and duly approved financial statements (comptes annuels) and any (unaudited) interim financial statements signed by its board of directors (administrateurs); and
(b)an amount equal to the sum of the Luxembourg Guarantor’s Net Assets (Capitaux Propres), as referred to in the Regulation, and its subordinated debt (dettes subordonnées), as reflected in the financial information of the Luxembourg Guarantor available to the Secured Parties as at the date the Guarantee is called, including, without limitation, its most recently and duly approved financial statements (comptes annuels) and any (unaudited) interim financial statements signed by its board of directors (administrateurs).
(2)The limitation set forth at paragraph (i) above shall not apply to any amounts borrowed under this Agreement and made available, in any form whatsoever, to such Luxembourg Guarantor or any of its direct or indirect subsidiaries.
172
    



(3)The Luxembourg Guarantor’s obligations under this Section 8 will not extend to include any obligations or liabilities if such inclusion would constitute a breach of the financial assistance prohibitions contained at Article 430-19 (where applicable) of the Luxembourg law on commercial companies of 10 August 1915, as amended.
(ii)Limitations in the United Kingdom. Notwithstanding anything to the contrary contained in this Agreement or in any other Loan Documents, this Guarantee does not apply to any liability to the extent that it would result in such Guarantee constituting unlawful financial assistance within the meaning of sections 678 or 679 of the United Kingdom Companies Act 2006.
(iii)Limitations in Spain. Notwithstanding anything to the contrary contained in this Agreement or in any other Loan Document, the aggregate obligations of a Spanish Guarantor will not extend to any liability to the extent that it would result in such guarantee constituting unlawful financial assistance within the meaning of Sections 143.2 and 150 of the Spanish Companies’ Act (Ley de Sociedades de Capital). This Guarantee is independent and separate from the obligations of the Borrowers or other Guarantors and, consequently, the guarantee granted by any Spanish Loan Party under this Agreement will in no event be construed or configured as a Spanish “fianza” for the purposes of article 1,822 seq of the Spanish Civil Code. The obligations of each Spanish Loan Party under this Clause 8 will not be affected by any action made under the Additional Section 4 (Disposición Adicional Cuarta) of the Spanish Insolvency Law, 22/2003 (Ley Concursal) in relation to any other Spanish Loan Party. For the purposes of article 135 of the Spanish Insolvency Law, the obligations of a Guarantor that is a Spanish Loan Party under this Agreement vis-á-vis each Lender shall be governed by the terms of this Agreement at any time such that each Spanish Loan Party’s obligations pursuant to this Section 8 shall not be affected in any way by the settlement agreement that may be agreed in the insolvency proceedings of any other Spanish Loan Party (nor shall they be deemed amended as a consequence of the approval of that settlement agreement) that each of the Lenders has approved or acceded to or irrespective of the fact that any such Lender has not approved or acceded to, that settlement agreement.
(iv)Limitations in Germany.
(1)The Secured Parties agree not to enforce the Guarantee granted under this Section 8 (Guarantee) against a Guarantor incorporated in Germany as a limited liability company (GmbH) (a “German GmbH Guarantor”), or as a limited partnership (Kommanditgesellschaft) with a limited liability company as sole general partner (GmbH & Co. KG) (the “German GmbH & Co. KG Guarantor”, together with any German GmbH Guarantor hereinafter referred to as a “German Guarantor”) to the extent that this Guarantee secures liabilities of an affiliated company (verbundenes Unternehmen) within the meaning of Section 15 et seq. of the German Stock Corporation Act (AktG Aktiengesetz) of that German Guarantor (other than the German Guarantor’s (direct or indirect) Subsidiaries) (the “Guaranteed Loan Party”) if and to the extent that a payment under the Guarantee would cause that German Guarantor’s, or, in the case of a German GmbH & Co. KG Guarantor, its general partner’s, net assets (to be calculated in accordance with generally accepted accounting principles applicable in Germany consistently applied by the German Guarantor in preparing its unconsolidated balance sheets (Jahresabschluss according to § 42 GmbH-Act, §§ 242, 264 of the German Commercial Code (HGB Handelsgesetzbuch)) being the German Guarantors’ or, in the case of a German GmbH & Co. KG Guarantor, its general partner’s, assets less the sum of (i) the German Guarantor’s liabilities (to be calculated in accordance with generally accepted accounting principles applicable in Germany consistently applied by the German Guarantor in preparing its unconsolidated balance sheets (Jahresabschluss according to § 42 GmbH-Act, §§ 242, 264 of the German Commercial Code), (disregarding, for the avoidance of doubt, (x) any provision in respect of the guarantee created under this Agreement, and (y) any provision in respect of or liabilities of the German Guarantor under any Guarantee of senior unsecured indebtedness or Indebtedness subordinated in right of payment to the Obligations which Guarantee contains a limitation as to maximum amount similar to that set forth in this paragraph, pursuant to which the liability of such Guarantor hereunder is included in the liabilities taken into account in determining such maximum amount), (ii) the amounts of profits (Gewinne) not available for distribution to its shareholders and (iii) the stated share capital (Stammkapital) of the German Guarantor or, in the case of a German Guarantor in the legal form of GmbH & Co. KG, its general partner (the “Net Assets”), (as adjusted in accordance with sub-paragraph (ii) below) to be reduced below zero, or further reduced if already below zero.
173
    



(2)For the purposes of the calculation of the Net Assets the following balance sheet items shall be adjusted as follows:
(a)the amount of any increase of the stated share capital (Stammkapital) of the German Guarantor, or, in case of a German GmbH & Co. KG Guarantor, its general partner, after the Closing Date (A) that has been effected without the prior written consent of the Administrative Agent out of retained earnings (Kapitalerhöhung aus Gesellschaftsmitteln) or (B) to the extent that it is not fully paid up, shall be deducted from the stated share capital;
(b)loans and contractual liabilities incurred in violation of the provisions of the Loan Documents shall be disregarded; and
(c)any liabilities of the German Guarantor in respect of intercompany indebtedness owed to any other Loan Party to the extent that such intercompany indebtedness may be permanently discharged in an amount equal to the amount paid by such German Guarantor hereunder by way of set-off, contribution, waiver or otherwise (and the relevant Loan Parties are actually permitted to do so under the Loan Documents and applicable law at the relevant time).
(3)In addition, each German Guarantor, and, in case of a German GmbH & Co. KG Guarantor, its general partner, shall, for the purposes of determining the Net Assets, upon the request of the Collateral Agent realize, to the extent legally permitted and commercially justifiable with respect to the cost and efforts involved, in a situation where such German Guarantor, and, in the case of a German GmbH & Co. KG Guarantor, its general partner, does not have sufficient Net Assets to maintain its stated share capital, any and all of its assets that are shown in the balance sheet of the German Guarantor, or, in case of a German GmbH & Co. KG Guarantor, its general partner, with a book value (Buchwert) that is significantly lower than the market value of the assets if the asset is not necessary for such German Guarantor’s, and, in the case of a German GmbH & Co. KG Guarantor, its general partner’s, business, (betriebsnotwendig) (the “Realizable Assets”).
(4)No Secured Party shall enforce this Agreement against the relevant German Guarantor before the Net Assets (as determined in accordance with clauses (i) and (ii) of this Section 8.12(d)), i.e., the amounts which may be claimed against a relevant German Guarantor, or, in the case of a German GmbH & Co. KG Guarantor, its general partner, have been determined in accordance with the following further procedure:
(a)following a notification by the Collateral Agent to the relevant German Guarantor of the Secured Parties’ intention to enforce this Guarantee such German Guarantor shall notify the Collateral Agent in writing within twenty (20) Business Days of such notification of the Net Assets (the “Management Determination”). If the Collateral Agent disagrees with this Management Determination such German Guarantor, acting reasonably, shall engage at its expense a firm of auditors of international standard and repute which shall proceed to audit the relevant German Guarantor with a view to investigating such German Guarantor’s Net Assets (the “Auditors’ Determination”) within thirty (30) Business Days (or such longer period as has been agreed between the German Guarantor and the Collateral Agent) from the date the Collateral Agent has contested the Management Determination and the German Guarantor shall give notice of such engagement to the Collateral Agent. Each relevant German Guarantor shall render any and all reasonable assistance requested by the auditors for the purposes of facilitating the Auditors’ Determination and shall allow full access to and inspection of its books and any other necessary documents.
(b)The Auditors’ Determination of the Net Assets shall take into account, in addition to the terms set forth in clauses (i), (ii) and (iii) of this Section 8.12(d), the generally accepted accounting principles applicable in Germany and be based on the same principles that were applied when establishing the previous year’s balance sheet.
174
    



(c)The Secured Parties may proceed to enforce this Guarantee granted by the relevant German Guarantor, if and to the extent that (i) the German Guarantor has not provided the Management Determination within the twenty (20) Business Days period or (ii) an Auditors’ Determination cannot has not been obtained within the thirty (30) Business Days following notice by the Collateral Agent to the relevant German Guarantor that it disagrees with its Management Determination. The maximum amount that may be claimed against such relevant German Guarantor in those circumstances will be the amount determined by the Collateral Agent in good faith acting reasonably by reference to the most recent financial statements delivered in respect of the relevant German Guarantor under this Agreement and, based on such determination by the Collateral Agent, the payment of which would not result in such German Guarantor, or, in the case of a German GmbH & Co. KG Guarantor, its general partner, having insufficient assets to maintain its stated share capital. For the purpose of calculating such amount, the adjustments referred to in clauses (i) and (ii) of this Section 8.12(d) will be made to the most recent financial statements delivered as aforesaid.
(5)If the amount payable under the relevant Guarantee was determined in accordance with Section 8.12(d)(iv)(3), because an Auditors’ Determination or Management Determination could not be obtained as outlined in Section 8.12(d)(iv)(1), and, in such case, an Auditors’ Determination delivered by the relevant German Guarantor to the Collateral Agent within sixty (60) Business Days after the respective auditor should have been engaged in accordance with Section 8.12(d)(iv)(1) confirms that the amount available under the relevant Guarantee granted hereunder at the time of enforcement was less than the amount recovered by the Collateral Agent, the Secured Parties agree to release to the relevant German Guarantor an amount of the proceeds equal to the amount by which the recoveries relating to the relevant Guarantee exceeded the amount determined to be available.
(6)The limitations set out in clause (i) of this Section 8.12(d) shall not apply:
(a)to any amounts due and payable under any Loan Document which relate to funds which have been drawn under the Loans and on-lent to the relevant German Guarantor or to any of its (direct or indirect) Subsidiaries and such amounts on-lent have not been repaid prior to a demand for payment being made under this Guarantee and are still outstanding ;
(b)if the German Guarantor is subject to a domination and/or profit transfer agreement (Beherrschungs- und/oder Gewinnabführungsvertrag) (a “DPTA”) (as dominated entity) with the Guaranteed Loan Party, whether directly or indirectly through a chain of DPTAs between each company and its shareholder (or in case of a German GmbH & Co. KG Guarantor between its general partner and its shareholder), if and to the extent that the existence of a DPTA leads to the inapplicability of Section 30 para. 1 sentence 1 of the German Limited Liability Companies Act;
(c)if and to the extent that the relevant German Guarantor holds on the date of enforcement of the Guarantee a fully recoverable indemnity claim or claim for refund (“vollwertiger Gegenleistungs- oder Rückgewähranspruch”) against the Guaranteed Loan Party; or
(d)if and to the extent it is not required in order to avoid any personal liability of the managing directors of the German Guarantors (or, in case of a German GmbH & Co. KG Guarantor, of its general partner) as a result of a breach of section 30 GmbHG.
(7)None of the reduction of the amount enforceable under this Agreement in accordance with the above limitations set out in this Section 8.12(d) will prejudice the rights of the Secured Parties to continue enforcing this Guarantee (subject always to the operation of the limitations set forth above at the time of such enforcement) until full satisfaction of the Guarantor Obligations of the German Guarantor.
175
    



(v)Each Guarantor that as of the Closing Date or thereafter is incorporated, organized or formed, as the case may be, under the laws of any jurisdiction other than those jurisdictions set forth in clauses (a) through (d) above (an “Other Guarantor”), and by its acceptance hereof, each Lender and the Administrative Agent, hereby confirm that it is the intention of all such parties that the Guarantee of an Other Guarantor (i) does not constitute a fraudulent transfer or conveyance for purposes of, or otherwise violate, applicable Law and (ii) shall be subject to the Agreed Security Principles. To effectuate the foregoing intention, each Lender and each Other Guarantor hereby irrevocably agrees that the obligations of an Other Guarantor under its Guarantee shall be limited to the maximum amount as will, after giving effect to all other contingent and fixed liabilities of such Other Guarantor result in the obligations of such Other Guarantor not constituting such a fraudulent transfer or conveyance or otherwise violating applicable Law and be subject to such other limitations in accordance with the Agreement Security Principles or under applicable Law and as are described in such Other Guarantor’s Guarantor Joinder Agreement and/or Borrower Joinder.
(vi)Notwithstanding anything in this Section 8.12 to the contrary, if following the Closing Date:
(1)there shall be any change in the Laws of any of the jurisdictions set forth in clauses (a) and (b) of this Section 8.12;
(2)there shall be any change in the Laws under which any Other Guarantor is incorporated, organized or formed, as the case may be; or
(3)any Person shall be required to execute a Guarantee pursuant to Section 6.9 and such Person is incorporated, organized or formed, as the case may be, under the laws of any jurisdiction other than those in which entities are contemplated to become Guarantors as of the Closing Date, including those jurisdictions addressed in clauses (a) and (b) of this Section 8.12 and other than any jurisdiction in which a then existing Other Guarantor is incorporated, organized or formed, as the case may be (a “Future Guarantor”), and the Borrower Representative shall reasonably determine that the provisions of Section 8.12 hereof with respect to any Other Guarantor shall not adequately address the limitations on such Guarantee as set forth in the Agreed Security Principles or imposed by applicable Law of the jurisdiction of incorporation, organization or formation, as the case may be, of such Future Guarantor,
then the Administrative Agent and the Borrower Representative shall be permitted to amend such clause or add such additional provisions to such clause, as the case may be, to the extent necessary so that the Guarantee of a Guarantor is subject to the limitations set forth in the Agreed Security Principles or does not violate applicable Law.
(vii)With respect to any Guarantor, this Guarantee is subject to any limitations set out in any Guarantor Joinder Agreement and/or Borrower Joinder applicable to such Guarantor.
SECTION 9.
EVENTS OF DEFAULT
9.aEvents of Default. An Event of Default shall occur if any of the following events shall occur and be continuing; provided that any requirement for the giving of notice, the lapse of time, or both, has been satisfied (any such event, an “Event of Default”):
(i)any Borrower shall fail to pay (x) any principal of any Loan or Reimbursement Obligation when due in accordance with the terms hereof or (y) any interest on any Loan or Reimbursement Obligation, or any other amount payable hereunder or under any other Loan Document, within three Business Days after any such interest or other amount becomes due in accordance with the terms hereof; or
(ii)any representation or warranty made or deemed made by any Loan Party herein or in any other Loan Document or that is contained in any certificate furnished by it at any time under or in connection with this Agreement or any such other Loan Document shall prove to have been inaccurate in
176
    



any material respect (except where such representations and warranties are already qualified by materiality, in which case, in any respect) on or as of the date made or deemed made (or if any representation or warranty is expressly stated to have been made as of a specific date, inaccurate in any material respect as of such specific date), and shall (to the extent capable of cure), remain inaccurate for a period of 30 days; it being understood and agreed that any breach of representation, warranty or certification resulting from the failure of the Administrative Agent to file any Uniform Commercial Code continuation statement (or other similar statement) shall not result in an Event of Default under this clause (b) or any other provision of any Loan Document; or
(iii)any Loan Party shall default in the observance or performance of any agreement contained in Section 6.4(a)(i) (in respect of Holdings and UK Holdco), Section 6.7(a) (provided that (x) the delivery of a notice of Default or Event of Default at any time or (y) the curing of the underlying Default or Event of Default with respect to which notice is required to be given will, in each case, cure an Event of Default arising from the failure to timely deliver such notice of Default or Event of Default, as applicable, in each case unless a Responsible Officer of a Loan Party had actual knowledge of such Default or Event of Default or any Loan Party knowingly fails to give timely notice of any such Default or Event of Default) or Section 7 of this Agreement (other than Section 7.1); or
(iv)subject to Section 9.4, UK Holdco shall default in the observance or performance of its agreement contained in Section 7.1; provided that, notwithstanding anything to the contrary in this Agreement or any other Loan Document, a breach of the requirements of Section 7.1 shall not constitute an Event of Default for purposes of any Facility other than the Revolving Facility; or
(v)any Loan Party shall default in the observance or performance of any other agreement contained in this Agreement or any other Loan Document (other than as provided in paragraphs (a) through (d) of this Section 9.1), and such default shall continue unremedied for a period of 30 days after notice to the Borrower Representative from the Administrative Agent or the Required Lenders; or
(vi)any Group Member shall (i) default in making any payment of any principal of any Indebtedness (including any Guarantee Obligation in respect of Indebtedness, but excluding the Loans) on the scheduled or original due date with respect thereto; or (ii) default in making any payment of any interest on any such Indebtedness beyond the period of grace, if any, provided in the instrument or agreement under which such Indebtedness was created; or (iii) default in the observance or performance of any other agreement or condition relating to any such Indebtedness or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, in each case beyond the applicable notice period and grace period, if any, provided therefor, the effect of which default or other event or condition is to (x) cause, or to permit the holder or beneficiary of such Indebtedness (or a trustee or agent on behalf of such holder or beneficiary) to cause, with the giving of notice if required, such Indebtedness to become due prior to its stated maturity or (in the case of any such Indebtedness constituting a Guarantee Obligation) to become payable or (y) to cause, with the giving of notice if required, any Group Member to purchase or redeem or make an offer to purchase or redeem such Indebtedness prior to its stated maturity; provided that a default, event or condition described in clause (i), (ii) or (iii) of this Section 9.1(f) shall not at any time constitute a Default or an Event of Default unless, at such time, one or more defaults, events or conditions of the type described in clauses (i), (ii) and (iii) of this Section 9.1(f) shall have occurred and be continuing with respect to Indebtedness the outstanding principal amount of which exceeds in the aggregate $125,000,000; provided, further, that clause (iii) of this Section 9.1(f) shall not apply to secured Indebtedness that becomes due as a result of the voluntary Disposition of the property or assets securing such Indebtedness, if such Disposition is permitted hereunder and such Indebtedness that becomes due is paid upon such Disposition; or
(vii)(i) any Borrower, any Guarantor (other than any Guarantor that is an Immaterial Subsidiary) or any Significant Subsidiary shall commence any case, proceeding or other action (A) under any existing or future law of any jurisdiction, domestic or foreign, relating to bankruptcy, insolvency, reorganization, suspension of payments, moratorium of any indebtedness, winding up, dissolution, administration, scheme of arrangement or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding up, liquidation, dissolution, composition, compromise or assignment or other relief with respect to it or its debts, or (B) seeking appointment of a liquidator, receiver,
177
    



administrative receiver, administrator, compulsory manager, trustee, custodian, conservator or other similar official for it or for all or any substantial part of its assets or any Borrower, any Guarantor (other than any Guarantor that is an Immaterial Subsidiary) or any Significant Subsidiary shall make a general assignment for the benefit of its creditors; or (ii) there shall be commenced against any Borrower, any Guarantor (other than any Guarantor that is an Immaterial Subsidiary) or any Significant Subsidiary any case, proceeding, analogous procedure, step or other action of a nature referred to in clause (i) above that results in the entry of an order for relief or any such adjudication or appointment that (1) in respect of any US Subsidiary of UK Holdco, remains undismissed, undischarged or unbonded pending appeal for a period of 60 days and (2) in respect of Holdings, UK Holdco, the Lux Borrower and any Foreign Subsidiary, remains undismissed, undischarged or unbonded pending appeal for a period of 30 days; or (iii) there shall be commenced against any Borrower, any Guarantor (other than any Guarantor that is an Immaterial Subsidiary) or any Significant Subsidiary any case, proceeding or other action seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets that results in the entry of an order for any such relief that (1) in respect of any US Subsidiary of UK Holdco, shall not have been vacated, discharged, or stayed or bonded pending appeal within 60 days from the entry thereof and (2) in respect of Holdings, UK Holdco, the Lux Borrower and any Foreign Subsidiary, shall not have been vacated, discharged, or stayed or bonded pending appeal within 30 days from the entry thereof; or (iv) any Borrower, any Guarantor (other than any Guarantor that is an Immaterial Subsidiary) or any Significant Subsidiary shall take any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in clause (i), (ii), or (iii) above or (v) any Borrower, any Guarantor (other than any Guarantor that is an Immaterial Subsidiary) or any Significant Subsidiary shall generally not, or shall be unable to, or shall admit in writing its inability to, pay its debts as they become due;
(viii)(i) any Person shall engage in any “prohibited transaction” (as defined in Section 406 of ERISA or Section 4975 of the Code) involving any Plan; (ii) any Plan shall fail to meet the minimum funding standards of Section 412 or 430 of the Code or Section 302 or 303 of ERISA or any Lien in favor of the PBGC or a Plan shall arise on the assets of any Group Member or any Commonly Controlled Entity; (iii) a Reportable Event shall occur with respect to, or proceedings shall commence to have a trustee appointed, or a trustee shall be appointed, to administer or to terminate, any Single Employer Plan, which Reportable Event or commencement of proceedings or appointment of a trustee is reasonably likely to result in the termination of such Plan for purposes of Title IV of ERISA; (iv) any Single Employer Plan shall terminate for purposes of Title IV of ERISA; (v)  any Group Member or any Commonly Controlled Entity shall, or is reasonably likely to, incur any liability in connection with a complete or partial withdrawal from, or the Insolvency of, a Multiemployer Plan; (vi) any other event or condition shall occur or exist with respect to a Plan that could give rise to liability under Title IV of ERISA; or (vii) any Foreign Benefit Plan Event shall occur; and in each case in clauses (i) through (vii) above, such event or condition, together with all other such events or conditions, if any, would reasonably be expected to have a Material Adverse Effect; or
(ix)one or more judgments or decrees shall be entered against any Group Member involving in the aggregate a liability (not (x) paid or covered by insurance as to which the relevant insurance company has been notified of the claim and has not denied coverage or (y) covered by valid third party indemnification obligation from a third party which is Solvent and which third party has been notified of the claim under such indemnification obligation and not disputed that it is liable for such claim) in an amount of at least $125,000,000, and all such judgments or decrees shall not have been vacated, discharged, stayed or bonded pending appeal within 60 days from the entry thereof; or
(x)any of the Security Documents shall cease, for any reason, to be in full force and effect, other than pursuant to the terms hereof or thereof, or any Loan Party shall so assert in writing, or any Lien created by any of the Security Documents shall cease to be enforceable and of the same effect and priority purported to be created thereby (other than pursuant to the terms hereof or thereof), except (A) to the extent that (x) any such loss of perfection or priority results from the failure of the Administrative Agent to maintain possession of certificates actually delivered to it representing securities pledged under any Security Agreement or from the failure of the Administrative Agent to file UCC continuation statements (or similar statements or filings in other jurisdictions) and (y) the Loan Parties take such action as the Administrative Agent may reasonably request to remedy such loss of perfection or priority or (B) where the Fair Market Value of the assets affected thereby does not exceed $100,000,000; or
178
    



(xi)the Guarantee of Holdings, UK Holdco or a Significant Subsidiary of UK Holdco shall cease, for any reason, to be in full force and effect, other than as provided for in Sections 8.9 or 10.10, or any Loan Party or any Affiliate of any Loan Party shall so assert in writing;
(xii)a Change of Control shall occur; or
(xiii)any Loan Party repudiates or rescind this Agreement or the Loan Documents or evidences an intention to repudiate or rescind this Agreement or the Loan Documents in a manner which is materially adverse to the interests of the Lenders as a whole and, where capable of remedy, the circumstance are not remedied within 10 days of the earlier of (a) becoming aware of a failure to comply and (b) receiving a written notice of the Administrative Agent notifying it of that failure.
9.b[Reserved].
9.cAction in Event of Default.
(i)(x) Upon any Event of Default specified in Section 9.1(g)(i) or (ii) occurring and continuing with respect to any Borrower under the Bankruptcy Code or any other liquidation, conservatorship, bankruptcy, composition, compromise or assignment for the benefit of creditors, moratorium, rearrangement, receivership or administration, insolvency, reorganization, or similar debtor relief law of the United States from time to time in effect and affecting the rights of creditors generally, the Commitments to lend to such Borrower shall immediately terminate automatically and the Loans (with accrued interest thereon) and all other Obligations owing by such Borrower under this Agreement and the other Loan Documents (including all amounts of L/C Obligations, whether or not the beneficiaries of the then outstanding Letters of Credit shall have presented the documents required thereunder) shall automatically immediately become due and payable (provided that the occurrence of such event in relation to such Borrower shall not, except to the extent provided in this clause (x), result in any Loan being accelerated without a notice having been given pursuant to clause (y) below to the Borrowers (including, for the avoidance of doubt, any other Loan Party)), and (y) if any other Event of Default (other than under Section 9.1(g)(i) or (ii) in respect of a Borrower as set out in clause (x) above) occurs and is continuing, subject to Section 9.3(b) and (c), either or both of the following actions may be taken: (i) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice to the Borrowers declare the Revolving Commitments to be terminated forthwith, whereupon the Revolving Commitments shall immediately terminate; and/or (ii) with the consent of the Required Lenders, the Administrative Agent may, or upon the request of the Required Lenders, the Administrative Agent shall, by notice to the Borrowers, declare the Loans (with accrued interest thereon) and all other Obligations owing under this Agreement and the other Loan Documents (including all amounts of L/C Obligations, whether or not the beneficiaries of the then outstanding Letters of Credit shall have presented the documents required thereunder) to be due and payable forthwith, whereupon the same shall immediately become due and payable. In furtherance of the foregoing, the Administrative Agent may, or upon the request of the Required Lenders the Administrative Agent shall, exercise any and all other remedies available under the Loan Documents at law or in equity, including commencing and prosecuting any suits, actions or proceedings at law or in equity in any court of competent jurisdiction and collecting the Collateral or any portion thereof and enforcing any other right in respect of any Collateral.
(ii)Upon the occurrence of an Event of Default under Section 9.1(d) (a “Financial Covenant Event of Default”) that is uncured or unwaived, the Majority Revolving Lenders may, so long as a Financial Compliance Date continues to be in effect, either (x) terminate the Revolving Commitments and/or (y) take the actions specified in Section 9.3(a) and (c) in respect of the Revolving Commitments, the Revolving Loans, Letters of Credit and any Swingline Loans.
(iii)In respect of a Financial Covenant Event of Default that is continuing, the Required Lenders may take the actions specified in Section 9.3(a) on the date that the Majority Revolving Lenders terminate the Revolving Commitments and accelerate all Obligations in respect of the Revolving Commitments; provided, however, that the Required Lenders may not take such actions if either (i) the Revolving Loans have been repaid in full (other than contingent indemnification and reimbursement
179
    



obligations for which no claim has been made) and the Revolving Commitments have been terminated or (ii) the Financial Covenant Event of Default has been waived by the Majority Revolving Lenders.
(iv)With respect to all Letters of Credit with respect to which presentment for honor shall not have occurred at the time of an acceleration pursuant to this paragraph, the Borrowers shall at such time deposit in a Cash Collateral Account opened by the Administrative Agent an amount equal to the aggregate then undrawn and unexpired amount of such Letters of Credit. Amounts held in such Cash Collateral Account shall be applied by the Administrative Agent to the payment of drafts drawn under such Letters of Credit, and the unused portion thereof after all such Letters of Credit shall have expired or been fully drawn upon, if any, shall be applied to repay other Obligations of the Borrowers hereunder and under the other Loan Documents. After all such Letters of Credit shall have expired or been fully drawn upon and all amounts drawn thereunder have been reimbursed in full and all other Obligations of the Borrowers hereunder and under the other Loan Documents shall have been paid in full (other than contingent indemnification and reimbursement obligations for which no claim has been made), the balance, if any, in such Cash Collateral Account shall be returned to the Borrowers (or such other Person as may be lawfully entitled thereto). Except as expressly provided above in this Section 9.3, presentment, demand, protest and all other notices of any kind are hereby expressly waived by the Borrowers.
9.dRight to Cure.
(i)Notwithstanding anything to the contrary contained in Section 9, in the event that UK Holdco fails (or, but for the operation of this Section 9.4, would fail) to comply with the requirements of Section 7.1, Holdings shall have the right from the date of delivery of a Notice of Intent to Cure with respect to the fiscal quarter most recently ended for which financial results have been provided under Sections 6.1(a) or (b) until 10 Business Days thereafter (the “Cure Period”), to issue Permitted Cure Securities for cash or otherwise receive cash contributions to the equity capital of Holdings, and, in each case, to contribute any such cash to the equity capital of UK Holdco (collectively, the “Cure Right”), and upon the receipt by UK Holdco of such cash (the “Cure Amount”) pursuant to the exercise by Holdings of such Cure Right, the First Lien Net Leverage Ratio shall be recalculated by increasing Consolidated EBITDA (solely for purposes of compliance with Section 7.1 and determining whether an Event of Default is continuing for purposes of clause (y) of the definition of Applicable Margin) on a Pro Forma Basis solely for the purpose of measuring the First Lien Net Leverage Ratio and not for any other purpose under this Agreement, by an amount equal to the Cure Amount.
(ii)If, after giving effect to the foregoing recalculations, UK Holdco shall then be in compliance with the requirements of Section 7.1, then UK Holdco shall be deemed to have satisfied the requirements of Section 7.1 as of the relevant date of determination with the same effect as though there had been no failure to comply therewith at such date, and the applicable breach or default of Section 7.1 that had occurred shall be deemed not to have occurred for the purposes of this Agreement.
(iii)To the extent a fiscal quarter ended for which the First Lien Net Leverage Ratio was initially recalculated as a result of a Cure Right and such fiscal quarter is included in the calculation of the First Lien Net Leverage Ratio in a subsequent fiscal quarter, the Cure Amount shall be included in Consolidated EBITDA of such initial fiscal quarter.
(iv)Notwithstanding anything herein to the contrary, (i) in each four-fiscal-quarter period there shall be at least two fiscal quarters in which the Cure Right is not exercised, (ii) for purposes of this Section 9.4, the Cure Amount shall be no greater than the amount required for purposes of complying with the First Lien Net Leverage Ratio, determined at the time the Cure Right is exercised with respect to the fiscal quarter ended for which the First Lien Net Leverage Ratio was initially recalculated as a result of a Cure Right, (iii) the Cure Amount shall be disregarded for all other purposes of this Agreement, including, determining any baskets with respect to the covenants contained in Section 7, and shall not result in any adjustment to any amounts other than the amount of Consolidated EBITDA as described in clause (a) above, (iv) there shall be no pro forma reduction in Indebtedness with the proceeds of any Cure Amount for the fiscal quarter immediately preceding the fiscal quarter in which the Cure Right is exercised for purposes of determining compliance with Section 7.1 except to the extent the Cure Amount is actually applied to repay Indebtedness and (v) Holdings shall not exercise the Cure Right in excess of five instances over the term of this Agreement.
180
    



9.eApplication of Proceeds. If an Event of Default shall have occurred and be continuing, the Administrative Agent may apply, at such time or times as the Administrative Agent may elect, all or any part of proceeds constituting Collateral in payment of the Obligations (and in the event the Loans and other Obligations are accelerated pursuant to Section 9.3, the Administrative Agent shall, from time to time, apply the proceeds constituting Collateral in payment of the Obligations) in the following order:
(i)First, to the payment of all costs and expenses of any sale, collection or other realization on the Collateral, including reimbursement for all costs, expenses, liabilities and advances made or incurred by the Administrative Agent in connection therewith (including all reasonable costs and expenses of every kind incurred in connection any action taken pursuant to any Loan Document or incidental to the care or safekeeping of any of the Collateral or in any way relating to the Collateral or the rights of the Administrative Agent and the other Secured Parties hereunder, reasonable attorneys’ fees and disbursements and any other amount required by any provision of law (including Section 9-615(a)(3) of the Uniform Commercial Code) (or any equivalent law in any foreign jurisdiction)), and all amounts for which Administrative Agent is entitled to indemnification hereunder and under the other Loan Documents and all advances made by the Administrative Agent hereunder and thereunder for the account of any Loan Party (excluding principal and interest in respect of any Loans extended to such Loan Party), and to the payment of all costs and expenses paid or incurred by the Administrative Agent in connection with the exercise of any right or remedy hereunder or under this Agreement or any other Loan Document and to the payment or reimbursement of all indemnification obligations, fees, costs and expenses owing to the Administrative Agent hereunder or under this Agreement or any other Loan Document, all in accordance with the terms hereof or thereof;
(ii)Second, for application by it pro rata to (i) repay the Swingline Lender for any then outstanding Swingline Loans to the extent Revolving Lenders have not funded their obligations to acquire participations therein, (ii) cure any Funding Default that has occurred and is continuing at such time and (iii) repay the Issuing Lenders for any amounts not paid by L/C Participants pursuant to Section 3.4;
(iii)Third, for application by it towards all other Obligations (including, without duplication, Guarantor Obligations), pro rata among the Secured Parties according to the amounts of the Obligations then held by the Secured Parties (including all Obligations arising under Specified Cash Management Agreements, Specified Swap Agreements and including obligations to provide cash collateral with respect to Letters of Credit); and
(iv)Fourth, any balance of such Proceeds remaining after all of the Obligations shall have been satisfied by payment in full in immediately available funds (or in the case of Letters of Credit, terminated or Collateralized) and the Commitments shall have been terminated, be paid over to or upon the order of the applicable Loan Party or to whosoever may be lawfully entitled to receive the same or as a court of competent jurisdiction may direct.
9.fClean-Up Period.
(a)    Notwithstanding anything to the contrary set forth herein or in any other Loan Document, during the Clean-Up Period, the occurrence of any breach of a representation, covenant or an Event of Default (other than an Event of Default set out in Section 9.1(a)) will be deemed not to be a breach of a representation or warranty or a breach of a covenant or an Event of Default, as the case may be, if it would have been (if it were not for this provision) a breach of representation or warranty or a breach of a covenant or an Event of Default only by reason of circumstances relating exclusively to, with respect to any Permitted Acquisition or other Permitted Clean-Up Investment (or the subsidiaries of such target), the target of such Permitted Acquisition or Permitted Clean-Up Investment, and provided that such breach or Event of Default:
(1)is capable of being remedied within the Clean-Up Period and the Loan Parties are taking appropriate steps to remedy such breach or Event of Default;
(2)does not have and is not reasonably likely to have a Material Adverse Effect; and
181
    



(3)was not procured by or approved by Holdings or the Borrowers.
(v)Notwithstanding Section 9.6(a), if the relevant circumstances are continuing on or after the expiry of the Clean-Up Period, there shall be a breach of representation or warranty, breach of covenant or Event of Default, as the case may be, notwithstanding the above (and without prejudice to the rights and remedies of the Agents and the Lenders).
(vi)For the avoidance of doubt, if any breach of representation or warranty, breach of covenant or Event of Default shall be deemed to not exist due to Section 9.6(a) during the Clean-Up Period, then such breach of representation or warranty, breach of covenant or Event of Default shall be deemed not to exist for purposes of Section 5.2 for so long as (but in no event later than the end of the Clean-Up Period) such breach of representation or warranty, breach of covenant or Event of Default shall be deemed not to exist due to the provisions of Section 9.6(a).
SECTION 10.
ADMINISTRATIVE AGENT
10.aAppointment and Authority.
(i)Administrative Agent. Each of the Lenders and the Issuing Lenders hereby irrevocably appoints Bank of America, N.A. to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this Section 10 are solely for the benefit of the Administrative Agent, the Joint Bookrunners, the Joint Lead Arrangers, the Incremental Facility Arrangers, the Lenders and the Issuing Lenders, and, except to the extent that any Group Member has any express rights under this Section 10, no Group Member shall have rights as a third party beneficiary of any of such provisions. Each Joint Lead Arranger, Joint Bookrunner and Incremental Facility Arranger shall be an intended third party beneficiary of the provisions set forth in this Agreement that are applicable thereto. It is understood and agreed that the use of the term “agent” herein or in any other Loan Documents (or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable Law. Instead such term is used as a matter of market custom, and is intended to create or reflect only an administrative relationship between contracting parties.
(ii)Collateral Agent. The Administrative Agent shall also act as the “collateral agent” under the Loan Documents, and each of the Lenders (including in its capacities as a potential Qualified Counterparty and a potential Cash Management Provider) and the Issuing Lenders hereby irrevocably appoints and authorizes the Administrative Agent to act as the agent of such Lender and the Issuing Lenders (with the full power to appoint and to substitute and to delegate) on its behalf, or in its own name as joint and several creditor or creditor of a parallel debt (as the case may be) for purposes of acquiring, holding and enforcing any and all Liens on Collateral granted by any of the Loan Parties to secure any of the Obligations, together with such powers and discretion as are reasonably incidental thereto. In this connection, the Administrative Agent, as “collateral agent” and any co-agents, sub-agents and attorneys-in-fact appointed by the Administrative Agent pursuant to Section 10.5 for purposes of holding or enforcing any Lien on the Collateral (or any portion thereof) granted under the Security Documents, or for exercising any rights and remedies thereunder at the direction of the Administrative Agent, shall be entitled to the benefits of all provisions of this Section 10 and Section 11, as though such co-agents, sub-agents and attorneys-in-fact were the “collateral agent” under the Loan Documents as if set forth in full herein with respect thereto. Without limiting the generality of the foregoing, the Lenders hereby expressly authorize the Administrative Agent on its behalf and/or in its own name (including under any parallel debt) to execute any and all documents (including releases) with respect to the Collateral and the rights of the Secured Parties with respect thereto, as contemplated by and in accordance with the provisions of this Agreement and the Security Documents and acknowledge and agree that any such action by any Agent shall bind the Lenders. Each Lender agrees that it shall not take or institute any actions or proceedings, judicial or otherwise, for any right or remedy with respect to any Collateral against any Borrower or any other Loan Party or any other obligor under any of the Loan Documents, Specified Swap Agreements or any Specified Cash Management Agreement (including, in each case, the
182
    



exercise of any right of setoff, rights on account of any banker’s lien or similar claim or other rights of self-help), or institute any actions or proceedings, or otherwise commence any remedial procedures, with respect to any Collateral of any Borrower or any other Loan Party, without the prior written consent of the Administrative Agent. In the event of a foreclosure by the Administrative Agent on any of the Collateral pursuant to a public or private sale or a sale of any of the Collateral pursuant to Section 363 of the Bankruptcy Code (or an equivalent process in any foreign jurisdiction), the Administrative Agent or any Lender may be the purchaser of any or all of such Collateral at any such sale and the Administrative Agent, as agent for and representative of the Lenders (but not any Lender or Lenders in its or their respective individual capacities unless the Required Lenders shall otherwise agree in writing) shall be entitled, with the consent or at the direction of the Required Lenders, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale, to use and apply any of the Obligations as a credit on account of the purchase price for any Collateral payable by the Administrative Agent at such sale.
(iii)German Collateral. In relation to any Collateral created under Security Documents governed by German law (the “German Collateral”) the appointment pursuant to paragraph (b) above includes the appointment as trustee (Treuhänder) under German law and administrator for the purpose of accepting and administering the German Collateral for the benefit and account of the other Secured Parties and the Administrative Agent hereby accepts such appointment. The Administrative Agent shall, with respect to any security interest created under any Collateral Documents, or any other Collateral, which in each case is subject to German law, hold, administer and, as the case may be, release and (subject to it having become enforceable) realize in its own name as trustee (treuhänderisch) for the benefit and account of the Secured Parties, and not as trustee on behalf of any other party.
(iv)Spanish Collateral. In relation to any Collateral created under Security Documents governed by Spanish law, each of the Lenders hereby undertake, upon request by the Administrative Agent, to grant a power of attorney in its favor to exercise the powers contained in this Section 10.1, which shall be notarized and legalized by affixing an apostille pursuant to The Hague Convention of 1961.
10.bRights as a Lender. The Person serving as the Administrative Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent and the term “Lender” or “Lenders” shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with Holdings, UK Holdco, the Borrowers or any of their respective Subsidiaries or other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.
10.cExculpatory Provisions. The Administrative Agent or the Joint Lead Arrangers or the Incremental Arrangers, as applicable, shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents, and the Administrative Agent’s duties hereunder shall be administrative in nature. Without limiting the generality of the foregoing, the Administrative Agent or the Joint Lead Arrangers or the Incremental Arrangers, as applicable:
(i)shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing;
(ii)shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents), provided that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable Law, including for the avoidance of doubt any action that may be in violation of the automatic stay under any Debtor Relief Law or that may effect a forfeiture, modification or termination of property of a Defaulting Lender in violation of any Debtor Relief Law;
183
    



(iii)shall not have any duty or responsibility to disclose, and shall not be liable for the failure to disclose, any credit or other information concerning the business, prospects, operations, property, financial and other condition or creditworthiness of or otherwise relating to any of the Loan Parties or any of their Affiliates that is communicated to or obtained by or in possession of the Administrative Agent, the Joint Lead Arrangers, the Incremental Arrangers or any of their Related Parties in any capacity, except for notices, reports and other documents expressly required to be furnished to the Lenders by the Administrative Agent herein;
(iv)shall not be liable for any action taken or not taken by it (i) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in Section 11.1 and Section 9.3) or (ii) in the absence of its own gross negligence or willful misconduct, as determined by a court of competent jurisdiction by a final and nonappealable judgment. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until written notice describing such Default is given to the Administrative Agent by a Borrower, a Lender or the applicable Issuing Lender;
(v)shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document, or the creation, perfection or priority of any Lien purported to be created by the Security Documents, (v) the value or the sufficiency of any Collateral, or (vi) the satisfaction of any condition set forth in Section 5 or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent;
(vi)shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions hereof relating to Disqualified Lenders or Affiliated Lenders. Without limiting the generality of the foregoing, the Administrative Agent shall not (x) be obligated to ascertain, monitor or inquire as to whether any Lender or Participant or prospective Lender or Participant is a Disqualified Lender, (y) have any liability with respect to or arising out of any assignment or participation of Loans, or disclosure of confidential information, to any Disqualified Lender or (z) be obligated to ascertain, monitor or enforce any limitations in connection with any assignment to Debt Fund Affiliates and Affiliated Lenders or have any liability with respect thereto or any matter arising thereof;
(vii)shall not be responsible for or have a duty to ascertain or inquire into any representation or warranty regarding the existence, value or collectability of the Collateral, the existence, priority or perfection of the Administrative or the Collateral Agent’s Lien thereon, or any certificate prepared by any Loan Party in connection therewith, nor shall the Administrative Agent or the Collateral Agent be responsible or liable to the Lenders or any Issuing Lender for any failure to monitor or maintain any portion of the Collateral.
10.dReliance by Administrative Agent. The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan, or the issuance, extension, renewal or increase of a Letter of Credit, that by its terms must be fulfilled to the satisfaction of a Lender or the applicable Issuing Lender, the Administrative Agent may presume that such condition is satisfactory to such Lender or such Issuing Lender unless the Administrative Agent shall have received written notice to the contrary from such Lender or such Issuing Lender prior to the making of such Loan or the issuance such Letter of Credit. The Administrative Agent may consult with legal counsel (who may be counsel for the Borrowers), independent accountants and
184
    



other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts. The Administrative Agent shall be fully justified in failing or refusing to take any action under this Agreement or any other Loan Document unless it shall first receive such advice or concurrence of the Required Lenders (or such other number or percentage of Lenders as shall be provided for herein or in the other Loan Documents) as it deems appropriate or it shall first be indemnified to its satisfaction by the Lenders against any and all liability and expense that may be incurred by it by reason of taking or continuing to take any such action. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement and the other Loan Documents in accordance with a request of the Required Lenders (or such other number or percentage of Lenders as shall be provided for herein or in the other Loan Documents), and such request and any action taken or failure to act pursuant thereto shall be binding upon the Lenders and all future holders of the Loans.
10.eDelegation of Duties. The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Section 10 shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent. The Administrative Agent shall not be responsible for the negligence or misconduct of any sub-agents except to the extent that a court of competent jurisdiction determines in a final and nonappealable decision that the Administrative Agent acted with gross negligence, bad faith or willful misconduct in the selection of such sub-agents.
10.fResignation and Removal of Administrative Agent.
(i)The Administrative Agent may at any time give notice of its resignation to the Lenders, the Issuing Lenders and the Borrowers. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, subject to the approval of the Borrower Representative, not to be unreasonably withheld, for so long as no Specified Event of Default has occurred and is continuing, to appoint a successor, which shall be a bank with an office in the United States, or an Affiliate of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days after the retiring Administrative Agent gives notice of its resignation (or such earlier day as shall be agreed by the Required Lenders) (the “Resignation Effective Date”), then the retiring Administrative Agent may (but shall not be obligated to) on behalf of the Lenders and the Issuing Lenders, in consultation with the Borrower Representative, appoint a successor Administrative Agent meeting the qualifications set forth above; provided that in no event shall any such successor Administrative Agent be a Defaulting Lender. Whether or not a successor has been appointed, such resignation shall become effective in accordance with such notice on the Resignation Effective Date.
(ii)If the Person serving as Administrative Agent is a Defaulting Lender pursuant to clause (e) of the definition thereof, the Required Lenders may, to the extent permitted by applicable Law, by notice in writing to the Borrowers and such Person remove such Person as Administrative Agent and, subject to the approval of the Borrower Representative, not to be unreasonably withheld, for so long as no Specified Event of Default has occurred and is continuing, appoint a successor. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30 days (or such earlier day as shall be agreed by the Required Lenders) (the “Removal Effective Date”), then such removal shall nonetheless become effective in accordance with such notice on the Removal Effective Date.
(iii)With effect from the Resignation Effective Date or the Removal Effective Date (as applicable) (1) the retiring or removed Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents (except that in the case of any collateral security held by the Administrative Agent or the Collateral Agent on behalf of the Lenders or the Issuing Lenders under any of the Loan Documents, the retiring or removed Administrative Agent shall continue to hold such collateral security until such time as a successor Administrative Agent is appointed) and (2) except for any indemnity payments or other amounts then owed to the retiring or removed Administrative
185
    



Agent, all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender and the Issuing Lenders directly, until such time as the Required Lenders appoint a successor Administrative Agent as provided for above. Upon the acceptance of a successor’s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or removed) Administrative Agent (other than as provided in Section 2.19(f) and other than any rights to indemnity payments or other amounts owed to the retiring or removed Administrative Agent as of the Resignation Effective Date or the Removal Effective Date, as applicable), and the retiring or removed Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrowers to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrowers and such successor. After the retiring or removed Administrative Agent’s resignation or removal hereunder and under the other Loan Documents, the provisions of this Section 10 and Section 11.5 shall continue in effect for the benefit of such retiring or removed Administrative Agent, its sub agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them (i) while the retiring or removed Administrative Agent was acting as Administrative Agent and (ii) after such resignation or removal for as long as any of them continues to act in any capacity hereunder or under the other Loan Documents, including (a) acting as collateral agent or otherwise holding any collateral security on behalf of any of the Lenders and (b) in respect of any actions taken in connection with transferring the agency to any successor Administrative Agent.
(iv)Any resignation by Bank of America, N.A., as Administrative Agent pursuant to this Section 10.6 shall also constitute its resignation as Swingline Lender. If Bank of America, N.A. resigns as a Swingline Lender, it shall retain all the rights of a Swingline Lender provided for hereunder with respect to Swingline Loans made by it and outstanding as of the effective date of such resignation. Upon the appointment by the Borrower Representative of a successor Swingline Lender hereunder (which successor shall in all cases by a Lender other than Defaulting Lender), (a) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Swingline Lender and (b) the retiring Swingline Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents.
10.gNon-Reliance on Administrative Agent, the Joint Lead Arrangers, the Incremental Facility Arrangers and the Other Lenders. Each Lender and each Issuing Lender expressly acknowledges that none of the Administrative Agent nor the Joint Lead Arrangers nor the Incremental Facility Arrangers has made any representation or warranty to it, and that no act by the Administrative Agent or the Joint Lead Arrangers or the Incremental Facility Arrangers hereafter taken, including any consent to, and acceptance of, any assignment or review of the affairs of any Loan Party or any Affiliate thereof, shall be deemed to constitute any representation or warranty by the Administrative Agent or the Joint Lead Arrangers or the Incremental Facility Arrangers to any Lender or any Issuing Lender as to any matter, including whether the Administrative Agent or any Joint Lead Arranger or any Incremental Facility Arrangers has disclosed material information in its or their (or their Related Parties’) possession. Each Lender and each Issuing Lender represents that it has, independently and without reliance upon the Administrative Agent, any Joint Lead Arranger, any Incremental Facility Arranger or any other Lender or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis of, appraisal of, and investigation into, the business, prospects, operations, property, financial and other condition and creditworthiness of the Loan Parties and their Subsidiaries, and all applicable bank or other regulatory Laws relating to the transactions contemplated hereby, and made its own decision to enter into this Agreement and to extend credit to the Borrowers hereunder. Each Lender and each Issuing Lender also acknowledges that it will, independently and without reliance upon the Administrative Agent, the Joint Lead Arrangers, the Incremental Facility Arrangers or any other Lender or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own credit analysis, appraisals and decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder, and to make such investigations as it deems necessary to inform itself as to the business, prospects, operations, property, financial and other condition and creditworthiness of the Loan Parties. Each Lender and each Issuing Lender represents and warrants that (i) the Loan Documents set forth the terms of a commercial lending facility and (ii) it is
186
    



engaged in making, acquiring or holding commercial loans in the ordinary course and is entering into this Agreement as a Lender or Issuing Lender for the purpose of making, acquiring or holding commercial loans and providing other facilities set forth herein as may be applicable to such Lender or Issuing Lender, and not for the purpose of purchasing, acquiring or holding any other type of financial instrument, and each Lender and each Issuing Lender agrees not to assert a claim in contravention of the foregoing. Each Lender and each Issuing Lender represents and warrants that it is sophisticated with respect to decisions to make, acquire and/or hold commercial loans and to provide other facilities set forth herein, as may be applicable to such Lender or such Issuing Lender, and either it, or the Person exercising discretion in making its decision to make, acquire and/or hold such commercial loans or to provide such other facilities, is experienced in making, acquiring or holding such commercial loans or providing such other facilities.
10.hNo Other Duties, Etc. Anything herein to the contrary notwithstanding, none of the Administrative Agent, the Collateral Agent, Joint Bookrunner or Joint Lead Arrangers listed on the cover page hereof or the Incremental Facility Arrangers (each, an “Agent”) shall (a) have any powers, obligations, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, the Collateral Agent, a Lender or an Issuing Lender hereunder or (b) be obligated to carry out on behalf of any Lender (i) any “know your customer”, Beneficial Ownership Regulation or other checks in relation to any Person or (ii) any check on the extent to which any transaction contemplated by this Agreement might be unlawful for any Lender or Issuing Lender, and each Lender or Issuing Lender confirms to each Agent that it is solely responsible for any such checks it is required to carry out and that it may not rely on any statement in relation to such checks made by any Agent.
10.iAdministrative Agent May File Proofs of Claim; Credit Bidding.
(i) In case of the pendency of any proceeding under any Debtor Relief Law or any other judicial proceeding relative to any Loan Party, the Administrative Agent (irrespective of whether the principal of any Loan or L/C Obligation shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on any Borrower) shall be entitled and empowered, by intervention in such proceeding or otherwise:
(1)to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans, L/C Obligations and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders, the Issuing Lenders, the Administrative Agent and the Collateral Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders, the Issuing Lenders, the Administrative Agent and the Collateral Agent and their respective agents and counsel and all other amounts due the Lenders, the Issuing Lenders and the Administrative Agent under Sections 2.8, 3.3 and 11.5) allowed in such judicial proceeding; and
(2)to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same;
and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender and each Issuing Lender to make such payments to the Administrative Agent and, if the Administrative Agent shall consent to the making of such payments directly to the Lenders and the applicable Issuing Lender, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under Sections 2.8 and 11.5.
Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender or any Issuing Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or any Issuing Lender to authorize the Administrative Agent to vote in respect of the claim of any Lender or any Issuing Lender or in any such proceeding.
187
    



The Secured Parties hereby irrevocably authorize the Administrative Agent, at the direction of the Required Lenders, to credit bid all or any portion of the Obligations (including accepting some or all of the Collateral in satisfaction of some or all of the Obligations pursuant to a deed in lieu of foreclosure or otherwise) and in such manner purchase (either directly or through one or more acquisition vehicles) all or any portion of the Collateral (a) at any sale thereof conducted under the provisions of the Bankruptcy Code of the United States, including under Sections 363, 1123 or 1129 of the Bankruptcy Code of the United States, or any similar Laws in any other jurisdictions to which a Loan Party is subject, (b) at any other sale or foreclosure or acceptance of collateral in lieu of debt conducted by (or with the consent or at the direction of) the Administrative Agent (whether by judicial action or otherwise) in accordance with any applicable Law.  In connection with any such credit bid and purchase, the Obligations owed to the Secured Parties shall be entitled to be, and shall be, credit bid on a ratable basis (with Obligations with respect to contingent or unliquidated claims receiving contingent interests in the acquired assets on a ratable basis that would vest upon the liquidation of such claims in an amount proportional to the liquidated portion of the contingent claim amount used in allocating the contingent interests) in the asset or assets so purchased (or in the Equity Interests or debt instruments of the acquisition vehicle or vehicles that are used to consummate such purchase).  In connection with any such bid (i) the Administrative Agent shall be authorized to form one or more acquisition vehicles to make a bid, (ii) to adopt documents providing for the governance of the acquisition vehicle or vehicles (provided that any actions by the Administrative Agent with respect to such acquisition vehicle or vehicles, including any disposition of the assets or Equity Interests thereof shall be governed, directly or indirectly, by the vote of the Required Lenders, irrespective of the termination of this Agreement and without giving effect to the limitations on actions by the Required Lenders contained in Section 11.1 of this Agreement), (iii) the Administrative Agent shall be authorized to assign the relevant Obligations to any such acquisition vehicle pro rata by the Lenders, as a result of which each of the Lenders shall be deemed to have received a pro rata portion of any Equity Interests and/or debt instruments issued by such an acquisition vehicle on account of the assignment of the Obligations to be credit bid, all without the need for any Secured Party or acquisition vehicle to take any further action, and (iv) to the extent that Obligations that are assigned to an acquisition vehicle are not used to acquire Collateral for any reason (as a result of another bid being higher or better, because the amount of Obligations assigned to the acquisition vehicle exceeds the amount of debt credit bid by the acquisition vehicle or otherwise), such Obligations shall automatically be reassigned to the Lenders pro rata and the Equity Interests and/or debt instruments issued by any acquisition vehicle on account of the Obligations that had been assigned to the acquisition vehicle shall automatically be cancelled, without the need for any Secured Party or any acquisition vehicle to take any further action.
(ii)As regards any judicial proceeding relating to any Spanish Loan Party and for the purposes of Article 572 of the Spanish Civil procedural Law, the Parties expressly agree that:
(1)a statement as to any amount due to any Lender under this Agreement which is certified as being correct by the Administrative Agent or, failing which, by the relevant Lender shall, in the absence of manifest error or unless otherwise provided under this Agreement be prima facie evidence of the amount so due and that such amount is in fact true, net, due and payable. Such statement shall include the balance resulting from the calculation of the debt (in Spanish: liquidación) made by the Administrative Agent or the relevant Lender, as well as the extract of the credits and debits entries and those corresponding to the application of interest (if any) which determine the particular balance of the amount due;
(2)the balance of the specific ledgers in relation to the Loan Documents, opened and held by the Administrative Agent or the relevant Lender in the relevant Spanish Loan Party's name, in accordance with the terms of the Spanish Civil Procedure Law 1/2000, in which ledgers all amounts owed by the Spanish Loan Party shall be debited and all amounts paid by the Spanish Loan Party shall be credited, shall be considered by the parties hereof as determining the amount of debt of the Spanish Loan Party outstanding at the time enforcement action is taken;
(3)the Administrative Agent, failing which, the relevant Lender shall execute a notorial document (in Spanish: acta notarial) evidencing that the calculation of the debt owed by the Spanish Loan Party (in Spanish: liquidación) made has been done according to the procedure set forth in this Agreement by the Parties;
188
    



(4)prior to commencing enforcement actions in connection with this Agreement or any Loan Document affecting a Spanish Loan Party, to the extent permitted by law, the Administrative Agent, failing which, the relevant Lender, shall deliver a copy of the relevant statement referred to in (iii) above to the relevant Spanish Loan Party through judicial or notarial means, which shall express the total amount due; and
(5)if an Event of Default is continuing each Spanish Loan Party will, at the request of the Administrative Agent, enter into one or more notarial deeds (escritura pública) in the form and substance satisfactory to the Administrative Agent and take all other actions required by the Administrative Agent to ensure that the obligations of any Spanish Loan Party under any guarantee entered by it are raised to the status of a Spanish notarial deed.
The Spanish Loan Parties expressly authorise the Administrative Agent to request and obtain certificates and documents issued by the notary that raised this Agreement to a notarial status (or his/her successor(s)) in order to evidence compliance of the Agreement with the entries of her/his registry-book and the relevant entry date for the purpose of number 4 of Article 517.2, of the Spanish Civil Procedural Law. The cost of such certificate and documents will be for the account of the Loan Parties.
The Spanish Loan Parties further authorise the Administrative Agent and each Lender to request and obtain certificates evidencing the entry of this Agreement in the Register of Transactions of the Notary authorising the same, and to obtain the approval certificate referred to in number 5 of Article 517, of the Spanish Civil Procedural Law. The cost of such certificate will be for the account of the Loan Parties.
10.jCollateral and Guaranty Matters.
(i)Each of the Secured Parties and the Issuing Lenders hereby, and by their acceptance of the benefits of the Loan Documents, irrevocably authorize the Administrative Agent (without requirement of notice to or consent of any Secured Party except as expressly required by Section 11.1): (i) to release or confirm the release of any Lien on any property granted to or held by the Administrative Agent or Collateral Agent under any Loan Document (1) at the time the property subject to such Lien is Disposed of or to be Disposed of as part of or in connection with any Disposition permitted hereunder or under any other Loan Document to any Person other than a Loan Party, (2) subject to Section 11.1, if the release of such Lien is approved, authorized or ratified in writing by the Required Lenders, (3) if the property subject to such Lien is owned by a Guarantor, upon release of such Guarantor from its obligations under the Guarantee or (4) that constitutes Excluded Assets or any property that is excluded from the Collateral pursuant to the Agreed Security Principles; (ii) to release or subordinate, as expressly permitted hereunder, any Lien on any property granted to or held by the Administrative Agent or the Collateral Agent under any Loan Document to the holder of any Lien on such property that is permitted by this Agreement to the extent required by the holder of, or pursuant to the terms of any agreement governing, the obligations secured by such Liens; (iii) to release any Guarantor from its obligations under the Guarantee if such Person ceases to be a Restricted Subsidiary or becomes an Excluded Subsidiary as a result of a transaction, circumstance or designation permitted hereunder; (iv) to amend Section 8.12 to the extent permitted by Section 8.12(f) and to give effect to any limitations set forth in Section 8.12 in any Guarantor Joinder Agreement and/or Borrower Joinder applicable to any Guarantor; (v) to amend any Security Document to give effect to any limitations set forth in the Agreed Security Principles and (vi) to release any Collateral or Guarantor Obligations to the extent necessary to permit consummation of any transaction not prohibited by any Loan Document or that has been consented to in accordance with Section 11.1.
(ii)Upon request by the Administrative Agent at any time, the Required Lenders will confirm in writing the Administrative Agent’s authority to release or subordinate its interest in particular types or items of property, or to release or confirm the release of (pursuant to clause (a) above) any Guarantor from its obligations under the Guarantee.
(iii)On the Termination Date, the Collateral shall be automatically released from the Liens created by the Security Documents, and the Security Documents and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent and each Group Member under
189
    



the Security Documents shall automatically terminate, all without delivery of any instrument or performance of any act by any Person.
(iv)If (i) a Guarantor was released from its obligations under the Guarantee, (ii) an Additional Revolving Borrower was released from its obligations under the Loan Documents or (iii) the Collateral was released from the assignment and security interest granted under the Security Document (or the interest in such item subordinated), in each case in a manner not prohibited by this Agreement or another Loan Document, the Administrative Agent will (and each Lender irrevocably authorizes the Administrative Agent to) execute and deliver to the applicable Loan Party such documents as such Loan Party may reasonably request to evidence the release of such Guarantor from its obligations under the Guarantee or such Additional Revolving Borrower from its obligations under the Loan Documents, the release of such item of Collateral from the assignment and security interest granted under the Security Documents or to subordinate its interest in such item, in each case in accordance with the terms of the Loan Documents and this Section 10.10.
(v)If as a result of any transaction, event or circumstance not prohibited by this Agreement (i) any Guarantor or Additional Revolving Borrower becomes an Excluded Subsidiary or (ii) any Guarantor or Additional Revolving Borrower is sold (or consolidates or merges with a Person that is not a Loan Party), then (x) such Guarantor’s Guarantee (or the obligations of such Additional Revolving Borrower under the Loan Documents) shall be automatically released, and (y) the Capital Stock of such Guarantor or Additional Revolving Borrower (other than, in the case of a Guarantor or Additional Revolving Borrower that is an Excluded Subsidiary solely by reason of being a CFC or a FSHCO, 65% of the total outstanding voting Capital Stock and 100% of the total outstanding non-voting Capital Stock of such Guarantor or such Additional Revolving Borrower that, in each case, is directly owned by a Borrower or another Guarantor) shall be automatically released from the security interests created by the Loan Documents, or (iii) Capital Stock of any Subsidiary ceases to be directly owned by a Borrower or Guarantor (or a Person then required to be a Guarantor pursuant to this Agreement or any other Loan Document), then such Capital Stock of such Subsidiary shall be automatically released from any security interests created by the Loan Documents; provided that no Loan Party will dispose of a minority interest in any Guarantor for the primary purpose of releasing the Guarantee made by such Guarantor under the Loan Documents as determined by the Borrower Representative in good faith. In connection with any termination or release pursuant to this Section 10.10(e), the Administrative Agent and any applicable Lender shall promptly execute and deliver to any Loan Party, at such Loan Party’s expense, all documents that such Loan Party shall reasonably request to evidence such termination or release. Any execution and delivery of documents pursuant to this Section 10.10(e) shall be without recourse to or warranty by the Administrative Agent or any Lender.
10.kIntercreditor Agreements.
The Secured Parties hereby, and by their acceptance of the benefits of the Loan Documents: (a) irrevocably authorize and direct each of the Administrative Agent and the Collateral Agent, as applicable, to execute and deliver the Initial Intercreditor Agreement, (b) acknowledge that the obligations of the Borrowers and the Guarantors under any Permitted First Priority Refinancing Debt, Permitted Second Priority Refinancing Debt, Incremental Equivalent Debt and other Indebtedness permitted by Section 7.2 that is secured by Permitted Liens, and with respect to which such Indebtedness and/or Liens this Agreement contemplates an intercreditor, subordination, collateral trust or similar agreement, or that such Indebtedness shall or may be secured on a pari passu or junior basis to the Liens securing the Obligations, may be secured by Liens on assets of the Borrowers and the Guarantors that constitute Collateral and (c) irrevocably authorizes and directs each of the Administrative Agent and the Collateral Agent to execute and deliver, without any further consent, authorization or other action by such Secured Party (i) any such intercreditor, subordination, collateral trust or similar agreement (and any amendments, amendments and restatements, restatements or waivers of, or supplements or other modifications to, any such agreement or arrangement permitted under this Agreement) constituting an Acceptable Intercreditor Agreement and (ii) any documents, certificates or other instruments in connection therewith, and any such intercreditor, subordination, collateral trust or similar agreement will be binding upon the Secured Parties.
Each of the Lenders, the Issuing Lenders and the other Secured Parties hereby irrevocably (i) consents to the treatment of Liens to be provided for under the Intercreditor Agreements, (ii) agrees that,
190
    



upon the execution and delivery thereof, such Secured Party will be bound by the provisions of any Intercreditor Agreement as if it were a signatory thereto and will take no actions contrary to the provisions of any Intercreditor Agreement and (iii) authorizes and directs each of the Administrative Agent and the Collateral Agent to carry out the provisions and intent of each such document.
Except as otherwise expressly set forth herein or in any Security Document, no Qualified Counterparty or Cash Management Provider that obtains the benefits of Section 9.5, any Guarantee or any Collateral by virtue of the provisions hereof or of any Guarantee or any Security Document shall have any right to notice of any action or to consent to, direct or object to any action hereunder or under any other Loan Document or otherwise in respect of the Collateral (including the release or impairment of any Collateral) other than in its capacity as a Lender and, in such case, only to the extent expressly provided in the Loan Documents. Notwithstanding any other provisions of this Section 10 to the contrary, the Administrative Agent shall not be required to verify the payment of, or that other satisfactory arrangements have been made with respect to, Obligations arising under Cash Management Agreements and Hedge Agreements unless the Administrative Agent has received written notice of such Obligations, together with such supporting documentation as the Administrative Agent may request, from the applicable Qualified Counterparty or Cash Management Provider, as the case may be.
10.lWithholding Tax Indemnity. To the extent required by any applicable Laws, the Administrative Agent may withhold from any payment to any Lender an amount equivalent to any applicable withholding Tax. If the Internal Revenue Service or any other authority of the United States or other jurisdiction asserts a claim that the Administrative Agent did not properly withhold Tax from amounts paid to or for the account of any Lender for any reason (including because the appropriate form was not delivered or not properly executed, or because such Lender failed to notify the Administrative Agent of a change in circumstance that rendered the exemption from, or reduction of withholding Tax ineffective), such Lender shall, within 10 days after written demand therefor, indemnify and hold harmless the Administrative Agent (to the extent that the Administrative Agent has not already been reimbursed by the Borrowers or any other Loan Party pursuant to Sections 2.16 and 2.19 and without limiting or expanding the obligation of the Borrowers or any other Loan Party to do so) for all amounts paid, directly or indirectly, by the Administrative Agent as Taxes or otherwise, together with all expenses incurred, including legal expenses and any other out-of-pocket expenses, whether or not such Tax was correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under this Agreement or any other Loan Document against any amount due the Administrative Agent under this Section 10.12. The agreements in this Section 10.12 shall survive the resignation and/or replacement of the Administrative Agent, any assignment of rights by, or the replacement of, a Lender and the repayment, satisfaction or discharge of all other Obligations. For the avoidance of doubt, a “Lender” shall, for purposes of this Section 10.12, include any Issuing Lender and the Swingline Lender.
10.mIndemnification. Each of the Lenders agrees to indemnify the Administrative Agent, the Joint Lead Arrangers and the Incremental Facility Arrangers (and, in each case, their Related Parties) in their respective capacities as such (to the extent not reimbursed by any Loan Party and without limiting or expanding the obligation of the Loan Parties to do so), according to its Aggregate Exposure Percentage in effect on the date on which indemnification is sought under this Section 10.13 (or, if indemnification is sought after the date upon which the Commitments shall have terminated and the Loans shall have been paid in full, in accordance with its Aggregate Exposure Percentage immediately prior to such date), from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind whatsoever that may at any time (whether before or after the payment of the Loans) be imposed on, incurred by or asserted against the Administrative Agent, the Joint Lead Arrangers, the Incremental Facility Arrangers or their Related Parties (the foregoing, the “Lender Indemnitees”) in any way relating to or arising out of, the Commitments, this Agreement, any of the other Loan Documents or any documents contemplated by or referred to herein or therein or the transactions contemplated hereby or thereby or any action taken or omitted by the Administrative Agent or any other Person under or in connection with any of the foregoing; provided that no Lender shall be liable to any Lender Indemnitee for the payment of any portion of such liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements to the extent that they are found by a
191
    



final and nonappealable decision of a court of competent jurisdiction to have resulted from the gross negligence, bad faith or willful misconduct of such Lender Indemnitee. The agreements in this Section 10.13 shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.
10.nAppointment of Incremental Arrangers, Refinancing Arrangers and Loan Modification Agents. In the event that the Borrower Representative appoints or designates any Incremental Arranger, Refinancing Arranger or Loan Modification Agent pursuant to (and subject to) Sections 2.25, 2.26 and 2.28, as applicable, (i) each and every right, power, privilege or duty expressed or intended by this Agreement or any of the other Loan Documents to be exercised by or vested in or conveyed to an agent or arranger with respect to the Incremental Loans, Permitted Credit Agreement Refinancing Debt or Loan Modification Agreement, as applicable, shall be exercisable by and vest in such Incremental Arranger, Refinancing Arranger or Loan Modification Agent to the extent, and only to the extent, necessary to enable such Incremental Arranger, Refinancing Arranger or Loan Modification Agent to exercise such rights, powers and privileges with respect to the Incremental Loans, Permitted Credit Agreement Refinancing Debt or Loan Modification Agreement, as applicable, and to perform such duties with respect to such Incremental Loans, Permitted Credit Agreement Refinancing Debt or Loan Modification Agreement, as applicable, and every covenant and obligation contained in the Loan Documents and necessary to the exercise or performance thereof by such Incremental Arranger, Refinancing Arranger or Loan Modification Agent shall run to and be enforceable by either the Administrative Agent or such Incremental Arranger, Refinancing Arranger or Loan Modification Agent, and (ii) the provisions of this Section 10 and of Section 11.5 (obligating the Borrower Representative to pay the Administrative Agent’s expenses and to indemnify the Administrative Agent) that refer to the Administrative Agent shall inure to the benefit of the Administrative Agent and such Incremental Arranger, Refinancing Arranger or Loan Modification Agent and all references therein to the Administrative Agent shall be deemed to be references to the Administrative Agent and/or such Incremental Arranger, Refinancing Arranger or Loan Modification Agent, as the context may require. Each Lender and Issuing Lender hereby irrevocably appoints any Incremental Arranger, Refinancing Arranger or Loan Modification Agent to act on its behalf hereunder and under the other Loan Documents pursuant to (and subject to) Sections 2.25, 2.26 and 2.28, as applicable, and designates and authorizes such Incremental Arranger, Refinancing Arranger or Loan Modification Agent to take such actions on its behalf under the provisions of this Agreement and each other Loan Document and to exercise such powers and perform such duties as are expressly delegated to such Incremental Arranger, Refinancing Arranger or Loan Modification Agent by the terms of this Agreement or any other Loan Document, together with such actions and powers as are reasonably incidental thereto.
10.oCertain ERISA Matters. (a)    Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and not, for the avoidance of doubt, to or for the benefit of the Borrowers or any other Loan Party, that at least one of the following is and will be true:
(i) such Lender is not using “plan assets” (within the meaning of Section 3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments or this Agreement,

(ii) the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender’s
192
    



entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,

(iii) (A) such Lender is an investment fund managed by a “Qualified Professional Asset Manager” (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender’s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or

(iv) such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.

(b) In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and not, for the avoidance of doubt, to or for the benefit of the Borrower or any other Loan Party, that the Administrative Agent is not a fiduciary with respect to the assets of such Lender involved in such Lender’s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).
SECTION 11.
MISCELLANEOUS
11.aAmendments and Waivers.
(i)Except as otherwise provided in clause (b) below or elsewhere in this Agreement, neither this Agreement nor any other Loan Document (or any terms hereof or thereof) may be amended, supplemented or modified other than in accordance with the provisions of this Section 11.1. The Required Lenders and each Loan Party party to the relevant Loan Document (or, in the case of this Agreement, the Borrower Representative) may, or, with the written consent of the Required Lenders, the Administrative Agent and each Loan Party party to the relevant Loan Document (or, in the case of this Agreement, the Borrower Representative) may, from time to time, (i) enter into written amendments, supplements or modifications hereto and to the other Loan Documents for the purpose of adding any provisions to this Agreement or the other Loan Documents or changing in any manner the rights of the Lenders or of the Loan Parties hereunder or thereunder or (ii) waive, on such terms and conditions as the Required Lenders or the Administrative Agent, as the case may be, may specify in such instrument, any of the requirements of this Agreement or the other Loan Documents or any Default or Event of Default and its consequences; provided, however, that no such waiver and no such amendment, supplement or modification shall (A) forgive the principal amount or extend the final scheduled date of maturity of any Loan, extend the scheduled date of any amortization payment in respect of any Term Loan, reduce the stated rate of any interest or fee payable hereunder (except (x) in connection with the waiver of applicability of any post-default increase in interest rates (which waiver shall be effective with the consent of the Required Lenders), (y) that any amendment or modification of defined terms used in the financial covenants in this Agreement shall not constitute a reduction in the rate of interest or fees for purposes of this clause (A) and (z) in connection with the waiver of the MFN Provision (which waiver shall be effective with the consent
193
    



of the Required Lenders)) or extend the scheduled date of any payment thereof, or increase the amount or extend the expiration date of any Lender’s Commitment or increase such Lender’s Commitment, in each case without the written consent of each Lender directly and adversely affected thereby; (B) amend, modify, eliminate or reduce the voting rights of any Lender under this Section 11.1 without the written consent of all Lenders; (C) (x) reduce any percentage specified in the definition of Required Lenders, (y) consent to the assignment or transfer by any Borrower of any of its rights and obligations under this Agreement and the other Loan Documents and (z) release all or substantially all of the Collateral or release all or substantially all of the value of the Guarantees under Section 8 of this Agreement or under any Security Agreement, in each case other than as permitted under this Agreement and the Loan Documents, without the written consent of all Lenders; (D) amend, modify or waive any provision of Section 2.17(a) or (b) which results in a change to the pro rata application of Loans under any Facility without the written consent of each Lender directly and adversely affected thereby in respect of each Facility adversely affected thereby, unless the amendment is made in connection with an amendment pursuant to paragraph (b) below, in which case the written consent of the Required Lenders shall be required; (E) reduce the percentage specified in the definition of any of Majority Revolving Lenders or Majority Term Lenders without the written consent of all Lenders under such Facility; (F) [reserved]; (G) amend, modify or waive any provision of Sections 2.6 or 2.7 without the written consent of the Swingline Lender; (H) amend or modify the application of prepayments set forth in Section 2.11(g) in a manner that adversely affects any Facility without the written consent of the Majority Facility Lenders of each adversely affected Facility; (I) forgive the principal amount or extend the payment date of any Reimbursement Obligation without the written consent of each Lender directly and adversely affected thereby; or (J) change the currency in which any Loan is denominated without the written consent of each Lender holding such Loan; and provided further that no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent in addition to the Lenders required above, amend, waive or modify Section 10 in a manner that adversely affects the rights or duties of the Administrative Agent under this Agreement; and provided further that no amendment, waiver or consent shall, unless in writing and signed by the applicable Issuing Lender in addition to the Lenders required above, adversely affect its rights or duties under this Agreement or under any Application or other document, agreement or instrument entered into by such Issuing Lender and a Borrower (or any Restricted Subsidiary) pertaining to one or more Letters of Credit issued or to be issued by such Issuing Lender hereunder (except that this Agreement may be amended (A) to adjust the mechanics related to the issuance of Letters of Credit, including mechanical changes relating to the existence of multiple Issuing Lenders, with only the written consent of the Administrative Agent, the applicable Issuing Lender and the Borrower Representative if the obligations of the Revolving Lenders, if any, who have not executed such amendment, and if applicable the other Issuing Lenders, if any, who have not executed such amendment, are not adversely affected thereby and (B) to adjust the L/C Sublimits of one or more Issuing Lenders after consultation with the Administrative Agent and any affected Issuing Lenders in a manner which does not result in the aggregate L/C Sublimits exceeding the L/C Commitment with only the written consent (with a copy to the Administrative Agent and any affected Issuing Lenders) of the Borrower Representative or those Issuing Lenders whose L/C Sublimits may be increased). Any such waiver and any such amendment, supplement or modification shall apply equally to each of the Lenders and shall be binding upon the Loan Parties, the Lenders, the Administrative Agent and all future holders of the Loans. In the case of any waiver, the Loan Parties, the Lenders and the Administrative Agent shall be restored to their former position and rights hereunder and under the other Loan Documents, and any Default or Event of Default waived shall be deemed to be cured and not continuing during the period such waiver is effective; but no such waiver shall, unless it expressly so permits, extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon.
(ii)Notwithstanding anything in this Agreement (including clause (a) above) or any other Loan Document to the contrary:
(1)this Agreement may be amended (or amended and restated) with the written consent of the Administrative Agent, the Issuing Lenders (to the extent affected), each Lender participating in the additional or extended credit facilities contemplated under this paragraph (b)(i) and the Borrower Representative (w) to add one or more additional credit facilities to this Agreement or to increase the amount of the existing facilities under this Agreement and to permit the extensions of credit from time to time outstanding thereunder and the accrued interest and fees in respect thereof to share ratably in the benefits of this Agreement and the other Loan Documents with the Term Loans and
194
    



Revolving Extensions of Credit and the accrued interest and fees in respect thereof, (x) to permit any such additional credit facility which is a term loan facility or any such increase in the Term Facility to share in prepayments with the Term Loans, (y) to permit any such additional credit facility which is a revolving loan facility or any such increase in the Revolving Facility to share ratably in prepayments with the Revolving Facility and (z) to include appropriately the Lenders holding such credit facilities in any determination of the Required Lenders and Majority Facility Lenders;
(2)this Agreement may be amended with the written consent of the Administrative Agent, the Borrower Representative and the Lenders providing the relevant Repriced Term Loans (as defined below) to permit a (x) any prepayment, repayment, refinancing, substitution or replacement of all or a portion of the Term Loans with the proceeds of, or any conversion of Term Loans into, any new or replacement tranche of syndicated term loans bearing interest with an Effective Yield less than the Effective Yield applicable to the Term Loans and (y) any amendment to the Term Loans or any tranche thereof which reduces the Effective Yield applicable to such Term Loans, as applicable (“Repriced Term Loans”); provided that the Repriced Term Loans shall otherwise meet the Applicable Requirements;
(3)this Agreement may be amended with the written consent of the Administrative Agent, the Borrower Representative and the Lenders providing the relevant Repricing Indebtedness to permit any Repricing Transaction;
(4)this Agreement and the other Loan Documents may be amended or amended and restated as contemplated by Section 2.25 in connection with any Incremental Amendment and any related increase in Commitments or Loans, with the consent of the Borrower Representative, the Administrative Agent and the Incremental Lenders providing such increased Commitments or Loans (provided that, if any Incremental Term Loans are intended to have rights to share in the Collateral on a second lien basis to the Obligations, then the Administrative Agent may enter into an Acceptable Intercreditor Agreement (or amend, supplement or modify an Acceptable Intercreditor Agreement) as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent, to effect the terms of any such Incremental Term Loans);
(5)this Agreement and the other Loan Documents may be amended as a Refinancing Amendment in connection with the incurrence of any Permitted Credit Agreement Refinancing Debt pursuant to Section 2.26 to the extent (but only to the extent) necessary to reflect the existence and terms of such Permitted Credit Agreement Refinancing Debt (including any amendments necessary to treat the Loans and Commitments subject thereto as Other Term Loans, Other Revolving Loans, Other Revolving Commitments and/or Other Term Commitments) (provided that the Administrative Agent and the Borrower Representative may effect such amendments to this Agreement, any Acceptable Intercreditor Agreement (or enter into a replacement thereof) and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower Representative, to effect the terms of such Refinancing Amendment);
(6)this Agreement and the other Loan Documents may be amended in connection with any Permitted Amendment pursuant to a Loan Modification Offer in accordance with Section 2.28(b) (and the Administrative Agent and the Borrower Representative may effect such amendments to this Agreement, any Intercreditor Agreement (or enter into a replacement thereof) and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower Representative, to effect the terms of such Permitted Amendment);
(7)the Administrative Agent may enter into or amend any Acceptable Intercreditor Agreement or any other intercreditor agreement (or enter into a replacement thereof), additional Security Documents and/or replacement Security Documents (including a collateral trust agreement) in connection with the incurrence of (x) any Permitted First Priority Refinancing Debt to provide that a Senior Representative acting on behalf of the holders of such Indebtedness shall become a party thereto and shall have rights to share in the Collateral on a pari passu basis (but without regard to the control of remedies) with the Obligations, (y) any Permitted Second Priority Refinancing Debt to provide that a Senior Representative acting on behalf of the holders of such Indebtedness shall become a
195
    



party thereto and shall have rights to share in the Collateral on a second lien basis to the Obligations and the obligations in respect of any Permitted First Priority Refinancing Debt or (z) any Indebtedness described in Section 10.11 to provide that an agent, trustee or other representative acting on behalf of the holders of such Indebtedness shall become a party thereto and shall have rights to share in the Collateral on the basis contemplated by this Agreement;
(8)only the consent of the Majority Revolving Lenders shall be necessary to amend, modify or waive Sections 5.2 (with respect to the making of Revolving Loans or Swingline Loans or the issuance of Letters of Credit), 7.1, 9.1(d), 9.3(b) and 9.4; it being understood and agreed that any Default or Event of Default resulting from the inaccuracy of any representation or warranty made in connection with the making of Revolving Loans or Swingline Loans or the issuance of Letters of Credit may be waived with the consent of only the Majority Revolving Lenders;
(9)amendments and waivers of this Agreement and the other Loan Documents that affect solely the Lenders under any applicable Class under the Term Facility, Revolving Facility or any Incremental Facility (including waiver or modification of conditions to extensions of credit under the Term Facility, Revolving Facility or any Incremental Facility, the availability and conditions to funding of any Incremental Facility, pricing and other modifications, and in respect of the Revolving Facility, the obligations of Holdings contained in Section 7.1 (or the definition of First Lien Net Leverage Ratio for purposes thereof)) will require only the consent of Lenders holding more than 50% of the aggregate commitments or loans, as applicable, under such Class, and, in each case, (x) no other consents or approvals shall be required and (y) any fees or other consideration payable to obtain such amendments or waivers need only be offered on a pro rata basis to the Lenders under the affected Class;
(10)this Agreement and the other Loan Documents may be amended with the consent of the Administrative Agent and the Borrower Representative (A) (1) to the extent permitted by Section 8.12(f) or to give effect to any limitations set forth in the Agreed Security Principles and (2) to add, amend, remove or otherwise modify, in connection with the designation or appointment of any Borrower hereunder after the Closing Date organized under the laws of any Applicable Jurisdiction other than the United States, England & Wales and Luxembourg, the provisions hereof and thereof that relate to Taxes, foreign guarantee and collateral matters (including guarantee limitations and “parallel debt”) and any other provisions that pertain specifically to the laws of any such jurisdiction or as are reasonably necessary in connection with such designation or appointment and upon the advice of counsel, (B) to correct any mistakes or ambiguities of a technical nature (or to conform any other Loan Document to be consistent with the requirements of the Credit Agreement), (C) to add any terms or conditions for the benefit of Lenders (or any Class thereof) and (D) as contemplated by Sections 1.6, 1.8, 2.16(b), 7.10, 10.10, 10.11, the definition of “Applicable Requirements”, “GAAP”, “Permitted Refinancing Requirements” or to give effect to any other provision specifying that any change, waiver or modification may be made with the consent or approval of the Administrative Agent;
(11)(1) in connection with any determination as to whether the requisite Lenders have (A) consented (or not consented) to any amendment or waiver of any provision of this Agreement or any other Loan Document or any departure by any Loan Party therefrom, (B) otherwise acted on any matter related to any Loan Document or (C) directed or required the Administrative Agent or any Lender to undertake any action (or refrain from taking any action) with respect to or under any Loan Document, any Lender (other than (x) any Lender that is a Regulated Bank and (y) any Revolving Lender) that, as a result of its interest in any total return swap, total rate of return swap, credit default swap or other derivative contract (other than any such total return swap, total rate of return swap, credit default swap or other derivative contract entered into pursuant to bona fide market making activities or bona fide hedging activities), has a net short position with respect to the Loans and/or Commitments on the date, if any, that such Lender consents to such amendment or waiver, otherwise acts, or directs or requires the Administrative Agent or any Lender to undertake any such action (or refrain from taking any such action) (each, a “Net Short Lender”), shall have no right to vote any of its Loans and Commitments and shall be deemed to have voted its interest as a Lender without discretion in the same proportion as the allocation of voting with respect to such matter by Lenders who are not Net Short Lenders (in each case unless otherwise agreed to by the Borrower Representative). For purposes of determining whether a Lender has a “net short position” on any date of determination: (i) derivative contracts with respect to the Loans, Commitments and such contracts that are the functional equivalent thereof shall be counted at the
196
    



notional amount thereof in Dollars, (ii) notional amounts in other currencies shall be converted to the dollar equivalent thereof by such Lender in a commercially reasonable manner consistent with generally accepted financial practices and based on the prevailing conversion rate (determined on a mid-market basis) on the date of determination, (iii) derivative contracts in respect of an index that includes any of the Borrowers or any other Loan Party or any instrument issued or guaranteed by any of the Borrowers or any other Loan Party shall not be deemed to create a short position with respect to the Loans and/or Commitments, so long as (x) such index is not created, designed, administered or requested by such Lender and (y) the Borrowers and other Loan Parties and any instrument issued or guaranteed by any of the Borrowers or any other Loan Party, collectively, shall represent less than 5% of the components of such index, (iv) derivative transactions that are documented using either the 2014 ISDA Credit Derivatives Definitions or the 2003 ISDA Credit Derivatives Definitions (collectively, the “ISDA CDS Definitions”) shall be deemed to create a short position with respect to the Loans and/or Commitments if such Lender is a protection buyer or the equivalent thereof for such derivative transaction and (x) the Loans and/or the Commitments of any of the Borrowers or any other Loan Party are a “Reference Obligation” under the terms of such derivative transaction (whether specified by name in the related documentation, included as a “Standard Reference Obligation” on the most recent list published by Markit, if “Standard Reference Obligation” is specified as applicable in the relevant documentation or in any other manner), (y) the Loans and/or the Commitments of any of the Borrowers or any other Loan Party would be a “Deliverable Obligation” under the terms of such derivative transaction or (z) any of the Borrowers or any other Loan Party (or any of their respective successors) is designated as a “Reference Entity” under the terms of such derivative transactions, (v) credit derivative transactions or other derivatives transactions not documented using the ISDA CDS Definitions shall be deemed to create a short position with respect to the Loans and/or Commitments if such transactions are functionally equivalent to a transaction that offers the Lender protection in respect of the Loans, the Commitments or as to the credit quality of any of the Borrowers or any other Loan Party (or any of their respective successors) other than, in each case, as part of an index so long as (x) such index is not created, designed, administered or requested by such Lender and (y) the Borrowers and other Loan Parties and any instrument issued or guaranteed by any of the Borrowers or any other Loan Party, collectively, shall represent less than 5% of the components of such index. In connection with any such determination, each Lender (other than (x) a Lender that is a Regulated Bank and (y) any Revolving Lender) shall promptly notify the Administrative Agent in writing that it is a Net Short Lender, or shall otherwise be deemed to have represented and warranted to the Borrower Representative and the Administrative Agent that it is not a Net Short Lender (it being understood and agreed that the Borrower Representative and the Administrative Agent shall be entitled to rely on each such representation and deemed representation).
(a)The Administrative Agent shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions hereof relating to Net Short Lenders. Without limiting the generality of the foregoing, the Administrative Agent shall not (x) be obligated to ascertain, monitor or inquire as to whether any Lender is a Net Short Lender or (y) have any liability with respect to or arising out of the voting in any amendment or waiver to any Loan Documents by any Net Short Lender.
11.bNotices. All notices, requests and demands to or upon the respective parties hereto to be effective shall be in writing (including by facsimile or email, if applicable), and, unless otherwise expressly provided herein, shall be deemed to have been duly given or made when delivered, or three Business Days after being deposited in the mail, postage prepaid, or, in the case of facsimile or email notice, when received, addressed as follows in the case of the Borrower Representative, any Borrower, the Guarantors and the Administrative Agent, and as set forth in an administrative questionnaire delivered to the Administrative Agent in the case of the Lenders, or to such other address as may be hereafter notified by the respective parties hereto:
197
    



To the Borrower Representative:
Camelot U.S. Acquisition LLC
1500 Spring Garden, 4th Floor
Philadelphia, PA 19130
Attention: Legal Department
Phone: 215-386-0100
To any Borrower or Guarantor:c/o the Borrower Representative at the address set forth above

To the Administrative Agent and Collateral Agent:

As set forth on Schedule 11.2.

provided, that any notice, request or demand to or upon the Administrative Agent or the Lenders shall not be effective until received. In no event shall a voice mail message be effective as a notice, communication or confirmation hereunder. All telephonic notices to the Administrative Agent may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording.
Notices and other communications to the Lenders hereunder may be delivered or furnished by electronic communications pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to notices pursuant to Section 2 unless otherwise agreed by the Administrative Agent and the applicable Lender (“Approved Electronic Communications”). The Administrative Agent or the Borrowers may, in their discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it; provided that approval of such procedures may be limited to particular notices or communications. Unless the Administrative Agent otherwise prescribes, (a) notices and other communications sent to an email address shall be deemed received upon the sender’s receipt of an acknowledgment from the intended recipient (such as by the “return receipt requested” function, as available, return email or other written acknowledgment), provided that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Business Day for the recipient, and (b) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its email address as described in the foregoing clause (a) of notification that such notice or communication is available and identifying the website address therefor.
Each Loan Party agrees to assume all risk, and hold the Administrative Agent, the Joint Bookrunners and each Lender harmless from any losses, associated with, the electronic transmission of information (including the protection of confidential information), except to the extent caused by the gross negligence or willful misconduct of such Person.
THE PLATFORM IS PROVIDED “AS IS” AND “AS AVAILABLE.” NEITHER THE ADMINISTRATIVE AGENT NOR ANY OF ITS RELATED PARTIES WARRANTS THE ACCURACY OR COMPLETENESS OF THE COMMUNICATIONS OR THE ADEQUACY OF THE PLATFORM AND EACH EXPRESSLY DISCLAIMS LIABILITY FOR ERRORS OR OMISSIONS IN THE COMMUNICATIONS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS IS MADE BY THE ADMINISTRATIVE AGENT OR ANY OF ITS RELATED PARTIES IN CONNECTION WITH THE COMMUNICATIONS OR THE PLATFORM. IN NO EVENT SHALL THE ADMINISTRATIVE AGENT OR ANY OF ITS RELATED PARTIES HAVE ANY LIABILITY TO ANY LOAN PARTY, ANY LENDER OR ANY OTHER PERSON FOR DAMAGES OF ANY KIND, WHETHER OR NOT BASED ON STRICT LIABILITY AND INCLUDING DIRECT OR INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES (WHETHER IN TORT, CONTRACT OR OTHERWISE) ARISING OUT OF ANY LOAN PARTY’S OR THE ADMINISTRATIVE AGENT’S TRANSMISSION OF COMMUNICATIONS THROUGH THE INTERNET, EXCEPT TO THE EXTENT THE LIABILITY OF ANY SUCH PERSON IS FOUND IN A FINAL RULING BY A
198
    



COURT OF COMPETENT JURISDICTION TO HAVE RESULTED PRIMARILY FROM SUCH PERSON’S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT.
Each Loan Party, the Lenders, the Issuing Lenders, the Joint Lead Arrangers, the Joint Bookrunners, the Incremental Facility Arrangers and the Administrative Agent agree that the Administrative Agent may, but shall not be obligated to, store any Approved Electronic Communications on the Platform in accordance with Administrative Agent’s customary document retention procedures and policies.
Each of the Borrowers, the Guarantors, the Administrative Agent, Issuing Lenders and Swingline Lender may change its address, facsimile or telephone number for notices and other communications hereunder by notice to the other parties hereto. Each other Lender may change its address, facsimile or telephone number for notices and other communications hereunder by notice to the Borrower Representative, the Administrative Agent, the Issuing Lenders and the Swingline Lender. In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, facsimile number and electronic mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender. Furthermore, each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the “Private Side Information” or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender’s compliance procedures and applicable Law, including United States Federal and state securities Laws, to make reference to documents or notices that are not made available through the “Public Side Information” portion of the Platform and that may contain Private Lender Information.
11.cNo Waiver; Cumulative Remedies. No failure to exercise and no delay in exercising, on the part of the Administrative Agent or any Lender, any right, remedy, power or privilege hereunder or under the other Loan Documents shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.
11.dSurvival of Representations and Warranties. All representations and warranties made hereunder, in the other Loan Documents and in any document, certificate or statement delivered pursuant hereto or in connection herewith shall survive the execution and delivery of this Agreement and the making of the Loans and other extensions of credit hereunder.
11.ePayment of Expenses. The Borrowers agree upon the occurrence of the Closing Date (a) to pay or reimburse the Joint Lead Arrangers, the Joint Bookrunners, the Incremental Facility Arrangers, the Issuing Lenders, the Swingline Lender, the Administrative Agent and the Collateral Agent (without duplication) for all their reasonable and documented out-of-pocket costs and expenses incurred in connection with the syndication of the Facilities and the development, preparation and execution of, and any amendment, supplement or modification to, this Agreement and the other Loan Documents and any other documents prepared in connection herewith or therewith, and the consummation and administration of the transactions contemplated hereby and thereby, including the reasonable fees and disbursements of one primary outside counsel to the Administrative Agent, the Collateral Agent, the Issuing Lenders, the Swingline Lender, the Joint Lead Arrangers, the Joint Bookrunners and the Incremental Facility Arrangers, taken as a whole, and one local counsel to the foregoing Persons, taken as a whole, in each appropriate jurisdiction (which may include one special counsel acting in multiple jurisdictions) (and additional counsel in the case of actual or perceived conflicts where such Person informs the Borrowers of such conflict and retains such counsel), and filing and recording fees and expenses, with statements with respect to the foregoing to be submitted to the Borrowers on or prior to the Closing Date (in the case of amounts to be paid on the Closing Date) and from time to time thereafter on a quarterly basis or such other periodic basis as the Administrative Agent shall deem appropriate, (b) to pay or reimburse each Lender, each Issuing Lender, the Swingline Lender, the Administrative Agent and the Collateral Agent for all of their reasonable and documented out-of-pocket costs and expenses (other than allocated costs of in-house counsel) incurred in connection with the workout, restructuring, enforcement
199
    



or preservation of any rights under this Agreement, the other Loan Documents and any such other documents, including the reasonable and documented fees and disbursements of one primary counsel to the Lenders, the Issuing Lenders, the Swingline Lender, the Administrative Agent, the Collateral Agent, the Joint Lead Arrangers, the Joint Bookrunners and the Incremental Facility Arrangers, taken as a whole, and one local counsel to the foregoing Persons, taken as a whole, in each appropriate jurisdiction (which may include one special counsel acting in multiple jurisdictions) (and in the case of an actual or perceived conflict of interest by any of the foregoing Persons, where such Person informs the Borrowers of such conflict and retains such counsel, additional counsel to such affected Person), (c) to pay, indemnify, and hold each Lender, each Issuing Lender, the Swingline Lender, the Administrative Agent and the Collateral Agent harmless from, any and all recording and filing fees that may be payable or determined to be payable in connection with the execution and delivery of, or consummation or administration of any of the transactions contemplated by, or any amendment, supplement or modification of, or any waiver or consent under or in respect of, this Agreement, the other Loan Documents and any such other documents, and (d) to pay, indemnify, and hold each Lender, each Issuing Lender, the Swingline Lender, the Administrative Agent, the Collateral Agent, each Joint Lead Arranger, each Joint Bookrunner, each Incremental Facility Arranger, each of their respective Affiliates that are providing services in connection with the financing contemplated by this Agreement and each member (and successors and assigns), officer, director, trustee, employee, agent and controlling person of the foregoing (each, an “Indemnitee”) harmless from and against any and all other claims, liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever with respect to or arising out of or in connection with the Transactions, the transactions contemplated hereby, any transactions connected therewith and the execution, delivery, enforcement, performance and administration of this Agreement, the other Loan Documents and any such other documents (regardless of whether any Indemnitee is a party hereto and regardless of whether any such matter is initiated by a third party, the Borrowers, any other Loan Party or any other Person), including any of the foregoing relating to the use of proceeds of the Loans or the violation of, noncompliance with or liability under, any Environmental Law relating to Holdings or any Group Member or any of the Properties and the reasonable fees and expenses of one primary legal counsel to the Indemnitees, taken as a whole (or in the case of an actual or perceived conflict of interest by an Indemnitee, where such Person informs the Borrowers of such conflict and retains such counsel, additional counsel to the affected Indemnitees), and one local counsel in each appropriate jurisdiction (which may include one special counsel acting in multiple jurisdictions) to the Indemnitees in connection with claims, actions or proceedings by any Indemnitee against any Loan Party under any Loan Document (all the foregoing in this clause (d), collectively, the “Indemnified Liabilities”) (but excluding any losses, liabilities, claims, damages, costs or expenses relating to the matters referred to in Sections 2.18, 2.19 and 2.21 (which shall be the sole remedy in respect of the matters set forth therein) (other than losses, liabilities, claims, damages, costs or expenses arising from any legal proceeding or other dispute over such Sections)), provided that the Borrowers shall not have any obligation hereunder to any Indemnitee with respect to Indemnified Liabilities to the extent such Indemnified Liabilities are (i) (A) found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from the gross negligence, bad faith or willful misconduct of such Indemnitee, (B) found by a final and nonappealable decision of a court of competent jurisdiction to have resulted from a material breach of the Loan Documents by such Indemnitee, (C) any dispute that does not involve an act or omission by the Borrowers, Holdings or any of their respective Affiliates and that is brought by any Indemnitee against any other Indemnitee (other than in its capacity as Administrative Agent, Collateral Agent, Joint Lead Arranger, Joint Bookrunner, Incremental Facility Arranger, Swingline Lender, Issuing Lender or similar role hereunder) or (D) directly and exclusively caused, with respect to the violation of, noncompliance with or liability under, any Environmental Law relating to any of the Properties, by the act or omissions by Persons other than the Group Members, Loan Parties or any of their respective Subsidiaries or their respective Related Parties with respect to the applicable Property that occur after the Administrative Agent sells the respective Property pursuant to a foreclosure or has accepted a deed in lieu of foreclosure or (ii) settlements entered into by such person without the Borrowers’ written consent (such consent to not be unreasonably withheld, conditioned or delayed). All amounts due under this Section 11.5 shall be payable not later than 10 days after written demand therefor. Statements payable by the Borrowers pursuant to this Section 11.5 shall be submitted to the Borrowers at the address of the Borrowers set forth in Section 11.2, or to such other Person or address as may be hereafter designated by the Borrowers in a written notice to the Administrative Agent. This Section 11.5 shall not apply with respect to Taxes (other than any Taxes that represent losses, claims or damages arising from any non-Tax claim). The agreements in this
200
    



Section 11.5 shall survive the termination of this Agreement and the repayment of the Loans and all other amounts payable hereunder.
11.fSuccessors and Assigns; Participations and Assignments.
(i)The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any affiliate of any Issuing Lender that issues any Letter of Credit), except that, other than as expressly permitted hereunder, no Borrower may assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender and the Administrative Agent (and any attempted assignment or transfer by any Borrower without such consent shall be null and void).
(ii)(i) Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one or more Eligible Assignees (each, an “Assignee”) all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans at the time owing to it and the Note or Notes (if any) held by it) with the prior written consent (such consent not to be unreasonably withheld, conditioned or delayed) of:
(i)in the case of any Term Lender (other than with respect to Incremental Term Loans and Incremental Term Commitments), any Revolving Lender or Incremental Term Lender (with respect to Incremental Term Loans and Incremental Term Commitments), the Borrower Representative, provided that such consent shall be deemed to have been given if the Borrower Representative has not responded within (x) 10 Business Days after notice by the Administrative Agent in respect of an assignment under the Revolving Facility and (y) 5 Business Days after notice by the Administrative Agent in respect of an assignment under the Term Facility, provided, further, that no consent of the Borrower Representative shall be required (x) in the case of the Revolving Facility, for an assignment to any existing Lender under the Revolving Facility or an Affiliate of an existing Lender under the Revolving Facility or, if a Specified Event of Default has occurred and is continuing, any other Eligible Assignee or (y) in the case of the Term Facility, for an assignment to a Lender, an Affiliate of a Lender, an Approved Fund (as defined below) or, if a Specified Event of Default has occurred and is continuing, any other Eligible Assignee;
(ii)except with respect to an assignment of Term Loans to an existing Lender, an Affiliate of a Lender or an Approved Fund, or an assignment under the Revolving Facility by any affiliate of Barclays Bank Ireland PLC to Barclays Bank Ireland PLC, the Administrative Agent (such consent not to be unreasonably withheld, conditioned or delayed); and
(iii)with respect to any proposed assignment of all or a portion of any Revolving Loan or Revolving Commitment other than an assignment under the Revolving Facility by any affiliate of Barclays Bank Ireland PLC to Barclays Bank Ireland PLC, the Swingline Lender and each Issuing Lender.
201
    



(1)Assignments shall be subject to the following additional conditions:
(i)except in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender’s Commitments or Loans under any Facility, the amount of the Commitments or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than (i) with respect to Term Loans, $1,000,000, and (ii) with respect to Revolving Loans and Revolving Commitments, $5,000,000 (provided that, in each case, that simultaneous assignments to or by two or more Approved Funds shall be aggregated for purposes of determining such amount) unless the Administrative Agent and, in the case of Term Loans (other than Incremental Term Loans), Revolving Commitments or Revolving Loans or Incremental Term Loans or Incremental Term Commitments, the Borrower Representative otherwise consents;
(ii)the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption via an electronic settlement system acceptable to the Administrative Agent (or, if previously agreed with the Administrative Agent, manually), and shall pay to the Administrative Agent a processing and recordation fee of $3,500 (which such fee may be waived or reduced in the sole discretion of the Administrative Agent) for each assignment or group of affiliated or related assignments (it being understood that such recordation fee shall not apply to any assignments by any of the Joint Lead Arrangers or any of their Affiliates); and
(iii)the Assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an administrative questionnaire and applicable Forms.
This paragraph (b) shall not prohibit any Lender from assigning all or any portion of its rights and obligations among separate Facilities on a non-pro rata basis.
For the purposes of this Section 11.6, “Approved Fund” means any Person (other than a natural person (or a holding company, investment vehicle or trust for or owned and operated by or for the primary benefit of one or more natural persons)) that is engaged in making, purchasing, holding or investing in bank loans and similar extensions of credit in the ordinary course and that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.
(2)Assignments to Permitted Auction Purchasers. Each Lender acknowledges that each Permitted Auction Purchaser is an Eligible Assignee hereunder and may purchase or acquire Term Loans hereunder from Lenders from time to time (x) pursuant to a Dutch Auction in accordance with the terms of this Agreement (including Section 11.6 hereof), subject to the restrictions set forth in the definitions of “Eligible Assignee” and “Dutch Auction” or (y) pursuant to open market purchases, in each case, subject to the following limitations:
202
    



(i)each Permitted Auction Purchaser agrees that, notwithstanding anything herein or in any of the other Loan Documents to the contrary, with respect to any Auction Purchase or other acquisition of Term Loans, (1) under no circumstances, whether or not any Loan Party is subject to a bankruptcy or other insolvency proceeding, shall such Permitted Auction Purchaser be permitted to exercise any voting rights or other privileges with respect to any Term Loans and any Term Loans that are assigned to such Permitted Auction Purchaser shall have no voting rights or other privileges under this Agreement and the other Loan Documents and shall not be taken into account in determining any required vote or consent and (2) such Permitted Auction Purchaser shall not receive information provided solely to Lenders by the Administrative Agent or any Lender and shall not be permitted to attend or participate in meetings attended solely by Lenders and the Administrative Agent and their advisors; rather, all Loans held by any Permitted Auction Purchaser shall be automatically Cancelled immediately upon the purchase or acquisition thereof in accordance with the terms of this Agreement (including Section 11.6 hereof);
(ii)at the time any Permitted Auction Purchaser is making purchases of Loans it shall enter into an Assignment and Assumption Agreement;
(iii)immediately upon the effectiveness of each Auction Purchase or other acquisition of Term Loans, a Cancellation (it being understood that such Cancellation shall not constitute a voluntary repayment of Loans for purposes of this Agreement) shall be automatically irrevocably effected with respect to all of the Loans and related Obligations subject to such Auction Purchase, with the effect that such Loans and related Obligations shall for all purposes of this Agreement and the other Loan Documents no longer be outstanding, and the Borrowers and the Guarantors shall no longer have any Obligations relating thereto, it being understood that such forgiveness and cancellation shall result in the Borrowers and the Guarantors being irrevocably and unconditionally released from all claims and liabilities relating to such Obligations which have been so cancelled and forgiven, and the Collateral shall cease to secure any such Obligations which have been so cancelled and forgiven; and
(iv)at the time of such Purchase Notice and Auction Purchase or other acquisition of Term Loans, (w) no Event of Default shall have occurred and be continuing, (x) Holdings, the Borrowers or any of their respective Affiliates shall not be required to make any representation that it is not in possession of material non-public information with respect to Holdings, the Borrowers, their respective subsidiaries or their respective securities, (y) any Affiliated Lender that is a Purchaser shall identify itself as such and (z) no
203
    



proceeds of Revolving Loans shall be used to consummate the Auction Purchase.
Notwithstanding anything to the contrary herein, this Section 11.6(b)(iii) shall supersede any provisions in Section 2.17 to the contrary.
(3)Assignments to Affiliated Lenders. Any Lender may, at any time, assign all or a portion of its rights and obligations with respect to the Term Loans to an Affiliated Lender through (x) Dutch Auctions open to all Lenders (or all Lenders of a particular Class) on a pro rata basis or (y) open market purchases, in each case subject to the following limitations:
(i)notwithstanding anything in Section 11.1 or the definition of “Required Lenders” to the contrary, for purposes of determining whether the Lenders have (1) consented to any amendment, waiver or modification of any Loan Document (including such modifications pursuant to Section 11.1), (2) otherwise acted on any matter related to any Loan Document, (3) directed or required the Administrative Agent or any Lender to undertake any action (or refrain from taking any action) with respect to or under any Loan Document, or (4) subject to Section 2.23, voted on any plan of reorganization pursuant to Title 11 of the United States Code, that in either case does not require the consent of each Lender or each affected Lender or does not adversely affect such Affiliated Lender disproportionately in any material respect as compared to other Lenders, the Sponsors and any Non-Debt Fund Affiliate will be deemed to have voted in the same proportion as Lenders that are not Affiliated Lenders voting on such matter; and the Sponsors and each Non-Debt Fund Affiliate each hereby acknowledges, agrees and consents that if, for any reason, its vote to accept or reject any plan pursuant to Title 11 of the United States Code) is not deemed to have been so voted, then such vote will be (x) deemed not to be in good faith and (y) “designated” pursuant to Section 1126(e) of Title 11 of the United States Code such that the vote is not counted in determining whether the applicable class has accepted or rejected such plan in accordance with Section 1126(c) of Title 11 of the United States Code; provided that, for the avoidance of doubt, Debt Fund Affiliates shall not be subject to such limitation and shall be entitled to vote as any other Lender; provided, further, that, notwithstanding the foregoing or anything herein to the contrary, Debt Fund Affiliates may not in the aggregate account for more than 49.9% of the amounts set forth in the calculation of Required Lenders and any amount in excess of 49.9% will be subject to the limitations set forth in this clause (A);
(ii)the Sponsors and Non-Debt Fund Affiliates shall not receive information provided solely to Lenders by the Administrative Agent or any Lender and shall not be permitted to attend or participate in meetings attended solely by Lenders and the Administrative Agent and their advisors, other than the right to receive notices of Borrowings, notices of prepayments and other
204
    



administrative notices in respect of its Loans or Commitments required to be delivered to Lenders pursuant to Section 2;
(iii)at the time any Affiliated Lender is making purchases of Loans pursuant to a Dutch Auction it shall identify itself as an Affiliated Lender and shall enter into an Assignment and Assumption Agreement;
(iv)with respect to a Dutch Auction, at the time of such Purchase Notice and Auction Purchase, no Affiliated Lender shall be required to make any representation that it is not in possession of material non-public information with respect to Holdings, the Borrowers, their respective Subsidiaries or their respective securities; and
(v)the aggregate principal amount of all Term Loans which may be purchased by the Sponsors or any Non-Debt Fund Affiliate through Dutch Auctions or assigned to the Sponsors or any Non-Debt Fund Affiliate through open market purchases shall in no event exceed, as calculated at the time of the consummation of any aforementioned Purchases or assignments, 25% of the aggregate Outstanding Amount of the Term Loans at such time.
Notwithstanding anything to the contrary herein, this Section 11.6(b)(iv) shall supersede any provisions in Section 2.17 to the contrary.
(4)Subject to acceptance and recording thereof pursuant to Section 11.6(b)(vii) below, from and after the effective date specified in each Assignment and Assumption the Assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Sections 2.18, 2.19, 2.21 and 11.5). Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this Section 11.6(b) shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations if such transaction complies with the requirements of Section 11.6(c).
(5)The Administrative Agent, acting for this purpose as an agent of the Borrowers, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amount of (and any stated interest on) the Loans and L/C Obligations owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive, and the Borrowers, the Administrative Agent and the Lenders may treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by any Borrower and any Lender as to its own Commitments and amounts owing to it (and, in the case of any Issuing Lender, as to the identity of each other Revolving Lender), at any reasonable time and from time to time upon reasonable prior notice (but not to exceed once per calendar month), and to the extent otherwise necessary to establish that the Commitments, Loans, L/C Obligations or other obligations under the Loan Documents are in registered form under Sections 5f.103-1(c) and 1.871-14(c) of the United States Treasury Regulations.
(6)Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an Assignee, the Assignee’s completed administrative questionnaire
205
    



and applicable Forms (unless the Assignee shall already be a Lender hereunder), together with (x) any processing and recordation fee and (y) any written consent to such assignment required by Section 11.6(b), the Administrative Agent shall promptly accept such Assignment and Assumption and record the information contained therein in the Register. No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph.
(7)If, other than in the course of primary syndication, a Lender assigns any of its rights or obligations under this Section 11.6 and as a result of circumstances existing at the date the assignment occurs, a Loan Party would be obliged to make a payment with respect to non-U.S. Taxes to the assignee under Section 2.19(a) or Section 2.19(f) then the assignee is only entitled to receive payment under Section 2.19(a) or Section 2.19(f) with respect to such non-U.S. Taxes to the same extent as the assigning Lender would have been if the assignment had not occurred.
(iii)(i) Any Lender may, without the consent of the Borrowers or the Administrative Agent, sell participations to one or more banks or other entities (other than a Disqualified Lender, natural person, a Defaulting Lender, Holdings or any Subsidiary of Holdings) (a “Participant”) in all or a portion of such Lender’s rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans owing to it); provided that (A) such Lender’s obligations under this Agreement shall remain unchanged, (B) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (C) the Borrowers, the Administrative Agent, the Issuing Lenders and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement. Any agreement pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; provided that such agreement may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver that (1) requires, subject to Section 11.1(b), the consent of each Lender directly affected thereby pursuant to clauses (A) and (C) of Section 11.1(a) and (2) directly affects such Participant. Subject to Section 11.6(c)(ii), the Borrowers agree that each Participant shall be entitled to the benefits of Sections 2.18, 2.19 and 2.21 (subject to the requirements of those sections) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to Section 11.6(b). To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 11.8(b) as though it were a Lender, provided such Participant shall be subject to Section 11.8(a) as though it were a Lender. Each Lender that sells a participation shall, acting solely for U.S. federal income tax purposes as an agent of the Borrowers, maintain a register on which it enters the name and address of each Participant and the commitment of, and the principal amounts (and stated interest) of, each Participant’s interest in the Loans, L/C Obligations or other obligations under the Loan Documents (the “Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Person (including the identity of any Participant or any information relating to a Participant’s interest in any Commitments, Loans, L/C Obligations or its other obligations under any Loan Document) except to the extent that the relevant parties, acting reasonably and in good faith, determine that such disclosure is necessary to establish that such Commitment, Loan, L/C Obligation or other obligation is in registered form under Sections 5f.103-1(c) and 1.871-14(c) of the United States Treasury Regulations. Unless otherwise required by the Internal Revenue Service (“IRS”), any disclosure required by the foregoing sentence shall be made by the relevant Lender directly and solely to the IRS. The entries in the Participant Register shall be conclusive, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.
(1)A Participant shall not be entitled to receive any greater payment under Section 2.18 or 2.19 than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant. No Participant shall be entitled to the benefits of Section 2.19 unless such Participant complies with Sections 2.19(j), 2.19(k), 2.19(m) and 2.19(o).
(iv)Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or any other central bank, and this Section shall not apply to any such pledge or assignment of a security interest; provided that no such pledge or assignment of a
206
    



security interest shall release a Lender from any of its obligations hereunder or substitute any such pledgee or Assignee for such Lender as a party hereto.
(v)The Borrowers, upon receipt of written notice from the relevant Lender, agree to issue Notes to any Lender requiring Notes to facilitate transactions of the type described in Section 11.6(d) above.
(vi)[Reserved].
(vii)Each Lender, upon succeeding to an interest in Commitments or Loans, as the case may be, represents and warrants as of the effective date of the applicable Assignment and Assumption that it is an Eligible Assignee.
(viii)In case of assignment, transfer or novation by a Lender to a new lender or Participant, of all or any part of its rights and obligations under this Agreement, the Lenders and the new lender or Participant shall agree that, for the purposes of Article 1278 and/or Article 1281 of the Luxembourg Civil Code (to the extent applicable), any assignment, amendment, transfer and/or novation of any kind permitted under, and made in accordance with the provisions of the Agreement or any agreement referred to herein to which a Luxembourg Loan Party is a party (including any Security Document), any security created or guarantee given under the Agreement or in relation to the Agreement shall be preserved and continue in full force and effect to the benefit of the new lender or participant.
(ix)Each Spanish Loan Party hereby expressly consents to each assignment, transfer and/or novation of rights or obligations made in accordance with this Section 11.6 (Successors and Assigns; Participations and Assignments). Each Spanish Borrower and Spanish Guarantor also accepts and confirms, for the purposes of the Spanish Civil Code and all other purposes, that all guarantees, indemnities and, if applicable any security interests granted by it under any Loan Document and/or Security Documents will, notwithstanding any such assignment, transfer or novation, continue and be preserved for the benefit of the new lender and each of the other Loan Parties in accordance with the terms of the Loan Documents, expressly waiving any right the Spanish Loan Party may have in the future under Article 1535 of the Spanish Civil Code to any extent it may be applicable.
11.g[Reserved].
11.hAdjustments; Set-off.
(i)Except to the extent that this Agreement expressly provides for or permits payments to be allocated or made to a particular Lender or to the Lenders under a particular Facility, if any Lender (a “Benefited Lender”) shall receive any payment of all or part of the Obligations owing to it under any Facility, or receive any collateral in respect thereof (whether voluntarily or involuntarily, by set-off, pursuant to events or proceedings of the nature referred to in Section 9.1(g) or otherwise), in a greater proportion than any such payment to or collateral received by any other Lender, if any, in respect of the Obligations owing to such other Lender under such Facility, such Benefited Lender shall purchase for cash from the other Lenders under such Facility a participating interest in such portion of the Obligations owing to each such other Lender, or shall provide such other Lenders with the benefits of any such collateral, as shall be necessary to cause such Benefited Lender to share the excess payment or benefits of such collateral ratably with each of the Lenders under such Facility; provided, however, that if all or any portion of such excess payment or benefits is thereafter recovered from such Benefited Lender, such purchase shall be rescinded, and the purchase price and benefits returned, to the extent of such recovery, but without interest.
(ii)In addition to any rights and remedies of the Lenders provided by law, each Lender shall have the right, with the prior consent of the Administrative Agent, without prior notice to Holdings or any Borrower or any other Loan Party, any such notice being expressly waived by Holdings and the Borrowers and each other Loan Party to the extent permitted by applicable law, upon the occurrence and during the continuance of any Event of Default, to set off and appropriate and apply against the Obligations any and all deposits (general or special, time or demand, provisional or final), in any currency, and any other credits, indebtedness or claims, in any currency, in each case whether direct or
207
    



indirect, absolute or contingent, matured or unmatured, at any time held or owing by such Lender or any branch or agency thereof to or for the credit or the account of Holdings or the Borrowers or any such other Loan Party, as the case may be. Each Lender agrees promptly to notify the Borrowers and the Administrative Agent after any such setoff and application made by such Lender, provided that the failure to give such notice shall not affect the validity of such setoff and application.
11.i[Reserved].
11.jCounterparts; Electronic Execution.
(i)This Agreement may be executed by one or more of the parties to this Agreement on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Agreement or any document or instrument delivered in connection herewith by facsimile transmission or electronic PDF shall be effective as delivery of a manually executed counterpart of this Agreement or such other document or instrument, as applicable. A set of the copies of this Agreement signed by all the parties shall be lodged with the Borrower Representative and the Administrative Agent.
(ii)The words “execute,” “execution,” “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including without limitation Assignment and Assumptions, amendments or other modifications, notices, waivers and consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Administrative Agent, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; provided that notwithstanding anything contained herein to the contrary the Administrative Agent is under no obligation to agree to accept electronic signatures in any form or in any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it or pursuant to the Records Act or any other similar state laws based on the Uniform Electronic Transactions Act.
11.kSeverability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.
11.lIntegration. This Agreement, the other Loan Documents and any separate letter agreements with respect to fees payable to the Joint Lead Arrangers, the Joint Bookrunners, the Incremental Facility Arrangers and the Administrative Agent represent the entire agreement of the Borrowers, the Guarantors, the Administrative Agent and the Lenders with respect to the subject matter hereof and thereof, and there are no promises, undertakings, representations or warranties by the Administrative Agent or any Lender relative to the subject matter hereof not expressly set forth or referred to herein or in the other Loan Documents.
11.mGoverning Law. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THAT WOULD REQUIRE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION.
11.nSubmission To Jurisdiction; Waivers. Each party hereto hereby irrevocably and unconditionally:
208
    



(i)submits for itself and its property in any legal action or proceeding relating to this Agreement and the other Loan Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the exclusive general jurisdiction of the courts of the State of New York sitting in the borough of Manhattan in New York City, the courts of the United States for the Southern District of New York, and appellate courts from any thereof, to the extent such courts would have subject matter jurisdiction with respect thereto, and agrees that notwithstanding the foregoing (x) a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law and (y) legal actions or proceedings brought by the Secured Parties in connection with the exercise of rights and remedies with respect to Collateral may be brought in other jurisdictions where such Collateral is located or such rights or remedies may be exercised;
(ii)consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court and waives any right to claim that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same;
(iii)CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN SECTION 11.2. EACH FOREIGN LOAN PARTY HEREBY IRREVOCABLY APPOINTS THE BORROWER REPRESENTATIVE AS ITS AS ITS AUTHORIZED AGENT TO ACCEPT AND ACKNOWLEDGE SERVICE OF ANY AND ALL PROCESS WHICH MAY BE SERVED IN ANY SUIT, ACTION OR PROCEEDING OF THE NATURE REFERRED TO IN THIS SECTION 11.14 AND THE BORROWER REPRESENTATIVE HEREBY ACCEPTS SUCH APPOINTMENT. EACH FOREIGN LOAN PARTY AGREES THAT SUCH SERVICE (I) SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF PROCESS UPON IT IN ANY SUCH SUIT, ACTION OR PROCEEDING AND (II) SHALL, TO THE FULLEST EXTENT PERMITTED BY LAW, BE TAKEN AND HELD TO BE VALID PERSONAL SERVICE UPON AND PERSONAL DELIVERY TO IT;
(iv)agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or limit the right of any Lender to bring proceedings against any Foreign Loan Party in the courts of any jurisdiction or jurisdictions; and
(v)waives, to the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or proceeding arising out of, in connection with, or as a result of, this Agreement or any agreement or instrument contemplated hereby, the Transactions, the Amendment No. 1 Incremental Facility Transactions, the Amendment No. 2 Incremental Facility Transactions, any Loan or Letter of Credit or the use of the proceeds thereof, any special, exemplary, punitive or consequential damages against any Indemnitee.
11.oAcknowledgements. Each of the Borrowers and Guarantors hereby acknowledges that:
(i)it has been advised by counsel in the negotiation, execution and delivery of this Agreement and the other Loan Documents;
(ii)neither the Administrative Agent nor any Lender has any fiduciary relationship with or duty to the Borrowers or any Guarantor arising out of or in connection with this Agreement or any of the other Loan Documents, and the relationship between the Administrative Agent and Lenders, on one hand, and the Borrowers and each Guarantor, on the other hand, in connection herewith or therewith is solely that of debtor and creditor; and
(iii)no joint venture is created hereby or by the other Loan Documents or otherwise exists by virtue of the transactions contemplated hereby among the Lenders or among Holdings, the Borrowers or the Guarantors and the Lenders.
11.pAcknowledgement and Consent to Bail-In of EEA Financial Institutions. Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA
209
    



Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to Write-Down and Conversion Powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:
(i)the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution; and
(1)the effects of any Bail-in Action on any such liability, including, if applicable:
(2)a reduction in full or in part or cancellation of any such liability;
(3)a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or
the variation of the terms of such liability in connection with the exercise of the Write-Down and Conversion Powers of any EEA Resolution Authority.
11.qConfidentiality. Each of the Administrative Agent and each Lender agrees to keep confidential all non-public information provided to it by any Loan Party, the Administrative Agent or any Lender pursuant to or in connection with this Agreement that is not designated by the provider thereof as public information or non-confidential; provided that nothing herein shall prevent the Administrative Agent or any Lender from disclosing any such information (a) to the Administrative Agent, the Joint Lead Arrangers, the Joint Bookrunners, the Incremental Facility Arrangers, any other Lender or any Affiliate thereof, (b) subject to an agreement to comply with provisions no less restrictive than this Section, to any actual or prospective Transferee or any direct or indirect counterparty to any Swap Agreement (or any professional advisor to such counterparty) (other than Disqualified Lenders), (c) to its employees, officers, directors, trustees, agents, attorneys, accountants and other professional advisors and to the employees, officers, directors, trustees, agents, attorneys, accountants and other professional advisors of its Affiliates or of actual or prospective Transferees that, in each case, have been advised of the provisions of this Section and have been instructed to keep such information confidential, (d) upon the request or demand of any Governmental Authority or any self-regulatory authority having or asserting jurisdiction over such Person (including any Governmental Authority regulating any Lender or its Affiliates), in which case, to the extent permitted by law, you agree to inform the Borrowers promptly thereof prior to such disclosure to the extent practicable (except with respect to any routine audit or examination conducted by bank accountants or any governmental bank regulatory authority exercising examination or regulatory authority), (e) in response to any order of any court or other Governmental Authority or as may otherwise be required pursuant to any Requirement of Law, in which case, to the extent permitted by law, you agree to inform the Borrowers promptly thereof (except with respect to any routine audit or examination conducted by bank accountants or any governmental bank regulatory authority exercising examination or regulatory authority), (f) if requested or required to do so in connection with any litigation or similar proceeding, in which case, to the extent permitted by law, you agree to inform the Borrowers promptly thereof (except with respect to any audit or examination conducted by bank accountants or any governmental bank regulatory authority exercising examination or regulatory); provided that unless specifically prohibited by applicable law, reasonable efforts shall be made to notify the Borrowers of any such request prior to disclosure, (g) that has been publicly disclosed other than as a result of a breach of this Section, (h) to the National Association of Insurance Commissioners or any similar organization or any nationally recognized rating agency that requires access to information about a Lender’s investment portfolio in connection with ratings issued with respect to such Lender; provided, such Person has been advised of the provisions of this Section and instructed to keep such information confidential, (i) to market data collectors and service providers to the Administrative Agent or any Lender in connection with the administration and management of the Facilities, (j) to the extent that such information is or was received by the Administrative Agent or any Lender from a third party that is not to the knowledge of the Administrative Agent, such Lender or any affiliates thereof subject to confidentiality obligations owing to
210
    



any Loan Party, the Sponsors or any of their respective subsidiaries or (k) in connection with the exercise of any remedy hereunder or under any other Loan Document. In addition, the Administrative Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry, and service providers to the Administrative Agent and the Lenders in connection with the administration and management of this Agreement, the other Loan Documents, the Commitments, and the extensions of credit hereunder. Notwithstanding anything herein to the contrary, any party to this Agreement (and any employee, officer, representative, or other agent of any party to this Agreement) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the transactions contemplated by this Agreement and all materials of any kind (including opinions or other tax analyses) that are provided to it relating to such tax treatment and tax structure. However, any such information relating to the tax treatment or tax structure is required to be kept confidential to the extent necessary to comply with any applicable federal or state securities laws.
11.rWaivers Of Jury Trial. EACH OF THE BORROWERS, THE GUARANTORS, THE ADMINISTRATIVE AGENT AND THE LENDERS HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVE TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN.
11.sUSA Patriot Act Notification. Each Lender that is subject to the Patriot Act or the Beneficial Ownership Regulation and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrowers that pursuant to the requirements of the USA Patriot Act, it is required to obtain, verify and record information that identifies the Borrowers and each other Loan Party, which information includes the name and address of the Borrowers and each other Loan Party and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrowers and each other Loan Party in accordance with the Patriot Act.  The Borrowers and each other Loan Party shall, promptly following a request by the Administrative Agent or any Lender, provide all documentation and other information that the Administrative Agent or such Lender requests in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act and the Beneficial Ownership Regulation.
11.tMaximum Amount.
(i)It is the intention of the Borrowers and the Lenders to conform strictly to the usury and similar laws relating to interest from time to time in force, and all agreements between the Loan Parties and their respective Subsidiaries and the Lenders, whether now existing or hereafter arising and whether oral or written, are hereby expressly limited so that in no contingency or event whatsoever, whether by acceleration of maturity hereof or otherwise, shall the amount paid or agreed to be paid in the aggregate to the Lenders as interest (whether or not designated as interest, and including any amount otherwise designated but deemed to constitute interest by a court of competent jurisdiction) hereunder or under the other Loan Documents or in any other agreement given to secure the Indebtedness evidenced hereby or other Obligations of the Borrowers, or in any other document evidencing, securing or pertaining to the Indebtedness evidenced hereby, exceed the maximum amount permissible under applicable usury or such other laws (the “Maximum Amount”). If under any circumstances whatsoever fulfillment of any provision hereof, or any of the other Loan Documents, at the time performance of such provision shall be due, shall involve exceeding the Maximum Amount, then, ipso facto, the obligation to be fulfilled shall be reduced to the Maximum Amount. For the purposes of calculating the actual amount of interest paid and/or payable hereunder in respect of laws pertaining to usury or such other laws, all sums paid or agreed to be paid to the holder hereof for the use, forbearance or detention of the Indebtedness of the Borrowers evidenced hereby, outstanding from time to time shall, to the extent permitted by Applicable Law, be amortized, pro-rated, allocated and spread from the date of disbursement of the proceeds of the Loans until payment in full of all of such Indebtedness, so that the actual rate of interest on account of such Indebtedness is uniform through the term hereof. The terms and provisions of this Section 11.20(a) shall control and supersede every other provision of all agreements between the Borrowers or any endorser of the Loans and the Lenders.
211
    



(ii)If under any circumstances any Lender shall ever receive an amount which would exceed the Maximum Amount, such amount shall be deemed a payment in reduction of the principal amount of the Loans and shall be treated as a voluntary prepayment under Section 2.10 and shall be so applied in accordance with Section 2.17 or if such excessive interest exceeds the unpaid balance of the Loans and any other Indebtedness of the Borrowers in favor of such Lender, the excess shall be deemed to have been a payment made by mistake and shall be refunded to the Borrowers.
11.uLender Action. Each Lender agrees that it shall not take or institute any actions or proceedings, judicial or otherwise, for any right or remedy against any Loan Party or any other obligor under any of the Loan Documents (including, except as set forth in Section 11.8(b), the exercise of any right of setoff, rights on account of any banker’s lien or similar claim or other rights of self-help), or institute any actions or proceedings, or otherwise commence any remedial procedures, with respect to any Collateral or any other property of any such Loan Party, unless expressly provided for herein or in any other Loan Document, without the prior written consent of the Administrative Agent. The provisions of this Section 11.21 are for the sole benefit of the Lenders and shall not afford any right to, or constitute a defense available to, any Loan Party.
11.vNo Fiduciary Duty. Each of the Administrative Agent, the Joint Bookrunners, the Joint Lead Arrangers, the Incremental Facility Arrangers, each Lender and their Affiliates (collectively, solely for purposes of this paragraph, the “Lenders”), may have economic interests that conflict with those of the Loan Parties, their stockholders and/or their Affiliates. Each Loan Party agrees that nothing in the Loan Documents or otherwise will be deemed to create an advisory, fiduciary or agency relationship or fiduciary or other implied duty between any Lender, on the one hand, and such Loan Party, its stockholders or its Affiliates, on the other, except as otherwise explicitly provided herein. The Loan Parties acknowledge and agree that (i) the transactions contemplated by the Loan Documents (including the exercise of rights and remedies hereunder and thereunder) are arm’s-length commercial transactions between the Lenders, on the one hand, and the Loan Parties, on the other, and (ii) in connection therewith and with the process leading thereto, (x) no Lender has assumed an advisory or fiduciary responsibility in favor of any Loan Party, its stockholders or its Affiliates with respect to the transactions contemplated hereby (or the exercise of rights or remedies with respect thereto) or the process leading thereto (irrespective of whether any Lender has advised, is currently advising or will advise any Loan Party, its stockholders or its Affiliates on other matters) or any other obligation to any Loan Party except the obligations expressly set forth in the Loan Documents and (y) each Lender is acting solely as principal and not as the agent or fiduciary of any Loan Party, its management, stockholders, creditors or any other Person, except as otherwise explicitly provided herein. Each Loan Party acknowledges and agrees that it has consulted its own legal and financial advisors to the extent it deemed appropriate and that it is responsible for making its own independent judgment with respect to such transactions and the process leading thereto. Each Loan Party agrees that it will not claim that any Lender has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to such Loan Party, in connection with such transaction or the process leading thereto.
11.w[Reserved].
11.xConduct of Business by the Lenders. No provision of this Agreement will (a) interfere with the right of any Lender to arrange its affairs (tax or otherwise) in whatever manner it thinks fit or (b) oblige any Lender to investigate or claim any credit, relief, remission or repayment available to it or the extent, order and manner of any claim.
11.yAcknowledgment Regarding Any Supported QFCs. To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Swap Agreement or any other agreement or instrument that is a QFC (such support, “QFC Credit Support”, and each such QFC, a “Supported QFC”), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the “U.S. Special Resolution Regimes”) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and/or of the United States or any other state of the United States). In the event a Covered Entity that is party to a
212
    



Supported QFC (each, a “Covered Party”) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.

SECTION 12.
CO-BORROWER ARRANGEMENTS AND BORROWER REPRESENTATIVE
12.aAddition of Additional Revolving Borrowers. From time to time on or after the Closing Date, the Borrower Representative may designate one or more of the Restricted Subsidiaries as an “Additional Revolving Borrower” with respect to Revolving Borrowings under this Agreement; provided that such Restricted Subsidiary designated after the Closing Date shall not become an Additional Revolving Borrower hereunder unless and until each of the following has occurred:
(i)the Administrative Agent and the Revolving Lenders shall have received all documentation and other information that the Administrative Agent reasonably determines to be required by Governmental Authorities under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act;
(ii)such Additional Revolving Borrower shall be organized in an Applicable Jurisdiction;
(iii)such Additional Revolving Borrower shall have delivered to the Administrative Agent a duly authorized, executed and delivered counterpart signature page to a Borrower Joinder and a Guarantor Joinder Agreement; provided that such Borrower Joinder and, if necessary, such Guarantor Joinder Agreement will incorporate any provisions specific to the designated Additional Revolving Borrower’s jurisdiction of organization and applicable Laws of such jurisdiction of organization;
(iv)the Additional Revolving Borrower shall have delivered to the Administrative Agent a duly authorized, executed and delivered Security Agreement pursuant to Section 6.9 or other security agreements executed and delivered pursuant to Section 6.9, Section 6.11, Section 6.15 or Schedule 1.1C (as such schedule may be amended or supplemented from time to time in accordance with the Agreed Security Principles), together with other deliverables reasonably required pursuant to such Section as applied to such Additional Revolving Borrower (it being understood and agreed that the Administrative Agent and the Borrower Representative may waive or modify any such requirements to the extent they deem in their mutual discretion such changes are necessary or appropriate under the circumstances taking into account the designated Additional Revolving Borrower’s jurisdiction of organization and applicable Laws);
(v)the Administrative Agent shall have received, on behalf of itself and the Lenders, an opinion of counsel (local and/or New York, depending on the circumstances and the relevant market standard), in form and substance reasonably satisfactory to the Administrative Agent with respect to the foregoing documents; and
(vi)the Administrative Agent shall have received (i) a copy of the Organizational Documents, including all amendments thereto, of such designated Additional Revolving Borrower, certified, if
213
    



applicable, as of a recent date by the Secretary of State or similar Governmental Authority of the jurisdiction of its organization, where applicable, and, if applicable, a certificate as to the good standing of such designated Additional Revolving Borrower as of a recent date, from such Secretary of State or similar Governmental Authority, and (ii) a certificate of the Secretary or Assistant Secretary (or, in lieu thereof, director(s) authorized to sign on behalf of the designated Additional Revolving Borrower) of such designated Additional Revolving Borrower certifying (A) that attached thereto is a true and complete copy of the Organizational Documents of such Person as in effect on the date of the Additional Revolving Borrower Joinder, (B) that attached thereto is a true and complete copy of resolutions duly adopted by the board of directors or shareholders (or equivalent governing body) of such Person authorizing the execution, delivery and performance of the Loan Documents and the borrowings thereunder and that such resolutions have not been modified, rescinded or amended and are in full force and effect, (C) that Organizational Documents of such Person have not been amended since the date of the last amendment thereto shown on the Organizational Documents furnished pursuant to clause (i) above, and (D) as to the incumbency and specimen signature of each officer executing any Loan Document on behalf of such Person and countersigned by another officer as to the incumbency and specimen signature of the Secretary, Assistant Secretary or director of such Person executing the certificate pursuant to clause (ii) above.
12.bStatus of Borrowers.
(i)An Additional Revolving Borrower designated in accordance with Section 12.1 shall be a “Revolving Borrower” and a “Borrower” under the Revolving Facility and will have the right to directly request Revolving Borrowings in accordance with Section 2 hereof until the earlier to occur of the Revolving Termination Date or the date on which such Additional Revolving Borrower terminates its obligations under this Agreement in accordance with Section 12.3 or the date on which such Additional Revolving Borrower is released from its obligations under the Loan Documents in accordance with this Agreement.
(ii)Each Term Borrower hereby accepts joint and several liability hereunder with respect to the Term Loans and under the other Loan Documents in consideration of the financial accommodations with respect to the Term Loans to be provided by Lenders under this Agreement and the other Loan Documents, for the mutual benefit, directly and indirectly, of each Term Borrower and in consideration of the undertakings of each Term Borrower to accept joint and several liability for the Term Loans. Each Term Borrower, jointly and severally, hereby irrevocably and unconditionally accepts, not merely as a surety but also as a co-debtor, joint and several liability with each other such Term Borrower, with respect to the payment of the Term Loans, it being the intention of the parties hereto that the Term Loans shall be the joint and several obligations of the Term Borrowers without preferences or distinction among them. If and to the extent that any of the Term Borrowers shall fail to make any payment with respect to any of the Term Loans as and when due, then in each such event each other Term Borrower will make such payment with respect to the Term Loans.
(iii)For the avoidance of doubt, each Additional Revolving Borrower shall be liable solely for its direct Revolving Borrowings and interest and any Letter of Credit fees in respect of Letters of Credit requested by such Additional Revolving Borrower and any reimbursement obligations to the Administrative Agent, the Swingline Lender, the Issuing Lenders and the Lenders that may arise in respect of the foregoing, and no Additional Revolving Borrower in its capacity as such shall have any direct liability whatsoever for any of the Obligations of the Borrowers or any other Additional Revolving Borrower. Notwithstanding the term “Additional Revolving Borrower”, which is used for convenience only, under no circumstance shall any Additional Revolving Borrower in its capacity as such be deemed to be jointly and severally liable for the Obligations of any other Loan Party under any Loan Document. Notwithstanding anything to the contrary set forth in this Section 12.2(c), this Section 12.2(c) shall in no way limit the obligations of such Additional Revolving Borrower under the Guarantee.
12.cResignation of Additional Revolving Borrowers. An Additional Revolving Borrower may elect to terminate its eligibility to request Borrowings and to cease to be an Additional Revolving Borrower hereunder upon the occurrence of, and such resignation shall be effective upon, all of the following:
214
    



(i)such resigning Additional Revolving Borrower shall have paid in full in cash all of its direct Obligations under the Revolving Facility; and
(ii)such resigning Additional Revolving Borrower shall have delivered to the Administrative Agent a notice of resignation in form and substance reasonably satisfactory to the Administrative Agent; provided, however, that such resignation shall not, to the extent applicable, have any impact on such Person’s obligations as a Subsidiary Guarantor and such obligations, to the extent applicable, shall continue to be effective in accordance with Section 8 of this Agreement and the other provisions and undertakings hereunder related thereto.
12.dAppointment of Borrower Representative; Nature of Relationship. As of the Amendment No. 5 Effective Date, Camelot U.S. Acquisition LLC., a Delaware limited liability company, had been appointed by each of the other Borrowers as its contractual representative, and the Borrowers may appoint a different or additional contractual representative from time to time, subject to the Administrative Agent’s consent (such consent not be unreasonably withheld or delayed) (herein referred to as the “Borrower Representative”) hereunder and under each other Loan Document, and each of the other Borrowers irrevocably authorizes the Borrower Representative to act as the contractual representative of such Borrower with the rights and duties expressly set forth herein and in the other Loan Documents.
The Borrower Representative agrees to act as such contractual representative upon the express conditions contained in this Section 12. Additionally, the Borrowers hereby appoint the Borrower Representative as their agent to receive and direct all of the proceeds of the Loans, at which time the Borrower Representative shall promptly disburse such Loans to the appropriate Borrower. None of the Revolving Lenders or their respective officers, directors, agents or employees shall be liable to the Borrower Representative or any Borrower for any action taken or omitted to be taken by the Borrower Representative or the other Borrowers pursuant to this Section 12.4.
12.ePowers. The Borrower Representative shall have and may exercise such powers under the Loan Documents as are specifically delegated to the Borrower Representative by the terms of each thereof, together with such powers as are reasonably incidental thereto. The Borrower Representative shall have no implied duties to the other Borrowers, or any obligation to the Lenders to take any action thereunder except any action specifically provided by the Loan Documents to be taken by the Borrower Representative.
12.fEmployment of Agents. The Borrower Representative may execute any of its duties as the Borrower Representative hereunder and under any other Loan Document by or through its Responsible Officers.
12.gExecution of Loan Documents. The other Borrowers hereby empower and authorize the Borrower Representative, on behalf of such Borrowers, to execute and deliver to the Administrative Agent and the Lenders the Loan Documents and all related agreements, certificates, documents, or instruments as shall be necessary or appropriate to effect the purposes of the Loan Documents. Each Borrower agrees that any action taken by the Borrower Representative or the Borrowers in accordance with the terms of this Agreement or the other Loan Documents, and the exercise by the Borrower Representative of its powers set forth therein or herein, together with such other powers that are reasonably incidental thereto, shall be binding upon all of the Borrowers.





215
    



Exhibit B

Amended and Restated Exhibits E and H to the Credit Agreement

[See attached.]

216
    




EXHIBIT E
FORM OF PREPAYMENT NOTICE
Date: _____ ,
To:    Bank of America, N.A., as Administrative Agent
Mail Code: TX2-974-03-23
2380 Performance Dr., Bldg. C
Richardson, TX 75082
Attention: Devarshi Ojha
Telephone: (469) 201-8850
Facsimile: (214) 290-8373
Email: devarshi.ojha@bofa.com
Ladies and Gentlemen:
Reference is made to that certain Credit Agreement dated as of October 31, 2019, by and among Camelot UK Holdco Limited, a private limited liability company incorporated under the laws of England and Wales with registered number 10314173 (“Holdings”), Camelot UK Bidco Limited, a private limited liability company incorporated under the laws of England and Wales with registered number 10267893 (“UK Holdco”), the US Borrowers party thereto, Camelot Finance S.A., a public limited liability company (société anonyme) organized and established under the laws of the Grand Duchy of Luxembourg, having its registered office at 14, rue Edward Steichen, L-2540 Luxembourg registered with the Luxembourg Trade and Companies Register under the number B208514 (the “Lux Borrower” and, together with the US Borrowers, each a “Term Borrower” and, collectively, the “Term Borrowers”), certain Restricted Subsidiaries from time to time designated thereunder as Additional Revolving Borrowers (together with the Lux Borrower, UK Holdco and Camelot US Acquisition LLC, a limited liability company organized and established under the laws of Delaware, each a “Revolving Borrower” and, collectively, the “Revolving Borrowers” and the Revolving Borrowers, together with the Term Borrowers, each a “Borrower” and, collectively, the “Borrowers”), the Subsidiary Guarantors from time to time party thereto, the several banks, financial institutions, institutional investors and other entities from time to time party thereto as lenders (the “Lenders”), the Issuing Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent thereunder (the “Administrative Agent”) (as amended by that certain Incremental Facility Amendment dated as of February 28, 2020, that certain Incremental Facility Amendment dated as of October 1, 2020, that certain Incremental Facility Amendment dated as of November 30, 2021, that certain Incremental Facility Amendment dated as of March 31, 2022, that certain
Amendment No. 5, dated as of [    ], 2023, and as further amended, restated, amended and restated, supplemented, or otherwise modified from time to time, the “Credit Agreement”). Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.
This Prepayment Notice is delivered to you pursuant to [Section 2.10(a)] [Section 2.11(f)] of the Credit Agreement. The Borrower Representative hereby gives notice of a prepayment of [Term Loans] [Revolving Loans] as follows:


1.    (select Type(s) of Loans)
ABR Loans in the aggregate principal amount of $    .
Eurocurrency Loans with an Interest Period ending ______, 20__ in E-1
1
    



the aggregate principal amount of $    .
Term SOFR Loans with an Interest Period ending ______, 20__ in
the aggregate principal amount of $    .
E-2



2.    On    , 20__ (a Business Day).

[Notwithstanding anything to the contrary herein, this prepayment described above shall be subject to the occurrence of one or more conditions, which are as follows:
[●11
This Prepayment Notice and prepayment contemplated hereby comply with the Credit Agreement, including [Section 2.10] [Section 2.11] of the Credit Agreement.
Very truly yours,
BORROWER REPRESENTATIVE
By:    
Name:
Title:
E-2



EXHIBIT H
FORM OF BORROWING AND CONVERSION/CONTINUATION REQUEST
Date: [•], 20[•]
To:    Bank of America, N.A., as Administrative Agent
Mail Code: TX2-974-03-23
2380 Performance Dr., Bldg. C
Richardson, TX 75082
Attention: Devarshi Ojha
Telephone: (469) 201-8850
Facsimile: (214) 290-8373
Email: devarshi.ojha@bofa.com
Ladies and Gentlemen:
Reference is made to that certain Credit Agreement dated as of October 31, 2019 among by and among Camelot UK Holdco Limited, a private limited liability company incorporated under the laws of England and Wales with registered number 10314173 (“Holdings”), Camelot UK Bidco Limited, a private limited liability company incorporated under the laws of England and Wales with registered number 10267893 (“UK Holdco”), the US Borrowers party thereto, Camelot Finance S.A., a public limited liability company (société anonyme) organized and established under the laws of the Grand Duchy of Luxembourg, having its registered office at 14, rue Edward Steichen, L-2540 Luxembourg registered with the Luxembourg Trade and Companies Register under the number B208514 (the “Lux Borrower” and, together with the US Borrowers, each a “Term Borrower” and, collectively, the “Term Borrowers”), certain Restricted Subsidiaries from time to time designated thereunder as Additional Revolving Borrowers (together with the Lux Borrower, UK Holdco and Camelot US Acquisition LLC, a limited liability company organized and established under the laws of Delaware, each a “Revolving Borrower” and, collectively, the “Revolving Borrowers” and the Revolving Borrowers, together with the Term Borrowers, each a “Borrower” and, collectively, the “Borrowers”), the Subsidiary Guarantors from time to time party thereto, the several banks, financial institutions, institutional investors and other entities from time to time party thereto as lenders (the “Lenders”), the Issuing Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent thereunder (the “Administrative Agent”) (as amended by that certain Incremental Facility Amendment dated as of February 28, 2020, that certain Incremental Facility Amendment dated as of October 1, 2020, that certain Incremental Facility Amendment dated as of November 30, 2021, that certain Incremental Facility Amendment dated as of March 31, 2022, that certain
Amendment No. 5, dated as of [    ], 2023, and as further amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). Unless otherwise defined herein, terms defined in the Credit Agreement and used herein shall have the meanings given to them in the Credit Agreement.
The undersigned hereby requests (select one):
    A Borrowing:
Section 1.Borrower[s]: [    ].
Section 2.Proposed Borrowing Date: [    ].

H-1



Section 3.Principal Amount of Loan: [    ].
Section 4.Type of Loans:
[ ] a. Term Loans, in the amount of $[    ].
[ ] b. Revolving Loans, in the amount of $[    ]1 .
Section 5.Interest Rate Option:
[ ] a. ABR Loans, in the amount of $[    ].
[ ] b. Eurocurrency Loans, in the amount of $[    ], with an
initial Interest Period of
[[ ] days;]2
[ ] one month;
[ ] two months;
[ ] three months;
[ ] six months; or
[[ ] twelve months.]3
[ ] c. Term SOFR Loans, in the amount of $[    ], with an
initial Interest Period of
[ ] one month;
[ ] three months; or
[ ] six months.
Section 6.Remittance Instructions:
    A conversion or continuation of [Revolving][Term] Loans:
Section 1.On: [    ].
Section 2.Principal Amount of Loan: [    ].
Section 3.Type of Loan:
image_0a.jpg
1 To specify denomination in Dollars or the applicable Alternative Currency.
2 Subject to approval by all Lenders under the relevant Facility.
3 Subject to approval by all Lenders under the relevant Facility.


H-2



Section 1.Interest Rate Option:
[ ] a. ABR Loans, in the amount of $[    ].
[ ] b. Eurocurrency Loans, in the amount of $[    ], with an initial Interest Period of
[[ ] days;]4
[ ] one month;
[ ] two months;
[ ] three months;
[ ] six months; or
[[ ] twelve months.]5
[ ] c. Term SOFR Loans, in the amount of $[    ], with an initial Interest Period of
[ ] one month;
[ ] three months; or
[ ] six months.
Section 2.Remittance Instructions: [    ]
[The undersigned certifies in his/her capacity as a Responsible Officer, and not individually, that the conditions specified in Section [5.1]6 [2.25]7 of the Credit Agreement shall be satisfied on and as of the date of the Borrowing set forth above.] [The undersigned further certifies in his/her capacity as a Responsible Officer, and not individually, that]8:
(i)    [each of the representations and warranties made by any Loan Party in or pursuant to the Loan Documents is true and correct in all material respects (except where such representations and warranties are already qualified by materiality, in which case such representation and warranty shall be accurate in all respects) on and as of the date hereof to the same extent as made on and as of the date hereof, except to the extent such representations and warranties expressly relate to an earlier date, in which case such representations and warranties were true and correct in all material respects (except where such representations and warranties are already qualified by materiality, in which case such representation and warranty shall be accurate in all respects) as of such earlier date; and
image_1a.jpg
4 Subject to approval by all Lenders under the relevant Facility.
5 Subject to approval by all Lenders under the relevant Facility
6 Applies only to Borrowings on the Closing Date.
7 Applies only to Incremental Term Loans and Incremental Revolving Loans.
8 Applies only to Borrowings after the Closing Date.



H-3



(ii)    as of the date hereof and after giving effect to the extensions of credit requested hereby, no
Default or Event of Default has occurred and is continuing]9.
The undersigned hereby agreed to indemnify each Lender against any loss or expense that such Lender may sustain or incur as a consequence of the events described in Section 2.21 of the Credit
Agreement, such compensation to be in the amount, and determined in the manner contemplated by
Section 2.21 of the Credit Agreement.
[Signature page follows.]
image_2a.jpg
9 Applies only to Borrowings. Delete for any conversion/continuation request.


H-4



IN    WITNESS    WHEREOF,    the    undersigned    has    caused    this
[Borrowing][Conversion/Continuation] Request to be executed and delivered by a Responsible Officer thereunto duly authorized, as of the date set forth above.
BORROWER REPRESENTATIVE
By:     
Name:
Title:













































H-5

EX-31 3 exhibit31-q22023.htm EX-31 Document
Exhibit 31
CERTIFICATION
I, Jonathan Gear, certify that:
1.    I have reviewed this Quarterly Report on Form 10-Q of Clarivate Plc;
2.    Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;
3.    Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and
d)    Disclosed in this Report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 7, 2023
/s/ Jonathan Gear
Jonathan Gear
Chief Executive Officer and Director



CERTIFICATION
I, Jonathan M. Collins, certify that:
1.    I have reviewed this Quarterly Report on Form 10-Q of Clarivate Plc;
2.    Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;
3.    Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Report;
4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;
b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and
d)    Disclosed in this Report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 7, 2023
/s/ Jonathan M. Collins
Jonathan M. Collins
Executive Vice President and Chief Financial Officer

EX-32 4 exhibit32-q22023.htm EX-32 Document
Exhibit 32
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Clarivate Plc (the “Company”) on Form 10-Q for the quarter ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jonathan Gear, Chief Executive Officer and Director of the Company, certify to my knowledge, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that:
1.    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 7, 2023
/s/ Jonathan Gear
Jonathan Gear
Chief Executive Officer and Director


























CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Clarivate Plc (the “Company”) on Form 10-Q for the quarter ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jonathan M. Collins, Executive Vice President and Chief Financial Officer of the Company, certify to my knowledge, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that:
1.    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 7, 2023
/s/ Jonathan M. Collins
Jonathan M. Collins
Executive Vice President and Chief Financial Officer


EX-101.SCH 5 clvt-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Document - Audit Information link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Background and Nature of Operations link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Assets Held for Sale and Divested Operations link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Other Intangible Assets, net and Goodwill link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Derivative Instruments link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Share-based Compensation link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Earnings per Share link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Other Operating Expense (Income), Net link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Restructuring and Lease Impairments link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 9954701 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954702 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954703 - Disclosure - Other Intangible Assets, net and Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 9954704 - Disclosure - Derivative Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954705 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954706 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954707 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 9954708 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954709 - Disclosure - Share-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954710 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9954711 - Disclosure - Earnings per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954712 - Disclosure - Other Operating Expense (Income), Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954713 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954714 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954715 - Disclosure - Restructuring and Lease Impairments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954716 - Disclosure - Background and Nature of Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954717 - Disclosure - Assets Held for Sale and Divested Operations (Details) link:presentationLink link:calculationLink link:definitionLink 9954718 - Disclosure - Sublease income - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954719 - Disclosure - Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954720 - Disclosure - Other Intangible Assets, net and Goodwill - Intangible Assets by Major Class (Details) link:presentationLink link:calculationLink link:definitionLink 9954720 - Disclosure - Other Intangible Assets, net and Goodwill - Intangible Assets by Major Class (Details) link:presentationLink link:calculationLink link:definitionLink 9954721 - Disclosure - Other Intangible Assets - Narratives (Details) link:presentationLink link:calculationLink link:definitionLink 9954722 - Disclosure - Other Intangible Assets, net and Goodwill - Change in the Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954723 - Disclosure - Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954724 - Disclosure - Fair Value Measurements - Assets and liabilities that were recognized at fair value on a recurring basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954725 - Disclosure - Fair Value Measurements - Changes in Private Placement Warrants Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954726 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954727 - Disclosure - Debt - Summary of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954728 - Disclosure - Debt - Financing Transactions, Senior Notes (2029) and Senior Secured Notes (2028) - (Details) link:presentationLink link:calculationLink link:definitionLink 9954729 - Disclosure - Debt - Financing Transactions, Senior Secured Notes (2026) (Details) link:presentationLink link:calculationLink link:definitionLink 9954730 - Disclosure - Debt - The Credit Facilities, Revolving Credit Facility and Term Loan Facility (Details) link:presentationLink link:calculationLink link:definitionLink 9954731 - Disclosure - Revenue - Disaggregated Revenues and Cost to Obtain a Contract (Details) link:presentationLink link:calculationLink link:definitionLink 9954732 - Disclosure - Revenue - Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 9954733 - Disclosure - Revenue - Transaction Price Allocated to the Remaining Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 9954733 - Disclosure - Revenue - Transaction Price Allocated to the Remaining Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 9954734 - Disclosure - Shareholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 9954735 - Disclosure - Share-based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954736 - Disclosure - Share-based Compensation - Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954737 - Disclosure - Share-based Compensation - Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954738 - Disclosure - Share-based Compensation - Assumptions used to Value Options (Details) link:presentationLink link:calculationLink link:definitionLink 9954739 - Disclosure - Share-based Compensation - RSU and PSU Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954740 - Disclosure - Share-based Compensation - Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954741 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954742 - Disclosure - Earnings per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954743 - Disclosure - Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954744 - Disclosure - Other Operating Expense (Income), Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954745 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954746 - Disclosure - Segment Information - Revenue by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9954747 - Disclosure - Segment Information - Adjusted EBITDA by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9954748 - Disclosure - Commitments and Contingencies - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 9954749 - Disclosure - Commitments and Contingencies - Unconditional Purchase Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954750 - Disclosure - Commitments and Contingencies - Mandatory Convertible Preferred Share Dividends (Details) link:presentationLink link:calculationLink link:definitionLink 9954751 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 9954752 - Disclosure - Restructuring and Lease Impairments (Details) link:presentationLink link:calculationLink link:definitionLink 9954753 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 clvt-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 clvt-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 clvt-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Other Employee-related Liabilities, Current Other Employee-related Liabilities, Current Other non-current liabilities Other Noncurrent Liabilities [Member] A&G Segment Academia & Government Academia & Government Group [Member] Academia & Government Group Sublimit Line of Credit Facility, Maximum Borrowing Capacity Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Related Party and Former Parent Transactions Related Party Transaction [Line Items] Contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Deferred revenues adjustment Contract with Customer, Liability, Adjustments Contract with Customer, Liability, Adjustments Schedule of summarizes revenue by product group Revenue from External Customers by Products and Services [Table Text Block] Equity Award [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Other Operating Income (Expense), Net Other Operating Income and Expense [Policy Text Block] Disclosure of accounting policy related to other operating income and other operating expense items. Income tax benefit due to impairment of intangible assets Effective Income Tax Rate Reconciliation, Deductible Expense, Impairment Losses, Amount Effective Income Tax Rate Reconciliation, Deductible Expense, Impairment Losses, Amount Variable Consideration Variable Consideration Policy [Policy Text Block] Variable Consideration Policy [Policy Text Block] Deferred income taxes Deferred Income Tax Liabilities, Net Weighted-Average Remaining Contractual Life (in years) Weighted-Average Remaining Contractual Life [Abstract] Weighted-Average Remaining Contractual Life Small Product Group within IP Segment Small Product Group Within IP Segment [Member] Small Product Group Within IP Segment Insider Trading Policies and Procedures [Line Items] Number of options, vested and exercisable at the end of the year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Interest rate swap asset - current Derivative Asset, Current Disaggregation of revenues Disaggregation of Revenue Disaggregation of Revenue [Line Items] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Shareholders' Equity Equity [Text Block] Change in fair value of private placement warrants Dilutive Securities, Effect on Basic Earnings Per Share Other assets Increase (Decrease) in Other Noncurrent Assets Error Corrections and Prior Period Adjustments Restatement [Line Items] Error Corrections and Prior Period Adjustments Restatement [Line Items] Schedule of interest rate swap arrangements Open Swap Contract [Table Text Block] Business Combination, Contingent Consideration, Liability, Fair Value Disclosure Business Combination, Contingent Consideration, Liability, Fair Value Disclosure Fair value portion of liability recognized arising from contingent consideration in a business combination. Weighted-average expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Director Director [Member] Operation Simplification and Optimization Program Operation Simplification and Optimization Program [Member] Operation Simplification and Optimization Program Customer [Axis] Customer [Axis] Treasury share purchases settled after period end Treasury Stock, Value, Acquired, Cost Method, Settled in Subsequent Period Treasury Stock, Value, Acquired, Cost Method, Settled in Subsequent Period Current liabilities: Liabilities, Current [Abstract] Other Other Reconciling Items, EBITDA To Net Income (Loss) Attributable To Parent Other Reconciling Items, EBITDA To Net Income (Loss) Attributable To Parent Preferred Shares, no par value; 14.4 shares authorized; 5.25% Mandatory Convertible Preferred Shares, Series A, 14.4 shares issued and outstanding as of both June 30, 2023 and December 31, 2022 Preferred Stock, Value, Issued Dividends, Cash Dividends, Cash Subsequent Event Type [Domain] Subsequent Event Type [Domain] Derivative Instruments Derivative Instruments, Gain (Loss) [Line Items] Diluted (usd per share) Diluted EPS (usd per share) Earnings Per Share, Diluted Interest Rate Swap, $200 Million Term Loan Interest Rate Swap, 200 Million Term Loan [Member] Interest Rate Swap, 200 Million Term Loan Balance at beginning of the period Balance at end of the period Treasury Stock, Value Treasury Stock, Value Accounts receivable, net Accounts Receivables - Opening Accounts Receivables - Closing Accounts Receivable, after Allowance for Credit Loss, Current Forward currency contracts liability - current Foreign Currency Contracts, Liability, Fair Value Disclosure 2023 Recorded Unconditional Purchase Obligation, to be Paid, Year One Litigation Case [Axis] Litigation Case [Axis] Trading Symbol Trading Symbol Restructuring Plan [Domain] Restructuring Plan [Domain] Weighted average exercise price per share, granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price CPA Acquisition Integration Program CPA Acquisition Integration Program [Member] CPA Acquisition Integration Program Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Exercise of Private Placement Warrants (in shares) Stock Issued During Period, Shares, Private Warrants Exercised Stock Issued During Period, Shares, Private Warrants Exercised Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Audit Information [Abstract] Audit Information [Abstract] Total intangible assets, Gross Intangible Assets, Gross (Excluding Goodwill) Summary of unrecognized tax benefits, excluding interest and penalties: Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Other Intangible Assets Other Intangible Assets [Member] Schedule of basic and diluted EPS computations for our common stock Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Amounts of transaction Related Party Transaction, Amounts of Transaction Executive Category: Executive Category [Axis] RSUs and PSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Weighted average exercise price per share, exercised (in dollars per share) Exercise of Private Placement Warrants (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Warrant exercise price (usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Financial Instruments [Domain] Financial Instruments [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Stock options not granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Supplemental Unemployment Benefits, Severance Benefits Supplemental Unemployment Benefits, Severance Benefits Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Entity Small Business Entity Small Business Weighted-average expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Letter of credit Letter of Credit [Member] New Senior Secured Notes 2028 and Senior Unsecured Notes 2029 New Senior Secured Notes 2028 and Senior Unsecured Notes 2029 [Member] New Senior Secured Notes 2028 and Senior Unsecured Notes 2029 Increase (decrease) Increase Decrease In Contract With Customer, Current Liability It represents Amount of increase (decrease) in Current obligation to transfer good or service to customer for which consideration has been received or is receivable. Legal Costs Legal Costs, Policy [Policy Text Block] Notional Value Derivative, Notional Amount Derivative, Notional Amount Measurement Frequency [Axis] Measurement Frequency [Axis] Other Current and Non-Current Assets and Liabilities Other Current and Non-Current Assets and Liabilities [Policy Text Block] Disclosure of accounting policy related to other current and non-current assets and liabilities. RSUs Restricted Stock Units (RSUs) [Member] Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Depreciation Depreciation Proceeds from issuance of treasury shares Proceeds from Sale of Treasury Stock Transition Services Agreement Costs Transition Services Agreement Costs Transition Services Agreement Costs Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Restructuring Reserve, Beginning Balance Restructuring Reserve, Ending Balance Restructuring Reserve Transaction related costs Business Combination, Acquisition Related Costs Antidilutive shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Interest Rate Swap, $150 Million Term Loan Interest Rate Swap, 150 Million Term Loan [Member] Interest Rate Swap, 150 Million Term Loan Document Quarterly Report Document Quarterly Report Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Total computer hardware and other property Property, Plant and Equipment, Gross Related Party Transactions Related Party Transactions Disclosure [Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Leases Lessee, Finance Leases [Text Block] Schedule of income tax (benefit)/expense on income/(loss) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Restructuring Reserve, Settled without Cash Restructuring Reserve, Settled without Cash Schedule of other operating income, net Schedule Of Other Operating Income, Net [Table Text Block] Schedule Of Other Operating Income, Net Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Redemption due to change in control (as a percent) Debt Instrument, Redemption Price, Changes in Control, Percentage Percentage of principal amount of debt redeemed, changes in control. Current portion of operating lease liability Operating Lease, Liability, Current Prepaid expenses Prepaid Expense, Current Interest on lease liabilities Finance Lease, Interest Expense Computer software Computer Software, Intangible Asset [Member] Decision Resources Group Decision Resources Group [Member] Decision Resources Group [Member] Increase (decrease) of line of credit facility, net Line of Credit Facility, Increase (Decrease), Net Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Finite-lived intangible asets Total finite-lived intangible assets Finite-Lived Intangible Assets, Net Newly Adopted Accounting Standards and Recently Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Treasury stock acquired, average cost per share (in dollars per share) Shares Acquired, Average Cost Per Share Counterparty Name [Domain] Counterparty Name [Domain] Finite-lived intangible assets, Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Interest Rate Swap, Effective Date April 30, 2021, Fixed Rate 1.695% Interest Rate Swap, Effective Date April 30, 2021, Fixed Rate 1.695% [Member] Interest Rate Swap, Effective Date April 30, 2021, Fixed Rate 1.695% Fair vale of company's debt Debt Instrument, Fair Value Disclosure Schedule of components of pre-tax loss Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Intangible assets held for sale Disposal Group, Including Discontinued Operation, Intangible Assets Total consideration Business Combination, Consideration Transferred Loss recovery asset recognized Loss Contingency, Receivable, Proceeds Commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Current portion of deferred revenues Current portion of deferred revenues - Opening Current portion of deferred revenues - Closing Contract with Customer, Liability, Current Summary of assumption used to value options granted during the period presented and their expected lives Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Net decrease in restricted cash Restricted Cash, Period Increase (Decrease) Restricted Cash, Period Increase (Decrease) Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Segment Optimization Program Segment Optimization Program [Member] Segment Optimization Program 2019 Incentive Award Plan 2019 Incentive Award Plan [Member] 2019 Incentive Award Plan Selling, general and administrative costs Selling, General and Administrative Expense Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Stock Options Options Employee Stock Option [Member] Derivative Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Forward currency contracts asset - current Foreign Currency Contract, Asset, Fair Value Disclosure Total operating expenses Costs and Expenses Maximum Maximum [Member] Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Total remaining unamortized compensation costs Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Prepaid expenses Prepaid Expenses [Member] It represents Primary financial statement caption encompassing prepaid expenses. Document Type Document Type Debt Related Commitment Fees and Debt Issuance Costs Debt Related Commitment Fees and Debt Issuance Costs Tabular List, Table Tabular List [Table Text Block] Currency Swap Currency Swap [Member] Repurchases of ordinary shares Repurchase of ordinary shares Treasury Stock, Value, Acquired, Cost Method LS&H Segment Life Sciences and Healthcare Group [Member] It represents information pertaining to Science Group. One Of The Larger Legal Claims One Of The Larger Legal Claims [Member] One Of The Larger Legal Claims Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Subscribed number of shares Common Stock, Shares, Subscription Number of shares allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. Brand Protection, AntiPiracy, and AntiFraud Solutions Brand Protection, AntiPiracy, and AntiFraud solutions [Member] Brand Protection, AntiPiracy, and AntiFraud solutions [Member] Derivative Liability, Current Derivative Liability, Current Treasury Shares Treasury Stock [Policy Text Block] Treasury Stock Share-based Compensation Share-Based Payment Arrangement [Text Block] Other operating activities Other Noncash Income (Expense) Business Acquisition [Axis] Business Acquisition [Axis] Severance and Related Benefit Cost Severance and Related Benefit Cost [Member] Severance and Related Benefit Cost Customer Concentration Risk Customer Concentration Risk [Member] Preferred Stock, Convertible, Conversion Ratio Preferred Stock, Convertible, Conversion Ratio Variable Rate [Axis] Variable Rate [Axis] Miscellaneous (income) expense, net Other Nonrecurring (Income) Expense Shares withheld to cover exercise price (in shares) Class of Warrant or Right, Shares Withheld for Exercise Price Class of Warrant or Right, Shares Withheld for Exercise Price 2025 Recorded Unconditional Purchase Obligation, to be Paid, Year Three Forfeited/Unexercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Senior Notes New Senior Unsecured Notes 2029 [Member] New Senior Unsecured Notes 2029 Sublease income Sublease Income Related Party [Domain] Related Party, Type [Domain] Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Publons Publons Limited [Member] Publons Limited [Member] Plan modification, incremental cost Share-Based Payment Arrangement, Plan Modification, Incremental Cost Indefinite-lived intangible assets: Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Weighted average grant date fair value, beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Fixed Rate Derivative, Fixed Interest Rate Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-Based Payment Arrangement [Abstract] Deferred revenues adjustment Deferred revenues adjustment It represents information pertaining to Deferred revenues adjustment. Entity Tax Identification Number Entity Tax Identification Number Impact of foreign currency fluctuations Goodwill, Foreign Currency Translation Gain (Loss) Dividends to preferred shareholders Dividends, Preferred Stock Treasury stock sold, average cost per share (in dollars per share) Treasury Stock Reissued, Average Cost Per Share Treasury Stock Reissued, Average Cost Per Share Statistical Measurement [Axis] Statistical Measurement [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Management Incentive Plan Management Incentive Plan [Member] Represents the Management Incentive Plan under which certain employees may be eligible to purchase shares of the entity. Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Transaction revenues Transaction Revenues [Member] It represents the Amount of revenue from Transaction. Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Interest rate annual adjustment (as a percent) Debt instrument, Interest Rate, Annual Adjustment Debt instrument, Interest Rate, Annual Adjustment Redemption through equity offerings, redemption price (as a percent) Debt Instrument, Redemption Through Equity Offerings, Redemption Price, Percentage Debt Instrument, Redemption Through Equity Offerings, Redemption Price, Percentage Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Gain on legal settlement Gain on settlement Gain (Loss) Related to Litigation Settlement Name Outstanding Recovery, Individual Name Revenue Recognition and Deferred Revenues Revenue from Contract with Customer [Policy Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Schedule of deferred income tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Counterparty Name [Axis] Counterparty Name [Axis] Derivative Financial Instruments Derivatives, Policy [Policy Text Block] Furniture, fixtures and equipment Furniture Fixtures And Equipment [Member] Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases. Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Ordinary shares, outstanding (in shares) Common Stock, Shares, Outstanding Impairment charge on right-of-use assets Operating Lease, Impairment Loss Other Income and Expenses [Abstract] PEO PEO [Member] Loss Contingency, Estimate of Possible Loss Loss Contingency, Estimate of Possible Loss Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Auditor Location Auditor Location Ten Largest Customers Ten Largest Customers [Member] Ten Largest Customers Balance at beginning of the period (in shares) Balance at end of the period (in shares) Shares, Outstanding Ordinary shares, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Accrued legal liability Estimated Litigation Liability, Current Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Interest rate swap Interest rate swap asset Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Credit Facility [Axis] Credit Facility [Axis] Schedule of Maturities of Outstanding Borrowings Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Repayments of revolving credit facility Repayments of Long-Term Lines of Credit Preferred Stock Purchase Rights Preferred Stock Purchase Rights [Member] Preferred Stock Purchase Rights Preferred Stock, Dividends Per Share, Declared Preferred Stock, Dividends Per Share, Declared Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Leonard Green and Partners, LP Leonard Green and Partners, LP [Member] Leonard Green and Partners, LP IPM Product Line Ip Management Product Line [Member] Represents information pertaining to IP Management Product Line Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Subsequent Events Subsequent Event [Line Items] Affiliated Entity Affiliated Entity [Member] Reserve for probable claims Loss Contingency, Accrual, Current Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Preferred Shares Preferred Stock [Member] AOCI (net of tax) related to cash flow hedges Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Additional payments to acquire business Business Combination, Contingent Consideration, Liability Supplemental Cash Flow Information: Supplemental Cash Flow Information [Abstract] Restructuring Type [Axis] Restructuring Type [Axis] Earnings Per Share Earnings Per Share, Policy [Policy Text Block] Total debt outstanding Long-Term Debt and Lease Obligation, Including Current Maturities Other Intangible Assets, net and Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Concentration risk Concentration Risk, Percentage Class of Warrant or Right, Outstanding Class of Warrant or Right, Outstanding Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Amortization Finite Lived Intangible Assets, Amortization [Policy Text Block] Disclosure of accounting policy related to amortization. Weighted average grant date fair value, granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Noncash Impairment, Leases Noncash Impairment, Leases Noncash Impairment, Leases Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Estimated Amortization for Five Succeeding Years Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Debt Instrument, Redemption, Period Three Debt Instrument, Redemption, Period Three [Member] Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization Eurodollar Eurodollar [Member] Other operating income, net Other operating income, net Other Operating Income (Expense), Net Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Proceeds from warrant exercises Proceeds from Warrant Exercises CPA Global CPA Global [Member] CPA Global Goodwill impairment charge Goodwill, Impairment Loss Valuation allowances Deferred Tax Assets, Valuation Allowance Amortization rate (as a percent) Debt Instrument, Amortization Rate Debt Instrument, Amortization Rate Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Revenue recognized that was deferred at the beginning of the period Contract with Customer, Liability, Revenue Recognized Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Long-term debt Long-Term Debt and Lease Obligation Consecutive Trading Day Period Consecutive Trading Day Period Consecutive Trading Day Period Future unconditional purchase obligations Recorded Unconditional Purchase Obligation, Fiscal Year Maturity Schedule [Abstract] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Preferred stock, issued (in shares) Preferred Stock, Shares Issued Entity Emerging Growth Company Entity Emerging Growth Company Debt issuance costs Debt Issuance Costs, Net Other intangible assets, net Total intangible assets Intangible Assets, Net (Excluding Goodwill) Noncurrent assets Other noncurrent assets Other Noncurrent Assets [Member] Number of largest customers Concentration Risk, Largest Customers Description of risks that arise due to the volume of business transacted with a major customer. Transaction Price Allocated to the Remaining Performance Obligation Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Newly issued ordinary shares, value Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Ordinary Shares Common Stock [Member] Finance Lease, Impairment Loss Finance Lease, Impairment Loss Defined benefit pension plans, net of tax provision (benefit) of $0, $0 and $(0.1) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] Proceeds from issuance of preferred shares Proceeds from Issuance of Convertible Preferred Stock Entity Address, Postal Zip Code Entity Address, Postal Zip Code Income Statement Location [Domain] Income Statement Location [Domain] Interest rate swap asset - non-current Derivative Asset, Noncurrent Schedule of changes in Level 3 Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Weighted average interest rate (as a percent) Debt, Weighted Average Interest Rate Minimum Minimum [Member] Weighted average shares used to compute earnings per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Proceeds from issuance of debt Proceeds from Issuance of Long-Term Debt Net foreign exchange loss (gain) Gain (Loss), Foreign Currency Transaction, before Tax Operating leases, net Increase (Decrease) in Operating Lease Liability Payments related to tax withholding for stock-based compensation Payment, Tax Withholding, Share-Based Payment Arrangement Accounts Payable and Accruals Account Payables And Accruals [Policy Text Block] Disclosure of accounting policy related to account payables and accruals. Other current assets Other Current Assets [Member] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Deferred income taxes Deferred Income Tax Assets, Net Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Accumulated Deficit Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] IP Segment Intellectual Property Intellectual Property Group [Member] It represents information pertaining to Intellectual Property Group. Interest rate swaps Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Basic (usd per share) Basic EPS (usd per share) Earnings Per Share, Basic Total remaining unearned compensation costs, Stock Options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Restructuring Reserve, Accrual Adjustment Restructuring Reserve, Accrual Adjustment Gain on sale of assets Gain (Loss) on Disposition of Assets Sale of Stock [Domain] Sale of Stock [Domain] Senior Secured Notes New Senior Secured Notes 2028 [Member] New Senior Secured Notes 2028 Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current deferred revenues Contract With Customer , Current Liability [Abstract] n/a. Aggregate intrinsic value, exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Number of shares called per warrant (in shares) Beginning Balance (in shares) Ending Balance (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Discontinued Operations, Disposed of by Sale Discontinued Operations, Disposed of by Sale [Member] Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalent, Period Increase (Decrease) Cash and Cash Equivalent, Period Increase (Decrease) Cash paid for income tax Income Taxes Paid Principles of Consolidation Consolidation, Policy [Policy Text Block] Number of Shares Warrants And Rights, Outstanding [Roll Forward] Warrants And Rights, Outstanding Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Acquisition measurement period adjustments Goodwill, Purchase Accounting Adjustments Accounts payable Increase (Decrease) in Accounts Payable Repayment of term loan Repayments of Lines of Credit Redemption through equity offerings threshold, redemption period maximum Debt Instrument, Redemption Through Equity Offerings Threshold, Redemption Period Maximum Debt Instrument, Redemption Through Equity Offerings Threshold, Redemption Period Maximum Senior Secured Notes Senior Secured Notes [Member] Senior Secured Notes [Member] Entity Public Float Entity Public Float Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Address, Country Entity Address, Country Treasury stock average price at retirement date (usd per share) Treasury Stock Retired, Average Cost Per Share Treasury Stock Retired, Average Cost Per Share Derivative Instrument [Axis] Derivative Instrument [Axis] Change Charged to Expense/(Income) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Carrying Value Aggregate principal amount Long-Term Debt, Gross Liability Class [Axis] Liability Class [Axis] All Trading Arrangements All Trading Arrangements [Member] Net gain on sale Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Accumulated depreciation Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Sponsor agreement Sponsor Agreement [Member] Sponsor Agreement [Member] Conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Compensation Amount Outstanding Recovery Compensation Amount Lease termination fees Gain (Loss) on Termination of Lease Re-occurring Revenues Re-occurring Revenues [Member] Re-occurring Revenues Interest rate swap asset - non-current Derivative Asset Weighted average grant date fair value, forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Restructuring Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Proceeds from stock options exercised Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Finance lease, carrying value Finance lease liability Finance Lease, Liability Weighted average exercise price per share, forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited/Unexercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Newly issued ordinary shares (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Schedule of Identifiable Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One Debt Instrument, Redemption, Period One [Member] Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Collateralized amount Debt Instrument, Collateral Amount Stock issued Stock Issued During Period, Shares, Acquisitions Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Payments made Payments for Restructuring Document Period End Date Document Period End Date Adoption Date Trading Arrangement Adoption Date Revenue Revenue from Contract with Customer Benchmark [Member] Finance lease, effective interest rate Finance Lease, Weighted Average Discount Rate, Percent Treasury Stock, Common Treasury Stock, Common [Member] Amount reclassified out of Other comprehensive income (loss) Reclassification out of Accumulated Other Comprehensive Income [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Basis of Presentation Basis of Presentation and Significant Accounting Policies [Text Block] (Benefit) provision for income taxes Benefit (provision) for income taxes Income Tax Expense (Benefit) Deferred compensation liability Deferred Compensation Liability, Current and Noncurrent Designated as Hedging Instrument Designated as Hedging Instrument [Member] Fair Value Measurements Fair Value Disclosures [Text Block] Number of operating segments Number of Operating Segments Impairment of Long-Lived Assets to be Disposed of Impairment of Long-Lived Assets to be Disposed of Kopernio Kopernio [Member] Kopernio [Member] Warrant Liabilities Warrant Liability, Policy [Policy Text Block] Warrant Liability, Policy Shareholders’ equity: Equity [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Dividends on preferred shares Dividends on preferred shares Preferred Stock Dividends, Income Statement Impact Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and Cash Equivalents, at Carrying Value Payments for acquisitions and cost method investments, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Stock repurchased and retired (in shares) Stock Repurchased and Retired During Period, Shares Credit Facility [Domain] Credit Facility [Domain] Payments towards purchase obligations Payments For Purchase Obligations The cash outflow from payments for purchase obligations. Repurchase of ordinary shares (in shares) Repurchase of ordinary shares (in shares) Treasury Stock, Shares, Acquired Common stock, votes per share Common Stock, Votes Per Share Common Stock, Votes Per Share Identifiable Intangible Assets, net Intangible Assets, Finite-Lived, Policy [Policy Text Block] Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Current Interest rate spread (as a percent) Debt Instrument, Basis Spread on Variable Rate Reclassification adjustment for other comprehensive income (loss) Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Number of derivative instruments held Derivative, Number of Instruments Held Summary of Valuation Allowance Summary of Valuation Allowance [Table Text Block] Schedule of contract balances Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Warrant and Share-Based Payment Arrangement Warrant and Share-Based Payment Arrangement [Member] Warrant and Share-Based Payment Arrangement Revenue Revenue from Contract with Customer [Text Block] Tax benefit recorded for a settlement of an open tax dispute Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total cash and cash equivalents, and restricted cash, end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Commitments and Contingencies Loss Contingencies [Line Items] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Cover [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Payment Earn Out Liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Payment Earn Out Liability Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Payment Earn Out Liability Redemption period prior to closing of equity offering Debt Instrument, Redemption Period Prior to Closing of Equity Offering Debt Instrument, Redemption Period Prior to Closing of Equity Offering Interest Rate Swap, Effective Date August 5, 2022, Fixed Rate 3.063% Interest Rate Swap, Effective Date August 5, 2022, Fixed Rate 3.063% [Member] Interest Rate Swap, Effective Date August 5, 2022, Fixed Rate 3.063% Subsequent Events Subsequent Events [Text Block] UNITED STATES UNITED STATES Recurring Fair Value, Recurring [Member] Cash dividends on preferred shares Payments of Dividends Other non-current liabilities Other Liabilities, Noncurrent Lease Abandonment Costs Lease Abandonment Costs [Member] Lease Abandonment Costs Remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Interest Expense, Net Interest Expense, Policy [Policy Text Block] Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Segment Information Segment Reporting Disclosure [Text Block] Net increase (decrease) in cash and cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Equity Component [Domain] Equity Component [Domain] Life Sciences & Healthcare Life Science and Healthcare Group [Member] It represents information pertaining to Science Group. Computer hardware Computer Hardware [Member] Computer Hardware [Member] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] (Loss) income from operations Operating Income (Loss) Performance Obligations Performance Obligations Policy [Policy Text Block] Performance Obligations Policy [Policy Text Block] Redemption (as a percent) Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Dividends to preferred shareholders (in shares) Common Stock Dividends, Shares Open Market Purchases Open Market Purchases [Member] Open Market Purchases Segments [Axis] Segments [Axis] Property and Equipment, net Property, Plant and Equipment, Policy [Policy Text Block] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Schedule of Nonvested Performance-based Units Activity Schedule of Nonvested Performance-Based Units Activity [Table Text Block] Scenario [Domain] Scenario [Domain] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer relationships Customer Relationships [Member] Type of Restructuring [Domain] Type of Restructuring [Domain] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current [Abstract] Deferred Income Taxes and Tax Credits Deferred Income Taxes and Tax Credits Over-Allotment Option Over-Allotment Option [Member] Variable Rate [Domain] Variable Rate [Domain] Debt Instrument, Redemption Debt Instrument, Redemption [Line Items] Pay vs Performance Disclosure [Line Items] Entity Voluntary Filers Entity Voluntary Filers Statistical Measurement [Domain] Statistical Measurement [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Liquidation preference (usd per share) Preferred Stock, Liquidation Preference Per Share Beginning of year (in shares) End of year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Revolving Credit Facility Revolving Credit Facility [Member] Effects of exchange rates Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Impairment of finite-lived intangible assets Impairment of Intangible Assets, Finite-Lived MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] PSUs Performance Shares [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts payable Accounts Payable, Current Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Restatement Determination Date: Restatement Determination Date [Axis] Other liabilities Increase (Decrease) in Other Noncurrent Liabilities Commitments and contingencies (Note 17) Commitments and Contingencies Previously Reported Previously Reported [Member] Deferred closing consideration Disposal Group, Including Discontinued Operation, Consideration, Deferred Disposal Group, Including Discontinued Operation, Consideration, Deferred Summary of future unconditional purchase obligations Recorded Unconditional Purchase Obligations [Table Text Block] Subscription revenues Subscription Revenues [Member] It represents the Amount of revenue from subscription. Proceeds from issuance of ordinary shares Proceeds from Issuance of Common Stock Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] Income Taxes Income Tax Disclosure [Text Block] Deferred revenues Increase (Decrease) in Contract with Customer, Liability Purchase price period payable Disposal Group, Including Discontinued Operation, Consideration, Period Payable Disposal Group, Including Discontinued Operation, Consideration, Period Payable Total property and equipment, gross Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Leases Lessee, Leases [Policy Text Block] One Clarivate Program One Clarivate Program [Member] One Clarivate Program Income tax benefit due to change in deferred tax assets valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share RSUs Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Deferred Compensation, Excluding Share-based Payments and Retirement Benefits Deferred Compensation, Excluding Share-Based Payments and Retirement Benefits [Member] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Contingent purchase price payment Contingent purchase price paid Payment for Contingent Consideration Liability, Financing Activities PEO Total Compensation Amount PEO Total Compensation Amount Hedging Relationship [Axis] Hedging Relationship [Axis] Sale of treasury shares, net (in shares) Treasury Stock, Shares, Sold Treasury Stock, Shares, Sold Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Deferred compensation expense Deferred Compensation Arrangement with Individual, Compensation Expense Increase (decrease) Increase Decrease In Contract With Customer Accounts Receivable It represents Amount of increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. Goodwill [Roll Forward] Goodwill [Roll Forward] Private Warrants Private Warrants [Member] Private Warrants Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Treasury Stock, Common, Shares Treasury Stock, Common, Shares Outstanding at beginning of year (in shares) Outstanding at end of year (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised DRG Acquisition Integration Program DRG Acquisition Integration Program [Member] DRG Acquisition Integration Program Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net (loss) income Net income (loss) Net (loss) income available to ordinary shareholders Net (loss) income Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Leases Lessee, Operating Leases [Text Block] Property and equipment, net Total property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Federal Funds Effective Swap Rate Fed Funds Effective Rate Overnight Index Swap Rate [Member] Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Exercise of stock options (in shares) Exercised/Vested (in share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Accounts Receivable Receivable [Policy Text Block] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Litigation Status [Domain] Litigation Status [Domain] Founder shares Common Class B [Member] Foreign Exchange Contract Foreign Exchange Contract [Member] Name Measure Name Name Forgone Recovery, Individual Name Goodwill Goodwill, beginning balance Goodwill, ending balance Goodwill Underlying Securities Award Underlying Securities Amount Accounts receivable Increase (Decrease) in Accounts Receivable Forecast Forecast [Member] Public Warrant Public Warrant [Member] Public Warrant Selling, general and administrative costs Selling, General and Administrative Expenses [Member] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Warrant Warrant [Member] Operating lease liabilities Operating Lease, Liability, Noncurrent Goodwill, Impairment Loss, Excluding CTA Impact Goodwill, Impairment Loss, Excluding CTA Impact Goodwill, Impairment Loss, Excluding CTA Impact Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Payment of debt issuance costs and discounts Payments of Debt Issuance Costs Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] 2026 Recorded Unconditional Purchase Obligation, to be Paid, Year Four Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Income Statement Location [Axis] Income Statement Location [Axis] Assets Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Total share based compensation expense Share-Based Payment Arrangement, Expense, after Tax Debt discounts and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Weighted-average effect of potentially dilutive shares to purchase ordinary shares (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Foreign exchange forward Foreign Exchange Forward [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Cost to Obtain a Contract and Cost of Revenues Cost of Goods and Service [Policy Text Block] Product and Service [Domain] Product and Service [Domain] Principal payments on term loan Repayments of Other Long-Term Debt Other Performance Measure, Amount Other Performance Measure, Amount Share-based award activity (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited Cash Flows From Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Unconditional purchase obligations Unconditional Purchase Obligations (Excluding Capital Stock Redemptions) [Abstract] Litigation Status [Axis] Litigation Status [Axis] Underwriting Commitments Underwriting Commitments Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Interest rate swaps, tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent Plan Name [Domain] Plan Name [Domain] Redemption of Notes not exchanged Payment for Debt Extinguishment or Debt Prepayment Cost Interest expense and amortization of debt discount, net Interest expense and amortization of debt discount, net Interest Expense Capital expenditures included in accounts payable Capital Expenditures Incurred but Not yet Paid ProQuest ProQuest [Member] ProQuest Authorized grants (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Thereafter Recorded Unconditional Purchase Obligation Due After Fourth Year Recorded Unconditional Purchase Obligation Due After Fourth Year Weighted-Average Remaining Contractual Life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Trading Arrangement: Trading Arrangement [Axis] Use of Estimates Use of Estimates, Policy [Policy Text Block] Term Loan Facility Term Loan Facility [Member] Represents information pertaining to a Term Loan Facility. Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Discounts on notes Debt Instrument, Unamortized Discount Term of contract Derivative, Term of Contract Auditor Firm ID Auditor Firm ID Amortization of intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Restatement Determination Date Restatement Determination Date Prepaid expenses Increase (Decrease) in Prepaid Expense Debt Covenant Terms [Axis] Debt Covenant Terms [Axis] Debt Covenant Terms Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Total cash and cash equivalents, and restricted cash, beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Impairment of Long-lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Ordinary shares, issued (in shares) Common Stock, Shares, Issued Vesting of restricted stock units (in shares) Exercised/Vested (in share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Country Region Country Region Current portion of long-term debt Current portion of long-term debt Long-Term Debt and Lease Obligation, Current Treasury shares, at cost; 0 and 0 shares as of June 30, 2023 and December 31, 2022, respectively Treasury Stock, Common, Value Treasury Stock, Common, Value Total Assets, Fair Value Disclosure Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.487% Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.487% [Member] Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.487% Churchill Public Shareholders Churchill Public Shareholders [Member] Churchill Public Shareholders [Member] Dividends Payable [Line Items] Dividends Payable [Line Items] Public shares Common Class A [Member] Weighted average remaining service period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Exit, Disposal and Abandonment Costs Exit, Disposal and Abandonment Costs [Member] Exit, Disposal and Abandonment Costs Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Value of stock issued Stock Issued During Period, Value, Acquisitions Write off of accumulated foreign currency impacts Write Off of Accumulated Foreign Currency Impacts Write-off of amounts previously capitalized as foreign currency. Entity Address, Address Line One Entity Address, Address Line One Derivative variable interest rate floor Derivative, Variable Interest Rate, Floor Derivative, Variable Interest Rate, Floor Accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Liabilities Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] Subsequent Event [Table] Subsequent Event [Table] Debt Issuance Costs Debt Issuance Costs [Policy Text Block] Disclosure of accounting policy related to debt issuance costs. Fair Value Measurements Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Remaining performance obligation, percentage Revenue, Remaining Performance Obligation, Percentage Subsequent Event Subsequent Event [Member] Income Statement [Abstract] Income Statement [Abstract] Goodwill and Indefinite-Lived Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block] Issuance of shares, net (in shares) Stock Issued During Period, Shares, New Issues Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Debt Instrument Redemption Debt Instrument Redemption [Table Text Block] Derivative Liability Derivative Liability Reclassification of EBT Shares Stockholders' Equity, Other Shares Non-current deferred revenues Contract With Customer , Non Current Liability [Abstract] n/a. Other current assets Other Assets, Current Interest Rate Swap, Effective Date August 4, 2022, Fixed Rate 2.857% Interest Rate Swap, Effective Date August 4, 2022, Fixed Rate 2.857% [Member] Interest Rate Swap, Effective Date August 4, 2022, Fixed Rate 2.857% Contingent Liability Transaction-related Fee Contingent Liability Transaction-related Fee Contingent Liability Transaction-related Fee Dividends Payable [Table] Dividends Payable [Table] Diluted EPS Earnings Per Share, Diluted [Abstract] Total revenues, gross Revenue From Contract With Customer, Excluding Assessed Tax Including Deferred Revenues Adjustment It represents Amount, excluding tax collected from customer, Including of Deferred revenues adjustment. Financial Instrument [Axis] Financial Instrument [Axis] Assets Held for Sale and Divested Operations Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Total Shareholder Return Amount Total Shareholder Return Amount Exit and Disposal Costs Exit and Disposal Costs [Member] Exit and Disposal Costs Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Restructuring and impairments Restructuring Costs and Asset Impairment Charges Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Retirement of treasury shares Stock repurchased and retired Treasury Stock, Retired, Cost Method, Amount First Lien Leverage Ratios First Lien Leverage Ratios [Member] First Lien Leverage Ratios Segments [Domain] Segments [Domain] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accumulated deficit Retained Earnings (Accumulated Deficit) Debt face amount Debt Instrument, Face Amount Current assets: Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cash Flows From Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Accrued expenses and other current liabilities Accrued Expenses And Other Current Liabilities [Member] Primary financial statement caption encompassing accrued expenses and other current liabilities. Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Goodwill And Intangible Assets [Line Items] Goodwill And Intangible Assets [Line Items] The line item disclosure represents goodwill and intangible asset. Disposal Group Name [Domain] Disposal Group Name [Domain] Basic EPS Earnings Per Share, Basic [Abstract] Debt Instrument Redemption [Table] Debt Instrument Redemption [Table] Increase (decrease) Increase (Decrease) in Accounts and Other Receivables Class of Stock [Domain] Class of Stock [Domain] Customer [Domain] Customer [Domain] Net income (loss) attributable to ordinary shares Net (loss) income attributable to ordinary shares Net income (loss) attributable to ordinary shares Net Income (Loss) Available to Common Stockholders, Basic Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Litigation Settlement, Expense Litigation Settlement, Expense Effective tax rate Effective Income Tax Rate Reconciliation, Percent Share-based Payment Arrangement, Activity Share-Based Payment Arrangement, Activity [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Purchase price Disposal Group, Including Discontinued Operation, Consideration Schedule Of Private Placement Warrant Activity Schedule Of Private Placement Warrant Activity [Table Text Block] Schedule Of Private Placement Warrant Activity Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Release of liability for legal claims Loss Contingency Accrual, Period Increase (Decrease) All Executive Categories All Executive Categories [Member] Settled Litigation Settled Litigation [Member] Non-current portion of deferred revenues Non-current portion of deferred revenues - Opening Non-current portion of deferred revenues - Closing Contract with Customer, Liability, Noncurrent Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Plan Name [Axis] Plan Name [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Tax benefits Share-Based Payment Arrangement, Expense, Tax Benefit Number of reportable segments Number of Reportable Segments Earnings per share Earnings Per Share [Abstract] Total Non-Cash Financing Activities Total Non-Cash Financing Activities Total Non-Cash Financing Activities Cash and cash equivalents, end of period Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations Warrants exercised (in shares) Warrants exercised (in shares) Class of Warrant or Right, Exercised Class of Warrant or Right, Exercised Ordinary Shares, no par value; unlimited shares authorized at June 30, 2023 and December 31, 2022; 676.1 and 674.4 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Redemption price (as a percentage of principal) Debt Instrument, Redemption Price, Percentage Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Trade names Trade Names [Member] Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 0.451% Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 0.451% [Member] Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 0.451% Payments related to finance lease Finance Lease, Principal Payments Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Restricted cash, beginning of period Restricted cash, end of period Restricted Cash All Individuals All Individuals [Member] Severance liability, employer contribution, percent of employees' salary Supplemental Unemployment Benefits, Severance Liability, Employer Contribution, Percent of Employees' Gross Pay Supplemental Unemployment Benefits, Severance Liability, Employer Contribution, Percent of Employees' Gross Pay Litigation Case [Domain] Litigation Case [Domain] Entity Filer Category Entity Filer Category Prepaid Expenses Prepaid Assets [Policy Text Block] Disclosure of accounting policy related to prepaid assets. Class of Treasury Stock Class of Treasury Stock [Table Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Disposal Group, Held-for-sale, Not Discontinued Operations Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.471% Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.471% [Member] Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.471% Schedule of reconciliation of the statutory income tax rate to effective tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Exercise of public warrants (in shares) Stock Issued During Period, Shares, Public Warrants Exercised Stock Issued During Period, Shares, Public Warrants Exercised PEO Name PEO Name Expected volatility - Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued Debt Debt, Policy [Policy Text Block] Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Weighted Average Fair Value per Share Warrants And Rights, Outstanding, Weighted Average Fair Value Per Share [Roll Forward] Warrants And Rights, Outstanding, Weighted Average Fair Value Per Share Exercise of Private Placement Warrants Exercise of Private Placement Warrants Stock Issued During Period, Value, Private Warrants Exercised Stock Issued During Period, Value, Private Warrants Exercised Restricted cash Restricted Cash, Current Schedule of Change in the Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Other accrued expenses and other current liabilities Other Accrued Liabilities, Current Mark to market (gain) loss on financial instruments Mark to market gain on financial instruments Mark to market gain on financial instruments Fair Value Adjustment of Warrants Background and Nature of Operations Nature of Operations [Text Block] Deferred tax liabilities held for sale Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities Interest per annum Debt Instrument, Interest Rate, Stated Percentage Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Depreciation Depreciation, Depletion, and Amortization [Policy Text Block] Total shareholders’ equity Balance at beginning of the period Balance at end of the period Equity, Attributable to Parent Assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Shares Issued, Value, Share-Based Payment Arrangement, Forfeited Shares Issued, Value, Share-Based Payment Arrangement, Forfeited Recorded Unconditional Purchase Obligation Total Recorded Unconditional Purchase Obligation Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] TrademarkVision Trademarkvision Usa Llc [Member] Represents TrademarkVision USA, LLC [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Revision of Prior Period [Domain] Revision of Prior Period [Domain] Subsequent Events [Abstract] Subsequent Events [Abstract] Income (loss) before income taxes Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Significant Judgments Significant Judgments [Policy Text Block] Significant Judgments [Policy Text Block] ProQuest Acquisition Integration Program ProQuest Acquisition Integration Program [Member] ProQuest Acquisition Integration Program Restructuring and Lease Impairments Restructuring and Related Activities Disclosure [Text Block] Hedging Designation [Domain] Hedging Designation [Domain] Level 2 Fair Value, Inputs, Level 2 [Member] Shares issued as dividends on our 5.25% Series A Mandatory Convertible Preferred Shares Stock Issued During Period, Value, Stock Dividend Net Investment Hedging Net Investment Hedging [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 1.695% Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 1.695% [Member] Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 1.695% Schedule of summarizes non-current assets other than financial instruments and deferred tax assets by geography Long-Lived Assets by Geographic Areas [Table Text Block] Retirement of treasury shares (in shares) Stock repurchased and retired (in shares) Treasury Stock, Shares, Retired Disposal Group Classification [Domain] Disposal Group Classification [Domain] Effective Interest Rate Interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Increase (Decrease) in Shareholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Impairment charge on right-of-use assets Lease, Impairment Loss Lease, Impairment Loss Document Fiscal Period Focus Document Fiscal Period Focus Weighted average exercise price per share, outstanding at the beginning of the year (in dollars per share) Weighted average exercise price per share, outstanding at the end of the year (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based compensation Share-Based Payment Arrangement, Noncash Expense Schedule of summarizes revenues from external customers by geography Revenue from External Customers by Geographic Areas [Table Text Block] Incentive Award Plan 2019 Incentive Award Plan 2019 [Member] Incentive Award Plan 2019 [Member] Capital office leases - finance lease asset Finance Lease, Right-of-Use Asset, before Accumulated Amortization City Area Code City Area Code Product and Service [Axis] Product and Service [Axis] Earnings per Share Earnings Per Share [Text Block] Sale of treasury shares Treasury stock sold at lower than repurchase price Treasury Stock Reissued at Lower than Repurchase Price Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Weighted Average Exercise Price per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Schedule of Weighted-Average Amortization Period for Finite-Lived Intangible Assets Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Exercise of public warrants Stock Issued During Period, Value, Public Warrants Exercised Stock Issued During Period, Value, Public Warrants Exercised Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Number of votes per share Common Stock, Voting Rights Total Liabilities, Fair Value Disclosure Senior Unsecured Notes Senior Unsecured Notes [Member] Represents information pertaining to Senior Unsecured Notes. Share-based Payment Arrangement, Expensed and Capitalized, Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Total Liabilities and Shareholders’ Equity Liabilities and Equity Other non-current assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Weighted-average risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Expected volatility - Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Other Restructuring Plans Other Restructuring Programs [Member] Other Restructuring Programs Net loss attributable to ordinary shares, diluted Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Costs and Expenses, Related Party Costs and Expenses, Related Party Decrease due to error correction adjustment Revision of Prior Period, Error Correction, Adjustment [Member] Sale of treasury shares (in shares) Stock Issued During Period, Shares, Treasury Stock Reissued Restructuring and impairment Restructuring and lease impairments Expenses recorded Restructuring Charges Contingent Liability Discount on Debt for the Underwriter's Fee Contingent Liability Discount on Debt for the Underwriter's Fee Contingent Liability Discount on Debt for the Underwriter's Fee Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Stock repurchase program, remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Termination Date Trading Arrangement Termination Date Document Information [Table] Document Information [Table] Vesting of restricted stock units (in shares) Vesting of Restricted Stock Units Vesting of Restricted Stock Units Other Operating Expense (Income), Net Other Operating Income and Expense [Text Block] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Repurchases of ordinary shares Payments for Repurchase of Equity CPA Global Equity Plan Phantom Share Units (PSUs) [Member] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Debt Covenant Terms [Domain] Debt Covenant Terms [Domain] Debt Covenant Terms [Domain] Non-Cash Financing Activities: Noncash Financing Items [Abstract] Noncash Financing Items Award Timing Disclosures [Line Items] Schedule Of Goodwill and Intangible Assets Disclosure [Table] Schedule Of Goodwill and Intangible Assets Disclosure [Table] The table disclosure represents goodwill and intangible asset. Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares Dividends Payable Document Information [Line Items] Document Information [Line Items] Restructuring Plan [Axis] Restructuring Plan [Axis] Prepaid sales commissions Prepaid Sales Commissions It represents Amount of asset related to sales commission paid in advance that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Remaining performance obligation, greater than one year, percentage Revenue, Remaining Performance Obligation, Greater than One Year, Percentage Revenue, Remaining Performance Obligation, Greater than One Year, Percentage Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Taxation Income Tax, Policy [Policy Text Block] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Insider Trading Arrangements [Line Items] Noncash items and other adjustments Restructuring Reserve, Asset Impairment Charge Restructuring Reserve, Asset Impairment Charge Proceeds from divestitures, net of cash and restricted cash Proceeds from Divestiture of Businesses, Net of Cash Divested Related Party [Axis] Related Party, Type [Axis] Aggregate intrinsic value, at the beginning of the year Aggregate intrinsic value, at the end of the year Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Noncash items Restructuring Reserve, Noncash Items And Other Adjustments Restructuring Reserve, Noncash Items And Other Adjustments Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Warrant liability Beginning balance Ending balance Warrants and Rights Outstanding Total Adjusted EBITDA Adjusted EBITDA Adjusted EBITDA Adjustment to Compensation, Amount Adjustment to Compensation Amount Accrued expenses and other current liabilities Increase (Decrease) in Other Current Liabilities Increase (decrease) in contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Cost of revenues Cost of Sales [Member] Databases and content Databases And Content [Member] The member represents the databases and content. Auditor Name Auditor Name Proceeds from revolving credit facility Proceeds from Lines of Credit Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Private Warrant Private Placement Warrant [Member] Private Placement Warrant Preferred stock, dividend rate (as a percent) Preferred Stock, Dividend Rate, Percentage Disposal Group Name [Axis] Disposal Group Name [Axis] Summary of the Company's assets and liabilities that were recognized at fair value on a recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Vested and exercisable at the end of the year (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Internally Developed Software and Content Internal Use Software, Policy [Policy Text Block] Repayment of long-term debt Repayments of Long-Term Debt 2024 Recorded Unconditional Purchase Obligation, to be Paid, Year Two Entity Central Index Key Entity Central Index Key Loss (gain) from the mark to market adjustment Derivative, Gain (Loss) on Derivative, Net Contingent Considerations Contingent Considerations [Policy Text Block] Disclosure of accounting policy related to contingent considerations. Share-based compensation expense Share-Based Payment Arrangement, Expense Long-term Debt Long-Term Debt [Member] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Finite-lived intangible assets, Gross Finite-Lived Intangible Assets, Gross Impairment of Leasehold Impairment of Leasehold Accrued compensation Employee-related Liabilities, Current Business Combination, Integration Related Costs Business Combination, Integration Related Costs Senior Secured Notes Senior Secured Notes 2026 [Member] Senior Secured Notes 2026 Name Trading Arrangement, Individual Name Total other comprehensive income (loss), net of tax Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Increase (decrease) Increase Decrease In Contract With Customer, Non Current Liability It represents Amount of increase (decrease) in Non Current obligation to transfer good or service to customer for which consideration has been received or is receivable. Schedule of disaggregated revenues Schedule of Revenue by reportable segment Disaggregation of Revenue [Table Text Block] Issuance of shares, net Shares issued to Capri Acquisition Topco Limited Stock Issued During Period, Value, New Issues Revenues, net Total revenues, net Total Revenues, net Revenue from Contract with Customer, Excluding Assessed Tax Amendment Flag Amendment Flag Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Clarivate stock to be issued Treasury Stock Acquired, Noncash Treasury Stock Acquired, Noncash Loss recovery asset Loss Contingency, Receivable Debt Instrument, Redemption, Period Four Debt Instrument, Redemption, Period Four [Member] Required principal amount remaining after redemption (as a percent) Debt Instrument. Redemption Through Equity Offerings, Threshold Minimum, Percentage Of Original Aggregate Principal Amount Remaining Outstanding Debt Instrument. Redemption Through Equity Offerings, Threshold Minimum, Percentage Of Original Aggregate Principal Amount Remaining Outstanding Stock issued, warrants exercised Stock Issued During Period, Shares, Warrants Exercised Stock Issued During Period, Shares, Warrants Exercised Business Combinations Business Combinations Policy [Policy Text Block] Stock repurchase program, authorized repurchases, price per share (in dollars per share) Stock Repurchase Program, Authorized Repurchases, Price Per Share Stock Repurchase Program, Authorized Repurchases, Price Per Share Leasehold improvements Leasehold Improvements [Member] Selling, General and Administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Diluted (in shares) Diluted weighted-average number of ordinary shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Goodwill, Written off Related to Sale of Business Unit Goodwill, Written off Related to Sale of Business Unit DRG DRG [Member] DRG Operating Expenses: Operating Expenses [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Total Assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Share Repurchase Program [Axis] Share Repurchase Program [Axis] Share-based award activity APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Amortization of debt issuance costs Increase (Decrease) in Deferred Charges Series A Preferred Stock Series A Preferred Stock [Member] Weighted average grant date fair value, vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Prime Prime Rate [Member] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Cash Flows From Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Goodwill and intangible asset impairments Goodwill and intangible asset impairments Goodwill and Intangible Asset Impairment Adjustment to Compensation: Adjustment to Compensation [Axis] Severance pay deposits, employer contribution, percent of employees salary Supplemental Unemployment Benefits, Severance Pay Deposits, Employer Contribution, Percent of Employees' Gross Pay Supplemental Unemployment Benefits, Severance Pay Deposits, Employer Contribution, Percent of Employees' Gross Pay Clarivate stock to be issued Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Debt Instrument [Line Items] Debt Instrument [Line Items] Scenario [Axis] Scenario [Axis] Basic (in shares) Basic weighted-average number of ordinary shares outstanding (in shares) Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Other consideration Disposal Group, Including Discontinued Operation, Consideration, Other Disposal Group, Including Discontinued Operation, Consideration, Other Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Debt Instrument, Redemption, Period Two Debt Instrument, Redemption, Period Two [Member] Other Property, Plant and Equipment, Other Types [Member] Revenue Remaining Performance Obligation Current Percentage Revenue Remaining Performance Obligation Current Percentage Revenue Remaining Performance Obligation Current Percentage Cost of revenues Cost of Revenue Loss on treasury stock sold at lower than repurchase price Treasury Stock Sold at Lower than Repurchase Price Treasury Stock Sold at Lower than Repurchase Price Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Schedule of Debt Schedule of Debt [Table Text Block] Stock repurchase program, shares authorized to be repurchased (in shares) Stock Repurchase Program, Number of Shares Authorized to be Repurchased Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] EX-101.PRE 9 clvt-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 10 image_0a.jpg begin 644 image_0a.jpg MB5!.1PT*&@H -24A$4@ ^\ %" ( "[+TH+ .4E$051X7NW6 MP0T , P"L>R_=/,N$P3)_B$6N!D *#$^^4- "8! *!5UGQL "@A9H' 8 (!6"_KFL)/N:"^. $E%3D2N0F"" end GRAPHIC 11 image_1a.jpg begin 644 image_1a.jpg MB5!.1PT*&@H -24A$4@ _< '" ( #"GBH< 3$E$051X7NW6 MP0D , P#L>Z_= MYFB[@(#V-![AS " 6O GRAPHIC 12 image_2a.jpg begin 644 image_2a.jpg MB5!.1PT*&@H -24A$4@ _D '" ( #<5QJO 3$E$051X7NW6 MP0D , P#L>Z_= MYFB[@(#V-![AS " 0 !)14Y$KD)@@@$! end XML 13 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Jul. 28, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Period End Date Jun. 30, 2023  
Document Quarterly Report true  
Current Fiscal Year End Date --12-31  
Document Transition Report false  
Entity File Number 001-38911  
Entity Registrant Name CLARIVATE PLC  
Entity Incorporation, State or Country Code Y9  
Entity Address, Address Line One 70 St. Mary Axe  
Entity Address, City or Town London  
Entity Address, Postal Zip Code EC3A 8BE  
Entity Address, Country GB  
Country Region 44  
City Area Code 207  
Local Phone Number 4334000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   676,234,313
Entity Central Index Key 0001764046  
Amendment Flag false  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus FY  
Entity Tax Identification Number 00-0000000  
Ordinary Shares    
Document Information [Line Items]    
Trading Symbol CLVT  
Security Exchange Name NYSE  
Title of 12(b) Security Ordinary Shares, no par value  
Series A Preferred Stock    
Document Information [Line Items]    
Trading Symbol CLVT PR A  
Security Exchange Name NYSE  
Title of 12(b) Security 5.25% Series A Mandatory Convertible Preferred Shares, no par value  
Preferred Stock Purchase Rights    
Document Information [Line Items]    
Security Exchange Name NYSE  
Title of 12(b) Security Series B Preferred Stock Purchase Rights  
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 436.1 $ 348.8
Restricted cash 7.0 8.0
Accounts receivable, net 769.7 872.1
Prepaid expenses 101.9 89.4
Other current assets 76.8 76.9
Assets held for sale 26.1 0.0
Total current assets 1,417.6 1,395.2
Property and equipment, net 50.7 54.5
Other intangible assets, net 9,186.4 9,437.7
Goodwill 2,895.5 2,876.5
Other non-current assets 76.0 97.9
Deferred income taxes 26.5 24.2
Operating lease right-of-use assets 52.9 58.9
Total Assets 13,705.6 13,944.9
Current liabilities:    
Accounts payable 108.2 101.4
Accrued compensation 101.2 132.1
Accrued expenses and other current liabilities 317.1 352.1
Current portion of deferred revenues 939.6 947.5
Current portion of operating lease liability 24.2 25.7
Current portion of long-term debt 1.1 1.0
Liabilities held for sale 6.5 0.0
Total current liabilities 1,497.9 1,559.8
Long-term debt 4,863.2 5,005.0
Non-current portion of deferred revenues 37.9 38.5
Other non-current liabilities 41.4 140.1
Deferred income taxes 262.1 316.1
Operating lease liabilities 64.8 72.9
Total liabilities 6,767.3 7,132.4
Shareholders’ equity:    
Preferred Shares, no par value; 14.4 shares authorized; 5.25% Mandatory Convertible Preferred Shares, Series A, 14.4 shares issued and outstanding as of both June 30, 2023 and December 31, 2022 1,392.6 1,392.6
Ordinary Shares, no par value; unlimited shares authorized at June 30, 2023 and December 31, 2022; 676.1 and 674.4 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 11,809.2 11,744.7
Accumulated other comprehensive loss (487.6) (665.9)
Accumulated deficit (5,775.9) (5,658.9)
Total shareholders’ equity 6,938.3 6,812.5
Total Liabilities and Shareholders’ Equity $ 13,705.6 $ 13,944.9
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
shares in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value (in dollars per share) $ 0 $ 0
Preferred stock, authorized (in shares) 14.4 14.4
Preferred stock, dividend rate (as a percent) 5.25% 5.25%
Preferred stock, issued (in shares) 14.4 14.4
Preferred stock, outstanding (in shares) 14.4 14.4
Ordinary shares, par value (in dollars per share) $ 0 $ 0
Ordinary shares, issued (in shares) 676.1 674.4
Ordinary shares, outstanding (in shares) 676.1 674.4
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues, net $ 668.8 $ 686.6 $ 1,297.9 $ 1,348.8
Operating Expenses:        
Cost of revenues 224.2 244.1 453.9 493.3
Selling, general and administrative costs 192.9 186.1 387.7 379.8
Depreciation and amortization 178.1 175.6 350.7 352.0
Restructuring and impairment 12.2 19.2 21.6 30.9
Goodwill and intangible asset impairments 135.2 0.0 135.2 0.0
Other operating income, net 14.5 (24.6) (17.5) (38.3)
Total operating expenses 757.1 600.4 1,331.6 1,217.7
(Loss) income from operations (88.3) 86.2 (33.7) 131.1
Mark to market (gain) loss on financial instruments (2.9) (49.0) (1.8) (149.4)
Interest expense and amortization of debt discount, net 73.0 62.3 146.6 121.8
Income (loss) before income taxes (158.4) 72.9 (178.5) 158.7
(Benefit) provision for income taxes (35.3) 10.5 (98.9) 26.8
Net (loss) income (123.1) 62.4 (79.6) 131.9
Dividends on preferred shares 18.6 18.7 37.4 37.4
Net income (loss) attributable to ordinary shares $ (141.7) $ 43.7 $ (117.0) $ 94.5
Earnings per share        
Basic (usd per share) $ (0.21) $ 0.06 $ (0.17) $ 0.14
Diluted (usd per share) $ (0.21) $ 0.00 $ (0.17) $ (0.07)
Weighted average shares used to compute earnings per share:        
Basic (in shares) 675.9 674.3 675.4 678.3
Diluted (in shares) 675.9 678.4 675.4 683.2
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statement of Comprehensive Income [Abstract]        
Net income (loss) $ (123.1) $ 62.4 $ (79.6) $ 131.9
Other comprehensive income (loss), net of tax:        
Interest rate swaps 7.3 3.9 (5.1) 15.8
Foreign currency translation adjustment 82.6 (626.6) 183.4 (861.7)
Total other comprehensive income (loss), net of tax 89.9 (622.7) 178.3 (845.9)
Comprehensive income (loss) $ (33.2) $ (560.3) $ 98.7 $ (714.0)
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Ordinary Shares
Preferred Shares
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Treasury Stock, Common
Increase (Decrease) in Shareholders' Equity            
Treasury Stock, Common, Shares           500,000
Balance at beginning of the period (in shares) at Dec. 31, 2021   683,100,000 14,400,000      
Balance at beginning of the period at Dec. 31, 2021 $ 11,925.9 $ 11,827.9 $ 1,392.6 $ 326.7 $ (1,604.4)  
Balance at beginning of the period at Dec. 31, 2021           $ 16.9
Increase (Decrease) in Shareholders' Equity            
Reclassification of EBT Shares   (500,000)        
Exercise of stock options (in shares)   200,000        
Exercise of stock options 0.4 $ 0.4        
Vesting of restricted stock units (in shares)   700,000        
Share-based award activity (in shares)   (400,000)        
Share-based award activity 21.5 $ 21.5        
Repurchase of ordinary shares (in shares)   (4,100,000)       (4,100,000)
Repurchases of ordinary shares (66.4)         $ (66.4)
Retirement of treasury shares (in shares)           (2,100,000)
Retirement of treasury shares   $ (34.8)     1.5 $ 33.3
Sale of treasury shares (in shares)           0
Sale of treasury shares 0.6       (0.7) $ 1.3
Dividends to preferred shareholders (18.7)       (18.7)  
Net income (loss) 69.5       69.5  
Other comprehensive income (loss) (223.2)     (223.2)    
Balance at end of the period (in shares) at Mar. 31, 2022   679,000,000.0 14,400,000      
Balance at end of the period at Mar. 31, 2022 11,709.6 $ 11,815.0 $ 1,392.6 103.5 (1,552.8)  
Balance at end of the period at Mar. 31, 2022           (48.7)
Balance at beginning of the period (in shares) at Dec. 31, 2021   683,100,000 14,400,000      
Balance at beginning of the period at Dec. 31, 2021 $ 11,925.9 $ 11,827.9 $ 1,392.6 326.7 (1,604.4)  
Balance at beginning of the period at Dec. 31, 2021           16.9
Increase (Decrease) in Shareholders' Equity            
Repurchase of ordinary shares (in shares) (10,700,000)          
Repurchases of ordinary shares $ (175.0)          
Retirement of treasury shares (in shares) (10,700,000)          
Retirement of treasury shares $ (167.3)       (7.7) 175.0
Sale of treasury shares (in shares) 41,700          
Sale of treasury shares         (0.7)  
Net income (loss) $ 131.9          
Other comprehensive income (loss) (845.9)          
Balance at end of the period (in shares) at Jun. 30, 2022     14,400,000      
Balance at end of the period at Jun. 30, 2022 11,040.7 $ 11,700.9 $ 1,392.6 (519.2) (1,518.0)  
Balance at end of the period at Jun. 30, 2022           $ (15.6)
Increase (Decrease) in Shareholders' Equity            
Treasury Stock, Common, Shares           2,500,000
Balance at beginning of the period (in shares) at Mar. 31, 2022   679,000,000.0 14,400,000      
Balance at beginning of the period at Mar. 31, 2022 11,709.6 $ 11,815.0 $ 1,392.6 103.5 (1,552.8)  
Balance at beginning of the period at Mar. 31, 2022           $ (48.7)
Increase (Decrease) in Shareholders' Equity            
Exercise of stock options (in shares)   0        
Exercise of stock options 0.1 $ 0.1        
Vesting of restricted stock units (in shares)   (1,300,000)        
Share-based award activity (in shares)   (400,000)        
Share-based award activity 18.3 $ 18.3        
Repurchase of ordinary shares (in shares)   (6,600,000)       (6,600,000)
Repurchases of ordinary shares (108.6)         $ (108.6)
Retirement of treasury shares (in shares)   0       (8,600,000)
Retirement of treasury shares   $ (132.5)     (9.2) $ 141.7
Sale of treasury shares (in shares)   0       0
Sale of treasury shares 0.3       0.3 $ 0.0
Dividends to preferred shareholders (in shares)   0        
Dividends to preferred shareholders (18.7) $ 0.0     (18.7)  
Net income (loss) 62.4       62.4  
Other comprehensive income (loss) (622.7)     (622.7)    
Balance at end of the period (in shares) at Jun. 30, 2022     14,400,000      
Balance at end of the period at Jun. 30, 2022 $ 11,040.7 $ 11,700.9 $ 1,392.6 (519.2) (1,518.0)  
Balance at end of the period at Jun. 30, 2022           $ (15.6)
Increase (Decrease) in Shareholders' Equity            
Treasury Stock, Common, Shares           500,000
Treasury Stock, Common, Shares 0         0
Balance at beginning of the period (in shares) at Dec. 31, 2022   674,400,000 14,400,000      
Balance at beginning of the period at Dec. 31, 2022 $ 6,812.5 $ 11,744.7 $ 1,392.6 (665.9) (5,658.9)  
Balance at beginning of the period at Dec. 31, 2022           $ 0.0
Increase (Decrease) in Shareholders' Equity            
Vesting of restricted stock units (in shares)   1,800,000        
Share-based award activity (in shares)   (600,000)        
Share-based award activity 33.7 $ 33.7        
Dividends to preferred shareholders (18.8)       (18.8)  
Net income (loss) 43.5       43.5  
Other comprehensive income (loss) 88.4     88.4    
Balance at end of the period (in shares) at Mar. 31, 2023   675,600,000 14,400,000      
Balance at end of the period at Mar. 31, 2023 6,959.3 $ 11,778.4 $ 1,392.6 (577.5) (5,634.2)  
Balance at end of the period at Mar. 31, 2023           0.0
Balance at beginning of the period (in shares) at Dec. 31, 2022   674,400,000 14,400,000      
Balance at beginning of the period at Dec. 31, 2022 6,812.5 $ 11,744.7 $ 1,392.6 (665.9) (5,658.9)  
Balance at beginning of the period at Dec. 31, 2022           0.0
Increase (Decrease) in Shareholders' Equity            
Retirement of treasury shares 0.0          
Net income (loss) (79.6)          
Other comprehensive income (loss) 178.3          
Balance at end of the period (in shares) at Jun. 30, 2023   676,100,000 14,400,000      
Balance at end of the period at Jun. 30, 2023 6,938.3 $ 11,809.2 $ 1,392.6 (487.6) (5,775.9)  
Balance at end of the period at Jun. 30, 2023           $ 0.0
Increase (Decrease) in Shareholders' Equity            
Treasury Stock, Common, Shares           0
Balance at beginning of the period (in shares) at Mar. 31, 2023   675,600,000 14,400,000      
Balance at beginning of the period at Mar. 31, 2023 6,959.3 $ 11,778.4 $ 1,392.6 (577.5) (5,634.2)  
Balance at beginning of the period at Mar. 31, 2023           $ 0.0
Increase (Decrease) in Shareholders' Equity            
Vesting of restricted stock units (in shares)   800,000        
Share-based award activity (in shares)   (300,000)        
Share-based award activity 30.8 $ 30.8        
Dividends to preferred shareholders (18.6)       (18.6)  
Net income (loss) (123.1)       (123.1)  
Other comprehensive income (loss) 89.9     89.9    
Balance at end of the period (in shares) at Jun. 30, 2023   676,100,000 14,400,000      
Balance at end of the period at Jun. 30, 2023 $ 6,938.3 $ 11,809.2 $ 1,392.6 $ (487.6) $ (5,775.9)  
Balance at end of the period at Jun. 30, 2023           $ 0.0
Increase (Decrease) in Shareholders' Equity            
Treasury Stock, Common, Shares 0         0
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows From Operating Activities    
Net income (loss) $ (79.6) $ 131.9
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 350.7 352.0
Deferred Income Taxes and Tax Credits (47.8) (0.9)
Share-based compensation 71.6 47.2
Restructuring and impairments 138.7 (1.0)
Mark to market gain on financial instruments (1.8) (149.4)
Amortization of debt issuance costs 9.1 7.6
Gain on legal settlement (49.4) 0.0
Other operating activities 18.8 (33.6)
Changes in operating assets and liabilities:    
Accounts receivable 121.7 53.8
Prepaid expenses (11.9) (26.9)
Other assets 38.6 (24.8)
Accounts payable 6.2 (8.8)
Accrued expenses and other current liabilities (74.2) (150.3)
Deferred revenues (18.4) (29.5)
Operating leases, net (4.5) 3.4
Other liabilities (77.9) (6.1)
Net cash provided by operating activities 389.9 164.6
Cash Flows From Investing Activities    
Capital expenditures (116.9) (89.1)
Payments for acquisitions and cost method investments, net of cash acquired (1.1) (14.3)
Proceeds from divestitures, net of cash and restricted cash 10.5 0.0
Net cash used in investing activities (107.5) (103.4)
Cash Flows From Financing Activities    
Principal payments on term loan (150.0) (14.3)
Payment of debt issuance costs and discounts 0.1 2.1
Proceeds from issuance of treasury shares 0.0 0.9
Repurchases of ordinary shares 0.0 (175.0)
Cash dividends on preferred shares (37.7) (37.7)
Proceeds from stock options exercised 0.0 0.5
Payments related to finance lease (0.5) (1.0)
Payments related to tax withholding for stock-based compensation (9.7) (10.7)
Net cash used in financing activities (197.8) (239.4)
Effects of exchange rates 1.7 (36.5)
Net increase (decrease) in cash and cash equivalents 87.3 (71.2)
Net decrease in restricted cash (1.0) (143.5)
Net increase (decrease) in cash and cash equivalents, and restricted cash 86.3 (214.7)
Cash and cash equivalents, beginning of period 348.8 430.9
Restricted cash, beginning of period 8.0 156.7
Total cash and cash equivalents, and restricted cash, beginning of period 356.8 587.6
Cash and cash equivalents, end of period 436.1 359.7
Restricted cash, end of period 7.0 13.2
Total cash and cash equivalents, and restricted cash, end of period 443.1 372.9
Supplemental Cash Flow Information:    
Cash paid for interest 136.4 113.4
Cash paid for income tax 22.5 23.7
Capital expenditures included in accounts payable 10.3 23.8
Non-Cash Financing Activities:    
Stock repurchased and retired 0.0 167.3
Total Non-Cash Financing Activities 6.2 (168.8)
Treasury Stock, Common    
Non-Cash Financing Activities:    
Stock repurchased and retired   (175.0)
Series A Preferred Stock    
Non-Cash Financing Activities:    
Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares $ 6.2 $ 6.2
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Statement of Cash Flows [Abstract]    
Preferred stock, dividend rate (as a percent) 5.25% 5.25%
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Background and Nature of Operations
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Background and Nature of Operations Background and Nature of Operations
Clarivate Plc (“Clarivate,” “us,” “we,” “our,” or the “Company”), is a public limited company organized under the laws of Jersey, Channel Islands, pursuant to the definitive agreement entered into on May 13, 2019 to effect a merger between Camelot Holdings (Jersey) Limited ("Jersey") and Churchill Capital Corp, a Delaware corporation ("Churchill") (the “2019 Transaction”).
The Company is a provider of proprietary and comprehensive information, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science and healthcare companies, corporations and law firms to power the entire innovation lifecycle, from cultivating curiosity to protecting the world's critical intellectual property assets. Clarivate has three reportable segments: Academia & Government ("A&G"), Intellectual Property ("IP"), and Life Sciences & Healthcare ("LS&H"). Our segment structure is organized based on the products we offer and the markets they serve. See Note 16 - Segment Information, for additional information on the Company's reportable segments.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Presentation
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements of the Company have been prepared on substantially the same basis as our annual consolidated financial statements and should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022. Results from interim periods should not be considered indicative of results for the full year. In the opinion of management, these Condensed Consolidated Financial Statements reflect all adjustments necessary for a fair statement of financial position, results of operations, and cash flows for the periods presented, and such adjustments are of a normal, recurring nature.
The Condensed Consolidated Financial Statements of the Company include the accounts of all of its subsidiaries. Subsidiaries are entities over which the Company has control, where control is defined as the power to govern financial and operating policies. Generally, the Company has a shareholding of more than 50% of the voting rights in its subsidiaries. The effect of potential voting rights that are currently exercisable is considered when assessing whether control exists. Subsidiaries are fully consolidated from the date control is transferred to the Company, and are de-consolidated from the date control ceases. Intercompany accounts and transactions have been eliminated in consolidation.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Our significant accounting policies are those that we believe are important to the portrayal of our financial condition and results of operations, as well as those that involve significant judgments or estimates about matters that are inherently uncertain. There have been no material changes to the significant accounting policies discussed in Item 8. Financial Statements and Supplementary Data – Notes to the Consolidated Financial Statements – Note 3 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 1, 2023.
Newly Adopted Accounting Standards
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform between March 12, 2020 and December 31, 2022. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides additional optional guidance on the transition from LIBOR to include derivative instruments that use an interest rate for margining, discounting or contract price alignment. The standard will ease, if warranted, the requirements for accounting for the future effects of the rate reform. Additionally, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform: Deferral of the Sunset Date of Topic 848, which deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024 to align with the amended cessation date of LIBOR. In 2020, the Company adopted ASU 2020-04, and, upon meeting the specified criteria in the guidance, elected the optional expedients for its interest rate swaps and debt agreements with reference to LIBOR. Accordingly, the Company has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt agreements. ASU 2021-01 and ASU 2022-06 did not have an effect on how
the Company accounts for its interest rate swaps and debt agreements due to our election and application of the optional expedients discussed above in connection with ASU 2020-04.
During the second quarter of 2023, the Company modified the contractual terms of its interest rate swaps and debt agreements to replace the previous LIBOR-based reference rate with the Term SOFR (Secured Overnight Financing Rate). The Company utilized the practical expedients set forth in Topic 848 and has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt instruments.
Recently Issued Accounting Standards
There were no other new accounting standards or updates issued or effective as of June 30, 2023, that have, or are expected to have, a material impact on the Company's Condensed Consolidated Financial Statements.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Assets Held for Sale and Divested Operations
6 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Assets Held for Sale and Divested Operations
Note 4: Assets Held for Sale and Divested Operations
During the second quarter 2023, the Company entered into a commercial agreement to sell a small product group within its IP segment for approximately $34 payable over ten years. The divestiture enables improved focus on our core IP business assets and empowers product development and innovation teams to build upon our market-leading IP intelligence, IP lifecycle management and IP services solutions. The transaction, which is expected to close during the fourth quarter of 2023, does not represent a strategic shift, nor is it expected to have a material impact on the Company’s operations or financial results. Accordingly, the divestiture meets the held-for-sale criteria but does not qualify as a discontinued operation as of June 30, 2023.
Prior to the held-for-sale determination and accompanying impairment testing as of June 30, 2023, the carrying amount of the expected assets to be disposed of consisted almost entirely of purchase-related identifiable customer relationship intangible assets of approximately $158. These intangible assets were reduced to estimated fair value of $26.1 based on the estimated present value of the consideration to be paid over ten years and were reclassified to Assets held-for-sale on the Condensed Consolidated Balance Sheet as of June 30, 2023. The related impairment charge of $132.2 is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. The carrying amount of the expected liabilities to be transferred consisted of the remaining deferred tax liabilities associated with those intangibles of $6.5, which were reclassified to Liabilities held-for-sale on the Condensed Consolidated Balance Sheet as of June 30, 2023.
On October 31, 2022, the Company completed the sale of the MarkMonitor Domain Management business (IP segment) to Newfold Digital, a leading web presence solutions provider. During the second quarter 2023, the Company received the $10.5 of deferred closing consideration included in the aggregate sale price.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment, Net
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net Property and Equipment, Net
Property and equipment, net consisted of the following:
June 30,December 31,
20232022
Computer hardware$49.3 $45.1 
Leasehold improvements15.6 16.1 
Furniture, fixtures and equipment42.0 39.0 
Capital office leases - finance lease asset8.0 8.0 
Other2.2 2.1 
Total property and equipment, gross$117.1 $110.3 
Accumulated depreciation(66.4)(55.8)
Total property and equipment, net$50.7 $54.5 
Depreciation expense was $5.4 and $9.8 for the three months ended June 30, 2023 and 2022, respectively, and $11.3 and $20.4 for the six months ended June 30, 2023 and 2022, respectively.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Other Intangible Assets, net and Goodwill
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Other Intangible Assets, net and Goodwill Other Intangible Assets, net and Goodwill
Other Intangible Assets, net
The following tables summarize the gross carrying amounts and accumulated amortization of the Company’s identifiable intangible assets by major class:
June 30, 2023December 31, 2022
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
Finite-lived intangible assets:
Customer relationships$7,778.4 $(994.7)$6,783.7 $7,809.0 $(821.5)$6,987.5 
Databases and content2,733.7 (889.7)1,844.0 2,681.0 (780.5)1,900.5 
Computer software828.2 (469.2)359.0 765.1 (422.2)342.9 
Other88.7 (45.9)42.8 88.8 (38.9)49.9 
Finite-lived intangible assets$11,429.0 $(2,399.5)$9,029.5 $11,343.9 $(2,063.1)$9,280.8 
Indefinite-lived intangible assets:
Trade names156.9 — 156.9 156.9 — 156.9 
Total intangible assets$11,585.9 $(2,399.5)$9,186.4 $11,500.8 $(2,063.1)$9,437.7 
Intangible amortization expense was $172.7 and $165.8 for the three months ended June 30, 2023, and 2022, respectively, and $339.4 and $331.6 for the six months ended June 30, 2023, and 2022, respectively.
Goodwill
The change in the carrying amount of goodwill by segment is shown below:
A&G
Segment
IP
Segment
LS&H
Segment
Consolidated Total
Balance as of December 31, 2022$1,109.8 $590.3 $1,176.4 $2,876.5 
Goodwill impairment(1)
— (3.0)— (3.0)
Impact of foreign currency fluctuations(0.2)22.2 — 22.0 
Balance as of June 30, 2023$1,109.6 $609.5 $1,176.4 $2,895.5 
(1) Recorded in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Instruments
6 Months Ended
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Derivative InstrumentsThe Company has interest rate swap arrangements with counterparties to reduce its exposure to variability in cash flows relating to interest payments on its outstanding SOFR-based Term Loan arrangements (see Note 3 - Summary of Significant Accounting Policies for additional information). Our interest rate swap arrangements are subject to hedge accounting, by designating the interest rate swaps as hedges on applicable future quarterly interest payments. The following table provides a summary of the Company's interest rate swap arrangements by maturity date as of June 30, 2023:
Notional ValueEffective DateMaturity DateFixed Rate
$48.9March 31, 2021September 29, 20231.640%
$48.9April 30, 2021September 29, 20231.640%
$100.0March 31, 2021March 31, 20240.401%
$100.0October 31, 2022March 31, 20240.421%
$150.0October 31, 2022March 31, 20240.445%
$384.1August 4, 2022October 31, 20262.809%
$384.1August 5, 2022October 31, 20263.010%
Changes in fair value are recorded in Accumulated other comprehensive income (loss) ("AOCI") in the Condensed Consolidated Balance Sheets and the amounts reclassified out of AOCI are recorded to Interest expense and amortization of debt discount, net in the Condensed Consolidated Statements of Operations.
The fair value of the interest rate swaps is recorded in Other current assets or Accrued expenses and other current liabilities and Other non-current assets or Other non-current liabilities in the Condensed Consolidated Balance Sheets, according to the duration of related cash flows. The fair value of the interest rate swaps was an asset balance of $44.4 and $49.5 as of June 30, 2023 and December 31, 2022, respectively. See Note 8 - Fair Value Measurements for additional information related to the fair value of these derivative instruments.
For additional information on our interest rate risk, see Item 3. Quantitative and Qualitative Disclosures about Market Risk, and see Note 9 - Debt for additional information on our outstanding Term Loan.
Foreign Currency Forward Contracts
The Company periodically enters into foreign currency contracts, which generally do not exceed 180 days in duration, to help manage the Company’s exposure to foreign exchange rate risks. The contracts are not designated as accounting hedges under the applicable sections of ASC 815, Derivatives and Hedging.
The Company accounts for these forward contracts at fair value and recognizes the associated realized and unrealized gains and losses in Other operating income, net in the Condensed Consolidated Statements of Operations. The Company recognized a loss (gain) from the mark to market adjustment of $2.9 and $(1.0), for the three months ended June 30, 2023 and 2022, respectively, and $(0.3) and $5.7 for the six months ended June 30, 2023 and 2022, respectively. The amounts disclosed for the three and six months ended June 30, 2022 were revised from the previously reported losses of $5.7 and $12.4, respectively. The principal amount of outstanding foreign currency contracts was $162.0 and $165.1 as of June 30, 2023 and December 31, 2022, respectively.
The total fair value of the forward contracts represented an asset balance of $1.3 and $0.8, and a liability balance of $0.6 and $0.4, as of June 30, 2023 and December 31, 2022, respectively, which are classified as Other current assets and Accrued expenses and other current liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 8 - Fair Value Measurements for additional information related to the fair value of derivative instruments.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Assets and Liabilities Recorded at Fair Value on a Recurring Basis
The following table provides a summary of the Company’s assets and liabilities that were recognized at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:
June 30, 2023
Level 2Level 3Total
Fair Value
Assets
Forward currency contracts - current$1.3 $— $1.3 
Interest rate swaps - current13.4 — 13.4 
Interest rate swaps - non-current31.0 — 31.0 
Total$45.7 $— $45.7 
Liabilities
Forward currency contracts - current$0.6 $— $0.6 
Warrant liability - current— 19.2 19.2 
Total$0.6 $19.2 $19.8 
December 31, 2022
Level 2Level 3Total
Fair Value
Assets
Forward currency contracts - current$0.8 $— $0.8 
Interest rate swaps - current2.3 — 2.3 
Interest rate swaps - non-current47.2 — 47.2 
Total$50.3 $— $50.3 
Liabilities
Forward currency contracts - current$0.4 $— $0.4 
Warrant liability - non-current— 21.0 21.0 
Total$0.4 $21.0 $21.4 
There were no transfers of assets or liabilities between levels during the six months ended June 30, 2023 or year ended December 31, 2022.
Private Placement Warrants - The following table summarizes the changes in the Private Placement Warrants liability for the three and six months ended June 30, 2023 and 2022:
20232022
Balance as of January 1$21.0 $227.8 
Mark to market loss (gain) on financial instruments1.1 (100.4)
Exercise of Private Placement Warrants— — 
Balance as of March 31$22.1 $127.4 
Mark to market gain on financial instruments(2.9)(49.0)
Exercise of Private Placement Warrants— — 
Balance as of June 30$19.2 $78.4 
Non-Financial Assets Valued on a Non-Recurring Basis
The Company’s long-lived assets, including goodwill, indefinite-lived intangible and finite-lived intangible assets subject to amortization, are measured at fair value on a non-recurring basis. These assets are measured at cost but are written-down to fair value, if necessary, as a result of impairment.
Finite-lived Intangible Assets - If a triggering event occurs, the Company determines the estimated fair value of finite-lived intangible assets by determining the present value of the expected cash flows. During the second quarter of 2023, the Company recorded an impairment charge of $132.2 in connection with intangible assets classified as Assets held-for-sale. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information. Goodwill - Goodwill represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets resulting from business combinations. The Company evaluates its goodwill for impairment at the reporting unit level, defined as an operating segment or one level below an operating segment, annually as of October 1 or more frequently if impairment indicators arise in accordance with ASC Topic 350. The Company performs qualitative analysis of macroeconomic conditions, industry and market considerations, internal cost factors, financial performance, fair value history and other company specific events. If this qualitative analysis indicates that it is more likely than not that the estimated fair value is less than the book value for the respective reporting unit, the Company applies a one-step impairment test in which the Company determines whether the estimated fair value of the reporting unit is in excess of its carrying value. If the carrying value of the net assets assigned to the reporting unit exceeds the estimated fair value of the reporting unit, the Company performs the second step of the impairment test to determine the implied estimated fair value of the reporting unit’s goodwill. The Company determines the implied estimated fair value of goodwill by determining the present value of the estimated future cash flows for each reporting unit and comparing the reporting unit’s risk profile and growth prospects to selected, reasonably similar publicly traded companies. During the second quarter of 2023, the Company recorded an impairment charge of $3.0 in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 6 - Other Intangible Assets, net and Goodwill for additional information.
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Debt
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Debt Debt
The following table is a summary of the Company’s debt:
June 30, 2023December 31, 2022
TypeMaturityEffective
Interest
Rate
Carrying
Value
Effective
Interest
Rate
Carrying
Value
Senior Notes20294.875 %$921.4 4.875 %$921.4 
Senior Secured Notes20283.875 %921.2 3.875 %921.2 
Revolving Credit Facility20277.952 %— 7.234 %— 
Term Loan Facility 20268.217 %2,347.4 7.384 %2,497.4 
Senior Secured Notes20264.500 %700.0 4.500 %700.0 
Finance lease20366.936 %30.8 6.936 %31.3 
Total debt outstanding4,920.8 5,071.3 
Debt discounts and issuance costs(56.5)(65.3)
Current portion of long-term debt(1.1)(1.0)
Long-term debt$4,863.2 $5,005.0 
Financing Transactions
Senior Notes (2029) and Senior Secured Notes (2028)
The Company has $921.2 aggregate principal amount of its Senior Secured Notes due 2028 and $921.4 aggregate principal amount of its Senior Notes due 2029 bearing interest at a rate of 3.875% and 4.875% per annum, respectively, payable semi-annually to holders of record on June 30 and December 30 of each year. The first interest payment was paid in December 2021. Both of these series of Notes were issued by Clarivate Science Holdings Corporation (the "Issuer"), an indirect wholly-owned subsidiary of Clarivate.
The Senior Secured Notes due 2028 are secured on a first-lien pari passu basis with borrowings under the existing credit facilities and Senior Secured Notes due 2026. Both of these series of Notes are guaranteed on a joint and several basis by each of Clarivate’s indirect subsidiaries that is an obligor or guarantor under Clarivate’s existing credit facilities and Senior Secured Notes due 2026. The Senior Notes due 2029 are the Issuer’s and such guarantors’ unsecured obligations.

Senior Secured Notes (2026)
The Company has $700.0 aggregate principal amount of its Senior Secured Notes due 2026 bearing interest at a rate of 4.50% per annum, payable semi-annually to holders of record on May 1 and November 1 of each year. The first interest payment was paid in May 2020. The Senior Secured Notes due 2026 were issued by Camelot Finance S.A. (the "Lux Issuer"), an indirect wholly-owned subsidiary of Clarivate, and are secured on a first-lien pari passu basis with borrowings under the Credit Facilities and Senior Secured Notes due 2028. These Notes are guaranteed on a joint and several basis by each of Clarivate's indirect subsidiaries that is an obligor or guarantor under the Credit Facilities and are general senior secured obligations of the Lux Issuer and are secured on a first-priority basis by the collateral now owned or hereafter acquired by the Lux Issuer and each of the guarantors that secures the Issuer’s and such guarantor’s obligations under Clarivate's credit facilities (subject to permitted liens and other exceptions).
The Credit Facilities
The Company's Credit Facilities consist of a $750.0 Revolving Credit Facility with a $80.0 letter of credit sublimit, due 2027, and a $2,860.0 Term Loan Facility due 2026.
Revolving Credit Facility
As of June 30, 2023 and December 31, 2022, the Company had no outstanding balance on its Revolving Credit Facility. The facility provides for revolving loans, same-day borrowings and letters of credit pursuant to commitments in an aggregate principal amount of $750.0 with a letter of credit sublimit of $80.0. Proceeds of loans made under the Revolving Credit Facility may be borrowed, repaid and reborrowed prior to the maturity of the Revolving Credit Facility. Our ability to draw under the Revolving Credit Facility or issue letters of credit thereunder is conditioned upon, among other things, delivery of required notices, accuracy of the representations and warranties contained in the Credit Agreement and the absence of any default or event of default under the Credit Agreement.
As of June 30, 2023, letters of credit totaling $8.8 were collateralized by the Revolving Credit Facility, and, notwithstanding the Revolving Credit Facility, the Company had unsecured corporate guarantees outstanding of $13.6 and cash collateralized letters of credit of $3.6, which were not collateralized by the Revolving Credit Facility.
Term Loan Facility (2026)
The Company has a Term Loan Facility of $2,860.0 due 2026, which was fully drawn at closing. During the fourth quarter 2022, the Company made a $300.0 prepayment on its Term Loan Facility and prepayments of $150.0 during the six months ended June 30, 2023. Prior to the initial prepayment, the principal amount of the Term Loan Facility was repaid by the Company on the last business day of each March, June, September and December, in an amount equal to 0.25% of the aggregate original par principal amount of the initial term loans.
The carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value due to the short-term nature of the interest rate benchmark rates. The fair value of the fixed rate debt is estimated based on market observable data for debt with similar prepayment features. The fair value of the Company’s debt was $4,647.4 and $4,709.6 at June 30, 2023 and December 31, 2022, respectively, and is considered Level 2 under the fair value hierarchy.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregated Revenues
We disaggregate our revenues by segment (see Note 16 - Segment Information) and by transaction type based on revenue recognition pattern as follows:
Subscription-based revenues are recurring revenues that are earned under annual, evergreen or multi-year contracts pursuant to which we license the right to use our products to our customers or provide maintenance services over a contractual term. Revenues from the sale of subscription data, maintenance services, and analytics solutions are recognized ratably over the contractual period.
Re-occurring revenues are earned under contracts for specific deliverables that are typically quoted on a product, data set or project basis and often derived from repeat customers. These contracts include either evergreen clauses, in which at least six month advance notice is required prior to cancellation, or the contract is for multiple years. Deliverables are usually received by the customer instantly or in a short period of time, at which time the revenues are recognized. The most significant component of our re-occurring revenues is our 'renewal' business within CPA Global.
Transactional and other revenues are earned under contracts for specific deliverables that are typically quoted on a product, data set or project basis and often derived from repeat customers, including customers that also generate subscription-based revenues. Transactional and other revenues may involve sales to the same customer on multiple occasions but with different products or services comprising the order. Other revenues relate to professional services including implementation for software and software as a service ("SaaS") subscriptions. These contracts vary in length from several months to years for multi-year projects. Revenue is recognized over time utilizing a reasonable measure of progress depicting the satisfaction of the related performance obligation. Other revenues also includes one-time perpetual archive license revenues.
The following table presents the Company’s revenues by transaction type based on revenue recognition pattern for the periods presented:
Three Months Ended June 30,
20232022
Subscription revenues$406.0 $407.4 
Re-occurring revenues111.0 112.0 
Transactional and other revenues151.8 168.0 
Deferred revenues adjustment— (0.8)
Revenues, net$668.8 $686.6 
Six Months Ended June 30,
20232022
Subscription revenues$799.2 $811.2 
Re-occurring revenues218.7 226.5 
Transactional and other revenues280.0 311.7 
Deferred revenues adjustment— (0.6)
Revenues, net$1,297.9 $1,348.8 
Contract Balances
Balances, as of:Accounts receivable, netCurrent
deferred revenues
Non-current
deferred revenues
December 31, 2022$872.1 $947.5 $38.5 
June 30, 2023769.7 939.6 37.9 
Decrease$(102.4)$(7.9)$(0.6)
December 31, 2021$906.4 $1,030.4 $54.2 
June 30, 2022812.4 956.7 50.3 
Decrease$(94.0)$(73.7)$(3.9)
The Company recognized revenue of $588.9 during the six months ended June 30, 2023, attributable to deferred revenues recorded at the beginning of each such period. During the three months ended June 30, 2023, we revised the disclosure in this Note by $113.9 to decrease the revenue recognized that was included in the opening deferred revenue balance to $343.9 for the three months ended March 31, 2023. This correction did not have an impact on the accompanying Condensed Consolidated Balance Sheets or Statements of Operations. Those amounts primarily consisted of subscription revenues recognized ratably over the contractual term during the respective reporting periods.
Transaction Price Allocated to Remaining Performance Obligations
Revenue allocated to remaining performance obligations represents the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. Our most significant remaining performance obligations relate to contracts in which we license the right to use our products to our customers or provide maintenance services over the remaining contractual term, a majority of which are contracts with a duration of one year or less. As of June 30, 2023, approximately 90% of the aggregate transaction price allocated to remaining performance obligations are expected to be satisfied within one year.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
As of June 30, 2023, there were unlimited shares of ordinary stock authorized and 676.1 million shares issued and outstanding, with no par value. The Company did not hold any shares as treasury shares as of June 30, 2023 and December 31, 2022. The Company’s ordinary shareholders are entitled to one vote per share.
MCPS Offering
In June 2021, concurrently with the June 2021 Ordinary Share Offering (see Note 1 - Background and Nature of Operations, in our Annual Report on Form 10-K), we completed a public offering of 14.4 million of our 5.25% Series A Mandatory Convertible Preferred Shares ("MCPS") (which included 1.9 million of our MCPS that the underwriters purchased pursuant to their option to purchase additional shares). Dividends on our mandatory convertible preferred shares are payable, as and if declared by our Board of Directors, at an annual rate of 5.25% of the liquidation preference of $100.00 per share. We may pay declared dividends on March 1, June 1, September 1 and December 1 of each year, commencing on September 1, 2021, and ending on, and including, June 1, 2024. Each of our convertible preferred shares has a liquidation preference of $100.00.
As of June 30, 2023, we accrued $6.2 of preferred share dividends within Accrued expenses and other current liabilities. While the dividends on the MCPS are cumulative, they will not be paid until declared by the Company’s Board of Directors. If the dividends are not declared, they will continue to accumulate until paid, due to a backstop contained in the agreement (even if never declared).
Treasury Shares
CPA Global Acquisition Shares - During the six months ended June 30, 2022, 41.7 thousand shares held in the Employee Benefit Trust ("EBT"), established for the CPA Global Equity Plan, were sold at an average net price per share of $15.01 to fund the payment to the respective employees. Given the original share value of $30.99 as of the date of the acquisition, an associated loss was recognized within the Condensed Consolidated Statement of Changes in Equity in the amount of $0.7 during the six months ended June 30, 2022. The CPA Global Equity Plan was terminated during the year ended December 31, 2022 after all remaining shares were sold and payments were made to respective employees.
Share Repurchase Program and Share Retirements - In February 2022, the Company's Board of Directors approved the purchase of up to $1,000.0 of the Company's ordinary shares through open-market purchases, to be executed through December 31, 2023. During the six months ended June 30, 2022, the Company repurchased 10.7 million ordinary shares at an average price per share of $16.33 with a total carrying value of $175.0 all of which were subsequently retired at an average price at retirement of $15.61 and restored as authorized but unissued ordinary shares. Upon formal retirement and in accordance with ASC Topic 505, Equity, the Company reduced its ordinary shares account by the carrying amount of the treasury shares. Additionally, given the differences of the original repurchase share value and the value at the time of formal retirements, an associated loss was recognized within the Condensed Consolidated Statement of Changes in Equity in the amount of $7.7.
In May 2023, the Company's Board of Directors approved the extension of its share repurchase authorization through December 31, 2024, and reduced the authorization from $1,000.0 to $500.0. To enable the buybacks under the Board's authorization, the Company obtained shareholder approval on July 27, 2023 to permit it to conduct open-market purchases of up to 100.0 million of its ordinary shares from time to time as approved by the Board of Directors at a minimum purchase price of $1 per share and maximum purchase price of $35 per share. As of June 30, 2023, the Company had $500.0 of availability remaining under the Board's authorization.
Six Months Ended June 30,
20232022
Total number of shares repurchased— 10.7 
Average price paid per share$— $16.33 
Total
$— $175.0 
Total shares retired— 10.7 
Average price at retirement date$— $15.61 
Total
$— $167.3 
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation Share-based Compensation
The Company grants share-based awards under the Clarivate Plc 2019 Incentive Award Plan ("the Plan"). As of June 30, 2023, approximately 24.8 million of the Company’s ordinary shares were available for share-based awards. The Plan provides for the issuance of stock options, restricted stock units ("RSUs"), and performance share units ("PSUs").
Share-based compensation expense is recorded to the “Cost of revenues" and “Selling, general and administrative” line items on the accompanying Consolidated Statements of Operations. Total share-based compensation expense for the three and six months ended June 30, 2023 and 2022, comprised of the following:
Three Months Ended June 30, 2023
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $10.2 $0.1 $— $10.3 
Selling, general and administrative costs— 16.2 4.0 — 20.2 
Total share-based compensation expense$— $26.4 $4.1 $— $30.5 
Six Months Ended June 30, 2023
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $23.0 $0.3 $— $23.3 
Selling, general and administrative costs1.9 32.9 13.6 — 48.4 
Total share-based compensation expense$1.9 $55.9 $13.9 $— $71.7 

Three Months Ended June 30, 2022
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $7.5 $0.1 $(0.2)$7.4 
Selling, general and administrative costs— 12.6 0.9 0.8 14.3 
Total share-based compensation expense$— $20.1 $1.0 $0.6 $21.7 
Six Months Ended June 30, 2022
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $17.1 $0.3 $(0.6)$16.8 
Selling, general and administrative costs— 28.8 1.9 0.9 31.6 
Total share-based compensation expense$— $45.9 $2.2 $0.3 $48.4 

The following table summarizes the Company’s existing share-based compensation awards program activity for the six months ended June 30, 2023, and 2022, respectively:
Six Months Ended June 30, 2023
Stock OptionsRSUsPSUs
Balance at December 31, 20223.7 13.5 2.1 
Granted— 5.6 1.5 
Exercised/Vested— (2.5)(0.1)
Forfeited— (0.9)(0.5)
Balance at June 30, 20233.7 15.7 3.0 
Total remaining unamortized compensation costs$— $97.6 $45.8 
Weighted average remaining service period0 years1.07 years2.21 years
Six Months Ended June 30, 2022
Stock OptionsRSUsPSUs
Balance at December 31, 20214.8 4.5 1.4 
Granted— 4.5 0.9 
Exercised/Vested(0.2)(2.0)— 
Forfeited(0.1)(0.4)(0.1)
Balance at June 30, 20224.5 6.6 2.2 
Total remaining unamortized compensation costs$— $72.1 $9.4 
Weighted average remaining service period0 years1.43 years1.69 years
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period.
During the three months ended June 30, 2023, the income tax benefit of $35.3 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized, $33.0 tax benefit was associated with the impairment of intangible assets, and $17.1 tax benefit was related to the partial release of valuation allowance recorded against certain US tax attributes that are now considered realizable due to sufficient cumulative income and continued projections of future taxable income. During the three months ended June 30, 2022, the income tax provision of $10.5 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized.
During the six months ended June 30, 2023, the income tax benefit of $98.9 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized, $70.4 tax benefit was recorded on the settlement of an open tax dispute, $33.0 tax benefit was associated with the impairment of intangible assets, and $17.1 tax benefit was related to the partial release of valuation allowance recorded against certain US tax attributes that are now considered realizable due to sufficient cumulative income and continued projections of future taxable income. During the six months ended June 30, 2022, the income tax provision of $26.8 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized and tax expense on the mark to market gain on private warrants.
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings per Share
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings per Share Earnings Per ShareBasic net earnings per ordinary share from continuing operations (“EPS”) is calculated by taking Net income (loss) available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding for the applicable period. Diluted net EPS is computed by taking net earnings adjusted for the effect of the fair value of Private Placement Warrants
divided by the weighted average number of ordinary shares outstanding increased by the number of additional shares which have a dilutive effect.
Potential ordinary shares on a gross basis of 30.7 million and 9.7 million options, RSUs, PSUs, and Warrants related to the 2019 Incentive Award Plan were excluded from diluted EPS for the six months ended June 30, 2023 and 2022, respectively, as their inclusion would have been anti-dilutive or their performance metric was not met. Potential ordinary shares on a gross basis of 30.0 million and 10.1 million options, RSUs, PSUs, and Warrants related to the 2019 Incentive Award Plan were excluded from diluted EPS for the three months ended June 30, 2023 and 2022, respectively, as their inclusion would have been anti-dilutive or their performance metric was not met. See Note 11 - Shareholders’ Equity and Note 12 - Share-based Compensation for additional information.
The potential dilutive effect of our MCPS outstanding during the period was calculated using the if-converted method assuming the conversion as of the earliest period reported or at the date of issuance, if later. The resulting weighted-average ordinary shares of 55.3 million related to our MCPS are not included in the dilutive weighted-average ordinary shares outstanding calculation for the three and six months ended June 30, 2023, as their effect would be anti-dilutive.
The basic and diluted EPS computations for our ordinary shares are calculated as follows:
Three Months Ended June 30,
20232022
Basic EPS
Net (loss) income available to ordinary shareholders$(123.1)$62.4 
Dividends on preferred shares18.6 18.7 
Net (loss) income attributable to ordinary shares$(141.7)$43.7 
Basic weighted-average number of ordinary shares outstanding675.9 674.3 
Basic EPS$(0.21)$0.06 
Diluted EPS
Net (loss) income attributable to ordinary shares$(141.7)$43.7 
Change in fair value of private placement warrants— (46.8)
Net loss attributable to ordinary shares, diluted$(141.7)$(3.1)
Denominator:
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic675.9 674.3 
Weighted-average effect of potentially dilutive shares to purchase ordinary shares — 4.1 
Diluted weighted-average number of ordinary shares outstanding675.9 678.4 
Diluted EPS$(0.21)$0.00 
Six Months Ended June 30,
20232022
Basic EPS
Net (loss) income available to ordinary shareholders$(79.6)$131.9 
Dividends on preferred shares37.4 37.4 
Net (loss) income attributable to ordinary shares$(117.0)$94.5 
Basic weighted-average number of ordinary shares outstanding675.4 678.3 
Basic EPS$(0.17)$0.14 
Diluted EPS
Net (loss) income attributable to ordinary shares$(117.0)$94.5 
Change in fair value of private placement warrants— (141.7)
Net loss attributable to ordinary shares, diluted$(117.0)$(47.2)
Denominator:
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic675.4 678.3 
Weighted-average effect of potentially dilutive shares to purchase ordinary shares — 4.9 
Diluted weighted-average number of ordinary shares outstanding675.4 683.2 
Diluted EPS$(0.17)$(0.07)
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Other Operating Expense (Income), Net
6 Months Ended
Jun. 30, 2023
Other Income and Expenses [Abstract]  
Other Operating Expense (Income), Net Other Operating Expense (Income), Net
Other operating expense (income), net, consisted of the following for the three and six months ended June 30, 2023 and 2022:
Three Months Ended June 30,
20232022
Net foreign exchange loss (gain)11.7 (23.5)
Miscellaneous expense (income), net2.8 (1.1)
Other operating expense (income), net$14.5 $(24.6)

Six Months Ended June 30,
20232022
Gain on legal settlement(1)
(49.4)— 
Net foreign exchange loss (gain)32.3 (43.9)
Miscellaneous (income) expense, net(0.4)5.6 
Other operating income, net$(17.5)$(38.3)
(1) Refer to Note 17 - Commitments and Contingencies for further information.
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
The Chief Executive Officer is the Company’s Chief Operating Decision Maker (“CODM”). The CODM evaluates segment performance based primarily on revenue and Adjusted EBITDA. The CODM does not review assets by segment for the purposes of assessing performance or allocating resources.
Below is the overview of the product groups within each reportable segment. This structure enables a sharp focus on cross-selling opportunities within the markets we serve and provides substantial scale.
The A&G segment consists of our Academia & Government product group, which drives research excellence across institutions, empower researchers to tackle today’s global challenges, and help academic institutions and libraries improve operational efficiency and effectiveness.
The IP segment consists of our Patent Intelligence, Brand IP Intelligence, and IP Lifecycle Management product groups, which enable customers to establish, protect, and manage their intellectual property.
The LS&H segment consists of our Life Sciences & Healthcare product group, which includes products and solutions that provide insight and foresight across the drug and device lifecycle, empowering life science and healthcare organizations to create a healthier tomorrow.
Each of the three segments represent the segments for which discrete financial information is available and upon which operating results are regularly evaluated by the CODM in order to assess performance and allocate resources. The CODM evaluates performance based primarily on segment revenue and Adjusted EBITDA. Adjusted EBITDA represents net income (loss) before the provision for income taxes, depreciation and amortization, and interest expense adjusted to exclude acquisition and disposal-related transaction costs, losses on extinguishment of debt, share-based compensation, unrealized foreign currency remeasurement, transformational and restructuring expenses, acquisition-related adjustments to deferred revenues prior to the adoption of FASB ASU No. 2021-08 in 2021, non-operating income or expense, the impact of certain non-cash mark-to-market adjustments on financial instruments, legal settlements, impairments, and other items that are included in net income (loss) for the period that the Company does not consider indicative of its ongoing operating performance and certain unusual items impacting results in a particular period.
Revenues, net by segment
The following table summarizes revenue by reportable segment for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government$342.0 $332.7 $656.7 $644.5 
Intellectual Property216.3 238.4 425.4 480.2 
Life Sciences & Healthcare110.5 115.5 215.8 224.1 
Total Revenues, net$668.8 $686.6 $1,297.9 $1,348.8 

Adjusted EBITDA by segment
The following table presents segment profitability and a reconciliation to net income for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government$146.8 $122.9 $272.2 $227.4 
Intellectual Property100.1 107.8 194.7 225.4 
Life Sciences & Healthcare38.0 43.7 70.7 83.9 
Total Adjusted EBITDA$284.9 $274.4 $537.6 $536.7 
Benefit (provision) for income taxes35.3 (10.5)98.9 (26.8)
Depreciation and amortization(178.1)(175.6)(350.7)(352.0)
Interest expense and amortization of debt discount, net(73.0)(62.3)(146.6)(121.8)
Mark to market gain on financial instruments(1)
2.9 49.0 1.8 149.4 
Deferred revenues adjustment— (0.8)— (0.6)
Transaction related costs(2)
(0.7)(5.1)(2.4)(11.8)
Share-based compensation expense(30.5)(22.1)(71.7)(59.1)
Restructuring and lease impairments(3)
(12.2)(19.2)(21.6)(30.9)
Goodwill and intangible asset impairments(4)
(135.2)— (135.2)— 
Other(5)
(16.5)34.6 10.3 48.8 
Net (loss) income$(123.1)$62.4 $(79.6)$131.9 
Dividends on preferred shares(18.6)(18.7)(37.4)(37.4)
Net (loss) income attributable to ordinary shares$(141.7)$43.7 $(117.0)$94.5 
(1) Reflects mark-to-market adjustments on the Private Placement Warrants under ASC 815, Derivatives and Hedging. Refer to Note 8 - Fair Value Measurements for further information.
(2) Includes costs incurred to complete business combination transactions, including acquisitions, dispositions, and capital market activities and include advisory, legal, and other professional and consulting costs.
(3) Primarily reflects severance and related benefit costs related to approved restructuring programs. Refer to Note 19 - Restructuring and Lease Impairments for further information.
(4) Primarily includes the intangible assets impairment recorded during the three months ended June 30, 2023 further discussed in Note 4 - Assets Held for Sale and Divested Operations
(5) The current year periods primarily include net losses on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. The current year-to-date period was offset by a gain on legal settlement. The prior year periods include net gains on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. Refer to Note 15 - Other Operating Expense (Income), Net and Note 17 - Commitments and Contingencies for further information.
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
The Company does not have any recorded or unrecorded guarantees of the indebtedness of others.
Lawsuits and Legal Claims
The Company is engaged in various legal proceedings, claims, audits, and investigations that have arisen in the ordinary course of business. These matters may include among others, antitrust/competition claims, intellectual property infringement claims, employment matters, and commercial matters. The outcome of all of the matters against the Company is subject to future resolution, including the uncertainties of litigation.
From time to time, we are involved in litigation in the ordinary course of our business, including claims or contingencies that may arise related to matters occurring prior to our acquisition of businesses. At the present time, primarily because the matters are generally in early stages, we can give no assurance as to the outcome of any pending litigation to which we are currently a party, and we are unable to determine the ultimate resolution of these matters or the effect they may have on us.
Our best estimate of the Company's potential liability for the larger legal claims is approximately $4, which includes estimated legal costs and accrued interest. The recorded probable loss is an estimate and the actual costs arising from our litigation could be materially lower or higher. We have and will continue to vigorously defend ourselves against these
claims. We maintain appropriate levels of insurance, which we expect are likely to provide coverage for some of these liabilities or other losses that may arise from these litigation matters.
During the six months ended June 30, 2023, we reached settlement related to the potential liability for one of the larger legal claims, which was covered by insurance. We recognized a total gain on settlement of $49.4 which is included in Other operating expense (income), net in the Condensed Consolidated Statement of Operations.
Between January and March 2022, three putative securities class action complaints were filed in the United States District Court for the Eastern District of New York against Clarivate and certain of its executives and directors alleging that there were weaknesses in the Company’s internal controls over financial reporting and financial reporting procedures that it failed to disclose in violation of federal securities law. The complaints were consolidated into a single proceeding on May 18, 2022. On August 8, 2022, plaintiffs filed a consolidated amended complaint, seeking damages on behalf of a putative class of shareholders who acquired Clarivate securities between July 30, 2020, and February 2, 2022, and/or acquired Clarivate common or preferred shares in connection with offerings on June 10, 2021, or Clarivate common shares in connection with a September 13, 2021, offering. The amended complaint, like the prior complaints, references an error in the accounting treatment of an equity plan included in the Company’s 2020 business combination with CPA Global that was disclosed on December 27, 2021, and related restatements issued on February 3, 2022, of certain of the Company’s previously issued financial statements; the amended complaint also alleges that the Company and certain of its executives and directors made false or misleading statements relating to the Company’s product quality and expected organic revenues and organic growth rate, and that they failed to disclose significant known changes to the Company’s business model. Defendants moved to dismiss the amended complaint on October 7, 2022. Without deciding the motion, the court entered an order on June 23, 2023 allowing plaintiffs limited leave to amend, and plaintiffs filed an amended complaint on July 14, 2023. The Company intends to seek dismissal of the amended complaint. On June 7, 2022, a class action was filed in Pennsylvania state court in the Court of Common Pleas of Philadelphia asserting claims under the Securities Act of 1933, based on substantially similar allegations, with respect to alleged misstatements and omissions in the offering documents for two issuances of Clarivate ordinary shares in June and September 2021. The Company moved to stay this proceeding on August 19, 2022, and filed its preliminary objections to the state court complaint on October 21, 2022. Briefing on defendants' preliminary objections was completed on December 12, 2022, and the preliminary objections remain pending. On January 4, 2023, the court granted a partial stay of all proceedings until further court order after oral argument on the stay motion. Following oral argument on April 11, 2023, the court denied a further stay of the proceedings on April 17, 2023. Clarivate does not believe that the claims alleged in the complaints have merit and will vigorously defend against them. Given the early stage of the proceedings, we are unable to estimate the reasonably possible loss or range of loss, if any, arising from these matters.
Warrant Liabilities
Under Accounting Standards Codification 815, Derivatives and Hedging, ("ASC 815"), warrant instruments that do not meet the criteria to be considered indexed to an entity's own stock shall be initially classified as a liability at their estimated fair values, regardless of the likelihood that such instruments will ever be settled in cash. In periods subsequent to issuance, changes in the estimated fair value of the liabilities are reported through earnings. As of June 30, 2023, the Private Placement Warrants are set to expire within one year. Therefore, the remaining liability is included in Accrued expenses and other current liabilities on the Condensed Consolidated Balance Sheet as of June 30, 2023 (refer to Note 8 - Fair Value Measurements for additional information).

Contingent Liabilities
As of June 30, 2023 and December 31, 2022, there were no outstanding contingent liabilities.
MCPS Dividends
As noted in Note 11 - Shareholders’ Equity, dividends on our convertible preferred shares will be payable on a cumulative basis when, as and if declared by our Board of Directors, or an authorized committee of our Board of Directors, at an annual rate of 5.25% of the liquidation preference of $100.00 per share. Refer to Note 11 - Shareholders’ Equity for further details.
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions Related Party TransactionsOn December 1, 2021, Clarivate closed its acquisition of ProQuest from CIG, Atairos and certain other equity holders (the "Seller Group"). The aggregate consideration included $1,094.9 from the issuance of 46.9 million ordinary shares to the
Seller Group. As part of the acquisition, and as a result, CIG is a related party to Clarivate. Clarivate assumed a Finance lease in which CIG is the Lessor as part of the acquisition. For the three and six months ended June 30, 2023, interest expense of $0.6 and $1.1, respectively, and amortization of the Finance lease right of use asset ("ROU") of $0.1 and $0.2, respectively, is reflected in the Condensed Consolidated Statements of Operations. The Finance lease ROU asset of $8.0 is presented within Property, Plant, and Equipment (see Note 5 - Property and Equipment, Net) and the corresponding lease liability of $30.8 is treated as an item of indebtedness (see Note 9 - Debt) within the Condensed Consolidated Balance Sheet.
Clarivate has a vendor and customer arrangement with an affiliate of one of our directors. The Company recognized revenues, net of $0.2 and $0.2 and incurred expenses of $1.3 and $1.2, respectively during the three months ended June 30, 2023 and 2022, related to the arrangement. During the six months ended June 30, 2023 and 2022, the Company recognized revenues, net of $0.4 and $0.4 and incurred expenses of $2.5 and $2.3, respectively, related to the arrangement. As of June 30, 2023 and December 31, 2022, the Company had no outstanding receivables and payables related to the arrangement.
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Restructuring and Lease Impairments
6 Months Ended
Jun. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring and Lease Impairments Restructuring and Lease Impairments
One Clarivate Program - During the second quarter of 2021, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings driver being from a reduction in workforce.
ProQuest Acquisition Integration Program - During the fourth quarter of 2021, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings driver being from a reduction in workforce.
Segment Optimization Program - During the second quarter of 2023, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings driver being from a reduction in workforce.
Other Restructuring Programs - During the fourth quarter of 2019 and throughout 2020, we engaged a strategic consulting firm to assist us in optimizing our structure and cost base, resulting in the implementation of several cost-saving and margin improvement programs designed to generate substantial incremental cash flows.
The following table summarizes the pre-tax charges by activity and program during the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Severance and Related Benefit Costs:
One Clarivate Program$— $5.5 $— $11.1 
ProQuest Acquisition Integration Program7.6 7.7 16.9 12.0 
Segment Optimization Program2.3 — 2.3 — 
Other Restructuring Programs— (1.1)— (0.7)
Total Severance and Related Benefit Costs$9.9 $12.1 $19.2 $22.4 
Exit and Disposal Costs:
One Clarivate Program— — — — 
ProQuest Acquisition Integration Program$— $0.1 $0.1 $1.9 
Segment Optimization Program— — — — 
Other Restructuring Programs— 0.2 — 0.1 
Total Exit and Disposal Costs$— $0.3 $0.1 $2.0 
Lease Abandonment Costs:
One Clarivate Program— — — — 
ProQuest Acquisition Integration Program— 6.2 — 6.2 
Segment Optimization Program2.3 — 2.3 — 
Other Restructuring Programs— 0.6 — 0.3 
Total Lease Abandonment Costs$2.3 $6.8 $2.3 $6.5 
Restructuring and Lease Impairment Costs$12.2 $19.2 $21.6 $30.9 
The following table summarizes the pre-tax charges by program and segment during the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government:
One Clarivate Program$— $3.2 $— $6.1 
ProQuest Acquisition Integration Program4.2 8.0 9.3 11.3 
Segment Optimization1.6 — 1.6 — 
Other Restructuring Programs— 0.2 — — 
Total Academia & Government$5.8 $11.4 $10.9 $17.4 
Intellectual Property:
One Clarivate Program$— $1.1 $— $3.0 
ProQuest Acquisition Integration Program1.9 4.0 4.6 5.9 
Segment Optimization1.4 — 1.4 — 
Other Restructuring Programs— (0.4)— (0.2)
Total Intellectual Property$3.3 $4.7 $6.0 $8.7 
Life Sciences & Healthcare:
One Clarivate Program$— $1.2 $— $2.0 
ProQuest Acquisition Integration Program1.5 2.0 3.1 2.9 
Segment Optimization1.6 — 1.6 — 
Other Restructuring Programs— (0.1)— (0.1)
Total Life Sciences & Healthcare$3.1 $3.1 $4.7 $4.8 
Restructuring and Lease Impairment Costs$12.2 $19.2 $21.6 $30.9 
The following table summarizes the activity relating to the restructuring reserves across each of Clarivate's cost-saving programs during the periods indicated:
Severance and
Related Benefit Costs
Exit, Disposal
and Abandonment Costs
Total
Reserve Balance as of December 31, 2022$11.5 $0.1 $11.6 
Expenses recorded19.2 2.4 21.6 
Payments made(23.4)(1.5)(24.9)
Noncash items(2.7)(0.8)(3.5)
Reserve Balance as of June 30, 2023$4.6 $0.2 $4.8 
Reserve Balance as of December 31, 2021$28.3 $0.7 $29.0 
Expenses recorded22.4 8.5 30.9 
Payments made(34.6)(2.7)(37.3)
Noncash items(2.6)(5.4)(8.0)
Reserve Balance as of June 30, 2022$13.5 $1.1 $14.6 
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
Effective July 12, 2023, the Company entered into €100.0 of cross-currency swaps designated as hedges of euro denominated net investments in subsidiaries to mitigate FX exposure. The Company expects these swaps to qualify for hedge accounting.
Management has evaluated the impact of events that have occurred subsequent to June 30, 2023. Based on this evaluation, other than disclosed within these Condensed Consolidated Financial Statements and related notes, the Company has determined no other events were required to be recognized or disclosed.
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Pay vs Performance Disclosure            
Net income (loss) $ (123.1) $ 43.5 $ 62.4 $ 69.5 $ (79.6) $ 131.9
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Newly Adopted Accounting Standards and Recently Issued Accounting Standards
Newly Adopted Accounting Standards
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform between March 12, 2020 and December 31, 2022. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provides additional optional guidance on the transition from LIBOR to include derivative instruments that use an interest rate for margining, discounting or contract price alignment. The standard will ease, if warranted, the requirements for accounting for the future effects of the rate reform. Additionally, in December 2022, the FASB issued ASU 2022-06, Reference Rate Reform: Deferral of the Sunset Date of Topic 848, which deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024 to align with the amended cessation date of LIBOR. In 2020, the Company adopted ASU 2020-04, and, upon meeting the specified criteria in the guidance, elected the optional expedients for its interest rate swaps and debt agreements with reference to LIBOR. Accordingly, the Company has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt agreements. ASU 2021-01 and ASU 2022-06 did not have an effect on how
the Company accounts for its interest rate swaps and debt agreements due to our election and application of the optional expedients discussed above in connection with ASU 2020-04.
During the second quarter of 2023, the Company modified the contractual terms of its interest rate swaps and debt agreements to replace the previous LIBOR-based reference rate with the Term SOFR (Secured Overnight Financing Rate). The Company utilized the practical expedients set forth in Topic 848 and has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt instruments.
Recently Issued Accounting Standards
There were no other new accounting standards or updates issued or effective as of June 30, 2023, that have, or are expected to have, a material impact on the Company's Condensed Consolidated Financial Statements.
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment, Net (Tables)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment, Net
Property and equipment, net consisted of the following:
June 30,December 31,
20232022
Computer hardware$49.3 $45.1 
Leasehold improvements15.6 16.1 
Furniture, fixtures and equipment42.0 39.0 
Capital office leases - finance lease asset8.0 8.0 
Other2.2 2.1 
Total property and equipment, gross$117.1 $110.3 
Accumulated depreciation(66.4)(55.8)
Total property and equipment, net$50.7 $54.5 
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Other Intangible Assets, net and Goodwill (Tables)
6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Identifiable Intangible Assets
The following tables summarize the gross carrying amounts and accumulated amortization of the Company’s identifiable intangible assets by major class:
June 30, 2023December 31, 2022
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
Finite-lived intangible assets:
Customer relationships$7,778.4 $(994.7)$6,783.7 $7,809.0 $(821.5)$6,987.5 
Databases and content2,733.7 (889.7)1,844.0 2,681.0 (780.5)1,900.5 
Computer software828.2 (469.2)359.0 765.1 (422.2)342.9 
Other88.7 (45.9)42.8 88.8 (38.9)49.9 
Finite-lived intangible assets$11,429.0 $(2,399.5)$9,029.5 $11,343.9 $(2,063.1)$9,280.8 
Indefinite-lived intangible assets:
Trade names156.9 — 156.9 156.9 — 156.9 
Total intangible assets$11,585.9 $(2,399.5)$9,186.4 $11,500.8 $(2,063.1)$9,437.7 
Schedule of Change in the Carrying Amount of Goodwill
The change in the carrying amount of goodwill by segment is shown below:
A&G
Segment
IP
Segment
LS&H
Segment
Consolidated Total
Balance as of December 31, 2022$1,109.8 $590.3 $1,176.4 $2,876.5 
Goodwill impairment(1)
— (3.0)— (3.0)
Impact of foreign currency fluctuations(0.2)22.2 — 22.0 
Balance as of June 30, 2023$1,109.6 $609.5 $1,176.4 $2,895.5 
(1) Recorded in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information.
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of the Company's assets and liabilities that were recognized at fair value on a recurring basis The following table provides a summary of the Company’s assets and liabilities that were recognized at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:
June 30, 2023
Level 2Level 3Total
Fair Value
Assets
Forward currency contracts - current$1.3 $— $1.3 
Interest rate swaps - current13.4 — 13.4 
Interest rate swaps - non-current31.0 — 31.0 
Total$45.7 $— $45.7 
Liabilities
Forward currency contracts - current$0.6 $— $0.6 
Warrant liability - current— 19.2 19.2 
Total$0.6 $19.2 $19.8 
December 31, 2022
Level 2Level 3Total
Fair Value
Assets
Forward currency contracts - current$0.8 $— $0.8 
Interest rate swaps - current2.3 — 2.3 
Interest rate swaps - non-current47.2 — 47.2 
Total$50.3 $— $50.3 
Liabilities
Forward currency contracts - current$0.4 $— $0.4 
Warrant liability - non-current— 21.0 21.0 
Total$0.4 $21.0 $21.4 
Private Placement Warrants - The following table summarizes the changes in the Private Placement Warrants liability for the three and six months ended June 30, 2023 and 2022:
20232022
Balance as of January 1$21.0 $227.8 
Mark to market loss (gain) on financial instruments1.1 (100.4)
Exercise of Private Placement Warrants— — 
Balance as of March 31$22.1 $127.4 
Mark to market gain on financial instruments(2.9)(49.0)
Exercise of Private Placement Warrants— — 
Balance as of June 30$19.2 $78.4 
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Debt (Tables)
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Debt
The following table is a summary of the Company’s debt:
June 30, 2023December 31, 2022
TypeMaturityEffective
Interest
Rate
Carrying
Value
Effective
Interest
Rate
Carrying
Value
Senior Notes20294.875 %$921.4 4.875 %$921.4 
Senior Secured Notes20283.875 %921.2 3.875 %921.2 
Revolving Credit Facility20277.952 %— 7.234 %— 
Term Loan Facility 20268.217 %2,347.4 7.384 %2,497.4 
Senior Secured Notes20264.500 %700.0 4.500 %700.0 
Finance lease20366.936 %30.8 6.936 %31.3 
Total debt outstanding4,920.8 5,071.3 
Debt discounts and issuance costs(56.5)(65.3)
Current portion of long-term debt(1.1)(1.0)
Long-term debt$4,863.2 $5,005.0 
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue (Tables)
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of disaggregated revenues
The following table presents the Company’s revenues by transaction type based on revenue recognition pattern for the periods presented:
Three Months Ended June 30,
20232022
Subscription revenues$406.0 $407.4 
Re-occurring revenues111.0 112.0 
Transactional and other revenues151.8 168.0 
Deferred revenues adjustment— (0.8)
Revenues, net$668.8 $686.6 
Six Months Ended June 30,
20232022
Subscription revenues$799.2 $811.2 
Re-occurring revenues218.7 226.5 
Transactional and other revenues280.0 311.7 
Deferred revenues adjustment— (0.6)
Revenues, net$1,297.9 $1,348.8 
The following table summarizes revenue by reportable segment for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government$342.0 $332.7 $656.7 $644.5 
Intellectual Property216.3 238.4 425.4 480.2 
Life Sciences & Healthcare110.5 115.5 215.8 224.1 
Total Revenues, net$668.8 $686.6 $1,297.9 $1,348.8 
Schedule of contract balances
Balances, as of:Accounts receivable, netCurrent
deferred revenues
Non-current
deferred revenues
December 31, 2022$872.1 $947.5 $38.5 
June 30, 2023769.7 939.6 37.9 
Decrease$(102.4)$(7.9)$(0.6)
December 31, 2021$906.4 $1,030.4 $54.2 
June 30, 2022812.4 956.7 50.3 
Decrease$(94.0)$(73.7)$(3.9)
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Class of Treasury Stock
Six Months Ended June 30,
20232022
Total number of shares repurchased— 10.7 
Average price paid per share$— $16.33 
Total
$— $175.0 
Total shares retired— 10.7 
Average price at retirement date$— $15.61 
Total
$— $167.3 
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Share-based Payment Arrangement, Expensed and Capitalized, Amount Total share-based compensation expense for the three and six months ended June 30, 2023 and 2022, comprised of the following:
Three Months Ended June 30, 2023
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $10.2 $0.1 $— $10.3 
Selling, general and administrative costs— 16.2 4.0 — 20.2 
Total share-based compensation expense$— $26.4 $4.1 $— $30.5 
Six Months Ended June 30, 2023
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $23.0 $0.3 $— $23.3 
Selling, general and administrative costs1.9 32.9 13.6 — 48.4 
Total share-based compensation expense$1.9 $55.9 $13.9 $— $71.7 

Three Months Ended June 30, 2022
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $7.5 $0.1 $(0.2)$7.4 
Selling, general and administrative costs— 12.6 0.9 0.8 14.3 
Total share-based compensation expense$— $20.1 $1.0 $0.6 $21.7 
Six Months Ended June 30, 2022
Stock OptionsRSUsPSUsCPA Global Equity PlanTotal
Cost of revenues$— $17.1 $0.3 $(0.6)$16.8 
Selling, general and administrative costs— 28.8 1.9 0.9 31.6 
Total share-based compensation expense$— $45.9 $2.2 $0.3 $48.4 
Share-based Payment Arrangement, Activity The following table summarizes the Company’s existing share-based compensation awards program activity for the six months ended June 30, 2023, and 2022, respectively:
Six Months Ended June 30, 2023
Stock OptionsRSUsPSUs
Balance at December 31, 20223.7 13.5 2.1 
Granted— 5.6 1.5 
Exercised/Vested— (2.5)(0.1)
Forfeited— (0.9)(0.5)
Balance at June 30, 20233.7 15.7 3.0 
Total remaining unamortized compensation costs$— $97.6 $45.8 
Weighted average remaining service period0 years1.07 years2.21 years
Six Months Ended June 30, 2022
Stock OptionsRSUsPSUs
Balance at December 31, 20214.8 4.5 1.4 
Granted— 4.5 0.9 
Exercised/Vested(0.2)(2.0)— 
Forfeited(0.1)(0.4)(0.1)
Balance at June 30, 20224.5 6.6 2.2 
Total remaining unamortized compensation costs$— $72.1 $9.4 
Weighted average remaining service period0 years1.43 years1.69 years
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings per Share (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of basic and diluted EPS computations for our common stock
The basic and diluted EPS computations for our ordinary shares are calculated as follows:
Three Months Ended June 30,
20232022
Basic EPS
Net (loss) income available to ordinary shareholders$(123.1)$62.4 
Dividends on preferred shares18.6 18.7 
Net (loss) income attributable to ordinary shares$(141.7)$43.7 
Basic weighted-average number of ordinary shares outstanding675.9 674.3 
Basic EPS$(0.21)$0.06 
Diluted EPS
Net (loss) income attributable to ordinary shares$(141.7)$43.7 
Change in fair value of private placement warrants— (46.8)
Net loss attributable to ordinary shares, diluted$(141.7)$(3.1)
Denominator:
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic675.9 674.3 
Weighted-average effect of potentially dilutive shares to purchase ordinary shares — 4.1 
Diluted weighted-average number of ordinary shares outstanding675.9 678.4 
Diluted EPS$(0.21)$0.00 
Six Months Ended June 30,
20232022
Basic EPS
Net (loss) income available to ordinary shareholders$(79.6)$131.9 
Dividends on preferred shares37.4 37.4 
Net (loss) income attributable to ordinary shares$(117.0)$94.5 
Basic weighted-average number of ordinary shares outstanding675.4 678.3 
Basic EPS$(0.17)$0.14 
Diluted EPS
Net (loss) income attributable to ordinary shares$(117.0)$94.5 
Change in fair value of private placement warrants— (141.7)
Net loss attributable to ordinary shares, diluted$(117.0)$(47.2)
Denominator:
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic675.4 678.3 
Weighted-average effect of potentially dilutive shares to purchase ordinary shares — 4.9 
Diluted weighted-average number of ordinary shares outstanding675.4 683.2 
Diluted EPS$(0.17)$(0.07)
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Other Operating Expense (Income), Net (Tables)
6 Months Ended
Jun. 30, 2023
Other Income and Expenses [Abstract]  
Schedule of other operating income, net
Other operating expense (income), net, consisted of the following for the three and six months ended June 30, 2023 and 2022:
Three Months Ended June 30,
20232022
Net foreign exchange loss (gain)11.7 (23.5)
Miscellaneous expense (income), net2.8 (1.1)
Other operating expense (income), net$14.5 $(24.6)

Six Months Ended June 30,
20232022
Gain on legal settlement(1)
(49.4)— 
Net foreign exchange loss (gain)32.3 (43.9)
Miscellaneous (income) expense, net(0.4)5.6 
Other operating income, net$(17.5)$(38.3)
(1) Refer to Note 17 - Commitments and Contingencies for further information.
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Schedule of Revenue by reportable segment
The following table presents the Company’s revenues by transaction type based on revenue recognition pattern for the periods presented:
Three Months Ended June 30,
20232022
Subscription revenues$406.0 $407.4 
Re-occurring revenues111.0 112.0 
Transactional and other revenues151.8 168.0 
Deferred revenues adjustment— (0.8)
Revenues, net$668.8 $686.6 
Six Months Ended June 30,
20232022
Subscription revenues$799.2 $811.2 
Re-occurring revenues218.7 226.5 
Transactional and other revenues280.0 311.7 
Deferred revenues adjustment— (0.6)
Revenues, net$1,297.9 $1,348.8 
The following table summarizes revenue by reportable segment for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government$342.0 $332.7 $656.7 $644.5 
Intellectual Property216.3 238.4 425.4 480.2 
Life Sciences & Healthcare110.5 115.5 215.8 224.1 
Total Revenues, net$668.8 $686.6 $1,297.9 $1,348.8 
Schedule of Segment Reporting Information, by Segment The following table presents segment profitability and a reconciliation to net income for the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government$146.8 $122.9 $272.2 $227.4 
Intellectual Property100.1 107.8 194.7 225.4 
Life Sciences & Healthcare38.0 43.7 70.7 83.9 
Total Adjusted EBITDA$284.9 $274.4 $537.6 $536.7 
Benefit (provision) for income taxes35.3 (10.5)98.9 (26.8)
Depreciation and amortization(178.1)(175.6)(350.7)(352.0)
Interest expense and amortization of debt discount, net(73.0)(62.3)(146.6)(121.8)
Mark to market gain on financial instruments(1)
2.9 49.0 1.8 149.4 
Deferred revenues adjustment— (0.8)— (0.6)
Transaction related costs(2)
(0.7)(5.1)(2.4)(11.8)
Share-based compensation expense(30.5)(22.1)(71.7)(59.1)
Restructuring and lease impairments(3)
(12.2)(19.2)(21.6)(30.9)
Goodwill and intangible asset impairments(4)
(135.2)— (135.2)— 
Other(5)
(16.5)34.6 10.3 48.8 
Net (loss) income$(123.1)$62.4 $(79.6)$131.9 
Dividends on preferred shares(18.6)(18.7)(37.4)(37.4)
Net (loss) income attributable to ordinary shares$(141.7)$43.7 $(117.0)$94.5 
(1) Reflects mark-to-market adjustments on the Private Placement Warrants under ASC 815, Derivatives and Hedging. Refer to Note 8 - Fair Value Measurements for further information.
(2) Includes costs incurred to complete business combination transactions, including acquisitions, dispositions, and capital market activities and include advisory, legal, and other professional and consulting costs.
(3) Primarily reflects severance and related benefit costs related to approved restructuring programs. Refer to Note 19 - Restructuring and Lease Impairments for further information.
(4) Primarily includes the intangible assets impairment recorded during the three months ended June 30, 2023 further discussed in Note 4 - Assets Held for Sale and Divested Operations
(5) The current year periods primarily include net losses on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. The current year-to-date period was offset by a gain on legal settlement. The prior year periods include net gains on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. Refer to Note 15 - Other Operating Expense (Income), Net and Note 17 - Commitments and Contingencies for further information.
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Restructuring and Lease Impairments (Tables)
6 Months Ended
Jun. 30, 2023
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs The following table summarizes the pre-tax charges by activity and program during the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Severance and Related Benefit Costs:
One Clarivate Program$— $5.5 $— $11.1 
ProQuest Acquisition Integration Program7.6 7.7 16.9 12.0 
Segment Optimization Program2.3 — 2.3 — 
Other Restructuring Programs— (1.1)— (0.7)
Total Severance and Related Benefit Costs$9.9 $12.1 $19.2 $22.4 
Exit and Disposal Costs:
One Clarivate Program— — — — 
ProQuest Acquisition Integration Program$— $0.1 $0.1 $1.9 
Segment Optimization Program— — — — 
Other Restructuring Programs— 0.2 — 0.1 
Total Exit and Disposal Costs$— $0.3 $0.1 $2.0 
Lease Abandonment Costs:
One Clarivate Program— — — — 
ProQuest Acquisition Integration Program— 6.2 — 6.2 
Segment Optimization Program2.3 — 2.3 — 
Other Restructuring Programs— 0.6 — 0.3 
Total Lease Abandonment Costs$2.3 $6.8 $2.3 $6.5 
Restructuring and Lease Impairment Costs$12.2 $19.2 $21.6 $30.9 
The following table summarizes the pre-tax charges by program and segment during the periods indicated:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Academia & Government:
One Clarivate Program$— $3.2 $— $6.1 
ProQuest Acquisition Integration Program4.2 8.0 9.3 11.3 
Segment Optimization1.6 — 1.6 — 
Other Restructuring Programs— 0.2 — — 
Total Academia & Government$5.8 $11.4 $10.9 $17.4 
Intellectual Property:
One Clarivate Program$— $1.1 $— $3.0 
ProQuest Acquisition Integration Program1.9 4.0 4.6 5.9 
Segment Optimization1.4 — 1.4 — 
Other Restructuring Programs— (0.4)— (0.2)
Total Intellectual Property$3.3 $4.7 $6.0 $8.7 
Life Sciences & Healthcare:
One Clarivate Program$— $1.2 $— $2.0 
ProQuest Acquisition Integration Program1.5 2.0 3.1 2.9 
Segment Optimization1.6 — 1.6 — 
Other Restructuring Programs— (0.1)— (0.1)
Total Life Sciences & Healthcare$3.1 $3.1 $4.7 $4.8 
Restructuring and Lease Impairment Costs$12.2 $19.2 $21.6 $30.9 
The following table summarizes the activity relating to the restructuring reserves across each of Clarivate's cost-saving programs during the periods indicated:
Severance and
Related Benefit Costs
Exit, Disposal
and Abandonment Costs
Total
Reserve Balance as of December 31, 2022$11.5 $0.1 $11.6 
Expenses recorded19.2 2.4 21.6 
Payments made(23.4)(1.5)(24.9)
Noncash items(2.7)(0.8)(3.5)
Reserve Balance as of June 30, 2023$4.6 $0.2 $4.8 
Reserve Balance as of December 31, 2021$28.3 $0.7 $29.0 
Expenses recorded22.4 8.5 30.9 
Payments made(34.6)(2.7)(37.3)
Noncash items(2.6)(5.4)(8.0)
Reserve Balance as of June 30, 2022$13.5 $1.1 $14.6 
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Assets Held for Sale and Divested Operations (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2023
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Finite-lived intangible asets   $ 9,029.5 $ 9,029.5   $ 9,280.8
Proceeds from divestitures, net of cash and restricted cash   10.5 10.5 $ 0.0  
Customer relationships          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Finite-lived intangible asets   6,783.7 6,783.7   $ 6,987.5
Disposal Group, Held-for-sale, Not Discontinued Operations | Small Product Group within IP Segment          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Intangible assets held for sale   26.1 26.1    
Impairment of finite-lived intangible assets   132.2      
Deferred tax liabilities held for sale   6.5 6.5    
Disposal Group, Held-for-sale, Not Discontinued Operations | Small Product Group within IP Segment | Customer relationships          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Finite-lived intangible asets   $ 158.0 $ 158.0    
Disposal Group, Held-for-sale, Not Discontinued Operations | Small Product Group within IP Segment | Forecast          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Purchase price $ 34.0        
Purchase price period payable 10 years        
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Property and Equipment, Net (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Property, Plant and Equipment [Line Items]          
Capital office leases - finance lease asset $ 8.0   $ 8.0   $ 8.0
Total property and equipment, gross 117.1   117.1   110.3
Accumulated depreciation (66.4)   (66.4)   (55.8)
Total property and equipment, net 50.7   50.7   54.5
Depreciation 5.4 $ 9.8 11.3 $ 20.4  
Computer hardware          
Property, Plant and Equipment [Line Items]          
Total computer hardware and other property 49.3   49.3   45.1
Leasehold improvements          
Property, Plant and Equipment [Line Items]          
Total computer hardware and other property 15.6   15.6   16.1
Furniture, fixtures and equipment          
Property, Plant and Equipment [Line Items]          
Total computer hardware and other property 42.0   42.0   39.0
Other          
Property, Plant and Equipment [Line Items]          
Total computer hardware and other property $ 2.2   $ 2.2   $ 2.1
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Other Intangible Assets, net and Goodwill - Intangible Assets by Major Class (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Goodwill And Intangible Assets [Line Items]    
Finite-lived intangible assets, Gross $ 11,429.0 $ 11,343.9
Finite-lived intangible assets, Accumulated Amortization (2,399.5) (2,063.1)
Total finite-lived intangible assets 9,029.5 9,280.8
Total intangible assets, Gross 11,585.9 11,500.8
Total intangible assets 9,186.4 9,437.7
Trade names    
Goodwill And Intangible Assets [Line Items]    
Indefinite-lived intangible assets: 156.9 156.9
Customer relationships    
Goodwill And Intangible Assets [Line Items]    
Finite-lived intangible assets, Gross 7,778.4 7,809.0
Finite-lived intangible assets, Accumulated Amortization (994.7) (821.5)
Total finite-lived intangible assets 6,783.7 6,987.5
Databases and content    
Goodwill And Intangible Assets [Line Items]    
Finite-lived intangible assets, Gross 2,733.7 2,681.0
Finite-lived intangible assets, Accumulated Amortization (889.7) (780.5)
Total finite-lived intangible assets 1,844.0 1,900.5
Computer software    
Goodwill And Intangible Assets [Line Items]    
Finite-lived intangible assets, Gross 828.2 765.1
Finite-lived intangible assets, Accumulated Amortization (469.2) (422.2)
Total finite-lived intangible assets 359.0 342.9
Other Intangible Assets    
Goodwill And Intangible Assets [Line Items]    
Finite-lived intangible assets, Gross 88.7 88.8
Finite-lived intangible assets, Accumulated Amortization (45.9) (38.9)
Total finite-lived intangible assets $ 42.8 $ 49.9
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Other Intangible Assets - Narratives (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization of intangible assets $ 172.7 $ 165.8 $ 339.4 $ 331.6
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Other Intangible Assets, net and Goodwill - Change in the Carrying Amount of Goodwill (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Goodwill [Roll Forward]    
Goodwill, beginning balance   $ 2,876.5
Impact of foreign currency fluctuations   22.0
Goodwill, ending balance $ 2,895.5 2,895.5
Goodwill impairment charge   (3.0)
A&G Segment    
Goodwill [Roll Forward]    
Goodwill, beginning balance   1,109.8
Impact of foreign currency fluctuations   (0.2)
Goodwill, ending balance 1,109.6 1,109.6
Goodwill impairment charge   0.0
IP Segment    
Goodwill [Roll Forward]    
Goodwill, beginning balance   590.3
Impact of foreign currency fluctuations   22.2
Goodwill, ending balance 609.5 609.5
Goodwill impairment charge (3.0)  
LS&H Segment    
Goodwill [Roll Forward]    
Goodwill, beginning balance   1,176.4
Impact of foreign currency fluctuations   0.0
Goodwill, ending balance $ 1,176.4 1,176.4
Goodwill impairment charge   $ 0.0
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Instruments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 1.695%          
Derivative Instruments          
Notional Value $ 48.9   $ 48.9    
Fixed Rate 1.64%   1.64%    
Interest Rate Swap, Effective Date August 5, 2022, Fixed Rate 3.063%          
Derivative Instruments          
Notional Value $ 384.1   $ 384.1    
Fixed Rate 3.01%   3.01%    
Interest Rate Swap, Effective Date August 4, 2022, Fixed Rate 2.857%          
Derivative Instruments          
Notional Value $ 384.1   $ 384.1    
Fixed Rate 2.809%   2.809%    
Interest Rate Swap, Effective Date April 30, 2021, Fixed Rate 1.695%          
Derivative Instruments          
Notional Value $ 48.9   $ 48.9    
Fixed Rate 1.64%   1.64%    
Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.487%          
Derivative Instruments          
Notional Value $ 150.0   $ 150.0    
Fixed Rate 0.445%   0.445%    
Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 0.451%          
Derivative Instruments          
Notional Value $ 100.0   $ 100.0    
Fixed Rate 0.401%   0.401%    
Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.471%          
Derivative Instruments          
Notional Value $ 100.0   $ 100.0    
Fixed Rate 0.421%   0.421%    
Interest rate swap          
Derivative Instruments          
Interest rate swap asset - non-current $ 44.4   $ 44.4   $ 49.5
Foreign Exchange Contract          
Derivative Instruments          
Notional Value 162.0   162.0   165.1
Loss (gain) from the mark to market adjustment $ 2.9 $ (1.0) (0.3) $ 5.7  
Foreign Exchange Contract | Previously Reported          
Derivative Instruments          
Loss (gain) from the mark to market adjustment   $ 5.7   $ 12.4  
Foreign Exchange Contract | Maximum          
Derivative Instruments          
Term of contract 180 days        
Foreign exchange forward          
Derivative Instruments          
Interest rate swap asset - non-current $ 1.3   1.3   0.8
Derivative Liability $ 0.6   $ 0.6   $ 0.4
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements - Assets and liabilities that were recognized at fair value on a recurring basis (Details) - Recurring - USD ($)
$ in Millions
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Assets            
Total $ 45.7   $ 50.3      
Liabilities            
Warrant liability 19.2   21.0      
Total 19.8   21.4      
Level 2            
Assets            
Total 45.7   50.3      
Liabilities            
Total 0.6   0.4      
Level 3            
Liabilities            
Warrant liability 19.2 $ 22.1 21.0 $ 78.4 $ 127.4 $ 227.8
Total 19.2   21.0      
Foreign exchange forward            
Assets            
Forward currency contracts asset - current 1.3   0.8      
Liabilities            
Forward currency contracts liability - current 0.6   0.4      
Foreign exchange forward | Level 2            
Assets            
Forward currency contracts asset - current 1.3   0.8      
Liabilities            
Forward currency contracts liability - current 0.6   0.4      
Interest rate swap asset            
Assets            
Interest rate swap asset - current 13.4   2.3      
Interest rate swap asset - non-current 31.0   47.2      
Interest rate swap asset | Level 2            
Assets            
Interest rate swap asset - current 13.4   2.3      
Interest rate swap asset - non-current $ 31.0   $ 47.2      
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements - Changes in Private Placement Warrants Liabilities (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]            
Mark to market gain on financial instruments $ (2.9)   $ (49.0)   $ (1.8) $ (149.4)
Recurring            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]            
Beginning balance   $ 21.0     21.0  
Ending balance 19.2       19.2  
Level 3 | Recurring            
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]            
Beginning balance 22.1 21.0 127.4 $ 227.8 21.0 227.8
Mark to market gain on financial instruments (2.9) 1.1 (49.0) (100.4)    
Ending balance $ 19.2 $ 22.1 $ 78.4 $ 127.4 $ 19.2 $ 78.4
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Goodwill impairment charge   $ (3.0)
IP Segment    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Goodwill impairment charge $ (3.0)  
Disposal Group, Held-for-sale, Not Discontinued Operations | Small Product Group within IP Segment    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Impairment of finite-lived intangible assets $ 132.2  
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Summary of Debt (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Finance lease, effective interest rate 6.936% 6.936%
Finance lease, carrying value $ 30.8 $ 31.3
Total debt outstanding 4,920.8 5,071.3
Debt discounts and issuance costs (56.5) (65.3)
Current portion of long-term debt (1.1) (1.0)
Long-term debt $ 4,863.2 $ 5,005.0
Senior Notes    
Debt Instrument [Line Items]    
Effective Interest Rate 4.875% 4.875%
Carrying Value $ 921.4 $ 921.4
Senior Secured Notes    
Debt Instrument [Line Items]    
Effective Interest Rate 3.875% 3.875%
Carrying Value $ 921.2 $ 921.2
Revolving Credit Facility    
Debt Instrument [Line Items]    
Effective Interest Rate 7.952% 7.234%
Carrying Value $ 0.0 $ 0.0
Term Loan Facility    
Debt Instrument [Line Items]    
Effective Interest Rate 8.217% 7.384%
Carrying Value $ 2,347.4 $ 2,497.4
Senior Secured Notes    
Debt Instrument [Line Items]    
Effective Interest Rate 4.50% 4.50%
Carrying Value $ 700.0 $ 700.0
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Financing Transactions, Senior Notes (2029) and Senior Secured Notes (2028) - (Details) - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Senior Secured Notes    
Debt Instrument [Line Items]    
Debt face amount $ 921.2  
Interest rate (as a percent) 3.875% 3.875%
Senior Notes    
Debt Instrument [Line Items]    
Debt face amount $ 921.4  
Interest rate (as a percent) 4.875% 4.875%
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - Financing Transactions, Senior Secured Notes (2026) (Details) - Senior Secured Notes - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Debt Instrument, Redemption    
Aggregate principal amount $ 700.0 $ 700.0
Effective Interest Rate 4.50% 4.50%
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.23.2
Debt - The Credit Facilities, Revolving Credit Facility and Term Loan Facility (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2022
Jun. 30, 2023
Debt Instrument [Line Items]    
Fair vale of company's debt $ 4,709.6 $ 4,647.4
Revolving Credit Facility    
Debt Instrument [Line Items]    
Collateralized amount   8.8
Letter of credit    
Debt Instrument [Line Items]    
Collateralized amount   3.6
Revolving Credit Facility    
Debt Instrument [Line Items]    
Sublimit   750.0
Aggregate principal amount 0.0 0.0
Letter of credit    
Debt Instrument [Line Items]    
Sublimit   80.0
Term Loan Facility    
Debt Instrument [Line Items]    
Aggregate principal amount 2,497.4 2,347.4
Repayment of long-term debt 300.0 $ 150.0
Redemption (as a percent)   0.25%
Debt face amount   $ 2,860.0
Senior Unsecured Notes    
Debt Instrument [Line Items]    
Collateralized amount   13.6
Senior Secured Notes    
Debt Instrument [Line Items]    
Aggregate principal amount $ 700.0 $ 700.0
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue - Disaggregated Revenues and Cost to Obtain a Contract (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of revenues        
Deferred revenues adjustment $ 0.0 $ (0.8) $ 0.0 $ (0.6)
Total revenues, net 668.8 686.6 1,297.9 1,348.8
Subscription revenues        
Disaggregation of revenues        
Total revenues, gross 406.0 407.4 799.2 811.2
Re-occurring Revenues        
Disaggregation of revenues        
Total revenues, gross 111.0 112.0 218.7 226.5
Transaction revenues        
Disaggregation of revenues        
Total revenues, gross $ 151.8 $ 168.0 $ 280.0 $ 311.7
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue - Contract Balances (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Accounts receivable, net      
Accounts Receivables - Opening $ 872.1 $ 872.1 $ 906.4
Accounts Receivables - Closing   769.7 812.4
Increase (decrease)   (102.4) (94.0)
Current deferred revenues      
Current portion of deferred revenues - Opening 947.5 947.5 1,030.4
Current portion of deferred revenues - Closing   939.6 956.7
Increase (decrease)   (7.9) (73.7)
Non-current deferred revenues      
Non-current portion of deferred revenues - Opening 38.5 38.5 54.2
Non-current portion of deferred revenues - Closing   37.9 50.3
Increase (decrease)   (0.6) $ (3.9)
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Revenue recognized that was deferred at the beginning of the period 343.9 $ 588.9  
Decrease due to error correction adjustment      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Revenue recognized that was deferred at the beginning of the period $ (113.9)    
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue - Transaction Price Allocated to the Remaining Performance Obligation (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
Jun. 30, 2023
Transaction Price Allocated to the Remaining Performance Obligation  
Remaining performance obligation, percentage 90.00%
Expected timing of satisfaction, period 1 year
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 27, 2023
Oct. 01, 2021
Jun. 30, 2021
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
May 24, 2023
Feb. 07, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Ordinary shares, issued (in shares)           676,100,000   674,400,000    
Ordinary shares, outstanding (in shares)           676,100,000   674,400,000    
Ordinary shares, par value (in dollars per share)           $ 0   $ 0    
Treasury Stock, Common, Shares           0   0    
Number of votes per share           one        
Preferred stock, dividend rate (as a percent)           5.25%   5.25%    
Sale of treasury shares (in shares)             41,700      
Treasury stock sold, average cost per share (in dollars per share)             $ 15.01      
Treasury stock acquired, average cost per share (in dollars per share)   $ 30.99         $ 16.33      
Treasury stock sold at lower than repurchase price       $ (0.3) $ (0.6)          
Stock repurchase program, authorized amount                 $ 500.0 $ 1,000.0
Repurchase of ordinary shares (in shares)             10,700,000      
Repurchase of ordinary shares       108.6 66.4   $ 175.0      
Treasury stock average price at retirement date (usd per share)             $ 15.61      
Stock repurchased and retired           $ 0.0 $ 167.3      
Stock repurchase program, remaining authorized repurchase amount           $ 500.0        
Stock repurchased and retired (in shares)             10,700,000      
Open Market Purchases | Subsequent Event                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock repurchase program, shares authorized to be repurchased (in shares) 100,000,000                  
Open Market Purchases | Minimum | Subsequent Event                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock repurchase program, authorized repurchases, price per share (in dollars per share) $ 1                  
Open Market Purchases | Maximum | Subsequent Event                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock repurchase program, authorized repurchases, price per share (in dollars per share) $ 35                  
Accumulated Deficit                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Treasury stock sold at lower than repurchase price       (0.3) 0.7   $ 0.7      
Stock repurchased and retired       $ 9.2 $ (1.5)   $ 7.7      
Ordinary Shares                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Ordinary shares, outstanding (in shares)       673,300,000     673,300,000      
Sale of treasury shares (in shares)       0            
Repurchase of ordinary shares (in shares)       6,600,000 4,100,000          
Stock repurchased and retired       $ 132.5 $ 34.8          
Stock repurchased and retired (in shares)       0            
Dividends to preferred shareholders (in shares)       0            
Series A Preferred Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares issued (in shares)     14,400,000              
Preferred stock, dividend rate (as a percent)           5.25%        
Liquidation preference (usd per share)           $ 100.00        
Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares       $ 6.2   $ 6.2 $ 6.2      
Series A Preferred Stock | Over-Allotment Option                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares issued (in shares)     1,900,000              
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation - Narrative (Details)
Jun. 30, 2023
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Authorized grants (in shares) 24,800,000
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation - Share-based Compensation Expense (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense $ 30.5 $ 21.7 $ 71.7 $ 48.4
Stock Options        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 0.0 0.0 1.9 0.0
RSUs        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 26.4 20.1 55.9 45.9
PSUs        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 4.1 1.0 13.9 2.2
CPA Global Equity Plan        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 0.0 0.6 0.0 0.3
Cost of revenues        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 10.3 7.4 23.3 16.8
Cost of revenues | Stock Options        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 0.0 0.0 0.0 0.0
Cost of revenues | RSUs        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 10.2 7.5 23.0 17.1
Cost of revenues | PSUs        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 0.1 0.1 0.3 0.3
Cost of revenues | CPA Global Equity Plan        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 0.0 (0.2) 0.0 (0.6)
Selling, general and administrative costs        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 20.2 14.3 48.4 31.6
Selling, general and administrative costs | Stock Options        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 0.0 0.0 1.9 0.0
Selling, general and administrative costs | RSUs        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 16.2 12.6 32.9 28.8
Selling, general and administrative costs | PSUs        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense 4.0 0.9 13.6 1.9
Selling, general and administrative costs | CPA Global Equity Plan        
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total share based compensation expense $ 0.0 $ 0.8 $ 0.0 $ 0.9
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation - Option Activity (Details) - Stock Options
shares in Millions, $ in Millions
6 Months Ended
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
shares
Number of Options    
Outstanding at beginning of year (in shares) 3.7 4.8
Granted (in shares) 0.0 0.0
Exercised/Vested (in share) 0.0 (0.2)
Forfeited/Unexercised (in shares) 0.0 (0.1)
Outstanding at end of year (in shares) 3.7 4.5
Aggregate Intrinsic Value    
Total remaining unamortized compensation costs | $ $ 0.0 $ 0.0
Weighted average remaining service period (in years) 0 years 0 years
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based Compensation - RSU and PSU Activity (Details) - USD ($)
shares in Millions, $ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
RSUs    
RSUs and PSUs    
Beginning of year (in shares) 13.5 4.5
Granted (in shares) 5.6 4.5
Exercised/Vested (in share) (2.5) (2.0)
Forfeited/Unexercised (in shares) (0.9) (0.4)
End of year (in shares) 15.7 6.6
Total remaining unamortized compensation costs $ 97.6 $ 72.1
Weighted average remaining service period (in years) 1 year 25 days 1 year 5 months 4 days
PSUs    
RSUs and PSUs    
Beginning of year (in shares) 2.1 1.4
Granted (in shares) 1.5 0.9
Exercised/Vested (in share) (0.1) 0.0
Forfeited/Unexercised (in shares) (0.5) (0.1)
End of year (in shares) 3.0 2.2
Total remaining unamortized compensation costs $ 45.8 $ 9.4
Weighted average remaining service period (in years) 2 years 2 months 15 days 1 year 8 months 8 days
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Tax Disclosure [Abstract]        
(Benefit) provision for income taxes $ (35.3) $ 10.5 $ (98.9) $ 26.8
Income tax benefit due to impairment of intangible assets 33.0   33.0  
Income (loss) before income taxes (158.4) $ 72.9 (178.5) $ 158.7
Tax benefit recorded for a settlement of an open tax dispute     70.4  
Income tax benefit due to change in deferred tax assets valuation allowance $ 17.1   $ 17.1  
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings per Share - Narrative (Details) - shares
shares in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Warrant and Share-Based Payment Arrangement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive shares (in shares) 30.0 10.1 30.7 9.7
Series A Preferred Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive shares (in shares)     55.3  
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Basic EPS            
Net (loss) income available to ordinary shareholders $ (123.1) $ 43.5 $ 62.4 $ 69.5 $ (79.6) $ 131.9
Dividends on preferred shares 18.6   18.7   37.4 37.4
Net (loss) income attributable to ordinary shares $ (141.7)   $ 43.7   $ (117.0) $ 94.5
Basic weighted-average number of ordinary shares outstanding (in shares) 675.9   674.3   675.4 678.3
Basic EPS (usd per share) $ (0.21)   $ 0.06   $ (0.17) $ 0.14
Diluted EPS            
Net income (loss) attributable to ordinary shares $ (141.7)   $ 43.7   $ (117.0) $ 94.5
Change in fair value of private placement warrants 0.0   (46.8)   0.0 (141.7)
Net loss attributable to ordinary shares, diluted $ (141.7)   $ (3.1)   $ (117.0) $ (47.2)
Denominator:            
Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic (in shares) 675.9   674.3   675.4 678.3
Weighted-average effect of potentially dilutive shares to purchase ordinary shares (in shares) 0.0   4.1   0.0 4.9
Diluted weighted-average number of ordinary shares outstanding (in shares) 675.9   678.4   675.4 683.2
Diluted EPS (usd per share) $ (0.21)   $ 0.00   $ (0.17) $ (0.07)
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.23.2
Other Operating Expense (Income), Net (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Other Income and Expenses [Abstract]        
Net foreign exchange loss (gain) $ 11.7 $ (23.5) $ 32.3 $ (43.9)
Gain on legal settlement     (49.4) 0.0
Miscellaneous (income) expense, net 2.8 (1.1) (0.4) 5.6
Other operating income, net $ 14.5 $ (24.6) $ (17.5) $ (38.3)
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information - Narrative (Details)
6 Months Ended
Jun. 30, 2023
segment
Disaggregation of Revenue  
Number of reportable segments 3
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information - Revenue by Segment (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue        
Total Revenues, net $ 668.8 $ 686.6 $ 1,297.9 $ 1,348.8
Academia & Government        
Disaggregation of Revenue        
Total Revenues, net 342.0 332.7 656.7 644.5
Intellectual Property        
Disaggregation of Revenue        
Total Revenues, net 216.3 238.4 425.4 480.2
LS&H Segment        
Disaggregation of Revenue        
Total Revenues, net $ 110.5 $ 115.5 $ 215.8 $ 224.1
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information - Adjusted EBITDA by Segment (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]            
Total Adjusted EBITDA $ 284.9   $ 274.4   $ 537.6 $ 536.7
Benefit (provision) for income taxes 35.3   (10.5)   98.9 (26.8)
Depreciation and amortization (178.1)   (175.6)   (350.7) (352.0)
Interest expense and amortization of debt discount, net (73.0)   (62.3)   (146.6) (121.8)
Mark to market gain on financial instruments 2.9   49.0   1.8 149.4
Deferred revenues adjustment 0.0   (0.8)   0.0 (0.6)
Transaction related costs (0.7)   (5.1)   (2.4) (11.8)
Share-based compensation expense (30.5)   (22.1)   (71.7) (59.1)
Restructuring and lease impairments (12.2)   (19.2)   (21.6) (30.9)
Goodwill and intangible asset impairments (135.2)   0.0   (135.2) 0.0
Other (16.5)   34.6   10.3 48.8
Net (loss) income (123.1) $ 43.5 62.4 $ 69.5 (79.6) 131.9
Dividends on preferred shares (18.6)   (18.7)   (37.4) (37.4)
Net income (loss) attributable to ordinary shares (141.7)   43.7   (117.0) 94.5
Academia & Government            
Segment Reporting Information [Line Items]            
Total Adjusted EBITDA 146.8   122.9   272.2 227.4
Restructuring and lease impairments (5.8)   (11.4)   (10.9) (17.4)
Intellectual Property            
Segment Reporting Information [Line Items]            
Total Adjusted EBITDA 100.1   107.8   194.7 225.4
Restructuring and lease impairments (3.3)   (4.7)   (6.0) (8.7)
LS&H Segment            
Segment Reporting Information [Line Items]            
Total Adjusted EBITDA $ 38.0   $ 43.7   $ 70.7 $ 83.9
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies - Contingencies (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Commitments and Contingencies    
Reserve for probable claims $ 4.0  
Gain on settlement 49.4 $ 0.0
One Of The Larger Legal Claims    
Commitments and Contingencies    
Gain on settlement $ 49.4  
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.23.2
Commitments and Contingencies - Mandatory Convertible Preferred Share Dividends (Details) - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Dividends Payable [Line Items]    
Preferred stock, dividend rate (as a percent) 5.25% 5.25%
Series A Preferred Stock    
Dividends Payable [Line Items]    
Preferred stock, dividend rate (as a percent) 5.25%  
Liquidation preference (usd per share) $ 100.00  
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 01, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Related Party and Former Parent Transactions            
Capital office leases - finance lease asset   $ 8.0   $ 8.0   $ 8.0
Finance lease liability   30.8   30.8   $ 31.3
Total Revenues, net   668.8 $ 686.6 1,297.9 $ 1,348.8  
ProQuest            
Related Party and Former Parent Transactions            
Clarivate stock to be issued $ 1,094.9          
Newly issued ordinary shares (in shares) 46.9          
Affiliated Entity            
Related Party and Former Parent Transactions            
Interest on lease liabilities   0.6   1.1    
Amortization of right-of-use assets   0.1   0.2    
Capital office leases - finance lease asset   8.0   8.0    
Finance lease liability   30.8   30.8    
Director            
Related Party and Former Parent Transactions            
Costs and Expenses, Related Party   1.3 1.2 2.5 2.3  
Total Revenues, net   $ 0.2 $ 0.2 $ 0.4 $ 0.4  
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.23.2
Restructuring and Lease Impairments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Restructuring Reserve [Roll Forward]        
Restructuring Reserve, Beginning Balance     $ 11.6 $ 29.0
Expenses recorded $ 12.2 $ 19.2 21.6 30.9
Payments made     (24.9) (37.3)
Noncash items     (3.5) (8.0)
Restructuring Reserve, Ending Balance 4.8 14.6 4.8 14.6
Academia & Government        
Restructuring Reserve [Roll Forward]        
Expenses recorded 5.8 11.4 10.9 17.4
Intellectual Property        
Restructuring Reserve [Roll Forward]        
Expenses recorded 3.3 4.7 6.0 8.7
Life Sciences & Healthcare        
Restructuring Reserve [Roll Forward]        
Expenses recorded 3.1 3.1 4.7 4.8
One Clarivate Program | Academia & Government        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 3.2 0.0 6.1
One Clarivate Program | Intellectual Property        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 1.1 0.0 3.0
One Clarivate Program | Life Sciences & Healthcare        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 1.2 0.0 2.0
ProQuest Acquisition Integration Program | Academia & Government        
Restructuring Reserve [Roll Forward]        
Expenses recorded 4.2 8.0 9.3 11.3
ProQuest Acquisition Integration Program | Intellectual Property        
Restructuring Reserve [Roll Forward]        
Expenses recorded 1.9 4.0 4.6 5.9
ProQuest Acquisition Integration Program | Life Sciences & Healthcare        
Restructuring Reserve [Roll Forward]        
Expenses recorded 1.5 2.0 3.1 2.9
Segment Optimization Program | Academia & Government        
Restructuring Reserve [Roll Forward]        
Expenses recorded 1.6 0.0 1.6 0.0
Segment Optimization Program | Intellectual Property        
Restructuring Reserve [Roll Forward]        
Expenses recorded 1.4 0.0 1.4 0.0
Segment Optimization Program | Life Sciences & Healthcare        
Restructuring Reserve [Roll Forward]        
Expenses recorded 1.6 0.0 1.6 0.0
Other Restructuring Plans | Academia & Government        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.2 0.0 0.0
Other Restructuring Plans | Intellectual Property        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 (0.4) 0.0 (0.2)
Other Restructuring Plans | Life Sciences & Healthcare        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 (0.1) 0.0 (0.1)
Severance and Related Benefit Cost        
Restructuring Reserve [Roll Forward]        
Restructuring Reserve, Beginning Balance     11.5 28.3
Expenses recorded 9.9 12.1 19.2 22.4
Payments made     (23.4) (34.6)
Noncash items     (2.7) (2.6)
Restructuring Reserve, Ending Balance 4.6 13.5 4.6 13.5
Severance and Related Benefit Cost | One Clarivate Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 5.5 0.0 11.1
Severance and Related Benefit Cost | ProQuest Acquisition Integration Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 7.6 7.7 16.9 12.0
Severance and Related Benefit Cost | Segment Optimization Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 2.3 0.0 2.3 0.0
Severance and Related Benefit Cost | Other Restructuring Plans        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 (1.1) 0.0 (0.7)
Exit and Disposal Costs        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.3 0.1 2.0
Exit and Disposal Costs | One Clarivate Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.0 0.0 0.0
Exit and Disposal Costs | ProQuest Acquisition Integration Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.1 0.1 1.9
Exit and Disposal Costs | Segment Optimization Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.0 0.0 0.0
Exit and Disposal Costs | Other Restructuring Plans        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.2 0.0 0.1
Lease Abandonment Costs        
Restructuring Reserve [Roll Forward]        
Expenses recorded 2.3 6.8 2.3 6.5
Lease Abandonment Costs | One Clarivate Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.0 0.0 0.0
Lease Abandonment Costs | ProQuest Acquisition Integration Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 6.2 0.0 6.2
Lease Abandonment Costs | Segment Optimization Program        
Restructuring Reserve [Roll Forward]        
Expenses recorded 2.3 0.0 2.3 0.0
Lease Abandonment Costs | Other Restructuring Plans        
Restructuring Reserve [Roll Forward]        
Expenses recorded 0.0 0.6 0.0 0.3
Exit, Disposal and Abandonment Costs        
Restructuring Reserve [Roll Forward]        
Restructuring Reserve, Beginning Balance     0.1 0.7
Expenses recorded     2.4 8.5
Payments made     (1.5) (2.7)
Noncash items     (0.8) (5.4)
Restructuring Reserve, Ending Balance $ 0.2 $ 1.1 $ 0.2 $ 1.1
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events (Details)
€ in Millions
Jul. 12, 2023
EUR (€)
Subsequent Event | Currency Swap | Designated as Hedging Instrument | Net Investment Hedging  
Subsequent Events  
Derivative, Notional Amount € 100.0
XML 88 clvt-20230630_htm.xml IDEA: XBRL DOCUMENT 0001764046 2023-01-01 2023-06-30 0001764046 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001764046 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-06-30 0001764046 clvt:PreferredStockPurchaseRightsMember 2023-01-01 2023-06-30 0001764046 2023-07-28 0001764046 2023-06-30 0001764046 2022-12-31 0001764046 2022-01-01 2022-12-31 0001764046 2023-04-01 2023-06-30 0001764046 2022-04-01 2022-06-30 0001764046 2022-01-01 2022-06-30 0001764046 us-gaap:CommonStockMember 2022-12-31 0001764046 us-gaap:PreferredStockMember 2022-12-31 0001764046 us-gaap:TreasuryStockCommonMember 2022-12-31 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001764046 us-gaap:RetainedEarningsMember 2022-12-31 0001764046 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001764046 2023-01-01 2023-03-31 0001764046 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001764046 us-gaap:CommonStockMember 2023-03-31 0001764046 us-gaap:PreferredStockMember 2023-03-31 0001764046 us-gaap:TreasuryStockCommonMember 2023-03-31 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001764046 us-gaap:RetainedEarningsMember 2023-03-31 0001764046 2023-03-31 0001764046 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001764046 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001764046 us-gaap:CommonStockMember 2023-06-30 0001764046 us-gaap:PreferredStockMember 2023-06-30 0001764046 us-gaap:TreasuryStockCommonMember 2023-06-30 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001764046 us-gaap:RetainedEarningsMember 2023-06-30 0001764046 us-gaap:CommonStockMember 2021-12-31 0001764046 us-gaap:PreferredStockMember 2021-12-31 0001764046 us-gaap:TreasuryStockCommonMember 2021-12-31 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001764046 us-gaap:RetainedEarningsMember 2021-12-31 0001764046 2021-12-31 0001764046 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001764046 2022-01-01 2022-03-31 0001764046 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001764046 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001764046 us-gaap:CommonStockMember 2022-03-31 0001764046 us-gaap:PreferredStockMember 2022-03-31 0001764046 us-gaap:TreasuryStockCommonMember 2022-03-31 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001764046 us-gaap:RetainedEarningsMember 2022-03-31 0001764046 2022-03-31 0001764046 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001764046 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001764046 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001764046 us-gaap:CommonStockMember 2022-06-30 0001764046 us-gaap:PreferredStockMember 2022-06-30 0001764046 us-gaap:TreasuryStockCommonMember 2022-06-30 0001764046 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001764046 us-gaap:RetainedEarningsMember 2022-06-30 0001764046 2022-06-30 0001764046 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-06-30 0001764046 us-gaap:SeriesAPreferredStockMember 2023-06-30 0001764046 us-gaap:SeriesAPreferredStockMember 2022-06-30 0001764046 srt:ScenarioForecastMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember clvt:SmallProductGroupWithinIPSegmentMember 2023-12-31 0001764046 srt:ScenarioForecastMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember clvt:SmallProductGroupWithinIPSegmentMember 2023-10-01 2023-12-31 0001764046 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember us-gaap:CustomerRelationshipsMember clvt:SmallProductGroupWithinIPSegmentMember 2023-06-30 0001764046 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember clvt:SmallProductGroupWithinIPSegmentMember 2023-06-30 0001764046 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember clvt:SmallProductGroupWithinIPSegmentMember 2023-04-01 2023-06-30 0001764046 clvt:ComputerHardwareMember 2023-06-30 0001764046 clvt:ComputerHardwareMember 2022-12-31 0001764046 us-gaap:LeaseholdImprovementsMember 2023-06-30 0001764046 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001764046 clvt:FurnitureFixturesAndEquipmentMember 2023-06-30 0001764046 clvt:FurnitureFixturesAndEquipmentMember 2022-12-31 0001764046 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2023-06-30 0001764046 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2022-12-31 0001764046 us-gaap:CustomerRelationshipsMember 2023-06-30 0001764046 us-gaap:CustomerRelationshipsMember 2022-12-31 0001764046 clvt:DatabasesAndContentMember 2023-06-30 0001764046 clvt:DatabasesAndContentMember 2022-12-31 0001764046 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-06-30 0001764046 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001764046 us-gaap:OtherIntangibleAssetsMember 2023-06-30 0001764046 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0001764046 us-gaap:TradeNamesMember 2023-06-30 0001764046 us-gaap:TradeNamesMember 2022-12-31 0001764046 clvt:AcademiaGovernmentGroupMember 2022-12-31 0001764046 clvt:IntellectualPropertyGroupMember 2022-12-31 0001764046 clvt:LifeSciencesAndHealthcareGroupMember 2022-12-31 0001764046 clvt:AcademiaGovernmentGroupMember 2023-01-01 2023-06-30 0001764046 clvt:IntellectualPropertyGroupMember 2023-04-01 2023-06-30 0001764046 clvt:LifeSciencesAndHealthcareGroupMember 2023-01-01 2023-06-30 0001764046 clvt:IntellectualPropertyGroupMember 2023-01-01 2023-06-30 0001764046 clvt:AcademiaGovernmentGroupMember 2023-06-30 0001764046 clvt:IntellectualPropertyGroupMember 2023-06-30 0001764046 clvt:LifeSciencesAndHealthcareGroupMember 2023-06-30 0001764046 clvt:InterestRateSwapEffectiveDateMarch312021FixedRate1695Member 2023-06-30 0001764046 clvt:InterestRateSwapEffectiveDateApril302021FixedRate1695Member 2023-06-30 0001764046 clvt:InterestRateSwapEffectiveDateMarch312021FixedRate0451Member 2023-06-30 0001764046 clvt:InterestRateSwapEffectiveDateOctober312022FixedRate0471Member 2023-06-30 0001764046 clvt:InterestRateSwapEffectiveDateOctober312022FixedRate0487Member 2023-06-30 0001764046 clvt:InterestRateSwapEffectiveDateAugust42022FixedRate2857Member 2023-06-30 0001764046 clvt:InterestRateSwapEffectiveDateAugust52022FixedRate3063Member 2023-06-30 0001764046 us-gaap:InterestRateSwapMember 2023-06-30 0001764046 us-gaap:InterestRateSwapMember 2022-12-31 0001764046 srt:MaximumMember us-gaap:ForeignExchangeContractMember 2023-04-01 2023-06-30 0001764046 us-gaap:ForeignExchangeContractMember 2023-04-01 2023-06-30 0001764046 us-gaap:ForeignExchangeContractMember 2022-04-01 2022-06-30 0001764046 us-gaap:ForeignExchangeContractMember 2023-01-01 2023-06-30 0001764046 us-gaap:ForeignExchangeContractMember 2022-01-01 2022-06-30 0001764046 srt:ScenarioPreviouslyReportedMember us-gaap:ForeignExchangeContractMember 2022-04-01 2022-06-30 0001764046 srt:ScenarioPreviouslyReportedMember us-gaap:ForeignExchangeContractMember 2022-01-01 2022-06-30 0001764046 us-gaap:ForeignExchangeContractMember 2023-06-30 0001764046 us-gaap:ForeignExchangeContractMember 2022-12-31 0001764046 us-gaap:ForeignExchangeForwardMember 2023-06-30 0001764046 us-gaap:ForeignExchangeForwardMember 2022-12-31 0001764046 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001764046 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001764046 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001764046 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001764046 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001764046 us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-06-30 0001764046 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001764046 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001764046 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001764046 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001764046 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001764046 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-01-01 2023-03-31 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-01-01 2022-03-31 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-04-01 2023-06-30 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-04-01 2022-06-30 0001764046 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001764046 clvt:NewSeniorUnsecuredNotes2029Member 2023-06-30 0001764046 clvt:NewSeniorUnsecuredNotes2029Member 2022-12-31 0001764046 clvt:NewSeniorSecuredNotes2028Member 2023-06-30 0001764046 clvt:NewSeniorSecuredNotes2028Member 2022-12-31 0001764046 us-gaap:RevolvingCreditFacilityMember 2023-06-30 0001764046 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001764046 clvt:TermLoanFacilityMember 2023-06-30 0001764046 clvt:TermLoanFacilityMember 2022-12-31 0001764046 clvt:SeniorSecuredNotes2026Member 2023-06-30 0001764046 clvt:SeniorSecuredNotes2026Member 2022-12-31 0001764046 us-gaap:LetterOfCreditMember 2023-06-30 0001764046 us-gaap:RevolvingCreditFacilityMember 2023-06-30 0001764046 clvt:SeniorUnsecuredNotesMember 2023-06-30 0001764046 us-gaap:LetterOfCreditMember 2023-06-30 0001764046 clvt:TermLoanFacilityMember 2022-10-01 2022-12-31 0001764046 clvt:TermLoanFacilityMember 2023-01-01 2023-06-30 0001764046 clvt:SubscriptionRevenuesMember 2023-04-01 2023-06-30 0001764046 clvt:SubscriptionRevenuesMember 2022-04-01 2022-06-30 0001764046 clvt:ReOccurringRevenuesMember 2023-04-01 2023-06-30 0001764046 clvt:ReOccurringRevenuesMember 2022-04-01 2022-06-30 0001764046 clvt:TransactionRevenuesMember 2023-04-01 2023-06-30 0001764046 clvt:TransactionRevenuesMember 2022-04-01 2022-06-30 0001764046 clvt:SubscriptionRevenuesMember 2023-01-01 2023-06-30 0001764046 clvt:SubscriptionRevenuesMember 2022-01-01 2022-06-30 0001764046 clvt:ReOccurringRevenuesMember 2023-01-01 2023-06-30 0001764046 clvt:ReOccurringRevenuesMember 2022-01-01 2022-06-30 0001764046 clvt:TransactionRevenuesMember 2023-01-01 2023-06-30 0001764046 clvt:TransactionRevenuesMember 2022-01-01 2022-06-30 0001764046 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2023-01-01 2023-03-31 0001764046 2023-07-01 2023-06-30 0001764046 us-gaap:SeriesAPreferredStockMember 2021-06-01 2021-06-30 0001764046 us-gaap:SeriesAPreferredStockMember us-gaap:OverAllotmentOptionMember 2021-06-01 2021-06-30 0001764046 2021-10-01 2021-10-01 0001764046 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001764046 2022-02-07 0001764046 2023-05-24 0001764046 clvt:OpenMarketPurchasesMember us-gaap:SubsequentEventMember 2023-07-27 0001764046 srt:MinimumMember clvt:OpenMarketPurchasesMember us-gaap:SubsequentEventMember 2023-07-27 2023-07-27 0001764046 srt:MaximumMember clvt:OpenMarketPurchasesMember us-gaap:SubsequentEventMember 2023-07-27 2023-07-27 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001764046 us-gaap:CostOfSalesMember 2023-04-01 2023-06-30 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001764046 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-01 2023-06-30 0001764046 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2023-04-01 2023-06-30 0001764046 us-gaap:PerformanceSharesMember 2023-04-01 2023-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember 2023-04-01 2023-06-30 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001764046 us-gaap:CostOfSalesMember 2023-01-01 2023-06-30 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001764046 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001764046 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-06-30 0001764046 us-gaap:PerformanceSharesMember 2023-01-01 2023-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember 2023-01-01 2023-06-30 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001764046 us-gaap:CostOfSalesMember 2022-04-01 2022-06-30 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001764046 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-04-01 2022-06-30 0001764046 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001764046 us-gaap:PerformanceSharesMember 2022-04-01 2022-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember 2022-04-01 2022-06-30 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001764046 us-gaap:CostOfSalesMember 2022-01-01 2022-06-30 0001764046 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001764046 us-gaap:PerformanceSharesMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001764046 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001764046 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001764046 us-gaap:PerformanceSharesMember 2022-01-01 2022-06-30 0001764046 us-gaap:PhantomShareUnitsPSUsMember 2022-01-01 2022-06-30 0001764046 us-gaap:EmployeeStockOptionMember 2022-12-31 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001764046 us-gaap:PerformanceSharesMember 2022-12-31 0001764046 us-gaap:EmployeeStockOptionMember 2023-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2023-06-30 0001764046 us-gaap:PerformanceSharesMember 2023-06-30 0001764046 us-gaap:EmployeeStockOptionMember 2021-12-31 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001764046 us-gaap:PerformanceSharesMember 2021-12-31 0001764046 us-gaap:EmployeeStockOptionMember 2022-06-30 0001764046 us-gaap:RestrictedStockUnitsRSUMember 2022-06-30 0001764046 us-gaap:PerformanceSharesMember 2022-06-30 0001764046 clvt:WarrantAndShareBasedPaymentArrangementMember 2023-01-01 2023-06-30 0001764046 clvt:WarrantAndShareBasedPaymentArrangementMember 2022-01-01 2022-06-30 0001764046 clvt:WarrantAndShareBasedPaymentArrangementMember 2023-04-01 2023-06-30 0001764046 clvt:WarrantAndShareBasedPaymentArrangementMember 2022-04-01 2022-06-30 0001764046 us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-06-30 0001764046 clvt:AcademiaGovernmentGroupMember 2023-04-01 2023-06-30 0001764046 clvt:AcademiaGovernmentGroupMember 2022-04-01 2022-06-30 0001764046 clvt:AcademiaGovernmentGroupMember 2022-01-01 2022-06-30 0001764046 clvt:IntellectualPropertyGroupMember 2022-04-01 2022-06-30 0001764046 clvt:IntellectualPropertyGroupMember 2022-01-01 2022-06-30 0001764046 clvt:LifeSciencesAndHealthcareGroupMember 2023-04-01 2023-06-30 0001764046 clvt:LifeSciencesAndHealthcareGroupMember 2022-04-01 2022-06-30 0001764046 clvt:LifeSciencesAndHealthcareGroupMember 2022-01-01 2022-06-30 0001764046 clvt:OneOfTheLargerLegalClaimsMember 2023-01-01 2023-06-30 0001764046 clvt:ProQuestMember 2021-12-01 2021-12-01 0001764046 srt:AffiliatedEntityMember 2023-04-01 2023-06-30 0001764046 srt:AffiliatedEntityMember 2023-01-01 2023-06-30 0001764046 srt:AffiliatedEntityMember 2023-06-30 0001764046 srt:DirectorMember 2023-04-01 2023-06-30 0001764046 srt:DirectorMember 2022-04-01 2022-06-30 0001764046 srt:DirectorMember 2023-01-01 2023-06-30 0001764046 srt:DirectorMember 2022-01-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OneClarivateProgramMember 2023-04-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OneClarivateProgramMember 2022-04-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OneClarivateProgramMember 2023-01-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OneClarivateProgramMember 2022-01-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:ProQuestAcquisitionIntegrationProgramMember 2023-04-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:ProQuestAcquisitionIntegrationProgramMember 2022-04-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:ProQuestAcquisitionIntegrationProgramMember 2023-01-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:ProQuestAcquisitionIntegrationProgramMember 2022-01-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:SegmentOptimizationProgramMember 2023-04-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:SegmentOptimizationProgramMember 2022-04-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:SegmentOptimizationProgramMember 2023-01-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:SegmentOptimizationProgramMember 2022-01-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OtherRestructuringProgramsMember 2023-04-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OtherRestructuringProgramsMember 2022-04-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OtherRestructuringProgramsMember 2023-01-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember clvt:OtherRestructuringProgramsMember 2022-01-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2023-04-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2022-04-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2023-01-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2022-01-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OneClarivateProgramMember 2023-04-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OneClarivateProgramMember 2022-04-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OneClarivateProgramMember 2023-01-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OneClarivateProgramMember 2022-01-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2023-04-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2022-04-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2023-01-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2022-01-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:SegmentOptimizationProgramMember 2023-04-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:SegmentOptimizationProgramMember 2022-04-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:SegmentOptimizationProgramMember 2023-01-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:SegmentOptimizationProgramMember 2022-01-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OtherRestructuringProgramsMember 2023-04-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OtherRestructuringProgramsMember 2022-04-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OtherRestructuringProgramsMember 2023-01-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember clvt:OtherRestructuringProgramsMember 2022-01-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember 2023-04-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember 2022-04-01 2022-06-30 0001764046 clvt:ExitAndDisposalCostsMember 2023-01-01 2023-06-30 0001764046 clvt:ExitAndDisposalCostsMember 2022-01-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OneClarivateProgramMember 2023-04-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OneClarivateProgramMember 2022-04-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OneClarivateProgramMember 2023-01-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OneClarivateProgramMember 2022-01-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2023-04-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2022-04-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2023-01-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:ProQuestAcquisitionIntegrationProgramMember 2022-01-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:SegmentOptimizationProgramMember 2023-04-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:SegmentOptimizationProgramMember 2022-04-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:SegmentOptimizationProgramMember 2023-01-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:SegmentOptimizationProgramMember 2022-01-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OtherRestructuringProgramsMember 2023-04-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OtherRestructuringProgramsMember 2022-04-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OtherRestructuringProgramsMember 2023-01-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember clvt:OtherRestructuringProgramsMember 2022-01-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember 2023-04-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember 2022-04-01 2022-06-30 0001764046 clvt:LeaseAbandonmentCostsMember 2023-01-01 2023-06-30 0001764046 clvt:LeaseAbandonmentCostsMember 2022-01-01 2022-06-30 0001764046 clvt:OneClarivateProgramMember clvt:AcademiaGovernmentGroupMember 2023-04-01 2023-06-30 0001764046 clvt:OneClarivateProgramMember clvt:AcademiaGovernmentGroupMember 2022-04-01 2022-06-30 0001764046 clvt:OneClarivateProgramMember clvt:AcademiaGovernmentGroupMember 2023-01-01 2023-06-30 0001764046 clvt:OneClarivateProgramMember clvt:AcademiaGovernmentGroupMember 2022-01-01 2022-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:AcademiaGovernmentGroupMember 2023-04-01 2023-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:AcademiaGovernmentGroupMember 2022-04-01 2022-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:AcademiaGovernmentGroupMember 2023-01-01 2023-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:AcademiaGovernmentGroupMember 2022-01-01 2022-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:AcademiaGovernmentGroupMember 2023-04-01 2023-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:AcademiaGovernmentGroupMember 2022-04-01 2022-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:AcademiaGovernmentGroupMember 2023-01-01 2023-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:AcademiaGovernmentGroupMember 2022-01-01 2022-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:AcademiaGovernmentGroupMember 2023-04-01 2023-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:AcademiaGovernmentGroupMember 2022-04-01 2022-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:AcademiaGovernmentGroupMember 2023-01-01 2023-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:AcademiaGovernmentGroupMember 2022-01-01 2022-06-30 0001764046 clvt:OneClarivateProgramMember clvt:IntellectualPropertyGroupMember 2023-04-01 2023-06-30 0001764046 clvt:OneClarivateProgramMember clvt:IntellectualPropertyGroupMember 2022-04-01 2022-06-30 0001764046 clvt:OneClarivateProgramMember clvt:IntellectualPropertyGroupMember 2023-01-01 2023-06-30 0001764046 clvt:OneClarivateProgramMember clvt:IntellectualPropertyGroupMember 2022-01-01 2022-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:IntellectualPropertyGroupMember 2023-04-01 2023-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:IntellectualPropertyGroupMember 2022-04-01 2022-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:IntellectualPropertyGroupMember 2023-01-01 2023-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:IntellectualPropertyGroupMember 2022-01-01 2022-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:IntellectualPropertyGroupMember 2023-04-01 2023-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:IntellectualPropertyGroupMember 2022-04-01 2022-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:IntellectualPropertyGroupMember 2023-01-01 2023-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:IntellectualPropertyGroupMember 2022-01-01 2022-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:IntellectualPropertyGroupMember 2023-04-01 2023-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:IntellectualPropertyGroupMember 2022-04-01 2022-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:IntellectualPropertyGroupMember 2023-01-01 2023-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:IntellectualPropertyGroupMember 2022-01-01 2022-06-30 0001764046 clvt:OneClarivateProgramMember clvt:LifeScienceAndHealthcareGroupMember 2023-04-01 2023-06-30 0001764046 clvt:OneClarivateProgramMember clvt:LifeScienceAndHealthcareGroupMember 2022-04-01 2022-06-30 0001764046 clvt:OneClarivateProgramMember clvt:LifeScienceAndHealthcareGroupMember 2023-01-01 2023-06-30 0001764046 clvt:OneClarivateProgramMember clvt:LifeScienceAndHealthcareGroupMember 2022-01-01 2022-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2023-04-01 2023-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2022-04-01 2022-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2023-01-01 2023-06-30 0001764046 clvt:ProQuestAcquisitionIntegrationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2022-01-01 2022-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2023-04-01 2023-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2022-04-01 2022-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2023-01-01 2023-06-30 0001764046 clvt:SegmentOptimizationProgramMember clvt:LifeScienceAndHealthcareGroupMember 2022-01-01 2022-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:LifeScienceAndHealthcareGroupMember 2023-04-01 2023-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:LifeScienceAndHealthcareGroupMember 2022-04-01 2022-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:LifeScienceAndHealthcareGroupMember 2023-01-01 2023-06-30 0001764046 clvt:OtherRestructuringProgramsMember clvt:LifeScienceAndHealthcareGroupMember 2022-01-01 2022-06-30 0001764046 clvt:LifeScienceAndHealthcareGroupMember 2023-04-01 2023-06-30 0001764046 clvt:LifeScienceAndHealthcareGroupMember 2022-04-01 2022-06-30 0001764046 clvt:LifeScienceAndHealthcareGroupMember 2023-01-01 2023-06-30 0001764046 clvt:LifeScienceAndHealthcareGroupMember 2022-01-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2022-12-31 0001764046 clvt:ExitDisposalAndAbandonmentCostsMember 2022-12-31 0001764046 clvt:ExitDisposalAndAbandonmentCostsMember 2023-01-01 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2023-06-30 0001764046 clvt:ExitDisposalAndAbandonmentCostsMember 2023-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2021-12-31 0001764046 clvt:ExitDisposalAndAbandonmentCostsMember 2021-12-31 0001764046 clvt:ExitDisposalAndAbandonmentCostsMember 2022-01-01 2022-06-30 0001764046 clvt:SeveranceAndRelatedBenefitCostMember 2022-06-30 0001764046 clvt:ExitDisposalAndAbandonmentCostsMember 2022-06-30 0001764046 us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SubsequentEventMember 2023-07-12 shares iso4217:USD iso4217:USD shares pure clvt:segment iso4217:EUR 0001764046 false --12-31 2023 FY 00-0000000 10-Q true 2023-06-30 false 001-38911 CLARIVATE PLC Y9 70 St. Mary Axe London EC3A 8BE GB 44 207 4334000 Ordinary Shares, no par value CLVT NYSE 5.25% Series A Mandatory Convertible Preferred Shares, no par value CLVT PR A NYSE Series B Preferred Stock Purchase Rights NYSE Yes Yes Large Accelerated Filer false false false 676234313 436100000 348800000 7000000.0 8000000.0 769700000 872100000 101900000 89400000 76800000 76900000 26100000 0.0 1417600000 1395200000 50700000 54500000 9186400000 9437700000 2895500000 2876500000 76000000.0 97900000 26500000 24200000 52900000 58900000 13705600000 13944900000 108200000 101400000 101200000 132100000 317100000 352100000 939600000 947500000 24200000 25700000 1100000 1000000.0 6500000 0.0 1497900000 1559800000 4863200000 5005000000 37900000 38500000 41400000 140100000 262100000 316100000 64800000 72900000 6767300000 7132400000 0 0 14400000 14400000 0.0525 0.0525 14400000 14400000 14400000 14400000 1392600000 1392600000 0 0 676100000 676100000 674400000 674400000 11809200000 11744700000 -487600000 -665900000 -5775900000 -5658900000 6938300000 6812500000 13705600000 13944900000 668800000 686600000 224200000 244100000 192900000 186100000 178100000 175600000 12200000 19200000 135200000 0 -14500000 24600000 757100000 600400000 -88300000 86200000 -2900000 -49000000.0 73000000.0 62300000 -158400000 72900000 -35300000 10500000 -123100000 62400000 18600000 18700000 -141700000 43700000 -0.21 0.06 -0.21 0.00 675900000 674300000 675900000 678400000 1297900000 1348800000 453900000 493300000 387700000 379800000 350700000 352000000.0 21600000 30900000 135200000 0 17500000 38300000 1331600000 1217700000 -33700000 131100000 -1800000 -149400000 146600000 121800000 -178500000 158700000 -98900000 26800000 -79600000 131900000 37400000 37400000 -117000000.0 94500000 -0.17 0.14 -0.17 -0.07 675400000 678300000 675400000 683200000 -123100000 62400000 7300000 3900000 82600000 -626600000 89900000 -622700000 -33200000 -560300000 -79600000 131900000 -5100000 15800000 183400000 -861700000 178300000 -845900000 98700000 -714000000.0 674400000 11744700000 14400000 1392600000 0 0 -665900000 -5658900000 6812500000 1800000 600000 33700000 33700000 18800000 18800000 43500000 43500000 88400000 88400000 675600000 11778400000 14400000 1392600000 0 0 -577500000 -5634200000 6959300000 800000 300000 30800000 30800000 18600000 18600000 -123100000 -123100000 89900000 89900000 676100000 11809200000 14400000 1392600000 0 0 -487600000 -5775900000 6938300000 683100000 11827900000 14400000 1392600000 500000 -16900000 326700000 -1604400000 11925900000 -500000 200000 400000 400000 700000 400000 21500000 21500000 4100000 4100000 66400000 66400000 34800000 2100000 -33300000 -1500000 0 -1300000 700000 -600000 18700000 18700000 69500000 69500000 -223200000 -223200000 679000000.0 11815000000 14400000 1392600000 2500000 48700000 103500000 -1552800000 11709600000 0 100000 100000 -1300000 400000 18300000 18300000 6600000 6600000 108600000 108600000 0 132500000 8600000 -141700000 9200000 0 0 0 -300000 -300000 0 0 18700000 18700000 62400000 62400000 -622700000 -622700000 673300000 11700900000 14400000 1392600000 500000 15600000 -519200000 -1518000000 11040700000 -79600000 131900000 350700000 352000000.0 71600000 47200000 138700000 -1000000.0 -1800000 -149400000 -9100000 -7600000 49400000 0 -47800000 -900000 -18800000 33600000 -121700000 -53800000 11900000 26900000 -38600000 24800000 6200000 -8800000 -74200000 -150300000 -18400000 -29500000 -4500000 3400000 -77900000 -6100000 389900000 164600000 116900000 89100000 1100000 14300000 10500000 0 -107500000 -103400000 150000000.0 14300000 100000 2100000 0 900000 0 175000000.0 37700000 37700000 0 500000 500000 1000000.0 9700000 10700000 -197800000 -239400000 1700000 -36500000 87300000 -71200000 -1000000.0 -143500000 86300000 -214700000 348800000 430900000 8000000.0 156700000 356800000 587600000 436100000 359700000 7000000.0 13200000 443100000 372900000 136400000 113400000 22500000 23700000 10300000 23800000 0 -175000000.0 0.0525 6200000 6200000 6200000 -168800000 Background and Nature of Operations <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clarivate Plc (“Clarivate,” “us,” “we,” “our,” or the “Company”), is a public limited company organized under the laws of Jersey, Channel Islands, pursuant to the definitive agreement entered into on May 13, 2019 to effect a merger between Camelot Holdings (Jersey) Limited ("Jersey") and Churchill Capital Corp, a Delaware corporation ("Churchill") (the “2019 Transaction”).</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a provider of proprietary and comprehensive information, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science and healthcare companies, corporations and law firms to power the entire innovation lifecycle, from cultivating curiosity to protecting the world's critical intellectual property assets. Clarivate has three reportable segments: Academia &amp; Government ("A&amp;G"), Intellectual Property ("IP"), and Life Sciences &amp; Healthcare ("LS&amp;H"). Our segment structure is organized based on the products we offer and the markets they serve. See Note 16 - Segment Information, for additional information on the Company's reportable segments.</span></div> 3 Basis of Presentation<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements of the Company have been prepared on substantially the same basis as our annual consolidated financial statements and should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022. Results from interim periods should not be considered indicative of results for the full year. In the opinion of management, these Condensed Consolidated Financial Statements reflect all adjustments necessary for a fair statement of financial position, results of operations, and cash flows for the periods presented, and such adjustments are of a normal, recurring nature.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Condensed Consolidated Financial Statements of the Company include the accounts of all of its subsidiaries. Subsidiaries are entities over which the Company has control, where control is defined as the power to govern financial and operating policies. Generally, the Company has a shareholding of more than 50% of the voting rights in its subsidiaries. The effect of potential voting rights that are currently exercisable is considered when assessing whether control exists. Subsidiaries are fully consolidated from the date control is transferred to the Company, and are de-consolidated from the date control ceases. Intercompany accounts and transactions have been eliminated in consolidation.</span></div> Summary of Significant Accounting Policies <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are those that we believe are important to the portrayal of our financial condition and results of operations, as well as those that involve significant judgments or estimates about matters that are inherently uncertain. There have been no material changes to the significant accounting policies discussed in Item 8. Financial Statements and Supplementary Data – Notes to the Consolidated Financial Statements – Note 3 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 1, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Newly Adopted Accounting Standards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform between March 12, 2020 and December 31, 2022. In January 2021, the FASB issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides additional optional guidance on the transition from LIBOR to include derivative instruments that use an interest rate for margining, discounting or contract price alignment. The standard will ease, if warranted, the requirements for accounting for the future effects of the rate reform. Additionally, in December 2022, the FASB issued ASU 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform: Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024 to align with the amended cessation date of LIBOR. In 2020, the Company adopted ASU 2020-04, and, upon meeting the specified criteria in the guidance, elected the optional expedients for its interest rate swaps and debt agreements with reference to LIBOR. Accordingly, the Company has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt agreements. ASU 2021-01 and ASU 2022-06 did not have an effect on how </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company accounts for its interest rate swaps and debt agreements due to our election and application of the optional expedients discussed above in connection with ASU 2020-04. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, the Company modified the contractual terms of its interest rate swaps and debt agreements to replace the previous LIBOR-based reference rate with the Term SOFR (Secured Overnight Financing Rate). The Company utilized the practical expedients set forth in Topic 848 and has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt instruments.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other new accounting standards or updates issued or effective as of June 30, 2023, that have, or are expected to have, a material impact on the Company's Condensed Consolidated Financial Statements.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Newly Adopted Accounting Standards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform between March 12, 2020 and December 31, 2022. In January 2021, the FASB issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which provides additional optional guidance on the transition from LIBOR to include derivative instruments that use an interest rate for margining, discounting or contract price alignment. The standard will ease, if warranted, the requirements for accounting for the future effects of the rate reform. Additionally, in December 2022, the FASB issued ASU 2022-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform: Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024 to align with the amended cessation date of LIBOR. In 2020, the Company adopted ASU 2020-04, and, upon meeting the specified criteria in the guidance, elected the optional expedients for its interest rate swaps and debt agreements with reference to LIBOR. Accordingly, the Company has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt agreements. ASU 2021-01 and ASU 2022-06 did not have an effect on how </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company accounts for its interest rate swaps and debt agreements due to our election and application of the optional expedients discussed above in connection with ASU 2020-04. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, the Company modified the contractual terms of its interest rate swaps and debt agreements to replace the previous LIBOR-based reference rate with the Term SOFR (Secured Overnight Financing Rate). The Company utilized the practical expedients set forth in Topic 848 and has continued to account for its interest rate swaps in accordance with hedge accounting and has not applied modification accounting to its debt instruments.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other new accounting standards or updates issued or effective as of June 30, 2023, that have, or are expected to have, a material impact on the Company's Condensed Consolidated Financial Statements.</span></div> <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4: Assets Held for Sale and Divested Operations</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter 2023, the Company entered into a commercial agreement to sell a small product group within its IP segment for approximately $34 payable over ten years. The divestiture enables improved focus on our core IP business assets and empowers product development and innovation teams to build upon our market-leading IP intelligence, IP lifecycle management and IP services solutions. The transaction, which is expected to close during the fourth quarter of 2023, does not represent a strategic shift, nor is it expected to have a material impact on the Company’s operations or financial results. Accordingly, the divestiture meets the held-for-sale criteria but does not qualify as a discontinued operation as of June 30, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the held-for-sale determination and accompanying impairment testing as of June 30, 2023, the carrying amount of the expected assets to be disposed of consisted almost entirely of purchase-related identifiable customer relationship intangible assets of approximately $158. These intangible assets were reduced to estimated fair value of $26.1 based on the estimated present value of the consideration to be paid over ten years and were reclassified to Assets held-for-sale on the Condensed Consolidated Balance Sheet as of June 30, 2023. The related impairment charge of $132.2 is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. The carrying amount of the expected liabilities to be transferred consisted of the remaining deferred tax liabilities associated with those intangibles of $6.5, which were reclassified to Liabilities held-for-sale on the Condensed Consolidated Balance Sheet as of June 30, 2023.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, the Company completed the sale of the MarkMonitor Domain Management business (IP segment) to Newfold Digital, a leading web presence solutions provider. During the second quarter 2023, the Company received the $10.5 of deferred closing consideration included in the aggregate sale price.</span></div> 34000000 P10Y 158000000 26100000 132200000 6500000 10500000 Property and Equipment, Net<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following: </span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital office leases - finance lease asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $5.4 and $9.8 for the three months ended June 30, 2023</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022, respectively, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11.3</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $20.4 for the six months ended June 30, 2023 and 2022, respectively.</span> <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following: </span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital office leases - finance lease asset</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, gross</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.3 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div> 49300000 45100000 15600000 16100000 42000000.0 39000000.0 8000000.0 8000000.0 2200000 2100000 117100000 110300000 66400000 55800000 50700000 54500000 5400000 9800000 11300000 20400000 Other Intangible Assets, net and Goodwill<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Intangible Assets, net</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gross carrying amounts and accumulated amortization of the Company’s identifiable intangible assets by major class:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Finite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,778.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(994.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,783.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,809.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,987.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases and content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(889.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,844.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,429.0 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,399.5)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,029.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,343.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,063.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,280.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,585.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,399.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,186.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,500.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,063.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible amortization expense was $172.7 and $165.8 for the three months ended June 30, 2023, and 2022, respectively, and $339.4 and $331.6 for the six months ended June 30, 2023, and 2022, respectively.</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill by segment is shown below:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.849%"><tr><td style="width:1.0%"></td><td style="width:40.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A&amp;G<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IP<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LS&amp;H<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information. </span></div></td></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the gross carrying amounts and accumulated amortization of the Company’s identifiable intangible assets by major class:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Finite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,778.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(994.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,783.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,809.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,987.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Databases and content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,733.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(889.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,844.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(469.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finite-lived intangible assets</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,429.0 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,399.5)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,029.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,343.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,063.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,280.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Indefinite-lived intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,585.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,399.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,186.4 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,500.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,063.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,437.7 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div> 7778400000 994700000 6783700000 7809000000 821500000 6987500000 2733700000 889700000 1844000000 2681000000 780500000 1900500000 828200000 469200000 359000000.0 765100000 422200000 342900000 88700000 45900000 42800000 88800000 38900000 49900000 11429000000 2399500000 9029500000 11343900000 2063100000 9280800000 156900000 156900000 156900000 156900000 11585900000 2399500000 9186400000 11500800000 2063100000 9437700000 172700000 165800000 339400000 331600000 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill by segment is shown below:</span></div><div style="margin-bottom:4pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.849%"><tr><td style="width:1.0%"></td><td style="width:40.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.884%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A&amp;G<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IP<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LS&amp;H<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176.4 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of foreign currency fluctuations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,895.5 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information. </span></div></td></tr></table></div> 1109800000 590300000 1176400000 2876500000 0 3000000.0 0 3000000.0 200000 -22200000 0 -22000000.0 1109600000 609500000 1176400000 2895500000 Derivative InstrumentsThe Company has interest rate swap arrangements with counterparties to reduce its exposure to variability in cash flows relating to interest payments on its outstanding SOFR-based Term Loan arrangements (see Note 3 - Summary of Significant Accounting Policies for additional information). Our interest rate swap arrangements are subject to hedge accounting, by designating the interest rate swaps as hedges on applicable future quarterly interest payments. The following table provides a summary of the Company's interest rate swap arrangements by maturity date as of June 30, 2023:<div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.771%"><tr><td style="width:1.0%"></td><td style="width:22.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notional Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fixed Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48.9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.640%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 29, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.640%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.401%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.421%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$150.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.445%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$384.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 31, 2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.809%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$384.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 5, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 31, 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.010%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in fair value are recorded in Accumulated other comprehensive income (loss) ("AOCI") in the Condensed Consolidated Balance Sheets and the amounts reclassified out of AOCI are recorded to Interest expense and amortization of debt discount, net in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the interest rate swaps is recorded in Other current assets or Accrued expenses and other current liabilities and Other non-current assets or Other non-current liabilities in the Condensed Consolidated Balance Sheets, according to the duration of related cash flows. The fair value of the interest rate swaps was an asset balance of $44.4 and $49.5 as of June 30, 2023 and December 31, 2022, respectively. See Note 8 - Fair Value Measurements for additional information related to the fair value of these derivative instruments.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#010302;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our interest rate risk, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk, and </span><span style="color:#010302;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">see Note 9 - Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our</span><span style="color:#010302;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outstanding Term Loan.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Forward Contracts</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company periodically enters into foreign currency contracts, which generally do not exceed 180 days in duration, to help manage the Company’s exposure to foreign exchange rate risks. The contracts are not designated as accounting hedges under the applicable sections of ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for these forward contracts at fair value and recognizes the associated realized and unrealized gains and losses in Other operating income, net in the Condensed Consolidated Statements of Operations. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Company recognized a loss (gain) from the mark to market adjustment of $2.9 and $(1.0), for the three months ended June 30, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, and $(0.3) and $5.7 for the six months ended June 30,</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2023 and 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. The amounts disclosed for the three and six months ended June 30, 2022 were revised from the previously reported losses of $5.7 and $12.4, respectively. The principal amount of outstanding foreign currency contracts was $162.0 and $165.1 as of June 30, 2023 and December 31, 2022, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of the forward contracts represented an asset balance of $1.3 and $0.8, and a liability balance of $0.6 and $0.4, as of June 30, 2023 and December 31, 2022, respectively, which are classified as Other current assets and Accrued expenses and other current liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 8 - Fair Value Measurements for additional information related to the fair value of derivative instruments.</span></div> 48900000 0.01640 48900000 0.01640 100000000.0 0.00401 100000000.0 0.00421 150000000.0 0.00445 384100000 0.02809 384100000 0.03010 44400000 49500000 P180D -2900000 1000000.0 300000 -5700000 -5700000 -12400000 162000000.0 165100000 1300000 800000 600000 400000 Fair Value Measurements<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the Company’s assets and liabilities that were recognized at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.506%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.506%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total <br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability - non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="18" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of assets or liabilities between levels during the six months ended June 30, 2023 or year ended December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private Placement Warrants </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The following table summarizes the changes in the Private Placement Warrants liability for the three and six months ended June 30, 2023 and 2022:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.967%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark to market loss (gain) on financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark to market gain on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of Private Placement Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Financial Assets Valued on a Non-Recurring Basis</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s long-lived assets, including goodwill, indefinite-lived intangible and finite-lived intangible assets subject to amortization, are measured at fair value on a non-recurring basis. These assets are measured at cost but are written-down to fair value, if necessary, as a result of impairment.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finite-lived Intangible Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - If a triggering event occurs, the Company determines the estimated fair value of finite-lived intangible assets by determining the present value of the expected cash flows. During the second quarter of 2023, the Company recorded an impairment charge of $132.2 in connection with intangible assets classified as Assets held-for-sale. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 4 - Assets Held for Sale and Divested Operations for additional information. </span>Goodwill - Goodwill represents the difference between the purchase price and the fair value of the identifiable tangible and intangible net assets resulting from business combinations. The Company evaluates its goodwill for impairment at the reporting unit level, defined as an operating segment or one level below an operating segment, annually as of October 1 or more frequently if impairment indicators arise in accordance with ASC Topic 350. The Company performs qualitative analysis of macroeconomic conditions, industry and market considerations, internal cost factors, financial performance, fair value history and other company specific events. If this qualitative analysis indicates that it is more likely than not that the estimated fair value is less than the book value for the respective reporting unit, the Company applies a one-step impairment test in which the Company determines whether the estimated fair value of the reporting unit is in excess of its carrying value. If the carrying value of the net assets assigned to the reporting unit exceeds the estimated fair value of the reporting unit, the Company performs the second step of the impairment test to determine the implied estimated fair value of the reporting unit’s goodwill. The Company determines the implied estimated fair value of goodwill by determining the present value of the estimated future cash flows for each reporting unit and comparing the reporting unit’s risk profile and growth prospects to selected, reasonably similar publicly traded companies. During the second quarter of 2023, the Company recorded an impairment charge of $3.0 in connection with the assets held-for-sale and their allocated portion of the IP segment reporting unit's goodwill balance. The impairment charge is included in Goodwill and intangible asset impairments in the Condensed Consolidated Statement of Operations. Refer to Note 6 - Other Intangible Assets, net and Goodwill for additional information. The following table provides a summary of the Company’s assets and liabilities that were recognized at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.506%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.506%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.863%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total <br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps - non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward currency contracts - current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liability - non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="18" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private Placement Warrants </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The following table summarizes the changes in the Private Placement Warrants liability for the three and six months ended June 30, 2023 and 2022:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.967%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark to market loss (gain) on financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark to market gain on financial instruments</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of Private Placement Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of June 30</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 1300000 1300000 13400000 13400000 31000000.0 31000000.0 45700000 45700000 600000 600000 19200000 19200000 600000 19200000 19800000 800000 800000 2300000 2300000 47200000 47200000 50300000 50300000 400000 400000 21000000.0 21000000.0 400000 21000000.0 21400000 21000000.0 227800000 1100000 -100400000 22100000 127400000 -2900000 -49000000.0 19200000 78400000 132200000 3000000.0 Debt<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company’s debt:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective<br/>Interest<br/>Rate</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective<br/>Interest<br/>Rate</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,347.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.384 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,071.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discounts and issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,863.2 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005.0 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financing Transactions</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes (2029) and Senior Secured Notes (2028)</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $921.2 aggregate principal amount of its Senior Secured Notes due 2028 and $921.4 aggregate principal amount of its Senior Notes due 2029 bearing interest at a rate of 3.875% and 4.875% per annum, respectively, payable semi-annually to holders of record on June 30 and December 30 of each year. The first interest payment was paid in December 2021. Both of these series of Notes were issued by Clarivate Science Holdings Corporation (the "Issuer"), an indirect wholly-owned subsidiary of Clarivate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Secured Notes due 2028 are secured on a first-lien pari passu basis with borrowings under the existing credit facilities and Senior Secured Notes due 2026. Both of these series of Notes are guaranteed on a joint and several basis by each of Clarivate’s indirect subsidiaries that is an obligor or guarantor under Clarivate’s existing credit facilities and Senior Secured Notes due 2026. The Senior Notes due 2029 are the Issuer’s and such guarantors’ unsecured obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Secured Notes (2026)</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has $700.0 aggregate principal amount of its Senior Secured Notes due 2026 bearing interest at a rate of 4.50% per annum, payable semi-annually to holders of record on May 1 and November 1 of each year. The first interest payment was paid in May 2020. The Senior Secured Notes due 2026 were issued by Camelot Finance S.A. (the "Lux Issuer"), an indirect wholly-owned subsidiary of Clarivate, and are secured on a first-lien pari passu basis with borrowings under the Credit Facilities and Senior Secured Notes due 2028. These Notes are guaranteed on a joint and several basis by each of Clarivate's indirect subsidiaries that is an obligor or guarantor under the Credit Facilities and are general senior secured obligations of the Lux Issuer and are secured on a first-priority basis by the collateral now owned or hereafter acquired by the Lux Issuer and each of the guarantors that secures the Issuer’s and such guarantor’s obligations under Clarivate's credit facilities (subject to permitted liens and other exceptions).</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Credit Facilities</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Credit Facilities consist of a $750.0 Revolving Credit Facility with a $80.0 letter of credit sublimit, due 2027, and a $2,860.0 Term Loan Facility due 2026.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 and December 31, 2022, the Company had no outstanding balance on its Revolving Credit Facility. The facility provides for revolving loans, same-day borrowings and letters of credit pursuant to commitments in an aggregate principal amount of $750.0 with a letter of credit sublimit of $80.0. Proceeds of loans made under the Revolving Credit Facility may be borrowed, repaid and reborrowed prior to the maturity of the Revolving Credit Facility. Our ability to draw under the Revolving Credit Facility or issue letters of credit thereunder is conditioned upon, among other things, delivery of required notices, accuracy of the representations and warranties contained in the Credit Agreement and the absence of any default or event of default under the Credit Agreement.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, letters of credit totaling $8.8 were collateralized by the Revolving Credit Facility, and, notwithstanding the Revolving Credit Facility, the Company had unsecured corporate guarantees outstanding of $13.6 and cash collateralized letters of credit of $3.6, which were not collateralized by the Revolving Credit Facility.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Term Loan Facility (2026)</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Term Loan Facility of $2,860.0 due 2026, which was fully drawn at closing. During the fourth quarter 2022, the Company made a $300.0 prepayment on its Term Loan Facility and prepayments of $150.0 during the six months ended June 30, 2023. Prior to the initial prepayment, the principal amount of the Term Loan Facility was repaid by the Company on the last business day of each March, June, September and December, in an amount equal to 0.25% of the aggregate original par principal amount of the initial term loans.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value due to the short-term nature of the interest rate benchmark rates. The fair value of the fixed rate debt is estimated based on market observable data for debt with similar prepayment features. The fair value of the Company’s debt was $4,647.4 and $4,709.6 at June 30, 2023 and December 31, 2022, respectively, and is considered Level 2 under the fair value hierarchy.</span></div> <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company’s debt:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.461%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective<br/>Interest<br/>Rate</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective<br/>Interest<br/>Rate</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.875 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.875 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">921.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Facility </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.217 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,347.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.384 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.500 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.936 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,071.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discounts and issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,863.2 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005.0 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div> 0.04875 921400000 0.04875 921400000 0.03875 921200000 0.03875 921200000 0.07952 0 0.07234 0 0.08217 2347400000 0.07384 2497400000 0.04500 700000000.0 0.04500 700000000.0 0.06936 30800000 0.06936 31300000 4920800000 5071300000 56500000 65300000 1100000 1000000.0 4863200000 5005000000 921200000 921400000 0.03875 0.04875 700000000.0 0.0450 750000000.0 80000000.0 2860000000 0 0 750000000.0 80000000.0 8800000 13600000 3600000 2860000000 300000000.0 150000000.0 0.0025 4647400000 4709600000 Revenue<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenues</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate our revenues by segment (see Note 16 - Segment Information) and by transaction type based on revenue recognition pattern as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Subscription-based revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are recurring revenues that are earned under annual, evergreen or multi-year contracts pursuant to which we license the right to use our products to our customers or provide maintenance services over a contractual term. Revenues from the sale of subscription data, maintenance services, and analytics solutions are recognized ratably over the contractual period.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Re-occurring revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are earned under contracts for specific deliverables that are typically quoted on a product, data set or project basis and often derived from repeat customers. These contracts include either evergreen clauses, in which at least six month advance notice is required prior to cancellation, or the contract is for multiple years. Deliverables are usually received by the customer instantly or in a short period of time, at which time the revenues are recognized. The most significant component of our re-occurring revenues is our 'renewal' business within CPA Global.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Transactional and other revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are earned under contracts for specific deliverables that are typically quoted on a product, data set or project basis and often derived from repeat customers, including customers that also generate subscription-based revenues. Transactional and other revenues may involve sales to the same customer on multiple occasions but with different products or services comprising the order. Other revenues relate to professional services including implementation for software and software as a service ("SaaS") subscriptions. These contracts vary in length from several months to years for multi-year projects. Revenue is recognized over time utilizing a reasonable measure of progress depicting the satisfaction of the related performance obligation. Other revenues also includes one-time perpetual archive license revenues.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues by transaction type based on revenue recognition pattern for the periods presented: </span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Re-occurring revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactional and other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Re-occurring revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactional and other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Balances, as of:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current<br/>deferred revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current <br/>deferred revenues</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.0)</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.7)</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recognized revenue of $588.9 during the six months ended June 30, 2023, attributable to deferred revenues recorded at the beginning of each such period. During the three months ended June 30, 2023, we revised the disclosure in this Note by $113.9 to decrease the revenue recognized that was included in the opening deferred revenue balance to $343.9 for the three months ended March 31, 2023. This correction did not have an impact on the accompanying Condensed Consolidated Balance Sheets or Statements of Operations. Those amounts primarily consisted of subscription revenues recognized ratably over the contractual term during the respective reporting periods.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transaction Price Allocated to Remaining Performance Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue allocated to remaining performance obligations represents the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. Our most significant remaining performance obligations relate to contracts in which we license the right to use our products to our customers or provide maintenance services over the remaining contractual term, a majority of which are contracts with a duration of one year or less. As of June 30, 2023, approximately 90% of the aggregate transaction price allocated to remaining performance obligations are expected to be satisfied within one year.</span></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company’s revenues by transaction type based on revenue recognition pattern for the periods presented: </span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Re-occurring revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactional and other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">811.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Re-occurring revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transactional and other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297.9 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.8 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by reportable segment for the periods indicated:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia &amp; Government</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences &amp; Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 406000000.0 407400000 111000000.0 112000000.0 151800000 168000000.0 0 800000 668800000 686600000 799200000 811200000 218700000 226500000 280000000.0 311700000 0 600000 1297900000 1348800000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Balances, as of:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current<br/>deferred revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current <br/>deferred revenues</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">872.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,030.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.0)</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73.7)</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 872100000 947500000 38500000 769700000 939600000 37900000 -102400000 -7900000 -600000 906400000 1030400000 54200000 812400000 956700000 50300000 -94000000.0 -73700000 -3900000 588900000 -113900000 343900000 0.90 P1Y Shareholders’ Equity<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, there were unlimited shares of ordinary stock authorized and 676.1 million shares issued and outstanding, with no par value. The Company did not hold any shares as treasury shares as of June 30, 2023 and December 31, 2022. The Company’s ordinary shareholders are entitled to one vote per share.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MCPS Offering</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, concurrently with the June 2021 Ordinary Share Offering (see Note 1 - Background and Nature of Operations, in our Annual Report on Form 10-K), we completed a public offering of 14.4 million of our 5.25% Series A Mandatory Convertible Preferred Shares ("MCPS") (which included 1.9 million of our MCPS that the underwriters purchased pursuant to their option to purchase additional shares). Dividends on our mandatory convertible preferred shares are payable, as and if declared by our Board of Directors, at an annual rate of 5.25% of the liquidation preference of $100.00 per share. We may pay declared dividends on March 1, June 1, September 1 and December 1 of each year, commencing on September 1, 2021, and ending on, and including, June 1, 2024. Each of our convertible preferred shares has a liquidation preference of $100.00.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023, we accrued $6.2 of preferred share dividends within Accrued expenses and other current liabilities. While the dividends on the MCPS are cumulative, they will not be paid until declared by the Company’s Board of Directors. If the dividends are not declared, they will continue to accumulate until paid, due to a backstop contained in the agreement (even if never declared).</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Shares</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CPA Global Acquisition Shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, 41.7 thousand shares held in the Employee Benefit Trust ("EBT"), established for the CPA Global Equity Plan, were sold at an average net price per share of $15.01 to fund the payment to the respective employees. Given the original share value of $30.99 as of the date of the acquisition, an associated loss was recognized within the Condensed Consolidated Statement of Changes in Equity in the amount of $0.7 during the six months ended June 30, 2022. The CPA Global Equity Plan was terminated during the year ended December 31, 2022 after all remaining shares were sold and payments were made to respective employees. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program and Share Retirements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, the Company's Board of Directors approved the purchase of up to $1,000.0 of the Company's ordinary shares through open-market purchases, to be executed through December 31, 2023. During the six months ended June 30, 2022, the Company repurchased 10.7 million ordinary shares at an average price per share of $16.33 with a total carrying value of $175.0 all of which were subsequently retired at an average price at retirement of $15.61 and restored as authorized but unissued ordinary shares. Upon formal retirement and in accordance with ASC Topic 505, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company reduced its ordinary shares account by the carrying amount of the treasury shares. Additionally, given the differences of the original repurchase share value and the value at the time of formal retirements, an associated loss was recognized within the Condensed Consolidated Statement of Changes in Equity in the amount of $7.7. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, the Company's Board of Directors approved the extension of its share repurchase authorization through December 31, 2024, and reduced the authorization from $1,000.0 to $500.0. To enable the buybacks under the Board's authorization, the Company obtained shareholder approval on July 27, 2023 to permit it to conduct open-market purchases of up to 100.0 million of its ordinary shares from time to time as approved by the Board of Directors at a minimum purchase price of $1 per share and maximum purchase price of $35 per share. As of June 30, 2023, the Company had $500.0 of availability remaining under the Board's authorization.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.068%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares retired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price at retirement date</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 676100000 676100000 0 0 0 one 14400000 0.0525 1900000 0.0525 100.00 100.00 6200000 41700 15.01 30.99 700000 1000000000 10700000 16.33 175000000.0 15.61 7700000 1000000000 500000000.0 100000000 1 35 500000000.0 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.068%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares retired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price at retirement date</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> 10700000 16.33 175000000.0 10700000 15.61 167300000 Share-based Compensation<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants share-based awards under the Clarivate Plc 2019 Incentive Award Plan ("the Plan"). As of June 30, 2023, approximately 24.8 million of the Company’s ordinary shares were available for share-based awards. The Plan provides for the issuance of stock options, restricted stock units ("RSUs"), and performance share units ("PSUs"). </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is recorded to the “Cost of revenues" and “Selling, general and administrative” line items on the accompanying Consolidated Statements of Operations. Total share-based compensation expense for the three and six months ended June 30, 2023 and 2022, comprised of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s existing share-based compensation awards program activity for the six months ended June 30, 2023, and 2022, respectively:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.917%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total remaining unamortized compensation costs</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining service period</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21 years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total remaining unamortized compensation costs</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining service period</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69 years</span></td></tr></table></div> 24800000 Total share-based compensation expense for the three and six months ended June 30, 2023 and 2022, comprised of the following:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CPA Global Equity Plan</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div> 0 10200000 100000 0 10300000 0 16200000 4000000.0 0 20200000 0 26400000 4100000 0 30500000 0 23000000.0 300000 0 23300000 1900000 32900000 13600000 0 48400000 1900000 55900000 13900000 0 71700000 0 7500000 100000 -200000 7400000 0 12600000 900000 800000 14300000 0 20100000 1000000.0 600000 21700000 0 17100000 300000 -600000 16800000 0 28800000 1900000 900000 31600000 0 45900000 2200000 300000 48400000 The following table summarizes the Company’s existing share-based compensation awards program activity for the six months ended June 30, 2023, and 2022, respectively:<div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.917%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total remaining unamortized compensation costs</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining service period</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21 years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.915%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised/Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total remaining unamortized compensation costs</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining service period</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69 years</span></td></tr></table></div> 3700000 13500000 2100000 0 5600000 1500000 0 2500000 100000 0 900000 500000 3700000 15700000 3000000.0 0 97600000 45800000 P0Y P1Y25D P2Y2M15D 4800000 4500000 1400000 0 4500000 900000 200000 2000000.0 0 100000 400000 100000 4500000 6600000 2200000 0 72100000 9400000 P0Y P1Y5M4D P1Y8M8D Income Taxes<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2023, the income tax benefit of $35.3 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized, $33.0 tax benefit was associated with the impairment of intangible assets, and $17.1 tax benefit was related to the partial release of valuation allowance recorded against certain US tax attributes that are now considered realizable due to sufficient cumulative income and continued projections of future taxable income. During the three months ended June 30, 2022, the income tax provision of $10.5 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, the income tax benefit of $98.9 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized, $70.4 tax benefit was recorded on the settlement of an open tax dispute, $33.0 tax benefit was associated with the impairment of intangible assets, and $17.1 tax benefit was related to the partial release of valuation allowance recorded against certain US tax attributes that are now considered realizable due to sufficient cumulative income and continued projections of future taxable income. During the six months ended June 30, 2022, the income tax provision of $26.8 was primarily due to the mix of taxing jurisdictions in which pre-tax profits and losses were recognized and tax expense on the mark to market gain on private warrants.</span></div> -35300000 33000000.0 -17100000 10500000 -98900000 70400000 33000000.0 -17100000 26800000 Earnings Per ShareBasic net earnings per ordinary share from continuing operations (“EPS”) is calculated by taking Net income (loss) available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding for the applicable period. Diluted net EPS is computed by taking net earnings adjusted for the effect of the fair value of Private Placement Warrants <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">divided by the weighted average number of ordinary shares outstanding increased by the number of additional shares which have a dilutive effect.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential ordinary shares on a gross basis of 30.7 million and 9.7 million options, RSUs, PSUs, and Warrants related to the 2019 Incentive Award Plan were excluded from diluted EPS for the six months ended June 30, 2023 and 2022, respectively, as their inclusion would have been anti-dilutive or their performance metric was not met. Potential ordinary shares on a gross basis of 30.0 million and 10.1 million options, RSUs, PSUs, and Warrants related to the 2019 Incentive Award Plan were excluded from diluted EPS for the three months ended June 30, 2023 and 2022, respectively, as their inclusion would have been anti-dilutive or their performance metric was not met. See Note 11 - Shareholders’ Equity and Note 12 - Share-based Compensation for additional information.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential dilutive effect of our MCPS outstanding during the period was calculated using the if-converted method assuming the conversion as of the earliest period reported or at the date of issuance, if later. The resulting weighted-average ordinary shares of 55.3 million related to our MCPS are not included in the dilutive weighted-average ordinary shares outstanding calculation for the three and six months ended June 30, 2023, as their effect would be anti-dilutive.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The basic and diluted EPS computations for our ordinary shares are calculated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income available to ordinary shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preferred shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of private placement warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to ordinary shares, diluted</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average effect of potentially dilutive shares to purchase ordinary shares </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income available to ordinary shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preferred shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of private placement warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to ordinary shares, diluted</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.2)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average effect of potentially dilutive shares to purchase ordinary shares </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 30700000 9700000 30000000 10100000 55300000 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The basic and diluted EPS computations for our ordinary shares are calculated as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income available to ordinary shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preferred shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.06 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of private placement warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to ordinary shares, diluted</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average effect of potentially dilutive shares to purchase ordinary shares </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00 </span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.665%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Basic EPS</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income available to ordinary shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preferred shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic EPS</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Diluted EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of private placement warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to ordinary shares, diluted</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.0)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.2)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average effect of potentially dilutive shares to purchase ordinary shares </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average number of ordinary shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.07)</span></td><td style="background-color:#ffffff;border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> -123100000 62400000 18600000 18700000 -141700000 43700000 675900000 674300000 -0.21 0.06 -141700000 43700000 0 -46800000 -141700000 -3100000 675900000 674300000 0 4100000 675900000 678400000 -0.21 0.00 -79600000 131900000 37400000 37400000 -117000000.0 94500000 675400000 678300000 -0.17 0.14 -117000000.0 94500000 0 -141700000 -117000000.0 -47200000 675400000 678300000 0 4900000 675400000 683200000 -0.17 -0.07 Other Operating Expense (Income), Net<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense (income), net, consisted of the following for the three and six months ended June 30, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other operating expense (income), net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on legal settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other operating income, net</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Refer to Note 17 - Commitments and Contingencies for further information.</span></div></td></tr></table></div> <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense (income), net, consisted of the following for the three and six months ended June 30, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other operating expense (income), net</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.266%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.268%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on legal settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.4)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange loss (gain)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other operating income, net</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.3)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Refer to Note 17 - Commitments and Contingencies for further information.</span></div></td></tr></table></div> -11700000 23500000 2800000 -1100000 -14500000 24600000 49400000 0 -32300000 43900000 -400000 5600000 17500000 38300000 Segment Information<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Executive Officer is the Company’s Chief Operating Decision Maker (“CODM”). The CODM evaluates segment performance based primarily on revenue and Adjusted EBITDA. The CODM does not review assets by segment for the purposes of assessing performance or allocating resources. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is the overview of the product groups within each reportable segment. This structure enables a sharp focus on cross-selling opportunities within the markets we serve and provides substantial scale.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The A&amp;G segment consists of our Academia &amp; Government product group, which drives research excellence across institutions, empower researchers to tackle today’s global challenges, and help academic institutions and libraries improve operational efficiency and effectiveness.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The IP segment consists of our Patent Intelligence, Brand IP Intelligence, and IP Lifecycle Management product groups, which enable customers to establish, protect, and manage their intellectual property.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The LS&amp;H segment consists of our Life Sciences &amp; Healthcare product group, which includes products and solutions that provide insight and foresight across the drug and device lifecycle, empowering life science and healthcare organizations to create a healthier tomorrow.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the three segments represent the segments for which discrete financial information is available and upon which operating results are regularly evaluated by the CODM in order to assess performance and allocate resources. The CODM evaluates performance based primarily on segment revenue and Adjusted EBITDA. Adjusted EBITDA represents net income (loss) before the provision for income taxes, depreciation and amortization, and interest expense adjusted to exclude acquisition and disposal-related transaction costs, losses on extinguishment of debt, share-based compensation, unrealized foreign currency remeasurement, transformational and restructuring expenses, acquisition-related adjustments to deferred revenues prior to the adoption of FASB ASU No. 2021-08 in 2021, non-operating income or expense, the impact of certain non-cash mark-to-market adjustments on financial instruments, legal settlements, impairments, and other items that are included in net income (loss) for the period that the Company does not consider indicative of its ongoing operating performance and certain unusual items impacting results in a particular period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues, net by segment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by reportable segment for the periods indicated:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Academia &amp; Government</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life Sciences &amp; Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348.8 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA by segment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents segment profitability and a reconciliation to net income for the periods indicated:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Academia &amp; Government</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Life Sciences &amp; Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">284.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">274.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">537.6 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">536.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Benefit (provision) for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">98.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(178.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(350.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense and amortization of debt discount, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(73.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(146.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mark to market gain on financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred revenues adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Transaction related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(30.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(71.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Restructuring and lease impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill and intangible asset impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(123.1)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">62.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(79.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">131.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preferred shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(141.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(117.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">94.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects mark-to-market adjustments on the Private Placement Warrants under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Refer to Note 8 - Fair Value Measurements for further information.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Includes costs incurred to complete business combination transactions, including acquisitions, dispositions, and capital market activities and include advisory, legal, and other professional and consulting costs.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Primarily reflects severance and related benefit costs related to approved restructuring programs. Refer to Note 19 - Restructuring and Lease Impairments for further information.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Primarily includes the intangible assets impairment recorded during the three months ended June 30, 2023 further discussed in Note 4 - Assets Held for Sale and Divested Operations </span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The current year periods primarily include net losses on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. The current year-to-date period was offset by a gain on legal settlement. The prior year periods include net gains on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. Refer to Note 15 - Other Operating Expense (Income), Net and Note 17 - Commitments and Contingencies for further information. </span></div></td></tr></table> 3 342000000.0 332700000 656700000 644500000 216300000 238400000 425400000 480200000 110500000 115500000 215800000 224100000 668800000 686600000 1297900000 1348800000 The following table presents segment profitability and a reconciliation to net income for the periods indicated:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Academia &amp; Government</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Intellectual Property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Life Sciences &amp; Healthcare</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">284.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">274.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">537.6 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">536.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Benefit (provision) for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">98.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.8)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(178.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(350.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense and amortization of debt discount, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(73.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(146.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mark to market gain on financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred revenues adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Transaction related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(30.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(71.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Restructuring and lease impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill and intangible asset impairments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(123.1)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">62.4 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(79.6)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">131.9 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends on preferred shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (loss) income attributable to ordinary shares</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(141.7)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(117.0)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">94.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Reflects mark-to-market adjustments on the Private Placement Warrants under ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">. Refer to Note 8 - Fair Value Measurements for further information.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Includes costs incurred to complete business combination transactions, including acquisitions, dispositions, and capital market activities and include advisory, legal, and other professional and consulting costs.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Primarily reflects severance and related benefit costs related to approved restructuring programs. Refer to Note 19 - Restructuring and Lease Impairments for further information.</span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Primarily includes the intangible assets impairment recorded during the three months ended June 30, 2023 further discussed in Note 4 - Assets Held for Sale and Divested Operations </span></div></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> The current year periods primarily include net losses on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. The current year-to-date period was offset by a gain on legal settlement. The prior year periods include net gains on foreign exchange re-measurement and other individually insignificant items that do not reflect our ongoing operating performance. Refer to Note 15 - Other Operating Expense (Income), Net and Note 17 - Commitments and Contingencies for further information. </span></div></td></tr></table> 146800000 122900000 272200000 227400000 100100000 107800000 194700000 225400000 38000000.0 43700000 70700000 83900000 284900000 274400000 537600000 536700000 -35300000 10500000 -98900000 26800000 178100000 175600000 350700000 352000000.0 73000000.0 62300000 146600000 121800000 -2900000 -49000000.0 -1800000 -149400000 0 800000 0 600000 700000 5100000 2400000 11800000 30500000 22100000 71700000 59100000 12200000 19200000 21600000 30900000 135200000 0 135200000 0 16500000 -34600000 -10300000 -48800000 -123100000 62400000 -79600000 131900000 18600000 18700000 37400000 37400000 -141700000 43700000 -117000000.0 94500000 Commitments and Contingencies<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any recorded or unrecorded guarantees of the indebtedness of others.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lawsuits and Legal Claims</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is engaged in various legal proceedings, claims, audits, and investigations that have arisen in the ordinary course of business. These matters may include among others, antitrust/competition claims, intellectual property infringement claims, employment matters, and commercial matters. The outcome of all of the matters against the Company is subject to future resolution, including the uncertainties of litigation.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in litigation in the ordinary course of our business, including claims or contingencies that may arise related to matters occurring prior to our acquisition of businesses. At the present time, primarily because the matters are generally in early stages, we can give no assurance as to the outcome of any pending litigation to which we are currently a party, and we are unable to determine the ultimate resolution of these matters or the effect they may have on us. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our best estimate of the Company's potential liability for the larger legal claims is approximately $4, which includes estimated legal costs and accrued interest. The recorded probable loss is an estimate and the actual costs arising from our litigation could be materially lower or higher. We have and will continue to vigorously defend ourselves against these </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">claims. We maintain appropriate levels of insurance, which we expect are likely to provide coverage for some of these liabilities or other losses that may arise from these litigation matters.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2023, we reached settlement related to the potential liability for one of the larger legal claims, which was covered by insurance. We recognized a total gain on settlement of $49.4 which is included in Other operating expense (income), net in the Condensed Consolidated Statement of Operations.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between January and March 2022, three putative securities class action complaints were filed in the United States District Court for the Eastern District of New York against Clarivate and certain of its executives and directors alleging that there were weaknesses in the Company’s internal controls over financial reporting and financial reporting procedures that it failed to disclose in violation of federal securities law. The complaints were consolidated into a single proceeding on May 18, 2022. On August 8, 2022, plaintiffs filed a consolidated amended complaint, seeking damages on behalf of a putative class of shareholders who acquired Clarivate securities between July 30, 2020, and February 2, 2022, and/or acquired Clarivate common or preferred shares in connection with offerings on June 10, 2021, or Clarivate common shares in connection with a September 13, 2021, offering. The amended complaint, like the prior complaints, references an error in the accounting treatment of an equity plan included in the Company’s 2020 business combination with CPA Global that was disclosed on December 27, 2021, and related restatements issued on February 3, 2022, of certain of the Company’s previously issued financial statements; the amended complaint also alleges that the Company and certain of its executives and directors made false or misleading statements relating to the Company’s product quality and expected organic revenues and organic growth rate, and that they failed to disclose significant known changes to the Company’s business model. Defendants moved to dismiss the amended complaint on October 7, 2022. Without deciding the motion, the court entered an order on June 23, 2023 allowing plaintiffs limited leave to amend, and plaintiffs filed an amended complaint on July 14, 2023. The Company intends to seek dismissal of the amended complaint. On June 7, 2022, a class action was filed in Pennsylvania state court in the Court of Common Pleas of Philadelphia asserting claims under the Securities Act of 1933, based on substantially similar allegations, with respect to alleged misstatements and omissions in the offering documents for two issuances of Clarivate ordinary shares in June and September 2021. The Company moved to stay this proceeding on August 19, 2022, and filed its preliminary objections to the state court complaint on October 21, 2022. Briefing on defendants' preliminary objections was completed on December 12, 2022, and the preliminary objections remain pending. On January 4, 2023, the court granted a partial stay of all proceedings until further court order after oral argument on the stay motion. Following oral argument on April 11, 2023, the court denied a further stay of the proceedings on April 17, 2023. Clarivate does not believe that the claims alleged in the complaints have merit and will vigorously defend against them. Given the early stage of the proceedings, we are unable to estimate the reasonably possible loss or range of loss, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrant Liabilities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Accounting Standards Codification 815, Derivatives and Hedging, ("ASC 815"), warrant instruments that do not meet the criteria to be considered indexed to an entity's own stock shall be initially classified as a liability at their estimated fair values, regardless of the likelihood that such instruments will ever be settled in cash. In periods subsequent to issuance, changes in the estimated fair value of the liabilities are reported through earnings. As of June 30, 2023, the Private Placement Warrants are set to expire within one year. Therefore, the remaining liability is included in Accrued expenses and other current liabilities on the Condensed Consolidated Balance Sheet as of June 30, 2023 (refer to Note 8 - Fair Value Measurements for additional information).</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Liabilities</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2023 and December 31, 2022, there were no outstanding contingent liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MCPS Dividends</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted in Note 11 - Shareholders’ Equity, dividends on our convertible preferred shares will be payable on a cumulative basis when, as and if declared by our Board of Directors, or an authorized committee of our Board of Directors, at an annual rate of 5.25% of the liquidation preference of $100.00 per share. Refer to Note 11 - Shareholders’ Equity for further details.</span></div> 4000000 49400000 0.0525 100.00 Related Party TransactionsOn December 1, 2021, Clarivate closed its acquisition of ProQuest from CIG, Atairos and certain other equity holders (the "Seller Group"). The aggregate consideration included $1,094.9 from the issuance of 46.9 million ordinary shares to the <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seller Group. As part of the acquisition, and as a result, CIG is a related party to Clarivate. Clarivate assumed a Finance lease in which CIG is the Lessor as part of the acquisition. For the three and six months ended June 30, 2023, interest expense of $0.6 and $1.1, respectively, and amortization of the Finance lease right of use asset ("ROU") of $0.1 and $0.2, respectively, is reflected in the Condensed Consolidated Statements of Operations. The Finance lease ROU asset of $8.0 is presented within Property, Plant, and Equipment (see Note 5 - Property and Equipment, Net) and the corresponding lease liability of $30.8 is treated as an item of indebtedness (see Note 9 - Debt) within the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clarivate has a vendor and customer arrangement with an affiliate of one of our directors. The Company recognized revenues, net of $0.2 and $0.2 and incurred expenses of $1.3 and $1.2, respectively during the three months ended June 30, 2023 and 2022, related to the arrangement. During the six months ended June 30, 2023 and 2022, the Company recognized revenues, net of $0.4 and $0.4 and incurred expenses of $2.5 and $2.3, respectively, related to the arrangement. As of June 30, 2023 and December 31, 2022, the Company had no outstanding receivables and payables related to the arrangement.</span></div> 1094900000 46900000 600000 1100000 100000 200000 8000000.0 30800000 200000 200000 1300000 1200000 400000 400000 2500000 2300000 Restructuring and Lease Impairments<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">One Clarivate Program -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the second quarter of 2021, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">driver</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> being from a reduction in workforce.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProQuest Acquisition Integration Program</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uring the fourth quarter of 2021, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings</span><span style="color:#202428;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> driver</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> being from a reduction in workforce.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Optimization Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - During the second quarter of 2023, the Company approved a restructuring plan to streamline operations within targeted areas of the Company to reduce operational costs, with the primary cost savings</span><span style="color:#202428;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> driver</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> being from a reduction in workforce.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Restructuring Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - During the fourth quarter of 2019 and throughout 2020, we engaged a strategic consulting firm to assist us in optimizing our structure and cost base, resulting in the implementation of several cost-saving and margin improvement programs designed to generate substantial incremental cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax charges by activity and program during the periods indicated:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Severance and Related Benefit Costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Severance and Related Benefit Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exit and Disposal Costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Exit and Disposal Costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Lease Abandonment Costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Abandonment Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring and Lease Impairment Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax charges by program and segment during the periods indicated:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Academia &amp; Government:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Academia &amp; Government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intellectual Property:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Intellectual Property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Life Sciences &amp; Healthcare:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Life Sciences &amp; Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring and Lease Impairment Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity relating to the restructuring reserves across each of Clarivate's cost-saving programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the periods indicated:</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.044%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.920%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Severance and<br/>Related Benefit Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exit, Disposal<br/>and Abandonment Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses recorded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses recorded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div> The following table summarizes the pre-tax charges by activity and program during the periods indicated:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.770%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Severance and Related Benefit Costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Severance and Related Benefit Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exit and Disposal Costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Exit and Disposal Costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Lease Abandonment Costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Lease Abandonment Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring and Lease Impairment Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the pre-tax charges by program and segment during the periods indicated:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Academia &amp; Government:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Academia &amp; Government</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intellectual Property:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Intellectual Property</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Life Sciences &amp; Healthcare:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Clarivate Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ProQuest Acquisition Integration Program</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Optimization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring Programs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Life Sciences &amp; Healthcare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restructuring and Lease Impairment Costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity relating to the restructuring reserves across each of Clarivate's cost-saving programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the periods indicated:</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.044%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.918%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.920%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Severance and<br/>Related Benefit Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exit, Disposal<br/>and Abandonment Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses recorded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of June 30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses recorded</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments made</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reserve Balance as of June 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6 </span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div> 0 5500000 0 11100000 7600000 7700000 16900000 12000000.0 2300000 0 2300000 0 0 -1100000 0 -700000 9900000 12100000 19200000 22400000 0 0 0 0 0 100000 100000 1900000 0 0 0 0 0 200000 0 100000 0 300000 100000 2000000.0 0 0 0 0 0 6200000 0 6200000 2300000 0 2300000 0 0 600000 0 300000 2300000 6800000 2300000 6500000 12200000 19200000 21600000 30900000 0 3200000 0 6100000 4200000 8000000.0 9300000 11300000 1600000 0 1600000 0 0 200000 0 0 5800000 11400000 10900000 17400000 0 1100000 0 3000000.0 1900000 4000000.0 4600000 5900000 1400000 0 1400000 0 0 -400000 0 -200000 3300000 4700000 6000000.0 8700000 0 1200000 0 2000000.0 1500000 2000000.0 3100000 2900000 1600000 0 1600000 0 0 -100000 0 -100000 3100000 3100000 4700000 4800000 12200000 19200000 21600000 30900000 11500000 100000 11600000 19200000 2400000 21600000 23400000 1500000 24900000 -2700000 -800000 -3500000 4600000 200000 4800000 28300000 700000 29000000.0 22400000 8500000 30900000 34600000 2700000 37300000 -2600000 -5400000 -8000000.0 13500000 1100000 14600000 Subsequent Events<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective July 12, 2023, the Company entered into €100.0 of cross-currency swaps designated as hedges of euro denominated net investments in subsidiaries to mitigate FX exposure. The Company expects these swaps to qualify for hedge accounting.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has evaluated the impact of events that have occurred subsequent to June 30, 2023. Based on this evaluation, other than disclosed within these Condensed Consolidated Financial Statements and related notes, the Company has determined no other events were required to be recognized or disclosed.</span></div> 100000000.0 false false false false EXCEL 89 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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

WNKOFO-!G?#&E7UF9]934 MP+4?DMB+W:$X"L.-W#2XV]U=)E7TD0MS$U158G$4AANY:7 9O:M?G52Z:>;1 M(0:VO:NP-].[<])3U583R>N>.[A*W@4H0@/$O@>Q5\>[BI-5I&,U5%;IU -N MSQW<]>X:KADTG4EB -CW'E1&/N)&&RS&I]O_-5:>OW2 M>['Q%*\3[P4]O+[F^(OSN_R&OW3+VUUUWEG MY7RLVK;:'7Z\9=WGONX-NO^_KJKV\9>^@H>J_G1HSL7_ 5!+ P04 " !3 M, =7PT\#:#H" *!0 &0 'AL+W=O[&TTL[LC*557$OUJG>(!MYS+O2$[(PIQD&@TQWF5/=D@<+N;*3*J;&A MV@:Z4$@S#\IY$(7A*,@I$R2)_=I");$L#6<"%PITF>=4?4R1RWI"^F2_L&3; MG7$+01(7=(LK-"_%0MDHZ%@REJ/03 I0N)F0N_YX.G3Y/N$WPUH?S,$Y64OY MZH+';$)")P@YIL8Q4#M4.$/.'9&5\=9RDJZD Q[.]^P_O7?K94TUSB3_PS*S MFY ; AEN:,G-4M8/V/JY=GRIY-I_H6YS0P)IJ8W,6[!5D#/1C/2]_0\'@"CZ M A"U@,CK;@IYE7-J:!(K68-RV9;-3;Q5C[;BF'"'LC+*[C*+,\FJ7&M\*U$8 MN*_L5\/%' UE7%_"^=G-8#2\!2;@B7%N?Z*. V.+.FB0M@6F38'HBP*_2MZ# M?G0%41@-X/YE"1HV9; M00UF0#4\8+9E8@N/0AM5Y@WDV5[^1U&A-GZAS3GF]:0:UT!C7= 4)\1VB$95 M(4G.S_JC\/:$UT'G=>#9!]\]JF,"!_]!X+ 3.#QY&'-4K**NRZ[@6;JFHQSN MN'IZYCW$WRA([< MFZ.WWY>Y.G_CF.O!NX.#WDGOYOA\%SFJH6/7LSH^VW;<.OH;,7R$(E0/YG1@ M5=,[[.CI'6+DZ%$Y>BA)J*[8KFM;&*ILT+/06RI*\^T3^OWS%Y+D%NFDV:LK M;#Q,<]$66N :@XY,,NK<$CYR)X2SJ63 2DG&^-J8^V"8Y3R7CM(5KJ7X8"GO M#.R;'A1_[2=C(I=5;!/!?$_KX3O I@<"&>>-P+YK#.-A092B4ESH3C6X,MZ# MG+I]O2ZTPKDD:[]_YK:$ZJ*#3'.94-F$\=V-:3SD- 4YDLT7<%5YX0&H5)[I M1L+(/!>DTK!AU WM=D8YOX(GP[=TR_O<4JG8K&OY(4EQ35=J4TZK%-?27#U5=@5;-=:O^]PL#C_TWPB=#X& MP[1%5B1".1'*,2P;,JE.+(Z=$^O#/M,X#H(PQ#(ZF5@53+"\A2%\[-XP;<# MXD"DI^4:7VV\0AZN VQ-'ZH0;*9X)6(SQ7,-B#UOP(AC^VIC<8"!K0)6.Q#? M'@=JRLX) EA53!MV!^-('&,(U**]1L,0R4X(IWU]L+LD".+8C@!F5Q $& )W M(XY@"D #A@1!]1[<>1]YF_>4U_[S.?X#4$L#!!0 ( %,P!U>7BKL

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end XML 90 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 91 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 92 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 391 288 1 false 80 0 false 6 false false R1.htm 0000001 - Document - Cover Sheet http://clarivate.com/role/Cover Cover Cover 1 false false R2.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Sheet http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) Statements 5 false false R6.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Sheet http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statements 6 false false R7.htm 0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 0000010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Statements 8 false false R9.htm 0000011 - Disclosure - Background and Nature of Operations Sheet http://clarivate.com/role/BackgroundandNatureofOperations Background and Nature of Operations Notes 9 false false R10.htm 0000012 - Disclosure - Basis of Presentation Sheet http://clarivate.com/role/BasisofPresentation Basis of Presentation Notes 10 false false R11.htm 0000013 - Disclosure - Summary of Significant Accounting Policies Sheet http://clarivate.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 11 false false R12.htm 0000014 - Disclosure - Assets Held for Sale and Divested Operations Sheet http://clarivate.com/role/AssetsHeldforSaleandDivestedOperations Assets Held for Sale and Divested Operations Notes 12 false false R13.htm 0000016 - Disclosure - Property and Equipment, Net Sheet http://clarivate.com/role/PropertyandEquipmentNet Property and Equipment, Net Notes 13 false false R14.htm 0000017 - Disclosure - Other Intangible Assets, net and Goodwill Sheet http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwill Other Intangible Assets, net and Goodwill Notes 14 false false R15.htm 0000018 - Disclosure - Derivative Instruments Sheet http://clarivate.com/role/DerivativeInstruments Derivative Instruments Notes 15 false false R16.htm 0000019 - Disclosure - Fair Value Measurements Sheet http://clarivate.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 0000020 - Disclosure - Debt Sheet http://clarivate.com/role/Debt Debt Notes 17 false false R18.htm 0000021 - Disclosure - Revenue Sheet http://clarivate.com/role/Revenue Revenue Notes 18 false false R19.htm 0000022 - Disclosure - Shareholders' Equity Sheet http://clarivate.com/role/ShareholdersEquity Shareholders' Equity Notes 19 false false R20.htm 0000023 - Disclosure - Share-based Compensation Sheet http://clarivate.com/role/SharebasedCompensation Share-based Compensation Notes 20 false false R21.htm 0000024 - Disclosure - Income Taxes Sheet http://clarivate.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 0000025 - Disclosure - Earnings per Share Sheet http://clarivate.com/role/EarningsperShare Earnings per Share Notes 22 false false R23.htm 0000026 - Disclosure - Other Operating Expense (Income), Net Sheet http://clarivate.com/role/OtherOperatingExpenseIncomeNet Other Operating Expense (Income), Net Notes 23 false false R24.htm 0000027 - Disclosure - Segment Information Sheet http://clarivate.com/role/SegmentInformation Segment Information Notes 24 false false R25.htm 0000028 - Disclosure - Commitments and Contingencies Sheet http://clarivate.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 25 false false R26.htm 0000029 - Disclosure - Related Party Transactions Sheet http://clarivate.com/role/RelatedPartyTransactions Related Party Transactions Notes 26 false false R27.htm 0000030 - Disclosure - Restructuring and Lease Impairments Sheet http://clarivate.com/role/RestructuringandLeaseImpairments Restructuring and Lease Impairments Notes 27 false false R28.htm 0000031 - Disclosure - Subsequent Events Sheet http://clarivate.com/role/SubsequentEvents Subsequent Events Notes 28 false false R29.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 29 false false R30.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 30 false false R31.htm 9954701 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://clarivate.com/role/SummaryofSignificantAccountingPolicies 31 false false R32.htm 9954702 - Disclosure - Property and Equipment, Net (Tables) Sheet http://clarivate.com/role/PropertyandEquipmentNetTables Property and Equipment, Net (Tables) Tables http://clarivate.com/role/PropertyandEquipmentNet 32 false false R33.htm 9954703 - Disclosure - Other Intangible Assets, net and Goodwill (Tables) Sheet http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillTables Other Intangible Assets, net and Goodwill (Tables) Tables http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwill 33 false false R34.htm 9954705 - Disclosure - Fair Value Measurements (Tables) Sheet http://clarivate.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://clarivate.com/role/FairValueMeasurements 34 false false R35.htm 9954706 - Disclosure - Debt (Tables) Sheet http://clarivate.com/role/DebtTables Debt (Tables) Tables http://clarivate.com/role/Debt 35 false false R36.htm 9954707 - Disclosure - Revenue (Tables) Sheet http://clarivate.com/role/RevenueTables Revenue (Tables) Tables http://clarivate.com/role/Revenue 36 false false R37.htm 9954708 - Disclosure - Shareholders' Equity (Tables) Sheet http://clarivate.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://clarivate.com/role/ShareholdersEquity 37 false false R38.htm 9954709 - Disclosure - Share-based Compensation (Tables) Sheet http://clarivate.com/role/SharebasedCompensationTables Share-based Compensation (Tables) Tables http://clarivate.com/role/SharebasedCompensation 38 false false R39.htm 9954711 - Disclosure - Earnings per Share (Tables) Sheet http://clarivate.com/role/EarningsperShareTables Earnings per Share (Tables) Tables http://clarivate.com/role/EarningsperShare 39 false false R40.htm 9954712 - Disclosure - Other Operating Expense (Income), Net (Tables) Sheet http://clarivate.com/role/OtherOperatingExpenseIncomeNetTables Other Operating Expense (Income), Net (Tables) Tables http://clarivate.com/role/OtherOperatingExpenseIncomeNet 40 false false R41.htm 9954713 - Disclosure - Segment Information (Tables) Sheet http://clarivate.com/role/SegmentInformationTables Segment Information (Tables) Tables http://clarivate.com/role/SegmentInformation 41 false false R42.htm 9954715 - Disclosure - Restructuring and Lease Impairments (Tables) Sheet http://clarivate.com/role/RestructuringandLeaseImpairmentsTables Restructuring and Lease Impairments (Tables) Tables http://clarivate.com/role/RestructuringandLeaseImpairments 42 false false R43.htm 9954717 - Disclosure - Assets Held for Sale and Divested Operations (Details) Sheet http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails Assets Held for Sale and Divested Operations (Details) Details http://clarivate.com/role/AssetsHeldforSaleandDivestedOperations 43 false false R44.htm 9954719 - Disclosure - Property and Equipment, Net (Details) Sheet http://clarivate.com/role/PropertyandEquipmentNetDetails Property and Equipment, Net (Details) Details http://clarivate.com/role/PropertyandEquipmentNetTables 44 false false R45.htm 9954720 - Disclosure - Other Intangible Assets, net and Goodwill - Intangible Assets by Major Class (Details) Sheet http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails Other Intangible Assets, net and Goodwill - Intangible Assets by Major Class (Details) Details 45 false false R46.htm 9954721 - Disclosure - Other Intangible Assets - Narratives (Details) Sheet http://clarivate.com/role/OtherIntangibleAssetsNarrativesDetails Other Intangible Assets - Narratives (Details) Details 46 false false R47.htm 9954722 - Disclosure - Other Intangible Assets, net and Goodwill - Change in the Carrying Amount of Goodwill (Details) Sheet http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails Other Intangible Assets, net and Goodwill - Change in the Carrying Amount of Goodwill (Details) Details 47 false false R48.htm 9954723 - Disclosure - Derivative Instruments (Details) Sheet http://clarivate.com/role/DerivativeInstrumentsDetails Derivative Instruments (Details) Details http://clarivate.com/role/DerivativeInstruments 48 false false R49.htm 9954724 - Disclosure - Fair Value Measurements - Assets and liabilities that were recognized at fair value on a recurring basis (Details) Sheet http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails Fair Value Measurements - Assets and liabilities that were recognized at fair value on a recurring basis (Details) Details 49 false false R50.htm 9954725 - Disclosure - Fair Value Measurements - Changes in Private Placement Warrants Liabilities (Details) Sheet http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails Fair Value Measurements - Changes in Private Placement Warrants Liabilities (Details) Details 50 false false R51.htm 9954726 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://clarivate.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 51 false false R52.htm 9954727 - Disclosure - Debt - Summary of Debt (Details) Sheet http://clarivate.com/role/DebtSummaryofDebtDetails Debt - Summary of Debt (Details) Details 52 false false R53.htm 9954728 - Disclosure - Debt - Financing Transactions, Senior Notes (2029) and Senior Secured Notes (2028) - (Details) Notes http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details Debt - Financing Transactions, Senior Notes (2029) and Senior Secured Notes (2028) - (Details) Details 53 false false R54.htm 9954729 - Disclosure - Debt - Financing Transactions, Senior Secured Notes (2026) (Details) Notes http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details Debt - Financing Transactions, Senior Secured Notes (2026) (Details) Details 54 false false R55.htm 9954730 - Disclosure - Debt - The Credit Facilities, Revolving Credit Facility and Term Loan Facility (Details) Sheet http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails Debt - The Credit Facilities, Revolving Credit Facility and Term Loan Facility (Details) Details 55 false false R56.htm 9954731 - Disclosure - Revenue - Disaggregated Revenues and Cost to Obtain a Contract (Details) Sheet http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails Revenue - Disaggregated Revenues and Cost to Obtain a Contract (Details) Details 56 false false R57.htm 9954732 - Disclosure - Revenue - Contract Balances (Details) Sheet http://clarivate.com/role/RevenueContractBalancesDetails Revenue - Contract Balances (Details) Details 57 false false R58.htm 9954733 - Disclosure - Revenue - Transaction Price Allocated to the Remaining Performance Obligation (Details) Sheet http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails Revenue - Transaction Price Allocated to the Remaining Performance Obligation (Details) Details 58 false false R59.htm 9954734 - Disclosure - Shareholders' Equity (Details) Sheet http://clarivate.com/role/ShareholdersEquityDetails Shareholders' Equity (Details) Details http://clarivate.com/role/ShareholdersEquityTables 59 false false R60.htm 9954735 - Disclosure - Share-based Compensation - Narrative (Details) Sheet http://clarivate.com/role/SharebasedCompensationNarrativeDetails Share-based Compensation - Narrative (Details) Details 60 false false R61.htm 9954736 - Disclosure - Share-based Compensation - Share-based Compensation Expense (Details) Sheet http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails Share-based Compensation - Share-based Compensation Expense (Details) Details 61 false false R62.htm 9954737 - Disclosure - Share-based Compensation - Option Activity (Details) Sheet http://clarivate.com/role/SharebasedCompensationOptionActivityDetails Share-based Compensation - Option Activity (Details) Details 62 false false R63.htm 9954739 - Disclosure - Share-based Compensation - RSU and PSU Activity (Details) Sheet http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails Share-based Compensation - RSU and PSU Activity (Details) Details 63 false false R64.htm 9954741 - Disclosure - Income Taxes (Details) Sheet http://clarivate.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://clarivate.com/role/IncomeTaxes 64 false false R65.htm 9954742 - Disclosure - Earnings per Share - Narrative (Details) Sheet http://clarivate.com/role/EarningsperShareNarrativeDetails Earnings per Share - Narrative (Details) Details 65 false false R66.htm 9954743 - Disclosure - Earnings per Share (Details) Sheet http://clarivate.com/role/EarningsperShareDetails Earnings per Share (Details) Details http://clarivate.com/role/EarningsperShareTables 66 false false R67.htm 9954744 - Disclosure - Other Operating Expense (Income), Net (Details) Sheet http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails Other Operating Expense (Income), Net (Details) Details http://clarivate.com/role/OtherOperatingExpenseIncomeNetTables 67 false false R68.htm 9954745 - Disclosure - Segment Information - Narrative (Details) Sheet http://clarivate.com/role/SegmentInformationNarrativeDetails Segment Information - Narrative (Details) Details 68 false false R69.htm 9954746 - Disclosure - Segment Information - Revenue by Segment (Details) Sheet http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails Segment Information - Revenue by Segment (Details) Details 69 false false R70.htm 9954747 - Disclosure - Segment Information - Adjusted EBITDA by Segment (Details) Sheet http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails Segment Information - Adjusted EBITDA by Segment (Details) Details 70 false false R71.htm 9954748 - Disclosure - Commitments and Contingencies - Contingencies (Details) Sheet http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails Commitments and Contingencies - Contingencies (Details) Details 71 false false R72.htm 9954750 - Disclosure - Commitments and Contingencies - Mandatory Convertible Preferred Share Dividends (Details) Sheet http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails Commitments and Contingencies - Mandatory Convertible Preferred Share Dividends (Details) Details 72 false false R73.htm 9954751 - Disclosure - Related Party Transactions (Details) Sheet http://clarivate.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://clarivate.com/role/RelatedPartyTransactions 73 false false R74.htm 9954752 - Disclosure - Restructuring and Lease Impairments (Details) Sheet http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails Restructuring and Lease Impairments (Details) Details http://clarivate.com/role/RestructuringandLeaseImpairmentsTables 74 false false R75.htm 9954753 - Disclosure - Subsequent Events (Details) Sheet http://clarivate.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://clarivate.com/role/SubsequentEvents 75 false false All Reports Book All Reports [dq-60546-SecurityExchangeName-TradingSymbol, NoTradingSymbolFlag-Dependency] In submission type 10-Q, SecurityExchangeName should have a value if one of TradingSymbol, NoTradingSymbolFlag has a value in context c-4. clvt-20230630.htm 4 [EFM.6.05.45.coverPageFactNotVisible] Submission type 10-Q has 1 cover page fact(s) in ix:hidden that should be visible or referenced by an -sec-ix-hidden style property: EntityTaxIdentificationNumber - clvt-20230630.htm 4 - clvt-20230630.htm 4 clvt-20230630.htm clvt-20230630.xsd clvt-20230630_cal.xml clvt-20230630_def.xml clvt-20230630_lab.xml clvt-20230630_pre.xml exhibit101-q22023.htm exhibit31-q22023.htm exhibit32-q22023.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 95 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "clvt-20230630.htm": { "axisCustom": 0, "axisStandard": 31, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1112, "http://xbrl.sec.gov/dei/2023": 35, "http://xbrl.sec.gov/ecd/2023": 4 }, "contextCount": 391, "dts": { "calculationLink": { "local": [ "clvt-20230630_cal.xml" ] }, "definitionLink": { "local": [ "clvt-20230630_def.xml" ] }, "inline": { "local": [ "clvt-20230630.htm" ] }, "labelLink": { "local": [ "clvt-20230630_lab.xml" ] }, "presentationLink": { "local": [ "clvt-20230630_pre.xml" ] }, "schema": { "local": [ "clvt-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] } }, "elementCount": 924, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 6, "total": 6 }, "keyCustom": 17, "keyStandard": 271, "memberCustom": 36, "memberStandard": 40, "nsprefix": "clvt", "nsuri": "http://clarivate.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://clarivate.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Basis of Presentation", "menuCat": "Notes", "order": "10", "role": "http://clarivate.com/role/BasisofPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "11", "role": "http://clarivate.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Assets Held for Sale and Divested Operations", "menuCat": "Notes", "order": "12", "role": "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperations", "shortName": "Assets Held for Sale and Divested Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Property and Equipment, Net", "menuCat": "Notes", "order": "13", "role": "http://clarivate.com/role/PropertyandEquipmentNet", "shortName": "Property and Equipment, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Other Intangible Assets, net and Goodwill", "menuCat": "Notes", "order": "14", "role": "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwill", "shortName": "Other Intangible Assets, net and Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Derivative Instruments", "menuCat": "Notes", "order": "15", "role": "http://clarivate.com/role/DerivativeInstruments", "shortName": "Derivative Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "16", "role": "http://clarivate.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Debt", "menuCat": "Notes", "order": "17", "role": "http://clarivate.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Revenue", "menuCat": "Notes", "order": "18", "role": "http://clarivate.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Shareholders' Equity", "menuCat": "Notes", "order": "19", "role": "http://clarivate.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Share-based Compensation", "menuCat": "Notes", "order": "20", "role": "http://clarivate.com/role/SharebasedCompensation", "shortName": "Share-based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "21", "role": "http://clarivate.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Earnings per Share", "menuCat": "Notes", "order": "22", "role": "http://clarivate.com/role/EarningsperShare", "shortName": "Earnings per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Other Operating Expense (Income), Net", "menuCat": "Notes", "order": "23", "role": "http://clarivate.com/role/OtherOperatingExpenseIncomeNet", "shortName": "Other Operating Expense (Income), Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Segment Information", "menuCat": "Notes", "order": "24", "role": "http://clarivate.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "25", "role": "http://clarivate.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "26", "role": "http://clarivate.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Restructuring and Lease Impairments", "menuCat": "Notes", "order": "27", "role": "http://clarivate.com/role/RestructuringandLeaseImpairments", "shortName": "Restructuring and Lease Impairments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "28", "role": "http://clarivate.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "menuCat": "Notes", "order": "29", "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "shortName": "Pay vs Performance Disclosure", "subGroupType": "", "uniqueAnchor": null }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:Rule10b51ArrAdoptedFlag", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995445 - Disclosure - Insider Trading Arrangements", "menuCat": "Notes", "order": "30", "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "shortName": "Insider Trading Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": null, "first": true, "lang": "en-US", "name": "ecd:Rule10b51ArrAdoptedFlag", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954701 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "31", "role": "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954702 - Disclosure - Property and Equipment, Net (Tables)", "menuCat": "Tables", "order": "32", "role": "http://clarivate.com/role/PropertyandEquipmentNetTables", "shortName": "Property and Equipment, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954703 - Disclosure - Other Intangible Assets, net and Goodwill (Tables)", "menuCat": "Tables", "order": "33", "role": "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillTables", "shortName": "Other Intangible Assets, net and Goodwill (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954705 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "34", "role": "http://clarivate.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954706 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "35", "role": "http://clarivate.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954707 - Disclosure - Revenue (Tables)", "menuCat": "Tables", "order": "36", "role": "http://clarivate.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954708 - Disclosure - Shareholders' Equity (Tables)", "menuCat": "Tables", "order": "37", "role": "http://clarivate.com/role/ShareholdersEquityTables", "shortName": "Shareholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954709 - Disclosure - Share-based Compensation (Tables)", "menuCat": "Tables", "order": "38", "role": "http://clarivate.com/role/SharebasedCompensationTables", "shortName": "Share-based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954711 - Disclosure - Earnings per Share (Tables)", "menuCat": "Tables", "order": "39", "role": "http://clarivate.com/role/EarningsperShareTables", "shortName": "Earnings per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "lang": "en-US", "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "clvt:ScheduleOfOtherOperatingIncomeNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954712 - Disclosure - Other Operating Expense (Income), Net (Tables)", "menuCat": "Tables", "order": "40", "role": "http://clarivate.com/role/OtherOperatingExpenseIncomeNetTables", "shortName": "Other Operating Expense (Income), Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "clvt:ScheduleOfOtherOperatingIncomeNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954713 - Disclosure - Segment Information (Tables)", "menuCat": "Tables", "order": "41", "role": "http://clarivate.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954715 - Disclosure - Restructuring and Lease Impairments (Tables)", "menuCat": "Tables", "order": "42", "role": "http://clarivate.com/role/RestructuringandLeaseImpairmentsTables", "shortName": "Restructuring and Lease Impairments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954717 - Disclosure - Assets Held for Sale and Divested Operations (Details)", "menuCat": "Details", "order": "43", "role": "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "shortName": "Assets Held for Sale and Divested Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-65", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954719 - Disclosure - Property and Equipment, Net (Details)", "menuCat": "Details", "order": "44", "role": "http://clarivate.com/role/PropertyandEquipmentNetDetails", "shortName": "Property and Equipment, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-7", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954720 - Disclosure - Other Intangible Assets, net and Goodwill - Intangible Assets by Major Class (Details)", "menuCat": "Details", "order": "45", "role": "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails", "shortName": "Other Intangible Assets, net and Goodwill - Intangible Assets by Major Class (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954721 - Disclosure - Other Intangible Assets - Narratives (Details)", "menuCat": "Details", "order": "46", "role": "http://clarivate.com/role/OtherIntangibleAssetsNarrativesDetails", "shortName": "Other Intangible Assets - Narratives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-7", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954722 - Disclosure - Other Intangible Assets, net and Goodwill - Change in the Carrying Amount of Goodwill (Details)", "menuCat": "Details", "order": "47", "role": "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails", "shortName": "Other Intangible Assets, net and Goodwill - Change in the Carrying Amount of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "-5", "lang": "en-US", "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-98", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954723 - Disclosure - Derivative Instruments (Details)", "menuCat": "Details", "order": "48", "role": "http://clarivate.com/role/DerivativeInstrumentsDetails", "shortName": "Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-106", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-123", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954724 - Disclosure - Fair Value Measurements - Assets and liabilities that were recognized at fair value on a recurring basis (Details)", "menuCat": "Details", "order": "49", "role": "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "shortName": "Fair Value Measurements - Assets and liabilities that were recognized at fair value on a recurring basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-123", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "menuCat": "Statements", "order": "5", "role": "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954725 - Disclosure - Fair Value Measurements - Changes in Private Placement Warrants Liabilities (Details)", "menuCat": "Details", "order": "50", "role": "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails", "shortName": "Fair Value Measurements - Changes in Private Placement Warrants Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-137", "decimals": "-5", "lang": "en-US", "name": "us-gaap:FairValueAdjustmentOfWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954726 - Disclosure - Fair Value Measurements - Narrative (Details)", "menuCat": "Details", "order": "51", "role": "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "5", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954727 - Disclosure - Debt - Summary of Debt (Details)", "menuCat": "Details", "order": "52", "role": "http://clarivate.com/role/DebtSummaryofDebtDetails", "shortName": "Debt - Summary of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "5", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-142", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954728 - Disclosure - Debt - Financing Transactions, Senior Notes (2029) and Senior Secured Notes (2028) - (Details)", "menuCat": "Details", "order": "53", "role": "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "shortName": "Debt - Financing Transactions, Senior Notes (2029) and Senior Secured Notes (2028) - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-142", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-148", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954729 - Disclosure - Debt - Financing Transactions, Senior Secured Notes (2026) (Details)", "menuCat": "Details", "order": "54", "role": "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "shortName": "Debt - Financing Transactions, Senior Secured Notes (2026) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R55": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-7", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954730 - Disclosure - Debt - The Credit Facilities, Revolving Credit Facility and Term Loan Facility (Details)", "menuCat": "Details", "order": "55", "role": "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails", "shortName": "Debt - The Credit Facilities, Revolving Credit Facility and Term Loan Facility (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-7", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "clvt:ContractwithCustomerLiabilityAdjustments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954731 - Disclosure - Revenue - Disaggregated Revenues and Cost to Obtain a Contract (Details)", "menuCat": "Details", "order": "56", "role": "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails", "shortName": "Revenue - Disaggregated Revenues and Cost to Obtain a Contract (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "clvt:ContractwithCustomerLiabilityAdjustments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-7", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954732 - Disclosure - Revenue - Contract Balances (Details)", "menuCat": "Details", "order": "57", "role": "http://clarivate.com/role/RevenueContractBalancesDetails", "shortName": "Revenue - Contract Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-40", "decimals": "-5", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-169", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954733 - Disclosure - Revenue - Transaction Price Allocated to the Remaining Performance Obligation (Details)", "menuCat": "Details", "order": "58", "role": "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails", "shortName": "Revenue - Transaction Price Allocated to the Remaining Performance Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-169", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954734 - Disclosure - Shareholders' Equity (Details)", "menuCat": "Details", "order": "59", "role": "http://clarivate.com/role/ShareholdersEquityDetails", "shortName": "Shareholders' Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "lang": "en-US", "name": "us-gaap:CommonStockVotingRights", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-37", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "menuCat": "Statements", "order": "6", "role": "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-37", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954735 - Disclosure - Share-based Compensation - Narrative (Details)", "menuCat": "Details", "order": "60", "role": "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "shortName": "Share-based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954736 - Disclosure - Share-based Compensation - Share-based Compensation Expense (Details)", "menuCat": "Details", "order": "61", "role": "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails", "shortName": "Share-based Compensation - Share-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-235", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954737 - Disclosure - Share-based Compensation - Option Activity (Details)", "menuCat": "Details", "order": "62", "role": "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "shortName": "Share-based Compensation - Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-235", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-236", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954739 - Disclosure - Share-based Compensation - RSU and PSU Activity (Details)", "menuCat": "Details", "order": "63", "role": "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "shortName": "Share-based Compensation - RSU and PSU Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-236", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954741 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "64", "role": "http://clarivate.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "lang": "en-US", "name": "clvt:EffectiveIncomeTaxRateReconciliationDeductibleExpenseImpairmentLossesAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-249", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954742 - Disclosure - Earnings per Share - Narrative (Details)", "menuCat": "Details", "order": "65", "role": "http://clarivate.com/role/EarningsperShareNarrativeDetails", "shortName": "Earnings per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-249", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954743 - Disclosure - Earnings per Share (Details)", "menuCat": "Details", "order": "66", "role": "http://clarivate.com/role/EarningsperShareDetails", "shortName": "Earnings per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DilutiveSecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "clvt:ScheduleOfOtherOperatingIncomeNetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954744 - Disclosure - Other Operating Expense (Income), Net (Details)", "menuCat": "Details", "order": "67", "role": "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails", "shortName": "Other Operating Expense (Income), Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "clvt:ScheduleOfOtherOperatingIncomeNetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954745 - Disclosure - Segment Information - Narrative (Details)", "menuCat": "Details", "order": "68", "role": "http://clarivate.com/role/SegmentInformationNarrativeDetails", "shortName": "Segment Information - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954746 - Disclosure - Segment Information - Revenue by Segment (Details)", "menuCat": "Details", "order": "69", "role": "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails", "shortName": "Segment Information - Revenue by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-252", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "7", "role": "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "-5", "lang": "en-US", "name": "us-gaap:DeferredIncomeTaxesAndTaxCredits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "clvt:AdjustedEBITDA", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954747 - Disclosure - Segment Information - Adjusted EBITDA by Segment (Details)", "menuCat": "Details", "order": "70", "role": "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "shortName": "Segment Information - Adjusted EBITDA by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-9", "decimals": "-5", "first": true, "lang": "en-US", "name": "clvt:AdjustedEBITDA", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954748 - Disclosure - Commitments and Contingencies - Contingencies (Details)", "menuCat": "Details", "order": "71", "role": "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "shortName": "Commitments and Contingencies - Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockDividendRatePercentage", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockDividendRatePercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954750 - Disclosure - Commitments and Contingencies - Mandatory Convertible Preferred Share Dividends (Details)", "menuCat": "Details", "order": "72", "role": "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails", "shortName": "Commitments and Contingencies - Mandatory Convertible Preferred Share Dividends (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-6", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954751 - Disclosure - Related Party Transactions (Details)", "menuCat": "Details", "order": "73", "role": "http://clarivate.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-261", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-7", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954752 - Disclosure - Restructuring and Lease Impairments (Details)", "menuCat": "Details", "order": "74", "role": "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails", "shortName": "Restructuring and Lease Impairments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-7", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-391", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "eur", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "9954753 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "75", "role": "http://clarivate.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-391", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "eur", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockDividendRatePercentage", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockDividendRatePercentage", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000010 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "menuCat": "Statements", "order": "8", "role": "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Background and Nature of Operations", "menuCat": "Notes", "order": "9", "role": "http://clarivate.com/role/BackgroundandNatureofOperations", "shortName": "Background and Nature of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "clvt-20230630.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 80, "tag": { "clvt_A2019IncentiveAwardPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 Incentive Award Plan", "label": "2019 Incentive Award Plan [Member]", "terseLabel": "2019 Incentive Award Plan" } } }, "localname": "A2019IncentiveAwardPlanMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "clvt_AcademiaGovernmentGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Academia & Government Group", "label": "Academia & Government Group [Member]", "terseLabel": "A&G Segment", "verboseLabel": "Academia & Government" } } }, "localname": "AcademiaGovernmentGroupMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails", "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "domainItemType" }, "clvt_AccountPayablesAndAccrualsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to account payables and accruals.", "label": "Account Payables And Accruals [Policy Text Block]", "terseLabel": "Accounts Payable and Accruals" } } }, "localname": "AccountPayablesAndAccrualsPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_AccruedExpensesAndOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities [Member]", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "clvt_AdjustedEBITDA": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjusted EBITDA", "label": "Adjusted EBITDA", "terseLabel": "Total Adjusted EBITDA" } } }, "localname": "AdjustedEBITDA", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "clvt_AuditInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Audit Information [Abstract]", "label": "Audit Information [Abstract]" } } }, "localname": "AuditInformationAbstract", "nsuri": "http://clarivate.com/20230630", "xbrltype": "stringItemType" }, "clvt_BrandProtectionAntiPiracyandAntiFraudsolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Brand Protection, AntiPiracy, and AntiFraud solutions [Member]", "label": "Brand Protection, AntiPiracy, and AntiFraud solutions [Member]", "terseLabel": "Brand Protection, AntiPiracy, and AntiFraud Solutions" } } }, "localname": "BrandProtectionAntiPiracyandAntiFraudsolutionsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "domainItemType" }, "clvt_BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure", "terseLabel": "Business Combination, Contingent Consideration, Liability, Fair Value Disclosure" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityFairValueDisclosure", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_CPAAcquisitionIntegrationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CPA Acquisition Integration Program", "label": "CPA Acquisition Integration Program [Member]", "terseLabel": "CPA Acquisition Integration Program" } } }, "localname": "CPAAcquisitionIntegrationProgramMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_CPAGlobalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CPA Global", "label": "CPA Global [Member]", "terseLabel": "CPA Global" } } }, "localname": "CPAGlobalMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_CashAndCashEquivalentPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and Cash Equivalent, Period Increase (Decrease)", "label": "Cash and Cash Equivalent, Period Increase (Decrease)", "terseLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentPeriodIncreaseDecrease", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "clvt_ChurchillPublicShareholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Churchill Public Shareholders [Member]", "label": "Churchill Public Shareholders [Member]", "terseLabel": "Churchill Public Shareholders" } } }, "localname": "ChurchillPublicShareholdersMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right, Exercised", "label": "Class of Warrant or Right, Exercised", "negatedTerseLabel": "Warrants exercised (in shares)", "terseLabel": "Warrants exercised (in shares)" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "clvt_ClassOfWarrantOrRightSharesWithheldForExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right, Shares Withheld for Exercise Price", "label": "Class of Warrant or Right, Shares Withheld for Exercise Price", "terseLabel": "Shares withheld to cover exercise price (in shares)" } } }, "localname": "ClassOfWarrantOrRightSharesWithheldForExercisePrice", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "clvt_CommonStockSharesSubscription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares, Subscription", "terseLabel": "Subscribed number of shares" } } }, "localname": "CommonStockSharesSubscription", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "clvt_CommonStockVotesPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Votes Per Share", "label": "Common Stock, Votes Per Share", "terseLabel": "Common stock, votes per share" } } }, "localname": "CommonStockVotesPerShare", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "integerItemType" }, "clvt_ComputerHardwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Hardware [Member]", "label": "Computer Hardware [Member]", "terseLabel": "Computer hardware" } } }, "localname": "ComputerHardwareMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "clvt_ConcentrationRiskLargestCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of risks that arise due to the volume of business transacted with a major customer.", "label": "Concentration Risk, Largest Customers", "terseLabel": "Number of largest customers" } } }, "localname": "ConcentrationRiskLargestCustomers", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "clvt_ConsecutiveTradingDayPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consecutive Trading Day Period", "label": "Consecutive Trading Day Period", "terseLabel": "Consecutive Trading Day Period" } } }, "localname": "ConsecutiveTradingDayPeriod", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "durationItemType" }, "clvt_ContingentConsiderationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to contingent considerations.", "label": "Contingent Considerations [Policy Text Block]", "terseLabel": "Contingent Considerations" } } }, "localname": "ContingentConsiderationsPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_ContingentLiabilityDiscountOnDebtForTheUnderwritersFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingent Liability Discount on Debt for the Underwriter's Fee", "label": "Contingent Liability Discount on Debt for the Underwriter's Fee", "terseLabel": "Contingent Liability Discount on Debt for the Underwriter's Fee" } } }, "localname": "ContingentLiabilityDiscountOnDebtForTheUnderwritersFee", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_ContingentLiabilityTransactionRelatedFee": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contingent Liability Transaction-related Fee", "label": "Contingent Liability Transaction-related Fee", "terseLabel": "Contingent Liability Transaction-related Fee" } } }, "localname": "ContingentLiabilityTransactionRelatedFee", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_ContractWithCustomerCurrentLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a.", "label": "Contract With Customer , Current Liability [Abstract]", "terseLabel": "Current deferred revenues" } } }, "localname": "ContractWithCustomerCurrentLiabilityAbstract", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "clvt_ContractWithCustomerNonCurrentLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a.", "label": "Contract With Customer , Non Current Liability [Abstract]", "terseLabel": "Non-current deferred revenues" } } }, "localname": "ContractWithCustomerNonCurrentLiabilityAbstract", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "clvt_ContractwithCustomerLiabilityAdjustments": { "auth_ref": [], "calculation": { "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails": { "order": 2.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contract with Customer, Liability, Adjustments", "label": "Contract with Customer, Liability, Adjustments", "negatedTerseLabel": "Deferred revenues adjustment" } } }, "localname": "ContractwithCustomerLiabilityAdjustments", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "monetaryItemType" }, "clvt_DRGAcquisitionIntegrationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DRG Acquisition Integration Program", "label": "DRG Acquisition Integration Program [Member]", "terseLabel": "DRG Acquisition Integration Program" } } }, "localname": "DRGAcquisitionIntegrationProgramMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_DRGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DRG", "label": "DRG [Member]", "terseLabel": "DRG" } } }, "localname": "DRGMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "clvt_DatabasesAndContentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The member represents the databases and content.", "label": "Databases And Content [Member]", "terseLabel": "Databases and content" } } }, "localname": "DatabasesAndContentMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "clvt_DebtCovenantTermsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Covenant Terms", "label": "Debt Covenant Terms [Axis]", "terseLabel": "Debt Covenant Terms [Axis]" } } }, "localname": "DebtCovenantTermsAxis", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "stringItemType" }, "clvt_DebtCovenantTermsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Covenant Terms [Domain]", "label": "Debt Covenant Terms [Domain]", "terseLabel": "Debt Covenant Terms [Domain]" } } }, "localname": "DebtCovenantTermsDomain", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "clvt_DebtInstrument.RedemptionThroughEquityOfferingsThresholdMinimumPercentageOfOriginalAggregatePrincipalAmountRemainingOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument. Redemption Through Equity Offerings, Threshold Minimum, Percentage Of Original Aggregate Principal Amount Remaining Outstanding", "label": "Debt Instrument. Redemption Through Equity Offerings, Threshold Minimum, Percentage Of Original Aggregate Principal Amount Remaining Outstanding", "terseLabel": "Required principal amount remaining after redemption (as a percent)" } } }, "localname": "DebtInstrument.RedemptionThroughEquityOfferingsThresholdMinimumPercentageOfOriginalAggregatePrincipalAmountRemainingOutstanding", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "percentItemType" }, "clvt_DebtInstrumentAmortizationRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Amortization Rate", "label": "Debt Instrument, Amortization Rate", "terseLabel": "Amortization rate (as a percent)" } } }, "localname": "DebtInstrumentAmortizationRate", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "percentItemType" }, "clvt_DebtInstrumentInterestRateAnnualAdjustment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument, Interest Rate, Annual Adjustment", "label": "Debt instrument, Interest Rate, Annual Adjustment", "terseLabel": "Interest rate annual adjustment (as a percent)" } } }, "localname": "DebtInstrumentInterestRateAnnualAdjustment", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "percentItemType" }, "clvt_DebtInstrumentRedemptionPeriodPriorToClosingOfEquityOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Redemption Period Prior to Closing of Equity Offering", "label": "Debt Instrument, Redemption Period Prior to Closing of Equity Offering", "terseLabel": "Redemption period prior to closing of equity offering" } } }, "localname": "DebtInstrumentRedemptionPeriodPriorToClosingOfEquityOffering", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details" ], "xbrltype": "durationItemType" }, "clvt_DebtInstrumentRedemptionPriceChangesInControlPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of principal amount of debt redeemed, changes in control.", "label": "Debt Instrument, Redemption Price, Changes in Control, Percentage", "terseLabel": "Redemption due to change in control (as a percent)" } } }, "localname": "DebtInstrumentRedemptionPriceChangesInControlPercentage", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "percentItemType" }, "clvt_DebtInstrumentRedemptionThroughEquityOfferingsRedemptionPricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Redemption Through Equity Offerings, Redemption Price, Percentage", "label": "Debt Instrument, Redemption Through Equity Offerings, Redemption Price, Percentage", "terseLabel": "Redemption through equity offerings, redemption price (as a percent)" } } }, "localname": "DebtInstrumentRedemptionThroughEquityOfferingsRedemptionPricePercentage", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "percentItemType" }, "clvt_DebtInstrumentRedemptionThroughEquityOfferingsThresholdRedemptionPeriodMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Redemption Through Equity Offerings Threshold, Redemption Period Maximum", "label": "Debt Instrument, Redemption Through Equity Offerings Threshold, Redemption Period Maximum", "terseLabel": "Redemption through equity offerings threshold, redemption period maximum" } } }, "localname": "DebtInstrumentRedemptionThroughEquityOfferingsThresholdRedemptionPeriodMaximum", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "durationItemType" }, "clvt_DebtIssuanceCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt issuance costs.", "label": "Debt Issuance Costs [Policy Text Block]", "terseLabel": "Debt Issuance Costs" } } }, "localname": "DebtIssuanceCostsPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_DecisionResourcesGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Decision Resources Group [Member]", "label": "Decision Resources Group [Member]", "terseLabel": "Decision Resources Group" } } }, "localname": "DecisionResourcesGroupMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_DeferredRevenuesAdjustment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents information pertaining to Deferred revenues adjustment.", "label": "Deferred revenues adjustment", "negatedTerseLabel": "Deferred revenues adjustment" } } }, "localname": "DeferredRevenuesAdjustment", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "clvt_DerivativeVariableInterestRateFloor": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative, Variable Interest Rate, Floor", "label": "Derivative, Variable Interest Rate, Floor", "terseLabel": "Derivative variable interest rate floor" } } }, "localname": "DerivativeVariableInterestRateFloor", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "percentItemType" }, "clvt_DisposalGroupIncludingDiscontinuedOperationConsiderationDeferred": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Deferred", "label": "Disposal Group, Including Discontinued Operation, Consideration, Deferred", "terseLabel": "Deferred closing consideration" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationDeferred", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "clvt_DisposalGroupIncludingDiscontinuedOperationConsiderationOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Other", "label": "Disposal Group, Including Discontinued Operation, Consideration, Other", "terseLabel": "Other consideration" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationOther", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "clvt_DisposalGroupIncludingDiscontinuedOperationConsiderationPeriodPayable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Period Payable", "label": "Disposal Group, Including Discontinued Operation, Consideration, Period Payable", "terseLabel": "Purchase price period payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationPeriodPayable", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails" ], "xbrltype": "durationItemType" }, "clvt_EffectiveIncomeTaxRateReconciliationDeductibleExpenseImpairmentLossesAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Deductible Expense, Impairment Losses, Amount", "label": "Effective Income Tax Rate Reconciliation, Deductible Expense, Impairment Losses, Amount", "terseLabel": "Income tax benefit due to impairment of intangible assets" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductibleExpenseImpairmentLossesAmount", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_ExitAndDisposalCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exit and Disposal Costs", "label": "Exit and Disposal Costs [Member]", "terseLabel": "Exit and Disposal Costs" } } }, "localname": "ExitAndDisposalCostsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_ExitDisposalAndAbandonmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exit, Disposal and Abandonment Costs", "label": "Exit, Disposal and Abandonment Costs [Member]", "terseLabel": "Exit, Disposal and Abandonment Costs" } } }, "localname": "ExitDisposalAndAbandonmentCostsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisPaymentEarnOutLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Payment Earn Out Liability", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Payment Earn Out Liability", "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Payment Earn Out Liability" } } }, "localname": "FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisPaymentEarnOutLiability", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_FiniteLivedIntangibleAssetsAmortizationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to amortization.", "label": "Finite Lived Intangible Assets, Amortization [Policy Text Block]", "terseLabel": "Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_FirstLienLeverageRatiosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Leverage Ratios", "label": "First Lien Leverage Ratios [Member]", "terseLabel": "First Lien Leverage Ratios" } } }, "localname": "FirstLienLeverageRatiosMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "clvt_FurnitureFixturesAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture Fixtures And Equipment [Member]", "terseLabel": "Furniture, fixtures and equipment" } } }, "localname": "FurnitureFixturesAndEquipmentMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "clvt_GoodwillAndIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The line item disclosure represents goodwill and intangible asset.", "label": "Goodwill And Intangible Assets [Line Items]", "terseLabel": "Goodwill And Intangible Assets [Line Items]" } } }, "localname": "GoodwillAndIntangibleAssetsLineItems", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "clvt_GoodwillImpairmentLossExcludingCTAImpact": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Goodwill, Impairment Loss, Excluding CTA Impact", "label": "Goodwill, Impairment Loss, Excluding CTA Impact", "terseLabel": "Goodwill, Impairment Loss, Excluding CTA Impact" } } }, "localname": "GoodwillImpairmentLossExcludingCTAImpact", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "clvt_IncentiveAwardPlan2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Award Plan 2019 [Member]", "label": "Incentive Award Plan 2019 [Member]", "terseLabel": "Incentive Award Plan 2019" } } }, "localname": "IncentiveAwardPlan2019Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "clvt_IncreaseDecreaseInContractWithCustomerAccountsReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents Amount of increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase Decrease In Contract With Customer Accounts Receivable", "terseLabel": "Increase (decrease)" } } }, "localname": "IncreaseDecreaseInContractWithCustomerAccountsReceivable", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_IncreaseDecreaseInContractWithCustomerCurrentLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents Amount of increase (decrease) in Current obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase Decrease In Contract With Customer, Current Liability", "terseLabel": "Increase (decrease)" } } }, "localname": "IncreaseDecreaseInContractWithCustomerCurrentLiability", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_IncreaseDecreaseInContractWithCustomerNonCurrentLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents Amount of increase (decrease) in Non Current obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase Decrease In Contract With Customer, Non Current Liability", "terseLabel": "Increase (decrease)" } } }, "localname": "IncreaseDecreaseInContractWithCustomerNonCurrentLiability", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_IntellectualPropertyGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents information pertaining to Intellectual Property Group.", "label": "Intellectual Property Group [Member]", "terseLabel": "IP Segment", "verboseLabel": "Intellectual Property" } } }, "localname": "IntellectualPropertyGroupMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails", "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwap150MillionTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, 150 Million Term Loan", "label": "Interest Rate Swap, 150 Million Term Loan [Member]", "terseLabel": "Interest Rate Swap, $150 Million Term Loan" } } }, "localname": "InterestRateSwap150MillionTermLoanMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwap200MillionTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, 200 Million Term Loan", "label": "Interest Rate Swap, 200 Million Term Loan [Member]", "terseLabel": "Interest Rate Swap, $200 Million Term Loan" } } }, "localname": "InterestRateSwap200MillionTermLoanMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwapEffectiveDateApril302021FixedRate1695Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, Effective Date April 30, 2021, Fixed Rate 1.695%", "label": "Interest Rate Swap, Effective Date April 30, 2021, Fixed Rate 1.695% [Member]", "terseLabel": "Interest Rate Swap, Effective Date April 30, 2021, Fixed Rate 1.695%" } } }, "localname": "InterestRateSwapEffectiveDateApril302021FixedRate1695Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwapEffectiveDateAugust42022FixedRate2857Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, Effective Date August 4, 2022, Fixed Rate 2.857%", "label": "Interest Rate Swap, Effective Date August 4, 2022, Fixed Rate 2.857% [Member]", "terseLabel": "Interest Rate Swap, Effective Date August 4, 2022, Fixed Rate 2.857%" } } }, "localname": "InterestRateSwapEffectiveDateAugust42022FixedRate2857Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwapEffectiveDateAugust52022FixedRate3063Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, Effective Date August 5, 2022, Fixed Rate 3.063%", "label": "Interest Rate Swap, Effective Date August 5, 2022, Fixed Rate 3.063% [Member]", "terseLabel": "Interest Rate Swap, Effective Date August 5, 2022, Fixed Rate 3.063%" } } }, "localname": "InterestRateSwapEffectiveDateAugust52022FixedRate3063Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwapEffectiveDateMarch312021FixedRate0451Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 0.451%", "label": "Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 0.451% [Member]", "terseLabel": "Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 0.451%" } } }, "localname": "InterestRateSwapEffectiveDateMarch312021FixedRate0451Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwapEffectiveDateMarch312021FixedRate1695Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 1.695%", "label": "Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 1.695% [Member]", "terseLabel": "Interest Rate Swap, Effective Date March 31, 2021, Fixed Rate 1.695%" } } }, "localname": "InterestRateSwapEffectiveDateMarch312021FixedRate1695Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwapEffectiveDateOctober312022FixedRate0471Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.471%", "label": "Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.471% [Member]", "terseLabel": "Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.471%" } } }, "localname": "InterestRateSwapEffectiveDateOctober312022FixedRate0471Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_InterestRateSwapEffectiveDateOctober312022FixedRate0487Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.487%", "label": "Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.487% [Member]", "terseLabel": "Interest Rate Swap, Effective Date October 31, 2022, Fixed Rate 0.487%" } } }, "localname": "InterestRateSwapEffectiveDateOctober312022FixedRate0487Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "clvt_IpManagementProductLineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to IP Management Product Line", "label": "Ip Management Product Line [Member]", "terseLabel": "IPM Product Line" } } }, "localname": "IpManagementProductLineMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "domainItemType" }, "clvt_KopernioMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kopernio [Member]", "label": "Kopernio [Member]", "terseLabel": "Kopernio" } } }, "localname": "KopernioMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "clvt_LeaseAbandonmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Abandonment Costs", "label": "Lease Abandonment Costs [Member]", "terseLabel": "Lease Abandonment Costs" } } }, "localname": "LeaseAbandonmentCostsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_LeaseImpairmentLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lease, Impairment Loss", "label": "Lease, Impairment Loss", "terseLabel": "Impairment charge on right-of-use assets" } } }, "localname": "LeaseImpairmentLoss", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "clvt_LeonardGreenAndPartnersLPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leonard Green and Partners, LP", "label": "Leonard Green and Partners, LP [Member]", "terseLabel": "Leonard Green and Partners, LP" } } }, "localname": "LeonardGreenAndPartnersLPMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_LifeScienceAndHealthcareGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents information pertaining to Science Group.", "label": "Life Science and Healthcare Group [Member]", "terseLabel": "Life Sciences & Healthcare" } } }, "localname": "LifeScienceAndHealthcareGroupMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_LifeSciencesAndHealthcareGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents information pertaining to Science Group.", "label": "Life Sciences and Healthcare Group [Member]", "terseLabel": "LS&H Segment" } } }, "localname": "LifeSciencesAndHealthcareGroupMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "domainItemType" }, "clvt_ManagementIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the Management Incentive Plan under which certain employees may be eligible to purchase shares of the entity.", "label": "Management Incentive Plan [Member]", "terseLabel": "Management Incentive Plan" } } }, "localname": "ManagementIncentivePlanMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_NewSeniorSecuredNotes2028AndSeniorUnsecuredNotes2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Senior Secured Notes 2028 and Senior Unsecured Notes 2029", "label": "New Senior Secured Notes 2028 and Senior Unsecured Notes 2029 [Member]", "terseLabel": "New Senior Secured Notes 2028 and Senior Unsecured Notes 2029" } } }, "localname": "NewSeniorSecuredNotes2028AndSeniorUnsecuredNotes2029Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details" ], "xbrltype": "domainItemType" }, "clvt_NewSeniorSecuredNotes2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Senior Secured Notes 2028", "label": "New Senior Secured Notes 2028 [Member]", "terseLabel": "Senior Secured Notes" } } }, "localname": "NewSeniorSecuredNotes2028Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "domainItemType" }, "clvt_NewSeniorUnsecuredNotes2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Senior Unsecured Notes 2029", "label": "New Senior Unsecured Notes 2029 [Member]", "terseLabel": "Senior Notes" } } }, "localname": "NewSeniorUnsecuredNotes2029Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "domainItemType" }, "clvt_NoncashFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncash Financing Items", "label": "Noncash Financing Items [Abstract]", "terseLabel": "Non-Cash Financing Activities:" } } }, "localname": "NoncashFinancingItemsAbstract", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "clvt_NoncashImpairmentLeases": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash Impairment, Leases", "label": "Noncash Impairment, Leases", "terseLabel": "Noncash Impairment, Leases" } } }, "localname": "NoncashImpairmentLeases", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "clvt_OneClarivateProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Clarivate Program", "label": "One Clarivate Program [Member]", "terseLabel": "One Clarivate Program" } } }, "localname": "OneClarivateProgramMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_OneOfTheLargerLegalClaimsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Of The Larger Legal Claims", "label": "One Of The Larger Legal Claims [Member]", "terseLabel": "One Of The Larger Legal Claims" } } }, "localname": "OneOfTheLargerLegalClaimsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "clvt_OpenMarketPurchasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Open Market Purchases", "label": "Open Market Purchases [Member]", "terseLabel": "Open Market Purchases" } } }, "localname": "OpenMarketPurchasesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_OperationSimplificationAndOptimizationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operation Simplification and Optimization Program", "label": "Operation Simplification and Optimization Program [Member]", "terseLabel": "Operation Simplification and Optimization Program" } } }, "localname": "OperationSimplificationAndOptimizationProgramMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_OtherCurrentAndNonCurrentAssetsAndLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to other current and non-current assets and liabilities.", "label": "Other Current and Non-Current Assets and Liabilities [Policy Text Block]", "terseLabel": "Other Current and Non-Current Assets and Liabilities" } } }, "localname": "OtherCurrentAndNonCurrentAssetsAndLiabilitiesPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_OtherOperatingIncomeAndExpensePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to other operating income and other operating expense items.", "label": "Other Operating Income and Expense [Policy Text Block]", "terseLabel": "Other Operating Income (Expense), Net" } } }, "localname": "OtherOperatingIncomeAndExpensePolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_OtherReconcilingItemsEBITDAToNetIncomeLossAttributableToParent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Reconciling Items, EBITDA To Net Income (Loss) Attributable To Parent", "label": "Other Reconciling Items, EBITDA To Net Income (Loss) Attributable To Parent", "negatedTerseLabel": "Other" } } }, "localname": "OtherReconcilingItemsEBITDAToNetIncomeLossAttributableToParent", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "clvt_OtherRestructuringProgramsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Restructuring Programs", "label": "Other Restructuring Programs [Member]", "terseLabel": "Other Restructuring Plans" } } }, "localname": "OtherRestructuringProgramsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_PaymentsForPurchaseObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from payments for purchase obligations.", "label": "Payments For Purchase Obligations", "terseLabel": "Payments towards purchase obligations" } } }, "localname": "PaymentsForPurchaseObligations", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "clvt_PerformanceObligationsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Obligations Policy [Policy Text Block]", "label": "Performance Obligations Policy [Policy Text Block]", "terseLabel": "Performance Obligations" } } }, "localname": "PerformanceObligationsPolicyPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_PreferredStockPurchaseRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stock Purchase Rights", "label": "Preferred Stock Purchase Rights [Member]", "terseLabel": "Preferred Stock Purchase Rights" } } }, "localname": "PreferredStockPurchaseRightsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "domainItemType" }, "clvt_PrepaidAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to prepaid assets.", "label": "Prepaid Assets [Policy Text Block]", "terseLabel": "Prepaid Expenses" } } }, "localname": "PrepaidAssetsPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_PrepaidExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents Primary financial statement caption encompassing prepaid expenses.", "label": "Prepaid Expenses [Member]", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpensesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "domainItemType" }, "clvt_PrepaidSalesCommissions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents Amount of asset related to sales commission paid in advance that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Sales Commissions", "terseLabel": "Prepaid sales commissions" } } }, "localname": "PrepaidSalesCommissions", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "monetaryItemType" }, "clvt_PrivatePlacementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrant", "label": "Private Placement Warrant [Member]", "terseLabel": "Private Warrant" } } }, "localname": "PrivatePlacementWarrantMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails" ], "xbrltype": "domainItemType" }, "clvt_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Warrants", "label": "Private Warrants [Member]", "terseLabel": "Private Warrants" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "clvt_ProQuestAcquisitionIntegrationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ProQuest Acquisition Integration Program", "label": "ProQuest Acquisition Integration Program [Member]", "terseLabel": "ProQuest Acquisition Integration Program" } } }, "localname": "ProQuestAcquisitionIntegrationProgramMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_ProQuestMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ProQuest", "label": "ProQuest [Member]", "terseLabel": "ProQuest" } } }, "localname": "ProQuestMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "clvt_PublicWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrant", "label": "Public Warrant [Member]", "terseLabel": "Public Warrant" } } }, "localname": "PublicWarrantMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_PublonsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Publons Limited [Member]", "label": "Publons Limited [Member]", "terseLabel": "Publons" } } }, "localname": "PublonsLimitedMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "clvt_ReOccurringRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Re-occurring Revenues", "label": "Re-occurring Revenues [Member]", "terseLabel": "Re-occurring Revenues" } } }, "localname": "ReOccurringRevenuesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "domainItemType" }, "clvt_RecordedUnconditionalPurchaseObligationDueAfterFourthYear": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails": { "order": 5.0, "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recorded Unconditional Purchase Obligation Due After Fourth Year", "label": "Recorded Unconditional Purchase Obligation Due After Fourth Year", "terseLabel": "Thereafter" } } }, "localname": "RecordedUnconditionalPurchaseObligationDueAfterFourthYear", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "clvt_RestrictedCashPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restricted Cash, Period Increase (Decrease)", "label": "Restricted Cash, Period Increase (Decrease)", "terseLabel": "Net decrease in restricted cash" } } }, "localname": "RestrictedCashPeriodIncreaseDecrease", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "clvt_RestructuringReserveAssetImpairmentCharge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Restructuring Reserve, Asset Impairment Charge", "label": "Restructuring Reserve, Asset Impairment Charge", "terseLabel": "Noncash items and other adjustments" } } }, "localname": "RestructuringReserveAssetImpairmentCharge", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "clvt_RestructuringReserveNoncashItemsAndOtherAdjustments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Restructuring Reserve, Noncash Items And Other Adjustments", "label": "Restructuring Reserve, Noncash Items And Other Adjustments", "terseLabel": "Noncash items" } } }, "localname": "RestructuringReserveNoncashItemsAndOtherAdjustments", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "clvt_RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment": { "auth_ref": [], "calculation": { "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails": { "order": 1.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents Amount, excluding tax collected from customer, Including of Deferred revenues adjustment.", "label": "Revenue From Contract With Customer, Excluding Assessed Tax Including Deferred Revenues Adjustment", "terseLabel": "Total revenues, gross" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "monetaryItemType" }, "clvt_RevenueRemainingPerformanceObligationCurrentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Remaining Performance Obligation Current Percentage", "label": "Revenue Remaining Performance Obligation Current Percentage", "terseLabel": "Revenue Remaining Performance Obligation Current Percentage" } } }, "localname": "RevenueRemainingPerformanceObligationCurrentPercentage", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "percentItemType" }, "clvt_RevenueRemainingPerformanceObligationGreaterThanOneYearPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue, Remaining Performance Obligation, Greater than One Year, Percentage", "label": "Revenue, Remaining Performance Obligation, Greater than One Year, Percentage", "terseLabel": "Remaining performance obligation, greater than one year, percentage" } } }, "localname": "RevenueRemainingPerformanceObligationGreaterThanOneYearPercentage", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "percentItemType" }, "clvt_ScheduleOfGoodwillAndIntangibleAssetsDisclosureTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The table disclosure represents goodwill and intangible asset.", "label": "Schedule Of Goodwill and Intangible Assets Disclosure [Table]", "terseLabel": "Schedule Of Goodwill and Intangible Assets Disclosure [Table]" } } }, "localname": "ScheduleOfGoodwillAndIntangibleAssetsDisclosureTable", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "clvt_ScheduleOfOtherOperatingIncomeNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Other Operating Income, Net", "label": "Schedule Of Other Operating Income, Net [Table Text Block]", "terseLabel": "Schedule of other operating income, net" } } }, "localname": "ScheduleOfOtherOperatingIncomeNetTableTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetTables" ], "xbrltype": "textBlockItemType" }, "clvt_ScheduleOfPrivatePlacementWarrantActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Private Placement Warrant Activity", "label": "Schedule Of Private Placement Warrant Activity [Table Text Block]", "terseLabel": "Schedule Of Private Placement Warrant Activity" } } }, "localname": "ScheduleOfPrivatePlacementWarrantActivityTableTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "clvt_SegmentOptimizationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Segment Optimization Program", "label": "Segment Optimization Program [Member]", "terseLabel": "Segment Optimization Program" } } }, "localname": "SegmentOptimizationProgramMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_SeniorSecuredNotes2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Notes 2026", "label": "Senior Secured Notes 2026 [Member]", "terseLabel": "Senior Secured Notes" } } }, "localname": "SeniorSecuredNotes2026Member", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "clvt_SeniorSecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Notes [Member]", "label": "Senior Secured Notes [Member]", "terseLabel": "Senior Secured Notes" } } }, "localname": "SeniorSecuredNotesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "domainItemType" }, "clvt_SeniorUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Senior Unsecured Notes.", "label": "Senior Unsecured Notes [Member]", "terseLabel": "Senior Unsecured Notes" } } }, "localname": "SeniorUnsecuredNotesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "clvt_SeveranceAndRelatedBenefitCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Severance and Related Benefit Cost", "label": "Severance and Related Benefit Cost [Member]", "terseLabel": "Severance and Related Benefit Cost" } } }, "localname": "SeveranceAndRelatedBenefitCostMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "clvt_SignificantJudgmentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Significant Judgments [Policy Text Block]", "label": "Significant Judgments [Policy Text Block]", "terseLabel": "Significant Judgments" } } }, "localname": "SignificantJudgmentsPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_SmallProductGroupWithinIPSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Small Product Group Within IP Segment", "label": "Small Product Group Within IP Segment [Member]", "terseLabel": "Small Product Group within IP Segment" } } }, "localname": "SmallProductGroupWithinIPSegmentMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "clvt_SponsorAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor Agreement [Member]", "label": "Sponsor Agreement [Member]", "terseLabel": "Sponsor agreement" } } }, "localname": "SponsorAgreementMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "clvt_StockIssuedDuringPeriodSharesPrivateWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Private Warrants Exercised", "label": "Stock Issued During Period, Shares, Private Warrants Exercised", "terseLabel": "Exercise of Private Placement Warrants (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesPrivateWarrantsExercised", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "sharesItemType" }, "clvt_StockIssuedDuringPeriodSharesPublicWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Public Warrants Exercised", "label": "Stock Issued During Period, Shares, Public Warrants Exercised", "terseLabel": "Exercise of public warrants (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesPublicWarrantsExercised", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "sharesItemType" }, "clvt_StockIssuedDuringPeriodSharesWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Warrants Exercised", "label": "Stock Issued During Period, Shares, Warrants Exercised", "terseLabel": "Stock issued, warrants exercised" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "clvt_StockIssuedDuringPeriodValuePrivateWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Private Warrants Exercised", "label": "Stock Issued During Period, Value, Private Warrants Exercised", "negatedTerseLabel": "Exercise of Private Placement Warrants", "terseLabel": "Exercise of Private Placement Warrants" } } }, "localname": "StockIssuedDuringPeriodValuePrivateWarrantsExercised", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "clvt_StockIssuedDuringPeriodValuePublicWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Public Warrants Exercised", "label": "Stock Issued During Period, Value, Public Warrants Exercised", "terseLabel": "Exercise of public warrants" } } }, "localname": "StockIssuedDuringPeriodValuePublicWarrantsExercised", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "clvt_StockRepurchaseProgramAuthorizedRepurchasesPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program, Authorized Repurchases, Price Per Share", "label": "Stock Repurchase Program, Authorized Repurchases, Price Per Share", "terseLabel": "Stock repurchase program, authorized repurchases, price per share (in dollars per share)" } } }, "localname": "StockRepurchaseProgramAuthorizedRepurchasesPricePerShare", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "clvt_SubscriptionRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the Amount of revenue from subscription.", "label": "Subscription Revenues [Member]", "terseLabel": "Subscription revenues" } } }, "localname": "SubscriptionRevenuesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "domainItemType" }, "clvt_SupplementalUnemploymentBenefitsSeveranceLiabilityEmployerContributionPercentOfEmployeesGrossPay": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplemental Unemployment Benefits, Severance Liability, Employer Contribution, Percent of Employees' Gross Pay", "label": "Supplemental Unemployment Benefits, Severance Liability, Employer Contribution, Percent of Employees' Gross Pay", "terseLabel": "Severance liability, employer contribution, percent of employees' salary" } } }, "localname": "SupplementalUnemploymentBenefitsSeveranceLiabilityEmployerContributionPercentOfEmployeesGrossPay", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "percentItemType" }, "clvt_SupplementalUnemploymentBenefitsSeverancePayDepositsEmployerContributionPercentOfEmployeesGrossPay": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplemental Unemployment Benefits, Severance Pay Deposits, Employer Contribution, Percent of Employees' Gross Pay", "label": "Supplemental Unemployment Benefits, Severance Pay Deposits, Employer Contribution, Percent of Employees' Gross Pay", "terseLabel": "Severance pay deposits, employer contribution, percent of employees salary" } } }, "localname": "SupplementalUnemploymentBenefitsSeverancePayDepositsEmployerContributionPercentOfEmployeesGrossPay", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "percentItemType" }, "clvt_TenLargestCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten Largest Customers", "label": "Ten Largest Customers [Member]", "terseLabel": "Ten Largest Customers" } } }, "localname": "TenLargestCustomersMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "clvt_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to a Term Loan Facility.", "label": "Term Loan Facility [Member]", "terseLabel": "Term Loan Facility" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "clvt_TotalNonCashFinancingActivities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total Non-Cash Financing Activities", "label": "Total Non-Cash Financing Activities", "terseLabel": "Total Non-Cash Financing Activities" } } }, "localname": "TotalNonCashFinancingActivities", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "clvt_TrademarkvisionUsaLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents TrademarkVision USA, LLC [Member]", "label": "Trademarkvision Usa Llc [Member]", "terseLabel": "TrademarkVision" } } }, "localname": "TrademarkvisionUsaLlcMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "clvt_TransactionRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents the Amount of revenue from Transaction.", "label": "Transaction Revenues [Member]", "terseLabel": "Transaction revenues" } } }, "localname": "TransactionRevenuesMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "domainItemType" }, "clvt_TransitionServicesAgreementCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transition Services Agreement Costs", "label": "Transition Services Agreement Costs", "negatedTerseLabel": "Transition Services Agreement Costs" } } }, "localname": "TransitionServicesAgreementCosts", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "clvt_TreasuryStockAcquiredNoncash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Treasury Stock Acquired, Noncash", "label": "Treasury Stock Acquired, Noncash", "negatedTerseLabel": "Clarivate stock to be issued" } } }, "localname": "TreasuryStockAcquiredNoncash", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "clvt_TreasuryStockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock", "label": "Treasury Stock [Policy Text Block]", "terseLabel": "Treasury Shares" } } }, "localname": "TreasuryStockPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_TreasuryStockReissuedAverageCostPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock Reissued, Average Cost Per Share", "label": "Treasury Stock Reissued, Average Cost Per Share", "terseLabel": "Treasury stock sold, average cost per share (in dollars per share)" } } }, "localname": "TreasuryStockReissuedAverageCostPerShare", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "clvt_TreasuryStockRetiredAverageCostPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock Retired, Average Cost Per Share", "label": "Treasury Stock Retired, Average Cost Per Share", "terseLabel": "Treasury stock average price at retirement date (usd per share)" } } }, "localname": "TreasuryStockRetiredAverageCostPerShare", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "clvt_TreasuryStockSharesSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury Stock, Shares, Sold", "label": "Treasury Stock, Shares, Sold", "terseLabel": "Sale of treasury shares, net (in shares)" } } }, "localname": "TreasuryStockSharesSold", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "clvt_TreasuryStockSoldAtLowerThanRepurchasePrice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Treasury Stock Sold at Lower than Repurchase Price", "label": "Treasury Stock Sold at Lower than Repurchase Price", "terseLabel": "Loss on treasury stock sold at lower than repurchase price" } } }, "localname": "TreasuryStockSoldAtLowerThanRepurchasePrice", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "clvt_TreasuryStockValueAcquiredCostMethodSettledInSubsequentPeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Treasury Stock, Value, Acquired, Cost Method, Settled in Subsequent Period", "label": "Treasury Stock, Value, Acquired, Cost Method, Settled in Subsequent Period", "terseLabel": "Treasury share purchases settled after period end" } } }, "localname": "TreasuryStockValueAcquiredCostMethodSettledInSubsequentPeriod", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "clvt_VariableConsiderationPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Consideration Policy [Policy Text Block]", "label": "Variable Consideration Policy [Policy Text Block]", "terseLabel": "Variable Consideration" } } }, "localname": "VariableConsiderationPolicyPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_VestingOfRestrictedStockUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting of Restricted Stock Units", "label": "Vesting of Restricted Stock Units", "terseLabel": "Vesting of restricted stock units (in shares)" } } }, "localname": "VestingOfRestrictedStockUnits", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "sharesItemType" }, "clvt_WarrantAndShareBasedPaymentArrangementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant and Share-Based Payment Arrangement", "label": "Warrant and Share-Based Payment Arrangement [Member]", "terseLabel": "Warrant and Share-Based Payment Arrangement" } } }, "localname": "WarrantAndShareBasedPaymentArrangementMember", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "clvt_WarrantLiabilityPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liability, Policy", "label": "Warrant Liability, Policy [Policy Text Block]", "terseLabel": "Warrant Liabilities" } } }, "localname": "WarrantLiabilityPolicyPolicyTextBlock", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "clvt_WarrantsAndRightsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants And Rights, Outstanding", "label": "Warrants And Rights, Outstanding [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "WarrantsAndRightsOutstandingRollForward", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails" ], "xbrltype": "stringItemType" }, "clvt_WarrantsAndRightsOutstandingWeightedAverageFairValuePerShareRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants And Rights, Outstanding, Weighted Average Fair Value Per Share", "label": "Warrants And Rights, Outstanding, Weighted Average Fair Value Per Share [Roll Forward]", "terseLabel": "Weighted Average Fair Value per Share" } } }, "localname": "WarrantsAndRightsOutstandingWeightedAverageFairValuePerShareRollForward", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails" ], "xbrltype": "stringItemType" }, "clvt_WeightedAverageRemainingContractualLifeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted-Average Remaining Contractual Life", "label": "Weighted-Average Remaining Contractual Life [Abstract]", "terseLabel": "Weighted-Average Remaining Contractual Life (in years)" } } }, "localname": "WeightedAverageRemainingContractualLifeAbstract", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "stringItemType" }, "clvt_WriteOffOfAccumulatedForeignCurrencyImpacts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write-off of amounts previously capitalized as foreign currency.", "label": "Write Off of Accumulated Foreign Currency Impacts", "terseLabel": "Write off of accumulated foreign currency impacts" } } }, "localname": "WriteOffOfAccumulatedForeignCurrencyImpacts", "nsuri": "http://clarivate.com/20230630", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r1013", "r1015", "r1028" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/AuditInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r1013", "r1015", "r1028" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r1013", "r1015", "r1028" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/AuditInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region", "terseLabel": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r1014" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r1049" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1011" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r1088" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1010" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r1089" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r1013", "r1015", "r1028" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1009" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1012" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://clarivate.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "ecd_Additional402vDisclosureTextBlock": { "auth_ref": [ "r1050" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "localname": "Additional402vDisclosureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToCompAmt": { "auth_ref": [ "r1056" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "localname": "AdjToCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AdjToCompAxis": { "auth_ref": [ "r1056" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "localname": "AdjToCompAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "auth_ref": [ "r1056" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "localname": "AdjToNonPeoNeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AdjToPeoCompFnTextBlock": { "auth_ref": [ "r1056" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "localname": "AdjToPeoCompFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AggtErrCompAmt": { "auth_ref": [ "r1020", "r1032", "r1042", "r1067" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "localname": "AggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "auth_ref": [ "r1023", "r1035", "r1045", "r1070" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "localname": "AggtErrCompNotYetDeterminedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AllAdjToCompMember": { "auth_ref": [ "r1056" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "localname": "AllAdjToCompMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllExecutiveCategoriesMember": { "auth_ref": [ "r1063" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "localname": "AllExecutiveCategoriesMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllIndividualsMember": { "auth_ref": [ "r1027", "r1036", "r1046", "r1063", "r1071", "r1075", "r1083" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "localname": "AllIndividualsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_AllTradingArrangementsMember": { "auth_ref": [ "r1081" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "localname": "AllTradingArrangementsMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "domainItemType" }, "ecd_AwardExrcPrice": { "auth_ref": [ "r1078" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "localname": "AwardExrcPrice", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "perShareItemType" }, "ecd_AwardGrantDateFairValue": { "auth_ref": [ "r1079" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "localname": "AwardGrantDateFairValue", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_AwardTmgDiscLineItems": { "auth_ref": [ "r1074" ], "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "localname": "AwardTmgDiscLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "auth_ref": [ "r1074" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMethodTextBlock": { "auth_ref": [ "r1074" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "localname": "AwardTmgMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgMnpiCnsdrdFlag": { "auth_ref": [ "r1074" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "localname": "AwardTmgMnpiCnsdrdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardTmgMnpiDiscTextBlock": { "auth_ref": [ "r1074" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "localname": "AwardTmgMnpiDiscTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_AwardTmgPredtrmndFlag": { "auth_ref": [ "r1074" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "localname": "AwardTmgPredtrmndFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_AwardUndrlygSecuritiesAmt": { "auth_ref": [ "r1077" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "localname": "AwardUndrlygSecuritiesAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_AwardsCloseToMnpiDiscIndName": { "auth_ref": [ "r1076" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "localname": "AwardsCloseToMnpiDiscIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTable": { "auth_ref": [ "r1075" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "localname": "AwardsCloseToMnpiDiscTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "auth_ref": [ "r1075" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "localname": "AwardsCloseToMnpiDiscTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ChangedPeerGroupFnTextBlock": { "auth_ref": [ "r1054" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "localname": "ChangedPeerGroupFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CoSelectedMeasureAmt": { "auth_ref": [ "r1055" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "localname": "CoSelectedMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_CoSelectedMeasureName": { "auth_ref": [ "r1055" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "localname": "CoSelectedMeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "auth_ref": [ "r1060" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "auth_ref": [ "r1059" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "localname": "CompActuallyPaidVsNetIncomeTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "auth_ref": [ "r1061" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "auth_ref": [ "r1058" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "auth_ref": [ "r1057" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompAnalysisTextBlock": { "auth_ref": [ "r1020", "r1032", "r1042", "r1067" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "localname": "ErrCompAnalysisTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ErrCompRecoveryTable": { "auth_ref": [ "r1017", "r1029", "r1039", "r1064" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "localname": "ErrCompRecoveryTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ExecutiveCategoryAxis": { "auth_ref": [ "r1063" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "localname": "ExecutiveCategoryAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "auth_ref": [ "r1024", "r1036", "r1046", "r1071" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "auth_ref": [ "r1024", "r1036", "r1046", "r1071" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "auth_ref": [ "r1024", "r1036", "r1046", "r1071" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "auth_ref": [ "r1024", "r1036", "r1046", "r1071" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_ForgoneRecoveryIndName": { "auth_ref": [ "r1024", "r1036", "r1046", "r1071" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "ForgoneRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_IndividualAxis": { "auth_ref": [ "r1027", "r1036", "r1046", "r1063", "r1071", "r1075", "r1083" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "localname": "IndividualAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_InsiderTradingArrLineItems": { "auth_ref": [ "r1081" ], "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "localname": "InsiderTradingArrLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTradingPoliciesProcLineItems": { "auth_ref": [ "r1016", "r1087" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "localname": "InsiderTradingPoliciesProcLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "auth_ref": [ "r1016", "r1087" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "localname": "InsiderTrdPoliciesProcAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "booleanItemType" }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "auth_ref": [ "r1016", "r1087" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "xbrltype": "textBlockItemType" }, "ecd_MeasureAxis": { "auth_ref": [ "r1055" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "localname": "MeasureAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_MeasureName": { "auth_ref": [ "r1055" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "localname": "MeasureName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_MnpiDiscTimedForCompValFlag": { "auth_ref": [ "r1074" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "localname": "MnpiDiscTimedForCompValFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "booleanItemType" }, "ecd_MtrlTermsOfTrdArrTextBlock": { "auth_ref": [ "r1082" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "localname": "MtrlTermsOfTrdArrTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "textBlockItemType" }, "ecd_NamedExecutiveOfficersFnTextBlock": { "auth_ref": [ "r1056" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "localname": "NamedExecutiveOfficersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonGaapMeasureDescriptionTextBlock": { "auth_ref": [ "r1055" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "localname": "NonGaapMeasureDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_NonNeosMember": { "auth_ref": [ "r1024", "r1036", "r1046", "r1063", "r1071" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "localname": "NonNeosMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "auth_ref": [ "r1053" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoAvgTotalCompAmt": { "auth_ref": [ "r1052" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "localname": "NonPeoNeoAvgTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_NonPeoNeoMember": { "auth_ref": [ "r1063" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "localname": "NonPeoNeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_NonRule10b51ArrAdoptedFlag": { "auth_ref": [ "r1082" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "localname": "NonRule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_NonRule10b51ArrTrmntdFlag": { "auth_ref": [ "r1082" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "localname": "NonRule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_OtherPerfMeasureAmt": { "auth_ref": [ "r1055" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "localname": "OtherPerfMeasureAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "decimalItemType" }, "ecd_OutstandingAggtErrCompAmt": { "auth_ref": [ "r1022", "r1034", "r1044", "r1069" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "localname": "OutstandingAggtErrCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryCompAmt": { "auth_ref": [ "r1025", "r1037", "r1047", "r1072" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "localname": "OutstandingRecoveryCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_OutstandingRecoveryIndName": { "auth_ref": [ "r1025", "r1037", "r1047", "r1072" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "localname": "OutstandingRecoveryIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PayVsPerformanceDisclosureLineItems": { "auth_ref": [ "r1051" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "localname": "PayVsPerformanceDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_PeerGroupIssuersFnTextBlock": { "auth_ref": [ "r1054" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "localname": "PeerGroupIssuersFnTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_PeerGroupTotalShareholderRtnAmt": { "auth_ref": [ "r1054" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "localname": "PeerGroupTotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoActuallyPaidCompAmt": { "auth_ref": [ "r1053" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "localname": "PeoActuallyPaidCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PeoMember": { "auth_ref": [ "r1063" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "localname": "PeoMember", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "domainItemType" }, "ecd_PeoName": { "auth_ref": [ "r1056" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "localname": "PeoName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "normalizedStringItemType" }, "ecd_PeoTotalCompAmt": { "auth_ref": [ "r1052" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "localname": "PeoTotalCompAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_PvpTable": { "auth_ref": [ "r1051" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "localname": "PvpTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "stringItemType" }, "ecd_PvpTableTextBlock": { "auth_ref": [ "r1051" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "localname": "PvpTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "auth_ref": [ "r1017", "r1029", "r1039", "r1064" ], "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "localname": "RecoveryOfErrCompDisclosureLineItems", "nsuri": "http://xbrl.sec.gov/ecd/2023", "xbrltype": "stringItemType" }, "ecd_RestatementDateAxis": { "auth_ref": [ "r1018", "r1030", "r1040", "r1065" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "localname": "RestatementDateAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "stringItemType" }, "ecd_RestatementDeterminationDate": { "auth_ref": [ "r1019", "r1031", "r1041", "r1066" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "localname": "RestatementDeterminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "dateItemType" }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "auth_ref": [ "r1026", "r1038", "r1048", "r1073" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "localname": "RestatementDoesNotRequireRecoveryTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_Rule10b51ArrAdoptedFlag": { "auth_ref": [ "r1082" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "localname": "Rule10b51ArrAdoptedFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_Rule10b51ArrTrmntdFlag": { "auth_ref": [ "r1082" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "localname": "Rule10b51ArrTrmntdFlag", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "booleanItemType" }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "auth_ref": [ "r1021", "r1033", "r1043", "r1068" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "localname": "StkPrcOrTsrEstimationMethodTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TabularListTableTextBlock": { "auth_ref": [ "r1062" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "localname": "TabularListTableTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TotalShareholderRtnAmt": { "auth_ref": [ "r1054" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "localname": "TotalShareholderRtnAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "auth_ref": [ "r1061" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "textBlockItemType" }, "ecd_TradingArrAxis": { "auth_ref": [ "r1081" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "localname": "TradingArrAxis", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TradingArrByIndTable": { "auth_ref": [ "r1083" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "localname": "TradingArrByIndTable", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrAdoptionDate": { "auth_ref": [ "r1084" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "localname": "TrdArrAdoptionDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrDuration": { "auth_ref": [ "r1085" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "localname": "TrdArrDuration", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "durationItemType" }, "ecd_TrdArrIndName": { "auth_ref": [ "r1083" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "localname": "TrdArrIndName", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrIndTitle": { "auth_ref": [ "r1083" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "localname": "TrdArrIndTitle", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_TrdArrSecuritiesAggAvailAmt": { "auth_ref": [ "r1086" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "localname": "TrdArrSecuritiesAggAvailAmt", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "sharesItemType" }, "ecd_TrdArrTerminationDate": { "auth_ref": [ "r1084" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "localname": "TrdArrTerminationDate", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "xbrltype": "stringItemType" }, "ecd_UndrlygSecurityMktPriceChngPct": { "auth_ref": [ "r1080" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "localname": "UndrlygSecurityMktPriceChngPct", "nsuri": "http://xbrl.sec.gov/ecd/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "pureItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r867", "r945", "r998", "r1185", "r1227", "r1228", "r1229" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r298", "r299", "r483", "r513", "r700", "r955", "r957" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r1137", "r1246" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Director" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]", "terseLabel": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]", "terseLabel": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r376", "r975", "r1184", "r1241", "r1242" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r463", "r464", "r465", "r466", "r559", "r735", "r793", "r838", "r839", "r902", "r905", "r909", "r910", "r924", "r946", "r947", "r964", "r972", "r985", "r994", "r1179", "r1232", "r1233", "r1234", "r1235", "r1236", "r1237" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/SegmentInformationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r463", "r464", "r465", "r466", "r559", "r735", "r793", "r838", "r839", "r902", "r905", "r909", "r910", "r924", "r946", "r947", "r964", "r972", "r985", "r994", "r1179", "r1232", "r1233", "r1234", "r1235", "r1236", "r1237" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r376", "r975", "r1184", "r1241", "r1242" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r372", "r740", "r787", "r788", "r789", "r790", "r791", "r792", "r950", "r973", "r993", "r1101", "r1174", "r1175", "r1184", "r1241" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r372", "r740", "r787", "r788", "r789", "r790", "r791", "r792", "r950", "r973", "r993", "r1101", "r1174", "r1175", "r1184", "r1241" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r463", "r464", "r465", "r466", "r551", "r559", "r592", "r593", "r594", "r711", "r735", "r793", "r838", "r839", "r902", "r905", "r909", "r910", "r924", "r946", "r947", "r964", "r972", "r985", "r994", "r997", "r1167", "r1179", "r1233", "r1234", "r1235", "r1236", "r1237" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/SegmentInformationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r463", "r464", "r465", "r466", "r551", "r559", "r592", "r593", "r594", "r711", "r735", "r793", "r838", "r839", "r902", "r905", "r909", "r910", "r924", "r946", "r947", "r964", "r972", "r985", "r994", "r997", "r1167", "r1179", "r1233", "r1234", "r1235", "r1236", "r1237" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/SegmentInformationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r298", "r299", "r483", "r513", "r700", "r956", "r957" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r250", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r339", "r411", "r412", "r627", "r651", "r652", "r653", "r654", "r679", "r693", "r694", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r805" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "terseLabel": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r250", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r339", "r411", "r412", "r627", "r651", "r652", "r653", "r654", "r679", "r693", "r694", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r805" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "domainItemType" }, "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": { "auth_ref": [ "r307", "r308", "r309", "r313", "r314", "r315", "r316" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Error Correction, Adjustment [Member]", "terseLabel": "Decrease due to error correction adjustment" } } }, "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r560", "r1133" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r250", "r302", "r304", "r305", "r306", "r307", "r308", "r316", "r339", "r627", "r651", "r652", "r653", "r679", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r805", "r1098", "r1102", "r1103", "r1104", "r1132", "r1147", "r1148", "r1220", "r1225", "r1226" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]", "terseLabel": "Previously Reported" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r317", "r560", "r1091", "r1133" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r374", "r375", "r831", "r834", "r836", "r904", "r907", "r911", "r926", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r951", "r974", "r997", "r1184", "r1241" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r374", "r375", "r831", "r834", "r836", "r904", "r907", "r911", "r926", "r933", "r936", "r937", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r951", "r974", "r997", "r1184", "r1241" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r317", "r560", "r1091", "r1092", "r1133" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r51", "r992" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r377", "r378" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "periodEndLabel": "Accounts Receivables - Closing", "periodStartLabel": "Accounts Receivables - Opening", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r14", "r64", "r638" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "AOCI (net of tax) related to cash flow hedges" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r63", "r64", "r183", "r265", "r765", "r799", "r803" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r12", "r32", "r64", "r644", "r647", "r694", "r794", "r795", "r1117", "r1118", "r1119", "r1129", "r1130", "r1131" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r119", "r120", "r563" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based award activity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r596", "r609" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "negatedTerseLabel": "Share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Expense, after Tax", "terseLabel": "Total share based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r24", "r94", "r99" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsNarrativesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive shares (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r225", "r261", "r296", "r347", "r362", "r368", "r409", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r636", "r639", "r663", "r759", "r860", "r992", "r1008", "r1177", "r1178", "r1230" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r254", "r268", "r296", "r409", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r636", "r639", "r663", "r992", "r1177", "r1178", "r1230" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r145" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "verboseLabel": "Total" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r11", "r164", "r170", "r202", "r204", "r252", "r253" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r567", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r591", "r592", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r136", "r139" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/BasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r633", "r983", "r984" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/RelatedPartyTransactionsDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r124", "r125", "r633", "r983", "r984" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/RelatedPartyTransactionsDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r221" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "terseLabel": "Newly issued ordinary shares, value" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "terseLabel": "Newly issued ordinary shares (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r123" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "negatedLabel": "Transaction related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r7", "r8", "r30" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Total consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r7", "r8" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Clarivate stock to be issued" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r635", "r1122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Increase (decrease) in contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r9", "r128", "r634" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "verboseLabel": "Additional payments to acquire business" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIntegrationRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.", "label": "Business Combination, Integration Related Costs", "negatedTerseLabel": "Business Combination, Integration Related Costs" } } }, "localname": "BusinessCombinationIntegrationRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r76", "r77", "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Capital expenditures included in accounts payable" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r73", "r256", "r953" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodStartLabel": "Cash and cash equivalents, beginning of period", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents.", "label": "Cash and Cash Equivalents, at Carrying Value, Including Discontinued Operations", "periodEndLabel": "Cash and cash equivalents, end of period" } } }, "localname": "CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r73", "r192", "r292" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodStartLabel": "Total cash and cash equivalents, and restricted cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r73", "r192", "r292" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Total cash and cash equivalents, and restricted cash, end of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r10", "r192" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r248", "r262", "r263", "r264", "r296", "r322", "r326", "r333", "r335", "r341", "r342", "r409", "r470", "r472", "r473", "r474", "r477", "r478", "r510", "r511", "r515", "r518", "r525", "r663", "r808", "r809", "r810", "r811", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r848", "r869", "r894", "r927", "r928", "r929", "r930", "r931", "r1090", "r1125", "r1134" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails", "http://clarivate.com/role/Cover", "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Warrant exercise price (usd per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)", "terseLabel": "Number of shares called per warrant (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of Warrant or Right, Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r59", "r159", "r762", "r847" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 17)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r209", "r459", "r460", "r935", "r1170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [ "r1248" ], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Public shares" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [ "r1248" ], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Founder shares" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockDividendsShares": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.", "label": "Common Stock Dividends, Shares", "terseLabel": "Dividends to preferred shareholders (in shares)" } } }, "localname": "CommonStockDividendsShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r995", "r996", "r997", "r999", "r1000", "r1001", "r1004", "r1129", "r1130", "r1219", "r1243", "r1248" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/Cover", "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Ordinary shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Ordinary shares, issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r33", "r178", "r848", "r866", "r1248", "r1249" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Ordinary shares, outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r178", "r764", "r992" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Ordinary Shares, no par value; unlimited shares authorized at June 30, 2023 and December 31, 2022; 676.1 and 674.4 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights", "terseLabel": "Number of votes per share" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r65", "r276", "r278", "r284", "r756", "r773" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r952", "r1160", "r1161" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]", "terseLabel": "Computer software" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r82", "r84", "r150", "r151", "r376", "r934" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r82", "r84", "r150", "r151", "r376", "r804", "r934" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r82", "r84", "r150", "r151", "r376", "r934", "r1097" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r162", "r237" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r82", "r84", "r150", "r151", "r376" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "verboseLabel": "Concentration risk" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r82", "r84", "r150", "r151", "r376", "r934" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r129", "r958" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r1183" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "verboseLabel": "Schedule of contract balances" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r528", "r529", "r548" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "periodEndLabel": "Current portion of deferred revenues - Closing", "periodStartLabel": "Current portion of deferred revenues - Opening", "terseLabel": "Current portion of deferred revenues" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r528", "r529", "r548" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "periodEndLabel": "Non-current portion of deferred revenues - Closing", "periodStartLabel": "Non-current portion of deferred revenues - Opening", "terseLabel": "Non-current portion of deferred revenues" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r549" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized that was deferred at the beginning of the period" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r187", "r296", "r409", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r663", "r1177" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r1105" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of Goods and Service [Policy Text Block]", "terseLabel": "Cost to Obtain a Contract and Cost of Revenues" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r186" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesRelatedParty": { "auth_ref": [ "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.", "label": "Costs and Expenses, Related Party", "terseLabel": "Costs and Expenses, Related Party" } } }, "localname": "CostsAndExpensesRelatedParty", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": { "auth_ref": [ "r47", "r207", "r208" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.", "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]", "terseLabel": "Restructuring" } } }, "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.", "label": "Currency Swap [Member]", "terseLabel": "Currency Swap" } } }, "localname": "CurrencySwapMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r83", "r376" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r127" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r210", "r294", "r479", "r485", "r486", "r487", "r488", "r489", "r490", "r495", "r502", "r503", "r505" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r48", "r174", "r175", "r226", "r228", "r301", "r480", "r481", "r482", "r483", "r484", "r486", "r491", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r678", "r967", "r968", "r969", "r970", "r971", "r1126" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Interest rate spread (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r48", "r228", "r506" ], "calculation": { "http://clarivate.com/role/DebtSummaryofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "netLabel": "Carrying Value", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentCollateralAmount": { "auth_ref": [ "r161" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets pledged to secure a debt instrument.", "label": "Debt Instrument, Collateral Amount", "terseLabel": "Collateralized amount" } } }, "localname": "DebtInstrumentCollateralAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r153", "r155", "r480", "r678", "r968", "r969" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r493", "r662", "r968", "r969" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair vale of company's debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r56", "r153", "r508", "r678" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective Interest Rate", "verboseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r56", "r481" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest per annum" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [ "r301", "r480", "r481", "r482", "r483", "r484", "r486", "r491", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r504", "r678", "r967", "r968", "r969", "r970", "r971", "r1126" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r57", "r301", "r480", "r481", "r482", "r483", "r484", "r486", "r491", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r678", "r967", "r968", "r969", "r970", "r971", "r1126" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument, Redemption [Line Items]", "terseLabel": "Debt Instrument, Redemption" } } }, "localname": "DebtInstrumentRedemptionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFourMember": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Four [Member]", "terseLabel": "Debt Instrument, Redemption, Period Four" } } }, "localname": "DebtInstrumentRedemptionPeriodFourMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "Debt Instrument, Redemption, Period One", "verboseLabel": "Debt Instrument, Redemption, Period One" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Three [Member]", "terseLabel": "Debt Instrument, Redemption, Period Three" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Debt Instrument, Redemption, Period Two" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price (as a percentage of principal)" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of principal amount of debt redeemed.", "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed", "terseLabel": "Redemption (as a percent)" } } }, "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentRedemptionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption.", "label": "Debt Instrument Redemption [Table]", "terseLabel": "Debt Instrument Redemption [Table]" } } }, "localname": "DebtInstrumentRedemptionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorSecuredNotes2026Details" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption.", "label": "Debt Instrument Redemption [Table Text Block]", "terseLabel": "Debt Instrument Redemption" } } }, "localname": "DebtInstrumentRedemptionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r57", "r105", "r107", "r152", "r153", "r155", "r160", "r212", "r213", "r301", "r480", "r481", "r482", "r483", "r484", "r486", "r491", "r492", "r493", "r494", "r496", "r497", "r498", "r499", "r500", "r501", "r504", "r678", "r967", "r968", "r969", "r970", "r971", "r1126" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtFinancingTransactionsSeniorNotes2029andSeniorSecuredNotes2028Details", "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r152", "r155", "r1180" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Discounts on notes" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r154", "r491", "r507", "r968", "r969" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "negatedTerseLabel": "Debt discounts and issuance costs" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "auth_ref": [ "r189" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.", "label": "Debt Related Commitment Fees and Debt Issuance Costs", "terseLabel": "Debt Related Commitment Fees and Debt Issuance Costs" } } }, "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of debt outstanding.", "label": "Debt, Weighted Average Interest Rate", "terseLabel": "Weighted average interest rate (as a percent)" } } }, "localname": "DebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense": { "auth_ref": [ "r115", "r215" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The compensation expense recognized during the period pertaining to the deferred compensation arrangement.", "label": "Deferred Compensation Arrangement with Individual, Compensation Expense", "terseLabel": "Deferred compensation expense" } } }, "localname": "DeferredCompensationArrangementWithIndividualCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred compensation arrangements that are neither equity-based payments, nor pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonus, certain rabbi trusts, perquisites, postemployment benefits, and certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, which contain a promise by the employer to pay certain amounts or benefits at designated future dates, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Other \"sub-members\" can be added as necessary.", "label": "Deferred Compensation, Excluding Share-Based Payments and Retirement Benefits [Member]", "terseLabel": "Deferred Compensation, Excluding Share-based Payments and Retirement Benefits" } } }, "localname": "DeferredCompensationExcludingShareBasedPaymentsAndRetirementBenefitsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Deferred Compensation Liability, Current and Noncurrent", "terseLabel": "Deferred compensation liability" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r154", "r1180" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r613", "r614" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r613", "r614", "r760" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "verboseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r194" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred Income Taxes and Tax Credits" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r622" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "terseLabel": "Valuation allowances" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r24", "r101" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r24", "r352" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "negatedLabel": "Depreciation and amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock": { "auth_ref": [ "r959" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.", "label": "Depreciation, Depletion, and Amortization [Policy Text Block]", "terseLabel": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortizationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r269", "r270", "r662", "r829", "r830", "r831", "r832", "r833", "r835", "r836", "r837", "r838", "r839", "r854", "r855", "r912", "r917", "r920", "r921", "r922", "r923", "r957", "r997", "r1244" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Interest rate swap asset - non-current" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsCurrent": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Current", "terseLabel": "Interest rate swap asset - current" } } }, "localname": "DerivativeAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsNoncurrent": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset, Noncurrent", "terseLabel": "Interest rate swap asset - non-current" } } }, "localname": "DerivativeAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r837", "r839", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r881", "r882", "r883", "r884", "r887", "r888", "r889", "r890", "r912", "r914", "r920", "r922", "r995", "r997" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "terseLabel": "Fixed Rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r1217" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "negatedTerseLabel": "Loss (gain) from the mark to market adjustment" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r137", "r138", "r140", "r141", "r837", "r839", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r881", "r882", "r883", "r884", "r887", "r888", "r889", "r890", "r912", "r914", "r920", "r922", "r957", "r995", "r997" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r223", "r642", "r649" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "verboseLabel": "Derivative Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r34", "r137", "r140" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r34", "r137", "r140", "r141", "r143", "r144", "r641" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [ "r641" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "verboseLabel": "Derivative Instruments" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r269", "r270", "r662", "r829", "r830", "r831", "r832", "r835", "r836", "r837", "r838", "r839", "r861", "r863", "r864", "r914", "r915", "r917", "r920", "r921", "r922", "r923", "r957", "r1244" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative Liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative Liability, Current" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r1215", "r1216" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Derivative, Notional Amount", "verboseLabel": "Notional Value" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "auth_ref": [ "r132", "r133", "r838", "r912", "r913", "r916", "r997" ], "lang": { "en-us": { "role": { "documentation": "The number of derivative instruments of a particular group held by the entity.", "label": "Derivative, Number of Instruments Held", "terseLabel": "Number of derivative instruments held" } } }, "localname": "DerivativeNumberOfInstrumentsHeld", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DerivativeTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative, Term of Contract", "terseLabel": "Term of contract" } } }, "localname": "DerivativeTermOfContract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r34", "r130", "r131", "r135", "r142", "r300" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DilutiveSecurities": { "auth_ref": [ "r79" ], "calculation": { "http://clarivate.com/role/EarningsperShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.", "label": "Dilutive Securities, Effect on Basic Earnings Per Share", "terseLabel": "Change in fair value of private placement warrants" } } }, "localname": "DilutiveSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [ "r547", "r973", "r974", "r975", "r976", "r977", "r978", "r979" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue", "verboseLabel": "Disaggregation of revenues" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails", "http://clarivate.com/role/SegmentInformationNarrativeDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r547", "r973", "r974", "r975", "r976", "r977", "r978", "r979" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails", "http://clarivate.com/role/SegmentInformationNarrativeDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r1184" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Revenue by reportable segment", "verboseLabel": "Schedule of disaggregated revenues" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTables", "http://clarivate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r561", "r566", "r597", "r598", "r601", "r986" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "verboseLabel": "Share-based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]", "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]", "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.", "label": "Discontinued Operations, Disposed of by Sale [Member]", "terseLabel": "Discontinued Operations, Disposed of by Sale" } } }, "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r16", "r42", "r252" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Purchase price" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities": { "auth_ref": [ "r11", "r164", "r170", "r204" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as deferred tax liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities held for sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets": { "auth_ref": [ "r11", "r164", "r170", "r204" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets", "verboseLabel": "Intangible assets held for sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": { "auth_ref": [ "r443", "r1123", "r1163" ], "calculation": { "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal", "terseLabel": "Net gain on sale" } } }, "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of income that includes gain (loss) recognized on sale or disposal of disposal group. Excludes discontinued operation.", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r163", "r200" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Assets Held for Sale and Divested Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r983", "r984" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r21", "r214" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Cash", "terseLabel": "Dividends, Cash" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r175", "r176", "r227", "r1005", "r1239" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Dividends Payable [Line Items]", "terseLabel": "Dividends Payable [Line Items]" } } }, "localname": "DividendsPayableLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DividendsPayableTable": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.", "label": "Dividends Payable [Table]", "terseLabel": "Dividends Payable [Table]" } } }, "localname": "DividendsPayableTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r21", "r214" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedTerseLabel": "Dividends to preferred shareholders" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r285", "r307", "r308", "r310", "r311", "r313", "r319", "r322", "r333", "r334", "r335", "r339", "r653", "r654", "r757", "r774", "r961" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (usd per share)", "verboseLabel": "Basic EPS (usd per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "verboseLabel": "Basic EPS" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r285", "r307", "r308", "r310", "r311", "r313", "r322", "r333", "r334", "r335", "r339", "r653", "r654", "r757", "r774", "r961" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (usd per share)", "verboseLabel": "Diluted EPS (usd per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted EPS" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r80", "r81" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r318", "r336", "r337", "r338" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r669" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effects of exchange rates" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r616" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r54" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r600" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Total remaining unamortized compensation costs" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average remaining service period (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r1212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Total remaining unearned compensation costs, Stock Options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "negatedTerseLabel": "Tax benefits" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Options", "verboseLabel": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Shareholders\u2019 equity:" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r33", "r249", "r280", "r281", "r282", "r302", "r303", "r304", "r306", "r314", "r316", "r340", "r410", "r413", "r527", "r602", "r603", "r604", "r626", "r627", "r643", "r644", "r645", "r646", "r647", "r648", "r652", "r670", "r671", "r672", "r673", "r674", "r675", "r694", "r794", "r795", "r796", "r817", "r894" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "auth_ref": [ "r307", "r308", "r309", "r313", "r314", "r315", "r316", "r339" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]", "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EurodollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.", "label": "Eurodollar [Member]", "terseLabel": "Eurodollar" } } }, "localname": "EurodollarMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r3", "r24" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Mark to market gain on financial instruments", "terseLabel": "Mark to market gain on financial instruments", "verboseLabel": "Mark to market (gain) loss on financial instruments" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [ "r656", "r657", "r660" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r656", "r657", "r660" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "verboseLabel": "Fair Value Measurements" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r145", "r148", "r149" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value, by Balance Sheet Grouping [Table]", "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r493", "r552", "r553", "r554", "r555", "r556", "r557", "r657", "r708", "r709", "r710", "r968", "r969", "r980", "r981", "r982" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r147", "r224" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r656", "r657", "r658", "r659", "r661" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r655" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r493", "r552", "r557", "r657", "r709", "r968", "r969", "r980", "r981", "r982" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r493", "r552", "r553", "r554", "r555", "r556", "r557", "r657", "r710", "r968", "r969", "r980", "r981", "r982" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r35", "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "verboseLabel": "Schedule of changes in Level 3" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r146" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r493", "r552", "r553", "r554", "r555", "r556", "r557", "r708", "r709", "r710", "r968", "r969", "r980", "r981", "r982" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r655", "r661" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r27", "r46" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r1218" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Federal Funds Effective Swap Rate" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseImpairmentLoss": { "auth_ref": [ "r681" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss from right-of-use asset from finance lease.", "label": "Finance Lease, Impairment Loss", "terseLabel": "Finance Lease, Impairment Loss" } } }, "localname": "FinanceLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r685", "r688", "r991" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r684", "r692" ], "calculation": { "http://clarivate.com/role/DebtSummaryofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Finance lease liability", "verboseLabel": "Finance lease, carrying value" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r686", "r690" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "negatedTerseLabel": "Payments related to finance lease" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r685", "r688", "r991" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "auth_ref": [ "r1093" ], "calculation": { "http://clarivate.com/role/PropertyandEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "terseLabel": "Capital office leases - finance lease asset" } } }, "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails", "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r691", "r991" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "verboseLabel": "Finance lease, effective interest rate" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r504", "r523", "r649", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r772", "r965", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1142", "r1143", "r1144", "r1145" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]", "verboseLabel": "Assets" } } }, "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]", "verboseLabel": "Liabilities" } } }, "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r259", "r440" ], "calculation": { "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 }, "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails_1": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Finite-lived intangible assets, Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r437", "r439", "r440", "r442", "r741", "r742" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r198", "r742" ], "calculation": { "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Finite-lived intangible assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r95", "r98" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r198", "r741" ], "calculation": { "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Finite-lived intangible asets", "totalLabel": "Total finite-lived intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.", "label": "Foreign Currency Contract, Asset, Fair Value Disclosure", "terseLabel": "Forward currency contracts asset - current" } } }, "localname": "ForeignCurrencyContractAssetFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "terseLabel": "Forward currency contracts liability - current" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r665", "r666", "r667", "r668", "r891" ], "calculation": { "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails": { "order": 2.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "negatedTerseLabel": "Net foreign exchange loss (gain)" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r957", "r980", "r990" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [ "r854", "r858", "r863", "r883", "r889", "r918", "r919", "r920", "r997" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign exchange forward" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r1123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "terseLabel": "Gain on sale of assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnTerminationOfLease": { "auth_ref": [ "r682" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.", "label": "Gain (Loss) on Termination of Lease", "negatedTerseLabel": "Lease termination fees" } } }, "localname": "GainLossOnTerminationOfLease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r1171" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement", "negatedTerseLabel": "Gain on legal settlement", "verboseLabel": "Gain on settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r258", "r424", "r755", "r966", "r992", "r1150", "r1157" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill, ending balance", "periodStartLabel": "Goodwill, beginning balance", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.", "label": "Goodwill and Intangible Asset Impairment", "negatedLabel": "Goodwill and intangible asset impairments", "terseLabel": "Goodwill and intangible asset impairments" } } }, "localname": "GoodwillAndIntangibleAssetImpairment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Other Intangible Assets, net and Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.", "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]", "terseLabel": "Goodwill and Indefinite-Lived Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r432" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "negatedTerseLabel": "Impact of foreign currency fluctuations" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r24", "r425", "r431", "r436", "r966" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "negatedTerseLabel": "Goodwill impairment charge" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [ "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r966" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r4", "r1156" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "terseLabel": "Acquisition measurement period adjustments" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": { "auth_ref": [ "r430", "r966" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Written off Related to Sale of Business Unit", "negatedLabel": "Goodwill, Written off Related to Sale of Business Unit" } } }, "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r34", "r641" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r1123", "r1162" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-Lived", "terseLabel": "Impairment of finite-lived intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLeasehold": { "auth_ref": [ "r24", "r100" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.", "label": "Impairment of Leasehold", "terseLabel": "Impairment of Leasehold" } } }, "localname": "ImpairmentOfLeasehold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r24", "r201" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of Long-Lived Assets to be Disposed of", "negatedTerseLabel": "Impairment of Long-Lived Assets to be Disposed of" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r1", "r206" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r2", "r184", "r230", "r347", "r361", "r367", "r370", "r758", "r770", "r963" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income (loss) before income taxes", "totalLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r983", "r984" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r28", "r42", "r50", "r164", "r165", "r166", "r167", "r168", "r169", "r171", "r172", "r173", "r205" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r444", "r450", "r877" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r450", "r877" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r297", "r610", "r617", "r619", "r624", "r628", "r630", "r631", "r632", "r813" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r233", "r245", "r315", "r316", "r355", "r615", "r629", "r775" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Benefit (provision) for income taxes", "verboseLabel": "(Benefit) provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/IncomeTaxesDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r279", "r611", "r612", "r619", "r620", "r623", "r625", "r807" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Taxation" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r1213" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "negatedTerseLabel": "Income tax benefit due to change in deferred tax assets valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r72", "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income tax" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r23" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase (Decrease) in Accounts and Other Receivables", "terseLabel": "Increase (decrease)" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r23" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r23" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r736", "r1122" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenues" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredCharges": { "auth_ref": [ "r23" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.", "label": "Increase (Decrease) in Deferred Charges", "negatedLabel": "Amortization of debt issuance costs" } } }, "localname": "IncreaseDecreaseInDeferredCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r1100", "r1122" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Operating leases, net" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r1122" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Increase (Decrease) in Other Current Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r1122" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r23" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Shareholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r323", "r324", "r325", "r335", "r565" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r438", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r199" ], "calculation": { "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "terseLabel": "Indefinite-lived intangible assets:" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r96", "r199" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r98", "r737", "r738", "r739", "r741", "r960" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "Identifiable Intangible Assets, net" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r258" ], "calculation": { "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails_1": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Total intangible assets, Gross" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r93", "r97" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangible assets, net", "totalLabel": "Total intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r154", "r232", "r283", "r351", "r677", "r878", "r1006", "r1247" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense and amortization of debt discount, net", "terseLabel": "Interest expense and amortization of debt discount, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpensePolicyTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing interest expense, including the method of amortizing debt issuance costs.", "label": "Interest Expense, Policy [Policy Text Block]", "terseLabel": "Interest Expense, Net" } } }, "localname": "InterestExpensePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r288", "r290", "r291" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r949", "r1002", "r1003" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest rate swap asset", "verboseLabel": "Interest rate swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InternalUseSoftwarePolicy": { "auth_ref": [ "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.", "label": "Internal Use Software, Policy [Policy Text Block]", "terseLabel": "Internally Developed Software and Content" } } }, "localname": "InternalUseSoftwarePolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_LegalCostsPolicyTextBlock": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.", "label": "Legal Costs, Policy [Policy Text Block]", "terseLabel": "Legal Costs" } } }, "localname": "LegalCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r53", "r296", "r409", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r637", "r639", "r640", "r663", "r846", "r962", "r1008", "r1177", "r1230", "r1231" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r182", "r229", "r767", "r992", "r1127", "r1146", "r1221" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r55", "r255", "r296", "r409", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r637", "r639", "r640", "r663", "r992", "r1177", "r1230", "r1231" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure", "terseLabel": "Total" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r11", "r164", "r170", "r202", "r204", "r252", "r253" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Liabilities held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Commitment fee percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r1126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net", "terseLabel": "Increase (decrease) of line of credit facility, net" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Sublimit" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationReserveCurrent": { "auth_ref": [ "r59", "r1171" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.", "label": "Estimated Litigation Liability, Current", "terseLabel": "Accrued legal liability" } } }, "localname": "LitigationReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Litigation Settlement, Expense", "terseLabel": "Litigation Settlement, Expense" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [ "r1171" ], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [ "r1171" ], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.", "label": "Long-Lived Assets by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of summarizes non-current assets other than financial instruments and deferred tax assets by geography" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r48", "r761" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long-Term Debt and Lease Obligation", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r54" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long-Term Debt and Lease Obligation, Current", "negatedLabel": "Current portion of long-term debt", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "calculation": { "http://clarivate.com/role/DebtSummaryofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.", "label": "Long-Term Debt and Lease Obligation, Including Current Maturities", "terseLabel": "Total debt outstanding" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long-Term Debt [Member]", "terseLabel": "Long-term Debt" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [ "r462", "r463", "r464", "r469", "r1172", "r1173" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r462", "r463", "r464", "r469", "r1172", "r1173" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "auth_ref": [ "r462" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.", "label": "Loss Contingency, Accrual, Current", "terseLabel": "Reserve for probable claims" } } }, "localname": "LossContingencyAccrualCarryingValueCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": { "auth_ref": [ "r1171" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in loss contingency liability.", "label": "Loss Contingency Accrual, Period Increase (Decrease)", "negatedTerseLabel": "Release of liability for legal claims" } } }, "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r463", "r464", "r468", "r469" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss", "terseLabel": "Loss Contingency, Estimate of Possible Loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyReceivable": { "auth_ref": [ "r1176" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable.", "label": "Loss Contingency, Receivable", "terseLabel": "Loss recovery asset" } } }, "localname": "LossContingencyReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyReceivableProceeds": { "auth_ref": [ "r1121", "r1176" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the collection of receivables related to a loss contingency.", "label": "Loss Contingency, Receivable, Proceeds", "terseLabel": "Loss recovery asset recognized" } } }, "localname": "LossContingencyReceivableProceeds", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r234", "r246" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Background and Nature of Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/BackgroundandNatureofOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r289" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r289" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows From Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r192", "r193", "r194" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS_1": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r185", "r194", "r231", "r253", "r274", "r277", "r282", "r296", "r305", "r307", "r308", "r310", "r311", "r315", "r316", "r331", "r347", "r361", "r367", "r370", "r409", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r654", "r663", "r771", "r868", "r892", "r893", "r963", "r1006", "r1177" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss)", "netLabel": "Net (loss) income", "terseLabel": "Net income (loss)", "totalLabel": "Net (loss) income", "verboseLabel": "Net (loss) income available to ordinary shareholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/EarningsperShareDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r286", "r307", "r308", "r310", "r311", "r319", "r320", "r332", "r335", "r347", "r361", "r367", "r370", "r963" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://clarivate.com/role/EarningsperShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Net income (loss) attributable to ordinary shares", "totalLabel": "Net income (loss) attributable to ordinary shares", "verboseLabel": "Net (loss) income attributable to ordinary shares" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/EarningsperShareDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r286", "r321", "r327", "r328", "r329", "r330", "r332", "r335" ], "calculation": { "http://clarivate.com/role/EarningsperShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net loss attributable to ordinary shares, diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r134" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Newly Adopted Accounting Standards and Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": { "auth_ref": [ "r76", "r77", "r78" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued", "terseLabel": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued" } } }, "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r1136" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r1136" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OpenSwapContractTableTextBlock": { "auth_ref": [ "r1245", "r1250" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contract to exchange cash flows from two different financial instruments over specified period or at future date.", "label": "Open Swap Contract [Table Text Block]", "terseLabel": "Schedule of interest rate swap arrangements" } } }, "localname": "OpenSwapContractTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r347", "r361", "r367", "r370", "r963" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "(Loss) income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseImpairmentLoss": { "auth_ref": [ "r1224" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.", "label": "Operating Lease, Impairment Loss", "terseLabel": "Impairment charge on right-of-use assets" } } }, "localname": "OperatingLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r684" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r684" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r683" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued expenses and other current liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r267", "r992" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r260" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent": { "auth_ref": [ "r22", "r31", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent", "terseLabel": "Reclassification adjustment for other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r271", "r272" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Interest rate swaps" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": { "auth_ref": [ "r273" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent", "terseLabel": "Interest rate swaps, tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r13" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r22", "r31", "r222", "r275", "r278" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Total other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r15", "r183" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Defined benefit pension plans, net of tax provision (benefit) of $0, $0 and $(0.1)" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r136", "r143" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherEmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred for employer-related costs classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Employee-related Liabilities, Current", "verboseLabel": "Other Employee-related Liabilities, Current" } } }, "localname": "OtherEmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other Intangible Assets" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r58" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r194" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other operating activities" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Noncurrent assets", "verboseLabel": "Other noncurrent assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonrecurringIncomeExpense": { "auth_ref": [ "r190" ], "calculation": { "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherOperatingIncomeExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature.", "label": "Other Nonrecurring (Income) Expense", "terseLabel": "Miscellaneous (income) expense, net" } } }, "localname": "OtherNonrecurringIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeAndExpenseTextBlock": { "auth_ref": [ "r875" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other operating income and other operating expense items.", "label": "Other Operating Income and Expense [Text Block]", "terseLabel": "Other Operating Expense (Income), Net" } } }, "localname": "OtherOperatingIncomeAndExpenseTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherOperatingExpenseIncomeNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": -1.0 }, "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedTerseLabel": "Other operating income, net", "negatedTotalLabel": "Other operating income, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/OtherOperatingExpenseIncomeNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r18" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payment for Contingent Consideration Liability, Financing Activities", "negatedTerseLabel": "Contingent purchase price payment", "terseLabel": "Contingent purchase price paid" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfEquity": { "auth_ref": [ "r69", "r811" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common and preferred stock.", "label": "Payments for Repurchase of Equity", "negatedTerseLabel": "Repurchases of ordinary shares" } } }, "localname": "PaymentsForRepurchaseOfEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r449", "r1121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Payments made" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r19" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedTerseLabel": "Redemption of Notes not exchanged" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r71" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "verboseLabel": "Payment of debt issuance costs and discounts" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r69" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedTerseLabel": "Cash dividends on preferred shares" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r287" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Payments related to tax withholding for stock-based compensation" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r67" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Payments for acquisitions and cost method investments, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r191" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "PSUs" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_PhantomShareUnitsPSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded as phantom share or unit.", "label": "Phantom Share Units (PSUs) [Member]", "terseLabel": "CPA Global Equity Plan" } } }, "localname": "PhantomShareUnitsPSUsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194", "r1195", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194", "r1195", "r1196", "r1197", "r1198", "r1199", "r1200", "r1201", "r1202", "r1203", "r1204", "r1205", "r1206", "r1207", "r1208", "r1209", "r1210", "r1211" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConvertibleConversionRatio": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted.", "label": "Preferred Stock, Convertible, Conversion Ratio", "terseLabel": "Preferred Stock, Convertible, Conversion Ratio" } } }, "localname": "PreferredStockConvertibleConversionRatio", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "pureItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r511", "r903", "r906", "r908", "r925" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Preferred stock, dividend rate (as a percent)" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical", "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "auth_ref": [], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.", "label": "Preferred Stock Dividends, Income Statement Impact", "negatedTerseLabel": "Dividends on preferred shares", "terseLabel": "Dividends on preferred shares" } } }, "localname": "PreferredStockDividendsIncomeStatementImpact", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/EarningsperShareDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendsPerShareDeclared": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding.", "label": "Preferred Stock, Dividends Per Share, Declared", "terseLabel": "Preferred Stock, Dividends Per Share, Declared" } } }, "localname": "PreferredStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r105", "r106", "r177", "r1125", "r1181" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Preferred Stock, Liquidation Preference Per Share", "terseLabel": "Liquidation preference (usd per share)" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r995", "r996", "r999", "r1000", "r1001", "r1004", "r1243", "r1248" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Shares" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r177", "r510" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r177", "r848" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r177", "r510" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r177", "r848", "r866", "r1248", "r1249" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r177", "r763", "r992" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Shares, no par value; 14.4 shares authorized; 5.25% Mandatory Convertible Preferred Shares, Series A, 14.4 shares issued and outstanding as of both June 30, 2023 and December 31, 2022" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r266", "r422", "r423", "r954" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r66" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from divestitures, net of cash and restricted cash" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/AssetsHeldforSaleandDivestedOperationsDetails", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r17" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of ordinary shares" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "auth_ref": [ "r17" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.", "label": "Proceeds from Issuance of Convertible Preferred Stock", "terseLabel": "Proceeds from issuance of preferred shares" } } }, "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r68", "r808" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r68", "r1126" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from revolving credit facility" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfTreasuryStock": { "auth_ref": [ "r17" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of an equity stock that has been previously reacquired by the entity.", "label": "Proceeds from Sale of Treasury Stock", "terseLabel": "Proceeds from issuance of treasury shares" } } }, "localname": "ProceedsFromSaleOfTreasuryStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r17", "r41" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock options exercised" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r1120" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "terseLabel": "Proceeds from warrant exercises" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r1094", "r1099", "r1166" ], "calculation": { "http://clarivate.com/role/PropertyandEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization", "negatedLabel": "Accumulated depreciation" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r1099", "r1164" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://clarivate.com/role/PropertyandEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "terseLabel": "Property and equipment, net", "totalLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r1093", "r1114", "r1165" ], "calculation": { "http://clarivate.com/role/PropertyandEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization", "totalLabel": "Total property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r200", "r238", "r243", "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r203", "r257", "r769" ], "calculation": { "http://clarivate.com/role/PropertyandEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Total computer hardware and other property" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentOtherTypesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Property, Plant and Equipment, Other Types [Member]", "terseLabel": "Other" } } }, "localname": "PropertyPlantAndEquipmentOtherTypesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r25", "r238", "r243", "r768" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r1138", "r1139", "r1140", "r1141" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Amount reclassified out of Other comprehensive income (loss)" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligation": { "auth_ref": [ "r461" ], "calculation": { "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the recorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts).", "label": "Recorded Unconditional Purchase Obligation", "terseLabel": "Recorded Unconditional Purchase Obligation", "totalLabel": "Total" } } }, "localname": "RecordedUnconditionalPurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear": { "auth_ref": [ "r461" ], "calculation": { "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails": { "order": 4.0, "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "RecordedUnconditionalPurchaseObligationDueInFourthYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear": { "auth_ref": [ "r461" ], "calculation": { "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails": { "order": 2.0, "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "RecordedUnconditionalPurchaseObligationDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear": { "auth_ref": [ "r461" ], "calculation": { "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails": { "order": 3.0, "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "RecordedUnconditionalPurchaseObligationDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": { "auth_ref": [ "r461" ], "calculation": { "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails": { "order": 1.0, "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationPaymentScheduleAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Recorded Unconditional Purchase Obligation, Fiscal Year Maturity Schedule [Abstract]", "terseLabel": "Future unconditional purchase obligations" } } }, "localname": "RecordedUnconditionalPurchaseObligationPaymentScheduleAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock": { "auth_ref": [ "r26", "r1169" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of unconditional purchase obligation recognized as liability.", "label": "Recorded Unconditional Purchase Obligations [Table Text Block]", "terseLabel": "Summary of future unconditional purchase obligations" } } }, "localname": "RecordedUnconditionalPurchaseObligationsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r558", "r698", "r699", "r841", "r842", "r843", "r844", "r845", "r865", "r867", "r901" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r157", "r698" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Amounts of transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r872", "r873", "r877" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party and Former Parent Transactions" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r558", "r698", "r699", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r841", "r842", "r843", "r844", "r845", "r865", "r867", "r901", "r1229" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r695", "r696", "r697", "r699", "r701", "r814", "r815", "r816", "r874", "r876", "r877", "r898", "r900" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r70", "r1126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "terseLabel": "Repayment of term loan" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r70", "r811" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "terseLabel": "Repayment of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r70" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-Term Lines of Credit", "negatedTerseLabel": "Repayments of revolving credit facility" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherLongTermDebt": { "auth_ref": [ "r70" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.", "label": "Repayments of Other Long-Term Debt", "negatedTerseLabel": "Principal payments on term loan" } } }, "localname": "RepaymentsOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r1113", "r1124", "r1238", "r1240" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "periodEndLabel": "Restricted cash, end of period", "periodStartLabel": "Restricted cash, beginning of period" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r1113", "r1124" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r446", "r447", "r449", "r452", "r458" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Lease Impairments" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairments" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r24", "r453", "r455", "r1168" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "negatedLabel": "Restructuring and lease impairments", "terseLabel": "Restructuring and impairment", "verboseLabel": "Expenses recorded" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r448", "r449", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [ "r448", "r449", "r450", "r451", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAndAssetImpairmentCharges": { "auth_ref": [ "r24" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs and Asset Impairment Charges", "terseLabel": "Restructuring and impairments" } } }, "localname": "RestructuringCostsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r449", "r454" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Restructuring Reserve, Ending Balance", "periodStartLabel": "Restructuring Reserve, Beginning Balance" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "auth_ref": [ "r449", "r456" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.", "label": "Restructuring Reserve, Accrual Adjustment", "terseLabel": "Restructuring Reserve, Accrual Adjustment" } } }, "localname": "RestructuringReserveAccrualAdjustment1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveSettledWithoutCash2": { "auth_ref": [ "r449", "r456" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.", "label": "Restructuring Reserve, Settled without Cash", "terseLabel": "Restructuring Reserve, Settled without Cash" } } }, "localname": "RestructuringReserveSettledWithoutCash2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r179", "r214", "r766", "r798", "r803", "r812", "r849", "r992" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r249", "r302", "r303", "r304", "r306", "r314", "r316", "r410", "r413", "r602", "r603", "r604", "r626", "r627", "r643", "r645", "r646", "r648", "r652", "r794", "r796", "r817", "r1248" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r348", "r349", "r360", "r365", "r366", "r372", "r374", "r376", "r546", "r547", "r740" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 }, "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total Revenues, net", "totalLabel": "Total revenues, net", "verboseLabel": "Revenues, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/RelatedPartyTransactionsDetails", "http://clarivate.com/role/RevenueDisaggregatedRevenuesandCosttoObtainaContractDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r376", "r1096" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r247", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r948" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition and Deferred Revenues" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r247", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r550" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of summarizes revenues from external customers by geography" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r241" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligation, amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "verboseLabel": "Transaction Price Allocated to the Remaining Performance Obligation" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Expected timing of satisfaction, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [ "r1095" ], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Remaining performance obligation, percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueTransactionPriceAllocatedtotheRemainingPerformanceObligationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtSummaryofDebtDetails", "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Number of shares issued (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r64", "r1222", "r1223" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DerivativeInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]", "terseLabel": "Schedule of Weighted-Average Amortization Period for Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of income tax (benefit)/expense on income/(loss)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of deferred income tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r1135" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of basic and diluted EPS computations for our common stock" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the statutory income tax rate to effective tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r118" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "terseLabel": "Schedule of summarizes revenue by product group" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "auth_ref": [ "r307", "r308", "r309", "r313", "r314", "r315", "r316", "r339" ], "lang": { "en-us": { "role": { "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.", "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]", "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r656", "r657" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "verboseLabel": "Summary of the Company's assets and liabilities that were recognized at fair value on a recurring basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r966" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r966", "r1149", "r1150", "r1151", "r1152", "r1153", "r1154", "r1155", "r1156", "r1157", "r1158", "r1159" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "verboseLabel": "Schedule of Change in the Carrying Amount of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r1128" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of components of pre-tax loss" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Schedule of Identifiable Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Outstanding Borrowings" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.", "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]", "terseLabel": "Schedule of Nonvested Performance-based Units Activity" } } }, "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/PropertyandEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r156", "r157", "r872", "r873", "r877" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r448", "r449", "r450", "r451", "r455", "r456", "r457" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r102", "r103", "r104" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r88", "r89", "r90", "r92" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r88", "r89", "r90", "r92" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r38", "r39", "r117" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Activity [Table Text Block]", "terseLabel": "Share-based Payment Arrangement, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r562", "r564", "r567", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r591", "r592", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Summary of assumption used to value options granted during the period presented and their expected lives" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "auth_ref": [ "r110", "r111", "r112", "r113" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table Text Block]", "terseLabel": "Class of Treasury Stock" } } }, "localname": "ScheduleOfTreasuryStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r989", "r1214" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Summary of unrecognized tax benefits, excluding interest and penalties:" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Estimated Amortization for Five Succeeding Years" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r1218" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r344", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r370", "r376", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r451", "r457", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r966", "r1101", "r1241" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails", "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r343", "r344", "r345", "r346", "r347", "r359", "r364", "r368", "r369", "r370", "r371", "r372", "r373", "r376" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r188" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "verboseLabel": "Selling, general and administrative costs" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general and administrative costs" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.", "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]", "terseLabel": "Selling, General and Administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r1115", "r1116", "r1182" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails", "http://clarivate.com/role/Cover", "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SettledLitigationMember": { "auth_ref": [ "r1171" ], "lang": { "en-us": { "role": { "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.", "label": "Settled Litigation [Member]", "terseLabel": "Settled Litigation" } } }, "localname": "SettledLitigationMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r23" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r986" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]", "terseLabel": "Weighted Average Exercise Price per Share" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited/Unexercised (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "End of year (in shares)", "periodStartLabel": "Beginning of year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "RSUs and PSUs" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r579", "r580" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Ending balance (in dollars per share)", "terseLabel": "Weighted average grant date fair value, beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "RSUs Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Exercised/Vested (in share)", "terseLabel": "Vesting of restricted stock units (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Weighted-average expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationAssumptionsusedtoValueOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Expected volatility - Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationAssumptionsusedtoValueOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Expected volatility - Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationAssumptionsusedtoValueOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Weighted-average risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationAssumptionsusedtoValueOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate", "terseLabel": "Weighted-average expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationAssumptionsusedtoValueOptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r562", "r564", "r567", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r591", "r592", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "terseLabel": "Issued and outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r988" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Authorized grants (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Stock options not granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Number of options, vested and exercisable at the end of the year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Vested and exercisable at the end of the year (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r586" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Aggregate intrinsic value, exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Forfeited/Unexercised (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "verboseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r116" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate intrinsic value, at the end of the year", "periodStartLabel": "Aggregate intrinsic value, at the beginning of the year" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at end of year (in shares)", "periodStartLabel": "Outstanding at beginning of year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price per share, outstanding at the end of the year (in dollars per share)", "periodStartLabel": "Weighted average exercise price per share, outstanding at the beginning of the year (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "auth_ref": [ "r599" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.", "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost", "terseLabel": "Plan modification, incremental cost" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r567", "r568", "r569", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r591", "r592", "r593", "r594", "r595" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Equity Award [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationNarrativeDetails", "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationRSUandPSUActivityDetails", "http://clarivate.com/role/SharebasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r576" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, exercised (in dollars per share)", "verboseLabel": "Exercise of Private Placement Warrants (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails", "http://clarivate.com/role/SharebasedCompensationWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r577" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r575" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price per share, granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r561", "r570", "r589", "r590", "r591", "r592", "r595", "r605", "r606", "r607", "r608" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r987" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "terseLabel": "Contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r591" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationAssumptionsusedtoValueOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r116" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Vested and exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted-Average Remaining Contractual Life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at end of the period (in shares)", "periodStartLabel": "Balance at beginning of the period (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r195", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r251", "r344", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r370", "r376", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r445", "r451", "r457", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r966", "r1101", "r1241" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsNarrativeDetails", "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillChangeintheCarryingAmountofGoodwillDetails", "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails", "http://clarivate.com/role/SegmentInformationAdjustedEBITDAbySegmentDetails", "http://clarivate.com/role/SegmentInformationRevenuebySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r248", "r262", "r263", "r264", "r296", "r322", "r326", "r333", "r335", "r341", "r342", "r409", "r470", "r472", "r473", "r474", "r477", "r478", "r510", "r511", "r515", "r518", "r525", "r663", "r808", "r809", "r810", "r811", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r825", "r826", "r827", "r828", "r848", "r869", "r894", "r927", "r928", "r929", "r930", "r931", "r1090", "r1125", "r1134" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CommitmentsandContingenciesMandatoryConvertiblePreferredShareDividendsDetails", "http://clarivate.com/role/Cover", "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r33", "r61", "r249", "r280", "r281", "r282", "r302", "r303", "r304", "r306", "r314", "r316", "r340", "r410", "r413", "r527", "r602", "r603", "r604", "r626", "r627", "r643", "r644", "r645", "r646", "r647", "r648", "r652", "r670", "r671", "r672", "r673", "r674", "r675", "r694", "r794", "r795", "r796", "r817", "r894" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/DerivativeInstrumentsDetails", "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r302", "r303", "r304", "r340", "r740", "r806", "r828", "r840", "r841", "r842", "r843", "r844", "r845", "r848", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r865", "r867", "r870", "r871", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r890", "r894", "r998" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r302", "r303", "r304", "r340", "r740", "r806", "r828", "r840", "r841", "r842", "r843", "r844", "r845", "r848", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r861", "r862", "r863", "r864", "r865", "r867", "r870", "r871", "r879", "r880", "r881", "r882", "r883", "r884", "r885", "r886", "r887", "r888", "r889", "r890", "r894", "r998" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockAppreciationRightsSARSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.", "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)" } } }, "localname": "StockAppreciationRightsSARSMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r177", "r178", "r214" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r33", "r177", "r178", "r214", "r808", "r894", "r928" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of shares, net (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited", "negatedLabel": "Share-based award activity (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r33", "r177", "r178", "r214", "r576" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised/Vested (in share)", "terseLabel": "Exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/SharebasedCompensationOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": { "auth_ref": [ "r33", "r178", "r214" ], "lang": { "en-us": { "role": { "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.", "label": "Stock Issued During Period, Shares, Treasury Stock Reissued", "terseLabel": "Sale of treasury shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r33", "r61", "r214" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Value of stock issued" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r33", "r177", "r178", "r214", "r817", "r894", "r928", "r1007" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of shares, net", "verboseLabel": "Shares issued to Capri Acquisition Topco Limited" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited", "negatedLabel": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockDividend": { "auth_ref": [ "r33", "r61", "r214" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued to shareholders as a dividend during the period.", "label": "Stock Issued During Period, Value, Stock Dividend", "terseLabel": "Shares issued as dividends on our 5.25% Series A Mandatory Convertible Preferred Shares" } } }, "localname": "StockIssuedDuringPeriodValueStockDividend", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r33", "r61", "r214" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased", "terseLabel": "Stock repurchase program, shares authorized to be repurchased (in shares)" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Stock repurchase program, remaining authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r33", "r177", "r178", "r214" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "terseLabel": "Stock repurchased and retired (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r178", "r180", "r181", "r196", "r850", "r866", "r895", "r896", "r992", "r1008", "r1127", "r1146", "r1221", "r1248" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Balance at end of the period", "periodStartLabel": "Balance at beginning of the period", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r211", "r295", "r509", "r511", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r524", "r527", "r650", "r897", "r899", "r932" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "terseLabel": "Conversion ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareNarrativeDetails", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "pureItemType" }, "us-gaap_StockholdersEquityOtherShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of increase (decrease) in shares of stock classified as other.", "label": "Stockholders' Equity, Other Shares", "terseLabel": "Reclassification of EBT Shares" } } }, "localname": "StockholdersEquityOtherShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_SubleaseIncome": { "auth_ref": [ "r689", "r991" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sublease income excluding finance and operating lease expense.", "label": "Sublease Income", "terseLabel": "Sublease income" } } }, "localname": "SubleaseIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubleaseincomeNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r676", "r703" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r676", "r703" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/ShareholdersEquityDetails", "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r676", "r703" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r676", "r703" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/ShareholdersEquityDetails", "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r676", "r703" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails", "http://clarivate.com/role/ShareholdersEquityDetails", "http://clarivate.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]", "terseLabel": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r702", "r704" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Summary of Valuation Allowance [Table Text Block]", "terseLabel": "Summary of Valuation Allowance" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Cash Flow Information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.", "label": "Supplemental Unemployment Benefits, Severance Benefits", "terseLabel": "Supplemental Unemployment Benefits, Severance Benefits" } } }, "localname": "SupplementalUnemploymentBenefitsSeveranceBenefits", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/OtherIntangibleAssetsnetandGoodwillIntangibleAssetsbyMajorClassDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r504", "r523", "r649", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r772", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1142", "r1143", "r1144", "r1145" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Shares Acquired, Average Cost Per Share", "terseLabel": "Treasury stock acquired, average cost per share (in dollars per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury Stock, Common" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury Stock, Common, Shares" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r62", "r110", "r113" ], "calculation": { "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "negatedLabel": "Treasury shares, at cost; 0 and 0 shares as of June 30, 2023 and December 31, 2022, respectively", "terseLabel": "Treasury Stock, Common, Value" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDBALANCESHEETS", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockReissuedAtLowerThanRepurchasePrice": { "auth_ref": [ "r33", "r109", "r178", "r214" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "In cases when treasury stock is reissued at a price lower than the cost to repurchase, the excess difference between the selling price and cost to repurchase is charged against retained earnings (assuming that all APIC arising from treasury stock transactions has first been exhausted).", "label": "Treasury Stock Reissued at Lower than Repurchase Price", "negatedTerseLabel": "Sale of treasury shares", "terseLabel": "Treasury stock sold at lower than repurchase price" } } }, "localname": "TreasuryStockReissuedAtLowerThanRepurchasePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockRetiredCostMethodAmount": { "auth_ref": [ "r33", "r108", "r178" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.", "label": "Treasury Stock, Retired, Cost Method, Amount", "negatedTerseLabel": "Retirement of treasury shares", "terseLabel": "Stock repurchased and retired" } } }, "localname": "TreasuryStockRetiredCostMethodAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r33", "r178", "r214" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedLabel": "Repurchase of ordinary shares (in shares)", "terseLabel": "Repurchase of ordinary shares (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesRetired": { "auth_ref": [ "r33", "r178", "r214" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common and preferred stock retired from treasury during the period.", "label": "Treasury Stock, Shares, Retired", "negatedTerseLabel": "Retirement of treasury shares (in shares)", "terseLabel": "Stock repurchased and retired (in shares)" } } }, "localname": "TreasuryStockSharesRetired", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r60", "r110", "r113" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedPeriodEndLabel": "Balance at end of the period", "negatedPeriodStartLabel": "Balance at beginning of the period", "terseLabel": "Treasury Stock, Value" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r33", "r110", "r214" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedTerseLabel": "Repurchases of ordinary shares", "terseLabel": "Repurchase of ordinary shares" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFCHANGESINEQUITY", "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r448", "r449", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/RestructuringandLeaseImpairmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnconditionalPurchaseObligationsExcludingCapitalStockRedemptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unconditional Purchase Obligations (Excluding Capital Stock Redemptions) [Abstract]", "terseLabel": "Unconditional purchase obligations" } } }, "localname": "UnconditionalPurchaseObligationsExcludingCapitalStockRedemptionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesUnconditionalPurchaseObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnderwritingCommitments": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Disclose the effect on the financial statements of underwriting commitments open at year-end and subsequently settled.", "label": "Underwriting Commitments", "terseLabel": "Underwriting Commitments" } } }, "localname": "UnderwritingCommitments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CommitmentsandContingenciesContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r618" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "terseLabel": "Tax benefit recorded for a settlement of an open tax dispute" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r85", "r86", "r87", "r235", "r236", "r239", "r240" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r621" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Change Charged to Expense/(Income)" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails", "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/DebtTheCreditFacilitiesRevolvingCreditFacilityandTermLoanFacilityDetails", "http://clarivate.com/role/DerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r995", "r996", "r999", "r1000", "r1001", "r1004" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/ShareholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "verboseLabel": "Warrant liability" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/FairValueMeasurementsAssetsandliabilitiesthatwererecognizedatfairvalueonarecurringbasisDetails", "http://clarivate.com/role/FairValueMeasurementsChangesinPrivatePlacementWarrantsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r1135" ], "calculation": { "http://clarivate.com/role/EarningsperShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "verboseLabel": "Weighted-average effect of potentially dilutive shares to purchase ordinary shares (in shares)" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r321", "r335" ], "calculation": { "http://clarivate.com/role/EarningsperShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted weighted-average number of ordinary shares outstanding (in shares)", "verboseLabel": "Diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average shares used to compute earnings per share:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r319", "r335" ], "calculation": { "http://clarivate.com/role/EarningsperShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "netLabel": "Shares used in computing net income (loss) attributable to per share to ordinary shareholders, basic (in shares)", "terseLabel": "Basic weighted-average number of ordinary shares outstanding (in shares)", "verboseLabel": "Basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://clarivate.com/role/EarningsperShareDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482914/835-10-05-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1000": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1001": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1002": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1003": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1004": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1005": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1006": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1007": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1008": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r1009": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1010": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1011": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1012": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1013": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1014": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1015": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1016": { "Name": "Form 20-F", "Paragraph": "a", "Publisher": "SEC", "Section": "16", "Subsection": "J", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1017": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1018": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1019": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "A", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1020": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "B", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1021": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "C", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1022": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "D", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1023": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Sentence": "E", "Subparagraph": "i", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1024": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1025": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "iii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1026": { "Name": "Form 20-F", "Paragraph": "2", "Publisher": "SEC", "Section": "6", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1027": { "Name": "Form 20-F", "Paragraph": "1", "Publisher": "SEC", "Section": "6", "Subparagraph": "ii", "Subsection": "F", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1028": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1029": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1030": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1031": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1032": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1033": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1034": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1035": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1036": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1037": { "Name": "Form 40-F", "Paragraph": "a", "Publisher": "SEC", "Section": "19", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1038": { "Name": "Form 40-F", "Paragraph": "b", "Publisher": "SEC", "Section": "19", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1039": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1040": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1041": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "i", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1042": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "ii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1043": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iii", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1044": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "iv", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1045": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Sentence": "v", "Subparagraph": "1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1046": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1047": { "Name": "Form N-CSR", "Paragraph": "a", "Publisher": "SEC", "Section": "18", "Subparagraph": "3", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1048": { "Name": "Form N-CSR", "Paragraph": "b", "Publisher": "SEC", "Section": "18", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1049": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1050": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1051": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1052": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1053": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1054": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1055": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subparagraph": "vi", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1056": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "3", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1057": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "4", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1058": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1059": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1060": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1061": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "5", "Publisher": "SEC", "Section": "402", "Subparagraph": "iv", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1062": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1063": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "6", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "v", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1064": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1065": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1066": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1067": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "B", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1068": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1069": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1070": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "i", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1071": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "ii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1072": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subparagraph": "iii", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1073": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "w", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1074": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1075": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1076": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "A", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1077": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "C", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1078": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "D", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1079": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "E", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1080": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "402", "Sentence": "F", "Subparagraph": "ii", "Subsection": "x", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1081": { "Name": "Regulation S-K", "Number": "229", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1082": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1083": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "A", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1084": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "B", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1085": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "C", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1086": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "2", "Publisher": "SEC", "Section": "408", "Subparagraph": "D", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1087": { "Name": "Regulation S-K", "Number": "229", "Paragraph": "1", "Publisher": "SEC", "Section": "408", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1088": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1089": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481108/505-30-30-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1090": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1091": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1092": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r1093": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1094": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1095": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1096": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1097": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1098": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1099": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1101": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1102": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org//705/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1106": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1107": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1108": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1109": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1110": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1111": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1112": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1117": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1119": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1120": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1121": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1122": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1123": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1124": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1129": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1130": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1132": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1134": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1136": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1137": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1142": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1163": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1169": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1170": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1173": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1174": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1180": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1183": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1213": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1214": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1216": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1217": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1218": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1221": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1222": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1224": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-23", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1230": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1231": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1233": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1234": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1235": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1237": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1241": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1242": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1244": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1245": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r1249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1250": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481804/940-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//205-20/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org//350/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.B)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org//280/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "https://asc.fasb.org//420/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "b", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org//830/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "40", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479092/842-20-40-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r695": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r702": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column G))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column H))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column I))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column J))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-16(Column K))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r859": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r861": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r862": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r863": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r864": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r865": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r866": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r868": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r869": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r870": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r871": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r872": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r873": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r874": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r875": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r876": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r877": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r878": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r879": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r880": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r881": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r882": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r883": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r884": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r885": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r886": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r887": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r888": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r889": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r890": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r891": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r892": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r893": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r894": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r895": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r896": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r897": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r898": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r899": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r900": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r901": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r902": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r903": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r904": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r905": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r906": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r907": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r908": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r909": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r910": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r911": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r912": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r913": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r914": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r915": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r916": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r917": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r918": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r919": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r920": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r921": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r922": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r923": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r924": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r925": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r926": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r927": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r928": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r929": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r930": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r931": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r932": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r933": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r934": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r935": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r936": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r937": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r938": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r939": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r940": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r941": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r942": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r943": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r944": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r945": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r946": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r947": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r948": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r949": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r950": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r951": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r952": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r953": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r954": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r955": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r956": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r957": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r958": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r959": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r960": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r961": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r962": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r963": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r964": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r965": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r966": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r967": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r968": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r969": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r970": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r971": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r972": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r973": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r974": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r975": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r976": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r977": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r978": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r979": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r980": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r981": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r982": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r983": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r984": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r985": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r986": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r987": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r988": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r989": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r990": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r991": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r992": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r993": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r994": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r995": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r996": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r997": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r998": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r999": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" } }, "version": "2.2" } ZIP 96 0001764046-23-000089-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001764046-23-000089-xbrl.zip M4$L#!!0 ( %,P!U=,.Z]6S+L! .*)'0 1 8VQV="TR,#(S,#8S,"YH M=&WLO6UWHTBR+OI]_PJNYIS95>M:*@%Z=77K')7+U>/9+MO;=G7ON5]FI2!E M,85 G8!MS:^_$0GH%;TCD8B2 M6JF6E/_3^>7_*9?_Y\OCK?+5-8(A=7SEBE'B4U-YL_R!X@^H\H?+?EJO1'FP MB=]WV;!HV_V^OTR4?OMW MRIM><=G+)[7=;G]ZQWM*X4V7U# G-[[WF%WQJ%%Y<5\_P85/.*?X1KQHS3V3 MWXY/U:I5_9/E>#YQ#!K?;UO.SS6WX^4>\2:W&_:K/[G=L D#,OJT8KA#/HIJ M0Z_&MWIL>F>?>#W^4/AP:;BF-3^UZ.6-3^'%^-; *[\0,EI^9G1A[KDFM9+I M!1?F;C3

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�(M#>-WQ<P M&8T,0%5^J?FEZCT/ZL,\HIXQLHE0)J9%2K7_60Z=9%(VCW'+23URT,/7;.+0 MYE\3B;$(5&.:C1'6NEQC_M%V5U]J16,T%(" )\DBF8"K8NS]YH!4/1C5&(>J MAZ#61)_J03$_=*91T26H5KN;AM@%X]V0(T'S.W9X& %H_J8"[;@QH?R3/+A& M#RV690^D 66+0^&JH11>JET_MT/J_8(;6/M??1+#L)NAL3<]A!3*;@GM32\S6! MY#=F'^99NHJH8:&^&NL"S$&ZG'.L!Y.H^!/JEDW4,^1:"GC)VWT,9K>4*!)7 M'HB_*9PP7 BURJV/39U6KM+Y%.LDR.TD8C4$&J?3(>,9!5\P7:4ZY];/$Y9M M IYCT9[+[=ZU%K#2E(7L ZHAFBCC)X;8\CV )%5%')%1\-Q[L EPI_,N4Z?XH&K&BBR1TA.(!XSY ;6?3YC MS#PS]Z!+A7LOD01 92-[.P24+-1^2"Z_0T ]!0348SM'=1F):G+:43L"8'); MMN"R5'[R50Q0,7T>?_7(K#?5(V_V7KZE*B 6JV4-7:Y(M5#T3?8_J M^/Z]$]NY"EZ-]EX=;*]C:3:$DT;UX*P+KC48QU!G#3UF%PPXRG*NVP0Q'J=Y M.LNL5 >,WRS];NC+4;;VPPU0[1&P?'$_+",0V N4:#MC%:)#-%K, LM2X_A&L8 MP0G7.0R%BC-J9Y> \*&':V[DL0YT$8<,;*7,$N ,U")=Y!>-41DB!Z+L.\DX M/'?:BD"^FE-L[Z;(T%M^P)WPTFS,-UO<"=E/:MZ[O^E.W.IQ=KX:_TO%DVQ\ M)'#VH#CKLDP65U#4 '-&I_$XG1>W<:2:X*J] 0B=/"68H-$7QT8"L-,P:53( MGS\2-)<,N!?9:#062L#N..(#I6@0):$T31-TW%.L+;<#NZCN^/7JW77L]>O.*JU&T=Y'TQL,C.K,&.C)-LSE-+T:\.W7I"S:4? MZ#?60JY]I<1S2/KG+(5,CI^-J-^11_%PC]:QF1H%43_567]2L\W&1A-C-O6; MSCK;-6-. K0%M;6?,NNPD4AH\CYZWMB-F@-H70TG?&@ 6HO6I')4(4[^;.H, M0>E&];W\N4]&J92'[H3N\>&&F+=ENU.#&])X.55%@TW3?&W1[MHR?;2PL5%7AN?@AQI\*(WOR;E9 Y'X:])_BTZ@82%D;8O M'X]@@*U?=I3I/8S+0$% \[2?+,@O]_=>;--GZ)TDUT7X#H*3BZ(*(EBS1H;S%0 M.^J-SMH_V!OA1*COT1'563&?4YC,JWB2,.LN1+4MLZFA0.Z>AG>3=50W MCMC6-_\$.N02FF%APR_*]!?OGHT_;7F> M%EL\B+B_G7V-@2(I2.QMILF2DN!N*TC6='6]<%5QZFP/;YQ5BLZQ \@T])GN MN<-@DB."O@;7L29O'/VO46Q$#/\OLB35X0]\\X%"?TT&!-SOI=PO&O0SH-"' M8 LG6:4^$[89!QFJ#$HLDSPM5I42A(I+NB$@=EO8M)&WNY2:32XORY1:'8#? MO%B58"VB8(JD(O?,1H*(1I5Z3R28J(,2#6)2V/JKNJB6PTR%@GXC6.YXSX%B1D:N;S&S2^9WT9;:)N^;*$S.1*_-B M=URM36\)S'>=;T4U;U7E,Q 2GFJ6XB;\7P?Q2U"W7,0'>QJ^8=PLLLU,B5YO MNIJXMI)8X.?:$G?1AA,]:KA.YJ-+K.Z 4U], 'X2%6=H_37(X&1"J P27BV+ M8JH2'>%[-?0/1R=3W=$G96HBO:I5F+@"I%TX8YN[7P*CN).RH$V/LRV%.W*C MW9_XGV-O82-->9*53"GBRH'> SW#'T;J;*M')> 5/,R)FC^C+JZR<;;4L!-" M5%N;5H)$$$;:""9A+ 0D2D(28H^N&*E" :?=6U-OJU9>/V?%?))L=5J0-/;) M=+=ZSUPZVLA^1(57K[:;6>TWMDV[5ST N$77*;G?4F[KU]P0*QCP),B7D JX MHL)L+"HWOP0?[L88\ ^AW8>_.\VYR0G=W)!=%I1VA[KPK^D M ,X:SN@/I!H.;:UWFE\FEV2$4L.(&#;.Y"JA/C8R6.1H@F$RA<\8,@5S&WR0 M2NK&KA+220-8)IF%M>3V.3(*L14PK *#3G(<%>"JI=N!,T,L5757K,LR<(*? MD2\[TN_T)5$1VG%4;AB5O>]#8NJW&I[>[XT-RN'I]8A6&W7Y8A'OA]2I+?I" M FL6;9LZP1R@QQKZ/OF6%[?S='HI17?4,:Y]]+@1\@9,A@/@PYX!/Y*W*&[P M9(*8%AV3<3] 4U/:!M99Y@%KYE?.OULMS2AE; VMVZ2(J*D*0T%U^WF J K. MK9ZS$?6Z&L9A @:)Y9G%S0>U8P ;4#*,>#>SSV=U [R%3B>0%K[&6U;5&!"P M/EH S/$"!T$)C/HB9%48&&U-&LW-,<#ME;I317_!=/#^+AW\<]/!NUSC'\XU MKCN@I,$I)DOR8@D'0K5,63.\6"%MN"VS43"=0C]FN_I^1==%.@E:V*\?")JJM@TQP% ME0#!1Y9HF\).]-2UPZ2W06"[FLT72)Q%UWA!C&^LX/H;LANRUB3Z4T&E:L46S<772%" MP(Q([$0JVC5W-2.5] MNN1&GSOC\N<:E[M4ZI]_A.IZPW6[*JND1Z>UM$'L:6O:) Q:K:P0NU*J=J/\ M&N.(#@DE]D2L_CF MY)R;PQ7B<1[9!TE?"%+Q5?&P[4#(RC*]*2:(7T^%&+UFK-CN;LI2U82*@:R5;PJZ]IB(K MXT\^K!)H.%PHYB:5XU2-U')#$41%'W2MOWNE2! [;E-0E@=A*):30.41Z MD%Y5N&B56T0HKKH98YI4EO[4/(+)I.!BQ33L$5KB:/6;$EK"%5%6A0R>(]_R M:FYZ%7KDF;SQQ_TIR$21GMOMJE,;WJF2[V:?>;RM":1(B 8X6R-DF/,66;1CR_HN5D?2)Y\N$^K=E^'$3];W=R@)?$A]VZVT51'#0&[OQ_B""FI6R M;>C H<=*%@-Q%7;T,X^)A:/LGFQ:313\M>KZ)G,-VS^@J>NEC2O*#K,++Z'H M 7O1\C?"<"BDO0)(T-'J<#+!('M! M2 MN>2LQ;UXR;R7,[P]X;:G!D92(221JL^2VN37.SE*B5@EW,,5[S?8_C&]0^^TB6\Y3(]>2E/D*W;RFU-L&*OJG4@H-AVV&Z@*/6]N6C$5'U$X3 M#[2M5I2DD/O:V69@!6VYOIR 9^3W)K/S"Z@?[#(V3QI1V-[()QN.G.2IG_JS1RP04E.3 M '\\3CE83<5J;+YKV&Y!2B?,6COG0P'"QD2QLIS3%D 92BI%62B\*KL%ZS[L M^CDWO>%(K:-TEUXS=M+X'FRWYC\TBCP4H7 V$K>*\)M8T.9,2L^P%.[%V[VW M_V'9?+AO3*V\89+,(68D3D3HX=@SFHF#P![Y/F%H#3U!#HH@%* " .%352?Z MPQUB;@OA@9IITV+55'\MR&X<-F[%("^,0EZ>*+E1^"F)3TE]]?'"(KLX.(QW MW&7474;]Q2ZC_M?-J <$);)Q?!Y[<((LT94FR=+0'?0+%2N<[/G'$];::N?1 M'6)Y"^=NB%2O!UHZ\>F=5C;X+KNZJ+,LO!AI\K)EH0-(61(*PX M,_>)%K1MKJW;PDY$6SQ6$!4AFJ+TJC%_Y(Z-:7%1OM!P.TH1Z Q^,L15(2#. M3C;@F_UM*O%[! ZJ1%X"\0+0M=2"X(L[#$K-_Q='^R^=CV]G^;,KC(@./<9? M7;'*T7X8R@Z;68Q )?V;Y2 B%K]S4T02JMT,HW M2PGO>*?:2,>RM9 0S9YX&7@W:;5TY_Z8"]1:GQY3?M1& .LP3\U[UD3 X.KE M:C3ZX%@1!)6=_LM8G5O-,3G!0W1F*$1G5-?X)[])V-N9!4NR"V MOK"^Z..5.+U<+B;7Z3P?C(T9^G#=>KVU*]I2YI!ZL\OQU6?)S,O;W;PTSP@UQGXG/'&],NK68J]+!R!YDSS_*S3VAASL4 N@%QQ M [O'YM+TP)T!#J0R;6P5$I(30$EMEQR[Q4M4BI*)'(G6O_D S#A(A[+ M2$YT!$FR,/P)R995L M(LX_))?*ME4!7=I_T/%J">AEH]*00IER@,5LAMG!Q.R+Q9TCV;T>5-<\XN? M\>KT@%H"Q/ M,5"6WU[!O@&)A(0*":L#/-O1=$I"X@BT-3/Q6O:=.GB-N]#7PU87C5.3W"39 M'*&V,R2CI$2,>2NFO+-=J61S2#JRHCT+0T MI03,_I\@R@GR N:!":#V\N45-T4*P@&VZ"1/ 7<'L6NX4P5=FK)*@:*]!F#, MO-*H5X2QICIZ- M7C!,N@Z-OH#I6I70E?>2X8?5DV%Z?]6_<_OK C$"%2'9%I1WBZ:K^1W9G"G2 MY;4>K-R(C(DKZT$MVLRJI9&.W]E(D'M29Y^B'5C.@>5>UB9C!Y;[R0V-MX6, M:^C.%0UT0TH)A]-9F\S-M$WO=+,P=](/(:I\214PZ$I"%0^GZKHZZ4DE#UQZ M6P((-[?E90V=62TVQ*B%?EJ70U7Z\<) M X>G 2O-N%-468H5!H'Q:,RWTZ+>;W*L9AV,9:I&1"BU:F%475GC'TJ#(^=.B'YJ(1A3]&> MM 65D8-G]BJM_VS=0 9R!*1H%81Z-\6JSE2 M)^+":+Q>)%2S(VJ=I$3.&5K5?B\H9(0&R79CR,6CF*39 M=B<)JXL]\0*BF1Q(BU6R5NIL1&)W(K@3P0>;I%#]H7W5K .158 C,$G5#.0@ MA>LJZ;-9J*>O$JJ9%W+;A[1T7K[<>WGP%&LK]OO/N&1D*:2. ]DJ5LN0CZ-& M5MSF L11E6(K=)5 1&G4'26A)XZ*WZ'BA#BUWP#S75;]]\H(#B*M) ;J-Z,$ MTX%)F'6@5&#W@H2VX'HT_^3;831(^IU2^"*SF"_[D%5 +HD&&D&5/OX1L)2F M=VIC*0SCZ"[KI"+IPQWEP08<%52K#D&OIG5;NUC2!P!2G<#F;_;J)50'#'ZM MW]6_F,N:X> R=\>F@WQ*<2\HD/:T$E"<[4Z;EA@08"X-O+W7T!Q"/4?\\ T3 M6/2-GU]Q@N51_30 \Z8I- V@MX'?$!66H%;T^V<8PLC9=@B__I'-(B@T85)];M!4TLI.@!I,,&:D F(]7ZPE\WS&6C'6'>UE61IQ"B@5Q:0\.+ H)_ MT&@Y)'SS:=Y*2P W\Z'W]0C-;E=OLJMIF>U:8*/7MN5%I@MCT'4>]^KP8>ZG M!A:_ED4E/2,T@!Q=K>+'P\0&3'V]"+.V<*)9E6-)T9;,V:7U 9&35*#Q14WV M'GIE(76C;?NBW Y0TQW:"6>UJO:(4X#_T4G3V++QQ[V9?3PA8>_@**U M%L2;;8/R,>**M?:AX/=5"_?"GPE-*R>3C\5_4"*X;2.V502-ACA6'@4YB1@Q M: P66& \!SX@/(/YAEDZQ2Z*63XI $N:?'=HBV[,O$/+.V@[PH8ABF&&BXBU MRL+:-:K=^D.>_N+XS<0&"RVL'0-) ;2](F![ &H?XF_">]M0C3V;.##R8/C4 M_@/<]53W">R^BP]M$A_*"S^X9SO&.NG$V&963>98[L*1>(C-N5A\$!ARR"@. M#3'R7T7T0[@Z7J7NP,_0J"_=ZC59NPOAU_> C*,%T[(M:RT$AHAT7RP#++N% MJD.1^@V\!<>NK9*T('J*$'LTX['E]]:A.9YXZ#P+[%,=&'GJTFS?F%ZXZ7V; M-!#<_,^"P4?F(L36.>R_!EIB"!X6,CAU9,_9A@12*M:6NDVDJUUDYKH47<\V)BRMV=MY<7=2H%EHKC>K9 MAOO6#S4^CS$.Q6U.J07BP?>LF0TZ=S=T'6HO'WHJJ,]1_U"?APU> ',K-X&M M8)DNL?RY?$S JW[$!?L+O=IZ9-#2:*NRAA;L5)-8-K52#!RL8CZU0"X_IW!: M/+$PN)7V[:XIH_YKH0:?N*#7,^D2"F\'_]IR(J>?$X53\VTW-6U3<[W]!&N/ M9Z?8=@#_(4W+EZ_V1MN$V=X,?:2I[E$<+;#%F*.$!6H:HCN^\UW]QIB$*N=I M)A@JZ&YIR'RG?!"HO[<81.Q.YH^HXT88I'C/0="SU,R0.?-_3?)O,E1RP:'^ M%JX [*O$),TP)67DC%LP,NXDGL)]O!H&@W7/M5G:Q<(VC(6MF=A=Z;8KW7Y5 MFXQ=Z?;3+-VN*UT!@B(7ITO;,T>JK:;4^M"QM)A]5:W&YH66JV4:JC/<=K84 M?(;7NI!04@4W MF/: 03@9%S[Y5&32+=)([:BP[)['C'T6>JIO$ M,G2I5N-)E)N1S&W3: _8SFT[Q*LP7P4NQ69TSYH,3? &K4\5XA,+=W5M8W52 MXA!^ %UY]U^_@9MB?@\.3?OY&]NO]^/J>WH]+E;E9724W61S:C8\\-.63JXX M1T^8%BI&_'0.F^P[Z>)S\UZ0[5;KRL4-Z7>8S0K)OJ0#><'=X9NT0HL M-Y-_M ONC@YD+4+X'([,RO9AI6.(6U5]THL.]R%MUCUA1/OQ .Q)3 MMY7TP+"]Z&=9>5TU*]$E-D:BFRC-B% RT/M4><@_H+['^(55 16$AJ;I=4XE MRL35.--GM*=%Q%*HHDO\/:;BLV4;P$1+:$U#55BH56>RM)[4NI,P=NH&7MA3 M1C)9[7H&=1*22\YT6:1L2D[]-ZEY8O"4H\G#N<5J#T.QF+P/UQ:JU5*['PPJ MS+%QZG^V6D(4CN;4'HC&U5[V;VL,IG-NXDTBWGJ?+9\5L]K!.YRMSG&S3#A@>=Z#N MO-B^4R8<7:Y0L8&)A+9I%=DFUMQY93XO)F+GX8F/'@(95*MY(G7?R'%1>'8] MJW!][7L*I-S1D>!B+GTGEOB5E+[EU>@#F,W&&AV81T \SDD3!PW6I8ECW#]J MW?(4I7=C\V[0Q9!@ZPZ;P9S3@]LK8IR\*>:K?)F4YJ7)WE:'"Y=7(HBR0=(F-VXO!>92$I M0:*/L=%FEB&@H"GUPK,\3(706[,^R'Z.@X;>K6)'K!3J#BR%^+D30_PSW'Q" MQB ];D&!31)CO=BPKT](T7!GOV3##$D'K&@:? QWXTN@L5=[$]P\/E]$[1K5 MYT,#D>PBN&G'2)GUC3V8\P2*U5NF:(F%:67*YP'\RFF'TGMH\,#(R#7BL'&$ MVI[MF,]=&O5QHEJNC.-XL]WCC'W(;-:"5D YZY#@K*)SB+H/ NB9&H&@,FC< M'*Q6K/Y0':^K"5AT4U4#)1RRVF!2C@#!:X!/>LCUHQ7_&U.==KO54<.[!79%LOO,%D'MPNUL'1 M#$\HCX6EF;U()M]KT*#ZC8O#[Z/0Z]MZU1B$J M4A#+:>!B0NG M1[.(J1U)L6) &3=UVK'##8SL,HT65 M$IT+RY?4C7GHR7Z:@WTPE5VQZ"S)YN#[F[6!M*)W["KX)VYZ?&/5^=+G3H5S%CTE,V^S9%)E9M$8O7B= M5157NZ=.K+Z\>]_4#,:;AJT.Z^2WPP%:)Q2@Z M9)^$W9B%=1U];EV ;I%S! 712A[LF\R+*?3$L$ZC]?#.!&Q&)WK70?_47'4 MT]X6Y;22I LO9!$KB)1O+^@!C(91""<)",S-OEB2G=8* M':P4V$NQU&@JURIFP\3\@RA=+=8"43?#)M5!HTGU)K13R%S,ZBMC@T^N8.@> MHH^A X*4*LWK1Y88!/ILZ%O ;,RPO1A3#EO>@^:H"1O=W])TP0\F3@'$,:C[ MPCUC&RHFP)E]7][#J!#GZ:7Q]DFYQ,I<*X4A.1ES>+YJU#1.5_+05HQP-/M^ MD9;/QL;>E]Y8,NKJKC*"T PX#>!^U*+'AJ2HCRF%.(+8BT_7(L5,ZI ^MPL) MM_@P+\9 HV0><(HKD\P1%IL"E.UPPGA(V.'_+,IOQ!'2XQQFO O[2BU2A MFD]*XFB"H581S0F'BK[F&=*7J'M?Z%UC[K@+Y6]6$56#&"UQ=[H.; Z"J0DP MVKW)3#(K>1%P##DR:>H/UZ@P1%1Q?9WDDC*0\FT7I\1[HAKJ4 %>FA:3LU,2 M0J4^R&\/>Q(K$7UP"=V[_VG<"S?C6V_<#$''G$/RAW4N$^5W\,ISH@8UY%4V MSI82'K+*>YZ*V/UK56;5-%.UFM*.&8U!_74,IX09KS4YF[,I\E"V7-53ZCR1H]H?3<,1-@'IV3;<%9;3XX\A6>8[T<; M0]_U1PS.7HCXO#D+6;R2[?7 M\ _L+9[CB6)\4;!U\> SSC;$>E4=D&.AXUH@<.VZSBL^:FPE'V5KNL<(>]>= MB^!VF@V[O*)-7*NHH).U37 >[<:][LW&/=A[#1/Q 5+GU'4MN86M^]O)>73X MX>SX^-/QZ45T>/K.?'0?3\^CS^_QVR^'9Q?SX[,'R>GT>'1T>>S=X>G1\?1[R<7O\7XE(^'O]LGGE\<7AS#'Z?'OT?_ M_'SV?_"ZSU\OHK/C#X=G9M"?X?;O/YX<7G1R=?/IJ17OQV>!'] M_OGKQW?F!__U]>3L.#K\\L517__>G9R_L[OJ26=/FUA!PRHSYNBHDEMESEQA$@E 2X MMN8^;^IYS;]P"OK-+@7]9Z>@^Y4%J&#/+0F5;OZ;SLF(0&1Z62S2TMGA%$TB MQ]!'#WN,N"W1PD:[S]9+E8J_*I:O)6G+!LXT2FNDLLR(SBON1?M [AA+'G5%*&CGRN@^]#LYR(,O+6R-6&-+QT@"4KH M)@$V0$K6_/JW\J@+%R%9,D!;\V7:(@G4D965QY-/PL^#\!X>JF&RA*FD#^567AV":F^R3(X(<)-N0*/X6HX_C0Z1;_BP_CR='AU! *_ M#2XNA ,@_OII="9\%.&J.,(I$%_&K]0SC'\U1$\%JK"[%5,&#@>G[V'1AJ-W M%\[YY> "?<;?'>%5#=_\[HS&X^&GR]/!F_/?P0^['.&&B'5_7WX6*S\> M?A@/8:.$@_9).&MBV<$?Y?_[*'R_\>C_P)-\!SZGV$OA0@X_D ,[./WGQ>7G M\^'9NZ&YQ8.+W^ECX9[*[?[\?B0&^MO@=W!8X;OLCXJO7GT<70N_E9;TR%VB04%@@RM7 '#. 3[^_@K*0"-T9X.39Q!K )W>OAI./Y=O/WJ@U@;9_CV M+2S1IV&6:OCX02S=Z%K+!SP]7TA@BHV1?&L3I -F_/;C^?GP2KSJ7]<@N1^& MX]]&U]<8)8'X0Q.&=SWXY_ "'_!^>(YR)?[X:7 ^.H/O7UU>#,[5 '%4\%7U MR=GP?(2S GF\?G857CF!9\(XQ?0@1Q&9T$9#%W6K8/I;S&T=Q+6,EV8<9UN, MB29E<#,BI,%X:&A5VD+"+^)DB+(A);H?:T"%R0R4HB9)3)!P&U)9D#!A_E%\ M1%S?WQ,''=DZRI]9NE_\Y68I_1HP4(S$F*QGT981VV+2]"(#)E0E2R6\6E>L M, (Q-M2H*6W;$QP@Q@91\69!7\O&D[DV,X\"E&4 9\AK--.PG"R0J!CG(FPY MG>SLQ;:?='G0IBG L8()0F;7: M@#M_)^'OL??W!C(G8B0S=^G>>/;9&#&QB?*WX"U!OP1W=@<>,:@7@%W&WD)J MY\"["87@4D9=(?>H(LP <#XB&O;]N=V!Y^,\<_.'@9U O'7)M9W[LXU0'6(% M)7]9?.NO*$@")6T;7;F7JE QF)@L]1!%).(1#8\;9ZU9(C: MU:@9E_ H\FOHM^NWH!@9;"+9O[Y$6\F"93''UPRISI">O&9( M7S1#6M'&9AYC93+DL"%FYM;T"4)$,77@F#5E'L%H"?TY$J[,_EEX'T@= W & M>.\'UOI8J@0G<.SA <$ZB12,\;Q8[."H[9YYP,UV']1T38;^"(?O= MV>M8PVP4 +,BV[K:R*N4O]IFAQ.YQ\BPR3*B^PA0"IOWVX D^FO)W60I8@GK MY9=G2N)+6&2OW1OM[HUXD#'\IX)L>->+>WC X: @+0(/1C5*@FGUN4]6I1O6 MK=^&091-.(9KQG(C/379350+";1DP13A$88>L'?ON9WL2O>H5\<]FFI%2[R( M%"0U.*::J8LSD/QI1KV?CI'B\<26N>AJRXQ\KO)L$GQ)/"Y8FU!G'L@D\J&K MDF_<^ZB268%CIY(9ZV_+ 00F9\(G@P"NI>5%JJQ'S&OA M>QLIMPS42")#TB*=W54LS:@DK1BZ6\+H&4]!A2XE$5%$OCKS:Y/@.25H6]$Y M\.]RAMI#KNVPL\[YWW71)\HY/P7V]!GE"'!ES5AU;J#-2U//B*,#):I$Q\X/ M=*B6*-A?;2;B#A?BH6IY-3C,,N1,TIN251%FJ5ZI&*2T#R'#-?.HXE"7#O.X M(IEKP1+:]/"1=BW8-V?[6FE:LM(TG3E>14B:6W;+$9/);>\M0GQSAQKN'KGP MLC5'9DWX"Y0U-:>YT_6&J.G$(_"V@^]?<]< :L>&K 6*2DZ2 M:IF$&,IMN[IW5\:9:DBBRRB<>S'3X&%RAWBT)XV#1(JOB*Q-V)'P,]%^82Q"T0!=X# M_"?1<+FR'HY;/V0,F(/!'(KX5N_DMD-*1LC2F6_=. HVVL2 3:,EN4RQZ5RR MU8+'Z$$*(]2_(_-JRH06J-M39\Q4?V*[9KQ=BLH1>L\!"['B290W.Y5#\1'2 M,0')@N8MYON1=[,1GD88"=E57Q##PY03=NP4=B?\PT9NW$DNWP]BIT -V&V MPHW1I ^7+I&*T)QM?.$0J:<\-*SF MF#C,?!>08S")0\,CPOPL8S8*A?4$5#X;!A=X7X1V#]0&SFB/Q8"A-:TELKP= M-^::X9)L<=1C-"!1!=.V;2/L*1<)# M8&OM4DP\[G\H9F@:"O#4,7T@JQW.B0CCI7=W1[=J+K=J+@\U8=[5ZHHIS(3( MAED&&"5"UI("(M2T"1H-]"W6OG#QMR_ZMUCUO539@#U*;# ;1@]T1SUIAG7N+7-646\,XCC<*K=\U$@1H,,R=BH$LT, MDV"4#UX8W;B!_V\E@<@MY\HZ3ED9]F^@'^)K41*>NFMYZ&.,L,2Q/H#T.'<" MD!#9@A'(LSI'OP+@\\ZCWC48JYJ'"S]36] +8QDH2IY5@W?T]:QLXZ(W+:$4 MZ*J<1?@$.]#7HKITH[^\-;0W=;$I YG-^&")"98>=^P4>&H)#S GT.0:O^3A MBT5T;RS*"/;8,(W?^',OJ\M0:H(^LS;$5MN0Q[BK+JQL-.-4E1F#X/>KW&(Q M]7L&*[&K709YTQG>Y-2.\%@M#U7KCU=$@D(D=-JOB(3O$9&0%5Z\ I\CU+V7(TJB3XP.WQH]BM>#NB69X5UM:A$^+9LXKVD %])5_0W)V"3#3RKZ M9-,)W7E-[1>[-T;A?LZ3]Q)2PKX/DP:OT%*(FUE\HD;C9UJFM?O%60/<4R.O MQ5_(6-A$)>";>(.FA!+&L83Z:G%?Q>9;S5!.N!(;SM7C;$V+=XL]7SS$7KS' M^+O(2Z893"(%O$FW3$+LZWOJ*62T2C&/C7\M^#L]]&%Z.KZS&7V;XS2:#. MA\#O=)59M"N^\O'B]/+B; 2ECX-S\;?/ WC$]7@T.(=BQO_Y./Y=UDJ>#]^) M/V:628Z'Y^+=XC^P/M)BDA)?A!\3%Q/6>)Y=GGY4/%5O^?/3RX\7U\/QZ?E@ M]!N,>SP<[2Y;4UP;*3MJG2!CV,>K@3!5UI$O7 2@';V X(1L^6!W_Y#>A&'U M@P8Q?RT;CF"S+P1T7"J\Q)B#WWQUYM[&C02)#3@OXC<3[]85?['J,O<)%F-=$!6L[G8J]!D)AM3B8838*AM.G>P^'27$66RI:AIC5#' M9HPGMX-54Q+HF,X@$5W3,P(@@L9[:S:+L'E35IU7=G6[AA;I/ 90>;Y976"R1Y33T-O8@189O\YUR23PQ\;ES>;%YYV*+R8 8>$P_FNUY?1LSA3SX M]!"HCIRIL('#)47#))4\$$#N+\/ @X@V/@*YGC8+3[+7R',9)RFZS:.MZIN* MS_:.-C-9UT8Q,P7K;UPG/5A"&N [:UHR6G,#2NSK&)B8KW03*>F5<9 )$C"$ M1%BH\L%-# 82.G[L+R)%MFDUJU:UU.X66G'!CWUL..(@(97N:F(0UIH5@4K? M^)X:GNW%7YE>?&("3=5'#XXK.LV<9-8,0Q*5CB1!_.V0[>W["#)301,=#K[W M- ,KNE! ]B^1Z0$@-U1OLBGU"T#XR[WX/ [)VY OP9+@J;?P(N6&8?LRGP'O M5'FI,IY-SFJ@6XP2*CQ!?T8MRQ1%ND=_Y%);]T9\1 M4\;7FAQ7,%/N/ R=E#5!5YMU=O,9]5Z8OTP SU$9>^@7F5G_O:SH2E'1878I M&+;E"JB!Y'3#S89'9F-&#^Z>8&K5-])#K(;**6KBY"M5:Q!^(.8_R6$CP0-B M0&;YYCTI'$<3.\IZ)-62R$%N/V1.X]B':REU3]'YM'O:X EMP)-JWUL-U MZ& /@;NY$=N;^I'89@@(38&"3AUN0-;/A7UG\BQJ%G6)#"M5*DVV#2I+L<]H M]G"X+\'-KONU;)2.P'[V=Q[+CC0M['7%4 \@OE="?\W=*=1"X7BLC@[BN3PG M4'2Z__!L,_44DBIU<;YE:U;X :LPIHY(4W5:WX6*FR;0&-+'X MQ\1S*1F+"*C$C6H=Z=0MFS[CX6:MHHOIRY(-[0+8Q$"?>P2[3/"*$)?FOSUJ M8+L/W/ SG#VS&N+-+6XR=Z:[T<^8N7/FQQ/AP5FY-<54(OLB"X$%\WCM+U2W M:U5:,E>-RF#YS=5HJMO2D(&(WZLD( S,WIJIAU"]H,_ $&(373-XG?<+.?0] MH^E01BZTGMI/9FB!T9%MN$8#JY=U078/7?)I,/P7@9 MG1F-8@!U&&4;;^$;0E=86RPB;PX+KHQ<-8*=S>]L:A-&E)5WK'X'TXR$CDFU MZ:^-IERX54QP2($2KNW)H%)O D$[Q8/M"-&5E+5'(OEX@[4@ HD$+= M<;&9B< WB/4MF5.-,DPHMIFB2W6#M'J>6IVNF")8)ON1 M.^D]=JJU1B)/!4V 2$_*E;)LPW6Z&\K)2^LL)KB SR"M3*IBE6;V-2TQ4SB38@+^VOSXJ1+D^\U.[VJ M6= <18)&JZL+/[;C/@LLQI39D]711X?Y51_.#2&/7.S(N91VCU!4P *:\562PFCR6F1O+@0P<8GC0U@H+6 M3D%H]\N,IG]4+>2L#;X$L_8M]#HA935 M^VI/PIIRED0L:F2D\L6#92XZR6U,A4U-)*+=1,!/!'T*X:^<5R58%7[M*2L3 MRN90U-8KWLMPCG2;<]N-XI-G)\],H]5RCC(.B&R?9=YO0',WQ609WV+ 5J)# M:@S2XK'N ]ED0'Q]K@BK%+&"G1'S%> N[ZO(I]T^DR] N&%?)X69)TND=]* MO0YLP)6'AJ!N@I99IV@=&ZE# 2.E_!8\AWNX?UMJ\JZ2A*/O#T]9,NQTC.>LO1WMEXTGUM+/"#5J\#*_'+ MSR>=7\<>;#>TF#OI_;JSB_NE-HMKT&1!X@+.T)N-N$Q E*49H[*/%Z&=X4P4 MM^#I5:Q$: X#@8NV"'+ZVS _-6H?X?BZ?@3P'/>+9:[N$7V"T&5WNIT.]LWQ M@[]B9T[4!HW)'ET^7N(=5)OM(P@LE*$A3!NAOH>B(V&O0K#)DRV$48'(:++I M8SNZAPGIW":#:;DN*S"(/> ]K1V5TH?:2:EF6L=-&8M;,4)M.P#&ILT*RN[% MU?"_;T]!7*_3=<\95H<$7,?T\Z:"4KC.#;'G$W=41GPYP1%E&0QY[7H4>2^, MTFD0\:-\-;O?\ GWRN%)L=_9U#AT_*'XHOB3_)FU -I3Q=NIT+=Q8T:M9YO& MD68H7$&21-69U\*(\IS12+[A+)S-]M]& M0#CR&4)C5VLQ7-AWQ+Q(GGVQL,) B\(UW]/PM,8ZO"$36FL?C39'M/YF<8/V MO7:MK!C(Q]95R[FB%D0F2:,0.I!SN;X)$!9NB[41.,STCCH-TU&24=6)!P41 M!GXQW20W6XIEDLU^-00IT%<2@X-DZ-I=*XP7<;IH;Q7A8[G-BXV(1&8;8DOV M8_GSU/?V6E#ZBZ<2 <&NV, [-.>&P=HW> ,T%]LKYL7 O'1?,2_?8^F^?6H; MH. -O5[/:*P\N.@JU2$F*Y3:-(3GFDR39CL^CJ8YQ9J]J<-!!X">X%U4=C7T2G,1 MNZS8,-8:(ZRIM=IS[L%/*;H1T[==P2V7>\EIO('SYOTI&BJ:,A79L>QO/I=$ MGWES%PBXQC1UO04)*X)HS,E+4^$ML$9T>"0E2+#@&9MA,J*KQO *@9$A7TAF MH-#<9*/H'R)YF7.#"8K(,.F9RCTQP:D2._6 KQ>[C/5Z;K'YG,E* 5\4!J^' M99FR0)B[.(7A3!OR'.++RB9(-"+[ 2ET@EQ!D"H+-TG57"S(B?ZW*N26U!3) MAY<4FL8 J4?7:F]I]IJ=UMU<<5/6AB+@Q4]O=Q77;8'X_'@XAVR M*UPAAT)._^U=#(1T6VY=5K]SU.HA=\* R9/@ ,K_1FT&!4]PADU X]M4*0U3 M(F+A)YSF4^89/Q-JR.XD*!YIDO$0N8XL;\3T(60/0LV&,V:R;M!J5DDJ]BMB MB[9PR+*"/*E&DM]$#L6LUA6OK(EE&$;QWLS:K0>K]#531@RD$IDHL+>%FVJD MLQG,!M<3U4UY!HQ&LR= LB><8I9S]EVV'"LD!-,K* %BM.0(.5$4C<]#$J&8 M8Q^PA$^88(%J^J9X2"8YU.)PMJMDA_C^FA[CP2P^3 K'SBRW7-T0F!60_V/4 MCS_[(E7?F[?T*N&)X8[:&O"???BG!(5T)*6<( M7Y'!J\8 *#^9&G*-WM+R[Z^7UN,OK:S%Q4YZBDJ."[8*EIO"&4*K<*;"LXO4 M-?.V%!CC3MQJO2 :W>[:,+<)J5$,K MHA!\,.3"Y.RJYVF4V/;#UDFE!U)A/6.YBD:U<\Z"OZYNZ=*8NB]/I]*ZBAU8 MGW[5I[.F*S2]]81^]IQ.JW-:Z1(UH& /\1=R2!RO=I<>%H=BFD3" HK'J>OE B-4%-EBRD0G,ET0:$HR!V/3',GO[4!Q>=C"(58&S_*CX M.FU ,T)/90^R0\A;_=.B^-"]BRAFB O-B+#2Z"ZB^"^370F\!\2M,C;8%[_> M("L*4#E''LZ5FJS= E@LQGR!Y@X.(PONJJ/]-BW FG&NT"]6%A-^$^MN[]DM MMQ-NF%N-Y7:7'\+("%0T;1I5@V+5*DH0#BSS7A,5VB80WW,:P-6S,!$H$I72 M= BFC-CW(&.[Y1LB;^'=N5@4CF3O"*=QHQFU.U-@(F#"QU^:1S 6K51Q]:5Q? AIAG #*H] MJ&P S2QSE5Q.(OVFLF>XZ4RAL1ZT8D2O\15?I/%%O5=\T;?FU*FJ6XA!I.Q2 M(AF*I]MS[&FME[_*+1I![@;XV!;$.Q7KM@ M0:MR-H0WKZ,-88R17]I;>Z44OAH1]_1"ZE5&#\D[?F:L:/%H.>S7=!IOGCA6 MC7V..:HT"U=&C> M]E(3YOTURD2G&SHM["00W7""#3,'$DQ#5-E2#776!6%LF>MIXEU-J3TO(!L> MKTKQG:DO_2+I(J&I&WF*\Q#IC FECGLFEOZ4E[[LEMOOER^*?9AI#+W?0RX%I.?_,A1 M66JHF:F$@,J3I3DY(CT--+8-#9>YA'(-=Y*%HMN:U ;W(0M@X![:X(G1 (_O M*2\^V 8C,"ZJ7>-S(Q-6B%6UA#0J=ZSPY?D0',I:\M>2'^H8BWZ HBLA)@#I M^>GB/VPI"[J%@UN A\X$]NS:[CK=2G>5Z9D)4(-V@RO&1[6/B*+1^"RYV->( M]*"(U1F;M_I^E;VJ2T04U_P@,1TT\5-]0Q)UHCNWM>+,]JH.YC]I9[#2?^&Y ML0Q>Y^U/RGC,#&R;N_B\?4&J1]T@,P$<"1NRQMTI5F))_D3")NKQ>(>%C O? M94(2;5=G10'QL9H,\B5M>R93NDIEB\J @ M99FG4[H-V83\DLJ,@_-<_]+42IW:8\A_-I4A;"\M?2M[GC@J"M3'.3^GZ#T0 M<11MBARK7HN6D][F)CV#A\Y/@9'S]@,URUTXQ5@P[9X8M3QT"R4>3719EN(W M1%+B.M T'6HXH%7X GAH8PQZ[@/_:2A?FS-TW%*CWQ2>]<2PL[9=EJOS4NJ9 M8]D I7W(54A0]\ )@A!Y] M#6A'P]FL94@C7%*O"13&=!FW0 <-WA=LE@94VM%6&5L M@Q-0.XDU_!?$(53E-15$&#MD"RB:/OAV:E.1\_JD=#ZK2JT>HR?[7[AWH3^3 MD8I9N)FLF<2N),H1SL7",WGLX!XC'9-M/9)^,>KMB T".(U@#%QV,@?N&;M^ MF[X3&U]B*Y4T9XD[5Y7D>?[2:!]AG(Z")!)W;89)P)I:],>C.-Z8@.!4ERI9 M<06MG+S$O!(U1$2>'(,IH18]4AG*1'5!BHUHIZVAQ;LW\;+O("GX\B)++%^"ZI6*KS1O<;+G=F[_YD3CYB1/5_U)7KNM M;F-:.9/QZSJ5CCY04>&]R\WCR-ZTA;N$IM5V]#M)U+*C@<9I;0*-LL!LS'&V MLC5F6P-W<#%Y"VGWR(@!*D=/;+QD=A0?RK!0XCJ'N#)XLJPP'U-PM)(TEE1. M1(:(P3@:&9-51H=1L;Z"[ NW4I^HO5R[!2(RB<&@&Z!BX4(F5L=!, 3T*%A@8*UW,1 MMIR^,U2GAG@J3MVEMPC71.@SF/Z]\ 3I(MRG6,"H!> M0B6 <_,UU[TC19H?*O7%9NLLS)<(R1WC 9G4G7SC:80,JB^V?AX:1?7G+Q>=,?%>KFZX(UEX3W M:NGE>Q6\X(5U5/:15)#K!]YL9P*U51X\N%MF.G';3&AHF>UG)5UT<.C$ M^!$WG,"8E6PL.Y.NJA$ORFP:CLWM*0%!:KW@A61$ FGQ"I($LC&Y;EB@DDIF M$9R5+@D,AJ8DM8QJ,V0U(4%X::S1YS#B&]E&"+JCA \@RLDL7:*C9G(JG.51 M'\L,$7=3@/Z/2$X56D2 ]&?&7!<\.DLSFLC4G3@DK8-*C\EN6L,5WNDY(?0/ M,C9>=!]8N=091_2'UK*9$*F,E2ZOB7;T",UKU<9?R8!,LMMHBS3/*,?8:*ITR=?GCHK"36U$0<86 MAK(."E$Z29X-.6"H:ER,=HR(I:&84Y!@Z2*@!+5^*VZ8XLIY"ZF3W M;U@L5&A*4^DTS3(;,,TV;.JMF?B$OT'/SO 27J2BYYEHD%\?_9R/_@&! ?U78, S @.^_;X> M/=*;'7ZY]2?^VGF3>PCRYE!\=.HBT0.C_AE(E/'2YDG'SA#__EX:!8PD5G?9 M=[HFV*#Q"OJ)<9%]"[LTOFK8;Z)A#[]'#0LK[<_^ZR?_I#=M]]U^M],^[AQX M)Y[;/>BW#R?'_7F[/>M,3O[H](]_JEPOLT2OP]4_VBU8+^G+8)[D'[W6H2WC M^.=B@2XW^X.#@Y^>>3S?4(([7;'2PW^]'[T973M;>T3 ;#J=5K=?CTX=./BW ME^/?G,NWSH?Q\,/@=VB#X5Q<7H].RTVFV^H;>X-^;^_DI%5)! "G _EUQ+8Z M?\#_G&;):70J&_%UB./-TSYOH(4DA)"6XO%3M^E,V(+04R]<_GGKEIM/+Z7M*IW0M;?P5K=AP">G<7!XLN=TVYW]X^-^>Q=WZ*T[19HR M.:%NYT!,Z*2]?]P[*JD+'GUTYO,7FU"AF[D4:H^F.6-!;(5"$'_Y^?#@UTDX M=UO3<%EJRKU6)R66W7Z%NWCN8N,V<"3?B0.'),2E^N#P=')FDS !CUJUQ=)T M#D!KRE)QJ-)HCREJ,IIJ@.0@U.)S'PVDG/Y'%E]HZJ&Y1O65B+D:4V M*RM>NB"(I82@[LXBUN3FEY9?7JO1=)L.@S72@(-A]*>HKEUHC]0Y,(]KTS < M43%)D^0J68X"EU?^K?48?2QK6G;C#*87M08BM),',4,\:[*4"5"Y!95*GAY; MG>R&#+]*[O.L7QWDE7V/K,K>K'LCX9; 3R7=W<0-_@(^1$7*"$@\?[U1_6K5 MO_"S.Z'50R;M(O@8!%'7V=>5]5JXIA8,'-P!:Y9&6I^M3K*F;5UML4&/RQ:9 M)D7]-Z@HWU7E;F$W-DGVC^A-(\8W"J;4-DR<)44QK!@=X\A MY-=M-Y_\*!D\['SM@R[".P^]TEX;']5Y^J-^ ?Q>'@AA:UJ-/?1? MS3:(3=7Y]1Z0UK)!2%:%>NVU81XRKTI-V'(^!@NH]-5K///F6.:K,.F(D9=_ MY9KJ5"($:UAB]3.SY J^O_3< (DQ;L1%("NIEGE/RP>E[W:2J8\%VW[L?(@\ M2=-[03Q(?FPS)SV$&ZN8%(]\51+3+]>4H-5I-]R]2O4/K/".K%6G,:_!6G'4 M/74""^O>N-H)SG)L$'E!+LPS6,%Q'S3E-$Z6_FB4A>M/X*Y LL.X./7\*&NB M&+K[ H^B2K+V\2XI)JK$:^59%(V8R#2O'U8>M(7CHKAX+W0':OHV.$8!F_&3*7 -Z![(T[>#?:VHO;-T'EAB2V# MQ6K_O[R=V5J]!3MPU#I)XS,..JUD%>C^RP")2FS,2;OR?<$A##=1R*RM#[P_ M&$UTP6UB@OH$TDOQ8U4) M''9J5B703>F!DUZ%R.^75GP(=:_BGCFHP3V#8T#CZ^KR[?A)VJQD,=5A^ZC5 M2]WQ[0- JGYSR3HY>2G!^@8!JVXI?3;])PA[Z>K0:CN.HY=9 MN@F)"G5!;,;P86=>/(W\"40HH;.LIE5(L&%:7/\.TI]%SC*,/(- 3S: ?:& MLIZN*87MC%*&E_$6M]]O&#K@(/3)X=')"X4PNB5'TLFWN>T5/.K7U0/O'.:' M!K$#M_XK2"TPXF&6@B,QV$K\04,?DN$J@@W45RJ'+7;3U7GX=@9#S^,AU?#B^O!]>A3J0)A,964O=-M'[2)>/+MXY@XLSY_3RXM-P?#6ZO/CEYX.C7\4_KT<7'X5VO[P0 MROY_/PZOKDMI^8-D-JK*;=(4$.Q4''>[AP1D <\U]6%]74$$%WD^ZIG8*W__,0.3.CPRN[P9!AP._5=VAZ=N7>7L M#O;>_0CL#OTZLCOT7]D=ZG8TZ\#N8)S.76)W*%[86K [I%:V=J6YCUC$FMS\ MK^P.-6)W*!:?^K [[/I!K!&[0V(I=Y_=H7CE7R7W>=:O#O+ZRN[PTM9LM>P. MZ:W^\=@=BC>H3NP.YFZ]LCN\'+M#'0"^N-FU9&TH/B_U96WH/S-KPTZ1-A1O M6EU(&TP%MVND#8DD5YTRX5#ECKL-7KW&4T?>WQLAV<),XM+G,/#VRN?#.JW# MU"2Q)#PQRY>9%Q1^526FQR7J+5]V3*GF<3BF ;N*8CL>D]9LI[;QJ#J2?M6T MO575[G83#7.[QZUV#]9#.F9XQ1&=@X7G*KCS2JN-&NY$MWX[\2$*H8U.+&].IY869X\4.7)4*W](RC0@_IM!Y#<*(:;TK9"]Z!U4L;B^U8+C&+C M,*]2R]$D3$W%.&/6PC^7C&70 %2R!KWCQ!I,6DZ"<^K1"_$BDGI$0.=MD\FX MAJ@TO0^_OO.BM3]U%WRO3ESAM,B(PPL%%;8RK^ .=*J*Q.#;RPIM&FI> \W8 MKY]F5*0A8P#$7:X4]/K)CG^--*1BY'I9!9F6M;JL@="0:?JKIRU&4_+,/+4T MHM,[K+#>U ^$JA7F6)(D)YR7#/ZDZ=9>A/&NQ'1Z!D^#VNF9\ +$N3UYP9AS MF6M-#"[G6MOO44UX[KU6KI=I1J?CJO8A>=B (F0I?G&+^_!TW5&3Z:SO0YI. M_)CY9)S[NLSG-O*\I\RHKA.*_2_F=)PPVCE5ULU29>M[;W$G=ZI5L3[K/EF? ME6N4VRV95:A"P*;L8VJNN6]C.GQ7ED,W7?)6^6G[F@NKMK-)Z?>R"G$G5/PN M!P0/Z^?VCKVEOUYC\= HB-?1!D?Z".:VS%OT>;+!R3!,*OEYT'VI9'"Y5]10LYF,NUO_UD[]T M;[P_VF[KS]7-3TX<35-_LO+?G=677^WMRW!B,)]/'\O,\4EW]>6G,@-[UL4] MW)H3.'JYC,1)J9=?ATZ\\J;^_,&9>4&X] .Z:0I>L5I1> >5% \. !@E0%^7O EW MW+N#3DH2$UWN_D"O_[D%=7OJ#"C,>U6M[*&MK)!ZV#9\G$IIE#ZQ)'_':9V#14Y<".)U+7KFZGE<0Z[O>J8FKJ M_EOZL<3KWB>G/7H+YMU+ZW.=) M?]9M0M]A\K/_]&LE^\9&KOJ:W-B'+YTG_=KK.M,8K(D>>E+2L;9*Z"N2CO6] M*AZ?=4R+6RV\O!H%Y:675Y1X+!&3?]H55S/F5DJ\)8IT@:0 *LJQ>^ZM'R,3 M/A2K3]V5.P7& R" %*OE5@O'Z*HET@C&%%Y>Q"NQ2_%BOBSC;L@YAMW+5N" M<;\N#M7Z5#Y=S^)T%MXJ:]+KW&R]WZJL.5+_/UZT^J*,1=9_LD5V^"I0V0(% M18VO$O4$B3JJ5*)R^I,9[1S%5&)4]<(28 (4_A'0RLC_UB75L;=VYF$$%C@T MAFP9#>.2EY4D4GF92VMG)>*XVG-4OO56MYV"+"1=C)K93 U_K\ P[/R*3(DL MTI&W$DXC\$61T0.2=N]&P&,'HHI<^5@I6 Z'H M-+"FDP;6=)X76-/;#JSAH3VKWMF.!H%RVX.J$ O'WP8-T@97^9N#01"QVJ]H M:?'E7[>TY4M JY':PRJE=@ P+_&T,!#Z6ZRO,C#A3V2S+H1YQ1P^-4%]'56) M^DJNF,EWJ4DN\%8P/TIP/]1@)6'[CVLJ>XC\*2U^CX=U[1;D*[\X;^<@7R<' MM8=\5>0W]=!ORG>)2GEWVYA::8(02)*6.'W<46-K)[918S- M257QB=XCF&OZYO&)V&:K$)N6PZ;J0L1M!J<"@B/+ #P&(0@^U%\[@+)/489 MQ(6#*'CAUXJSXU%F!MTU_O+2%7[>)D:V:_$]/Q"B1Z$S(74Q'"Y(F/%A]>XP M%#'SXFGD3ZI-Y?3*I'*<;JM;6=*BEPJ6/J(NO2*14]'<)DD)-,(1@D/! 2%Q M$\_&5U P=>8!0;+)C2P&$GA4"^@M5PLD$Y^4]%YZU4S_H/8"=5 0?2];,M9O M]\E,2+>'K@/*0T%,K[ MU":"+A WGC,/%XOP/@'+VA*YZ6=%E;KIJ%*W@JA2 M90[Z23V=I!:TSQ):!-) >''IFF+,[%A%Q6SS?<^%,?F8Y%WSDKKM=O5>4AU\ M(@C^C2[R/*+/H^N+X=55[L?OA^/AY=MFWN?B2LC[R+ @\[XBG(Z\CZ8N=#3( M?ZT?ESE-U38WP0O%(*R7# 2GMHXY-70,9:#'I&C8\/&^>-/-FMVRF7!L[K E M*ECD67EFV7U(_'BV$?K.W:QOPT@,>]9,IJV2^>^2=F**(K?;KZ[8^\WE>'SY M>3AVQL,/X^'5\.)Z<#WZ-"S)]IN&9%8ZEP>)"BRFVW@L$6/WJ%OG[U^]OK9ZV=U^ZQ^KDI^P5$]7)7_G(2S!_%_ MM^OEXK__/U!+ P04 " !3, =74!:G4N@' G/P % &5X:&EB:70S M,2UQ,C(P,C,N:'1M[5MM4^,X$OY^OT('=;-#51+R IL0&*HXAMGBJFY?IJ9V M/V[)5CO685M>24[(_?I[)#DOD&07"G9@.<^'3&*UI%;WTT^WW,59:O/L_"PE M+L[_=O;W=IM]5'&54V%9K(E;$JPRLIBP7P29&]9NUU*7JIQK.4DMZW?[ _:+ MTC=RRL.XE3:C\\4Z9X?A]]FAW^0L4F)^?B;DE$GQ84^*TCX_AH>-0; M\5'2.QGUAEP<#T4T&/5_[>UA*L3#'&/G&7W8RV713LGM/Q[V2WLZD\*FXUZW M^X^].W*6;FV;9W)2C+VV&$T4SE8/QRI3>KS?]?].W4@[X;G,YN-OOLB<#/N> M9NRSRGGQ32ZN)SA:I*Q5^?@$BZ^=((8U27_](PR/<(3+J\]?KC]=7UY\N?[A M^[NG>*C^_ZF,E;GY>LY1/B6F:2IHA MUFTJ#?NIXAI R^;L,Y5*6Z8*]DGIG/6Z[9^82MAEQC6BW1+[,8MAN9,W:[G^ M3LO]DQO8"Y;)Y^RF4+.,Q(1:P8"UV82"(H4"DV(?+@O&BSFK"JLKPCE@/D^S ML"=G.7YIR3.6\!B/-%,YZ,*J(+SB!6&IP,L0*3(Q1!;P@'/FRN(M@ /B&-9KX[)($'?< M2JPCBSBK!-:$5]?,VP(BI(O5$DYQ>'(XR[(58&I?F7M; Y-"NH5;3J+*( "4 M*+C2;V>\/C$W*4LR-3,+"&F:2&,UQT;\-34[N[3D,NN%222/ST-KUF7)/W'KPAHXRK$G5@. M8G'DXGX+:>),F0KS'.5HE04WEEK%)/#8L/?PFB# (+CFZC9&/IP0NT T?ZXR M2/0&O-T[?D\'?FKO6(1?!W[[^Q" A$L@3\J>@V]?MUOYP2ZW?B0#A6%)3Y]_ M;/V68_:85^;A4QS%1@27U3L%TE:5Q@((MJDT/H0A185?QQ4SJ^!?)Q!-&;X M)C5KK_S8JLG%#4H0 70Q*I/"E_^FBHP4$AG?'4"&W.(IK7 K5<;QO4>R\H)&5>H&L!3.)978I4W,"-DH?7DB6\1.4%0">:3>!)UO':, M10_$F'0W@"+0MX,+Y)',I)V[3+)M6X=[#PKO[P#9.Z)KY8EGPMOZ0&6E2^#-^,P7 MQTH+KX O5"94(*%E@!U&J'1X=B(HP@*T@'M9@O7>-+CBG>"ZFO*L\E'N+$]) M@D)!3F$SLR7A+]/6 U@K_+Q? RSO$P 39H)R3"@U(E79W2H\A%CY4II<'97\ M<5W*HD6%YN.#@BF@C\>"V^"MXD'L)IM@Z8VRS=]5 M=GY9RPA;5LV5L7CN7GY@+1-CH=_"!96]WS$E < 0_/>D:\51TY*_=+G[6%$M M]3H(6J7<+-.GHPT/2!*>3V&/)=?-<;6ZH:R^@=V3;SW91$\&X6LOEH^?N5CV M[S'$ K^M570[LEG'T"K0'0H>D5 WRJ:E:AREDU7:+'.8?X E<]SB+='O<&FD MD"7=N)#0SR_R'D@#PO:@?_I\7W!2ZYKD21 M0(&[B[A;32P);JOSS[((GA&_I"DS"[V + M6'B6Q-?9Z:&=K\G/SR)]_KAIUI?BM40$5)%NPU49+PV-%U].P95EQN=C67B# M^TFG=X%R#.],'>$BC=:[^ W#\*KITNF&QHN%IE8L=JZ'.W[HT(K-L:-1YZ2[ M>[C;Z>T<>Z9E#[W*06U8QI2\^+ WV%M,J*-DW"]O6>]NC+C N6^<8)?0@7J9 M2/D(U/M\P"ZJ"0 1HF38\EVZ>[VGVC;/>.R7./&[_2.$H/^\V]]9GO81?NZZ MX^[]KFWJ>+*J'$.6^??,>>K[=PNCK7>U2&?^*?AQ>W4UI M9Y^[-D]W-85'@&9E-Z?L3"OKGZE>N7!"[0A5SDV;)TAS8Y[-^-SL/6<[?J],>;_GC3'W^%;P"; M_GC3'W\K_?&F/?X:X-"TQYOV^(N#L&F/-^WQICW>M,>;]GC3'F_:XTU[_%G; MXZLF3],D?V"3_$\WV5_)*JN6]\\H,=F/N&)*EP5]*@Y=\4]+=J^[XIMF>^4M M\,/PA^J'_@_D_P=02P,$% @ 4S '5R8*!V+O! BR !0 !E>&AI M8FET,S(M<3(R,#(S+FAT;>U:;6_;-A#^OE]Q<[ V!2Q;DE]BRVX SW6V%%O2 MQNZZ?1HHB;*Y4*)*4DF\7[\C)2=Q$@=-US;IYB P+!UY+\^]D0B:A(::8ADI1H&D.A6#:']S%5I^ XU:JQR)>2S1<:?-=OP7LA M3]D9*>F::4[W5WR&S?)YV+1"AJ&(E_O#F)T!BU_66!AZ/1KVXS#NQ^UVMT]Z M;K=+N]U.V.ZXW1[]TZOA5EQ>[E%ZR>G+6LHR9T&-_&#/S_7@G,5Z$7BN^T-M M;9VF%]HAG,VSP&J+U$2@;14Y$ES(8,>U?P-#<1*2,KX,GL]82A4^_3/Z T7AF*+[K M^I]FWU^%TBQ9?G$#VW<:>)A!)+*,1IJ)#,Z97H!>4'A;$(FH\R6,,CV#7+GNWT?-\=C$6:DVQIG[S!"T!.!T*FX+G.6TB$M"P_E"R! M9C&6BM=%1J'EUFU1>+;C==T!49 PCK1++:8T*B33#,TE60R3BVA!LCG%DI*F M3"FC,?Z;E;%1:T$E13VO:U9JOU*L#H=U>"TRHI$/_$2)K,-XP6B"K%&49F<4 MCI.$1:BF$?B*200&]4>NAFEE9QUP@?$9: 'I$DXS<8YZSVD=\D*J@J ;D3(M M02V-,P%4<9D2&9*,*N?X@M,EC"*+K@D@V/5Z\*XQ;8P;Z[N]5L=%[5%MM*73 M&SP@TG(2QUB5'4X3';2Z=\9>^8JA8S(=.%XO__+5[^YH]!JEO;<_9PA<%8I) MP3$N(_0%-Y%Q&2V2?BC08::3*(/H#01W"0:F!*^S&[^X=,55@%T&5^4/K]]J M(];]@8F$_RK>_KUXLPQS-R6V,F"1T 3WQ_C60K=R!F&F2N22*H-[W9 )YX#; M4"7"T2LJ1T>HNMV5L(QDD7F/#&-F69M,PU4%+]TFK%:&0,94.NH.37-%@]640,Y5SL@Q89D&UFP;KP=!!#YR9.A$1 M7DFQ DORU3FDX99G$8V:ZG@EN2(W+*FIX]NT=J_1=S>3W8:WD?:9V#:MRJ7: MB(Q")[VLM6JK#54F!'Y^ =YZ'ICDN E.B4MY*'N<;'B%,6O+*XR*.09$F0E[ M98^Z<1RKL/F,9C^&Q<]VVGL#93_7^^*EM0_PLVO,K=V+395/6N0!K@4E.(O! MF#FX![55T7Q*P'T-L!X82 AJ[:[>9,!N-?8ZUWJ3O> $?L/O/$;G:7?,)>$C MCEUWI)Q%MVG+[<=TXX]J T]WUY;V_Z0]_%Y\/Y\J\SIM4P.$LL>N0%).3.IM MG(A48MVK+23$BEWHVULV*G']?U; M]?OM9&4[6?DOXKV=K&PG*]O)RG:RLC99N>J63VF^\N2P^WIX?=*(Y3$@^92S MU6W,;@U.OIW+8[/\,4#3_@CA'U!+ 0(4 Q0 ( %,P!U=,.Z]6S+L! .*) M'0 1 " 0 !C;'9T+3(P,C,P-C,P+FAT;5!+ 0(4 Q0 M ( %,P!U>!RQ&3;1H '$P 0 1 " ?N[ 0!C;'9T+3(P M,C,P-C,P+GAS9%!+ 0(4 Q0 ( %,P!U>K81VMA"( %: 0 5 M " 9?6 0!C;'9T+3(P,C,P-C,P7V-A;"YX;6Q02P$"% ,4 " !3 M, =7[R6=207% #:L0@ %0 @ %.^0$ 8VQV="TR,#(S,#8S M,%]D968N>&UL4$L! A0#% @ 4S '5\$!=$BZM $ "?T1 !4 M ( !AKX" &-L=G0M,C R,S V,S!?;&%B+GAM;%!+ 0(4 Q0 ( %,P M!U

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